hgnc_symbol	description	keep_in_list	comments	ensembl_gene_ids	uniprot_gn_ids	Protein.families	consensus_score	generic_categories	all_categories	receptor_uniprot	receptor_symbol	receptor_references	GO_cellular_component	GO_molecular_function	GO_biological_process	genecards_url	islet_tpm	islet_tpm_rank	islet_proteomics	islet_proteomics_rank	islet_specificity	islet_specificity_rank	Immune	Duct	Endothelial	Pericytes	Acinar	INS/SST	INS/GCG	PPY	Delta	Beta	Alpha	delta_rank	beta_rank	alpha_rank	mean_scRNAseq	delta_specificity	beta_specificity	alpha_specificity	delta_specificity_rank	beta_specificity_rank	alpha_specificity_rank	Islet, Beta Rank of Ranks
INHBA	inhibin subunit beta A	Yes		ENSG00000122641	P08476	TGF-beta family	21	ligand	extracellular, intracellular, ligand, ligand_regulator, secreted	P17813, P27037, P36896, P61160, P84022, Q03167, Q04771, Q13145, Q13705, Q8NER5	ACTR2, ACVR1, ACVR1_ACVR2A, ACVR1_ACVR2B, ACVR1B, ACVR1B_ACVR2A, ACVR1B_ACVR2B, ACVR1C, ACVR1C_ACVR2A, ACVR1C_ACVR2B, ACVR2A, ACVR2B, BAMBI, ENG, SMAD3, TGFBR3	ACVR2B [Baccin2019:9202237;CellTalkDB:9202237;HPRD:9202237;LRdb:9202237;SIGNOR:8622651;SignaLink3:16446785;SignaLink3:23331499;connectomeDB2020:9202237], ACTR2 [SignaLink3:16446785;SignaLink3:23331499], ACVR2A [Baccin2019:11266510;Baccin2019:12466190;BioGRID:10746731;CellTalkDB:12466190;DIP:9605406;HPMR:12466190;HPRD:11266516;LRdb:11;LRdb:12466190;SIGNOR:1646080;connectomeDB2020:11266516;connectomeDB2020:12466190], ACVR1B [Baccin2019:81675688397373;CellTalkDB:8167568;DIP:7890768;DIP:9605406;HPMR:8167568;HPRD:8397373;LRdb:8167568;LRdb:84;connectomeDB2020:8167568;connectomeDB2020:8397373], ACVR1C [connectomeDB2020:15196700], ACVR1 [CellTalkDB:11266516;HPRD:11266516;LRdb:11266516;connectomeDB2020:11266516], ENG [Baccin2019:9872992;CellTalkDB:9872992;HPRD:9872992;LRdb:9872992;connectomeDB2020:9872992], SMAD3 [CellTalkDB:32196115], BAMBI [CellTalkDB:10918299;HPMR:10918299;LRdb:10918299;connectomeDB2020:10918299], TGFBR3 [Baccin2019:10746731;CellTalkDB:10746731;Cellinker:10746731;HPRD:10746731;LRdb:10746731;connectomeDB2020:10746731]	activin A complex [GO:0043509]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; inhibin A complex [GO:0043512]; perinuclear region of cytoplasm [GO:0048471]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; inhibin binding [GO:0034711]; peptide hormone binding [GO:0017046]; protein-containing complex binding [GO:0044877]; type II activin receptor binding [GO:0070699]	activin receptor signaling pathway [GO:0032924]; cell-cell signaling [GO:0007267]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; cellular response to cholesterol [GO:0071397]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; defense response [GO:0006952]; endodermal cell differentiation [GO:0035987]; erythrocyte differentiation [GO:0030218]; extrinsic apoptotic signaling pathway [GO:0097191]; eyelid development in camera-type eye [GO:0061029]; GABAergic neuron differentiation [GO:0097154]; hair follicle development [GO:0001942]; hematopoietic progenitor cell differentiation [GO:0002244]; hemoglobin biosynthetic process [GO:0042541]; male gonad development [GO:0008584]; mesodermal cell differentiation [GO:0048333]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of follicle-stimulating hormone secretion [GO:0046882]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of phosphorylation [GO:0042326]; nervous system development [GO:0007399]; odontogenesis [GO:0042476]; ovarian follicle development [GO:0001541]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of gene expression [GO:0010628]; positive regulation of ovulation [GO:0060279]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone secretion [GO:0042701]; regulation of follicle-stimulating hormone secretion [GO:0046880]; regulation of transcription by RNA polymerase II [GO:0006357]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; SMAD protein signal transduction [GO:0060395]; striatal medium spiny neuron differentiation [GO:0021773]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=INHBA&keywords=INHBA	64.60	67	NA	NA	23.51	26	1.77	0.10	0.02	17.22	0.07	0.58	0.73	0.34	0.42	0.43	0.70	44	51	34	2.03	0.21	0.21	0.35	431	408	375	138
IL11	interleukin 11	Yes		ENSG00000095752	P20809	IL-6 superfamily	21	ligand	extracellular, intracellular, ligand, secreted	P08887, P40189, Q14626	IL11RA, IL11RA_IL6ST, IL6R, IL6ST	IL11RA [Baccin2019:10504396;Baccin2019:10948192;Baccin2019:7670098;CellTalkDB:10948192;DIP:8940087;HPMR:10948192;HPRD:10504396;HPRD:7670098;InnateDB:8940087;LRdb:10504396;LRdb:10948192;LRdb:7670098;Lit-BM-17:26551460;Lit-BM-17:8940087;SIGNOR:10948192;SignaLink3:12740032;SignaLink3:23331499;connectomeDB2020:10504396;connectomeDB2020:10948192;connectomeDB2020:7670098], IL6ST [Baccin2019:10948192;CellTalkDB:10948192;DIP:8360477;HPMR:10948192;InnateDB:9560294;LRdb:10948192;SIGNOR:9143707;connectomeDB2020:10948192], IL6R [Cellinker:26551279]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-11 receptor binding [GO:0005142]	B cell differentiation [GO:0030183]; fat cell differentiation [GO:0045444]; megakaryocyte differentiation [GO:0030219]; negative regulation of hormone secretion [GO:0046888]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL11&keywords=IL11	91.42	53	NA	NA	98.35	10	0.05	0.13	0.01	6.43	0.05	0.13	0.04	0.24	0.38	0.08	0.05	51	119	150	0.69	0.56	0.13	0.09	323	454	481	159
VEGFB	vascular endothelial growth factor B	Yes		ENSG00000173511	P49765	PDGF/VEGF growth factor family	21	ligand	extracellular, intracellular, ligand, secreted	O14786, P07550, P07949, P17948, P35968, Q06418	ADRB2, FLT1, FLT1_KDR, KDR, NRP1, RET, TYRO3	FLT1 [Baccin2019:9751730;Baccin2019:97517301;BioGRID:10409677;CellChatDB:16633338;CellTalkDB:9751730;Cellinker:9751730;HPRD:9751730;ICELLNET:11181169;ICELLNET:26285753;LRdb:97517301;LRdb:98;ProtMapper:29397867;SignaLink3:10409677;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:9751730;connectomeDB2020:9751730;connectomeDB2020:97517301], NRP1 [Baccin2019:40967710409677;CellTalkDB:10409677;Cellinker:10409677;Cellinker:409677;HPRD:10409677;ICELLNET:11181169;LRdb:1041;LRdb:409677;connectomeDB2020:10409677;connectomeDB2020:409677], RET [CellTalkDB:32196115], TYRO3 [NA], KDR [Cellinker:27834687], ADRB2 [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]	chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; vascular endothelial growth factor receptor 1 binding [GO:0043183]; vascular endothelial growth factor receptor binding [GO:0005172]	cardiac muscle contraction [GO:0060048]; coronary vasculature development [GO:0060976]; induction of positive chemotaxis [GO:0050930]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular wound healing [GO:0035470]; protein O-linked glycosylation [GO:0006493]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=VEGFB&keywords=VEGFB	37.44	113	NA	NA	0.27	482	0.06	0.08	0.04	0.15	0.08	0.42	0.39	0.18	0.25	0.29	0.09	69	64	116	0.19	1.35	1.55	0.52	68	47	316	177
LIF	LIF interleukin 6 family cytokine	Yes		ENSG00000128342	P15018	LIF/OSM family	21	ligand	extracellular, intracellular, ligand, secreted	P40189, P42702	IL6ST, IL6ST_LIFR, LIFR	LIFR [Baccin2019:12601009;Baccin2019:16051226;Baccin2019:9716487;CellTalkDB:12601009;DIP:8662595;DIP:8999038;DIP:9852103;DOMINO:16051226;HPMR:9716487;HPRD:12601009;HPRD:16051226;LRdb:12601009;LRdb:16051226;LRdb:9716487;SIGNOR:16051226;SIGNOR:24710148;SIGNOR:9143707;SignaLink3:10428964;SignaLink3:11306493;SignaLink3:12601009;SignaLink3:16051226;SignaLink3:19833085;SignaLink3:21840487;SignaLink3:22595692;SignaLink3:23331499;SignaLink3:24857661;SignaLink3:26192618;SignaLink3:7512720;SignaLink3:7521688;connectomeDB2020:12601009;connectomeDB2020:16051226;connectomeDB2020:9716487], IL6ST [Baccin2019:971648712707269;CellTalkDB:9716487;DOMINO:16051226;HPMR:9716487;HPRD:12707269;IntAct:14527405;IntAct:16051226;LRdb:127;LRdb:9716487;Lit-BM-17:14527405;Lit-BM-17:16051226;ProtMapper:10811661;SIGNOR:9143707;connectomeDB2020:12707269;connectomeDB2020:9716487]	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; leukemia inhibitory factor receptor binding [GO:0005146]; signaling receptor binding [GO:0005102]	blood vessel remodeling [GO:0001974]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; immune response [GO:0006955]; leukemia inhibitory factor signaling pathway [GO:0048861]; lung alveolus development [GO:0048286]; lung lobe morphogenesis [GO:0060463]; lung vasculature development [GO:0060426]; multicellular organism development [GO:0007275]; muscle organ morphogenesis [GO:0048644]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of hormone secretion [GO:0046888]; negative regulation of meiotic nuclear division [GO:0045835]; neuron development [GO:0048666]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 acetylation [GO:1901676]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of cell differentiation [GO:0045595]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; spongiotrophoblast differentiation [GO:0060708]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; trophoblast giant cell differentiation [GO:0060707]; tyrosine phosphorylation of STAT protein [GO:0007260]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LIF&keywords=LIF	51.52	83	NA	NA	14.78	35	0.01	0.15	0.00	0.65	0.02	0.01	0.01	0.01	0.02	0.00	0.00	243	310	318	0.08	0.31	0.15	0.14	405	444	451	218
TGFB1	transforming growth factor beta 1	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000105329	P01137	TGF-beta family	21	ecm, ligand, receptor	ecm, extracellular, intracellular, ligand, receptor, secreted	O15105, P00533, P02458, P04004, P05067, P05106, P05556, P06756, P07585, P07996, P08253, P09486, P12643, P14780, P17813, P18084, P18564, P21810, P26012, P27986, P29279, P34741, P35228, P36897, P37023, P37173, P61073, P61812, P63151, P84022, Q03135, Q03167, Q06710, Q6EMK4, Q6YHK3, Q93052	ACVR1_TGFBR1, ACVR1_TGFBR1_TGFBR2, ACVR1_TGFBR2, ACVR1B_TGFBR2, ACVR1C_TGFBR2, ACVRL1, APP, BGN, BMP2, CAV1, CCN2, CD109, COL2A1, CXCR4, DCN, EGFR, ENG, ITGAV, ITGAV_ITGB1, ITGAV_ITGB3, ITGAV_ITGB5, ITGAV_ITGB6, ITGAV_ITGB8, ITGB1, ITGB3, ITGB5, ITGB6, ITGB8, LPP, MMP2, MMP9, NOS2, PAX8, PIK3CA_PIK3R1, PIK3R1, PPP2R2A, SDC2, SMAD3, SMAD7, SPARC, TGFB2, TGFBR1, TGFBR1_TGFBR2, TGFBR2, TGFBR3, THBS1, VASN, VTN	NOS2 [SPIKE:10362813], APP [HPRD:12867422;HPRD:2119582;IntAct:2119582;IntAct:25241761;Lit-BM-17:2119582;Lit-BM-17:25241761;SPIKE:12867422;SPIKE:16189514], TGFBR2 [Baccin2019:10716993;Baccin2019:12809600;Baccin2019:7935686;CancerCellMap:11382746;CancerCellMap:12729750;CancerCellMap:8106553;CellTalkDB:10716993;DIP:10026191;DIP:7706250;DIP:7878020;DIP:9261125;HPMR:10716993;HPMR:12809600;HPRD:7935686;InnateDB:15034927;InnateDB:18382895;IntAct:20856203;IntAct:20860622;IntAct:21054789;IntAct:21441952;LRdb:10716993;LRdb:12809600;LRdb:7935686;Lit-BM-17:10026191;Lit-BM-17:11157754;Lit-BM-17:20860622;Lit-BM-17:21054789;Lit-BM-17:7706250;Lit-BM-17:7878020;Lit-BM-17:8242742;Lit-BM-17:9261125;NetPath:11323414;NetPath:1333888;NetPath:8047140;SIGNOR:1310899;SIGNOR:26194464;SPIKE:11382746;SPIKE:7852346;SignaLink3:10678166;SignaLink3:11013220;SignaLink3:11133108;SignaLink3:11157754;SignaLink3:11274345;SignaLink3:11278410;SignaLink3:11279127;SignaLink3:11792802;SignaLink3:12154066;SignaLink3:12717440;SignaLink3:12724770;SignaLink3:12738796;SignaLink3:12767520;SignaLink3:12809600;SignaLink3:14557817;SignaLink3:15003992;SignaLink3:15099563;SignaLink3:15265520;SignaLink3:15282297;SignaLink3:15548370;SignaLink3:15653932;SignaLink3:15761148;SignaLink3:15761153;SignaLink3:16127449;SignaLink3:16200688;SignaLink3:16424049;SignaLink3:16446785;SignaLink3:16474430;SignaLink3:16572188;SignaLink3:17070508;SignaLink3:17404308;SignaLink3:17673906;SignaLink3:17768418;SignaLink3:17934056;SignaLink3:17979848;SignaLink3:18423981;SignaLink3:18490733;SignaLink3:18758450;SignaLink3:18855897;SignaLink3:18922473;SignaLink3:19010789;SignaLink3:19038247;SignaLink3:19050695;SignaLink3:19109155;SignaLink3:19732719;SignaLink3:19747910;SignaLink3:19920116;SignaLink3:20060931;SignaLink3:20519943;SignaLink3:20538542;SignaLink3:20616810;SignaLink3:20644162;SignaLink3:21041659;SignaLink3:21071413;SignaLink3:21098712;SignaLink3:21278795;SignaLink3:21372296;SignaLink3:21614932;SignaLink3:21900405;SignaLink3:22315516;SignaLink3:22703233;SignaLink3:22710166;SignaLink3:22874531;SignaLink3:22943793;SignaLink3:22949611;SignaLink3:23034983;SignaLink3:23070005;SignaLink3:23331499;SignaLink3:23784029;SignaLink3:24132110;SignaLink3:24336330;SignaLink3:24403530;SignaLink3:26192618;SignaLink3:26201938;SignaLink3:26966341;SignaLink3:2871107;SignaLink3:7594497;SignaLink3:8515656;SignaLink3:9311995;SignaLink3:9865696;connectomeDB2020:10716993;connectomeDB2020:12809600;connectomeDB2020:7935686], TGFBR3 [Baccin2019:7935686;CellTalkDB:7935686;Cellinker:7935686;DIP:10519421;DIP:11323414;DIP:9312157;HPRD:7935686;LRdb:7935686;Lit-BM-17:10519421;Lit-BM-17:11323414;Lit-BM-17:8106553;Lit-BM-17:9312157;NetPath:11278442;NetPath:11323414;SPIKE:11278442;SPIKE:8106553;connectomeDB2020:7935686], TGFBR1 [Baccin2019:12809600;Baccin2019:8235612;BioGRID:8235612;CellTalkDB:12809600;DIP:10187774;DIP:7706250;HPMR:12809600;HPRD:8235612;LRdb:12809600;LRdb:82;NetPath:11323414;NetPath:8047140;SIGNOR:22326956;SIGNOR:22703233;SIGNOR:26194464;SPIKE:7852346;connectomeDB2020:12809600;connectomeDB2020:8235612], ITGB8 [CellTalkDB:11970960;Cellinker:11970960;ELM:12415008;ELM:22278742;ELM:25383667;ELM:25617764;ELM:27033701;ELM:28117447;ELM:31792290;ELM:31955848;HPRD:11970960;LRdb:11970960;connectomeDB2020:11970960], ITGB6 [CellTalkDB:10025398;Cellinker:10025398;ELM:12415008;ELM:22278742;ELM:25383667;ELM:25617764;ELM:27033701;ELM:28117447;ELM:31792290;ELM:31955848;HPRD:10025398;LRdb:10025398;connectomeDB2020:10025398], MMP2 [HPRD:10652271;Lit-BM-17:10652271;Lit-BM-17:25241761], MMP9 [Lit-BM-17:10652271;Lit-BM-17:25241761], PIK3R1 [SIGNOR:19114990], PPP2R2A [SIGNOR:19114990], PAX8 [SIGNOR:14623893], ENG [Baccin2019:12015308;CellTalkDB:12015308;Cellinker:12015308;Cellinker:9872992;HPRD:12015308;InnateDB:8655583;LRdb:12015308;connectomeDB2020:12015308], EGFR [CellTalkDB:32103204;ProtMapper:19132220;ProtMapper:20953304;ProtMapper:28943431], SMAD3 [CellTalkDB:32196115;ProtMapper:21557273;ProtMapper:24075003;ProtMapper:24485922;ProtMapper:24899689;ProtMapper:28756206], ITGB3 [CellTalkDB:32196115;ELM:12415008;ELM:22278742;ELM:25383667;ELM:25617764;ELM:27033701;ELM:28117447;ELM:31792290;ELM:31955848], ACVRL1 [Baccin2019:1071699310716990;CellTalkDB:10716993;Cellinker:10716993;DIP:10187774;HPMR:10716993;HPRD:10716993;InnateDB:18333754;LRdb:10716993;NetPath:10716993;connectomeDB2020:10716993], ITGAV [CellTalkDB:11970960;Cellinker:11970960;ELM:12415008;ELM:22278742;ELM:25383667;ELM:25617764;ELM:27033701;ELM:28117447;ELM:31792290;ELM:31955848;HPRD:11970960;LRdb:11970960;connectomeDB2020:11970960], ITGB1 [CellTalkDB:12415008;ELM:12415008;ELM:22278742;ELM:25383667;ELM:25617764;ELM:27033701;ELM:28117447;ELM:31792290;ELM:31955848;ProtMapper:19115199], CAV1 [CellTalkDB:32196115], SDC2 [Baccin2019:14976204;CancerCellMap:14976204;CellTalkDB:14976204;Cellinker:14976204;HPRD:14976204;LRdb:14976204;NetPath:14976204;connectomeDB2020:14976204], CXCR4 [Baccin2019:27314628;CellTalkDB:32196115], ITGB5 [CellTalkDB:32196115], VASN [HPRD:15247411;connectomeDB2020:15247411;connectomeDB2020:21170088], CD109 [NA], DCN [BioGRID:7798269;BioGRID:8093006;BioGRID:9675033;Cellinker:23350913;HPRD:7638106;HPRD:7798269], LPP [Cellinker:23447672], SMAD7 [ACSN:11133108;ACSN:14557817;ACSN:15548370;ACSN:16474430;ACSN:17934056;ACSN:19010789;ACSN:19920116;ACSN:20519943;ACSN:21900405;ACSN:9335507;NetPath:14718519], SPARC [HPRD:15034927], THBS1 [HPRD:1550960], TGFB2 [HPRD:11157754], VTN [HPRD:11796824], BGN [HPRD:10383378;HPRD:8093006], BMP2 [HPRD:11456401], COL2A1 [HPRD:10085302], CCN2 [HPRD:10457363]	blood microparticle [GO:0072562]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; transforming growth factor beta complex [GO:0099126]; transforming growth factor beta ligand-receptor complex [GO:0070021]	antigen binding [GO:0003823]; cytokine activity [GO:0005125]; enzyme binding [GO:0019899]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; type III transforming growth factor beta receptor binding [GO:0034714]; type II transforming growth factor beta receptor binding [GO:0005114]; type I transforming growth factor beta receptor binding [GO:0034713]	aortic valve morphogenesis [GO:0003180]; ATP biosynthetic process [GO:0006754]; BMP signaling pathway [GO:0030509]; cell-cell junction organization [GO:0045216]; cell migration [GO:0016477]; cellular response to organic cyclic compound [GO:0071407]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chondrocyte differentiation [GO:0002062]; common-partner SMAD protein phosphorylation [GO:0007182]; connective tissue replacement involved in inflammatory response wound healing [GO:0002248]; embryonic liver development [GO:1990402]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial to mesenchymal transition [GO:0001837]; extracellular matrix assembly [GO:0085029]; extrinsic apoptotic signaling pathway [GO:0097191]; heart development [GO:0007507]; heart valve morphogenesis [GO:0003179]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaluronan catabolic process [GO:0030214]; inflammatory response [GO:0006954]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lymph node development [GO:0048535]; macrophage derived foam cell differentiation [GO:0010742]; MAPK cascade [GO:0000165]; membrane protein intracellular domain proteolysis [GO:0031293]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytolysis [GO:0045918]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix disassembly [GO:0010716]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of gene silencing by miRNA [GO:0060965]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; ossification involved in bone remodeling [GO:0043932]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of chemotaxis [GO:0050921]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of microglia differentiation [GO:0014008]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein secretion [GO:0050714]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular permeability [GO:0043117]; protein export from nucleus [GO:0006611]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; regulation of binding [GO:0051098]; regulation of blood vessel remodeling [GO:0060312]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of DNA binding [GO:0051101]; regulation of protein import into nucleus [GO:0042306]; regulation of SMAD protein signal transduction [GO:0060390]; regulation of striated muscle tissue development [GO:0016202]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to cholesterol [GO:0070723]; response to estradiol [GO:0032355]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; salivary gland morphogenesis [GO:0007435]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transforming growth factor beta receptor signaling pathway involved in heart development [GO:1905313]; vasculogenesis [GO:0001570]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TGFB1&keywords=TGFB1	25.68	149	NA	NA	0.45	401	0.05	0.03	0.24	0.76	0.07	0.21	0.14	0.04	0.12	0.12	0.02	110	95	201	0.16	0.74	0.77	0.18	244	227	431	218
IL6	interleukin 6	Yes		ENSG00000136244	P05231	IL-6 superfamily	21	ligand	extracellular, intracellular, ligand, secreted	O15146, O75015, P01023, P02741, P08887, P12272, P13726, P35367, P40189	A2M, CRP, F3, FCGR3B, HRH1, IL6_IL6R_IL6ST, IL6R, IL6R_IL6ST, IL6ST, MUSK, PTHLH	IL6ST [Baccin2019:14557255;Baccin2019:3136546;Baccin2019:8293462;CellTalkDB:14557255;DIP:11251120;DIP:7744001;Guide2Pharma:1995637;HPMR:15895091;HPMR:3136546;HPRD:14557255;InnateDB:15895091;LRdb:14557255;LRdb:3136546;LRdb:8293462;Lit-BM-17:11251120;Lit-BM-17:12829785;Lit-BM-17:18775332;Lit-BM-17:7744001;NetPath:2788034;SIGNOR:15895091;SPIKE:15895091;SPIKE:19715447;connectomeDB2020:14557255;connectomeDB2020:3136546;connectomeDB2020:8293462;scConnect:1995637], IL6R [AlzPathway:18067990;Baccin2019:12829785;Baccin2019:14557255;Baccin2019:3136546;BioGRID:14557255;BioGRID:2788034;CellTalkDB:12829785;DIP:7744001;DIP:8702737;DIP:9028955;DIP:9694899;Guide2Pharma:1995637;HPMR:15895091;HPMR:3136546;HPRD:12829785;HPRD:14557255;InnateDB:14557255;InnateDB:14656210;InnateDB:15895091;InnateDB:7744875;InnateDB:8706672;InnateDB:9694899;IntAct:11238858;IntAct:28265003;LRdb:12829785;LRdb:14557255;LRdb:3136546;Lit-BM-17:12643274;Lit-BM-17:12829785;Lit-BM-17:14557255;Lit-BM-17:18775332;Lit-BM-17:2788034;Lit-BM-17:7744001;Lit-BM-17:8702737;Lit-BM-17:9028955;Lit-BM-17:9694899;NetPath:2788034;NetPath:7893704;SIGNOR:15895091;SIGNOR:18923185;SIGNOR:23663276;SIGNOR:8676083;SignaLink3:11238858;SignaLink3:12643274;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:2788034;connectomeDB2020:12829785;connectomeDB2020:14557255;connectomeDB2020:3136546;scConnect:1995637], F3 [CellTalkDB:32196115], HRH1 [CellTalkDB:32103204], MUSK [Cellinker:32822567], FCGR3B [Cellinker:32822567], CRP [InnateDB:14656210], A2M [InnateDB:9780213], PTHLH [HPRD:12000745]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-6 receptor complex [GO:0005896]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-6 receptor binding [GO:0005138]	acute-phase response [GO:0006953]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; endocrine pancreas development [GO:0031018]; germinal center B cell differentiation [GO:0002314]; glucagon secretion [GO:0070091]; glucose homeostasis [GO:0042593]; hepatic immune response [GO:0002384]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; interleukin-6-mediated signaling pathway [GO:0070102]; liver regeneration [GO:0097421]; maintenance of blood-brain barrier [GO:0035633]; monocyte chemotaxis [GO:0002548]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine production [GO:0032682]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of lipid storage [GO:0010888]; negative regulation of neurogenesis [GO:0050768]; negative regulation of primary miRNA processing [GO:2000635]; neuron cellular homeostasis [GO:0070050]; neuron projection development [GO:0031175]; neutrophil apoptotic process [GO:0001781]; neutrophil mediated immunity [GO:0002446]; platelet activation [GO:0030168]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell activation [GO:0050871]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-21 production [GO:0032745]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of angiogenesis [GO:0045765]; regulation of astrocyte activation [GO:0061888]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of microglial cell activation [GO:1903978]; regulation of neuroinflammatory response [GO:0150077]; regulation of vascular endothelial growth factor production [GO:0010574]; response to activity [GO:0014823]; response to glucocorticoid [GO:0051384]; response to peptidoglycan [GO:0032494]; T follicular helper cell differentiation [GO:0061470]; T-helper 17 cell lineage commitment [GO:0072540]; vascular endothelial growth factor production [GO:0010573]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL6&keywords=IL6	43.55	99	NA	NA	9.44	47	0.00	0.01	0.00	1.31	0.04	0.00	0.00	0.00	0.00	0.00	0.00	300	352	336	0.12	0.08	0.09	0.09	486	476	479	244
TGFB2	transforming growth factor beta 2	Yes		ENSG00000092969	P61812	TGF-beta family	21	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	P01137, P10600, P17813, P29279, P36897, P37173, Q03167, Q04771	ACVR1, ACVR1_TGFBR1, ACVR1_TGFBR1_TGFBR2, ACVR1_TGFBR2, ACVR1B_TGFBR2, ACVR1C_TGFBR2, CCN2, ENG, TGFB1, TGFB3, TGFBR1, TGFBR1_TGFBR2, TGFBR2, TGFBR3	TGFBR2 [Baccin2019:11157754;Baccin2019:12809600;Baccin2019:8106553;CellTalkDB:11157754;HPMR:12809600;HPRD:11157754;HPRD:8106553;LRdb:11157754;LRdb:12809600;LRdb:8106553;NetPath:12729750;SIGNOR:11157754;SIGNOR:1310899;SignaLink3:11157754;SignaLink3:16446785;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:11157754;connectomeDB2020:12809600;connectomeDB2020:8106553], TGFBR1 [Baccin2019:11157750;Baccin2019:12809600;CellTalkDB:12809600;DIP:10187774;HPMR:12809600;HPRD:11157754;LRdb:11;LRdb:12809600;NetPath:7608141;SIGNOR:22326956;connectomeDB2020:11157754;connectomeDB2020:12809600], TGFBR3 [Baccin2019:11157750;Baccin2019:12809600;CellTalkDB:12809600;Cellinker:11157754;Cellinker:12809600;DIP:10519421;DIP:8041735;DIP:9312157;HPMR:12809600;HPRD:11157754;LRdb:11;LRdb:12809600;NetPath:11278442;SIGNOR:10746731;connectomeDB2020:11157754;connectomeDB2020:12809600], ENG [Baccin2019:12015308;CellTalkDB:12015308;Cellinker:12015308;HPRD:12015308;LRdb:12015308;connectomeDB2020:12015308], ACVR1 [Baccin2019:21102460;CellTalkDB:32196115;connectomeDB2020:21102460], TGFB1 [HPRD:11157754], TGFB3 [HPRD:11157754], CCN2 [HPRD:10457363]	axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; platelet alpha granule lumen [GO:0031093]; transforming growth factor beta complex [GO:0099126]	amyloid-beta binding [GO:0001540]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; transforming growth factor beta receptor binding [GO:0005160]; type III transforming growth factor beta receptor binding [GO:0034714]; type II transforming growth factor beta receptor binding [GO:0005114]	activation of protein kinase activity [GO:0032147]; ascending aorta morphogenesis [GO:0035910]; atrial septum morphogenesis [GO:0060413]; atrial septum primum morphogenesis [GO:0003289]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell proliferation [GO:0060038]; cardiac right ventricle morphogenesis [GO:0003215]; cardioblast differentiation [GO:0010002]; cell-cell junction organization [GO:0045216]; cell death [GO:0008219]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; collagen fibril organization [GO:0030199]; cranial skeletal system development [GO:1904888]; dopamine biosynthetic process [GO:0042416]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic digestive tract development [GO:0048566]; embryonic limb morphogenesis [GO:0030326]; endocardial cushion fusion [GO:0003274]; endocardial cushion morphogenesis [GO:0003203]; epithelial to mesenchymal transition [GO:0001837]; extrinsic apoptotic signaling pathway [GO:0097191]; eye development [GO:0001654]; generation of neurons [GO:0048699]; glial cell migration [GO:0008347]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; hemopoiesis [GO:0030097]; inner ear development [GO:0048839]; kidney development [GO:0001822]; male gonad development [GO:0008584]; membranous septum morphogenesis [GO:0003149]; negative regulation of alkaline phosphatase activity [GO:0010693]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905006]; negative regulation of gene expression [GO:0010629]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of Ras protein signal transduction [GO:0046580]; neural retina development [GO:0003407]; neural tube closure [GO:0001843]; neuron development [GO:0048666]; neutrophil chemotaxis [GO:0030593]; odontogenesis [GO:0042476]; outflow tract septum morphogenesis [GO:0003148]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell division [GO:0051781]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of heart contraction [GO:0045823]; positive regulation of immune response [GO:0050778]; positive regulation of integrin biosynthetic process [GO:0045726]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of ossification [GO:0045778]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein secretion [GO:0050714]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of timing of catagen [GO:0051795]; protein phosphorylation [GO:0006468]; pulmonary valve morphogenesis [GO:0003184]; regulation of apoptotic process involved in outflow tract morphogenesis [GO:1902256]; regulation of cell population proliferation [GO:0042127]; regulation of timing of catagen [GO:0051794]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; salivary gland morphogenesis [GO:0007435]; secondary palate development [GO:0062009]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; somatic stem cell division [GO:0048103]; substantia propria of cornea development [GO:1903701]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterine wall breakdown [GO:0042704]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TGFB2&keywords=TGFB2	12.39	214	NA	NA	3.05	110	0.05	0.22	0.01	0.13	0.01	0.00	0.00	0.00	0.01	0.00	0.00	285	371	378	0.04	0.32	0.23	0.22	401	403	413	275
BMP2	bone morphogenetic protein 2	Yes		ENSG00000125845	P12643	TGF-beta family	21	ligand	extracellular, intracellular, ligand, secreted, transmembrane	O00238, O60565, P08493, P17813, P27037, P35052, P36894, P37023, P61160, Q04771, Q13705, Q13873, Q6NW40, Q6ZVN8, Q99835, Q9H2X0	ACTR2, ACVR1, ACVR2A, ACVR2A_BMPR1A, ACVR2A_BMPR1B, ACVR2B, ACVR2B_BMPR1A, ACVR2B_BMPR1B, ACVRL1, BMPR1A, BMPR1A_BMPR1B_BMPR2, BMPR1A_BMPR2, BMPR1B, BMPR1B_BMPR2, BMPR2, CHRD, ENG, GPC1, GREM1, HJV, MGP, RGMB, SMO	BMPR2 [Baccin2019:10880440;Baccin2019:11263668;DIP:10880444;DIP:25938661;HPRD:10880444;InnateDB:17295905;InnateDB:18342887;LRdb:11;LRdb:11263668;Lit-BM-17:10712517;Lit-BM-17:10880444;Lit-BM-17:7791754;SIGNOR:7791754;SignaLink3:16446785;SignaLink3:17295905;SignaLink3:18342887;SignaLink3:23180781;SignaLink3:23331499;connectomeDB2020:10880444;connectomeDB2020:11263668], ACVR2B [Baccin2019:15064755;CellTalkDB:20385559;HPRD:15064755;InnateDB:17295905;LRdb:15064755;SignaLink3:15064755;SignaLink3:16446785;SignaLink3:18988627;SignaLink3:23331499;connectomeDB2020:28977600], ACTR2 [SignaLink3:16446785;SignaLink3:23331499], BMPR1B [Baccin2019:12700180;Baccin2019:15064755;Baccin2019:7811286;Baccin2019:9872992;HPMR:12700180;HPRD:15064755;HPRD:7811286;HPRD:9872992;LRdb:12700180;LRdb:15064755;LRdb:7811286;LRdb:9872992;Lit-BM-17:10712517;Lit-BM-17:19229295;connectomeDB2020:12700180;connectomeDB2020:15064755;connectomeDB2020:7811286;connectomeDB2020:9872992], ACVR2A [Baccin2019:20959140;CellTalkDB:21702718;DIP:10880444;DIP:25938661;InnateDB:17295905;InnateDB:17483092;Ramilowski2015:21702718;connectomeDB2020:21702718;talklr:21702718], BMPR1A [Baccin2019:10692589;Baccin2019:10881198;Baccin2019:11263668;Baccin2019:12700180;Baccin2019:15064755;BioGRID:10692589;BioGRID:11263668;CellTalkDB:15621726;DIP:10880444;DIP:10881198;DIP:11263668;DIP:16672363;DIP:25938661;HPMR:12700180;HPRD:10692589;HPRD:10881198;HPRD:11263668;HPRD:15064755;InnateDB:16672363;InnateDB:17483092;InnateDB:18937504;IntAct:10881198;IntAct:15064755;IntAct:16672363;IntAct:19804412;IntAct:20860622;IntAct:21054789;IntAct:25938661;LRdb:10692589;LRdb:10881198;LRdb:11263668;LRdb:12700180;LRdb:15064755;Lit-BM-17:10692589;Lit-BM-17:10712517;Lit-BM-17:10880444;Lit-BM-17:10881198;Lit-BM-17:11263668;Lit-BM-17:15064755;Lit-BM-17:19804412;Lit-BM-17:20860622;Lit-BM-17:21054789;SIGNOR:18937504;SIGNOR:26330344;connectomeDB2020:10692589;connectomeDB2020:10881198;connectomeDB2020:11263668;connectomeDB2020:12700180;connectomeDB2020:15064755], ACVRL1 [NA], ACVR1 [Baccin2019:8006002;CellTalkDB:28977600;HPRD:8006002;LRdb:8006002], SMO [CellTalkDB:32103204], GPC1 [CellTalkDB:23624389], HJV [CellTalkDB:18287331;Cellinker:18287331;DIP:25938661;LRdb:18287331;Ramilowski2015:18287331;connectomeDB2020:18287331;talklr:18287331], ENG [Baccin2019:9872992;CellTalkDB:9872992;Cellinker:9872992;HPRD:9872992;LRdb:9872992;connectomeDB2020:9872992], RGMB [DIP:25938661;IntAct:25938661;connectomeDB2020:15671031], GREM1 [Cellinker:29317497;HPRD:15064755], MGP [HPRD:11741887], CHRD [HPRD:15064755]	BMP receptor complex [GO:0070724]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]	BMP receptor binding [GO:0070700]; co-receptor binding [GO:0039706]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; phosphatase activator activity [GO:0019211]; protein serine/threonine kinase activator activity [GO:0043539]; signaling receptor binding [GO:0005102]; SMAD binding [GO:0046332]	animal organ morphogenesis [GO:0009887]; aortic valve development [GO:0003176]; atrioventricular canal morphogenesis [GO:1905222]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; BMP signaling pathway involved in heart development [GO:0061312]; BMP signaling pathway involved in heart induction [GO:0003130]; bone mineralization [GO:0030282]; bone mineralization involved in bone maturation [GO:0035630]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac atrium formation [GO:0003210]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac jelly development [GO:1905072]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiocyte differentiation [GO:0035051]; cell-cell signaling [GO:0007267]; cell fate commitment [GO:0045165]; cellular response to BMP stimulus [GO:0071773]; cellular response to organic cyclic compound [GO:0071407]; chondrocyte differentiation [GO:0002062]; corticotropin hormone secreting cell differentiation [GO:0060128]; embryonic heart tube anterior/posterior pattern specification [GO:0035054]; endocardial cushion formation [GO:0003272]; endocardial cushion morphogenesis [GO:0003203]; epithelial to mesenchymal transition [GO:0001837]; heart development [GO:0007507]; inflammatory response [GO:0006954]; inner ear development [GO:0048839]; in utero embryonic development [GO:0001701]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell proliferation involved in ureteric bud development [GO:0072138]; mesenchyme development [GO:0060485]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of calcium-independent cell-cell adhesion [GO:0051042]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of Wnt signaling pathway involved in heart development [GO:0003308]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; pericardium development [GO:0060039]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extracellular matrix constituent secretion [GO:0003331]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of odontogenesis [GO:0042482]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of phosphatase activity [GO:0010922]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of Wnt signaling pathway by BMP signaling pathway [GO:0060804]; protein destabilization [GO:0031648]; protein phosphorylation [GO:0006468]; proteoglycan metabolic process [GO:0006029]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of transcription, DNA-templated [GO:0006355]; response to bacterium [GO:0009617]; response to hypoxia [GO:0001666]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; telencephalon development [GO:0021537]; telencephalon regionalization [GO:0021978]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMP2&keywords=BMP2	9.45	245	NA	NA	1.64	192	0.00	0.30	0.04	0.31	0.09	0.05	0.03	0.01	0.06	0.01	0.02	162	272	209	0.08	0.71	0.18	0.31	256	425	388	284
IL7	interleukin 7	Yes		ENSG00000104432	P13232	IL-7/IL-9 family	21	ligand	extracellular, ligand, secreted	P16871, P31785, P80370	DLK1, IL2RG, IL2RG_IL7R, IL7R	IL7R [Baccin2019:10390077;Baccin2019:11858939;Baccin2019:7522165;CellTalkDB:11858939;DIP:1558969;DIP:19141282;DIP:8409434;HPMR:7522165;HPMR:8128231;HPRD:10390077;HPRD:11858939;InnateDB:8266077;IntAct:19141282;IntAct:8266077;LRdb:10390077;LRdb:11858939;LRdb:7522165;Lit-BM-17:1558969;Lit-BM-17:19141282;Lit-BM-17:8409434;NetPath:2317865;SIGNOR:20089933;SIGNOR:8204885;SignaLink3:23331499;SignaLink3:8204885;connectomeDB2020:10390077;connectomeDB2020:11858939;connectomeDB2020:7522165], IL2RG [Baccin2019:11858939;Baccin2019:7522165;Baccin2019:9010926;CellTalkDB:11858939;DIP:8128231;DIP:9371812;HPMR:7522165;HPMR:8128231;HPRD:11858939;HPRD:9010926;InnateDB:8266077;LRdb:11858939;LRdb:7522165;LRdb:9010926;Lit-BM-17:8128231;Lit-BM-17:9371812;SIGNOR:11418623;SIGNOR:20089933;connectomeDB2020:11858939;connectomeDB2020:7522165;connectomeDB2020:9010926], DLK1 [Cellinker:10733486]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-7 receptor binding [GO:0005139]	animal organ morphogenesis [GO:0009887]; bone resorption [GO:0045453]; cell-cell signaling [GO:0007267]; cytokine-mediated signaling pathway [GO:0019221]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; negative regulation of apoptotic process [GO:0043066]; negative regulation of catalytic activity [GO:0043086]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of organ growth [GO:0046622]; positive regulation of T cell differentiation [GO:0045582]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; T cell lineage commitment [GO:0002360]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL7&keywords=IL7	2.48	365	NA	NA	1.68	189	0.03	0.01	0.01	0.01	0.04	0.03	0.03	0.04	0.03	0.01	0.03	198	266	181	0.02	1.30	0.50	1.21	73	320	59	285
IL4	interleukin 4	Yes		ENSG00000113520	P05112	IL-4/IL-13 family	21	ligand	extracellular, ligand, secreted	P19397, P24394, P31785, P78552, P80370, Q14627, Q9HBE5	CD53, DLK1, IL13_IL13RA1_IL4R, IL13RA1, IL13RA1_IL4R, IL13RA2, IL13RA2_IL4R, IL21R, IL2RG, IL2RG_IL4R, IL4R	IL4R [Baccin2019:791837811786020;CellTalkDB:7918378;DIP:10219247;DIP:7721786;DIP:9874253;HPMR:11815609;HPMR:7918378;HPRD:11786020;InnateDB:21889455;InnateDB:2278997;InnateDB:2307934;InnateDB:8266078;InnateDB:8639787;IntAct:10219247;IntAct:18243101;IntAct:23597562;IntAct:8266078;LRdb:118;LRdb:7918378;Lit-BM-17:10219247;Lit-BM-17:11786020;Lit-BM-17:18243101;Lit-BM-17:23597562;Lit-BM-17:7721786;Lit-BM-17:8266078;Lit-BM-17:9874253;NetPath:10850446;NetPath:8266078;SIGNOR:10219247;SIGNOR:12704343;SIGNOR:18852293;SPIKE:11786020;SPIKE:17312100;SignaLink3:10219247;SignaLink3:23331499;connectomeDB2020:11786020;connectomeDB2020:7918378], IL2RG [Baccin2019:79183788266078;CellTalkDB:7918378;HPMR:11815609;HPMR:7918378;HPRD:8266078;InnateDB:8266078;LRdb:7918378;LRdb:827;Lit-BM-17:18243101;Lit-BM-17:8266078;NetPath:8266078;SIGNOR:11418623;connectomeDB2020:7918378;connectomeDB2020:8266078], IL13RA1 [CellTalkDB:18480254;IntAct:18243101;LRdb:10641437;LRdb:18480254;Lit-BM-17:18243101;Ramilowski2015:10641437;SIGNOR:12704343;connectomeDB2020:10641437;talklr:10641437], IL13RA2 [Baccin2019:9130652;CellTalkDB:9130652;HPRD:9130652;LRdb:9130652;connectomeDB2020:9130652], CD53 [Baccin2019:7963560;CellTalkDB:7963560;Cellinker:7963560;HPRD:7963560;LRdb:7963560;connectomeDB2020:7963560], DLK1 [Cellinker:10733486], IL21R [Cellinker:21058223]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-4 receptor binding [GO:0005136]	activation of Janus kinase activity [GO:0042976]; B cell costimulation [GO:0031296]; B cell differentiation [GO:0030183]; cholesterol metabolic process [GO:0008203]; dendritic cell differentiation [GO:0097028]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; immune response [GO:0006955]; innate immune response in mucosa [GO:0002227]; macrophage activation [GO:0042116]; microglial cell activation [GO:0001774]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular response to transforming growth factor beta stimulus [GO:1903845]; negative regulation of chronic inflammatory response [GO:0002677]; negative regulation of complement-dependent cytotoxicity [GO:1903660]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage activation [GO:0043031]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; neuroinflammatory response [GO:0150076]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular respiration [GO:1901857]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of eosinophil chemotaxis [GO:2000424]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of isotype switching to IgE isotypes [GO:0048295]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of immune response [GO:0050776]; regulation of isotype switching [GO:0045191]; regulation of phosphorylation [GO:0042325]; T cell activation [GO:0042110]; T-helper 2 cell differentiation [GO:0045064]; type 2 immune response [GO:0042092]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL4&keywords=IL4	0.47	529	NA	NA	4.00	91	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	310
TGFB3	transforming growth factor beta 3	Yes		ENSG00000119699	P10600	TGF-beta family	21	cell_surface_ligand, ecm, ligand	cell_surface_ligand, ecm, extracellular, intracellular, ligand, ligand_regulator, secreted, transmembrane	P05106, P05556, P17813, P18084, P18564, P36897, P37023, P37173, P61812, Q03167	ACVR1_TGFBR1, ACVR1_TGFBR1_TGFBR2, ACVR1_TGFBR2, ACVR1B_TGFBR2, ACVR1C_TGFBR2, ACVRL1, ENG, ITGB1, ITGB3, ITGB5, ITGB6, TGFB2, TGFBR1, TGFBR1_TGFBR2, TGFBR2, TGFBR3	TGFBR2 [Baccin2019:11382746;Baccin2019:11850637;Baccin2019:12729750;Baccin2019:8106553;BioGRID:11850637;BioGRID:12729750;CancerCellMap:11382746;CancerCellMap:11850637;CancerCellMap:12729750;CellTalkDB:11850637;DIP:7878020;Guide2Pharma:29170498;HPRD:11382746;HPRD:11850637;HPRD:12729750;HPRD:8106553;InnateDB:15017149;InnateDB:18243111;IntAct:11850637;IntAct:21423151;LRdb:11382746;LRdb:11850637;LRdb:12729750;LRdb:8106553;Lit-BM-17:11157754;Lit-BM-17:11850637;Lit-BM-17:12729750;Lit-BM-17:21423151;Lit-BM-17:7878020;Lit-BM-17:9872992;NetPath:11382746;SIGNOR:11157754;SignaLink3:11157754;SignaLink3:11382746;SignaLink3:11850637;SignaLink3:12729750;SignaLink3:15017149;SignaLink3:16446785;SignaLink3:18243111;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23180781;SignaLink3:23331499;SignaLink3:8106553;SignaLink3:9872992;connectomeDB2020:11382746;connectomeDB2020:11850637;connectomeDB2020:12729750;connectomeDB2020:8106553;scConnect:29170498], TGFBR1 [Baccin2019:11850637;Baccin2019:12060054;Baccin2019:12607775;CellTalkDB:11850637;DIP:10187774;HPRD:11850637;HPRD:12060054;HPRD:12607775;InnateDB:18243111;LRdb:11850637;LRdb:12060054;LRdb:12607775;Lit-BM-17:10187774;Lit-BM-17:21423151;connectomeDB2020:11850637], TGFBR3 [Baccin2019:11382746;CancerCellMap:11382746;CellTalkDB:11382746;Cellinker:11382746;HPRD:11382746;LRdb:11382746;NetPath:11382746;connectomeDB2020:11382746], ENG [Baccin2019:9872992;CellTalkDB:9872992;Cellinker:9872992;HPRD:9872992;LRdb:9872992;connectomeDB2020:9872992], ITGB1 [CellTalkDB:32196115], ITGB3 [CellTalkDB:32196115;ELM:25383667;ELM:31955848], ACVRL1 [Baccin2019:1185063710187770;CellTalkDB:11850637;Cellinker:10187774;Cellinker:11850637;DIP:10187774;HPRD:10187774;LRdb:1;LRdb:11850637;connectomeDB2020:10187774;connectomeDB2020:11850637], ITGB6 [CellTalkDB:11821050;ELM:25383667;ELM:31955848], ITGB5 [CellTalkDB:32196115], TGFB2 [HPRD:11157754]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; transforming growth factor beta complex [GO:0099126]; transforming growth factor beta ligand-receptor complex [GO:0070021]; T-tubule [GO:0030315]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; transforming growth factor beta binding [GO:0050431]; type III transforming growth factor beta receptor binding [GO:0034714]; type II transforming growth factor beta receptor binding [GO:0005114]; type I transforming growth factor beta receptor binding [GO:0034713]	aging [GO:0007568]; BMP signaling pathway [GO:0030509]; cell-cell junction organization [GO:0045216]; detection of hypoxia [GO:0070483]; digestive tract development [GO:0048565]; embryonic neurocranium morphogenesis [GO:0048702]; face morphogenesis [GO:0060325]; female pregnancy [GO:0007565]; frontal suture morphogenesis [GO:0060364]; inner ear development [GO:0048839]; in utero embryonic development [GO:0001701]; lung alveolus development [GO:0048286]; mammary gland development [GO:0030879]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; odontogenesis [GO:0042476]; ossification involved in bone remodeling [GO:0043932]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein secretion [GO:0050714]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to laminar fluid shear stress [GO:0034616]; response to progesterone [GO:0032570]; salivary gland morphogenesis [GO:0007435]; secondary palate development [GO:0062009]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterine wall breakdown [GO:0042704]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TGFB3&keywords=TGFB3	3.44	325	NA	NA	0.18	545	0.00	0.01	0.00	0.76	0.01	0.01	0.01	0.00	0.01	0.00	0.00	275	301	317	0.07	0.21	0.17	0.15	430	433	444	401
BMP6	bone morphogenetic protein 6	Yes		ENSG00000153162	P22004	TGF-beta family	21	ligand	extracellular, intracellular, ligand, secreted	O00238, P27037, P36894, P37023, Q04771, Q13705, Q13873, Q16671, Q6ZVN8, Q99717	ACVR1, ACVR1_ACVR2A, ACVR1_ACVR2B, ACVR1_BMPR2, ACVR2A, ACVR2A_BMPR1A, ACVR2A_BMPR1B, ACVR2B, ACVR2B_BMPR1A, ACVR2B_BMPR1B, ACVRL1, AMHR2, BMPR1A, BMPR1A_BMPR2, BMPR1B, BMPR1B_BMPR2, BMPR2, HJV, SMAD5	ACVR2B [SignaLink3:10504300;SignaLink3:16446785;SignaLink3:21071413;SignaLink3:23331499], BMPR2 [Baccin2019:11401330;HPRD:11401330;LRdb:11401330;SignaLink3:10504300;SignaLink3:16446785;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:10504300], AMHR2 [SignaLink3:16446785;SignaLink3:23331499], BMPR1B [Baccin2019:10504300;Baccin2019:11401330;HPRD:10504300;HPRD:11401330;LRdb:10504300;LRdb:11;connectomeDB2020:10504300;connectomeDB2020:11401330], ACVR2A [Baccin2019:10504300;CellTalkDB:10504300;HPRD:10504300;LRdb:10504300;connectomeDB2020:10504300], BMPR1A [Baccin2019:10504300;Baccin2019:11401330;Baccin2019:12297674;HPRD:10504300;HPRD:11401330;LRdb:10504300;LRdb:11401330;LRdb:12297674;connectomeDB2020:10504300;connectomeDB2020:11401330;connectomeDB2020:12297674], ACVRL1 [NA], ACVR1 [Baccin2019:12297674;CellTalkDB:12297674;LRdb:12297674;connectomeDB2020:12297674], HJV [CellTalkDB:23029472;InnateDB:19252486;connectomeDB2020:23029472], SMAD5 [HPRD:10504300]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; vesicle [GO:0031982]	BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein heterodimerization activity [GO:0046982]	BMP signaling pathway [GO:0030509]; cartilage development [GO:0051216]; cellular iron ion homeostasis [GO:0006879]; cellular response to BMP stimulus [GO:0071773]; cellular response to iron ion [GO:0071281]; cellular response to mechanical stimulus [GO:0071260]; endochondral ossification [GO:0001958]; eye development [GO:0001654]; immune response [GO:0006955]; inflammatory response [GO:0006954]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of aldosterone biosynthetic process [GO:0032349]; positive regulation of aldosterone secretion [GO:2000860]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein secretion [GO:0050714]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular permeability [GO:0043117]; response to activity [GO:0014823]; response to glucocorticoid [GO:0051384]; response to magnesium ion [GO:0032026]; response to retinoic acid [GO:0032526]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; type B pancreatic cell development [GO:0003323]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMP6&keywords=BMP6	1.28	424	NA	NA	0.21	526	0.00	0.00	0.03	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	302	407	398	0.00	0.72	0.70	0.70	252	253	235	403
IL10	interleukin 10	Yes		ENSG00000136634	P22301	IL-10 family	21	ligand	extracellular, ligand, secreted	P19838, P26842, P32970, Q08334, Q13651, Q8IU57, Q9P1W8	CD27, CD70, IFNLR1, IL10RA, IL10RA_IL10RB, IL10RB, NFKB1, SIRPG	IL10RA [Baccin2019:10231374;Baccin2019:11485736;Baccin2019:11717514;Baccin2019:12974481;Baccin2019:7759550;Baccin2019:8248239;Baccin2019:8897595;BioGRID:10231374;BioGRID:11485736;BioGRID:11717514;BioGRID:7759550;BioGRID:8248239;CellTalkDB:12974481;DIP:15837194;DIP:20462497;DIP:8120391;HPRD:10231374;HPRD:11485736;HPRD:11717514;HPRD:7759550;HPRD:8248239;HPRD:8897595;InnateDB:10788470;InnateDB:11717514;InnateDB:9568901;IntAct:11485736;IntAct:12513909;IntAct:15837194;IntAct:20462497;LRdb:10231374;LRdb:11485736;LRdb:11717514;LRdb:12974481;LRdb:7759550;LRdb:8248239;LRdb:8897595;Lit-BM-17:10231374;Lit-BM-17:11485736;Lit-BM-17:11717514;Lit-BM-17:12513909;Lit-BM-17:15837194;Lit-BM-17:8120391;SIGNOR:10347215;SIGNOR:26260587;SPIKE:11591769;SignaLink3:17208301;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:8248239;connectomeDB2020:10231374;connectomeDB2020:11485736;connectomeDB2020:11717514;connectomeDB2020:12974481;connectomeDB2020:7759550;connectomeDB2020:8248239;connectomeDB2020:8897595;scConnect:19161426], NFKB1 [SPIKE:12773629], IL10RB [CellTalkDB:12974481;DIP:20462497;DIP:9312047;HPRD:11485736;HPRD:9312047;LRdb:11485736;LRdb:12974481;LRdb:9312047;Lit-BM-17:12513909;Lit-BM-17:9312047;SIGNOR:10347215;SIGNOR:11035029;SignaLink3:11485736;SignaLink3:17208301;SignaLink3:23331499;SignaLink3:9312047;connectomeDB2020:11485736;connectomeDB2020:12974481;connectomeDB2020:9312047], SIRPG [NA], CD27 [Cellinker:9767422], CD70 [Cellinker:9767422], IFNLR1 [Cellinker:27133025]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-10 receptor binding [GO:0005141]; protein dimerization activity [GO:0046983]	aging [GO:0007568]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to lipopolysaccharide [GO:0071222]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; endothelial cell apoptotic process [GO:0072577]; hemopoiesis [GO:0030097]; leukocyte chemotaxis [GO:0030595]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of chronic inflammatory response to antigenic stimulus [GO:0002875]; negative regulation of cytokine activity [GO:0060302]; negative regulation of cytokine production [GO:0001818]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-18 production [GO:0032701]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of myeloid dendritic cell activation [GO:0030886]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of sensory perception of pain [GO:1904057]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytokine production [GO:0001819]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of macrophage activation [GO:0043032]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of plasma cell differentiation [GO:1900100]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of gene expression [GO:0010468]; regulation of isotype switching [GO:0045191]; regulation of response to wounding [GO:1903034]; regulation of synapse organization [GO:0050807]; response to activity [GO:0014823]; response to carbon monoxide [GO:0034465]; response to glucocorticoid [GO:0051384]; response to inactivity [GO:0014854]; response to insulin [GO:0032868]; response to molecule of bacterial origin [GO:0002237]; response to xenobiotic stimulus [GO:0009410]; type 2 immune response [GO:0042092]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL10&keywords=IL10	0.34	561	NA	NA	0.49	385	0.15	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	302	388	390	0.01	0.42	0.42	0.42	369	339	348	418
BMP4	bone morphogenetic protein 4	Yes		ENSG00000125378	P12644	TGF-beta family	21	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	O00238, O75581, P0CG37, P27037, P36894, P37023, Q04771, Q13705, Q13873, Q6NW40, Q6ZVN8, Q9H772	ACVR1, ACVR2A, ACVR2A_BMPR1A, ACVR2A_BMPR1B, ACVR2B, ACVR2B_BMPR1A, ACVR2B_BMPR1B, ACVRL1, BMPR1A, BMPR1A_BMPR1B_BMPR2, BMPR1A_BMPR2, BMPR1B, BMPR1B_BMPR2, BMPR2, CFC1, GREM2, HJV, LRP6, RGMB	BMPR2 [Baccin2019:7644468;Baccin2019:7673243;Baccin2019:8702914;BioGRID:12045205;DIP:7644468;DIP:7673243;HPRD:7644468;HPRD:8702914;LRdb:7644468;LRdb:7673243;LRdb:8702914;SIGNOR:7673243;SIGNOR:8006002;SignaLink3:16446785;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:7644468;connectomeDB2020:7644468;connectomeDB2020:7673243;connectomeDB2020:8702914], BMPR1B [Baccin2019:11282024;Baccin2019:7811286;Baccin2019:8006002;Baccin2019:8702914;HPRD:11282024;HPRD:7811286;HPRD:8702914;LRdb:11282024;LRdb:7811286;LRdb:8006002;LRdb:8702914;connectomeDB2020:11282024;connectomeDB2020:7811286;connectomeDB2020:8006002;connectomeDB2020:8702914], ACVR2A [Baccin2019:20959140], BMPR1A [Baccin2019:11241215;Baccin2019:7644468;Baccin2019:8006002;Baccin2019:8702914;HPRD:11241215;HPRD:7644468;HPRD:8702914;IntAct:20860622;IntAct:21054789;LRdb:11241215;LRdb:7644468;LRdb:8006002;LRdb:8702914;Lit-BM-17:20860622;Lit-BM-17:21054789;Lit-BM-17:8006002;SIGNOR:26330344;connectomeDB2020:11241215;connectomeDB2020:7644468;connectomeDB2020:8006002;connectomeDB2020:8702914], ACVRL1 [NA], ACVR1 [Baccin2019:20959140], ACVR2B [NA], LRP6 [CellTalkDB:19553665], HJV [CellTalkDB:18326817], CFC1 [connectomeDB2020:28126904], RGMB [connectomeDB2020:15671031], GREM2 [Cellinker:24614542;HPRD:15039429]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	BMP receptor binding [GO:0070700]; chemoattractant activity [GO:0042056]; co-receptor binding [GO:0039706]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]	anterior/posterior axis specification [GO:0009948]; aortic valve morphogenesis [GO:0003180]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; BMP signaling pathway [GO:0030509]; BMP signaling pathway involved in heart development [GO:0061312]; BMP signaling pathway involved in heart induction [GO:0003130]; BMP signaling pathway involved in nephric duct formation [GO:0071893]; BMP signaling pathway involved in renal system segmentation [GO:0061151]; BMP signaling pathway involved in ureter morphogenesis [GO:0061149]; branching involved in prostate gland morphogenesis [GO:0060442]; branching involved in ureteric bud morphogenesis [GO:0001658]; branching morphogenesis of an epithelial tube [GO:0048754]; bronchus development [GO:0060433]; bud dilation involved in lung branching [GO:0060503]; bud elongation involved in lung branching [GO:0060449]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum development [GO:0003279]; cellular response to BMP stimulus [GO:0071773]; chondrocyte differentiation [GO:0002062]; cloacal septation [GO:0060197]; common-partner SMAD protein phosphorylation [GO:0007182]; coronary vasculature development [GO:0060976]; cranial suture morphogenesis [GO:0060363]; deltoid tuberosity development [GO:0035993]; dorsal/ventral neural tube patterning [GO:0021904]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal joint morphogenesis [GO:0060272]; endocardial cushion development [GO:0003197]; endochondral ossification [GO:0001958]; endoderm development [GO:0007492]; epithelial cell proliferation involved in lung morphogenesis [GO:0060502]; epithelial-mesenchymal cell signaling [GO:0060684]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; erythrocyte differentiation [GO:0030218]; germ cell development [GO:0007281]; glomerular capillary formation [GO:0072104]; glomerular visceral epithelial cell development [GO:0072015]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear receptor cell differentiation [GO:0060113]; intermediate mesodermal cell differentiation [GO:0048392]; kidney development [GO:0001822]; lens induction in camera-type eye [GO:0060235]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; lymphoid progenitor cell differentiation [GO:0002320]; macrophage differentiation [GO:0030225]; mammary gland formation [GO:0060592]; membranous septum morphogenesis [GO:0003149]; mesenchymal cell differentiation involved in kidney development [GO:0072161]; mesenchymal cell proliferation involved in ureter development [GO:0072198]; mesenchymal cell proliferation involved in ureteric bud development [GO:0072138]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; mesodermal cell fate determination [GO:0007500]; mesonephros development [GO:0001823]; metanephric collecting duct development [GO:0072205]; monocyte differentiation [GO:0030224]; negative regulation of apoptotic process [GO:0043066]; negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway [GO:0072097]; negative regulation of branching involved in ureteric bud morphogenesis [GO:0090191]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart morphogenesis [GO:2000137]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of glomerular mesangial cell proliferation [GO:0072125]; negative regulation of glomerulus development [GO:0090194]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mesenchymal cell proliferation involved in ureter development [GO:0072200]; negative regulation of metanephric comma-shaped body morphogenesis [GO:2000007]; negative regulation of metanephric S-shaped body morphogenesis [GO:2000005]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of phosphorylation [GO:0042326]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of thymocyte apoptotic process [GO:0070244]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; neuron fate commitment [GO:0048663]; odontogenesis [GO:0042476]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; pharyngeal arch artery morphogenesis [GO:0061626]; pituitary gland development [GO:0021983]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of branching involved in lung morphogenesis [GO:0061047]; positive regulation of cardiac muscle fiber development [GO:0055020]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell death [GO:0010942]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation involved in outflow tract morphogenesis [GO:1901964]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epidermal cell differentiation [GO:0045606]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of kidney development [GO:0090184]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; protein localization to nucleus [GO:0034504]; pulmonary artery endothelial tube morphogenesis [GO:0061155]; pulmonary valve morphogenesis [GO:0003184]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of cell fate commitment [GO:0010453]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; regulation of protein import into nucleus [GO:0042306]; regulation of smooth muscle cell differentiation [GO:0051150]; renal system process [GO:0003014]; secondary heart field specification [GO:0003139]; sinoatrial node development [GO:0003163]; SMAD protein signal transduction [GO:0060395]; smooth muscle tissue development [GO:0048745]; specification of animal organ position [GO:0010159]; specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway [GO:0072101]; steroid hormone mediated signaling pathway [GO:0043401]; telencephalon development [GO:0021537]; telencephalon regionalization [GO:0021978]; tendon cell differentiation [GO:0035990]; trachea development [GO:0060438]; trachea formation [GO:0060440]; type B pancreatic cell development [GO:0003323]; ureter epithelial cell differentiation [GO:0072192]; ureteric bud development [GO:0001657]; ureter smooth muscle cell differentiation [GO:0072193]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMP4&keywords=BMP4	2.02	385	NA	NA	0.24	505	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	445
OSM	oncostatin M	Yes		ENSG00000099985	P13725	LIF/OSM family	21	ligand	extracellular, intracellular, ligand, secreted	P05231, P40189, P42702, Q99650	IL6, IL6ST, IL6ST_LIFR, IL6ST_OSMR, LIFR, OSMR	OSMR [Baccin2019:10997905;Baccin2019:8999038;CellTalkDB:8999038;HPMR:10854424;HPMR:8999038;HPRD:10997905;HPRD:8999038;LRdb:10997905;LRdb:8999038;SIGNOR:16286453;SignaLink3:16286453;SignaLink3:23331499;connectomeDB2020:10997905;connectomeDB2020:8999038], IL6ST [Baccin2019:10854424;Baccin2019:16051226;Baccin2019:8999038;CellTalkDB:16051226;DIP:8999038;DOMINO:16051226;HPMR:10854424;HPMR:8999038;HPRD:16051226;HPRD:8999038;LRdb:10854424;LRdb:16051226;LRdb:8999038;SIGNOR:9143707;connectomeDB2020:10854424;connectomeDB2020:16051226;connectomeDB2020:8999038], LIFR [Baccin2019:10854424;Baccin2019:1536831;Baccin2019:1542794;Baccin2019:16051226;CellTalkDB:10854424;DIP:8999038;DOMINO:16051226;HPRD:1536831;HPRD:1542794;HPRD:16051226;LRdb:10854424;LRdb:1536831;LRdb:1542794;LRdb:16051226;SIGNOR:1536831;connectomeDB2020:10854424;connectomeDB2020:1536831;connectomeDB2020:1542794;connectomeDB2020:16051226], IL6 [DIP:10681548]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; oncostatin-M receptor binding [GO:0005147]	immune response [GO:0006955]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hormone secretion [GO:0046888]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of growth [GO:0040008]; regulation of hematopoietic stem cell differentiation [GO:1902036]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=OSM&keywords=OSM	0.07	706	NA	NA	0.04	736	0.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	303	407	400	0.06	0.13	0.14	0.13	464	451	456	575
IL2	interleukin 2	Yes		ENSG00000109471	P60568	IL-2 family	21	ligand	extracellular, ligand, secreted	P01562, P01589, P08138, P14784, P15421, P19397, P29353, P31785, P80370	CD53, DLK1, GYPE, IFNA1, IL2_IL2RA_IL2RB_IL2RG, IL20RA_IL20RB_IL2RG, IL2RA, IL2RA_IL2RB_IL2RG, IL2RB, IL2RB_IL2RG, IL2RG, NGFR, SHC1	IL2RG [Baccin2019:10662798;Baccin2019:15265897;Baccin2019:8049354;CellTalkDB:15265897;DIP:8006584;HPMR:15265897;HPMR:15933202;HPRD:10662798;HPRD:8049354;InnateDB:11418623;InnateDB:7681595;InnateDB:8568232;LRdb:10662798;LRdb:15265897;LRdb:8049354;NetPath:8049354;NetPath:8260650;SIGNOR:16477002;SignaLink3:10807786;SignaLink3:10820393;SignaLink3:10849428;SignaLink3:11418623;SignaLink3:12095053;SignaLink3:15289500;SignaLink3:15563472;SignaLink3:16212621;SignaLink3:16799562;SignaLink3:17371980;SignaLink3:1825141;SignaLink3:18758473;SignaLink3:19528259;SignaLink3:19833085;SignaLink3:20856220;SignaLink3:21840487;SignaLink3:22224781;SignaLink3:23124025;SignaLink3:23180781;SignaLink3:23331499;SignaLink3:23650441;SignaLink3:24829413;SignaLink3:26192618;SignaLink3:26755705;SignaLink3:2965306;SignaLink3:6164929;SignaLink3:7512720;SignaLink3:7521688;SignaLink3:7681595;SignaLink3:7829965;SignaLink3:8683106;SignaLink3:9625766;connectomeDB2020:10662798;connectomeDB2020:15265897;connectomeDB2020:8049354], IL2RA [Baccin2019:15265897;Baccin2019:1993646;CellTalkDB:15265897;DIP:17032757;HPMR:15265897;HPMR:15933202;HPRD:1993646;InnateDB:12649439;InnateDB:15178252;InnateDB:1940342;InnateDB:3095922;InnateDB:6815536;InnateDB:8580082;InnateDB:8894436;InnateDB:8960125;IntAct:17032757;LRdb:15265897;LRdb:2;NetPath:3116143;NetPath:8260650;SIGNOR:16477002;connectomeDB2020:15265897;connectomeDB2020:1993646], IL2RB [Baccin2019:11035066;Baccin2019:15265897;Baccin2019:8049354;CellTalkDB:15265897;DIP:22446627;DIP:8006584;HPMR:15265897;HPMR:15933202;HPRD:11035066;HPRD:8049354;InnateDB:15178252;InnateDB:1940342;InnateDB:3095922;InnateDB:3098894;InnateDB:8568232;IntAct:22446627;LRdb:11035066;LRdb:15265897;LRdb:8049354;NetPath:3116143;NetPath:8260650;SIGNOR:16477002;connectomeDB2020:11035066;connectomeDB2020:15265897;connectomeDB2020:8049354], CD53 [CellTalkDB:7963560;Cellinker:7963560;HPRD:7963560;LRdb:7963560;connectomeDB2020:7963560], NGFR [Baccin2019:1316918;CellTalkDB:1316918;Cellinker:1316918;HPRD:1316918;LRdb:1316918], GYPE [NA], DLK1 [Cellinker:10733486], IFNA1 [HPRD:3262520], SHC1 [HPRD:10662798]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	carbohydrate binding [GO:0030246]; cytokine activity [GO:0005125]; glycosphingolipid binding [GO:0043208]; growth factor activity [GO:0008083]; interleukin-2 receptor binding [GO:0005134]; kappa-type opioid receptor binding [GO:0031851]; kinase activator activity [GO:0019209]	adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; gene expression [GO:0010467]; immune response [GO:0006955]; leukocyte activation involved in immune response [GO:0002366]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of heart contraction [GO:0045822]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lymphocyte proliferation [GO:0050672]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of plasma cell differentiation [GO:1900100]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of tissue remodeling [GO:0034105]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of T cell homeostatic proliferation [GO:0046013]; response to ethanol [GO:0045471]; T cell differentiation [GO:0030217]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL2&keywords=IL2	0.01	840	NA	NA	0.33	453	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	647
BMP7	bone morphogenetic protein 7	Yes		ENSG00000101144	P18075	TGF-beta family	21	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	O00238, P17813, P27037, P36894, P36896, P37023, P61160, Q04771, Q13705, Q13873, Q15262, Q6X4U4, Q6ZVN8	ACTR2, ACVR1, ACVR1_ACVR2A, ACVR1_ACVR2B, ACVR1_BMPR2, ACVR1B, ACVR2A, ACVR2A_BMPR1A, ACVR2A_BMPR1B, ACVR2B, ACVR2B_BMPR1A, ACVR2B_BMPR1B, ACVRL1, BMPR1A, BMPR1A_BMPR1B_BMPR2, BMPR1A_BMPR2, BMPR1B, BMPR1B_BMPR2, BMPR2, ENG, HJV, PTPRK, SOSTDC1	ACVR2B [Baccin2019:9748228;CellTalkDB:9748228;HPRD:9748228;LRdb:9748228;SIGNOR:9748228;SignaLink3:16446785;SignaLink3:23331499;connectomeDB2020:9748228], BMPR2 [Baccin2019:7791754;DIP:7644468;HPRD:7791754;InnateDB:18342887;LRdb:7791754;SIGNOR:7644468;SignaLink3:16446785;SignaLink3:23331499;connectomeDB2020:7791754], ACTR2 [SIGNOR:16446785;SignaLink3:16446785;SignaLink3:23331499], BMPR1B [Baccin2019:106311828605097;CellTalkDB:15621726;HPRD:8605097;LRdb:10631182;LRdb:86;connectomeDB2020:10631182;connectomeDB2020:8605097], ACVR2A [Baccin2019:12667445;Baccin2019:7790373;Baccin2019:9748228;CellTalkDB:7790373;HPRD:12667445;HPRD:9748228;LRdb:12667445;LRdb:7790373;LRdb:9748228;SIGNOR:9748228;connectomeDB2020:12667445;connectomeDB2020:7790373;connectomeDB2020:9748228], BMPR1A [Baccin2019:12297674;Baccin2019:7791754;Baccin2019:8605097;HPRD:7791754;HPRD:8605097;LRdb:12297674;LRdb:7791754;LRdb:8605097;connectomeDB2020:12297674;connectomeDB2020:7791754;connectomeDB2020:8605097], ACVRL1 [NA], ACVR1 [Baccin2019:122976748006002;CellTalkDB:31619522;HPRD:8006002;LRdb:12297674;LRdb:8;SIGNOR:11282024;connectomeDB2020:12297674;connectomeDB2020:8006002], ENG [Baccin2019:9872992;CellTalkDB:9872992;Cellinker:9872992;HPRD:9872992;LRdb:9872992;connectomeDB2020:9872992], HJV [connectomeDB2020:23029472], ACVR1B [Cellinker:31619522], PTPRK [NA], SOSTDC1 [HPRD:14623234;HPRD:15020244]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; vesicle [GO:0031982]	BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]	allantois development [GO:1905069]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; cellular response to BMP stimulus [GO:0071773]; cellular response to hypoxia [GO:0071456]; chorio-allantoic fusion [GO:0060710]; dendrite development [GO:0016358]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint morphogenesis [GO:0060272]; endocardial cushion formation [GO:0003272]; epithelial cell differentiation [GO:0030855]; epithelial to mesenchymal transition [GO:0001837]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; mesenchymal cell differentiation [GO:0048762]; mesenchyme development [GO:0060485]; mesoderm formation [GO:0001707]; mesonephros development [GO:0001823]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephric mesenchyme morphogenesis [GO:0072133]; metanephros development [GO:0001656]; monocyte aggregation [GO:0070487]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell death [GO:0060548]; negative regulation of glomerular mesangial cell proliferation [GO:0072125]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:0072040]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of striated muscle cell apoptotic process [GO:0010664]; negative regulation of transcription, DNA-templated [GO:0045892]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural fold elevation formation [GO:0021502]; neuron projection morphogenesis [GO:0048812]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of hyaluranon cable assembly [GO:1900106]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; regulation of removal of superoxide radicals [GO:2000121]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to vitamin D [GO:0033280]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; steroid hormone mediated signaling pathway [GO:0043401]; ureteric bud development [GO:0001657]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMP7&keywords=BMP7	0.25	594	NA	NA	0.03	765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	680
BMP5	bone morphogenetic protein 5	Yes		ENSG00000112175	P22003	TGF-beta family	20	ligand	extracellular, intracellular, ligand, secreted	O00238, P23468, P27037, P36894, P37023, Q04771, Q13705, Q13873, Q6ZVN8	ACVR1, ACVR1_ACVR2A, ACVR1_ACVR2B, ACVR1_BMPR2, ACVR2A, ACVR2A_BMPR1A, ACVR2A_BMPR1B, ACVR2B, ACVR2B_BMPR1A, ACVR2B_BMPR1B, ACVRL1, BMPR1A, BMPR1A_BMPR2, BMPR1B, BMPR1B_BMPR2, BMPR2, HJV, PTPRD	BMPR1B [NA], ACVR2A [NA], BMPR1A [Baccin2019:11580864;HPRD:11580864;LRdb:11580864], ACVRL1 [NA], ACVR1 [NA], ACVR2B [NA], BMPR2 [NA], HJV [CellTalkDB:23029472;connectomeDB2020:23029472], PTPRD [Cellinker:32589946]	extracellular space [GO:0005615]; vesicle [GO:0031982]	BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]	allantois development [GO:1905069]; anterior head development [GO:0097065]; BMP signaling pathway [GO:0030509]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; chorio-allantoic fusion [GO:0060710]; ear development [GO:0043583]; endocardial cushion formation [GO:0003272]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; male genitalia development [GO:0030539]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of steroid biosynthetic process [GO:0010894]; neural fold elevation formation [GO:0021502]; ossification [GO:0001503]; pattern specification process [GO:0007389]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; type B pancreatic cell development [GO:0003323]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMP5&keywords=BMP5	33.68	125	1418.92	147	26.00	23	0.01	0.06	0.01	0.01	0.10	0.99	0.86	0.16	0.68	0.89	0.02	34	32	199	0.34	1.93	2.55	0.09	35	10	477	67
VEGFA	vascular endothelial growth factor A	Yes		ENSG00000112715	P15692	PDGF/VEGF growth factor family	20	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted, transmembrane	O14786, O60462, P00533, P05106, P05556, P06756, P07949, P13611, P16070, P17948, P29323, P35052, P35968, P78324, Q06418, Q13224, Q13797, Q16236, Q16665	CD44, EGFR, EPHB2, FLT1, FLT1_KDR, GPC1, GRIN2B, HIF1A, ITGA9, ITGAV, ITGB1, ITGB3, KDR, NFE2L2, NRP1, NRP2, RET, SIRPA, TYRO3, VCAN	FLT1 [Baccin2019:15637071;Baccin2019:17051153;Baccin2019:8621427;Baccin2019:9393862;CellChatDB:16633338;CellTalkDB:17051153;Cellinker:15637071;Cellinker:17051153;Cellinker:8621427;Cellinker:9393862;DIP:8621427;DIP:8631822;HPMR:8356051;HPRD:17051153;HPRD:8621427;HPRD:9393862;ICELLNET:26285753;IntAct:10543948;IntAct:20660291;IntAct:9393862;LRdb:15637071;LRdb:17051153;LRdb:8621427;LRdb:9393862;Lit-BM-17:10543948;Lit-BM-17:21939755;Lit-BM-17:8621427;Lit-BM-17:8631822;Lit-BM-17:9393862;ProtMapper:21441409;ProtMapper:22348123;SIGNOR:14704231;connectomeDB2020:15637071;connectomeDB2020:17051153;connectomeDB2020:8621427;connectomeDB2020:9393862], KDR [Baccin2019:15637071;Baccin2019:17318185;Baccin2019:8621427;BioGRID:16901919;CellChatDB:16633338;CellTalkDB:8621427;Cellinker:15637071;Cellinker:17318185;Cellinker:8621427;DIP:11333271;DIP:20145116;DIP:8621427;DIP:8631822;DIP:9556609;HPMR:8356051;HPRD:17318185;HPRD:8621427;ICELLNET:11181169;ICELLNET:1417831;IntAct:1417831;IntAct:16763549;IntAct:20145116;IntAct:20660291;IntAct:21596751;IntAct:22897854;IntAct:23374253;IntAct:23583373;IntAct:31932617;LRdb:15637071;LRdb:17318185;LRdb:8621427;Lit-BM-17:11333271;Lit-BM-17:12716911;Lit-BM-17:16423422;Lit-BM-17:16763549;Lit-BM-17:18325345;Lit-BM-17:19818105;Lit-BM-17:20145116;Lit-BM-17:22897854;Lit-BM-17:23374253;Lit-BM-17:23583373;Lit-BM-17:8621427;Lit-BM-17:8631822;Lit-BM-17:9556609;ProtMapper:12189247;ProtMapper:22174934;ProtMapper:24023956;ProtMapper:24966171;ProtMapper:27005951;SIGNOR:17658244;connectomeDB2020:15637071;connectomeDB2020:17318185;connectomeDB2020:8621427;scConnect:31023826], NFE2L2 [NRF2ome:22033923], NRP1 [Baccin2019:10409677;Baccin2019:11986311;Baccin2019:15637071;Baccin2019:16763549;Baccin2019:17222790;Baccin2019:9529250;BioGRID:11986311;BioGRID:20363638;CellTalkDB:11986311;Cellinker:10409677;Cellinker:11986311;Cellinker:15637071;Cellinker:16763549;Cellinker:17222790;Cellinker:9529250;DIP:10498602;DIP:11333271;DIP:9712843;HPRD:10409677;HPRD:11986311;HPRD:16763549;HPRD:17222790;HPRD:9529250;ICELLNET:11181169;ICELLNET:21653826;IntAct:16763549;IntAct:17222790;LRdb:10409677;LRdb:11986311;LRdb:15637071;LRdb:16763549;LRdb:17222790;LRdb:9529250;Lit-BM-17:10498602;Lit-BM-17:11333271;Lit-BM-17:11986311;Lit-BM-17:16423422;Lit-BM-17:16763549;Lit-BM-17:17222790;Lit-BM-17:18325345;Lit-BM-17:20363638;Lit-BM-17:21939755;Lit-BM-17:22318724;Lit-BM-17:22897854;Lit-BM-17:9529250;Lit-BM-17:9712843;connectomeDB2020:10409677;connectomeDB2020:11986311;connectomeDB2020:15637071;connectomeDB2020:16763549;connectomeDB2020:17222790;connectomeDB2020:9529250], NRP2 [Baccin2019:10748121;CellTalkDB:10748121;Cellinker:10748121;DIP:10748121;ELM:26991001;HPRD:10748121;ICELLNET:11181169;LRdb:10748121;connectomeDB2020:10748121], ITGAV [CellTalkDB:32196115], TYRO3 [CellTalkDB:32196115], GPC1 [CellTalkDB:10196157;Cellinker:10196157;HPRD:10196157;LRdb:10196157;connectomeDB2020:10196157], ITGA9 [CellTalkDB:17363377], EGFR [CellTalkDB:32196115], RET [CellTalkDB:32196115], EPHB2 [Baccin2019:17318185;HPRD:17318185;LRdb:17318185], ITGB1 [CellTalkDB:32196115], SIRPA [CellTalkDB:32196115], ITGB3 [CellTalkDB:32196115], GRIN2B [CellTalkDB:32103204], CD44 [Cellinker:26181364], VCAN [Cellinker:16045811], HIF1A [BioGRID:11901189;BioGRID:22952674]	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; secretory granule [GO:0030141]	chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; extracellular matrix binding [GO:0050840]; fibronectin binding [GO:0001968]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; neuropilin binding [GO:0038191]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; receptor ligand activity [GO:0048018]; vascular endothelial growth factor receptor 1 binding [GO:0043183]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; vascular endothelial growth factor receptor binding [GO:0005172]	activation of protein kinase activity [GO:0032147]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; basophil chemotaxis [GO:0002575]; branching involved in blood vessel morphogenesis [GO:0001569]; camera-type eye morphogenesis [GO:0048593]; cardiac muscle cell development [GO:0055013]; cardiac vascular smooth muscle cell development [GO:0060948]; cell maturation [GO:0048469]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hypoxia [GO:0071456]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular stress response to acid chemical [GO:0097533]; commissural neuron axon guidance [GO:0071679]; coronary artery morphogenesis [GO:0060982]; coronary vein morphogenesis [GO:0003169]; dopaminergic neuron differentiation [GO:0071542]; endothelial cell chemotaxis [GO:0035767]; epithelial cell differentiation [GO:0030855]; eye photoreceptor cell development [GO:0042462]; heart morphogenesis [GO:0003007]; induction of positive chemotaxis [GO:0050930]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lactation [GO:0007595]; lung development [GO:0030324]; lymph vessel morphogenesis [GO:0036303]; macrophage differentiation [GO:0030225]; mammary gland alveolus development [GO:0060749]; mesoderm development [GO:0007498]; monocyte differentiation [GO:0030224]; motor neuron migration [GO:0097475]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of establishment of endothelial barrier [GO:1903141]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; outflow tract morphogenesis [GO:0003151]; ovarian follicle development [GO:0001541]; positive chemotaxis [GO:0050918]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of cellular component movement [GO:0051272]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phosphorylation [GO:0042327]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein kinase D signaling [GO:1903572]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; positive regulation of retinal ganglion cell axon guidance [GO:1902336]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of trophoblast cell migration [GO:1901165]; positive regulation of vascular permeability [GO:0043117]; post-embryonic camera-type eye development [GO:0031077]; primitive erythrocyte differentiation [GO:0060319]; regulation of cell shape [GO:0008360]; regulation of nitric oxide mediated signal transduction [GO:0010749]; regulation of retinal ganglion cell axon guidance [GO:0090259]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; surfactant homeostasis [GO:0043129]; tube formation [GO:0035148]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]; VEGF-activated neuropilin signaling pathway [GO:0038190]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=VEGFA&keywords=VEGFA	167.31	39	2852.25	117	2.04	150	0.24	0.40	0.04	0.44	0.24	0.92	1.02	0.22	0.20	0.83	0.17	79	35	77	0.43	0.48	1.90	0.41	352	23	350	73
IL1A	interleukin 1 alpha	Yes		ENSG00000115008	P01583	IL-1 family	20	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted	P14778, P27930, Q9NPH3	IL1B_IL1R1_IL1RAP, IL1B_IL1R2_IL1RAP, IL1R1, IL1R1_IL1RAP, IL1R2, IL1R2_IL1RAP, IL1RAP	IL1R1 [Baccin2019:29469592946959;CellTalkDB:2946959;HPRD:2946959;InnateDB:8142597;LRdb:2946959;NetPath:17507369;NetPath:2946959;NetPath:7775431;SIGNOR:7964161;SIGNOR:9565970;SPIKE:19479203;SignaLink3:23331499;SignaLink3:2946959;SignaLink3:9565970;connectomeDB2020:2946959], IL1RAP [Baccin2019:9820540;CellTalkDB:9820540;HPRD:9820540;LRdb:9820540;NetPath:17507369;NetPath:7775431;NetPath:9862719;connectomeDB2020:9820540], IL1R2 [Baccin2019:78780467878046;CellTalkDB:7878046;Cellinker:7878046;HPRD:7878046;InnateDB:1833184;InnateDB:23395675;IntAct:16971486;IntAct:25241761;LRdb:7878046;NetPath:7878046;NetPath:9862719;connectomeDB2020:7878046]	cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	copper ion binding [GO:0005507]; cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149]	apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; cellular response to lipopolysaccharide [GO:0071222]; cellular sodium ion homeostasis [GO:0006883]; connective tissue replacement involved in inflammatory response wound healing [GO:0002248]; cytokine-mediated signaling pathway [GO:0019221]; ectopic germ cell programmed cell death [GO:0035234]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fever generation [GO:0001660]; heart development [GO:0007507]; immune response [GO:0006955]; inflammatory response [GO:0006954]; keratinization [GO:0031424]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of establishment of Sertoli cell barrier [GO:1904445]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of cytokine production [GO:0001819]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein secretion [GO:0050714]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of sensory perception of pain [GO:0051930]; response to copper ion [GO:0046688]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to L-ascorbic acid [GO:0033591]; response to organonitrogen compound [GO:0010243]; response to ozone [GO:0010193]; spermatogenesis [GO:0007283]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL1A&keywords=IL1A	3.16	332	NA	NA	3.96	92	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	212
TGFA	transforming growth factor alpha	Yes		ENSG00000163235	P01135	NA	20	cell_surface_ligand, ligand, receptor	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O95406, P00533, P04626, P21860, P23468, P78536, Q15303, Q969F2	ADAM17, CNIH1, EGFR, EGFR_ERBB2, ERBB2, ERBB3, ERBB4, NKD2, PTPRD	EGFR [Baccin2019:12297049;Baccin2019:3018723;CellTalkDB:3018723;HPRD:12297049;ICELLNET:27635238;IntAct:12297049;IntAct:24658140;IntAct:28988771;IntAct:31980649;LRdb:123;LRdb:3018723;Lit-BM-17:10775655;Lit-BM-17:12297049;Lit-BM-17:24658140;Lit-BM-17:25402006;Lit-BM-17:8663070;ProtMapper:21722395;ProtMapper:23155381;SIGNOR:16585207;SPIKE:12648464;SPIKE:17145710;SignaLink3:10209155;SignaLink3:12297049;SignaLink3:23331499;connectomeDB2020:12297049;connectomeDB2020:3018723], ADAM17 [Cellinker:23801765;HPRD:11823465], ERBB4 [Baccin2019:10918572;CellTalkDB:10918572;HPRD:10918572;LRdb:10918572;connectomeDB2020:10918572], ERBB3 [CellTalkDB:32196115], ERBB2 [Baccin2019:10918572;CellTalkDB:10918572;HPRD:10918572;LRdb:10918572;connectomeDB2020:10918572], PTPRD [Cellinker:32589946], NKD2 [Cellinker:27635238;HPRD:15064403], CNIH1 [Cellinker:27635238]	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]	angiogenesis [GO:0001525]; epidermal growth factor receptor signaling pathway [GO:0007173]; hepatocyte proliferation [GO:0072574]; intracellular signal transduction [GO:0035556]; mammary gland alveolus development [GO:0060749]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitotic nuclear division [GO:0045840]; response to xenobiotic stimulus [GO:0009410]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TGFA&keywords=TGFA	25.06	152	NA	NA	5.68	68	0.06	0.75	0.00	0.00	0.10	0.01	0.00	0.00	0.00	0.00	0.00	303	353	366	0.08	0.11	0.12	0.12	474	456	465	257
IL15	interleukin 15	Yes		ENSG00000164136	P40933	IL-15/IL-21 family	20	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted	P01589, P14784, P31785, P80370, Q13261	DLK1, IL15_IL15RA_IL2RB_IL2RG, IL15RA, IL15RA_IL2RB, IL15RA_IL2RB_IL2RG, IL2RA, IL2RB, IL2RG	IL15RA [Baccin2019:15265897;Baccin2019:16284400;Baccin2019:7641685;CellTalkDB:15265897;Guide2Pharma:19710453;HPMR:15265897;HPRD:16284400;HPRD:7641685;InnateDB:16284400;IntAct:16284400;LRdb:15265897;LRdb:16284400;LRdb:7641685;Lit-BM-17:10903799;Lit-BM-17:16284400;SIGNOR:17709786;SignaLink3:23331499;SignaLink3:8530383;connectomeDB2020:15265897;connectomeDB2020:16284400;connectomeDB2020:7641685], IL2RG [Baccin2019:1526589;Baccin2019:78568232;CellTalkDB:15265897;Cellinker:15265897;Cellinker:8568232;DIP:10903799;DIP:8178155;DIP:9371812;Guide2Pharma:19710453;HPMR:15265897;HPRD:8568232;LRdb:15265897;LRdb:86;Lit-BM-17:10903799;Lit-BM-17:8178155;Lit-BM-17:9371812;NetPath:8026467;SIGNOR:11418623;connectomeDB2020:15265897;connectomeDB2020:8568232;scConnect:19710453], IL2RB [Baccin2019:15265897;Baccin2019:8026467;Baccin2019:9176231;CellTalkDB:15265897;DIP:10903799;Guide2Pharma:19710453;HPMR:15265897;HPRD:8026467;HPRD:9176231;InnateDB:8026467;InnateDB:8178155;IntAct:23104097;IntAct:25416956;LRdb:15265897;LRdb:8026467;LRdb:9176231;Lit-BM-17:10903799;NetPath:8026467;connectomeDB2020:15265897;connectomeDB2020:8026467;connectomeDB2020:9176231], IL2RA [CellTalkDB:8734356;LRdb:8734356;Ramilowski2015:8734356;connectomeDB2020:8734356;talklr:8734356], DLK1 [Cellinker:10733486]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]	cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]	aging [GO:0007568]; cell-cell signaling [GO:0007267]; cell maturation [GO:0048469]; cellular response to vitamin D [GO:0071305]; extrathymic T cell selection [GO:0045062]; hyaluronan metabolic process [GO:0030212]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-15-mediated signaling pathway [GO:0035723]; lymph node development [GO:0048535]; macrophage differentiation [GO:0030225]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of smooth muscle cell proliferation [GO:0048662]; neutrophil activation [GO:0042119]; NK T cell proliferation [GO:0001866]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production [GO:0001819]; positive regulation of immune response [GO:0050778]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein O-linked glycosylation [GO:1904100]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tissue remodeling [GO:0034105]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of defense response to virus by host [GO:0050691]; regulation of T cell differentiation [GO:0045580]; signal transduction [GO:0007165]; skeletal muscle atrophy [GO:0014732]; tyrosine phosphorylation of STAT protein [GO:0007260]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL15&keywords=IL15	2.41	371	NA	NA	1.03	260	0.12	0.07	0.04	0.05	0.09	0.04	0.02	0.02	0.03	0.02	0.02	210	201	196	0.05	0.67	0.51	0.60	271	315	284	287
WNT5A	Wnt family member 5A	Yes		ENSG00000114251	P41221	Wnt family	20	ecm, ligand, receptor	ecm, extracellular, intracellular, ligand, receptor, secreted	O00144, O60353, O75084, O75197, O75581, P01130, P07550, P34925, P43121, P98164, Q01973, Q01974, Q13308, Q13467, Q14332, Q15262, Q15375, Q96CG8, Q9H461, Q9H6X2, Q9NPG1, Q9UBE8, Q9ULK5, Q9ULV1, Q9ULW2, Q9UP38	ADRB2, ANTXR1, CTHRC1, EPHA7, FZD1, FZD10, FZD2, FZD3, FZD4, FZD5, FZD6, FZD7, FZD8, FZD9, LDLR, LRP2, LRP5, LRP6, MCAM, NLK, PTK7, PTPRK, ROR1, ROR2, RYK, VANGL2	FZD2 [Baccin2019:9389482;CellPhoneDB:24032637;CellTalkDB:24032637;Cellinker:9389482;LRdb:9389482;NetPath:19910923;SIGNOR:19008118;SIGNOR:19910923;SIGNOR:2808370;SPIKE:19910923;connectomeDB2020:19910923;connectomeDB2020:9389482], FZD5 [Baccin2019:9054360;CellPhoneDB:24032637;CellTalkDB:9054360;Cellinker:9054360;HPRD:9054360;ICELLNET:11029007;LRdb:9054360;SIGNOR:9054360;SPIKE:9054360;SignaLink3:23331499;SignaLink3:9054360;connectomeDB2020:9054360], ROR2 [Baccin2019:12839624;CellTalkDB:12839624;Cellinker:18606138;HPRD:12839624;LRdb:12839624;NetPath:12839624;SIGNOR:26690702;SPIKE:12839624;SPIKE:20215527;SPIKE:21069266;SignaLink3:17203201;SignaLink3:23331499;connectomeDB2020:12839624], FZD4 [Baccin2019:10990458;Cellinker:10990458;HPMR:10990458;LRdb:10990458;SIGNOR:16602827;SignaLink3:10990458;SignaLink3:23331499;connectomeDB2020:10990458], ROR1 [CellTalkDB:18287027;Cellinker:18287027;LRdb:18287027;NetPath:18287027;Ramilowski2015:18287027;SIGNOR:22343533;SIGNOR:23151663;SIGNOR:26690702;SignaLink3:21481194;SignaLink3:23331499;connectomeDB2020:18287027;talklr:18287027], NLK [SignaLink3:20706670;SignaLink3:23331499], FZD6 [Baccin2019:21665003;CellPhoneDB:24032637;Cellinker:21665003;Guide2Pharma:21665003;LRdb:21665003;SIGNOR:16273260;connectomeDB2020:21665003;scConnect:21665003], LRP6 [Baccin2019:28143772;CellTalkDB:23462101;Cellinker:18606138;NetPath:19056682;SIGNOR:15578921], RYK [Baccin2019:15598975;CellTalkDB:15598975;Cellinker:15598975;HPMR:15598975;LRdb:15598975;SIGNOR:22773843;connectomeDB2020:15598975], FZD3 [CellPhoneDB:24032637;CellTalkDB:24032637;Cellinker:24032637;LRdb:24032637;NetPath:17804197;SIGNOR:15578921;SIGNOR:16273260;SIGNOR:21903638;connectomeDB2020:24032637], PTK7 [CellTalkDB:26499793], LDLR [CellTalkDB:32196115], LRP5 [Baccin2019:19056682;CellTalkDB:16602827;LRdb:16602827;Ramilowski2015:16602827;connectomeDB2020:16602827;talklr:16602827], EPHA7 [CellTalkDB:32103204], VANGL2 [CellTalkDB:21316585], PTPRK [CellTalkDB:32103204], ADRB2 [CellTalkDB:32196115], FZD1 [Baccin2019:10557084;CellPhoneDB:24032637;CellTalkDB:10557084;Cellinker:10557084;HPRD:10557084;LRdb:10557084;MPPI:10557084;connectomeDB2020:10557084], FZD9 [CellTalkDB:27402827], FZD7 [Baccin2019:10990458;Cellinker:10990458;HPMR:10990458;LRdb:10990458;connectomeDB2020:10990458], FZD8 [CellTalkDB:21518267;LRdb:21518267;NetPath:20093360;Ramilowski2015:21518267;connectomeDB2020:21518267;talklr:21518267], ANTXR1 [CellTalkDB:32103204], LRP2 [CellTalkDB:32196115], MCAM [CellChatDB:24335906;CellTalkDB:24335906;Cellinker:24335906;LRdb:24335906;Ramilowski2015:24335906;connectomeDB2020:24335906;talklr:24335906], FZD10 [NA], CTHRC1 [Cellinker:18606138]	cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]	chemoattractant activity involved in axon guidance [GO:1902379]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase-like orphan receptor binding [GO:0005115]	activation of GTPase activity [GO:0090630]; activation of protein kinase B activity [GO:0032148]; anterior/posterior axis specification, embryo [GO:0008595]; atrial septum development [GO:0003283]; axon guidance [GO:0007411]; canonical Wnt signaling pathway [GO:0060070]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cellular protein localization [GO:0034613]; cellular response to calcium ion [GO:0071277]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cervix development [GO:0060067]; chemoattraction of serotonergic neuron axon [GO:0036517]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; cochlea morphogenesis [GO:0090103]; convergent extension involved in axis elongation [GO:0060028]; convergent extension involved in organogenesis [GO:0060029]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; epithelial to mesenchymal transition [GO:0001837]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; excitatory synapse assembly [GO:1904861]; face development [GO:0060324]; genitalia development [GO:0048806]; heart looping [GO:0001947]; hematopoietic stem cell proliferation [GO:0071425]; hindgut morphogenesis [GO:0007442]; hypophysis morphogenesis [GO:0048850]; inhibitory synapse assembly [GO:1904862]; JNK cascade [GO:0007254]; keratinocyte differentiation [GO:0030216]; kidney development [GO:0001822]; lateral sprouting involved in mammary gland duct morphogenesis [GO:0060599]; lens development in camera-type eye [GO:0002088]; lung development [GO:0030324]; male gonad development [GO:0008584]; mammary gland branching involved in thelarche [GO:0060744]; melanocyte proliferation [GO:0097325]; mesenchymal-epithelial cell signaling [GO:0060638]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; midgut development [GO:0007494]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation in midbrain [GO:1904934]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of melanin biosynthetic process [GO:0048022]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of synapse assembly [GO:0051964]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; notochord morphogenesis [GO:0048570]; olfactory bulb interneuron development [GO:0021891]; optic cup formation involved in camera-type eye development [GO:0003408]; paraxial mesoderm formation [GO:0048341]; planar cell polarity pathway involved in axis elongation [GO:0003402]; planar cell polarity pathway involved in axon guidance [GO:1904938]; planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:0061350]; planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:0061349]; planar cell polarity pathway involved in gastrula mediolateral intercalation [GO:0060775]; planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation [GO:1904955]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar cell polarity pathway involved in outflow tract morphogenesis [GO:0061347]; planar cell polarity pathway involved in pericardium morphogenesis [GO:0061354]; planar cell polarity pathway involved in ventricular septum morphogenesis [GO:0061348]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endocytosis [GO:0045807]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway [GO:0090082]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of ossification [GO:0045778]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of timing of anagen [GO:0051885]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; post-anal tail morphogenesis [GO:0036342]; postsynapse assembly [GO:0099068]; presynapse assembly [GO:0099054]; primary heart field specification [GO:0003138]; primitive streak formation [GO:0090009]; protein phosphorylation [GO:0006468]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of postsynapse organization [GO:0099175]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of synapse organization [GO:0050807]; response to organic substance [GO:0010033]; secondary heart field specification [GO:0003139]; secondary palate development [GO:0062009]; somitogenesis [GO:0001756]; type B pancreatic cell development [GO:0003323]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vagina development [GO:0060068]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT5A&keywords=WNT5A	8.45	253	NA	NA	1.40	212	0.17	0.00	0.00	0.51	0.02	0.00	0.01	0.00	0.00	0.00	0.00	295	375	328	0.06	0.17	0.15	0.17	448	445	442	321
IL1B	interleukin 1 beta	Yes		ENSG00000125538	P01584	IL-1 family	20	ligand	extracellular, intracellular, ligand, secreted	P05187, P07550, P14778, P27930, Q6IA17, Q9NPH3	ADRB2, ALPP, IL1B_IL1R1_IL1RAP, IL1B_IL1R2_IL1RAP, IL1R1, IL1R1_IL1RAP, IL1R2, IL1R2_IL1RAP, IL1RAP, SIGIRR	IL1R2 [Baccin2019:7878046;Baccin2019:8332913;CellTalkDB:8332913;Cellinker:7878046;Cellinker:8332913;HPMR:8332913;HPRD:7878046;InnateDB:1833184;InnateDB:20802483;InnateDB:7878046;LRdb:788;LRdb:8332913;NetPath:7878046;SIGNOR:8332913;SPIKE:7878046;connectomeDB2020:7878046;connectomeDB2020:8332913], IL1R1 [Baccin2019:62193;Baccin2019:9062193;Baccin2019:9820540;CellTalkDB:9062193;HPRD:9062193;InnateDB:8142597;LRdb:62193;LRdb:9062193;LRdb:9820540;Lit-BM-17:7878046;Lit-BM-17:9062193;Macrophage:9062193;NetPath:2946959;NetPath:7775431;SIGNOR:24166242;SIGNOR:9625767;SPIKE:17145710;SPIKE:9062193;SignaLink3:23331499;SignaLink3:9062193;connectomeDB2020:62193;connectomeDB2020:9062193;connectomeDB2020:9820540], IL1RAP [Baccin2019:9820540;CellTalkDB:9820540;HPRD:9820540;InnateDB:20802483;LRdb:9820540;NetPath:7775431;SIGNOR:9820540;connectomeDB2020:9820540], SIGIRR [CellTalkDB:14715412], ADRB2 [CellTalkDB:11238007;HPRD:11238007;LRdb:11238007], ALPP [InnateDB:9099704]	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; secretory granule [GO:0030141]	cytokine activity [GO:0005125]; integrin binding [GO:0005178]; interleukin-1 receptor binding [GO:0005149]; protein domain specific binding [GO:0019904]	apoptotic process [GO:0006915]; astrocyte activation [GO:0048143]; cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; cellular response to xenobiotic stimulus [GO:0071466]; cytokine-mediated signaling pathway [GO:0019221]; ectopic germ cell programmed cell death [GO:0035234]; embryo implantation [GO:0007566]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fever generation [GO:0001660]; hyaluronan biosynthetic process [GO:0030213]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; MAPK cascade [GO:0000165]; monocyte aggregation [GO:0070487]; negative regulation of adiponectin secretion [GO:0070164]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of lipid metabolic process [GO:0045833]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neurogenesis [GO:0050768]; negative regulation of synaptic transmission [GO:0050805]; neutrophil chemotaxis [GO:0030593]; positive regulation of angiogenesis [GO:0045766]; positive regulation of calcidiol 1-monooxygenase activity [GO:0060559]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of complement activation [GO:0045917]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fever generation [GO:0031622]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of myosin light chain kinase activity [GO:0035505]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of phagocytosis [GO:0050766]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of RNA biosynthetic process [GO:1902680]; positive regulation of T cell mediated immunity [GO:0002711]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein kinase B signaling [GO:0043491]; regulation of defense response to virus by host [GO:0050691]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of nitric-oxide synthase activity [GO:0050999]; response to ATP [GO:0033198]; response to carbohydrate [GO:0009743]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; sequestering of triglyceride [GO:0030730]; signal transduction [GO:0007165]; smooth muscle adaptation [GO:0014805]; vascular endothelial growth factor production [GO:0010573]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL1B&keywords=IL1B	3.98	314	NA	NA	2.35	135	12.77	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	299	376	371	1.16	0.01	0.01	0.01	527	524	526	337
VEGFC	vascular endothelial growth factor C	Yes		ENSG00000150630	P49767	PDGF/VEGF growth factor family	20	ligand	extracellular, intracellular, ligand, secreted	O60462, P05556, P17948, P35916, P35968, P41587, Q13797, Q6UXH8, Q9Y5Y7	CCBE1, FLT1, FLT4, FLT4_KDR, ITGA9, ITGB1, KDR, LYVE1, NRP2, VIPR2	FLT4 [Baccin2019:12881528;Baccin2019:16530705;Baccin2019:8700872;CellChatDB:16633338;CellTalkDB:12881528;Cellinker:12881528;Cellinker:16530705;Cellinker:8700872;DIP:8700872;HPMR:12881528;HPRD:16530705;HPRD:8700872;ICELLNET:11532940;ICELLNET:16336962;LRdb:12881528;LRdb:16530705;LRdb:8700872;ProtMapper:24798152;SIGNOR:9435229;connectomeDB2020:12881528;connectomeDB2020:16530705;connectomeDB2020:8700872], KDR [Baccin2019:11332691;Baccin2019:8612600;CellChatDB:16633338;CellTalkDB:8612600;Cellinker:11332691;Cellinker:8612600;DIP:20145116;HPRD:11332691;ICELLNET:11181169;IntAct:20145116;LRdb:11332691;LRdb:8612600;Lit-BM-17:20145116;SIGNOR:9435229;connectomeDB2020:11332691;connectomeDB2020:8612600], NRP2 [Baccin2019:8612600;CellTalkDB:8612600;Cellinker:8612600;ELM:25752543;ICELLNET:16621967;LRdb:8612600;SIGNOR:16816121;connectomeDB2020:8612600], LYVE1 [CellTalkDB:32196115], ITGA9 [CellTalkDB:15590642], FLT1 [CellTalkDB:32196115], ITGB1 [CellTalkDB:15590642], CCBE1 [CellTalkDB:27159393], VIPR2 [Cellinker:12881528;HPMR:12881528;LRdb:12881528;connectomeDB2020:12881528]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]	chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; vascular endothelial growth factor receptor 3 binding [GO:0043185]; vascular endothelial growth factor receptor binding [GO:0005172]	animal organ morphogenesis [GO:0009887]; cellular response to leukemia inhibitory factor [GO:1990830]; induction of positive chemotaxis [GO:0050930]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of blood pressure [GO:0045776]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of lymphangiogenesis [GO:1901492]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein secretion [GO:0050714]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; substrate-dependent cell migration [GO:0006929]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=VEGFC&keywords=VEGFC	2.43	369	NA	NA	0.26	486	0.00	0.01	0.02	0.06	0.00	0.01	0.02	0.04	0.03	0.00	0.03	202	374	180	0.02	1.38	0.36	1.36	63	359	45	397
CXCL12	C-X-C motif chemokine ligand 12	Yes		ENSG00000107562	P48061	Intercrine alpha (chemokine CxC) family	20	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted	P01730, P02751, P05106, P05556, P06756, P08648, P08913, P13612, P25106, P27487, P31431, P37288, P48039, P49682, P51679, P61073, Q14831	ACKR3, ADRA2A, AVPR1A, CCR4, CD4, CXCR3, CXCR4, DPP4, FN1, GRM7, ITGA4, ITGA5, ITGAV, ITGB1, ITGB3, MTNR1A, SDC4	ACKR3 [Baccin2019:16107333;CellTalkDB:16107333;Cellinker:16107333;Cellinker:20956518;Cellinker:23396314;Guide2Pharma:20956518;Guide2Pharma:23396314;HPMR:16107333;ICELLNET:20161793;ICELLNET:22633458;ICELLNET:24218476;LRdb:16107333;LRdb:20956518;LRdb:23396314;SIGNOR:16107333;connectomeDB2020:16107333;connectomeDB2020:20956518;connectomeDB2020:23396314;scConnect:20956518;scConnect:23396314], CXCR3 [Cellinker:9660793;Guide2Pharma:9660793;LRdb:9660793;connectomeDB2020:9660793;scConnect:9660793], CXCR4 [Baccin2019:10233851;Baccin2019:12714578;Baccin2019:8752280;Baccin2019:8752281;Baccin2019:9551924;Baccin2019:9712844;BioGRID:21757744;BioGRID:25495026;CellPhoneDB:24218476;Cellinker:10233851;Cellinker:12714578;Cellinker:18448868;Cellinker:8752280;Cellinker:8752281;Cellinker:9551924;Cellinker:9712844;Guide2Pharma:16626895;Guide2Pharma:18648536;Guide2Pharma:30476826;Guide2Pharma:9551924;Guide2Pharma:9712844;HPMR:8752280;HPRD:10233851;HPRD:8752281;ICELLNET:22633458;InnateDB:16725153;InnateDB:19837984;LRdb:10699158;ProtMapper:24023874;ProtMapper:26582643;SIGNOR:11859124;connectomeDB2020:10233851;connectomeDB2020:12714578;connectomeDB2020:8752280;connectomeDB2020:8752281;connectomeDB2020:9551924;connectomeDB2020:9712844;scConnect:16626895;scConnect:18648536;scConnect:30476826;scConnect:9551924;scConnect:9712844], ITGB1 [CellTalkDB:18448868;Cellinker:18448868;LRdb:18448868;Ramilowski2015:18448868;connectomeDB2020:18448868;talklr:18448868], CD4 [CellTalkDB:10600606;Cellinker:10600606;HPRD:10600606;LRdb:10600606;connectomeDB2020:10600606], ADRA2A [CellTalkDB:32196115], AVPR1A [CellTalkDB:29386406], MTNR1A [CellTalkDB:32196115], CCR4 [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], DPP4 [CellPhoneDB:24218476;CellTalkDB:30759373;Cellinker:11390394;HPRD:11390394], SDC4 [Baccin2019:19695308;CellTalkDB:32196115], ITGA4 [connectomeDB2020:29301984], ITGA5 [connectomeDB2020:29301984], ITGAV [connectomeDB2020:29301984], ITGB3 [connectomeDB2020:29301984], FN1 [HPRD:11023498]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleus [GO:0005634]	chemokine activity [GO:0008009]; chemokine receptor binding [GO:0042379]; CXCR chemokine receptor binding [GO:0045236]; growth factor activity [GO:0008083]; integrin binding [GO:0005178]; signaling receptor binding [GO:0005102]	adult locomotory behavior [GO:0008344]; animal organ regeneration [GO:0031100]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; axon guidance [GO:0007411]; blood circulation [GO:0008015]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cellular calcium ion homeostasis [GO:0006874]; cellular response to chemokine [GO:1990869]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; defense response [GO:0006952]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; induction of positive chemotaxis [GO:0050930]; integrin activation [GO:0033622]; killing of cells of other organism [GO:0031640]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of leukocyte tethering or rolling [GO:1903237]; neuron migration [GO:0001764]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of T cell migration [GO:2000406]; regulation of actin polymerization or depolymerization [GO:0008064]; response to heat [GO:0009408]; response to hypoxia [GO:0001666]; response to peptide hormone [GO:0043434]; response to radiation [GO:0009314]; response to ultrasound [GO:1990478]; response to virus [GO:0009615]; signal transduction [GO:0007165]; T cell chemotaxis [GO:0010818]; telencephalon cell migration [GO:0022029]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCL12&keywords=CXCL12	8.11	257	NA	NA	0.16	563	0.05	0.00	0.15	0.05	0.16	0.01	0.00	0.01	0.03	0.00	0.01	205	371	271	0.04	0.77	0.21	0.31	232	413	390	401
NGF	nerve growth factor	Yes		ENSG00000134259	P01138	NGF-beta family	20	ligand	extracellular, intracellular, ligand, secreted	P04626, P04629, P08138, Q00994, Q8NER1, Q96PQ0, Q99523, Q9ULH0, Q9UPU3, Q9Y5V3	BEX3, ERBB2, KIDINS220, MAGED1, NGFR, NTRK1, SORCS2, SORCS3, SORT1, TRPV1	NTRK1 [AlzPathway:17404842;AlzPathway:9775403;Baccin2019:10490030;Baccin2019:14985763;BioGRID:10490030;CA1:1706478;CA1:9290260;CA1:9547236;CellChatDB:27908981;CellTalkDB:10490030;Cellinker:10490030;Cellinker:14985763;Cellinker:24224055;Cellinker:27908981;DIP:10490030;DIP:10713102;DIP:1849459;DIP:9083066;DIP:9857023;HPMR:10490030;HPRD:10490030;HPRD:14985763;IntAct:10490030;IntAct:14985763;LRdb:10490030;LRdb:15;Lit-BM-17:10490030;Lit-BM-17:10713102;Lit-BM-17:11729324;Lit-BM-17:11738045;Lit-BM-17:14985763;Lit-BM-17:1849459;Lit-BM-17:9083066;Lit-BM-17:9857023;ProtMapper:12067229;ProtMapper:17409494;ProtMapper:22666365;ProtMapper:23772401;ProtMapper:25611061;ProtMapper:27229480;ProtMapper:28090201;SIGNOR:11114882;SPIKE:14985763;SPIKE:17145710;SPIKE:8155326;connectomeDB2020:10490030;connectomeDB2020:14985763], NGFR [AlzPathway:16893414;AlzPathway:9775403;Baccin2019:11114882;Baccin2019:14985763;CellTalkDB:11114882;Cellinker:11114882;Cellinker:14985763;Cellinker:24224055;DIP:1372492;DIP:1714587;DIP:2172988;DIP:3037029;Guide2Pharma:22227462;HPMR:11114882;HPRD:14985763;LRdb:11114882;LRdb:15;Lit-BM-17:11729324;Lit-BM-17:1372492;Lit-BM-17:14985763;Lit-BM-17:1714587;Lit-BM-17:2172988;Lit-BM-17:3037029;SIGNOR:10764727;SIGNOR:14699954;connectomeDB2020:11114882;connectomeDB2020:14985763;scConnect:22227462], SORCS2 [CellTalkDB:30061605], TRPV1 [CellTalkDB:17074976], MAGED1 [CellTalkDB:32196115], BEX3 [CellTalkDB:32196115], SORCS3 [Baccin2019:15710408;CellTalkDB:15710408;Cellinker:15710408;HPRD:15710408;LRdb:15710408;connectomeDB2020:15710408], SORT1 [CellTalkDB:14985763;Cellinker:14985763;DIP:19122660;HPMR:14985763;HPRD:14985763;IntAct:14985763;IntAct:19122660;LRdb:14985763;Lit-BM-17:14985763;Lit-BM-17:19122660;connectomeDB2020:14985763], KIDINS220 [CellTalkDB:32196115], ERBB2 [Cellinker:12181354]	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; synaptic vesicle [GO:0008021]	cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; death receptor agonist activity [GO:0038177]; growth factor activity [GO:0008083]; lipid binding [GO:0008289]; metalloendopeptidase inhibitor activity [GO:0008191]; nerve growth factor receptor binding [GO:0005163]	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; nerve development [GO:0021675]; nerve growth factor signaling pathway [GO:0038180]; neuron apoptotic process [GO:0051402]; neuron projection morphogenesis [GO:0048812]; peripheral nervous system development [GO:0007422]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of DNA binding [GO:0043388]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of neuron differentiation [GO:0045664]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NGF&keywords=NGF	1.59	405	NA	NA	0.24	503	0.00	0.03	0.00	0.05	0.00	0.01	0.00	0.00	0.00	0.00	0.01	301	401	241	0.01	0.56	0.53	1.14	320	305	69	404
CSF3	colony stimulating factor 3	Yes		ENSG00000108342	P09919	IL-6 superfamily	20	ligand	extracellular, intracellular, ligand, secreted	P07333, P15509, P32927, Q99062	CSF1R, CSF2RA, CSF2RB, CSF3R	CSF3R [Baccin2019:10364174;CellTalkDB:10364174;Cellinker:10364174;DIP:16492764;HPRD:10364174;ICELLNET:10537111;LRdb:10364174;SIGNOR:16492764;SPIKE:15676205;SignaLink3:10364174;SignaLink3:16492764;SignaLink3:23331499;connectomeDB2020:10364174], CSF2RA [SIGNOR:10572088;SignaLink3:10572088;SignaLink3:23331499], CSF1R [NA], CSF2RB [NA]	endocytic vesicle lumen [GO:0071682]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]	cytokine activity [GO:0005125]; enzyme binding [GO:0019899]; granulocyte colony-stimulating factor receptor binding [GO:0005130]; growth factor activity [GO:0008083]	cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; granulocyte differentiation [GO:0030851]; immune response [GO:0006955]; negative regulation of neuron death [GO:1901215]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to ethanol [GO:0045471]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CSF3&keywords=CSF3	0.65	499	NA	NA	0.40	421	0.00	0.00	0.05	0.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	302	403	396	0.02	0.34	0.34	0.34	395	366	379	422
BDNF	brain derived neurotrophic factor	Yes		ENSG00000176697	P23560	NGF-beta family	20	ligand	extracellular, intracellular, ligand, secreted, transmembrane, transmembrane_predicted	P04626, P08138, P20783, P21917, Q00994, Q08345, Q16620, Q8TDT2, Q99523, Q9Y624	BEX3, DDR1, DRD4, ERBB2, F11R, GPR152, NGFR, NTF3, NTRK2, SORT1	NTRK2 [AlzPathway:9775403;Baccin2019:76445409312147;BioGRID:21651720;BioGRID:9312147;CA1:1645620;CA1:9648856;CellChatDB:27908981;CellTalkDB:7644540;Cellinker:27908981;Cellinker:7644540;Cellinker:9312147;DIP:9312147;HPMR:7644540;HPRD:9312147;LRdb:7644540;LRdb:931;Lit-BM-17:11855816;Lit-BM-17:21651720;Lit-BM-17:9312147;ProtMapper:21849472;ProtMapper:26740873;ProtMapper:26899129;ProtMapper:28679669;SIGNOR:7679912;SignaLink3:23331499;SignaLink3:9312147;connectomeDB2020:7644540;connectomeDB2020:9312147], NGFR [AlzPathway:9775403;Cellinker:19908279;connectomeDB2020:25354496], DRD4 [CellTalkDB:32196115], SORT1 [Baccin2019:15987945;CellTalkDB:15987945;Cellinker:15987945;DIP:19122660;HPRD:15987945;LRdb:15987945;connectomeDB2020:15987945], BEX3 [CellTalkDB:10764727;HPMR:7644540;LRdb:7644540], DDR1 [NA], ERBB2 [Cellinker:28446206], F11R [NA], GPR152 [NA], NTF3 [BioGRID:7703225;DIP:7703225;HPRD:7703225]	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; synaptic vesicle [GO:0008021]	growth factor activity [GO:0008083]; nerve growth factor receptor binding [GO:0005163]	axon guidance [GO:0007411]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; collateral sprouting [GO:0048668]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neuron apoptotic process [GO:0043524]; nerve development [GO:0021675]; nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; peripheral nervous system development [GO:0007422]; positive regulation of brain-derived neurotrophic factor receptor signaling pathway [GO:0031550]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of receptor binding [GO:1900122]; positive regulation of synapse assembly [GO:0051965]; regulation of neuron differentiation [GO:0045664]; regulation of protein localization to cell surface [GO:2000008]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BDNF&keywords=BDNF	0.42	540	NA	NA	0.57	356	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	448
IL5	interleukin 5	Yes		ENSG00000113525	P05113	IL-5 family	20	ligand	extracellular, ligand, secreted	P15509, P32927, Q01344	CSF2RA, CSF2RB, CSF2RB_IL5RA, IL5RA	IL5RA [Baccin2019:10880230;Baccin2019:11748263;Baccin2019:1732409;Baccin2019:7721873;BioGRID:10823900;BioGRID:1732409;CellTalkDB:11748263;DIP:1495999;DIP:22153509;HPRD:10880230;HPRD:1732409;HPRD:7721873;InnateDB:1732409;InnateDB:7721873;IntAct:22153509;LRdb:10880230;LRdb:11748263;LRdb:1732409;LRdb:7721873;Lit-BM-17:1495999;Lit-BM-17:1732409;Lit-BM-17:7721873;Lit-BM-17:7957082;NetPath:1732409;NetPath:1833065;SIGNOR:8567620;SignaLink3:22528658;SignaLink3:23331499;SignaLink3:8567620;connectomeDB2020:10880230;connectomeDB2020:11748263;connectomeDB2020:1732409;connectomeDB2020:7721873], CSF2RB [Baccin2019:11748263;CellTalkDB:11748263;DIP:7957082;InnateDB:1495999;LMPID:7957082;LRdb:11748263;Lit-BM-17:1495999;Lit-BM-17:7957082;NetPath:1833065;connectomeDB2020:11748263], CSF2RA [Cellinker:23046136]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-5 receptor binding [GO:0005137]	cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; inflammatory response [GO:0006954]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of eosinophil differentiation [GO:0045645]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of podosome assembly [GO:0071803]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription, DNA-templated [GO:0045893]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL5&keywords=IL5	0.15	642	NA	NA	0.82	296	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	469
THPO	thrombopoietin	Yes		ENSG00000090534	P40225	EPO/TPO family	20	ligand	extracellular, intracellular, ligand, secreted	O00241, P40238, Q5TFQ8	MPL, SIRPB1	MPL [Baccin2019:10495959;Baccin2019:9766811;CellTalkDB:10495959;Cellinker:10495959;Cellinker:8521814;Cellinker:9766811;DIP:9252374;HPRD:9766811;ICELLNET:11784712;LRdb:10495959;LRdb:98;SIGNOR:11784712;SignaLink3:23331499;SignaLink3:7543416;SignaLink3:9766811;connectomeDB2020:10495959;connectomeDB2020:9766811], SIRPB1 [NA], SIRPB1 [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]	cell population proliferation [GO:0008283]; cellular response to lipopolysaccharide [GO:0071222]; megakaryocyte development [GO:0035855]; multicellular organism development [GO:0007275]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; receptor signaling pathway via STAT [GO:0097696]; thrombopoietin-mediated signaling pathway [GO:0038163]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=THPO&keywords=THPO	0.17	630	NA	NA	0.07	681	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	656
NTF3	neurotrophin 3	Yes		ENSG00000185652	P20783	NGF-beta family	20	ligand	extracellular, intracellular, ligand, secreted	P04629, P08138, P23560, Q16288, Q16620	BDNF, NGFR, NTRK1, NTRK2, NTRK3	NTRK3 [AlzPathway:9775403;Baccin2019:7679912;Baccin2019:9488719;Baccin2019:9973222;CellChatDB:27908981;CellTalkDB:7679912;Cellinker:27908981;Cellinker:7679912;Cellinker:9488719;Cellinker:9973222;DIP:10713102;HPMR:1653651;HPMR:7679912;HPRD:9488719;HPRD:9973222;LRdb:7679912;LRdb:9488719;LRdb:9973222;SIGNOR:1653651;SignaLink3:1653651;SignaLink3:23331499;connectomeDB2020:7679912;connectomeDB2020:9488719;connectomeDB2020:9973222], NGFR [AlzPathway:9775403;CellTalkDB:20036257;connectomeDB2020:27434667], NTRK1 [CellChatDB:27908981;CellTalkDB:17439940;Cellinker:27908981;LRdb:17439940;Ramilowski2015:17439940;connectomeDB2020:17439940;talklr:17439940], NTRK2 [Baccin2019:8621424;CellChatDB:27908981;CellTalkDB:8621424;Cellinker:27908981;HPRD:8621424;LRdb:8621424;connectomeDB2020:8621424], BDNF [BioGRID:7703225;DIP:7703225;HPRD:7703225]	axon [GO:0030424]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; synaptic vesicle [GO:0008021]	chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; nerve growth factor receptor binding [GO:0005163]; signaling receptor binding [GO:0005102]	activation of GTPase activity [GO:0090630]; activation of protein kinase B activity [GO:0032148]; cell-cell signaling [GO:0007267]; induction of positive chemotaxis [GO:0050930]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; nerve development [GO:0021675]; nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; peripheral nervous system development [GO:0007422]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of receptor internalization [GO:0002092]; regulation of apoptotic process [GO:0042981]; regulation of neuron differentiation [GO:0045664]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NTF3&keywords=NTF3	0.07	701	NA	NA	0.03	770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	736
IL9	interleukin 9	Yes		ENSG00000145839	P15248	IL-7/IL-9 family	20	ligand	extracellular, ligand, secreted	P31785, P80370, Q01113	DLK1, IL2RG, IL2RG_IL9R, IL9R	IL9R [Baccin2019:953591811588013;CellTalkDB:9535918;DIP:9261146;HPMR:9535918;HPRD:11588013;LRdb:116;LRdb:9535918;NetPath:1376929;SIGNOR:10642536;SignaLink3:10642536;SignaLink3:23331499;connectomeDB2020:11588013;connectomeDB2020:9535918], IL2RG [Baccin2019:9535918;CellTalkDB:9535918;HPMR:9535918;LRdb:9535918;NetPath:7718508;SIGNOR:11418623;connectomeDB2020:9535918], DLK1 [Cellinker:10733486]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-9 receptor binding [GO:0005140]	B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; immunoglobulin mediated immune response [GO:0016064]; inflammatory response [GO:0006954]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of interleukin-5 production [GO:0032754]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL9&keywords=IL9	0.00	899	NA	NA	0.15	575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	737
IL13	interleukin 13	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000169194	P35225	IL-4/IL-13 family	20	ligand	extracellular, intracellular, ligand, secreted, transmembrane	P24394, P31785, P78552, Q14627, Q86XT9	IL13_IL13RA1_IL4R, IL13RA1, IL13RA1_IL4R, IL13RA2, IL13RA2_IL4R, IL2RG, IL4R, TMEM219	IL13RA1 [Baccin2019:1270434311278620;CellTalkDB:12704343;DIP:20223216;DIP:8910586;HPMR:12704343;HPRD:11278629;InnateDB:9013879;IntAct:18243101;IntAct:20223216;LRdb:11;LRdb:12704343;Lit-BM-17:18243101;Lit-BM-17:8910586;SIGNOR:12704343;SignaLink3:10485906;SignaLink3:11867689;SignaLink3:12223527;SignaLink3:12401408;SignaLink3:14610620;SignaLink3:14657224;SignaLink3:15099563;SignaLink3:16243976;SignaLink3:16413922;SignaLink3:17404308;SignaLink3:17485448;SignaLink3:18250477;SignaLink3:18451175;SignaLink3:19833085;SignaLink3:20184663;SignaLink3:20406969;SignaLink3:20510870;SignaLink3:20856220;SignaLink3:21097505;SignaLink3:21115385;SignaLink3:21469115;SignaLink3:21840487;SignaLink3:23124025;SignaLink3:23180781;SignaLink3:23331499;SignaLink3:23390297;SignaLink3:24030977;SignaLink3:24091328;SignaLink3:26192618;SignaLink3:26755705;SignaLink3:27216177;SignaLink3:7512720;SignaLink3:7521688;SignaLink3:7543512;SignaLink3:8910586;SignaLink3:9013879;SignaLink3:9535722;connectomeDB2020:11278629;connectomeDB2020:12704343], IL13RA2 [Baccin2019:1270434311003390;CellPhoneDB:26471366;CellTalkDB:26471366;DIP:20223216;DIP:8663118;HPMR:12704343;HPRD:11003391;ICELLNET:8663118;InnateDB:8663118;IntAct:20223216;IntAct:23972995;IntAct:27629921;LRdb:11;LRdb:12704343;SignaLink3:12223527;SignaLink3:12401408;SignaLink3:14610620;SignaLink3:14657224;SignaLink3:14985454;SignaLink3:15099563;SignaLink3:18250477;SignaLink3:18451175;SignaLink3:20184663;SignaLink3:21097505;SignaLink3:23180781;SignaLink3:23331499;SignaLink3:26192618;SignaLink3:26755705;SignaLink3:8663118;SignaLink3:9535722;connectomeDB2020:11003391;connectomeDB2020:12704343], IL4R [Baccin2019:1270434311709750;CellTalkDB:8920992;DIP:7721786;HPMR:12704343;HPRD:11709756;InnateDB:18243101;InnateDB:8910586;LRdb:12;LRdb:12704343;NetPath:7721786;SIGNOR:12704343;SIGNOR:19880493;connectomeDB2020:11709756;connectomeDB2020:12704343], TMEM219 [CellTalkDB:32103204], IL2RG [CellTalkDB:8920992;Ramilowski2015:8920992;connectomeDB2020:8920992;talklr:8920992]	cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; interleukin-13 receptor binding [GO:0005144]	cellular response to cytokine stimulus [GO:0071345]; cellular response to mechanical stimulus [GO:0071260]; immune response [GO:0006955]; inflammatory response [GO:0006954]; macrophage activation [GO:0042116]; microglial cell activation [GO:0001774]; negative regulation of complement-dependent cytotoxicity [GO:1903660]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lung ciliated cell differentiation [GO:1901247]; negative regulation of NAD(P)H oxidase activity [GO:0033861]; negative regulation of neuron death [GO:1901215]; negative regulation of transforming growth factor beta production [GO:0071635]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of gene expression [GO:0010628]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of lung goblet cell differentiation [GO:1901251]; positive regulation of macrophage activation [GO:0043032]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of pancreatic stellate cell proliferation [GO:2000231]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of proton transport [GO:0010155]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL13&keywords=IL13	0.02	783	NA	NA	0.03	783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	783
CCL25	C-C motif chemokine ligand 25	Yes		ENSG00000131142	O15444	Intercrine beta (chemokine CC) family	20	ligand	extracellular, intracellular, ligand, secreted	O00590, P08913, P46092, P48039, P51686, Q14831, Q9NPB9	ACKR2, ACKR4, ADRA2A, CCR10, CCR9, GRM7, MTNR1A	ACKR4 [CellPhoneDB:24218476;CellTalkDB:23341447;Cellinker:10706668;Cellinker:23341447;Guide2Pharma:23341447;HPRD:10706668;ICELLNET:22633458;InnateDB:10706668;LRdb:11;LRdb:23341447;connectomeDB2020:10706668;connectomeDB2020:23341447;scConnect:23341447], CCR9 [Baccin2019:10229797;Baccin2019:10498628;Baccin2019:11159507;CellPhoneDB:24218476;CellTalkDB:10699158;Cellinker:11159507;DIP:10229797;DIP:10498628;HPMR:11159507;HPRD:10229797;HPRD:10498628;ICELLNET:22633458;LRdb:10699158;SIGNOR:11159507;connectomeDB2020:10229797;connectomeDB2020:10498628;connectomeDB2020:11159507], ACKR2 [CellTalkDB:10706668;Cellinker:10706668;HPRD:10706668;LRdb:10706668;connectomeDB2020:10706668], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], CCR10 [Baccin2019:10706668;CellTalkDB:10706668;Cellinker:10706668;HPRD:10706668;LRdb:10706668;connectomeDB2020:10706668], GRM7 [CellTalkDB:32196115]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR10 chemokine receptor binding [GO:0031735]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; chemokine receptor binding [GO:0042379]; hormone activity [GO:0005179]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell chemotaxis [GO:0060326]; cell surface receptor signaling pathway [GO:0007166]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; negative regulation of leukocyte tethering or rolling [GO:1903237]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL25&keywords=CCL25	0.01	815	NA	NA	0.02	800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	808
WNT4	Wnt family member 4	Yes		ENSG00000162552	P56705	Wnt family	19	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	O60353, O75197, O75581, P46531, Q14332, Q99835, Q9H461, Q9NPG1, Q9UP38	FZD1, FZD1_LRP5, FZD1_LRP6, FZD10_LRP5, FZD10_LRP6, FZD2, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4_LRP5, FZD4_LRP6, FZD5_LRP5, FZD5_LRP6, FZD6, FZD6_LRP5, FZD6_LRP6, FZD7_LRP5, FZD7_LRP6, FZD8, FZD8_LRP5, FZD8_LRP6, FZD9_LRP5, FZD9_LRP6, LRP5, LRP6, NOTCH1, SMO	FZD3 [SignaLink3:14671310;SignaLink3:23331499], FZD6 [Baccin2019:15265686;Baccin2019:21541287;CellPhoneDB:24032637;Guide2Pharma:15265686;Guide2Pharma:21541287;HPMR:15265686;HPRD:15265686;LRdb:15265686;LRdb:21541287;NetPath:15265686;connectomeDB2020:15265686;connectomeDB2020:21541287;scConnect:15265686;scConnect:21541287], LRP5 [SIGNOR:15578921], LRP6 [SIGNOR:15578921], FZD8 [CellTalkDB:32103204], FZD2 [Baccin2019:12325120;CellTalkDB:12325120;HPMR:12325120;LRdb:12325120;connectomeDB2020:12325120], SMO [CellTalkDB:32103204], NOTCH1 [CellTalkDB:32103204], FZD1 [CellTalkDB:32103204]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; transcription corepressor activity [GO:0003714]	adrenal gland development [GO:0030325]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic epithelial tube formation [GO:0001838]; epithelial to mesenchymal transition [GO:0001837]; female gonad development [GO:0008585]; female sex determination [GO:0030237]; hormone metabolic process [GO:0042445]; immature T cell proliferation in thymus [GO:0033080]; kidney development [GO:0001822]; liver development [GO:0001889]; male gonad development [GO:0008584]; mammary gland epithelium development [GO:0061180]; mesenchymal to epithelial transition [GO:0060231]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric nephron morphogenesis [GO:0072273]; metanephric tubule formation [GO:0072174]; negative regulation of androgen biosynthetic process [GO:2000180]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression [GO:0010629]; negative regulation of male gonad development [GO:2000019]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of testicular blood vessel morphogenesis [GO:0061369]; negative regulation of testosterone biosynthetic process [GO:2000225]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of wound healing [GO:0061045]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway via MAPK cascade [GO:0038030]; oocyte development [GO:0048599]; paramesonephric duct development [GO:0061205]; positive regulation of aldosterone biosynthetic process [GO:0032349]; positive regulation of bone mineralization [GO:0030501]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cortisol biosynthetic process [GO:2000066]; positive regulation of dermatome development [GO:0061184]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of GTPase activity [GO:0043547]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell-cell adhesion [GO:0022407]; renal vesicle formation [GO:0072033]; renal vesicle induction [GO:0072034]; smooth muscle cell differentiation [GO:0051145]; somatotropin secreting cell differentiation [GO:0060126]; tertiary branching involved in mammary gland duct morphogenesis [GO:0060748]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT4&keywords=WNT4	36.94	116	NA	NA	11.31	43	0.02	0.18	0.01	0.03	0.13	1.42	1.95	0.53	0.24	1.44	0.22	70	22	66	0.56	0.44	2.55	0.40	364	11	352	48
CCL28	C-C motif chemokine ligand 28	Yes		ENSG00000151882	Q9NRJ3	Intercrine beta (chemokine CC) family	19	ligand	extracellular, ligand, secreted	O00590, P08913, P46092, P48039, P51677, Q14831, Q9NPB9	ACKR2, ACKR4, ADRA2A, CCR10, CCR3, GRM7, MTNR1A	CCR10 [Baccin2019:10781587;Baccin2019:10975800;Cellinker:10781587;Cellinker:10975800;HPRD:10781587;HPRD:10975800;ICELLNET:22633458;LRdb:10781587;LRdb:11;connectomeDB2020:10781587;connectomeDB2020:10975800], CCR3 [Baccin2019:10975800;Baccin2019:12964882;CellTalkDB:12964882;Cellinker:10975800;Cellinker:12964882;HPRD:10975800;ICELLNET:22633458;LRdb:11;LRdb:12964882;connectomeDB2020:10975800;connectomeDB2020:12964882], ACKR2 [Baccin2019:10781587;Cellinker:10781587;HPRD:10781587;LRdb:28843907;connectomeDB2020:10781587], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], ACKR4 [HPRD:10781587]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	chemokine activity [GO:0008009]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; cytolysis in other organism [GO:0051715]; immune response [GO:0006955]; killing of cells of other organism [GO:0031640]; negative regulation of leukocyte tethering or rolling [GO:1903237]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; response to nutrient [GO:0007584]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL28&keywords=CCL28	18.57	175	NA	NA	2.69	123	0.00	0.11	0.00	0.01	0.07	0.08	0.09	0.08	0.07	0.05	0.04	150	145	165	0.06	1.22	0.90	0.76	84	168	205	153
AREG	amphiregulin	Yes		ENSG00000109321	P15514	Amphiregulin family	19	cell_surface_ligand, ligand	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	P00533, P04626, P05362, P14780, P21860	EGFR, EGFR_ERBB2, ERBB2, ERBB3, ICAM1, MMP9	EGFR [Baccin2019:10085134;Baccin2019:2466334;CellTalkDB:2466334;HPRD:10085134;ICELLNET:2466334;LRdb:101;LRdb:2466334;ProtMapper:23762360;ProtMapper:29045902;SIGNOR:10085134;SIGNOR:10209155;SIGNOR:20513444;SignaLink3:10085134;SignaLink3:10209155;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:10085134;connectomeDB2020:2466334], ERBB2 [SIGNOR:7679104;SignaLink3:23331499;SignaLink3:7679104], ERBB3 [CellTalkDB:8702723;LRdb:8702723;Ramilowski2015:8702723;connectomeDB2020:8702723;talklr:8702723], ICAM1 [NA], MMP9 [HPRD:10389762]	cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]	cytokine activity [GO:0005125]; epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]	cell-cell signaling [GO:0007267]; dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis [GO:0060598]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; glial cell proliferation [GO:0014009]; G protein-coupled receptor signaling pathway [GO:0007186]; mammary gland alveolus development [GO:0060749]; mammary gland branching involved in thelarche [GO:0060744]; negative regulation of osteoblast differentiation [GO:0045668]; neuron projection development [GO:0031175]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of keratinocyte proliferation [GO:0010838]; response to cAMP [GO:0051591]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to peptide hormone [GO:0043434]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=AREG&keywords=AREG	16.05	188	NA	NA	1.86	172	0.11	1.14	0.00	0.14	0.09	0.06	0.03	0.02	0.10	0.02	0.15	126	202	86	0.17	0.61	0.16	0.87	299	435	153	249
CCL7	C-C motif chemokine ligand 7	Yes		ENSG00000108688	P80098	Intercrine beta (chemokine CC) family	19	ligand	extracellular, intracellular, ligand, secreted	O00590, P32246, P41597, P46092, P49682, P51677, P51681, Q16570, Q9NPB9	ACKR1, ACKR2, ACKR4, CCR1, CCR10, CCR2, CCR3, CCR5, CXCR3	CCR1 [Baccin2019:11994538;Baccin2019:12381680;Baccin2019:7545673;Baccin2019:8530354;Baccin2019:9115216;CellPhoneDB:24218476;Cellinker:11994538;Cellinker:12381680;Cellinker:7545673;Cellinker:8530354;Cellinker:9115216;DIP:7545673;DIP:8530354;DIP:9336350;Guide2Pharma:11994538;Guide2Pharma:12381680;HPRD:7545673;HPRD:8530354;ICELLNET:22633458;InnateDB:12381680;InnateDB:7545673;InnateDB:8530354;LRdb:10699158;SIGNOR:14991608;connectomeDB2020:11994538;connectomeDB2020:12381680;connectomeDB2020:7545673;connectomeDB2020:8530354;connectomeDB2020:9115216;scConnect:11994538;scConnect:12381680], CCR2 [Baccin2019:12554737;Baccin2019:8530354;Baccin2019:9276730;Baccin2019:9346309;CellPhoneDB:24218476;Cellinker:12554737;Cellinker:8530354;Cellinker:9276730;Cellinker:9346309;DIP:8530354;DIP:9195948;DIP:9312096;DIP:9336350;Guide2Pharma:12554737;Guide2Pharma:9276730;Guide2Pharma:9346309;HPRD:8530354;ICELLNET:22633458;InnateDB:7759884;InnateDB:8530354;InnateDB:9115216;LRdb:10699158;connectomeDB2020:12554737;connectomeDB2020:8530354;connectomeDB2020:9276730;connectomeDB2020:9346309;scConnect:12554737;scConnect:9276730;scConnect:9346309], CCR3 [CellPhoneDB:24218476;Cellinker:8642344;DIP:10733106;Guide2Pharma:8642344;HPRD:8642344;ICELLNET:22633458;InnateDB:8642344;LRdb:10699158;connectomeDB2020:8642344;scConnect:8642344], CCR5 [Baccin2019:10477710;Baccin2019:16298345;CellPhoneDB:24218476;Cellinker:10477718;Cellinker:16298345;DIP:10477718;Guide2Pharma:16298345;HPRD:10477718;ICELLNET:10477718;ICELLNET:22633458;InnateDB:10477718;LRdb:10699158;connectomeDB2020:10477718;connectomeDB2020:16298345;scConnect:16298345], CXCR3 [Baccin2019:9660793;CellTalkDB:9660793;Cellinker:9660793;DIP:9660793;Guide2Pharma:9660793;LRdb:9660793;connectomeDB2020:9660793;scConnect:9660793], ACKR2 [CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:26740381;Cellinker:9364936;Cellinker:9405404;HPRD:9364936;HPRD:9405404;ICELLNET:22633458;InnateDB:9405404;LRdb:10699158;connectomeDB2020:9364936;connectomeDB2020:9405404], ACKR4 [CellTalkDB:10734104;Cellinker:10734104;DIP:10734104;HPRD:10734104;HPRD:9364936;HPRD:9405404;InnateDB:10734104;LRdb:10734104;connectomeDB2020:10734104], CCR10 [Baccin2019:9364936;CellTalkDB:9364936;Cellinker:9364936;HPRD:9364936;LRdb:9364936;connectomeDB2020:10706668;connectomeDB2020:9364936], ACKR1 [Baccin2019:13679391;CellChatDB:26740381;Cellinker:13679391;Cellinker:26740381;HPRD:13679391;LRdb:10699158;LRdb:13679391;connectomeDB2020:13679391]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR1 chemokine receptor binding [GO:0031726]; CCR2 chemokine receptor binding [GO:0031727]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; heparin binding [GO:0008201]	cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell migration [GO:0030335]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of natural killer cell chemotaxis [GO:2000503]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL7&keywords=CCL7	4.46	301	NA	NA	56.44	15	0.05	0.06	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	303	409	401	0.01	0.48	0.48	0.48	349	325	332	263
PDGFC	platelet derived growth factor C	Yes		ENSG00000145431	Q9NRA1	PDGF/VEGF growth factor family	19	cell_surface_ligand, ligand, receptor	cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, receptor, secreted, transmembrane	P09619, P16234, P17948, P35916, P35968	FLT1, FLT4, KDR, PDGFRA, PDGFRB	PDGFRA [Baccin2019:10806482;Baccin2019:11297552;Baccin2019:11342471;CellChatDB:15207812;CellTalkDB:10806482;Cellinker:15207812;Cellinker:28267575;DIP:11297552;DIP:20534510;HPMR:10806482;HPMR:15207811;HPRD:10806482;HPRD:11297552;HPRD:11342471;ICELLNET:15207811;ICELLNET:9739761;IntAct:11297552;IntAct:20534510;LRdb:10806482;LRdb:11297552;LRdb:11342471;SignaLink3:10806482;SignaLink3:11297552;SignaLink3:11342471;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:10806482;connectomeDB2020:11297552;connectomeDB2020:11342471], PDGFRB [Baccin2019:19795151;CellTalkDB:32196115;SignaLink3:11297552;SignaLink3:23331499;connectomeDB2020:19795151], FLT4 [NA], KDR [NA], FLT1 [CellTalkDB:32196115]	cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	growth factor activity [GO:0008083]; growth factor receptor binding [GO:0070851]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]	activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; animal organ morphogenesis [GO:0009887]; bone development [GO:0060348]; cellular response to amino acid stimulus [GO:0071230]; central nervous system development [GO:0007417]; digestive tract development [GO:0048565]; embryonic organ development [GO:0048568]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein autophosphorylation [GO:0031954]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PDGFC&keywords=PDGFC	14.47	194	NA	NA	1.61	194	0.02	0.20	0.00	0.02	0.03	0.00	0.00	0.00	0.00	0.00	0.00	298	397	384	0.02	0.34	0.30	0.30	394	376	393	290
HGF	hepatocyte growth factor	Yes		ENSG00000019991	P14210	Peptidase S1 family, Plasminogen subfamily	19	ligand	extracellular, intracellular, ligand, secreted	O14786, P00749, P02751, P05556, P08581, P16070, P18827, P34741, Q9Y5Y6	CD44, FN1, ITGB1, MET, NRP1, PLAU, SDC1, SDC2, ST14	MET [Baccin2019:15167892;Baccin2019:1655405;Baccin2019:1846706;Baccin2019:18495663;BioGRID:1655405;CellChatDB:28475121;CellTalkDB:1846706;Cellinker:15167892;Cellinker:1655405;Cellinker:1846706;Cellinker:18495663;Cellinker:28475121;DIP:16537482;DIP:17804794;DIP:20624990;HPRD:15167892;HPRD:1655405;HPRD:18495663;ICELLNET:15218027;IntAct:15167892;IntAct:16537482;IntAct:17804794;IntAct:17981115;IntAct:1846706;IntAct:20624990;IntAct:22897854;LRdb:15167892;LRdb:1655405;LRdb:1846706;LRdb:18495663;Lit-BM-17:15167892;Lit-BM-17:17804794;Lit-BM-17:17981115;Lit-BM-17:1846706;Lit-BM-17:19433454;Lit-BM-17:22897854;Lit-BM-17:8380735;ProtMapper:16397249;ProtMapper:17667909;ProtMapper:20178463;ProtMapper:22001117;ProtMapper:24362531;ProtMapper:27147579;ProtMapper:28534512;SIGNOR:8380735;SPIKE:14685170;SPIKE:17145710;SPIKE:1846706;SignaLink3:23331499;SignaLink3:8380735;connectomeDB2020:15167892;connectomeDB2020:1655405;connectomeDB2020:1846706;connectomeDB2020:18495663], CD44 [CellTalkDB:10037743;Cellinker:10037743;Cellinker:26181364;LRdb:10037743;Ramilowski2015:10037743;connectomeDB2020:10037743;talklr:10037743], SDC1 [Baccin2019:11830493;CellTalkDB:11830493;Cellinker:11830493;HPRD:11830493;LRdb:11830493;connectomeDB2020:11830493], ITGB1 [CellTalkDB:32196115], SDC2 [Baccin2019:8157651;CellTalkDB:8157651;Cellinker:8157651;HPRD:8157651;LRdb:8157651;connectomeDB2020:8157651], NRP1 [CellTalkDB:18065694], ST14 [Baccin2019:10962009;Baccin2019:12372819;Cellinker:10962009;Cellinker:12372819;HPRD:10962009;HPRD:12372819;LRdb:11;LRdb:12372819;connectomeDB2020:10962009], FN1 [HPRD:15717924;Lit-BM-17:25241761;Lit-BM-17:8780385;MatrixDB:8780385], PLAU [HPRD:1334458]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]	chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]	animal organ regeneration [GO:0031100]; cell chemotaxis [GO:0060326]; cell morphogenesis [GO:0000902]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; mitotic cell cycle [GO:0000278]; myoblast proliferation [GO:0051450]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of myelination [GO:0031643]; positive regulation of neuron projection regeneration [GO:0070572]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of p38MAPK cascade [GO:1900744]; regulation of tau-protein kinase activity [GO:1902947]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=HGF&keywords=HGF	3.56	318	NA	NA	1.18	239	0.00	0.00	0.00	0.22	0.00	0.01	0.00	0.00	0.01	0.01	0.00	287	281	346	0.02	0.47	0.48	0.35	354	326	372	291
EGF	epidermal growth factor	Yes		ENSG00000138798	P01133	NA	19	cell_surface_ligand, ligand	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	O00300, O00459, O14786, O14939, P00533, P01130, P04626, P07550, P21860, P22681, P23945, P25098, P27986, P29353, P30530, P62993, P98164, Q03135, Q07889, Q15303, Q9NX52	ADRB2, AXL, CAV1, CBL, EGFR, EGFR_ERBB2, EGFR_ERBB4, ERBB2, ERBB3, ERBB4, FSHR, GRB2, GRK2, LDLR, LRP2, NRP1, PIK3R1, PIK3R2, PLD2, RHBDL2, SHC1, SOS1, TNFRSF11B	EGFR [AlzPathway:18270696;Baccin2019:10788520;Baccin2019:12093292;Baccin2019:12297050;Baccin2019:12620237;Baccin2019:15620700;Baccin2019:16274239;Baccin2019:6289330;BioGRID:12093292;BioGRID:26280537;CancerCellMap:3494473;CellTalkDB:12093292;DIP:10085134;DIP:10970856;DIP:11684674;DIP:17697999;DIP:18427122;DIP:21822280;DIP:26280537;DIP:8663535;HPMR:6289330;HPRD:10788520;HPRD:12093292;HPRD:12297050;HPRD:12620237;HPRD:15620700;HPRD:16274239;ICELLNET:8639530;IntAct:12297050;IntAct:12620237;IntAct:17697999;IntAct:21439278;IntAct:21822280;IntAct:25241761;IntAct:26280537;IntAct:2790960;IntAct:28988771;IntAct:30083275;IntAct:9135143;LRdb:10788520;LRdb:12093292;LRdb:12297050;LRdb:12620237;LRdb:15620700;LRdb:16274239;LRdb:6289330;Lit-BM-17:10085134;Lit-BM-17:10970856;Lit-BM-17:11684674;Lit-BM-17:12093292;Lit-BM-17:12297050;Lit-BM-17:12620237;Lit-BM-17:17697999;Lit-BM-17:18271526;Lit-BM-17:18427122;Lit-BM-17:19531499;Lit-BM-17:21439278;Lit-BM-17:23597562;Lit-BM-17:25080504;Lit-BM-17:25241761;Lit-BM-17:25453753;Lit-BM-17:26280537;Lit-BM-17:2790960;Lit-BM-17:8663535;NetPath:19531499;NetPath:3494473;ProtMapper:11116185;ProtMapper:12771140;ProtMapper:14568001;ProtMapper:15708576;ProtMapper:15958209;ProtMapper:16729043;ProtMapper:16843263;ProtMapper:17081983;ProtMapper:17563729;ProtMapper:17575160;ProtMapper:17971399;ProtMapper:18253097;ProtMapper:18320059;ProtMapper:18762250;ProtMapper:19129184;ProtMapper:19135477;ProtMapper:19531623;ProtMapper:19895983;ProtMapper:20813200;ProtMapper:20953304;ProtMapper:21107857;ProtMapper:21303971;ProtMapper:21311755;ProtMapper:21532939;ProtMapper:21649524;ProtMapper:21722395;ProtMapper:21858221;ProtMapper:22216880;ProtMapper:22260327;ProtMapper:23185569;ProtMapper:23613900;ProtMapper:23912460;ProtMapper:23950932;ProtMapper:24096486;ProtMapper:24709886;ProtMapper:25366117;ProtMapper:26821125;ProtMapper:26921391;ProtMapper:27387652;ProtMapper:27462018;ProtMapper:27564112;ProtMapper:29617357;ProtMapper:30197274;SIGNOR:12297050;SIGNOR:12648462;SPIKE:20458382;SignaLink3:10085134;SignaLink3:10209155;SignaLink3:19531499;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:10788520;connectomeDB2020:12093292;connectomeDB2020:12297050;connectomeDB2020:12620237;connectomeDB2020:15620700;connectomeDB2020:16274239;connectomeDB2020:6289330], ERBB2 [Baccin2019:12093292;CellTalkDB:12093292;HPRD:12093292;LRdb:12093292;ProtMapper:15748904;SIGNOR:11279155;SignaLink3:11279155;SignaLink3:23331499;connectomeDB2020:12093292], LDLR [CellTalkDB:32196115], FSHR [CellTalkDB:32196115], ERBB3 [Baccin2019:12093292;CellTalkDB:12093292;Cellinker:12093292;HPRD:12093292;LRdb:12093292;connectomeDB2020:12093292], ADRB2 [CellTalkDB:32196115], CAV1 [CellTalkDB:32196115], RHBDL2 [CellTalkDB:21494248], ERBB4 [CellTalkDB:9305636;LRdb:9305636;Ramilowski2015:9305636;connectomeDB2020:9305636;talklr:9305636], NRP1 [CellTalkDB:24556756], AXL [CellTalkDB:27775700], PLD2 [CellTalkDB:9837959], LRP2 [CellTalkDB:32196115], TNFRSF11B [Cellinker:32589946], CBL [NetPath:19531499], GRB2 [ACSN:17673906;HPRD:10973965;NetPath:19531499;ProtMapper:17081983], SOS1 [ACSN:17673906;NetPath:19531499], SHC1 [ACSN:17673906;NetPath:19531499], PIK3R2 [ACSN:17496910;HPRD:1334406;NetPath:19531499], PIK3R1 [ACSN:17496910;NetPath:19531499], GRK2 [HPRD:15620700]	clathrin-coated endocytic vesicle membrane [GO:0030669]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]	calcium ion binding [GO:0005509]; epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]; guanyl-nucleotide exchange factor activity [GO:0005085]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]	angiogenesis [GO:0001525]; branching morphogenesis of an epithelial tube [GO:0048754]; epidermal growth factor receptor signaling pathway [GO:0007173]; epidermal growth factor receptor signaling pathway via MAPK cascade [GO:0038029]; ERK1 and ERK2 cascade [GO:0070371]; mammary gland alveolus development [GO:0060749]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of secretion [GO:0051048]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cerebellar granule cell precursor proliferation [GO:0021940]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA replication [GO:0045740]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of gene expression [GO:0010628]; positive regulation of hyaluronan biosynthetic process [GO:1900127]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; regulation of calcium ion import [GO:0090279]; regulation of protein localization to cell surface [GO:2000008]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EGF&keywords=EGF	2.44	366	NA	NA	1.05	254	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	310
CSF1	colony stimulating factor 1	Yes		ENSG00000184371	P09603	NA	19	cell_surface_ligand, ligand, receptor	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P01375, P07333, P15509, P30825, P78324, Q99062, Q9NYQ7	CELSR3, CSF1R, CSF2RA, CSF3R, SIRPA, SLC7A1, TNF	CSF1R [Baccin2019:2408759;Baccin2019:7883784;Baccin2019:8355686;CellTalkDB:8355686;Cellinker:2408759;Cellinker:7883784;Cellinker:8355686;DIP:22153499;DIP:22483114;DIP:22902366;DIP:26235028;HPMR:1702217;HPMR:7883784;HPRD:2408759;HPRD:8355686;ICELLNET:26095744;IntAct:22153499;IntAct:22483114;IntAct:22902366;IntAct:26235028;LRdb:2408759;LRdb:7883784;LRdb:8355686;SIGNOR:24890514;connectomeDB2020:2408759;connectomeDB2020:7883784;connectomeDB2020:8355686], CSF2RA [SIGNOR:10572088;SignaLink3:10572088;SignaLink3:23331499], CSF3R [SIGNOR:16492764;SignaLink3:16492764;SignaLink3:23331499], SIRPA [CellTalkDB:32103204], SLC7A1 [NA], CELSR3 [NA], TNF [HPRD:8336080]	CSF1-CSF1R complex [GO:1990682]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; macrophage colony-stimulating factor receptor binding [GO:0005157]; protein homodimerization activity [GO:0042803]	branching involved in mammary gland duct morphogenesis [GO:0060444]; developmental process involved in reproduction [GO:0003006]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage colony-stimulating factor signaling pathway [GO:0038145]; macrophage differentiation [GO:0030225]; mammary duct terminal end bud growth [GO:0060763]; mammary gland fat development [GO:0060611]; microglial cell proliferation [GO:0061518]; monocyte activation [GO:0042117]; negative regulation of neuron death [GO:1901215]; odontogenesis [GO:0042476]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage colony-stimulating factor signaling pathway [GO:1902228]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of macrophage migration [GO:1905523]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of mononuclear cell proliferation [GO:0032946]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of odontogenesis of dentin-containing tooth [GO:0042488]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of macrophage derived foam cell differentiation [GO:0010743]; regulation of ossification [GO:0030278]; response to ischemia [GO:0002931]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CSF1&keywords=CSF1	9.20	249	NA	NA	0.31	461	0.02	0.11	0.02	0.02	0.02	0.02	0.03	0.03	0.01	0.01	0.01	258	233	226	0.03	0.57	0.56	0.64	310	299	264	311
KITLG	KIT ligand	Yes		ENSG00000049130	P21583	SCF family	19	cell_surface_ligand, ligand	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, secreted, transmembrane	P10721, P19235, Q9H3W5	EPOR, KIT, LRRN3	KIT [Baccin2019:1375232;Baccin2019:1698556;Baccin2019:7680037;BioGRID:1375232;BioGRID:7680037;CancerCellMap:7680037;CellTalkDB:1698556;Cellinker:12036870;Cellinker:1375232;Cellinker:1698556;Cellinker:7680037;Guide2Pharma:7536489;HPRD:1375232;HPRD:7680037;ICELLNET:17662946;LRdb:1375232;LRdb:1698556;LRdb:7680037;Lit-BM-17:1375232;Lit-BM-17:17662946;Lit-BM-17:7680037;NetPath:7680037;ProtMapper:25717186;ProtMapper:26358753;SIGNOR:1698556;SIGNOR:17259966;SPIKE:1375232;SPIKE:7680037;connectomeDB2020:1375232;connectomeDB2020:1698556;connectomeDB2020:7680037;scConnect:7536489], EPOR [CellTalkDB:11124255;Cellinker:11124255;HPRD:11124255;LRdb:11124255], LRRN3 [Cellinker:32589946]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; filopodium [GO:0030175]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; stem cell factor receptor binding [GO:0005173]	cell adhesion [GO:0007155]; ectopic germ cell programmed cell death [GO:0035234]; embryonic hemopoiesis [GO:0035162]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; male gonad development [GO:0008584]; negative regulation of mast cell apoptotic process [GO:0033026]; neural crest cell migration [GO:0001755]; ovarian follicle development [GO:0001541]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of myeloid leukocyte differentiation [GO:0002763]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Ras protein signal transduction [GO:0046579]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=KITLG&keywords=KITLG	13.94	199	NA	NA	1.29	225	0.01	0.21	0.09	0.26	0.04	0.01	0.00	0.00	0.01	0.00	0.00	253	382	355	0.06	0.35	0.16	0.17	391	439	441	311
CSF2	colony stimulating factor 2	Yes		ENSG00000164400	P04141	GM-CSF family	19	ligand	extracellular, intracellular, ligand, secreted	P05556, P07333, P15509, P26951, P32927, P34741, Q13797, Q99062	CSF1R, CSF2_CSF2RA_CSF2RB, CSF2RA, CSF2RA_CSF2RB, CSF2RB, CSF3R, IL3RA, ITGA9, ITGB1, SDC2	CSF2RA [Baccin2019:10572088;Baccin2019:1702217;Baccin2019:2828352;Baccin2019:8910448;Baccin2019:9211889;CellTalkDB:2828352;DIP:2555171;DIP:27396825;DIP:7957082;HPMR:10753826;HPMR:2828352;HPRD:10572088;HPRD:1702217;HPRD:8910448;HPRD:9211889;InnateDB:10572088;LRdb:10572088;LRdb:1702217;LRdb:2828352;LRdb:8910448;LRdb:9211889;Lit-BM-17:18692472;Lit-BM-17:2555171;Lit-BM-17:7957082;SIGNOR:10572088;SIGNOR:18551128;SIGNOR:9187659;SPIKE:10572088;SPIKE:2645577;SignaLink3:10572088;SignaLink3:11015446;SignaLink3:11306493;SignaLink3:11777960;SignaLink3:11867689;SignaLink3:12393492;SignaLink3:12811837;SignaLink3:14610620;SignaLink3:19833085;SignaLink3:20406969;SignaLink3:20805416;SignaLink3:21765015;SignaLink3:22323450;SignaLink3:22869907;SignaLink3:23046136;SignaLink3:23331499;SignaLink3:24030977;SignaLink3:24091328;SignaLink3:26192618;SignaLink3:27216177;connectomeDB2020:10572088;connectomeDB2020:1702217;connectomeDB2020:2828352;connectomeDB2020:8910448;connectomeDB2020:9211889], CSF3R [Baccin2019:11091218;CellTalkDB:11091218;Cellinker:11091218;Cellinker:16720384;DIP:11468284;HPMR:11091218;HPMR:7691413;LRdb:11091218;Lit-BM-17:11468284;Lit-BM-17:9187659;SIGNOR:16492764;SIGNOR:7691413;SignaLink3:16492764;SignaLink3:23331499;connectomeDB2020:11091218], CSF1R [NA], CSF2RB [Baccin2019:2645577;Baccin2019:2828352;Baccin2019:8278375;CellTalkDB:2828352;DIP:1702217;DIP:7957082;HPMR:10753826;HPMR:2828352;HPRD:2645577;HPRD:8278375;LMPID:7957082;LRdb:2645577;LRdb:2828352;LRdb:8278375;Lit-BM-17:1702217;Lit-BM-17:18692472;Lit-BM-17:7957082;connectomeDB2020:2645577;connectomeDB2020:2828352;connectomeDB2020:8278375], ITGB1 [CellTalkDB:32196115], IL3RA [Baccin2019:7957082;CellTalkDB:7957082;Cellinker:7957082;HPRD:7957082;LRdb:7957082;connectomeDB2020:7957082], SDC2 [Baccin2019:10734053;CellTalkDB:10734053;Cellinker:10734053;HPRD:10734053;InnateDB:10734053;LRdb:10734053;connectomeDB2020:10734053], ITGA9 [CellTalkDB:32196115]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; granulocyte macrophage colony-stimulating factor receptor complex [GO:0030526]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; granulocyte macrophage colony-stimulating factor receptor binding [GO:0005129]; growth factor activity [GO:0008083]	cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to lipopolysaccharide [GO:0071222]; dendritic cell differentiation [GO:0097028]; embryonic placenta development [GO:0001892]; epithelial fluid transport [GO:0042045]; granulocyte-macrophage colony-stimulating factor signaling pathway [GO:0038157]; histamine secretion [GO:0001821]; immune response [GO:0006955]; macrophage activation [GO:0042116]; macrophage differentiation [GO:0030225]; monocyte differentiation [GO:0030224]; myeloid cell differentiation [GO:0030099]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil differentiation [GO:0030223]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of leukocyte proliferation [GO:0070665]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of podosome assembly [GO:0071803]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; response to fluid shear stress [GO:0034405]; response to silicon dioxide [GO:0034021]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CSF2&keywords=CSF2	0.37	550	NA	NA	8.43	53	0.02	0.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	303	409	399	0.01	0.63	0.63	0.64	293	279	267	323
CX3CL1	C-X3-C motif chemokine ligand 1	Yes		ENSG00000006210	P78423	Intercrine delta family	19	cell_surface_ligand, ligand, receptor	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P05106, P06756, P49238	CX3CR1, ITGA4_ITGB1, ITGAV, ITGAV_ITGB3, ITGB3	CX3CR1 [Baccin2019:11432858;Baccin2019:14607932;Baccin2019:9390561;Baccin2019:9931005;CellPhoneDB:24218476;Cellinker:11432858;Cellinker:14607932;Cellinker:28389721;Cellinker:9390561;Cellinker:9931005;DIP:10488147;Guide2Pharma:14607932;HPMR:11432858;HPRD:9390561;HPRD:9931005;ICELLNET:22633458;InnateDB:9390561;InnateDB:9931005;LRdb:10699158;Lit-BM-17:10488147;Lit-BM-17:9931005;SIGNOR:11432858;connectomeDB2020:11432858;connectomeDB2020:14607932;connectomeDB2020:9390561;connectomeDB2020:9931005;scConnect:14607932], ITGAV [connectomeDB2020:24789099], ITGB3 [IntAct:24789099;connectomeDB2020:24789099]	cell projection [GO:0042995]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	CCR chemokine receptor binding [GO:0048020]; chemoattractant activity [GO:0042056]; chemokine activity [GO:0008009]; CX3C chemokine receptor binding [GO:0031737]; CXCR1 chemokine receptor binding [GO:0045237]; integrin binding [GO:0005178]; signaling receptor binding [GO:0005102]	aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; autocrine signaling [GO:0035425]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cell chemotaxis [GO:0060326]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; integrin activation [GO:0033622]; leukocyte adhesive activation [GO:0050902]; leukocyte chemotaxis [GO:0030595]; leukocyte migration involved in inflammatory response [GO:0002523]; lymphocyte chemotaxis [GO:0048247]; microglial cell activation [GO:0001774]; microglial cell proliferation [GO:0061518]; monocyte chemotaxis [GO:0002548]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of glutamate receptor signaling pathway [GO:1900450]; negative regulation of hippocampal neuron apoptotic process [GO:0110091]; negative regulation of interleukin-1 alpha production [GO:0032690]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron migration [GO:2001223]; negative regulation of tumor necrosis factor production [GO:0032720]; neuron cellular homeostasis [GO:0070050]; neuron remodeling [GO:0016322]; neutrophil chemotaxis [GO:0030593]; positive chemotaxis [GO:0050918]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of calcium-independent cell-cell adhesion [GO:0051041]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of inflammatory response [GO:0050729]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta1 production [GO:0032914]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; regulation of neurogenesis [GO:0050767]; regulation of synaptic plasticity [GO:0048167]; response to ischemia [GO:0002931]; synapse pruning [GO:0098883]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CX3CL1&keywords=CX3CL1	8.46	252	NA	NA	0.36	438	0.00	0.04	0.02	0.00	0.01	0.00	0.00	0.01	0.00	0.00	0.01	295	339	276	0.01	0.66	0.63	0.82	275	280	174	327
CXCL10	C-X-C motif chemokine ligand 10	Yes		ENSG00000169245	P02778	Intercrine alpha (chemokine CxC) family	19	ligand, receptor	extracellular, ligand, receptor, secreted	O00206, P08913, P27487, P31431, P48039, P49682, P51677, Q14831, Q16570	ACKR1, ADRA2A, CCR3, CXCR3, DPP4, GRM7, MTNR1A, SDC4, TLR4	CXCR3 [Baccin2019:10233762;Baccin2019:12571234;Baccin2019:12884299;Baccin2019:15761110;Baccin2019:9064356;Baccin2019:9660793;CellPhoneDB:24218476;Cellinker:10233762;Cellinker:12571234;Cellinker:12884299;Cellinker:15761110;Cellinker:9064356;Cellinker:9660793;DIP:9625760;DIP:9660793;Guide2Pharma:15761110;Guide2Pharma:9660793;HPMR:9064356;HPRD:10233762;HPRD:12571234;ICELLNET:12884299;LRdb:10699158;SIGNOR:12750173;SPIKE:10233762;SPIKE:12571234;connectomeDB2020:10233762;connectomeDB2020:12571234;connectomeDB2020:12884299;connectomeDB2020:15761110;connectomeDB2020:9064356;connectomeDB2020:9660793;scConnect:15761110;scConnect:9660793], CCR3 [Baccin2019:11110785;CellTalkDB:11110785;Cellinker:11110785;DIP:11110785;HPRD:11110785;ICELLNET:22633458;LRdb:11110785;connectomeDB2020:11110785], DPP4 [CellPhoneDB:24218476;CellTalkDB:24218476;Cellinker:21314817;HPRD:11390394;IntAct:18275857;IntAct:21314817], SDC4 [Baccin2019:20484822;Cellinker:20484822;LRdb:20484822;Ramilowski2015:20484822;connectomeDB2020:20484822;talklr:20484822], GRM7 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], ACKR1 [CellChatDB:26740381;Cellinker:26740381], TLR4 [Cellinker:21595283]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cAMP-dependent protein kinase regulator activity [GO:0008603]; chemoattractant activity [GO:0042056]; chemokine activity [GO:0008009]; CXCR3 chemokine receptor binding [GO:0048248]; CXCR chemokine receptor binding [GO:0045236]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; antiviral innate immune response [GO:0140374]; blood circulation [GO:0008015]; cell-cell signaling [GO:0007267]; cell surface receptor signaling pathway [GO:0007166]; cellular response to heat [GO:0034605]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to virus [GO:0098586]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; endothelial cell activation [GO:0042118]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myoblast fusion [GO:1901740]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of T cell migration [GO:2000406]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of cell population proliferation [GO:0042127]; regulation of endothelial tube morphogenesis [GO:1901509]; regulation of T cell chemotaxis [GO:0010819]; response to auditory stimulus [GO:0010996]; response to cold [GO:0009409]; response to gamma radiation [GO:0010332]; response to vitamin D [GO:0033280]; signal transduction [GO:0007165]; T cell chemotaxis [GO:0010818]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCL10&keywords=CXCL10	1.64	403	NA	NA	1.09	246	0.00	0.02	0.01	0.01	0.01	0.00	0.00	0.01	0.00	0.00	0.00	303	407	340	0.01	0.62	0.62	0.72	296	282	229	335
IL19	interleukin 19	Yes		ENSG00000142224	Q9UHD0	IL-10 family	19	ligand	extracellular, intracellular, ligand, secreted	Q6UXL0, Q9UHF4	IL20RA, IL20RA_IL20RB, IL20RB	IL20RA [Baccin2019:1297448111564760;CellTalkDB:12974481;HPRD:11564763;LRdb:12;LRdb:12974481;SIGNOR:11564763;SignaLink3:11564763;SignaLink3:17208301;SignaLink3:18988627;SignaLink3:23331499;connectomeDB2020:11564763;connectomeDB2020:12974481], IL20RB [CellTalkDB:12974481;InnateDB:14580208;IntAct:22802649;LRdb:12974481;Lit-BM-17:22802649;SIGNOR:17208301;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12974481]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]	apoptotic process [GO:0006915]; immune response [GO:0006955]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; reactive oxygen species metabolic process [GO:0072593]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL19&keywords=IL19	0.12	656	NA	NA	1.58	196	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	426
CCL4	C-C motif chemokine ligand 4	Yes		ENSG00000277943, ENSG00000275824, ENSG00000275302	P13236	Intercrine beta (chemokine CC) family	19	ligand	extracellular, intracellular, ligand, secreted	O00590, P10147, P30825, P32246, P32302, P34972, P51677, P51681, P51685, Q8TDT2, Q9NZD1	ACKR2, CCL3, CCR1, CCR3, CCR5, CCR8, CNR2, CXCR5, GPR152, GPRC5D, SLC7A1	CCR5 [Baccin2019:12427015;Baccin2019:12964882;Baccin2019:16298345;Baccin2019:8663314;Baccin2019:9790730;CellTalkDB:10699158;Cellinker:12427015;Cellinker:12964882;Cellinker:16298345;Cellinker:8663314;Cellinker:9790730;DIP:10477718;DIP:10498628;DIP:9334377;DIP:9468473;Guide2Pharma:16298345;Guide2Pharma:9790730;HPRD:12427015;HPRD:8663314;ICELLNET:22633458;InnateDB:10477718;InnateDB:12427015;InnateDB:16467191;LRdb:10699158;Lit-BM-17:10477718;Lit-BM-17:10498628;Lit-BM-17:23597562;Lit-BM-17:9334377;Lit-BM-17:9468473;SIGNOR:20219869;SPIKE:12427015;SPIKE:8663314;connectomeDB2020:12427015;connectomeDB2020:12964882;connectomeDB2020:16298345;connectomeDB2020:8663314;connectomeDB2020:9790730;scConnect:16298345;scConnect:9790730], CCR1 [Baccin2019:12381680;Baccin2019:7594543;Baccin2019:8530354;CellTalkDB:10699158;Cellinker:12381680;Cellinker:7594543;Cellinker:8530354;DIP:10910894;DIP:7545673;Guide2Pharma:12381680;Guide2Pharma:8530354;HPRD:7594543;InnateDB:12381680;LRdb:10699158;connectomeDB2020:12381680;connectomeDB2020:7594543;connectomeDB2020:8530354;scConnect:12381680;scConnect:8530354], ACKR2 [CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:26740381;Cellinker:29637711;Cellinker:9405404;HPRD:9405404;ICELLNET:22633458;InnateDB:9405404;LRdb:10699158;connectomeDB2020:9405404], CCR8 [Baccin2019:9521068;CellTalkDB:10699158;Cellinker:9521068;HPRD:9521068;LRdb:10699158;connectomeDB2020:9521068], CNR2 [CellTalkDB:32103204], CCR3 [Baccin2019:7622448;CellTalkDB:7622448;Cellinker:7622448;DIP:7622448;HPRD:7622448;LRdb:7622448;connectomeDB2020:7622448], GPRC5D [NA], GPR152 [NA], SLC7A1 [NA], CXCR5 [DIP:9312096], CCL3 [HPRD:11278300]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR1 chemokine receptor binding [GO:0031726]; CCR5 chemokine receptor binding [GO:0031730]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; cytokine activity [GO:0005125]; identical protein binding [GO:0042802]	cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; eosinophil chemotaxis [GO:0048245]; establishment or maintenance of cell polarity [GO:0007163]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; negative regulation by host of viral transcription [GO:0043922]; neutrophil chemotaxis [GO:0030593]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of natural killer cell chemotaxis [GO:2000503]; response to toxic substance [GO:0009636]; response to virus [GO:0009615]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL4&keywords=CCL4	3.02	339	NA	NA	0.29	469	6.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	303	391	386	0.60	0.02	0.02	0.02	524	520	522	430
INHBB	inhibin subunit beta B	Yes		ENSG00000163083	P09529	TGF-beta family	19	ligand	extracellular, intracellular, ligand, ligand_regulator, secreted	P0CG36, P0CG37, P27037, P36896, P84022, Q04771, Q13145, Q13705, Q8NER5	ACVR1, ACVR1_ACVR2A, ACVR1_ACVR2B, ACVR1B, ACVR1B_ACVR2A, ACVR1B_ACVR2B, ACVR1C, ACVR1C_ACVR2A, ACVR1C_ACVR2B, ACVR2A, ACVR2B, BAMBI, CFC1, CFC1B, SMAD3	ACVR2A [Baccin2019:1246619011266510;CellTalkDB:12466190;HPRD:11266516;LRdb:11;LRdb:12466190;connectomeDB2020:11266516;connectomeDB2020:12466190], ACVR1B [Baccin2019:11266516;Baccin2019:12032389;Baccin2019:15196700;CellTalkDB:11266516;HPRD:11266516;HPRD:12032389;HPRD:15196700;LRdb:11266516;LRdb:12032389;LRdb:15196700;connectomeDB2020:11266516;connectomeDB2020:15196700], ACVR2B [Baccin2019:9202237;CellTalkDB:9202237;HPRD:9202237;LRdb:9202237;connectomeDB2020:9202237], ACVR1C [Baccin2019:15196700;CellTalkDB:15196700;HPRD:15196700;LRdb:15196700;connectomeDB2020:15196700], SMAD3 [CellTalkDB:32196115], ACVR1 [Baccin2019:11266516;CellTalkDB:11266516;HPRD:11266516;LRdb:11266516;connectomeDB2020:11266516], CFC1 [connectomeDB2020:28126904], CFC1B [connectomeDB2020:28126904], BAMBI [HPMR:10918299]	cell periphery [GO:0071944]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; inhibin B complex [GO:0043513]; perinuclear region of cytoplasm [GO:0048471]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; host cell surface receptor binding [GO:0046789]; inhibin binding [GO:0034711]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]	activin receptor signaling pathway [GO:0032924]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to cholesterol [GO:0071397]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-1 [GO:0071347]; cellular response to leptin stimulus [GO:0044320]; cellular response to starvation [GO:0009267]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; cellular response to thyroid hormone stimulus [GO:0097067]; defense response [GO:0006952]; fat cell differentiation [GO:0045444]; negative regulation of follicle-stimulating hormone secretion [GO:0046882]; negative regulation of hepatocyte growth factor production [GO:0032686]; negative regulation of insulin secretion [GO:0046676]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; pituitary gland development [GO:0021983]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of ovulation [GO:0060279]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; reproductive senescence [GO:1990636]; response to gonadotropin [GO:0034698]; response to insecticide [GO:0017085]; response to wounding [GO:0009611]; seminiferous tubule development [GO:0072520]; SMAD protein signal transduction [GO:0060395]; spermatogenesis [GO:0007283]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=INHBB&keywords=INHBB	0.89	465	NA	NA	0.07	669	0.00	0.00	0.03	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	303	384	399	0.00	0.72	0.77	0.72	253	229	225	437
CCL22	C-C motif chemokine ligand 22	Yes		ENSG00000102962	O00626	Intercrine beta (chemokine CC) family	19	ligand	intracellular, ligand, secreted	O00590, P27487, P32248, P51679, Q16570	ACKR1, ACKR2, CCR4, CCR7, DPP4	CCR4 [Baccin2019:9430724;Baccin2019:9743322;Baccin2019:9933589;CellPhoneDB:24218476;Cellinker:29637711;DIP:9430724;Guide2Pharma:9430724;HPRD:9430724;HPRD:9743322;HPRD:9933589;ICELLNET:22633458;InnateDB:9430724;LRdb:10699158;connectomeDB2020:9430724;connectomeDB2020:9743322;connectomeDB2020:9933589;scConnect:9430724], ACKR2 [CellChatDB:26740381;CellTalkDB:10699158;Cellinker:26740381;Cellinker:29637711;ICELLNET:22633458;LRdb:10699158;connectomeDB2020:25297873], DPP4 [CellPhoneDB:24218476;CellTalkDB:24218476;Cellinker:21314817;HPRD:11390394;HPRD:9933589;InnateDB:9933589], ACKR1 [Baccin2019:24013383], CCR7 [InnateDB:15546958]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; response to virus [GO:0009615]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL22&keywords=CCL22	2.50	362	NA	NA	0.20	531	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	447
CCL5	C-C motif chemokine ligand 5	Yes		ENSG00000274233, ENSG00000271503	P13501	Intercrine beta (chemokine CC) family	19	ligand	extracellular, intracellular, ligand, secreted	O00421, O00590, O95800, P08913, P18827, P27487, P31431, P32246, P32302, P48039, P49682, P51677, P51679, P51681, Q14831, Q16570, Q9NPB9	ACKR1, ACKR2, ACKR4, ADRA2A, CCR1, CCR3, CCR4, CCR5, CCRL2, CXCR3, CXCR5, DPP4, GPR75, GRM7, MTNR1A, SDC1, SDC4	CCR5 [Baccin2019:10318947;Baccin2019:10477718;Baccin2019:11116158;Baccin2019:12964882;Baccin2019:14637022;Baccin2019:16298345;Baccin2019:8663314;Baccin2019:9289016;Baccin2019:9790730;BioGRID:14637022;CellPhoneDB:24218476;Cellinker:10318947;Cellinker:10477718;Cellinker:11116158;Cellinker:12964882;Cellinker:14637022;Cellinker:16298345;Cellinker:8663314;Cellinker:9289016;Cellinker:9790730;DIP:10477718;DIP:10488147;DIP:9207005;DIP:9334377;Guide2Pharma:10318947;Guide2Pharma:16298345;Guide2Pharma:9790730;HPRD:10477718;HPRD:11116158;HPRD:14637022;HPRD:8663314;HPRD:9289016;ICELLNET:22633458;InnateDB:10477718;InnateDB:12213786;IntAct:23480650;IntAct:28381538;LRdb:10699158;Lit-BM-17:10477718;Lit-BM-17:10488147;Lit-BM-17:11116158;Lit-BM-17:11449371;Lit-BM-17:14637022;Lit-BM-17:23480650;Lit-BM-17:9207005;Lit-BM-17:9334377;ProtMapper:25923671;SPIKE:10477718;connectomeDB2020:10318947;connectomeDB2020:10477718;connectomeDB2020:11116158;connectomeDB2020:12964882;connectomeDB2020:14637022;connectomeDB2020:16298345;connectomeDB2020:8663314;connectomeDB2020:9289016;connectomeDB2020:9790730;scConnect:10318947;scConnect:16298345;scConnect:9790730], CCR1 [Baccin2019:11116158;Baccin2019:12270118;Baccin2019:14637022;Baccin2019:7545673;Baccin2019:8530354;Baccin2019:9289016;Baccin2019:9624164;CellPhoneDB:24218476;Cellinker:11116158;Cellinker:12270118;Cellinker:14637022;Cellinker:7545673;Cellinker:8530354;Cellinker:9289016;Cellinker:9624164;DIP:10910894;DIP:7545673;DIP:7622448;DIP:8530354;DIP:9115216;DIP:9336350;Guide2Pharma:8530354;Guide2Pharma:9624164;HPRD:11116158;HPRD:12270118;HPRD:14637022;HPRD:7545673;HPRD:9289016;ICELLNET:22633458;InnateDB:7545673;InnateDB:8530354;InnateDB:9115216;LRdb:10699158;SIGNOR:10734056;connectomeDB2020:11116158;connectomeDB2020:12270118;connectomeDB2020:14637022;connectomeDB2020:7545673;connectomeDB2020:8530354;connectomeDB2020:9289016;connectomeDB2020:9624164;scConnect:8530354;scConnect:9624164], CCR3 [Baccin2019:8642344;Baccin2019:9289016;BioGRID:8642344;CellPhoneDB:24218476;Cellinker:8642344;Cellinker:9289016;DIP:10733106;DIP:7622448;Guide2Pharma:8642344;HPMR:8642344;HPRD:8642344;HPRD:9289016;ICELLNET:22633458;InnateDB:8642344;LRdb:10699158;SIGNOR:10734056;connectomeDB2020:8642344;connectomeDB2020:9289016;scConnect:8642344], CXCR3 [Baccin2019:9660793;Cellinker:9660793;DIP:9660793;Guide2Pharma:9660793;LRdb:9660793;connectomeDB2020:9660793;scConnect:9660793], GPR75 [Baccin2019:17001303;CellTalkDB:17001303;Cellinker:17001303;Guide2Pharma:17001303;LRdb:17001303;connectomeDB2020:17001303;scConnect:17001303], ACKR1 [CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:12081195;Cellinker:17416748;Cellinker:26740381;HPRD:12081195;HPRD:17416748;ICELLNET:22633458;InnateDB:7592830;InnateDB:8132497;InnateDB:9195930;LRdb:10699158;LRdb:12081195;LRdb:17;connectomeDB2020:12081195;connectomeDB2020:17416748], ACKR2 [CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:26740381;Cellinker:9405404;HPRD:9405404;ICELLNET:22633458;InnateDB:9405404;LRdb:10699158;connectomeDB2020:9405404], ACKR4 [Cellinker:9469451;HPRD:9405404;HPRD:9469451;LRdb:9469451], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], CCR4 [Baccin2019:12270118;Baccin2019:8573157;CellPhoneDB:24218476;Cellinker:12270118;HPRD:12270118;HPRD:8573157;LRdb:12270118;LRdb:86;connectomeDB2020:12270118;connectomeDB2020:8573157], CCRL2 [NA], GRM7 [CellTalkDB:32196115], SDC4 [Baccin2019:14637022;Cellinker:14637022;HPRD:14637022;LRdb:14637022;connectomeDB2020:14637022], SDC1 [Baccin2019:14637022;CellTalkDB:14637022;Cellinker:12270118;Cellinker:14637022;Cellinker:8573157;HPRD:14637022;LRdb:14637022;connectomeDB2020:14637022], DPP4 [Cellinker:21314817;HPRD:11390394;HPRD:9516414], CXCR5 [DIP:9312096]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR1 chemokine receptor binding [GO:0031726]; CCR4 chemokine receptor binding [GO:0031729]; CCR5 chemokine receptor binding [GO:0031730]; CCR chemokine receptor binding [GO:0048020]; chemoattractant activity [GO:0042056]; chemokine activity [GO:0008009]; chemokine receptor antagonist activity [GO:0046817]; chemokine receptor binding [GO:0042379]; identical protein binding [GO:0042802]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase activator activity [GO:0016004]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein self-association [GO:0043621]; receptor signaling protein tyrosine kinase activator activity [GO:0030298]	activation of phospholipase D activity [GO:0031584]; calcium ion transport [GO:0006816]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to organic cyclic compound [GO:0071407]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; dendritic cell chemotaxis [GO:0002407]; eosinophil chemotaxis [GO:0048245]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; leukocyte cell-cell adhesion [GO:0007159]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lymphocyte chemotaxis [GO:0048247]; macrophage chemotaxis [GO:0048246]; MAPK cascade [GO:0000165]; monocyte chemotaxis [GO:0002548]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of T cell apoptotic process [GO:0070233]; negative regulation of viral genome replication [GO:0045071]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular biosynthetic process [GO:0031328]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of innate immune response [GO:0045089]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of natural killer cell chemotaxis [GO:2000503]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phosphorylation [GO:0042327]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell apoptotic process [GO:0070234]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of translational initiation [GO:0045948]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of viral genome replication [GO:0045070]; protein kinase B signaling [GO:0043491]; regulation of chronic inflammatory response [GO:0002676]; regulation of insulin secretion [GO:0050796]; regulation of neuron death [GO:1901214]; regulation of T cell activation [GO:0050863]; response to toxic substance [GO:0009636]; response to virus [GO:0009615]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL5&keywords=CCL5	1.15	438	NA	NA	0.08	658	0.32	0.00	0.03	0.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	302	373	355	0.06	0.16	0.17	0.17	453	434	438	476
TNF	tumor necrosis factor	Yes		ENSG00000228978, ENSG00000204490, ENSG00000223952, ENSG00000228849, ENSG00000228321, ENSG00000230108, ENSG00000206439, ENSG00000232810	P01375	Tumor necrosis factor family	19	cell_surface_ligand, ligand, receptor	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, receptor, secreted, transmembrane, transmembrane_predicted	O15111, O15552, O75475, O75509, O94759, P01579, P09601, P10415, P19438, P20333, P25445, P35916, P36941, P46531, P48736, P78536, Q12933, Q13332, Q13546, Q15628, Q16236, Q8WWX8, Q9C0C4, Q9H7M9, Q9HCU4, Q9UHD2, Q9Y6K9, Q9Y6W8	ADAM17, BCL2, CELSR2, CHUK, FAS, FFAR2, FLT4, HMOX1, ICOS, IFNG, IKBKG, LTBR, NFE2L2, NOTCH1, PIK3CG, PSIP1, PTPRS, RIPK1, SEMA4C, SLC5A11, TBK1, TNFRSF1A, TNFRSF1B, TNFRSF21, TRADD, TRAF2, TRPM2, VSIR	PSIP1 [SPIKE:16403949], TNFRSF1B [Baccin2019:19084540;Baccin2019:2158863;Baccin2019:7664431;BioGRID:7930591;BioGRID:7966397;CancerCellMap:2158863;CancerCellMap:7664431;CellTalkDB:19084540;Cellinker:19084540;Cellinker:2158863;Cellinker:7664431;DIP:1328224;DIP:14743216;DIP:2172983;HPMR:2158863;HPRD:19084540;HPRD:2158863;HPRD:7664431;ICELLNET:11239407;InnateDB:11448951;InnateDB:14743216;InnateDB:19287455;IntAct:14743216;IntAct:24070898;LRdb:19084540;LRdb:2158863;LRdb:7664431;Lit-BM-17:1310388;Lit-BM-17:1328224;Lit-BM-17:14743216;Lit-BM-17:15485837;Lit-BM-17:2172983;Lit-BM-17:24070898;Lit-BM-17:7930591;Lit-BM-17:7966397;Lit-BM-17:8182064;Lit-BM-17:8805640;Lit-BM-17:9488135;Lit-BM-17:9568681;Macrophage:7852363;Macrophage:8590321;NetPath:15485837;NetPath:1655744;NetPath:7664431;SIGNOR:12040173;SIGNOR:14732063;SIGNOR:17151142;SPIKE:15450251;connectomeDB2020:19084540;connectomeDB2020:2158863;connectomeDB2020:7664431], TNFRSF1A [AlzPathway:18067990;Baccin2019:10634209;Baccin2019:14743216;Baccin2019:19084540;Baccin2019:7852363;BioGRID:2170559;CancerCellMap:10634209;CancerCellMap:14743216;CellTalkDB:19084540;Cellinker:10634209;Cellinker:14743216;Cellinker:19084540;Cellinker:7852363;DIP:14743216;DIP:20080539;DIP:2158863;DIP:2170974;DIP:22801493;DIP:23955153;HPMR:7852363;HPRD:10634209;HPRD:14743216;HPRD:19084540;ICELLNET:11239407;InnateDB:11448951;InnateDB:12887920;InnateDB:14743216;InnateDB:19287455;InnateDB:2158863;InnateDB:2848815;InnateDB:7852363;IntAct:14743216;IntAct:20103630;IntAct:24070898;IntAct:25241761;IntAct:2848815;LRdb:10634209;LRdb:14743216;LRdb:19084540;LRdb:7852363;Lit-BM-17:12753742;Lit-BM-17:12887920;Lit-BM-17:1310388;Lit-BM-17:14743216;Lit-BM-17:15485837;Lit-BM-17:20103630;Lit-BM-17:2158863;Lit-BM-17:2170559;Lit-BM-17:2170974;Lit-BM-17:22028622;Lit-BM-17:22099304;Lit-BM-17:22675546;Lit-BM-17:23032187;Lit-BM-17:23746843;Lit-BM-17:24070898;Lit-BM-17:24726327;Lit-BM-17:24980434;Lit-BM-17:25241761;Lit-BM-17:25911380;Lit-BM-17:26186194;Lit-BM-17:26670046;Lit-BM-17:27560715;Lit-BM-17:2848815;Lit-BM-17:8182064;Lit-BM-17:8288897;Lit-BM-17:8805640;Lit-BM-17:9488135;Lit-BM-17:9568681;Macrophage:1331108;Macrophage:2158863;NetPath:10634209;NetPath:15485837;NetPath:3034874;ProtMapper:21724995;SIGNOR:10634209;SIGNOR:11502070;SIGNOR:14732063;SIGNOR:17151142;SIGNOR:21133840;SIGNOR:23070005;SPIKE:10634209;SPIKE:19442713;SPIKE:2158863;connectomeDB2020:10634209;connectomeDB2020:14743216;connectomeDB2020:19084540;connectomeDB2020:7852363], HMOX1 [NRF2ome:18202225], NFE2L2 [NRF2ome:18202225], TNFRSF21 [Baccin2019:9714541;CellTalkDB:9714541;Cellinker:9714541;HPMR:9714541;LRdb:9714541;SIGNOR:9714541;connectomeDB2020:9714541], PIK3CG [SIGNOR:10485710], ADAM17 [HPRD:10799478;HPRD:12135369], FFAR2 [CellTalkDB:32103204], TRAF2 [Baccin2019:12887920;CellTalkDB:12887920;Cellinker:12887920;HPRD:12887920;InnateDB:12887920;InnateDB:19287455;LRdb:12887920;NetPath:15485837;ProtMapper:18981220;ProtMapper:19336568;ProtMapper:21119000;ProtMapper:23612498;ProtMapper:25134449;ProtMapper:27098354], RIPK1 [InnateDB:12887920;ProtMapper:28506461;ProtMapper:28842570], FLT4 [CellTalkDB:32103204], CELSR2 [CellTalkDB:32103204], NOTCH1 [CellTalkDB:32103204], ICOS [CellTalkDB:32103204], TRADD [CellTalkDB:32196115;InnateDB:12887920;InnateDB:19287455;NetPath:15485837], FAS [CellTalkDB:32103204], PTPRS [CellTalkDB:32103204], VSIR [CellTalkDB:32103204], TRPM2 [CellTalkDB:16306129], LTBR [Baccin2019:24636534;DIP:8171323], SLC5A11 [NA], SEMA4C [NA], BCL2 [HPRD-phos:10669763;HPRD-phos:15225643], TBK1 [NetPath:15485837;ProtMapper:23396211], CHUK [InnateDB:19287455;ProtMapper:21887257], IKBKG [IntAct:23104095], IFNG [HPRD:3139842]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]	cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; transcription cis-regulatory region binding [GO:0000976]; tumor necrosis factor receptor binding [GO:0005164]	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; acute inflammatory response [GO:0002526]; astrocyte activation [GO:0048143]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid stimulus [GO:0071230]; cellular response to amyloid-beta [GO:1904646]; cellular response to interferon-gamma [GO:0071346]; cellular response to nicotine [GO:0071316]; cellular response to organic cyclic compound [GO:0071407]; cellular response to retinoic acid [GO:0071300]; cellular response to toxic substance [GO:0097237]; chronic inflammatory response to antigenic stimulus [GO:0002439]; circadian rhythm [GO:0007623]; cognition [GO:0050890]; cortical actin cytoskeleton organization [GO:0030866]; defense response to Gram-positive bacterium [GO:0050830]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; embryonic digestive tract development [GO:0048566]; endothelial cell apoptotic process [GO:0072577]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; glucose metabolic process [GO:0006006]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; JNK cascade [GO:0007254]; leukocyte migration involved in inflammatory response [GO:0002523]; leukocyte tethering or rolling [GO:0050901]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; liver regeneration [GO:0097421]; MAPK cascade [GO:0000165]; microglial cell activation [GO:0001774]; necroptotic signaling pathway [GO:0097527]; negative regulation of alkaline phosphatase activity [GO:0010693]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of bile acid secretion [GO:0120190]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of branching involved in lung morphogenesis [GO:0061048]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of glucose import [GO:0046325]; negative regulation of heart rate [GO:0010459]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of L-glutamate import across plasma membrane [GO:0002037]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of lipid storage [GO:0010888]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of myelination [GO:0031642]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of neurogenesis [GO:0050768]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of viral genome replication [GO:0045071]; osteoclast differentiation [GO:0030316]; positive regulation of action potential [GO:0045760]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood microparticle formation [GO:2000334]; positive regulation of calcidiol 1-monooxygenase activity [GO:0060559]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cell adhesion [GO:0045785]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of chemokine production [GO:0032722]; positive regulation of chronic inflammatory response to antigenic stimulus [GO:0002876]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001272]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of fever generation [GO:0031622]; positive regulation of fractalkine production [GO:0032724]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of hair follicle development [GO:0051798]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-33 production [GO:0150129]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neutrophil activation [GO:1902565]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitrogen compound metabolic process [GO:0051173]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of podosome assembly [GO:0071803]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein transport [GO:0051222]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of synaptic transmission [GO:0050806]; positive regulation of synoviocyte proliferation [GO:1901647]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translational initiation by iron [GO:0045994]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of vitamin D biosynthetic process [GO:0060557]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of fat cell differentiation [GO:0045598]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of synapse organization [GO:0050807]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of transcription by RNA polymerase II [GO:0006357]; response to 3,3',5-triiodo-L-thyronine [GO:1905242]; response to activity [GO:0014823]; response to ethanol [GO:0045471]; response to glucocorticoid [GO:0051384]; response to gold nanoparticle [GO:1990268]; response to Gram-negative bacterium [GO:0140460]; response to hypoxia [GO:0001666]; response to nutrient levels [GO:0031667]; response to paracetamol [GO:1901554]; response to radiation [GO:0009314]; response to salt stress [GO:0009651]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; sequestering of triglyceride [GO:0030730]; skeletal muscle contraction [GO:0003009]; toll-like receptor 3 signaling pathway [GO:0034138]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor production [GO:0010573]; vasodilation [GO:0042311]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNF&keywords=TNF	0.26	590	NA	NA	0.09	651	0.07	0.03	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	303	409	401	0.01	0.51	0.51	0.51	339	317	320	492
CCL11	C-C motif chemokine ligand 11	Yes		ENSG00000172156	P51671	Intercrine beta (chemokine CC) family	19	ligand	extracellular, intracellular, ligand, secreted	O00590, P27487, P41597, P49682, P51677, P51681, Q16570, Q9NPB9	ACKR1, ACKR2, ACKR4, CCR2, CCR3, CCR5, CXCR3, DPP4	CCR2 [Baccin2019:11264152;Baccin2019:12149192;Baccin2019:12554737;Baccin2019:15207250;Baccin2019:9115216;Baccin2019:9195948;Baccin2019:9276730;CellTalkDB:12554737;Cellinker:11264152;Cellinker:12554737;Cellinker:15207250;Guide2Pharma:12554737;Guide2Pharma:15207250;HPRD:11264152;ICELLNET:22633458;InnateDB:11264152;LRdb:11264152;LRdb:12554737;LRdb:15207250;connectomeDB2020:11264152;connectomeDB2020:12554737;connectomeDB2020:15207250;scConnect:12554737;scConnect:15207250], CCR3 [Baccin2019:10488147;Baccin2019:10854442;Baccin2019:12149192;Baccin2019:12761559;Baccin2019:16339911;Baccin2019:8609214;Baccin2019:8642344;Baccin2019:8676064;Baccin2019:9005985;Baccin2019:9276730;Baccin2019:9712872;CellPhoneDB:24218476;CellTalkDB:10699158;Cellinker:10488147;Cellinker:10854442;Cellinker:12761559;Cellinker:16339911;Cellinker:8609214;Cellinker:8642344;Cellinker:8676064;Cellinker:9276730;Cellinker:9712872;DIP:10733106;DIP:25450766;DIP:9169459;DIP:9207005;Guide2Pharma:10488147;Guide2Pharma:10854442;Guide2Pharma:12761559;Guide2Pharma:16339911;Guide2Pharma:8642344;Guide2Pharma:9276730;HPRD:8609214;HPRD:8642344;HPRD:8676064;HPRD:9712872;ICELLNET:22633458;InnateDB:12218106;InnateDB:16102831;InnateDB:8642344;LRdb:10699158;Lit-BM-17:10733106;Lit-BM-17:23597562;Lit-BM-17:8642344;Lit-BM-17:9169459;Lit-BM-17:9207005;SIGNOR:10706854;SIGNOR:24702154;connectomeDB2020:10488147;connectomeDB2020:10854442;connectomeDB2020:12761559;connectomeDB2020:16339911;connectomeDB2020:8609214;connectomeDB2020:8642344;connectomeDB2020:8676064;connectomeDB2020:9276730;connectomeDB2020:9712872;scConnect:10488147;scConnect:10854442;scConnect:12761559;scConnect:16339911;scConnect:8642344;scConnect:9276730], CCR5 [Baccin2019:10477718;Baccin2019:11264152;Baccin2019:12964882;Baccin2019:9468473;Baccin2019:9790730;CellTalkDB:10699158;Cellinker:10477718;Cellinker:11264152;DIP:10477718;Guide2Pharma:10477718;HPRD:10477718;HPRD:11264152;ICELLNET:22633458;InnateDB:10477718;LRdb:10699158;connectomeDB2020:10477718;connectomeDB2020:11264152;scConnect:10477718], CXCR3 [Baccin2019:96607939660793;CellTalkDB:9660793;Cellinker:9660793;DIP:9660793;Guide2Pharma:9660793;ICELLNET:22633458;LRdb:9660793;connectomeDB2020:9660793;scConnect:9660793], ACKR1 [CellChatDB:26740381;CellTalkDB:10699158;Cellinker:26740381;Cellinker:29637711;ICELLNET:22633458;LRdb:10699158], ACKR2 [CellChatDB:26740381;CellPhoneDB:24218476;CellTalkDB:10699158;Cellinker:26740381;Cellinker:9405404;HPRD:9405404;ICELLNET:22633458;InnateDB:9405404;LRdb:10699158;connectomeDB2020:9405404], DPP4 [CellPhoneDB:24218476;CellTalkDB:9660793;Cellinker:17156337;HPRD:11390394;IntAct:18275857;IntAct:21314817], ACKR4 [CellTalkDB:10734104;Cellinker:10734104;HPRD:10734104;HPRD:9405404;LRdb:10734104;connectomeDB2020:10734104]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR3 chemokine receptor binding [GO:0031728]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; protein dimerization activity [GO:0046983]; receptor ligand activity [GO:0048018]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; learning or memory [GO:0007611]; lymphocyte chemotaxis [GO:0048247]; mammary duct terminal end bud growth [GO:0060763]; modulation of age-related behavioral decline [GO:0090647]; monocyte chemotaxis [GO:0002548]; negative regulation of neurogenesis [GO:0050768]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; response to radiation [GO:0009314]; response to virus [GO:0009615]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL11&keywords=CCL11	0.27	587	NA	NA	0.09	640	0.00	0.00	0.00	0.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	303	406	384	0.02	0.37	0.37	0.39	386	351	356	496
CCL13	C-C motif chemokine ligand 13	Yes		ENSG00000181374	Q99616	Intercrine beta (chemokine CC) family	19	ligand	extracellular, intracellular, ligand, secreted	O00590, P13500, P32246, P41597, P49682, P51677, P51681, P51686, Q16570, Q9NPB9	ACKR1, ACKR2, ACKR4, CCL2, CCR1, CCR2, CCR3, CCR5, CCR9, CXCR3	CCR1 [CellTalkDB:10699158;Cellinker:23846739;LRdb:10699158], CCR2 [Baccin2019:24890717;CellPhoneDB:24218476;Cellinker:12149192;Cellinker:12554737;Cellinker:9195948;Cellinker:9276730;DIP:9195948;Guide2Pharma:12554737;Guide2Pharma:9276730;HPRD:12149192;HPRD:9195948;ICELLNET:22633458;LRdb:10699158;connectomeDB2020:12149192;connectomeDB2020:12554737;connectomeDB2020:9195948;connectomeDB2020:9276730;scConnect:12554737;scConnect:9276730], CCR3 [CellPhoneDB:24218476;Cellinker:12149192;Cellinker:16339911;Cellinker:9005985;Cellinker:9276730;DIP:10733106;Guide2Pharma:16339911;Guide2Pharma:9276730;HPRD:12149192;ICELLNET:22633458;LRdb:10699158;connectomeDB2020:12149192;connectomeDB2020:16339911;connectomeDB2020:9005985;connectomeDB2020:9276730;scConnect:16339911;scConnect:9276730], CCR5 [CellTalkDB:9790730;Cellinker:10477718;Cellinker:9790730;DIP:10477718;Guide2Pharma:9790730;HPRD:10477718;InnateDB:10477718;LRdb:105;LRdb:9790730;connectomeDB2020:10477718;connectomeDB2020:9790730;scConnect:9790730], CXCR3 [CellTalkDB:9660793;Cellinker:9660793;DIP:9660793;Guide2Pharma:9660793;LRdb:9660793;connectomeDB2020:9660793;scConnect:9660793], ACKR1 [Baccin2019:24890717;CellChatDB:26740381;CellTalkDB:10699158;Cellinker:26740381;Cellinker:29637711;ICELLNET:22633458;LRdb:10699158], ACKR2 [Baccin2019:24890717;CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:26740381;Cellinker:9405404;HPRD:9405404;ICELLNET:22633458;InnateDB:9405404;LRdb:10699158;connectomeDB2020:9405404], ACKR4 [CellChatDB:26740381;CellTalkDB:10734104;Cellinker:10734104;Cellinker:26740381;DIP:10734104;HPRD:10734104;HPRD:9405404;InnateDB:10734104;LRdb:10734104;connectomeDB2020:10734104], CCR9 [CellTalkDB:32196115], CCL2 [InnateDB:16803905]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; signaling receptor binding [GO:0005102]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL13&keywords=CCL13	0.09	680	NA	NA	0.03	773	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	303	409	401	0.00	0.95	0.95	0.95	152	149	116	503
IGF1	insulin like growth factor 1	Yes		ENSG00000017427	P05019	Insulin family	19	ligand	extracellular, intracellular, ligand, secreted, transmembrane	P06213, P08069, P11717	APC_AXIN1_GSK3B, IGF1R, IGF2R, INSR, ITGA6_ITGB4, ITGAV_ITGB3	IGF1R [Baccin2019:1852007;Baccin2019:2877871;CA1:8408032;CellChatDB:14604834;CellTalkDB:2877871;Cellinker:14604834;Cellinker:1852007;Cellinker:2877871;DIP:11287679;DIP:21645859;HPMR:2877871;HPRD:1852007;IntAct:21645859;IntAct:8452530;LRdb:185;LRdb:2877871;ProtMapper:19258508;ProtMapper:23675206;SIGNOR:19029956;SIGNOR:21798082;SPIKE:1852007;SignaLink3:12067807;SignaLink3:1852007;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:1852007;connectomeDB2020:2877871], INSR [Baccin2019:23518924;CellTalkDB:32196115], IGF2R [CellTalkDB:32196115]	alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; exocytic vesicle [GO:0070382]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; insulin-like growth factor binding protein complex [GO:0016942]; insulin-like growth factor ternary complex [GO:0042567]; platelet alpha granule lumen [GO:0031093]	growth factor activity [GO:0008083]; hormone activity [GO:0005179]; insulin-like growth factor receptor binding [GO:0005159]; insulin receptor binding [GO:0005158]; integrin binding [GO:0005178]	activation of protein kinase B activity [GO:0032148]; bone mineralization involved in bone maturation [GO:0035630]; cell activation [GO:0001775]; cell population proliferation [GO:0008283]; cellular response to amyloid-beta [GO:1904646]; ERK1 and ERK2 cascade [GO:0070371]; glycolate metabolic process [GO:0009441]; insulin-like growth factor receptor signaling pathway [GO:0048009]; muscle hypertrophy [GO:0014896]; muscle organ development [GO:0007517]; myoblast differentiation [GO:0045445]; myoblast proliferation [GO:0051450]; myotube cell development [GO:0014904]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of oocyte development [GO:0060283]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of vascular associated smooth muscle cell apoptotic process [GO:1905460]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein secretion [GO:0050714]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of trophectodermal cell proliferation [GO:1904075]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; proteoglycan biosynthetic process [GO:0030166]; Ras protein signal transduction [GO:0007265]; regulation of gene expression [GO:0010468]; regulation of multicellular organism growth [GO:0040014]; response to heat [GO:0009408]; signal transduction [GO:0007165]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]; skeletal system development [GO:0001501]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IGF1&keywords=IGF1	0.19	616	NA	NA	0.02	786	0.06	0.00	0.00	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	303	406	397	0.01	0.57	0.58	0.58	309	292	292	525
IL3	interleukin 3	Yes		ENSG00000164399	P08700	IL-3 family	19	ligand	extracellular, ligand, secreted	P15509, P26951, P32927, P42336	CSF2RA, CSF2RB, CSF2RB_IL3RA, IL3RA, PIK3CA	IL3RA [BioGRID:8649415;CellTalkDB:11700046;DIP:8649415;HPMR:11700046;HPRD:8649415;HPRD:9278420;InnateDB:7957082;LRdb:11700046;LRdb:8649415;LRdb:9278420;NetPath:9278420;SIGNOR:11700046;SIGNOR:1465408;SignaLink3:1465408;SignaLink3:23331499;connectomeDB2020:11700046;connectomeDB2020:8649415;connectomeDB2020:9278420], CSF2RB [CellTalkDB:11700046;DIP:7957082;HPMR:11700046;HPRD:9278420;LRdb:11700046;LRdb:93;Lit-BM-17:18692472;Lit-BM-17:7957082;Lit-BM-17:8649415;NetPath:9278420;connectomeDB2020:11700046;connectomeDB2020:9278420], CSF2RA [Cellinker:23046136], PIK3CA [HPRD:9113989]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-3 receptor binding [GO:0005135]	cell-cell signaling [GO:0007267]; embryonic hemopoiesis [GO:0035162]; immune response [GO:0006955]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL3&keywords=IL3	0.00	864	NA	NA	1.01	264	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	564
EPO	erythropoietin	Yes		ENSG00000130427	P01588	EPO/TPO family	19	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted	P19235, P52799, P54760, Q8IUI8, Q9UIK4	CRLF3, DAPK2, EFNB2, EPHB4, EPOR	EPOR [Baccin2019:10318834;Baccin2019:16982323;Baccin2019:9442088;Baccin2019:9808045;BioGRID:10318834;BioGRID:15358619;BioGRID:17327410;BioGRID:9808045;Cellinker:10318834;Cellinker:16982323;Cellinker:9442088;Cellinker:9808045;DIP:10318834;DIP:8662939;DIP:9030560;DIP:9774108;Guide2Pharma:16982323;HPMR:9442088;HPRD:10318834;HPRD:9808045;ICELLNET:2163696;ICELLNET:9974393;InnateDB:21889455;InnateDB:9774108;IntAct:29997244;IntAct:9774108;LRdb:10318834;LRdb:16982323;LRdb:9442088;LRdb:9808045;Lit-BM-17:10318834;Lit-BM-17:15358619;Lit-BM-17:17327410;Lit-BM-17:8662939;Lit-BM-17:9030560;Lit-BM-17:9774108;Lit-BM-17:9808045;SIGNOR:9442088;SIGNOR:9774108;SPIKE:18586265;SignaLink3:23331499;SignaLink3:9774108;connectomeDB2020:10318834;connectomeDB2020:16982323;connectomeDB2020:9442088;connectomeDB2020:9808045;scConnect:16982323], DAPK2 [SPIKE:18535204], EPHB4 [CellTalkDB:26481148;connectomeDB2020:25586589;connectomeDB2020:26481148], CRLF3 [connectomeDB2020:28769759], EFNB2 [NA]	cell body [GO:0044297]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; erythropoietin receptor binding [GO:0005128]; hormone activity [GO:0005179]; protein kinase activator activity [GO:0030295]	acute-phase response [GO:0006953]; aging [GO:0007568]; apoptotic process [GO:0006915]; blood circulation [GO:0008015]; cellular hyperosmotic response [GO:0071474]; embryo implantation [GO:0007566]; erythrocyte differentiation [GO:0030218]; erythrocyte maturation [GO:0043249]; erythropoietin-mediated signaling pathway [GO:0038162]; hemoglobin biosynthetic process [GO:0042541]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of cation channel activity [GO:2001258]; negative regulation of erythrocyte apoptotic process [GO:1902251]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of neuron death [GO:1901215]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to axon injury [GO:0048678]; response to dexamethasone [GO:0071548]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to salt stress [GO:0009651]; response to testosterone [GO:0033574]; response to vitamin A [GO:0033189]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EPO&keywords=EPO	0.12	663	NA	NA	0.17	554	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	609
AMH	anti-Mullerian hormone	Yes		ENSG00000104899	P03971	TGF-beta family	19	ligand	extracellular, intracellular, ligand, secreted	O00238, P00533, P36894, Q04771, Q16671, Q9H772	ACVR1, ACVR1_AMHR2, AMHR2, AMHR2_BMPR1A, AMHR2_BMPR1B, BMPR1A, BMPR1B, EGFR, GREM2	AMHR2 [Baccin2019:79972308889695;CellTalkDB:7997230;HPMR:7997230;HPRD:8889695;LRdb:7997230;LRdb:889;SIGNOR:8119126;SignaLink3:16446785;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:8889695;connectomeDB2020:7997230;connectomeDB2020:8889695], BMPR1B [Cellinker:11420127], BMPR1A [NA], ACVR1 [CellTalkDB:14656470;LRdb:14656470;Ramilowski2015:14656470;connectomeDB2020:14656470;talklr:14656470], EGFR [Baccin2019:8596488;CellTalkDB:8596488;Cellinker:8596488;HPRD:8596488;LRdb:8596488;connectomeDB2020:8596488], GREM2 [Cellinker:24614542]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	growth factor activity [GO:0008083]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]; type II transforming growth factor beta receptor binding [GO:0005114]	aging [GO:0007568]; cell-cell signaling [GO:0007267]; gonadal mesoderm development [GO:0007506]; Leydig cell differentiation [GO:0033327]; Mullerian duct regression [GO:0001880]; negative regulation of ovarian follicle development [GO:2000355]; ovarian follicle development [GO:0001541]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of gene expression [GO:0010628]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; preantral ovarian follicle growth [GO:0001546]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410]; sex determination [GO:0007530]; sex differentiation [GO:0007548]; urogenital system development [GO:0001655]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=AMH&keywords=AMH	0.11	665	NA	NA	0.04	728	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	697
NTF4	neurotrophin 4	Yes		ENSG00000225950	P34130	NGF-beta family	19	ligand	extracellular, intracellular, ligand, secreted	P04629, P08138, P23560, Q00994, Q16288, Q16620	BDNF, BEX3, NGFR, NTRK1, NTRK2, NTRK3	NGFR [AlzPathway:9775403;Baccin2019:7541633;CellTalkDB:7541633;Cellinker:7541633;HPRD:7541633;LRdb:7541633;connectomeDB2020:7541633], NTRK1 [Baccin2019:11114882;CellTalkDB:11114882;Cellinker:11114882;LRdb:11114882;SIGNOR:11114882;connectomeDB2020:11114882], NTRK2 [AlzPathway:9775403;Baccin2019:767991211855816;CellChatDB:27908981;CellTalkDB:7679912;Cellinker:11855816;Cellinker:27908981;Cellinker:7679912;HPRD:11855816;LRdb:119;LRdb:7679912;Lit-BM-17:11738045;Lit-BM-17:11855816;Lit-BM-17:25241761;SIGNOR:7679912;connectomeDB2020:11855816;connectomeDB2020:7679912], BEX3 [CellTalkDB:7679912;LRdb:7679912;connectomeDB2020:7679912], NTRK3 [NA], BDNF [IntAct:10631974;IntAct:25241761;IntAct:29997244]	axon [GO:0030424]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; synaptic vesicle [GO:0008021]	growth factor activity [GO:0008083]; nerve growth factor receptor binding [GO:0005163]	adult locomotory behavior [GO:0008344]; epidermis development [GO:0008544]; ganglion mother cell fate determination [GO:0007402]; innervation [GO:0060384]; long-term memory [GO:0007616]; mechanoreceptor differentiation [GO:0042490]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; nerve development [GO:0021675]; nerve growth factor signaling pathway [GO:0038180]; neuron projection morphogenesis [GO:0048812]; peripheral nervous system development [GO:0007422]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of neuron differentiation [GO:0045664]; sensory organ boundary specification [GO:0008052]; taste bud development [GO:0061193]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NTF4&keywords=NTF4	0.05	733	NA	NA	0.03	774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	754
CTF1	cardiotrophin 1	Yes		ENSG00000150281	Q16619	IL-6 superfamily	19	ligand	extracellular, intracellular, ligand, secreted	P40189, P42702	IL6ST, IL6ST_LIFR, LIFR	IL6ST [Baccin2019:11834704;CellTalkDB:11834704;HPRD:11834704;LRdb:11834704;SIGNOR:9030543;SignaLink3:23331499;SignaLink3:9030543;connectomeDB2020:11834704], LIFR [Baccin2019:11834704;CellTalkDB:11834704;HPRD:11834704;LRdb:11834704;SIGNOR:11834704;SignaLink3:11834704;SignaLink3:23331499;SignaLink3:9030543;connectomeDB2020:11834704]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; leukemia inhibitory factor receptor binding [GO:0005146]	cell-cell signaling [GO:0007267]; cell surface receptor signaling pathway [GO:0007166]; leukemia inhibitory factor signaling pathway [GO:0048861]; muscle organ development [GO:0007517]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CTF1&keywords=CTF1	0.10	677	NA	NA	0.01	842	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	760
LTA	lymphotoxin alpha	Yes	cytokine	ENSG00000230279, ENSG00000238130, ENSG00000231408, ENSG00000223919, ENSG00000173503, ENSG00000226275, ENSG00000226979	P01374	Tumor necrosis factor family	19	cell_surface_ligand, ligand	cell_surface_ligand, extracellular, intracellular, ligand, secreted, transmembrane	P19438, P20333, P25101, P36941, Q13546, Q5VU97, Q92956	CACHD1, EDNRA, LTB_LTBR, LTBR, RIPK1, TNFRSF14, TNFRSF1A, TNFRSF1B	TNFRSF1A [Baccin2019:8387891;BioGRID:8387891;CellTalkDB:8387891;Cellinker:8387891;DIP:2170974;DIP:8387891;HPRD:8387891;ICELLNET:7995952;InnateDB:8171323;LRdb:8387891;Lit-BM-17:1310388;Lit-BM-17:2170974;Lit-BM-17:8182064;Lit-BM-17:8288897;Lit-BM-17:8387891;SPIKE:12387745;connectomeDB2020:8387891], TNFRSF14 [Baccin2019:9153189;Baccin2019:9462508;CellTalkDB:9153189;Cellinker:9153189;Cellinker:9462508;HPRD:9153189;HPRD:9462508;ICELLNET:7995952;InnateDB:11164894;LRdb:9153189;LRdb:946;connectomeDB2020:9153189;connectomeDB2020:9462508], TNFRSF1B [Baccin2019:2160731;Baccin2019:8123048;Baccin2019:9552007;CellTalkDB:9552007;Cellinker:2160731;Cellinker:8123048;Cellinker:9552007;DIP:1328224;HPRD:2160731;HPRD:8123048;HPRD:9552007;ICELLNET:7995952;LRdb:2160731;LRdb:8123048;LRdb:9552007;Lit-BM-17:1310388;Lit-BM-17:1328224;Lit-BM-17:8182064;connectomeDB2020:2160731;connectomeDB2020:8123048;connectomeDB2020:9552007], LTBR [Baccin2019:8171323;CellTalkDB:8171323;DIP:8171323;HPRD:8171323;LRdb:8171323;SIGNOR:7995952;connectomeDB2020:8171323], RIPK1 [CellTalkDB:32103204], CACHD1 [NA], EDNRA [NA]	extracellular space [GO:0005615]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]	apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; defense response to Gram-positive bacterium [GO:0050830]; humoral immune response [GO:0006959]; lymph node development [GO:0048535]; negative regulation of fibroblast proliferation [GO:0048147]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chronic inflammatory response to antigenic stimulus [GO:0002876]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of interferon-gamma production [GO:0032729]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LTA&keywords=LTA	0.02	801	NA	NA	0.00	865	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	833
BMP10	bone morphogenetic protein 10	Yes		ENSG00000163217	O95393	TGF-beta family	19	ligand, receptor	intracellular, ligand, receptor, secreted	O00238, O15552, P17813, P27037, P36894, P37023, P43628, P43629, Q04771, Q13705, Q13873, Q14943, Q8TDT2, Q9H7M9	ACVR1, ACVR2A, ACVR2A_ACVRL1, ACVR2B, ACVR2B_ACVRL1, ACVRL1, ACVRL1_BMPR2, BMPR1A, BMPR1B, BMPR2, ENG, FFAR2, GPR152, KIR2DL3, KIR3DL1, KIR3DS1, VSIR	BMPR1B [CellTalkDB:15621726;Cellinker:31127068;LRdb:16049014;Ramilowski2015:16049014;connectomeDB2020:16049014;talklr:16049014], ACVR2A [Baccin2019:16049014;CellTalkDB:16049014;LRdb:16049014;connectomeDB2020:16049014], BMPR1A [Baccin2019:16049014;Cellinker:16049014;LRdb:16049014;SIGNOR:16049014;connectomeDB2020:16049014], ACVRL1 [Baccin2019:17068149;CellTalkDB:17068149;LRdb:17068149;SIGNOR:17068149;connectomeDB2020:17068149], ACVR1 [Cellinker:27252362;Cellinker:30246251;Cellinker:30246252;Cellinker:31127068], ACVR2B [Cellinker:27252362], BMPR2 [Baccin2019:16049014;CellTalkDB:15621726;LRdb:16049014;connectomeDB2020:16049014], ENG [CellTalkDB:21737454;Cellinker:31540324;LRdb:21737454;Ramilowski2015:21737454;connectomeDB2020:21737454;talklr:21737454], KIR3DL1 [NA], KIR2DL3 [NA], VSIR [NA], KIR3DS1 [NA], GPR152 [NA], FFAR2 [NA]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Z disc [GO:0030018]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; receptor serine/threonine kinase binding [GO:0033612]; telethonin binding [GO:0031433]	activin receptor signaling pathway [GO:0032924]; adult heart development [GO:0007512]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; BMP signaling pathway [GO:0030509]; cardiac muscle cell proliferation [GO:0060038]; cell adhesion [GO:0007155]; heart trabecula formation [GO:0060347]; kidney development [GO:0001822]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell migration [GO:0010596]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell proliferation involved in heart morphogenesis [GO:2000138]; positive regulation of gene expression [GO:0010628]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle hypertrophy in response to stress [GO:1903242]; sarcomere organization [GO:0045214]; SMAD protein signal transduction [GO:0060395]; ventricular cardiac muscle cell development [GO:0055015]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMP10&keywords=BMP10	0.01	851	NA	NA	0.00	885	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	868
IGF2	insulin like growth factor 2	Yes		ENSG00000167244	P01344	Insulin family	18	ligand	extracellular, intracellular, ligand, secreted	P06213, P08069, P08833, P11717, Q8TDT2	GPR152, IGF1R, IGF2R, IGFBP1, INSR, ITGA6_ITGB4, ITGAV_ITGB3	IGF2R [Baccin2019:2964083;Baccin2019:7797478;Baccin2019:9722981;CellChatDB:14604834;CellTalkDB:2964083;Cellinker:14604834;Cellinker:2964083;Cellinker:7797478;Cellinker:9722981;DIP:11502794;DIP:17850746;DOMINO:18046459;HPMR:2852162;HPMR:2964083;HPRD:7797478;HPRD:9722981;LRdb:2964083;LRdb:7797478;LRdb:9722981;Lit-BM-17:11502794;Lit-BM-17:17850746;Lit-BM-17:18046459;SIGNOR:11867533;SPIKE:18046459;SPIKE:20980691;connectomeDB2020:2964083;connectomeDB2020:7797478;connectomeDB2020:9722981], IGF1R [Baccin2019:9972281;CellChatDB:14604834;CellPhoneDB:27102148;CellTalkDB:9972281;Cellinker:14604834;Cellinker:9972281;HPRD:9972281;LRdb:9972281;SIGNOR:22810696;SPIKE:20980691;SignaLink3:11867533;SignaLink3:23331499;connectomeDB2020:9972281], INSR [Baccin2019:9281335;Baccin2019:9722981;CellTalkDB:9281335;Cellinker:9281335;Cellinker:9722981;HPRD:9722981;LRdb:9281335;LRdb:972;SIGNOR:9281335;connectomeDB2020:9281335;connectomeDB2020:9722981], GPR152 [NA], IGFBP1 [BioGRID:10810289;DIP:22578544;HPRD:10810289]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]	growth factor activity [GO:0008083]; hormone activity [GO:0005179]; insulin-like growth factor receptor binding [GO:0005159]; insulin receptor binding [GO:0005158]; integrin binding [GO:0005178]; protein serine/threonine kinase activator activity [GO:0043539]; receptor ligand activity [GO:0048018]	animal organ morphogenesis [GO:0009887]; embryonic placenta development [GO:0001892]; embryonic placenta morphogenesis [GO:0060669]; exocrine pancreas development [GO:0031017]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; in utero embryonic development [GO:0001701]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of histone modification [GO:0031056]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast cell proliferation [GO:0060720]; striated muscle cell differentiation [GO:0051146]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IGF2&keywords=IGF2	45.08	97	NA	NA	1.88	171	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	134
TNFSF10	TNF superfamily member 10	Yes		ENSG00000121858	P50591	Tumor necrosis factor family	18	cell_surface_ligand, ligand	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, secreted, transmembrane, transmembrane_predicted	O00220, O00300, O14763, O14798, P51684, Q13546, Q14790, Q9UBN6	CASP8, CCR6, RIPK1, TNFRSF10A, TNFRSF10B, TNFRSF10C, TNFRSF10D, TNFRSF11B	TNFRSF10C [CellTalkDB:9314565;Cellinker:9314565;Cellinker:9325248;Cellinker:9613612;HPMR:9325248;HPRD:9314565;HPRD:9325248;HPRD:9613612;ICELLNET:11239407;LRdb:9314565;LRdb:9325248;LRdb:9613612;Lit-BM-17:20103630;Lit-BM-17:9325248;SPIKE:9082980;SPIKE:9314565;connectomeDB2020:9314565;connectomeDB2020:9325248;connectomeDB2020:9613612], TNFRSF10D [CellTalkDB:9242610;Cellinker:9242610;Cellinker:9430226;DIP:9382840;HPMR:9242610;HPRD:9430226;ICELLNET:11239407;LRdb:9242610;LRdb:943;Lit-BM-17:20103630;Lit-BM-17:9382840;Lit-BM-17:9430226;SPIKE:9430226;connectomeDB2020:9242610;connectomeDB2020:9430226], TNFRSF10B [BioGRID:11094155;BioGRID:9311998;CellTalkDB:10549288;Cellinker:10549288;Cellinker:15766588;Cellinker:9311998;Cellinker:9325248;HPMR:15766588;HPRD:10549288;HPRD:9311998;HPRD:9325248;ICELLNET:11239407;InnateDB:10894161;InnateDB:16227629;IntAct:10542098;IntAct:10549288;IntAct:20103630;LRdb:10549288;LRdb:15766588;LRdb:9311998;LRdb:9325248;Lit-BM-17:10542098;Lit-BM-17:10549288;Lit-BM-17:10894160;Lit-BM-17:11094155;Lit-BM-17:19427028;Lit-BM-17:20097879;Lit-BM-17:20103630;Lit-BM-17:21459798;Lit-BM-17:21525171;Lit-BM-17:21822306;Lit-BM-17:22266862;Lit-BM-17:22585859;Lit-BM-17:23678861;Lit-BM-17:9311998;Lit-BM-17:9325248;Macrophage:10549288;Macrophage:12628743;Macrophage:9242610;Macrophage:9311998;SIGNOR:14585074;SIGNOR:15766588;SPIKE:15538968;connectomeDB2020:10549288;connectomeDB2020:15766588;connectomeDB2020:9311998;connectomeDB2020:9325248], TNFRSF10A [Baccin2019:10549288;Baccin2019:15766588;Baccin2019:9082980;Baccin2019:9242610;Baccin2019:9311998;Baccin2019:9314565;Baccin2019:9325248;Baccin2019:9430226;Baccin2019:9613612;CellTalkDB:15766588;Cellinker:10549288;Cellinker:15766588;Cellinker:9082980;Cellinker:9325248;HPMR:15766588;HPRD:10549288;HPRD:9082980;HPRD:9325248;ICELLNET:11239407;InnateDB:10894161;IntAct:20103630;LRdb:10549288;LRdb:15766588;LRdb:9082980;LRdb:9325248;Lit-BM-17:10894160;Lit-BM-17:19427028;Lit-BM-17:20103630;Lit-BM-17:9082980;Macrophage:10549288;Macrophage:12628743;Macrophage:9082980;SIGNOR:14585074;SPIKE:15538968;connectomeDB2020:10549288;connectomeDB2020:15766588;connectomeDB2020:9082980;connectomeDB2020:9325248], TNFRSF11B [Baccin2019:12221720;Baccin2019:9520411;CellTalkDB:9520411;Cellinker:12221720;Cellinker:9520411;HPRD:12221720;HPRD:9520411;ICELLNET:11239407;LRdb:122;LRdb:9520411;connectomeDB2020:12221720;connectomeDB2020:9520411], RIPK1 [CellTalkDB:32103204], CCR6 [Cellinker:16230375], CASP8 [InnateDB:10894161;IntAct:23678861;ProtMapper:27821809]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]	cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; TRAIL binding [GO:0045569]; tumor necrosis factor receptor binding [GO:0005164]; zinc ion binding [GO:0008270]	apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; immune response [GO:0006955]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFSF10&keywords=TNFSF10	103.04	47	NA	NA	2.59	126	0.00	0.88	0.42	0.04	0.66	0.10	0.15	0.10	0.10	0.04	0.16	129	150	80	0.24	0.43	0.22	0.68	367	406	243	182
PDGFA	platelet derived growth factor subunit A	Yes		ENSG00000197461	P04085	PDGF/VEGF growth factor family	18	ligand	extracellular, intracellular, ligand, ligand_regulator, secreted	P09619, P09958, P16234	FURIN, PDGFRA, PDGFRB	PDGFRA [Baccin2019:152078112544881;CellChatDB:15207812;CellTalkDB:15207811;Cellinker:15207812;Cellinker:28267575;HPRD:2544881;ICELLNET:15207811;ICELLNET:9739761;IntAct:25241761;IntAct:7679113;LRdb:15207811;LRdb:25;Lit-BM-17:11297552;Lit-BM-17:15767546;Lit-BM-17:25241761;Lit-BM-17:2544881;Lit-BM-17:7679113;SIGNOR:11803579;SignaLink3:11803579;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:2544881;connectomeDB2020:15207811;connectomeDB2020:2544881], PDGFRB [CellChatDB:15207812;CellTalkDB:25737405;Cellinker:15207812;Lit-BM-17:7679113], FURIN [HPRD-phos:12670890;HPRD:12670890]	cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; microvillus [GO:0005902]; platelet alpha granule lumen [GO:0031093]; platelet-derived growth factor complex [GO:1990265]	collagen binding [GO:0005518]; growth factor activity [GO:0008083]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; platelet-derived growth factor binding [GO:0048407]; platelet-derived growth factor receptor binding [GO:0005161]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; cell activation [GO:0001775]; cell-cell signaling [GO:0007267]; cell projection assembly [GO:0030031]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic lung development [GO:1990401]; hair follicle development [GO:0001942]; inner ear development [GO:0048839]; lung alveolus development [GO:0048286]; male gonad development [GO:0008584]; negative chemotaxis [GO:0050919]; negative regulation of phosphatidylinositol biosynthetic process [GO:0010512]; negative regulation of platelet activation [GO:0010544]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway [GO:0035793]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling [GO:0060683]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of smooth muscle cell migration [GO:0014910]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to inorganic substance [GO:0010035]; response to retinoic acid [GO:0032526]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; skin development [GO:0043588]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PDGFA&keywords=PDGFA	17.64	180	NA	NA	0.64	327	0.00	0.19	0.15	0.23	0.34	0.20	0.17	0.12	0.09	0.12	0.09	132	96	123	0.15	0.61	0.81	0.58	301	208	296	203
CCL2	C-C motif chemokine ligand 2	Yes		ENSG00000108691	P13500	Intercrine beta (chemokine CC) family	18	ligand	extracellular, intracellular, ligand, secreted, transmembrane	O00590, P32246, P41597, P46092, P50281, P51677, P51679, P51681, Q16570, Q9NPB9	ACKR1, ACKR2, ACKR4, CCR1, CCR10, CCR2, CCR3, CCR4, CCR5, MMP14	MMP14 [SPIKE:15516694], CCR2 [Baccin2019:10529171;Baccin2019:10770925;Baccin2019:12554737;Baccin2019:15207250;Baccin2019:9276730;Baccin2019:9287323;Baccin2019:9346309;CellPhoneDB:24218476;Cellinker:10529171;Cellinker:10770925;Cellinker:12554737;Cellinker:15207250;Cellinker:28389721;Cellinker:9276730;Cellinker:9287323;Cellinker:9346309;DIP:10488147;DIP:10770925;DIP:11470772;DIP:8530354;DIP:9115216;DIP:9169459;DIP:9312096;DIP:9336350;Guide2Pharma:10770925;Guide2Pharma:12554737;Guide2Pharma:15207250;Guide2Pharma:9276730;Guide2Pharma:9346309;HPMR:9287323;HPRD:10529171;HPRD:9287323;ICELLNET:22633458;InnateDB:10529171;InnateDB:11310855;InnateDB:15629146;InnateDB:7759884;InnateDB:8530354;InnateDB:9115216;InnateDB:9287323;InnateDB:9837883;LRdb:10699158;SIGNOR:20219869;connectomeDB2020:10529171;connectomeDB2020:10770925;connectomeDB2020:12554737;connectomeDB2020:15207250;connectomeDB2020:9276730;connectomeDB2020:9287323;connectomeDB2020:9346309;scConnect:10770925;scConnect:12554737;scConnect:15207250;scConnect:9276730;scConnect:9346309], CCR3 [Baccin2019:8642344;CellTalkDB:8642344;Cellinker:8642344;Guide2Pharma:8642344;InnateDB:8642344;LRdb:8642344;connectomeDB2020:8642344;scConnect:8642344], CCR5 [Baccin2019:1629834510477710;CellTalkDB:16298345;Cellinker:10477718;Cellinker:16298345;DIP:10477718;Guide2Pharma:16298345;HPRD:10477718;InnateDB:10477718;LRdb:1;LRdb:16298345;connectomeDB2020:10477718;connectomeDB2020:16298345;scConnect:16298345], CCR4 [Baccin2019:16421945;CellTalkDB:16421945;LRdb:16421945;SIGNOR:17160712;connectomeDB2020:16421945], ACKR1 [CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:13679391;Cellinker:17416748;Cellinker:26740381;HPRD:13679391;HPRD:17416748;ICELLNET:22633458;InnateDB:8132497;LRdb:10699158;LRdb:13679391;LRdb:17;connectomeDB2020:13679391;connectomeDB2020:17416748], ACKR2 [Baccin2019:9364936;Baccin2019:9405404;CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:26740381;Cellinker:9364936;Cellinker:9405404;HPRD:9364936;HPRD:9405404;ICELLNET:22633458;InnateDB:9405404;LRdb:10699158;connectomeDB2020:9364936;connectomeDB2020:9405404], CCR1 [Baccin2019:76793288631787;CellTalkDB:10699158;Cellinker:7679328;Cellinker:8631787;DIP:9115216;HPMR:7679328;HPRD:8631787;InnateDB:9115216;LRdb:10699158;connectomeDB2020:7679328;connectomeDB2020:8631787], CCR10 [Baccin2019:10706668;Baccin2019:9364936;CellTalkDB:9364936;Cellinker:10706668;Cellinker:9364936;HPRD:10706668;HPRD:9364936;LRdb:107;LRdb:9364936;connectomeDB2020:10706668;connectomeDB2020:9364936], ACKR4 [Baccin2019:10734104;CellTalkDB:10734104;Cellinker:10734104;DIP:10734104;HPRD:10734104;HPRD:9364936;HPRD:9405404;InnateDB:10734104;LRdb:10734104;connectomeDB2020:10734104]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR2 chemokine receptor binding [GO:0031727]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]	angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; astrocyte cell migration [GO:0043615]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular homeostasis [GO:0019725]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to organic cyclic compound [GO:0071407]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; helper T cell extravasation [GO:0035684]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lymphocyte chemotaxis [GO:0048247]; macrophage chemotaxis [GO:0048246]; MAPK cascade [GO:0000165]; monocyte chemotaxis [GO:0002548]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of natural killer cell chemotaxis [GO:2000502]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; neutrophil chemotaxis [GO:0030593]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of calcium ion import [GO:0090280]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of T cell activation [GO:0050870]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell shape [GO:0008360]; response to bacterium [GO:0009617]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; viral genome replication [GO:0019079]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL2&keywords=CCL2	287.36	30	NA	NA	13.20	38	0.70	6.17	0.63	0.42	0.99	0.01	0.01	0.00	0.00	0.01	0.02	297	289	219	0.81	0.01	0.02	0.03	525	519	518	219
FGF19	fibroblast growth factor 19	Yes		ENSG00000162344	O95750	Heparin-binding growth factors family	18	ligand	extracellular, intracellular, ligand, secreted	P11362, P21802, P22455, P22607, Q86Z14	FGFR1, FGFR2, FGFR3, FGFR4, KLB	FGFR4 [Baccin2019:1473096710525310;CellTalkDB:16597617;Cellinker:10525310;Cellinker:14730967;Cellinker:22442730;Cellinker:31529503;DIP:10525310;DIP:19706524;Guide2Pharma:10525310;HPRD:10525310;LRdb:16597617;connectomeDB2020:10525310;connectomeDB2020:14730967], FGFR2 [CellTalkDB:16597617;LRdb:16597617;Ramilowski2015:16597617;connectomeDB2020:16597617;talklr:16597617], FGFR1 [CellTalkDB:16597617;Cellinker:22442730;LRdb:16597617;Ramilowski2015:16597617;connectomeDB2020:16597617;talklr:16597617], FGFR3 [CellTalkDB:16597617;LRdb:16597617;Ramilowski2015:16597617;connectomeDB2020:16597617;talklr:16597617], KLB [CellTalkDB:22442730;LRdb:22442730;Ramilowski2015:22442730;connectomeDB2020:22442730;talklr:22442730]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]	animal organ morphogenesis [GO:0009887]; bile acid and bile salt transport [GO:0015721]; cell differentiation [GO:0030154]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart development [GO:0007507]; negative regulation of bile acid biosynthetic process [GO:0070858]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; response to bacterium [GO:0009617]; response to ethanol [GO:0045471]; response to organic cyclic compound [GO:0014070]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF19&keywords=FGF19	4.80	294	NA	NA	135.24	9	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	303	409	401	0.00	0.92	0.92	0.92	170	164	133	219
CXCL6	C-X-C motif chemokine ligand 6	Yes		ENSG00000124875	P80162	Intercrine alpha (chemokine CxC) family	18	ligand	extracellular, ligand, secreted	P08913, P25024, P25025, P48039, Q14831, Q16570	ACKR1, ADRA2A, CXCR1, CXCR2, GRM7, MTNR1A	CXCR1 [Baccin2019:10593335;Baccin2019:12964882;Baccin2019:8702798;Baccin2019:9692902;CellPhoneDB:24218476;Cellinker:10593335;Cellinker:12964882;Cellinker:9692902;Guide2Pharma:9692902;HPMR:12964882;HPRD:10593335;HPRD:9692902;ICELLNET:22633458;InnateDB:9485196;LRdb:10699158;connectomeDB2020:10593335;connectomeDB2020:12964882;connectomeDB2020:9692902;scConnect:9692902], CXCR2 [Baccin2019:10593335;Baccin2019:12964882;Baccin2019:8702798;Baccin2019:9692902;CellPhoneDB:24218476;CellTalkDB:9692902;Cellinker:10593335;Cellinker:12964882;Cellinker:9692902;Guide2Pharma:9692902;HPRD:10593335;HPRD:9692902;ICELLNET:22633458;InnateDB:9485196;LRdb:10593335;LRdb:12964882;LRdb:9692902;connectomeDB2020:10593335;connectomeDB2020:12964882;connectomeDB2020:9692902;scConnect:9692902], ADRA2A [CellTalkDB:32196115], ACKR1 [Baccin2019:20643340;CellChatDB:26740381;CellTalkDB:10699158;Cellinker:26740381;Cellinker:29637711;LRdb:10699158], GRM7 [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; heparin binding [GO:0008201]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; defense response to bacterium [GO:0042742]; inflammatory response [GO:0006954]; leukocyte homeostasis [GO:0001776]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; regulation of chemokine production [GO:0032642]; regulation of neutrophil mediated killing of gram-negative bacterium [GO:0070951]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCL6&keywords=CXCL6	46.30	94	NA	NA	19.18	29	0.00	0.30	0.00	0.04	0.01	0.00	0.01	0.10	0.01	0.00	0.02	257	360	223	0.04	0.42	0.21	0.48	370	410	334	223
CXCL2	C-X-C motif chemokine ligand 2	Yes		ENSG00000081041	P19875	Intercrine alpha (chemokine CxC) family	18	ligand	extracellular, ligand, secreted	P08913, P25024, P25025, P27487, P46094, P48039, Q14831, Q16570	ACKR1, ADRA2A, CXCR1, CXCR2, DPP4, GRM7, MTNR1A, XCR1	CXCR2 [Baccin2019:10188995;Baccin2019:1379593;Baccin2019:8550564;Baccin2019:8702798;Baccin2019:8940121;Baccin2019:9260277;CellPhoneDB:24218476;Cellinker:8702798;Cellinker:9260277;DIP:8702798;Guide2Pharma:8702798;HPMR:12964882;HPRD:8702798;HPRD:9260277;ICELLNET:22633458;ICELLNET:8702798;LRdb:10699158;connectomeDB2020:8702798;connectomeDB2020:9260277;scConnect:8702798], ACKR1 [Baccin2019:28553950;CellChatDB:26740381;Cellinker:26740381;Cellinker:29637711;ICELLNET:22633458;ICELLNET:30446388], ADRA2A [CellTalkDB:32196115], CXCR1 [Baccin2019:12964882;Baccin2019:1379593;Baccin2019:8702798;Baccin2019:9260277;CellTalkDB:12964882;Cellinker:12964882;Cellinker:9260277;HPRD:9260277;LRdb:12964882;LRdb:93;connectomeDB2020:12964882;connectomeDB2020:9260277], MTNR1A [CellTalkDB:32196115], XCR1 [Baccin2019:10518929;CellTalkDB:10679309;Cellinker:10518929;LRdb:10518929;connectomeDB2020:10518929], GRM7 [CellTalkDB:32196115], DPP4 [CellPhoneDB:24218476;CellTalkDB:24218476;Cellinker:21314817;IntAct:18275857;IntAct:21314817]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; neutrophil chemotaxis [GO:0030593]; response to molecule of bacterial origin [GO:0002237]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCL2&keywords=CXCL2	45.43	96	NA	NA	3.03	112	0.50	0.75	0.06	0.81	0.77	0.01	0.02	0.12	0.04	0.01	0.06	195	234	148	0.29	0.15	0.07	0.22	454	484	411	232
CCL20	C-C motif chemokine ligand 20	Yes		ENSG00000115009	P78556	Intercrine beta (chemokine CC) family	18	ligand	extracellular, intracellular, ligand, secreted	P08913, P48039, P49682, P51684, Q14831, Q9NPB9	ACKR4, ADRA2A, CCR6, CXCR3, GRM7, MTNR1A	CCR6 [Baccin2019:12081481;Baccin2019:12964882;Baccin2019:9169459;Baccin2019:9223454;Baccin2019:9294137;CellPhoneDB:24218476;CellTalkDB:24218476;Cellinker:12081481;Cellinker:12964882;Cellinker:9169459;Cellinker:9223454;Cellinker:9294137;DIP:10488147;DIP:10498628;DIP:9169459;Guide2Pharma:12081481;Guide2Pharma:9169459;Guide2Pharma:9294137;HPMR:12964882;HPRD:9169459;HPRD:9223454;HPRD:9294137;ICELLNET:22633458;InnateDB:9169459;LRdb:10699158;connectomeDB2020:12081481;connectomeDB2020:12964882;connectomeDB2020:9169459;connectomeDB2020:9223454;connectomeDB2020:9294137;scConnect:12081481;scConnect:9169459;scConnect:9294137], CXCR3 [Baccin2019:9660793;Cellinker:9660793;Guide2Pharma:9660793;LRdb:9660793;connectomeDB2020:9660793;scConnect:9660793], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], ACKR4 [Cellinker:32480426;connectomeDB2020:32533638]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR6 chemokine receptor binding [GO:0031731]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell-cell signaling [GO:0007267]; cell chemotaxis [GO:0060326]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; defense response to bacterium [GO:0042742]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of T cell migration [GO:2000406]; signal transduction [GO:0007165]; T cell migration [GO:0072678]; thymocyte migration [GO:0072679]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL20&keywords=CCL20	53.19	80	NA	NA	58.87	13	0.98	0.27	0.00	0.16	0.00	0.00	0.00	0.05	0.00	0.00	0.02	293	356	217	0.14	0.09	0.08	0.19	478	480	426	232
CXCL1	C-X-C motif chemokine ligand 1	Yes		ENSG00000163739	P09341	Intercrine alpha (chemokine CxC) family	18	ligand	extracellular, intracellular, ligand, secreted	P08913, P17612, P25024, P25025, P48039, Q14831, Q16570, Q9P212	ACKR1, ADRA2A, CXCR1, CXCR2, GRM7, MTNR1A, PLCE1, PRKACA	CXCR2 [CellPhoneDB:24218476;Cellinker:10188995;Cellinker:1379593;Cellinker:28389721;Cellinker:8550564;Cellinker:8702798;Cellinker:8940121;DIP:10216072;DIP:8550564;DIP:9195914;Guide2Pharma:10188995;Guide2Pharma:1379593;Guide2Pharma:8940121;HPRD:1379593;HPRD:8550564;HPRD:8702798;HPRD:8940121;ICELLNET:22633458;ICELLNET:24218476;ICELLNET:8702798;InnateDB:12549928;InnateDB:12628493;InnateDB:7592830;InnateDB:8662882;InnateDB:8702798;InnateDB:9126332;LRdb:10699158;connectomeDB2020:10188995;connectomeDB2020:1379593;connectomeDB2020:8550564;connectomeDB2020:8702798;connectomeDB2020:8940121;scConnect:10188995;scConnect:1379593;scConnect:8940121], PRKACA [SIGNOR:17251915], PLCE1 [SIGNOR:17251915], ACKR1 [CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:12734373;Cellinker:26740381;Cellinker:7592830;DIP:7592830;HPMR:12734373;HPRD:7592830;ICELLNET:22633458;ICELLNET:24625696;InnateDB:7592830;InnateDB:8132497;InnateDB:9195930;LRdb:10699158;LRdb:12734373;LRdb:76;connectomeDB2020:12734373;connectomeDB2020:7592830], ADRA2A [CellTalkDB:32196115], CXCR1 [CellPhoneDB:24218476;Cellinker:12964882;Cellinker:1379593;Cellinker:8702798;DIP:9195914;HPRD:1379593;HPRD:8702798;LRdb:10699158;connectomeDB2020:12964882;connectomeDB2020:1379593;connectomeDB2020:8702798;scConnect:1379593], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; enzyme activator activity [GO:0008047]; growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102]	actin cytoskeleton organization [GO:0030036]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; killing of cells of other organism [GO:0031640]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; neutrophil chemotaxis [GO:0030593]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCL1&keywords=CXCL1	56.38	75	NA	NA	5.60	71	2.35	1.36	0.06	0.47	0.05	0.00	0.01	0.13	0.05	0.00	0.04	171	297	171	0.41	0.14	0.03	0.11	462	510	467	238
FGF7	fibroblast growth factor 7	Yes		ENSG00000140285	P21781	Heparin-binding growth factors family	18	ligand	extracellular, intracellular, ligand, secreted, transmembrane	O14786, P11362, P21802, P22455, P22607	FGFR1, FGFR2, FGFR3, FGFR4, NRP1	FGFR2 [Baccin2019:125919597687739;CellTalkDB:16597617;Cellinker:12591959;Cellinker:16597617;Cellinker:25772309;Cellinker:27192911;Cellinker:7687739;DIP:10339576;DIP:10950949;DIP:11121055;DIP:8663044;HPRD:7687739;LRdb:16597617;Lit-BM-17:10339576;Lit-BM-17:10950949;Lit-BM-17:11121055;Lit-BM-17:11714710;Lit-BM-17:1309608;Lit-BM-17:8663044;Lit-BM-17:9582367;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:8663044;SignaLink3:9582367;connectomeDB2020:12591959;connectomeDB2020:7687739], FGFR4 [CellTalkDB:7680645;Cellinker:7680645;HPRD:7680645;LRdb:7680645], FGFR1 [Baccin2019:8663044;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;Cellinker:8663044;HPRD:8663044;LRdb:16597617;connectomeDB2020:8663044], FGFR3 [CellTalkDB:8663044;Cellinker:8663044;DIP:9045692;HPRD:8663044;LRdb:8663044;connectomeDB2020:8663044], NRP1 [Baccin2019:15695515;CellTalkDB:16597617;Cellinker:15695515;HPRD:15695515;LRdb:15695515;connectomeDB2020:15695515]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]	chemoattractant activity [GO:0042056]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; type 2 fibroblast growth factor receptor binding [GO:0005111]	actin cytoskeleton reorganization [GO:0031532]; animal organ morphogenesis [GO:0009887]; branching involved in salivary gland morphogenesis [GO:0060445]; cell differentiation [GO:0030154]; epidermis development [GO:0008544]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hair follicle morphogenesis [GO:0031069]; lung development [GO:0030324]; mesenchymal cell proliferation [GO:0010463]; positive chemotaxis [GO:0050918]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to cell surface [GO:0034394]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell migration [GO:0030334]; response to wounding [GO:0009611]; secretion by lung epithelial cell involved in lung growth [GO:0061033]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF7&keywords=FGF7	3.16	331	NA	NA	0.27	479	0.00	0.05	0.02	0.23	0.05	0.18	0.16	0.10	0.12	0.16	0.08	109	90	125	0.10	1.15	1.44	0.80	99	57	191	239
IL24	interleukin 24	Yes		ENSG00000162892	Q13007	IL-10 family	18	ligand	extracellular, intracellular, ligand, secreted, transmembrane	P01574, Q04721, Q08334, Q6UXL0, Q8N6P7, Q9UHF4	IFNB1, IL10RB, IL20RA, IL20RA_IL20RB, IL20RB, IL20RB_IL22RA1, IL22RA1, NOTCH2	IFNB1 [SPIKE:18511292], IL22RA1 [Baccin2019:12974481;CellTalkDB:12974481;LRdb:12974481;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12974481], IL20RA [Baccin2019:1297448111706020;CellTalkDB:12974481;HPRD:11706020;LRdb:12;LRdb:12974481;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:11706020;connectomeDB2020:12974481], IL20RB [CellTalkDB:12974481;InnateDB:11706020;LRdb:12974481;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12974481], IL10RB [CellTalkDB:20061404], NOTCH2 [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]	apoptotic process [GO:0006915]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; serine phosphorylation of STAT protein [GO:0042501]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL24&keywords=IL24	21.13	164	NA	NA	9.31	48	0.17	0.01	0.01	4.97	0.04	0.01	0.00	0.10	0.01	0.01	0.01	256	247	272	0.48	0.04	0.04	0.03	508	506	516	241
BTC	betacellulin	Yes		ENSG00000174808	P35070	NA	18	cell_surface_ligand, ligand	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	P00533, P04626, P21860, Q15303	EGFR, EGFR_ERBB2, ERBB2, ERBB2_ERBB4, ERBB3, ERBB4	EGFR [Baccin2019:8144591;Baccin2019:9528863;CellTalkDB:8144591;HPRD:9528863;LRdb:8144591;LRdb:953;ProtMapper:24440602;SIGNOR:10209155;SIGNOR:14967450;SIGNOR:23382875;SIGNOR:9528863;SignaLink3:10209155;SignaLink3:23331499;SignaLink3:9528863;connectomeDB2020:8144591;connectomeDB2020:9528863], ERBB4 [Baccin2019:10214951;Baccin2019:11254912;CellTalkDB:10214951;HPRD:11254912;LRdb:10214951;LRdb:11;SIGNOR:10209155;SIGNOR:16829981;SIGNOR:22232668;SignaLink3:10209155;SignaLink3:23331499;connectomeDB2020:10214951;connectomeDB2020:11254912], ERBB3 [CellTalkDB:9312020;Cellinker:9312020;LRdb:9312020;Ramilowski2015:9312020;connectomeDB2020:9312020;talklr:9312020], ERBB2 [Baccin2019:9662041;CellTalkDB:9662041;HPRD:9662041;LRdb:9662041;ProtMapper:15163624;connectomeDB2020:9662041]	clathrin-coated endocytic vesicle membrane [GO:0030669]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]	epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of mitotic nuclear division [GO:0045840]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BTC&keywords=BTC	3.06	337	NA	NA	0.56	365	0.00	0.03	0.00	0.00	0.03	0.06	0.05	0.04	0.04	0.03	0.04	192	171	160	0.03	1.19	1.01	1.34	88	125	47	250
CXCL3	C-X-C motif chemokine ligand 3	Yes		ENSG00000163734	P19876	Intercrine alpha (chemokine CxC) family	18	ligand	extracellular, ligand, secreted	P08913, P25024, P25025, P48039, Q14831, Q16570	ACKR1, ADRA2A, CXCR1, CXCR2, GRM7, MTNR1A	CXCR2 [Baccin2019:8702798;CellPhoneDB:24218476;Cellinker:8702798;DIP:8702798;Guide2Pharma:8702798;HPRD:8702798;ICELLNET:22633458;ICELLNET:8702798;LRdb:10699158;connectomeDB2020:8702798;scConnect:8702798], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], CXCR1 [Baccin2019:129648828702798;CellTalkDB:12964882;Cellinker:12964882;Cellinker:8702798;HPRD:8702798;LRdb:12964882;LRdb:87;connectomeDB2020:12964882;connectomeDB2020:8702798], ACKR1 [CellChatDB:26740381;Cellinker:26740381;Cellinker:29637711]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; neutrophil chemotaxis [GO:0030593]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCL3&keywords=CXCL3	11.46	227	NA	NA	7.52	56	3.28	0.45	0.06	1.32	0.20	0.00	0.02	0.01	0.01	0.01	0.02	265	256	213	0.49	0.04	0.04	0.06	511	508	498	262
NRG4	neuregulin 4	Yes		ENSG00000169752	Q8WWG1	Neuregulin family	18	cell_surface_ligand, ligand	cell_surface, cell_surface_ligand, ligand, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	P00533, P04626, Q15303	EGFR, ERBB2, ERBB2_ERBB4, ERBB4	ERBB4 [Baccin2019:10348342;CellTalkDB:10348342;HPRD:10348342;LRdb:10348342;SIGNOR:14967450;SIGNOR:7477375;SignaLink3:10348342;SignaLink3:18988627;SignaLink3:23331499;connectomeDB2020:10348342], ERBB2 [CellTalkDB:32196115], EGFR [CellTalkDB:32196115]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	growth factor activity [GO:0008083]	nervous system development [GO:0007399]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NRG4&keywords=NRG4	5.82	281	NA	NA	3.49	100	0.00	0.00	0.00	0.00	0.12	0.00	0.00	0.00	0.00	0.00	0.00	302	370	378	0.01	0.49	0.52	0.50	347	312	324	266
NRG2	neuregulin 2	Yes		ENSG00000158458	O14511	Neuregulin family	18	cell_surface_ligand, ligand	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	O43300, O60462, O95866, P04626, P21860, Q15303, Q16653	ERBB2, ERBB2_ERBB3, ERBB2_ERBB4, ERBB3, ERBB4, LRRTM2, MOG, MPIG6B, NRP2	ERBB3 [Baccin2019:9168114;Baccin2019:9168115;CellTalkDB:9168115;HPMR:9168115;HPRD:9168114;HPRD:9168115;LRdb:9168115;LRdb:917;SIGNOR:7514177;SignaLink3:23331499;SignaLink3:9168114;SignaLink3:9168115;connectomeDB2020:9168114;connectomeDB2020:9168115], ERBB4 [Baccin2019:9168114;Baccin2019:9168115;CellTalkDB:9168115;HPRD:9168114;HPRD:9168115;LRdb:9168115;LRdb:917;SIGNOR:14967450;SIGNOR:7477375;SignaLink3:23331499;SignaLink3:9168114;SignaLink3:9168115;connectomeDB2020:9168114;connectomeDB2020:9168115], ERBB2 [CellTalkDB:32196115], MOG [Cellinker:32589946], NRP2 [Cellinker:32589946], LRRTM2 [Cellinker:32822567], MPIG6B [Cellinker:32822567]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102]	animal organ development [GO:0048513]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NRG2&keywords=NRG2	1.30	420	NA	NA	0.40	418	0.00	0.00	0.00	0.00	0.00	0.02	0.04	0.02	0.01	0.02	0.01	275	215	259	0.01	0.87	1.29	0.88	198	77	152	283
FGF2	fibroblast growth factor 2	Yes		ENSG00000138685	P09038	Heparin-binding growth factors family	18	ligand	extracellular, intracellular, ligand, secreted	O14786, O75056, O75487, P05106, P06756, P07996, P11362, P16070, P18827, P21802, P22455, P22607, P31431, P34741, P35442, Q8N441	CD44, FGFR1, FGFR2, FGFR3, FGFR4, FGFRL1, GPC4, ITGAV, ITGB3, NRP1, SDC1, SDC2, SDC3, SDC4, THBS1, THBS2	FGFR2 [Baccin2019:8663044;CellTalkDB:16597617;Cellinker:25772309;Cellinker:8663044;HPMR:8663044;IntAct:10830168;IntAct:11390973;LRdb:16597617;Lit-BM-17:10950949;Lit-BM-17:11121055;Lit-BM-17:11390973;Lit-BM-17:17981115;Lit-BM-17:26267536;ProtMapper:18332103;SIGNOR:11390973;SIGNOR:7687739;SignaLink3:23331499;SignaLink3:8663044;connectomeDB2020:8663044], FGFR4 [Baccin2019:86630448530375;CellTalkDB:16597617;Cellinker:25772309;Cellinker:8530375;Cellinker:8663044;DIP:7680645;HPRD:8530375;LRdb:16597617;SIGNOR:1385111;connectomeDB2020:8530375;connectomeDB2020:8663044], FGFR3 [Baccin2019:866304410574949;CellTalkDB:16597617;Cellinker:10574949;Cellinker:25772309;Cellinker:8663044;DIP:9045692;HPMR:8663044;HPRD:10574949;LRdb:16597617;SIGNOR:15780951;SIGNOR:22298955;connectomeDB2020:10574949;connectomeDB2020:8663044], SDC1 [Baccin2019:16982797;BioGRID:19802384;CellTalkDB:16982797;Cellinker:16982797;Cellinker:1969657;HPRD:16982797;LRdb:16982797;connectomeDB2020:16982797], FGFR1 [Baccin2019:10950949;Baccin2019:11030354;BioGRID:10950949;BioGRID:11786412;BioGRID:14505356;BioGRID:15096041;BioGRID:16829530;BioGRID:8868466;BioGRID:9174056;CellTalkDB:16597617;Cellinker:10950949;Cellinker:11030354;Cellinker:16597617;Cellinker:25772309;DIP:10574979;DIP:10950949;DIP:17086194;DIP:1722683;DIP:7730326;HPRD:10950949;HPRD:11030354;IntAct:10490103;IntAct:11030354;IntAct:14613973;IntAct:23597563;IntAct:26267536;LRdb:16597617;Lit-BM-17:10490103;Lit-BM-17:10574979;Lit-BM-17:10950949;Lit-BM-17:11030354;Lit-BM-17:1722683;Lit-BM-17:23597562;Lit-BM-17:23597563;Lit-BM-17:26267536;Lit-BM-17:7730326;Lit-BM-17:9174056;connectomeDB2020:10950949;connectomeDB2020:11030354], CD44 [Baccin2019:7532176;CellTalkDB:7532176;Cellinker:7532176;HPRD:7532176;LRdb:7532176;connectomeDB2020:7532176], SDC3 [Baccin2019:16982797;Baccin2019:8344959;CellTalkDB:16982797;Cellinker:16982797;Cellinker:8344959;HPRD:16982797;HPRD:8344959;LRdb:16982797;LRdb:83;connectomeDB2020:8344959], SDC4 [Baccin2019:9012653;CellTalkDB:9012653;Cellinker:9012653;HPMR:9012653;HPMR:9556568;LRdb:9012653;Lit-BM-17:16982797;Lit-BM-17:20382221;MatrixDB:20382221;connectomeDB2020:9012653], GPC4 [Baccin2019:11066092;CellTalkDB:11066092;Cellinker:11066092;HPRD:11066092;LRdb:11066092;connectomeDB2020:11066092], SDC2 [Baccin2019:1101561416982790;CellTalkDB:11015614;Cellinker:11015614;Cellinker:16982797;HPRD:16982797;LRdb:11015614;LRdb:17;Lit-BM-17:16982797;Lit-BM-17:20382221;MatrixDB:20382221;connectomeDB2020:11015614;connectomeDB2020:16982797], FGFRL1 [Baccin2019:11418238;CellTalkDB:11418238;Cellinker:11418238;HPRD:11418238;LRdb:11418238;connectomeDB2020:11418238], NRP1 [Baccin2019:15695515;CellTalkDB:15695515;Cellinker:15695515;HPRD:15695515;LRdb:15695515;connectomeDB2020:15695515], ITGAV [Cellinker:15297314], ITGB3 [Cellinker:15297314], THBS1 [Cellinker:30168023], THBS2 [Cellinker:30168023]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]	chemoattractant activity [GO:0042056]; chemokine binding [GO:0019956]; cytokine activity [GO:0005125]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; nuclear receptor coactivator activity [GO:0030374]; receptor-receptor interaction [GO:0090722]	aging [GO:0007568]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; animal organ morphogenesis [GO:0009887]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemotaxis [GO:0006935]; chondroblast differentiation [GO:0060591]; corticotropin hormone secreting cell differentiation [GO:0060128]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic morphogenesis [GO:0048598]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glial cell differentiation [GO:0010001]; growth factor dependent regulation of skeletal muscle satellite cell proliferation [GO:0014843]; hyaluronan catabolic process [GO:0030214]; inositol phosphate biosynthetic process [GO:0032958]; lung development [GO:0030324]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of gene expression [GO:0010629]; negative regulation of wound healing [GO:0061045]; nervous system development [GO:0007399]; organ induction [GO:0001759]; paracrine signaling [GO:0038001]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell division [GO:0051781]; positive regulation of cell fate specification [GO:0042660]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cerebellar granule cell precursor proliferation [GO:0021940]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of lens fiber cell differentiation [GO:1902748]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903587]; regulation of cell cycle [GO:0051726]; regulation of cell migration [GO:0030334]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000544]; regulation of retinal cell programmed cell death [GO:0046668]; release of sequestered calcium ion into cytosol [GO:0051209]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]; stem cell development [GO:0048864]; stem cell proliferation [GO:0072089]; substantia nigra development [GO:0021762]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF2&keywords=FGF2	16.30	186	NA	NA	1.46	206	0.00	0.51	0.01	1.42	0.03	0.01	0.01	0.01	0.01	0.01	0.01	281	277	283	0.18	0.08	0.08	0.08	485	479	484	287
IL18	interleukin 18	Yes		ENSG00000150782	Q14116	IL-1 family	18	ligand	extracellular, intracellular, ligand, secreted	O95256, O95998, P09326, P24158, Q13478, Q9HB29, Q9NZN1	CD48, IL18_IL18R1_IL18RAP, IL18BP, IL18R1, IL18R1_IL18RAP, IL18RAP, IL1RAPL1, IL1RL2, PRTN3	IL18R1 [Baccin2019:9325300;CellTalkDB:9325300;HPMR:11046021;HPMR:9325300;HPRD:9325300;InnateDB:12096920;InnateDB:9325300;LRdb:9325300;Lit-BM-17:25261253;Lit-BM-17:9325300;SIGNOR:9792649;connectomeDB2020:9325300], IL18RAP [Baccin2019:9792649;CellTalkDB:9792649;HPRD:9792649;LRdb:9792649;connectomeDB2020:9792649], CD48 [CellTalkDB:15760905], IL1RAPL1 [Baccin2019:9325300;CellTalkDB:9325300;Cellinker:9325300;HPMR:11046021;HPMR:9325300;LRdb:9325300;connectomeDB2020:9325300], IL18BP [CellTalkDB:24115947;HPRD:11907126;InnateDB:10023777;InnateDB:10094485;InnateDB:10655506;InnateDB:11278524;InnateDB:11907126;InnateDB:12381835;InnateDB:18203261], IL1RL2 [Baccin2019:9325300;CellTalkDB:9325300;Cellinker:9325300;HPRD:9325300;LRdb:9325300], PRTN3 [InnateDB:22270365]	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; interleukin-18 receptor binding [GO:0045515]	activation of protein kinase B activity [GO:0032148]; angiogenesis [GO:0001525]; cell-cell signaling [GO:0007267]; cell population proliferation [GO:0008283]; cellular response to organic cyclic compound [GO:0071407]; cholesterol homeostasis [GO:0042632]; inflammatory response [GO:0006954]; interleukin-18-mediated signaling pathway [GO:0035655]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; MAPK cascade [GO:0000165]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of myoblast differentiation [GO:0045662]; neutrophil activation [GO:0042119]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of chemokine production [GO:0032722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of tissue remodeling [GO:0034105]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of cell adhesion [GO:0030155]; sleep [GO:0030431]; T-helper 1 type immune response [GO:0042088]; triglyceride homeostasis [GO:0070328]; type 2 immune response [GO:0042092]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL18&keywords=IL18	12.12	220	NA	NA	0.60	342	0.06	0.03	0.00	0.00	0.13	0.00	0.00	0.00	0.00	0.00	0.00	299	318	369	0.02	0.37	0.42	0.35	385	338	370	305
HBEGF	heparin binding EGF like growth factor	Yes		ENSG00000113070	Q99075	NA	18	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	P00533, P04626, P16070, P16471, P21926, P27701, Q15303, Q16653	CD44, CD82, CD9, EGFR, EGFR_ERBB2, ERBB2, ERBB2_ERBB4, ERBB4, MOG, PRLR	EGFR [Baccin2019:12725245;BioGRID:12725245;CellTalkDB:12725245;HPRD:12725245;ICELLNET:12097488;ICELLNET:12621152;IntAct:28988771;IntAct:9135143;LRdb:12725245;ProtMapper:19531065;ProtMapper:22529914;ProtMapper:23888518;ProtMapper:28943431;ProtMapper:29274275;ProtMapper:30071291;SIGNOR:14967450;SignaLink3:10209155;SignaLink3:23331499;connectomeDB2020:12725245], ERBB4 [Baccin2019:1840698;Baccin2019:9135143;CellTalkDB:1840698;HPRD:9135143;ICELLNET:12621152;LRdb:1840698;LRdb:914;SIGNOR:10209155;SIGNOR:9135143;SignaLink3:10209155;SignaLink3:23331499;connectomeDB2020:1840698;connectomeDB2020:9135143], CD44 [Baccin2019:7532176;BioGRID:7532176;CellTalkDB:7532176;Cellinker:7532176;HPRD:7532176;LRdb:7532176;connectomeDB2020:7532176], CD9 [Cellinker:11735113;Cellinker:11846885;Cellinker:1939101;Cellinker:8194524;HPRD:11735113;HPRD:11846885;HPRD:1939101;HPRD:8194524;LRdb:11735113;LRdb:11846885;LRdb:1939101;LRdb:8194524;connectomeDB2020:11735113;connectomeDB2020:11846885;connectomeDB2020:1939101;connectomeDB2020:8194524], PRLR [CellTalkDB:32196115], ERBB2 [CellTalkDB:12958167;LRdb:12958167;Ramilowski2015:12958167;connectomeDB2020:12958167;talklr:12958167], CD82 [CellTalkDB:10749879;Cellinker:10749879;HPRD:10749879;LRdb:10749879;connectomeDB2020:10749879], MOG [Cellinker:32589946]	cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]	cell chemotaxis [GO:0060326]; epidermal growth factor receptor signaling pathway [GO:0007173]; muscle organ development [GO:0007517]; negative regulation of elastin biosynthetic process [GO:0051545]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of wound healing [GO:0090303]; regulation of heart contraction [GO:0008016]; signal transduction [GO:0007165]; wound healing, spreading of epidermal cells [GO:0035313]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=HBEGF&keywords=HBEGF	12.06	221	NA	NA	0.62	333	1.39	0.29	0.09	0.10	0.03	0.04	0.04	0.01	0.04	0.01	0.02	186	222	207	0.19	0.25	0.12	0.15	416	457	450	308
CCL8	C-C motif chemokine ligand 8	Yes		ENSG00000108700	P80075	Intercrine beta (chemokine CC) family	18	ligand	extracellular, intracellular, ligand, secreted	O00590, P32246, P41597, P46092, P51677, P51679, P51681, Q16570, Q9NPB9	ACKR1, ACKR2, ACKR4, CCR1, CCR10, CCR2, CCR3, CCR4, CCR5	CCR5 [Baccin2019:1629834510477710;CellPhoneDB:24218476;Cellinker:10477718;Cellinker:12964882;Cellinker:9468473;Cellinker:9790730;DIP:10477718;DIP:9468473;Guide2Pharma:9790730;HPRD:10477718;HPRD:9468473;ICELLNET:22633458;InnateDB:10477718;LRdb:10699158;SPIKE:10477718;connectomeDB2020:10477718;connectomeDB2020:12964882;connectomeDB2020:9468473;connectomeDB2020:9790730;scConnect:9790730], CCR1 [Baccin2019:76793288631787;CellPhoneDB:24218476;Cellinker:9115216;DIP:9115216;HPRD:9115216;ICELLNET:22633458;InnateDB:9115216;LRdb:10699158;connectomeDB2020:9115216], CCR2 [Baccin2019:10529171;Baccin2019:10770925;Baccin2019:12554737;Baccin2019:15207250;Baccin2019:9276730;Baccin2019:9287323;Baccin2019:9346309;CellPhoneDB:24218476;Cellinker:12149192;Cellinker:12554737;Cellinker:9115216;DIP:9115216;DIP:9195948;Guide2Pharma:12554737;HPRD:12149192;HPRD:9115216;ICELLNET:22633458;InnateDB:9115216;LRdb:10699158;connectomeDB2020:12149192;connectomeDB2020:12554737;connectomeDB2020:9115216;scConnect:12554737], CCR3 [Baccin2019:8642344;CellPhoneDB:24218476;Cellinker:9005985;HPRD:9005985;LRdb:10699158;connectomeDB2020:9005985], ACKR2 [Baccin2019:9364936;Baccin2019:9405404;CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:26740381;Cellinker:9405404;HPRD:9405404;ICELLNET:22633458;InnateDB:9405404;LRdb:10699158;connectomeDB2020:9405404], ACKR4 [Baccin2019:10734104;CellChatDB:26740381;CellTalkDB:10734104;Cellinker:10734104;Cellinker:26740381;DIP:10734104;HPRD:10734104;HPRD:9405404;InnateDB:10734104;LRdb:10734104;connectomeDB2020:10734104], ACKR1 [CellChatDB:26740381;CellTalkDB:13679391;Cellinker:13679391;Cellinker:26740381;HPRD:13679391;LRdb:13679391;connectomeDB2020:13679391], CCR10 [Baccin2019:10706668;Baccin2019:9364936], CCR4 [Baccin2019:16421945]	extracellular space [GO:0005615]	CCR2 chemokine receptor binding [GO:0031727]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; heparin binding [GO:0008201]; phospholipase activator activity [GO:0016004]; protein kinase activity [GO:0004672]	angiogenesis [GO:0001525]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; calcium ion transport [GO:0006816]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; eosinophil chemotaxis [GO:0048245]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of leukocyte proliferation [GO:0070664]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of leukocyte migration [GO:0002687]; response to virus [GO:0009615]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL8&keywords=CCL8	0.98	454	NA	NA	0.96	274	0.01	0.00	0.00	0.00	0.02	0.00	0.00	0.00	0.00	0.00	0.00	303	409	401	0.00	0.76	0.76	0.76	238	237	209	344
PDGFB	platelet derived growth factor subunit B	Yes		ENSG00000100311	P01127	PDGF/VEGF growth factor family	18	ligand, receptor	extracellular, intracellular, ligand, ligand_regulator, receptor, secreted	P01112, P06756, P09619, P16234, P21453, P52961, Q07954, Q8WXG9	ADGRV1, ART1, HRAS, ITGAV, LRP1, PDGFRA, PDGFRA_PDGFRB, PDGFRB, S1PR1	PDGFRA [Baccin2019:152078112544881;CellChatDB:15207812;CellTalkDB:15207811;Cellinker:15207812;Cellinker:28267575;HPRD:2544881;ICELLNET:15207811;ICELLNET:9739761;IntAct:10806482;IntAct:7679113;LRdb:15207811;LRdb:25;Lit-BM-17:10806482;Lit-BM-17:11297552;Lit-BM-17:15767546;Lit-BM-17:2544881;Lit-BM-17:7679113;Lit-BM-17:9677323;SIGNOR:11331882;SignaLink3:11803579;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:2544881;connectomeDB2020:15207811;connectomeDB2020:2544881], PDGFRB [Baccin2019:285049611903042;CellChatDB:15207812;CellTalkDB:2850496;Cellinker:15207812;Cellinker:28267575;DIP:11297552;DIP:20534510;HPMR:2850496;HPRD:11903042;ICELLNET:15207811;ICELLNET:9739761;IntAct:10806482;IntAct:11297552;IntAct:17981115;IntAct:20534510;IntAct:7679113;LRdb:119;LRdb:2850496;Lit-BM-17:10806482;Lit-BM-17:11297552;Lit-BM-17:17981115;Lit-BM-17:20577048;Lit-BM-17:7679113;ProtMapper:30150707;SIGNOR:11331882;connectomeDB2020:11903042;connectomeDB2020:2850496], LRP1 [CellTalkDB:11854294;Cellinker:11854294;HPRD:11854294;LRdb:11854294;connectomeDB2020:11854294], ART1 [Baccin2019:11498506;CellTalkDB:11498506;Cellinker:11498506;HPRD:11498506;LRdb:11498506;connectomeDB2020:11498506], ITGAV [CellTalkDB:32196115], S1PR1 [CellTalkDB:32196115], ADGRV1 [NA], HRAS [HPRD:10485711]	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; platelet alpha granule lumen [GO:0031093]; platelet-derived growth factor complex [GO:1990265]	chemoattractant activity [GO:0042056]; collagen binding [GO:0005518]; growth factor activity [GO:0008083]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; platelet-derived growth factor binding [GO:0048407]; platelet-derived growth factor receptor binding [GO:0005161]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; superoxide-generating NADPH oxidase activator activity [GO:0016176]	activation of protein kinase activity [GO:0032147]; activation of protein kinase B activity [GO:0032148]; cell chemotaxis [GO:0060326]; cellular response to growth factor stimulus [GO:0071363]; cellular response to mycophenolic acid [GO:0071506]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; embryonic placenta development [GO:0001892]; heart development [GO:0007507]; interleukin-18-mediated signaling pathway [GO:0035655]; metanephric glomerular mesangial cell development [GO:0072255]; monocyte chemotaxis [GO:0002548]; negative regulation of gene expression [GO:0010629]; negative regulation of phosphatidylinositol biosynthetic process [GO:0010512]; negative regulation of platelet activation [GO:0010544]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vascular associated smooth muscle cell differentiation [GO:1905064]; paracrine signaling [GO:0038001]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular filtration [GO:0003104]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of hyaluronan biosynthetic process [GO:1900127]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of metanephric mesenchymal cell migration [GO:2000591]; positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway [GO:0035793]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell dedifferentiation [GO:1905176]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein kinase C signaling [GO:0070528]; protein phosphorylation [GO:0006468]; reactive oxygen species metabolic process [GO:0072593]; response to wounding [GO:0009611]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PDGFB&keywords=PDGFB	6.49	274	NA	NA	0.48	389	0.02	0.12	0.50	0.07	0.02	0.02	0.01	0.00	0.03	0.00	0.01	217	300	265	0.07	0.44	0.17	0.21	363	429	416	348
CXCL9	C-X-C motif chemokine ligand 9	Yes		ENSG00000138755	Q07325	Intercrine alpha (chemokine CxC) family	18	ligand, receptor	extracellular, ligand, receptor, secreted	P08913, P12318, P27487, P43628, P48039, P49682, P51677, Q14831, Q16570	ACKR1, ADRA2A, CCR3, CXCR3, DPP4, FCGR2A, GRM7, KIR2DL3, MTNR1A	CXCR3 [Baccin2019:12782716;Baccin2019:12884299;Baccin2019:15761110;Baccin2019:9660793;BioGRID:12782716;BioGRID:9660793;CellPhoneDB:24218476;Cellinker:12782716;Cellinker:12884299;Cellinker:15761110;Cellinker:9660793;DIP:11259614;DIP:9625760;DIP:9660793;Guide2Pharma:15761110;Guide2Pharma:9660793;HPRD:12782716;HPRD:9660793;ICELLNET:12884299;LRdb:10699158;SIGNOR:12750173;SPIKE:9660793;connectomeDB2020:12782716;connectomeDB2020:12884299;connectomeDB2020:15761110;connectomeDB2020:9660793;scConnect:15761110;scConnect:9660793], CCR3 [Baccin2019:11110785;CellTalkDB:11110785;Cellinker:11110785;DIP:11110785;HPRD:11110785;ICELLNET:22633458;LRdb:11110785;connectomeDB2020:11110785], FCGR2A [CellTalkDB:32103204], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], KIR2DL3 [CellTalkDB:32103204], GRM7 [CellTalkDB:32196115], DPP4 [CellPhoneDB:24218476;CellTalkDB:24218476;Cellinker:21314817;HPRD:11390394;IntAct:18275857;IntAct:21314817], ACKR1 [CellChatDB:26740381;Cellinker:26740381]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	chemokine activity [GO:0008009]; CXCR3 chemokine receptor binding [GO:0048248]; CXCR chemokine receptor binding [GO:0045236]; cytokine activity [GO:0005125]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; defense response [GO:0006952]; defense response to virus [GO:0051607]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; neutrophil chemotaxis [GO:0030593]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of cell population proliferation [GO:0042127]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCL9&keywords=CXCL9	0.62	503	NA	NA	0.52	375	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	303	407	393	0.00	0.99	0.99	1.02	137	134	94	355
TSLP	thymic stromal lymphopoietin	Yes		ENSG00000145777	Q969D9	NA	18	ligand	extracellular, intracellular, ligand, secreted, transmembrane	P16871, P42229, Q9HC73	CRLF2, CRLF2_IL7R, CRLF2_IL7R_TSLP, IL7R, STAT5A	CRLF2 [HPRD:11418668;InnateDB:11418668;NetPath:10881176;NetPath:10974032;SIGNOR:11418668;SignaLink3:10570284;SignaLink3:11418668;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:29145629;connectomeDB2020:22915648;connectomeDB2020:26198769], IL7R [Baccin2019:11418668;CellTalkDB:11418668;HPRD:11418668;InnateDB:11418668;LRdb:11418668;NetPath:10881176;NetPath:10974032;connectomeDB2020:11418668], STAT5A [HPRD:10570284;HPRD:11418668]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; interleukin-7 receptor binding [GO:0005139]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine (C-C motif) ligand 1 production [GO:0071654]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell activation [GO:0033005]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TSLP&keywords=TSLP	0.81	476	NA	NA	0.84	293	0.01	0.01	0.00	0.72	0.01	0.00	0.00	0.00	0.01	0.01	0.01	274	258	279	0.07	0.23	0.22	0.20	425	407	419	359
TNFSF14	TNF superfamily member 14	Yes		ENSG00000125735	O43557	Tumor necrosis factor family	18	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, secreted, transmembrane, transmembrane_predicted	O95407, P36941, Q92956	LTBR, TNFRSF14, TNFRSF6B	LTBR [Baccin2019:10318773;Baccin2019:10799510;Baccin2019:9462508;CellTalkDB:10318773;Cellinker:10318773;Cellinker:10799510;Cellinker:9462508;HPMR:10799510;HPRD:10318773;HPRD:10799510;HPRD:9462508;ICELLNET:11239407;InnateDB:12571250;LRdb:10318773;LRdb:10799510;LRdb:9462508;Lit-BM-17:12571250;Lit-BM-17:26977880;SPIKE:9739048;connectomeDB2020:10318773;connectomeDB2020:10799510;connectomeDB2020:9462508], TNFRSF14 [Baccin2019:10894944;Baccin2019:11390428;Baccin2019:9462508;CellTalkDB:10894944;Cellinker:10894944;Cellinker:11390428;Cellinker:9462508;HPMR:10894944;HPRD:11390428;HPRD:9462508;ICELLNET:11239407;InnateDB:11164894;IntAct:10318773;IntAct:26977880;IntAct:9462508;LRdb:10894944;LRdb:11390428;LRdb:9462508;Lit-BM-17:10318773;Lit-BM-17:11390428;Lit-BM-17:26977880;Lit-BM-17:9462508;SIGNOR:10894944;connectomeDB2020:10894944;connectomeDB2020:11390428;connectomeDB2020:9462508], TNFRSF6B [CellTalkDB:11994433;Cellinker:11994433;HPMR:14697332;HPRD:11994433;ICELLNET:11239407;IntAct:21300286;IntAct:25087510;LRdb:11994433;connectomeDB2020:11994433]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]	apoptotic process [GO:0006915]; cellular response to mechanical stimulus [GO:0071260]; immune response [GO:0006955]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of T cell chemotaxis [GO:0010820]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell costimulation [GO:0031295]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFSF14&keywords=TNFSF14	0.80	479	NA	NA	0.27	481	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	300	387	395	0.00	0.92	0.87	0.85	174	182	166	382
IL20	interleukin 20	Yes		ENSG00000162891	Q9NYY1	IL-10 family	18	ligand	ligand, secreted	Q6UXL0, Q8N6P7, Q9UHF4	IL20RA, IL20RA_IL20RB, IL20RB, IL20RB_IL22RA1, IL22RA1	IL22RA1 [Baccin2019:12974481;CellTalkDB:12974481;LRdb:12974481;SIGNOR:11163236;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12974481], IL20RA [Baccin2019:11163236;Baccin2019:12351624;Baccin2019:12974481;Baccin2019:14580208;CellTalkDB:12974481;HPRD:11163236;HPRD:12351624;HPRD:14580208;IntAct:22802649;LRdb:11163236;LRdb:12351624;LRdb:12974481;LRdb:14580208;Lit-BM-17:22802649;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:11163236;connectomeDB2020:12351624;connectomeDB2020:12974481;connectomeDB2020:14580208], IL20RB [CellTalkDB:12974481;InnateDB:11163236;InnateDB:14580208;InnateDB:22232181;IntAct:22802649;LRdb:11163236;LRdb:12351624;LRdb:12974481;LRdb:14580208;Lit-BM-17:22802649;SIGNOR:11163236;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:11163236;connectomeDB2020:12351624;connectomeDB2020:12974481;connectomeDB2020:14580208]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; interleukin-20 receptor binding [GO:0045517]; interleukin-22 receptor binding [GO:0045518]	positive regulation of epidermal cell differentiation [GO:0045606]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of inflammatory response [GO:0050727]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL20&keywords=IL20	0.05	744	NA	NA	0.79	303	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	302	388	397	0.00	0.91	0.93	0.90	178	158	146	398
TNFSF13B	TNF superfamily member 13b	Yes		ENSG00000102524	Q9Y275	Tumor necrosis factor family	18	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, secreted, transmembrane, transmembrane_predicted	O14836, P02786, P04440, P25942, Q02223, Q96RJ3, Q99558	CD40, HLA-DPB1, MAP3K14, TFRC, TNFRSF13B, TNFRSF13C, TNFRSF17	MAP3K14 [SPIKE:17183360], TNFRSF13C [Baccin2019:11509692;Baccin2019:12721620;Baccin2019:15851487;CellTalkDB:15851487;Cellinker:11509692;Cellinker:12721620;Cellinker:15851487;HPMR:15851487;HPRD:11509692;HPRD:12721620;ICELLNET:11239407;InnateDB:12571250;LRdb:11509692;LRdb:12721620;LRdb:15851487;SIGNOR:15644327;SIGNOR:15851487;connectomeDB2020:11509692;connectomeDB2020:12721620;connectomeDB2020:15851487], TNFRSF17 [Baccin2019:10801128;Baccin2019:10908663;Baccin2019:10973284;BioGRID:10908663;CellTalkDB:10973284;Cellinker:10801128;Cellinker:10908663;Cellinker:10973284;HPRD:10801128;HPRD:10908663;HPRD:10973284;ICELLNET:11239407;InnateDB:12571250;LRdb:10801128;LRdb:10908663;LRdb:10973284;Lit-BM-17:10801128;Lit-BM-17:10908663;Lit-BM-17:12721620;connectomeDB2020:10801128;connectomeDB2020:10908663;connectomeDB2020:10973284], TNFRSF13B [Baccin2019:10801128;Baccin2019:10956646;CellTalkDB:10956646;Cellinker:10801128;Cellinker:10956646;DIP:10956646;HPRD:10801128;ICELLNET:11239407;IntAct:10801128;IntAct:10880535;IntAct:10956646;LRdb:10956646;LRdb:11;Lit-BM-17:10801128;Lit-BM-17:10880535;Lit-BM-17:10956646;SIGNOR:10956646;connectomeDB2020:10801128;connectomeDB2020:10956646], TFRC [CellTalkDB:32103204], CD40 [CellTalkDB:32103204], HLA-DPB1 [NA]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]	B cell costimulation [GO:0031296]; B cell differentiation [GO:0030183]; B cell homeostasis [GO:0001782]; immune response [GO:0006955]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of germinal center formation [GO:0002636]; positive regulation of T cell proliferation [GO:0042102]; signal transduction [GO:0007165]; T cell costimulation [GO:0031295]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFSF13B&keywords=TNFSF13B	0.52	518	NA	NA	0.16	569	0.30	0.01	0.01	0.01	0.01	0.05	0.03	0.01	0.02	0.01	0.02	246	235	211	0.04	0.48	0.39	0.52	348	348	315	418
FGF1	fibroblast growth factor 1	Yes		ENSG00000113578	P05230	Heparin-binding growth factors family	18	ligand	extracellular, intracellular, ligand, secreted	O14786, P00533, P05106, P06756, P11362, P16070, P21802, P22455, P22607, Q03167, Q6UVK1, Q8N441	CD44, CSPG4, EGFR, FGFR1, FGFR2, FGFR3, FGFR4, FGFRL1, ITGAV, ITGB3, NRP1, TGFBR3	FGFR1 [Baccin2019:10336501;Baccin2019:11032250;Baccin2019:8663044;Baccin2019:8756477;BioGRID:1309595;BioGRID:1383494;BioGRID:8756477;BioGRID:9624181;CellTalkDB:16597617;Cellinker:10336501;Cellinker:11032250;Cellinker:16597617;Cellinker:25772309;Cellinker:8663044;Cellinker:8756477;DIP:10830168;DIP:1722683;DIP:22244757;DIP:7730326;HPMR:8663044;HPRD:10336501;HPRD:11032250;IntAct:10830168;IntAct:14613973;IntAct:18441324;IntAct:25241761;LRdb:16597617;Lit-BM-17:10830168;Lit-BM-17:11030354;Lit-BM-17:11714710;Lit-BM-17:1722683;Lit-BM-17:18441324;Lit-BM-17:23597563;Lit-BM-17:25241761;Lit-BM-17:7730326;Lit-BM-17:8576175;MatrixDB:18441324;SIGNOR:11030354;SIGNOR:18940940;SignaLink3:11030354;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:8576175;connectomeDB2020:10336501;connectomeDB2020:11032250;connectomeDB2020:8663044;connectomeDB2020:8756477], FGFR2 [Baccin2019:10618369;Baccin2019:11069186;Baccin2019:14732692;BioGRID:10618369;CellTalkDB:16597617;Cellinker:10618369;Cellinker:11069186;Cellinker:14732692;Cellinker:25772309;DIP:10339576;DIP:10618369;DIP:11069186;DIP:8663044;HPRD:10618369;HPRD:11069186;HPRD:14732692;LRdb:16597617;Lit-BM-17:10339576;Lit-BM-17:10618369;Lit-BM-17:11069186;Lit-BM-17:11714710;Lit-BM-17:23597563;Lit-BM-17:25241761;Lit-BM-17:8576175;Lit-BM-17:8663044;SIGNOR:10618369;SignaLink3:10618369;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:8576175;connectomeDB2020:10618369;connectomeDB2020:11069186;connectomeDB2020:14732692], FGFR4 [Baccin2019:10336501;Baccin2019:10736564;Baccin2019:8663044;BioGRID:10336501;BioGRID:10736564;CellTalkDB:16597617;Cellinker:10336501;Cellinker:10736564;Cellinker:25772309;Cellinker:8663044;DIP:7680645;HPRD:10336501;HPRD:10736564;LRdb:16597617;Lit-BM-17:10336501;Lit-BM-17:10736564;Lit-BM-17:11714710;Lit-BM-17:25241761;Lit-BM-17:7680645;SIGNOR:1385111;connectomeDB2020:10336501;connectomeDB2020:10736564;connectomeDB2020:8663044], FGFR3 [Baccin2019:10574949;Baccin2019:14732692;CellTalkDB:16597617;Cellinker:10574949;Cellinker:14732692;Cellinker:25772309;DIP:22244757;DIP:9045692;HPRD:10574949;HPRD:14732692;LRdb:16597617;Lit-BM-17:10574949;Lit-BM-17:14732692;Lit-BM-17:8576175;Lit-BM-17:9045692;SIGNOR:22298955;connectomeDB2020:10574949;connectomeDB2020:14732692], TGFBR3 [CellTalkDB:32103204], NRP1 [Baccin2019:15695515;CellTalkDB:15695515;Cellinker:15695515;HPRD:15695515;LRdb:15695515;connectomeDB2020:15695515], EGFR [CellTalkDB:32196115], FGFRL1 [CellTalkDB:32196115], CD44 [Baccin2019:29812912;CellTalkDB:29812912;connectomeDB2020:29812912], CSPG4 [connectomeDB2020:29812912], ITGB3 [Cellinker:18441324], ITGAV [Cellinker:18441324]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; Hsp70 protein binding [GO:0030544]; integrin binding [GO:0005178]; S100 protein binding [GO:0044548]	activation of protein kinase B activity [GO:0032148]; anatomical structure morphogenesis [GO:0009653]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; branch elongation involved in ureteric bud branching [GO:0060681]; cell differentiation [GO:0030154]; cellular response to heat [GO:0034605]; fibroblast growth factor receptor signaling pathway [GO:0008543]; lung development [GO:0030324]; mesonephric epithelium development [GO:0072163]; organ induction [GO:0001759]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell migration [GO:0030334]; regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000544]; regulation of endothelial tube morphogenesis [GO:1901509]; signal transduction [GO:0007165]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF1&keywords=FGF1	1.29	422	NA	NA	0.05	714	0.00	0.01	0.00	0.03	0.00	0.00	0.01	0.02	0.00	0.00	0.00	295	313	378	0.01	0.74	0.77	0.61	246	230	283	420
EDN2	endothelin 2	Yes		ENSG00000127129	P20800	Endothelin/sarafotoxin family	18	ligand	intracellular, ligand, secreted	P23276, P24530, P25101	EDNRA, EDNRB, KEL	EDNRA [Baccin2019:2175397;Baccin2019:7647976;Baccin2019:9082970;CellTalkDB:2175397;Cellinker:2175397;Cellinker:7647976;Cellinker:9082970;Guide2Pharma:7647976;ICELLNET:8440682;LRdb:2175397;LRdb:7647976;LRdb:9082970;connectomeDB2020:2175397;connectomeDB2020:7647976;connectomeDB2020:9082970;scConnect:7647976], EDNRB [Cellinker:18199583;LRdb:14659083;Ramilowski2015:14659083;connectomeDB2020:14659083;talklr:14659083], KEL [Baccin2019:10438732;CellTalkDB:10438732;Cellinker:10438732;HPRD:10438732;LRdb:10438732;connectomeDB2020:10438732]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	endothelin B receptor binding [GO:0031708]; hormone activity [GO:0005179]	angiogenesis [GO:0001525]; artery smooth muscle contraction [GO:0014824]; axon extension [GO:0048675]; calcium-mediated signaling [GO:0019722]; cell surface receptor signaling pathway [GO:0007166]; cell tip growth [GO:0009932]; cellular calcium ion homeostasis [GO:0006874]; cytokine-mediated signaling pathway [GO:0019221]; endothelial cell migration [GO:0043542]; energy homeostasis [GO:0097009]; hormonal regulation of the force of heart contraction [GO:0003058]; inositol phosphate-mediated signaling [GO:0048016]; lung alveolus development [GO:0048286]; macrophage activation [GO:0042116]; macrophage chemotaxis [GO:0048246]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate [GO:0010460]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of the force of heart contraction by chemical signal [GO:0003099]; prostaglandin biosynthetic process [GO:0001516]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; temperature homeostasis [GO:0001659]; vasoconstriction [GO:0042310]; vein smooth muscle contraction [GO:0014826]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EDN2&keywords=EDN2	0.81	477	NA	NA	0.52	376	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	427
CCL1	C-C motif chemokine ligand 1	Yes		ENSG00000108702	P22362	Intercrine beta (chemokine CC) family	18	ligand	extracellular, intracellular, ligand, secreted	P32246, P51685, Q16570, Q9NPB9	ACKR1, ACKR4, CCR1, CCR8	CCR8 [Baccin2019:10419462;Baccin2019:11154210;Baccin2019:12645948;Baccin2019:12967681;Baccin2019:16221874;Baccin2019:9211859;CellPhoneDB:24218476;Cellinker:10419462;Cellinker:11154210;Cellinker:12645948;Cellinker:12967681;Cellinker:16221874;Cellinker:9211859;DIP:10910894;DIP:11470772;DIP:9211859;DIP:9469461;Guide2Pharma:10419462;Guide2Pharma:11154210;Guide2Pharma:16221874;HPMR:12645948;HPRD:12967681;HPRD:9211859;ICELLNET:9207005;InnateDB:9211859;LRdb:10699158;SIGNOR:12645948;connectomeDB2020:10419462;connectomeDB2020:11154210;connectomeDB2020:12645948;connectomeDB2020:12967681;connectomeDB2020:16221874;connectomeDB2020:9211859;scConnect:10419462;scConnect:11154210;scConnect:16221874], ACKR4 [NA], ACKR1 [CellChatDB:26740381;Cellinker:26740381], CCR1 [DIP:10910894;DIP:11470772]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of monocyte chemotaxis [GO:0090026]; signal transduction [GO:0007165]; viral process [GO:0016032]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL1&keywords=CCL1	0.02	795	NA	NA	0.90	285	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	540
CCL21	C-C motif chemokine ligand 21	Yes		ENSG00000137077	O00585	Intercrine beta (chemokine CC) family	18	ligand	extracellular, intracellular, ligand, secreted	O00590, P08913, P13611, P32248, P46092, P48039, P49682, Q14831, Q9NPB9	ACKR2, ACKR4, ADRA2A, CCR10, CCR7, CXCR3, GRM7, MTNR1A, VCAN	ACKR4 [CellPhoneDB:24218476;CellTalkDB:23341447;Cellinker:10706668;Cellinker:23341447;Guide2Pharma:23341447;HPRD:10706668;ICELLNET:22633458;InnateDB:10706668;LRdb:11;LRdb:23341447;connectomeDB2020:10706668;connectomeDB2020:23341447;scConnect:23341447], CCR7 [Baccin2019:11970971;Baccin2019:9507024;Baccin2019:9585422;CellPhoneDB:24218476;CellTalkDB:10699158;Cellinker:11970971;Cellinker:9507024;Cellinker:9585422;DIP:10488147;DIP:9507024;Guide2Pharma:9507024;HPRD:9507024;HPRD:9585422;ICELLNET:22633458;InnateDB:22221265;InnateDB:9507024;LRdb:10699158;SIGNOR:11970971;connectomeDB2020:11970971;connectomeDB2020:9507024;connectomeDB2020:9585422;scConnect:9507024], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], CXCR3 [Baccin2019:26888559;CellTalkDB:11907075;Cellinker:26888559;Ramilowski2015:11907075;connectomeDB2020:11907075;talklr:11907075], GRM7 [CellTalkDB:32196115], ACKR2 [CellTalkDB:10706668;HPRD:10706668;LRdb:10706668;connectomeDB2020:10706668], CCR10 [connectomeDB2020:10706668], VCAN [Cellinker:16045811;HPRD:11083865]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR7 chemokine receptor binding [GO:0031732]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; chemokine receptor binding [GO:0042379]	activation of GTPase activity [GO:0090630]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cell chemotaxis [GO:0060326]; cell maturation [GO:0048469]; cellular response to chemokine [GO:1990869]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; chemokine-mediated signaling pathway [GO:0070098]; dendritic cell chemotaxis [GO:0002407]; dendritic cell dendrite assembly [GO:0097026]; eosinophil chemotaxis [GO:0048245]; establishment of T cell polarity [GO:0001768]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; immunological synapse formation [GO:0001771]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; mesangial cell-matrix adhesion [GO:0035759]; monocyte chemotaxis [GO:0002548]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of dendritic cell dendrite assembly [GO:2000548]; negative regulation of leukocyte tethering or rolling [GO:1903237]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cell motility [GO:2000147]; positive regulation of chemotaxis [GO:0050921]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myeloid dendritic cell chemotaxis [GO:2000529]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of T cell migration [GO:2000406]; release of sequestered calcium ion into cytosol [GO:0051209]; response to prostaglandin E [GO:0034695]; ruffle organization [GO:0031529]; T cell costimulation [GO:0031295]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL21&keywords=CCL21	2.52	360	NA	NA	0.04	724	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	542
FGF10	fibroblast growth factor 10	Yes		ENSG00000070193	O15520	Heparin-binding growth factors family	18	ecm, ligand, receptor	ecm, extracellular, intracellular, ligand, receptor, secreted	P11362, P21802, P22455, P22607, Q8N441	FGFR1, FGFR2, FGFR3, FGFR4, FGFRL1	FGFR2 [Baccin2019:12591959;Baccin2019:9582367;CellTalkDB:16597617;Cellinker:12591959;Cellinker:16597617;Cellinker:25772309;Cellinker:9582367;HPRD:9582367;LRdb:16597617;Lit-BM-17:10339576;Lit-BM-17:12591959;Lit-BM-17:25241761;Lit-BM-17:9582367;SIGNOR:8663044;SIGNOR:9582367;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:8663044;SignaLink3:9582367;connectomeDB2020:12591959;connectomeDB2020:9582367], FGFRL1 [CellTalkDB:19920134;connectomeDB2020:19920134], FGFR1 [CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;Cellinker:30809251;LRdb:16597617;connectomeDB2020:16597617], FGFR3 [NA], FGFR4 [NA]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	chemoattractant activity [GO:0042056]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; type 2 fibroblast growth factor receptor binding [GO:0005111]	actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; blood vessel remodeling [GO:0001974]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching morphogenesis of an epithelial tube [GO:0048754]; bronchiole morphogenesis [GO:0060436]; bud elongation involved in lung branching [GO:0060449]; bud outgrowth involved in lung branching [GO:0060447]; cell differentiation [GO:0030154]; determination of left/right symmetry [GO:0007368]; embryonic camera-type eye development [GO:0031076]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic genitalia morphogenesis [GO:0030538]; embryonic pattern specification [GO:0009880]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; female genitalia morphogenesis [GO:0048807]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; hair follicle morphogenesis [GO:0031069]; Harderian gland development [GO:0070384]; induction of positive chemotaxis [GO:0050930]; lacrimal gland development [GO:0032808]; limb bud formation [GO:0060174]; limb development [GO:0060173]; lung epithelium development [GO:0060428]; lung proximal/distal axis specification [GO:0061115]; lung saccule development [GO:0060430]; male genitalia morphogenesis [GO:0048808]; mammary gland bud formation [GO:0060615]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal-epithelial cell signaling involved in lung development [GO:0060496]; mesonephros development [GO:0001823]; metanephros development [GO:0001656]; metanephros morphogenesis [GO:0003338]; muscle cell fate commitment [GO:0042693]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; odontogenesis of dentin-containing tooth [GO:0042475]; organ induction [GO:0001759]; otic vesicle formation [GO:0030916]; pancreas development [GO:0031016]; pituitary gland development [GO:0021983]; positive chemotaxis [GO:0050918]; positive regulation of ATPase activity [GO:0032781]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA repair [GO:0045739]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of hair follicle cell proliferation [GO:0071338]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urothelial cell proliferation [GO:0050677]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of white fat cell proliferation [GO:0070352]; prostatic bud formation [GO:0060513]; protein localization to cell surface [GO:0034394]; radial glial cell differentiation [GO:0060019]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell migration [GO:0030334]; regulation of saliva secretion [GO:0046877]; regulation of smoothened signaling pathway [GO:0008589]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; salivary gland development [GO:0007431]; secretion by lung epithelial cell involved in lung growth [GO:0061033]; semicircular canal fusion [GO:0060879]; smooth muscle cell differentiation [GO:0051145]; somatic stem cell population maintenance [GO:0035019]; spleen development [GO:0048536]; submandibular salivary gland formation [GO:0060661]; tear secretion [GO:0070075]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tissue regeneration [GO:0042246]; type II pneumocyte differentiation [GO:0060510]; urothelial cell proliferation [GO:0050674]; white fat cell differentiation [GO:0050872]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF10&keywords=FGF10	0.48	528	NA	NA	0.15	580	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	554
IL22	interleukin 22	Yes		ENSG00000127318	Q9GZX6	IL-10 family	18	ligand	extracellular, ligand, secreted	Q08334, Q13651, Q8N6P7, Q969J5, Q9HBE5, Q9UHF4	IL10RA, IL10RB, IL10RB_IL22RA1, IL20RA, IL20RB_IL22RA1, IL21R, IL22_IL22RA1, IL22RA1, IL22RA2	IL10RB [CellTalkDB:10875937;HPRD:10875937;LRdb:10875937;Lit-BM-17:10875937;Lit-BM-17:12513909;Lit-BM-17:15120653;SIGNOR:17208301;SPIKE:18509351;SignaLink3:10875937;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:10875937], IL20RA [SignaLink3:17208301;SignaLink3:23331499], IL22RA2 [Baccin2019:1139045311390450;CellTalkDB:11390453;Cellinker:11390453;HPMR:11390453;HPRD:11390453;ICELLNET:15032600;InnateDB:19193995;InnateDB:19285080;LRdb:11390453;Lit-BM-17:11390453;Lit-BM-17:15120653;Lit-BM-17:18599299;Lit-BM-17:19285080;SIGNOR:11390453;connectomeDB2020:11390453], IL22RA1 [Baccin2019:5898511035029;BioGRID:10875937;BioGRID:11035029;CellTalkDB:18675809;DIP:18599299;DIP:20462497;DOMINO:18675809;HPRD:11035029;InnateDB:18599299;IntAct:12513909;IntAct:18599299;IntAct:18675809;IntAct:20462497;LRdb:11035;LRdb:58985;Lit-BM-17:10875937;Lit-BM-17:11035029;Lit-BM-17:12513909;Lit-BM-17:15120653;Lit-BM-17:18599299;Lit-BM-17:18675809;SIGNOR:12941475;connectomeDB2020:11035029;connectomeDB2020:58985], IL10RA [Baccin2019:58985;CellTalkDB:10875937;LRdb:58985;connectomeDB2020:58985], IL21R [CellTalkDB:15546387]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; interleukin-22 receptor binding [GO:0045518]	acute-phase response [GO:0006953]; inflammatory response [GO:0006954]; response to glucocorticoid [GO:0051384]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL22&keywords=IL22	0.01	832	NA	NA	0.78	305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	569
FGF18	fibroblast growth factor 18	Yes		ENSG00000156427	O76093	Heparin-binding growth factors family	18	ligand	extracellular, intracellular, ligand, secreted	P11362, P21802, P22455, P22607	FGFR1, FGFR2, FGFR3, FGFR4	FGFR2 [Baccin2019:10751172;CellTalkDB:16597617;Cellinker:10751172;Cellinker:25772309;HPRD:10751172;LRdb:16597617;SIGNOR:8663044;SignaLink3:23331499;SignaLink3:8663044;connectomeDB2020:10751172], FGFR4 [Baccin2019:10751172;CellTalkDB:16597617;Cellinker:10751172;Cellinker:25772309;HPRD:10751172;LRdb:16597617;connectomeDB2020:10751172], FGFR1 [Baccin2019:10751172;CellTalkDB:16597617;Cellinker:25772309;HPRD:10751172;LRdb:16597617;connectomeDB2020:10751172], FGFR3 [Baccin2019:1578147310751170;CellTalkDB:16597617;Cellinker:10751172;Cellinker:15781473;Cellinker:16597617;Cellinker:25772309;HPRD:10751172;LRdb:16597617;connectomeDB2020:10751172;connectomeDB2020:15781473]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleolus [GO:0005730]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105]; type 2 fibroblast growth factor receptor binding [GO:0005111]	anatomical structure morphogenesis [GO:0009653]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; cell-cell signaling [GO:0007267]; cell differentiation [GO:0030154]; chondrocyte development [GO:0002063]; endochondral ossification [GO:0001958]; fibroblast growth factor receptor signaling pathway [GO:0008543]; intramembranous ossification [GO:0001957]; lung development [GO:0030324]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF18&keywords=FGF18	0.18	623	NA	NA	0.13	594	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	609
FGF6	fibroblast growth factor 6	Yes		ENSG00000111241	P10767	Heparin-binding growth factors family	18	ligand	extracellular, intracellular, ligand, secreted, transmembrane, transmembrane_predicted	P11362, P21802, P22455, P22607, P31431	FGFR1, FGFR2, FGFR3, FGFR4, SDC4	FGFR2 [Baccin2019:8663044;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;Cellinker:8663044;HPRD:8663044;LRdb:16597617;SIGNOR:8663044;SignaLink3:23331499;SignaLink3:8663044;connectomeDB2020:8663044], FGFR4 [Baccin2019:13851111385111;CellTalkDB:16597617;Cellinker:1385111;Cellinker:25772309;HPRD:1385111;LRdb:16597617;SIGNOR:1385111;connectomeDB2020:1385111], SDC4 [CellTalkDB:32196115], FGFR1 [Baccin2019:8663044;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;HPRD:8663044;LRdb:16597617;connectomeDB2020:8663044], FGFR3 [Baccin2019:8663044;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;Cellinker:8663044;HPRD:8663044;LRdb:16597617;connectomeDB2020:8663044]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; sarcolemma [GO:0042383]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]	angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; fibroblast growth factor receptor signaling pathway [GO:0008543]; myoblast differentiation [GO:0045445]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF6&keywords=FGF6	0.01	825	NA	NA	0.45	402	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	614
FGF17	fibroblast growth factor 17	Yes		ENSG00000158815	O60258	Heparin-binding growth factors family	18	ligand	extracellular, intracellular, ligand, secreted	P11362, P21802, P22455, P22607	FGFR1, FGFR2, FGFR3, FGFR4	FGFR2 [Baccin2019:10751172;CellTalkDB:16597617;Cellinker:10751172;Cellinker:25772309;HPRD:10751172;LRdb:16597617;SIGNOR:8663044;SignaLink3:23331499;SignaLink3:8663044;connectomeDB2020:10751172], FGFR1 [Baccin2019:10751172;CellTalkDB:16597617;Cellinker:25772309;HPRD:10751172;LRdb:16597617;connectomeDB2020:10751172], FGFR4 [Baccin2019:10751172;CellTalkDB:16597617;Cellinker:10751172;Cellinker:25772309;HPRD:10751172;LRdb:16597617;connectomeDB2020:10751172], FGFR3 [Baccin2019:10751172;CellTalkDB:16597617;Cellinker:10751172;Cellinker:16597617;Cellinker:25772309;HPRD:10751172;LRdb:16597617;connectomeDB2020:10751172]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105]; type 2 fibroblast growth factor receptor binding [GO:0005111]	animal organ morphogenesis [GO:0009887]; cell-cell signaling [GO:0007267]; cell differentiation [GO:0030154]; fibroblast growth factor receptor signaling pathway [GO:0008543]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF17&keywords=FGF17	0.27	585	NA	NA	0.04	751	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	668
XCL1	X-C motif chemokine ligand 1	Yes		ENSG00000143184	P47992	Intercrine gamma family	18	ligand	extracellular, intracellular, ligand, secreted	P46094, Q8WXG9	ADGRV1, XCR1	XCR1 [Baccin2019:11446740;Baccin2019:9632725;CellPhoneDB:24218476;Cellinker:11446740;Cellinker:19556286;Cellinker:9632725;Guide2Pharma:25497737;HPMR:9632725;HPRD:11446740;HPRD:9632725;ICELLNET:22633458;InnateDB:9632725;LRdb:10699158;SIGNOR:10518929;connectomeDB2020:11446740;connectomeDB2020:9632725;scConnect:25497737], ADGRV1 [CellTalkDB:32103204]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; chemokine receptor binding [GO:0042379]; protein homodimerization activity [GO:0042803]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-4 [GO:0071353]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; mature natural killer cell chemotaxis [GO:0035782]; monocyte chemotaxis [GO:0002548]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of T cell cytokine production [GO:0002725]; negative regulation of T-helper 1 cell activation [GO:2000518]; negative regulation of T-helper 1 type immune response [GO:0002826]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil chemotaxis [GO:0030593]; positive regulation of B cell chemotaxis [GO:2000538]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000566]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of granzyme A production [GO:2000513]; positive regulation of granzyme B production [GO:0071663]; positive regulation of GTPase activity [GO:0043547]; positive regulation of immunoglobulin production in mucosal tissue [GO:2000558]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of natural killer cell chemotaxis [GO:2000503]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of thymocyte migration [GO:2000412]; positive regulation of transforming growth factor beta production [GO:0071636]; regulation of inflammatory response [GO:0050727]; release of sequestered calcium ion into cytosol [GO:0051209]; response to virus [GO:0009615]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=XCL1&keywords=XCL1	0.03	767	NA	NA	0.09	644	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	706
CXCL13	C-X-C motif chemokine ligand 13	Yes		ENSG00000156234	O43927	Intercrine alpha (chemokine CxC) family	18	ligand	extracellular, ligand, ligand_regulator, secreted	P08913, P09038, P28223, P32302, P41143, P46092, P48039, P49682, Q14831, Q16570, Q9NPB9	ACKR1, ACKR4, ADRA2A, CCR10, CXCR3, CXCR5, FGF2, GRM7, HTR2A, MTNR1A, OPRD1	CXCR5 [Baccin2019:9463416;Baccin2019:9486651;CellPhoneDB:24218476;Cellinker:28389721;Cellinker:9463416;Cellinker:9486651;DIP:9463416;Guide2Pharma:22913878;HPMR:9463416;HPRD:9463416;HPRD:9486651;ICELLNET:22633458;LRdb:10699158;connectomeDB2020:9463416;connectomeDB2020:9486651;scConnect:22913878], CXCR3 [Baccin2019:11554781;CellTalkDB:11554781;Cellinker:11554781;HPRD:11554781;ICELLNET:11554781;ICELLNET:22633458;LRdb:11554781;connectomeDB2020:11554781], ACKR4 [Baccin2019:10706668;CellPhoneDB:24218476;Cellinker:10706668;HPRD:10706668;ICELLNET:22633458;ICELLNET:706668;LRdb:10706668;connectomeDB2020:10706668], CCR10 [Baccin2019:10706668;CellTalkDB:10706668;Cellinker:10706668;HPRD:10706668;LRdb:10706668;connectomeDB2020:10706668], GRM7 [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], OPRD1 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], ACKR1 [CellChatDB:26740381;Cellinker:26740381], HTR2A [NA], FGF2 [HPRD:11708770]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR10 chemokine receptor binding [GO:0031735]; chemokine activity [GO:0008009]; CXCR3 chemokine receptor binding [GO:0048248]; CXCR5 chemokine receptor binding [GO:0031724]; CXCR chemokine receptor binding [GO:0045236]; fibroblast growth factor binding [GO:0017134]; heparin binding [GO:0008201]; receptor ligand activity [GO:0048018]	activation of GTPase activity [GO:0090630]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; B cell chemotaxis [GO:0035754]; cell-cell signaling [GO:0007267]; cell surface receptor signaling pathway [GO:0007166]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chronic inflammatory response [GO:0002544]; defense response to bacterium [GO:0042742]; endothelial cell chemotaxis to fibroblast growth factor [GO:0035768]; germinal center formation [GO:0002467]; immune response [GO:0006955]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; lymphocyte chemotaxis across high endothelial venule [GO:0002518]; negative regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000545]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of integrin activation [GO:0033625]; positive regulation of T cell chemotaxis [GO:0010820]; regulation of angiogenesis [GO:0045765]; regulation of humoral immune response [GO:0002920]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCL13&keywords=CXCL13	0.18	620	NA	NA	0.02	802	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	711
FGF8	fibroblast growth factor 8	Yes		ENSG00000107831	P55075	Heparin-binding growth factors family	18	ligand	extracellular, intracellular, ligand, secreted	P11362, P21802, P22455, P22607, Q8N441	FGFR1, FGFR2, FGFR3, FGFR4, FGFRL1	FGFR2 [Baccin2019:10751172;Baccin2019:8663044;CellTalkDB:16597617;Cellinker:10751172;Cellinker:25772309;Cellinker:8663044;HPRD:10751172;HPRD:8663044;LRdb:16597617;SignaLink3:23331499;SignaLink3:8663044;connectomeDB2020:10751172;connectomeDB2020:8663044], FGFRL1 [CellTalkDB:23112089;connectomeDB2020:19920134], FGFR1 [Baccin2019:829025710574949;CellTalkDB:16597617;Cellinker:25772309;DIP:22244757;HPRD:10574949;LRdb:16597617;connectomeDB2020:10574949;connectomeDB2020:8290257], FGFR3 [Baccin2019:10574949;Baccin2019:11486033;Baccin2019:8663044;CellTalkDB:16597617;Cellinker:10574949;Cellinker:11486033;Cellinker:16597617;Cellinker:25772309;Cellinker:8663044;DIP:22244757;HPRD:10574949;LRdb:16597617;connectomeDB2020:10574949;connectomeDB2020:11486033;connectomeDB2020:8663044], FGFR4 [Baccin2019:1148603310736560;CellTalkDB:16597617;Cellinker:10736564;Cellinker:11486033;Cellinker:25772309;HPRD:10736564;LRdb:16597617;connectomeDB2020:10736564;connectomeDB2020:11486033]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105]; type 2 fibroblast growth factor receptor binding [GO:0005111]	anatomical structure morphogenesis [GO:0009653]; animal organ morphogenesis [GO:0009887]; aorta morphogenesis [GO:0035909]; blood vessel remodeling [GO:0001974]; bone development [GO:0060348]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cell migration involved in mesendoderm migration [GO:0090134]; cell proliferation in forebrain [GO:0021846]; corticotropin hormone secreting cell differentiation [GO:0060128]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic neurocranium morphogenesis [GO:0048702]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain morphogenesis [GO:0048853]; gastrulation [GO:0007369]; gonad development [GO:0008406]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; larynx morphogenesis [GO:0120223]; limb morphogenesis [GO:0035108]; lung morphogenesis [GO:0060425]; male genitalia development [GO:0030539]; MAPK cascade [GO:0000165]; mesodermal cell migration [GO:0008078]; mesonephros development [GO:0001823]; metanephros development [GO:0001656]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of cardiac muscle tissue development [GO:0055026]; negative regulation of neuron apoptotic process [GO:0043524]; neural plate morphogenesis [GO:0001839]; neuroepithelial cell differentiation [GO:0060563]; neuron differentiation [GO:0030182]; odontogenesis [GO:0042476]; organ induction [GO:0001759]; otic vesicle formation [GO:0030916]; outflow tract septum morphogenesis [GO:0003148]; pallium development [GO:0021543]; pharyngeal system development [GO:0060037]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; signal transduction involved in regulation of gene expression [GO:0023019]; subpallium development [GO:0021544]; thyroid gland development [GO:0030878]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF8&keywords=FGF8	0.00	891	NA	NA	0.07	668	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	780
LEP	leptin	Yes		ENSG00000174697	P41159	Leptin family	18	ligand	extracellular, intracellular, ligand, secreted	P02741, P48357, P54646, P98164, Q6UXK2	CRP, ISLR2, LEPR, LRP2, PRKAA2	LEPR [Baccin2019:8608603;Baccin2019:9463481;CellTalkDB:9463481;Cellinker:8608603;Cellinker:9463481;DIP:22405007;DIP:9786864;HPMR:9463481;HPRD:8608603;ICELLNET:9463481;LRdb:861;LRdb:9463481;NetPath:12226096;NetPath:9218470;SIGNOR:9463481;SignaLink3:23331499;SignaLink3:9207021;connectomeDB2020:8608603;connectomeDB2020:9463481], LRP2 [CellTalkDB:32196115], ISLR2 [Cellinker:32822567], CRP [HPRD:16582918;NetPath:16582918], PRKAA2 [HPRD:11797013]	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	DNA binding [GO:0003677]; hormone activity [GO:0005179]; leptin receptor binding [GO:1990460]; peptide hormone receptor binding [GO:0051428]	activation of protein kinase C activity [GO:1990051]; adipose tissue development [GO:0060612]; adult feeding behavior [GO:0008343]; angiogenesis [GO:0001525]; aorta development [GO:0035904]; bile acid metabolic process [GO:0008206]; bone growth [GO:0098868]; bone mineralization involved in bone maturation [GO:0035630]; cardiac muscle hypertrophy [GO:0003300]; cellular response to insulin stimulus [GO:0032869]; cellular response to L-ascorbic acid [GO:0071298]; cellular response to leptin stimulus [GO:0044320]; cellular response to retinoic acid [GO:0071300]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; circadian rhythm [GO:0007623]; determination of adult lifespan [GO:0008340]; eating behavior [GO:0042755]; elastin metabolic process [GO:0051541]; energy reserve metabolic process [GO:0006112]; fatty acid beta-oxidation [GO:0006635]; female pregnancy [GO:0007565]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycerol biosynthetic process [GO:0006114]; hormone metabolic process [GO:0042445]; insulin secretion [GO:0030073]; intestinal absorption [GO:0050892]; intracellular signal transduction [GO:0035556]; leptin-mediated signaling pathway [GO:0033210]; leukocyte tethering or rolling [GO:0050901]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of appetite [GO:0032099]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of autophagy [GO:0010507]; negative regulation of cartilage development [GO:0061037]; negative regulation of glucagon secretion [GO:0070093]; negative regulation of glucose import [GO:0046325]; negative regulation of glutamine transport [GO:2000486]; negative regulation of lipid storage [GO:0010888]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vasoconstriction [GO:0045906]; ovulation from ovarian follicle [GO:0001542]; phagocytosis [GO:0006909]; placenta development [GO:0001890]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of developmental growth [GO:0048639]; positive regulation of fat cell apoptotic process [GO:1904651]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of ion transport [GO:0043270]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of TOR signaling [GO:0032008]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; prostaglandin secretion [GO:0032310]; regulation of angiogenesis [GO:0045765]; regulation of blood pressure [GO:0008217]; regulation of bone remodeling [GO:0046850]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell cycle [GO:0051726]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of endothelial cell proliferation [GO:0001936]; regulation of gluconeogenesis [GO:0006111]; regulation of insulin secretion [GO:0050796]; regulation of intestinal cholesterol absorption [GO:0030300]; regulation of lipoprotein lipid oxidation [GO:0060587]; regulation of natural killer cell activation [GO:0032814]; regulation of natural killer cell mediated cytotoxicity [GO:0042269]; regulation of natural killer cell proliferation [GO:0032817]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of steroid biosynthetic process [GO:0050810]; response to activity [GO:0014823]; response to dietary excess [GO:0002021]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to vitamin E [GO:0033197]; sexual reproduction [GO:0019953]; T cell differentiation [GO:0030217]; tyrosine phosphorylation of STAT protein [GO:0007260]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LEP&keywords=LEP	0.04	760	NA	NA	0.01	845	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	803
WNT3A	Wnt family member 3A	Yes		ENSG00000154342	P56704	Wnt family	18	adhesion, ecm, ligand, receptor	adhesion, ecm, extracellular, intracellular, ligand, matrix_adhesion, receptor, secreted	O60353, O75084, O75197, O75473, O75581, O75787, P34925, Q01973, Q07954, Q13467, Q14332, Q8J025, Q96CG8, Q9H461, Q9NPG1, Q9ULV1, Q9ULW2, Q9UP38	APCDD1, ATP6AP2, CTHRC1, FZD1, FZD1_LRP5, FZD1_LRP6, FZD10, FZD10_LRP5, FZD10_LRP6, FZD2, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4, FZD4_LRP5, FZD4_LRP6, FZD5, FZD5_LRP5, FZD5_LRP6, FZD6, FZD6_LRP5, FZD6_LRP6, FZD7, FZD7_LRP5, FZD7_LRP6, FZD8, FZD8_LRP5, FZD8_LRP6, FZD9_LRP5, FZD9_LRP6, LGR5, LRP1, LRP5, LRP6, ROR1, RYK	RYK [Baccin2019:15454084;CellTalkDB:15454084;Cellinker:15454084;HPRD:15454084;LRdb:15454084;NetPath:15454084;SIGNOR:15454084;SignaLink3:15454084;SignaLink3:18988627;SignaLink3:23331499;connectomeDB2020:15454084], FZD6 [Baccin2019:21128903;Baccin2019:21665003;CellTalkDB:21665003;Guide2Pharma:21128903;Guide2Pharma:21665003;LRdb:21;LRdb:21665003;connectomeDB2020:21128903;connectomeDB2020:21665003;scConnect:21128903;scConnect:21665003], LRP5 [CellTalkDB:25425204;SIGNOR:15578921;SIGNOR:21078818], FZD8 [CellTalkDB:22303445;LRdb:22303445;NetPath:20093360;Ramilowski2015:22303445;SIGNOR:22653731;connectomeDB2020:22303445;talklr:22303445], LRP6 [Baccin2019:12897152;Baccin2019:14739301;BioGRID:19910923;CellTalkDB:14739301;DIP:21944579;HPRD:12897152;HPRD:14739301;IntAct:21944579;IntAct:22726442;LRdb:13;LRdb:14739301;NetPath:12897152;NetPath:19339249;NetPath:20093360;ProtMapper:16890161;ProtMapper:18772438;ProtMapper:22491013;ProtMapper:23400998;ProtMapper:24265322;SIGNOR:15578921;SIGNOR:16890161;SIGNOR:21078818;connectomeDB2020:12897152;connectomeDB2020:14739301], FZD2 [CellTalkDB:18215320;LRdb:18215320;NetPath:19910923;Ramilowski2015:18215320;SIGNOR:19910923;connectomeDB2020:18215320;connectomeDB2020:19910923;talklr:18215320], FZD3 [CellTalkDB:18212053;SIGNOR:10601008;SIGNOR:21078818], FZD1 [Baccin2019:10557084;CancerCellMap:10557084;CellTalkDB:10557084;HPRD:10557084;LRdb:10557084;MPPI:10557084;NetPath:10557084;SIGNOR:10601008;SIGNOR:21078818;connectomeDB2020:10557084], FZD5 [Baccin2019:24032637;CellTalkDB:22753465;LRdb:22753465;NetPath:17117926;Ramilowski2015:22753465;connectomeDB2020:22753465;talklr:22753465], ROR1 [CellTalkDB:27709494], ATP6AP2 [CellTalkDB:32196115], APCDD1 [CellTalkDB:20393562;Cellinker:20393562;LRdb:20393562;Ramilowski2015:20393562;connectomeDB2020:20393562;talklr:20393562], FZD7 [CellTalkDB:18215320;LRdb:18215320;Ramilowski2015:18215320;connectomeDB2020:18215320;talklr:18215320], LRP1 [Baccin2019:14739301;CellTalkDB:14739301;Cellinker:14739301;HPRD:14739301;LRdb:14739301;connectomeDB2020:14739301], LGR5 [CellTalkDB:22473993], FZD10 [connectomeDB2020:24599775], CTHRC1 [Cellinker:18606138], FZD4 [NetPath:19020754]	cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]	co-receptor binding [GO:0039706]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]	axis elongation involved in somitogenesis [GO:0090245]; axon guidance [GO:0007411]; calcium ion transmembrane transport via low voltage-gated calcium channel [GO:0090676]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment [GO:0061317]; cell fate commitment [GO:0045165]; cell population proliferation [GO:0008283]; cell proliferation in forebrain [GO:0021846]; cell proliferation in midbrain [GO:0033278]; cellular protein localization [GO:0034613]; cellular response to retinoic acid [GO:0071300]; COP9 signalosome assembly [GO:0010387]; dorsal/ventral neural tube patterning [GO:0021904]; extracellular matrix organization [GO:0030198]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hippocampus development [GO:0021766]; inner ear morphogenesis [GO:0042472]; in utero embryonic development [GO:0001701]; mammary gland development [GO:0030879]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of heart induction by canonical Wnt signaling pathway [GO:0003136]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron projection development [GO:0010977]; neuron differentiation [GO:0030182]; osteoblast differentiation [GO:0001649]; paraxial mesodermal cell fate commitment [GO:0048343]; platelet aggregation [GO:0070527]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation [GO:2000081]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collateral sprouting in absence of injury [GO:0048697]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytokine production [GO:0001819]; positive regulation of dermatome development [GO:0061184]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of mesodermal cell fate specification [GO:0048337]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor internalization [GO:0002092]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; postsynapse to nucleus signaling pathway [GO:0099527]; presynapse assembly [GO:0099054]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of presynapse assembly [GO:1905606]; regulation of synapse organization [GO:0050807]; secondary palate development [GO:0062009]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spinal cord association neuron differentiation [GO:0021527]; synaptic vesicle recycling [GO:0036465]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT3A&keywords=WNT3A	0.00	885	NA	NA	0.03	769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	827
GH1	growth hormone 1	Yes		ENSG00000259384	P01241	Somatotropin/prolactin family	18	ligand	extracellular, intracellular, ligand, secreted	P10912, P16471, P19235	EPOR, GHR, PRLR	PRLR [CellChatDB:23192981;CellTalkDB:27003442;Cellinker:23192981;Cellinker:31100495;Cellinker:9556914;HPRD:9556914;LRdb:9556914;SIGNOR:7984244;SignaLink3:15082796;SignaLink3:16546209;SignaLink3:20053995;SignaLink3:23331499;SignaLink3:24243840;SignaLink3:29145629;SignaLink3:7984244;connectomeDB2020:9556914], GHR [BioGRID:7862673;CellChatDB:10551877;CellTalkDB:7862673;Cellinker:10551877;Cellinker:31100495;Cellinker:7862673;DIP:9571026;ICELLNET:2387255;InnateDB:21889455;IntAct:31279174;IntAct:8943276;IntAct:9353194;LRdb:7862673;Lit-BM-17:17500058;Lit-BM-17:24280222;Lit-BM-17:7862673;Lit-BM-17:8943276;Lit-BM-17:9353194;Lit-BM-17:9571026;SIGNOR:7862673;SignaLink3:1549776;SignaLink3:1935820;SignaLink3:19927328;SignaLink3:23331499;SignaLink3:24243840;SignaLink3:2825030;SignaLink3:29145629;SignaLink3:3349036;SignaLink3:7691587;SignaLink3:9030599;connectomeDB2020:7862673], EPOR [Cellinker:11751584]	endosome lumen [GO:0031904]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; growth hormone receptor complex [GO:0070195]	growth factor activity [GO:0008083]; growth hormone receptor binding [GO:0005131]; hormone activity [GO:0005179]; metal ion binding [GO:0046872]; prolactin receptor binding [GO:0005148]	animal organ development [GO:0048513]; bone maturation [GO:0070977]; growth hormone receptor signaling pathway [GO:0060396]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of growth [GO:0045927]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to estradiol [GO:0032355]; response to nutrient levels [GO:0031667]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GH1&keywords=GH1	0.02	790	NA	NA	0.00	908	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	849
CCL24	C-C motif chemokine ligand 24	Yes		ENSG00000106178	O00175	Intercrine beta (chemokine CC) family	18	ligand	extracellular, intracellular, ligand, secreted	O00590, P41597, P51677	ACKR2, CCR2, CCR3	CCR2 [Baccin2019:15207250;CellTalkDB:15207250;Cellinker:15207250;Guide2Pharma:15207250;LRdb:15207250;connectomeDB2020:15207250;scConnect:15207250], CCR3 [Baccin2019:10488147;Baccin2019:12218106;Baccin2019:15207250;Baccin2019:16339911;CellPhoneDB:24218476;CellTalkDB:10699158;Cellinker:10488147;Cellinker:12218106;Cellinker:15207250;Cellinker:16339911;DIP:10733106;Guide2Pharma:15207250;Guide2Pharma:16339911;HPRD:12218106;ICELLNET:22633458;InnateDB:12218106;InnateDB:16102831;LRdb:10699158;connectomeDB2020:10488147;connectomeDB2020:12218106;connectomeDB2020:15207250;connectomeDB2020:16339911;scConnect:15207250;scConnect:16339911], ACKR2 [CellChatDB:26740381;CellTalkDB:10699158;Cellinker:26740381;ICELLNET:22633458;LRdb:10699158]	extracellular space [GO:0005615]	CCR3 chemokine receptor binding [GO:0031728]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; receptor ligand activity [GO:0048018]	cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of eosinophil migration [GO:2000418]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of inflammatory response [GO:0050729]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL24&keywords=CCL24	0.01	852	NA	NA	0.01	859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	856
INS	insulin	Yes		ENSG00000254647	P01308	Insulin family	17	ligand	extracellular, intracellular, ligand, secreted	P06213, P08069, P98164, Q8N423, Q8NHL6	IGF1R, INSR, LILRB1, LILRB2, LRP2	INSR [Baccin2019:2550426;CellChatDB:24633815;CellTalkDB:2550426;Cellinker:2550426;DIP:11278498;DIP:23302862;HPRD:2550426;IntAct:23302862;IntAct:29512653;LRdb:2550426;ProtMapper:17227660;ProtMapper:19752148;ProtMapper:19902173;ProtMapper:20332342;ProtMapper:21317886;ProtMapper:21743783;ProtMapper:22521887;ProtMapper:22832498;ProtMapper:23223021;ProtMapper:23304064;ProtMapper:23363978;ProtMapper:24296476;ProtMapper:26245346;ProtMapper:26374090;ProtMapper:29069585;ProtMapper:30197476;ProtMapper:8393875;SIGNOR:16956584;SIGNOR:2550426;SPIKE:15870194;SignaLink3:16956584;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:2550426;connectomeDB2020:2550426], IGF1R [Baccin2019:1851182;CellTalkDB:1851182;Cellinker:1851182;HPRD:1851182;LRdb:1851182;SIGNOR:1851182;SignaLink3:1851182;SignaLink3:18988627;SignaLink3:23331499;connectomeDB2020:1851182], LRP2 [Baccin2019:9773776;CellTalkDB:9773776;Cellinker:9773776;HPRD:9773776;LRdb:9773776;connectomeDB2020:9773776], LILRB1 [CellTalkDB:32103204], LILRB2 [CellTalkDB:32103204]	endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum lumen [GO:0005788]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; secretory granule lumen [GO:0034774]; transport vesicle [GO:0030133]	hormone activity [GO:0005179]; identical protein binding [GO:0042802]; insulin-like growth factor receptor binding [GO:0005159]; insulin receptor binding [GO:0005158]; protease binding [GO:0002020]	activation of protein kinase B activity [GO:0032148]; acute-phase response [GO:0006953]; alpha-beta T cell activation [GO:0046631]; cell-cell signaling [GO:0007267]; cognition [GO:0050890]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; G protein-coupled receptor signaling pathway [GO:0007186]; insulin receptor signaling pathway [GO:0008286]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of feeding behavior [GO:2000252]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of glycogen catabolic process [GO:0045818]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of NAD(P)H oxidase activity [GO:0033861]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein secretion [GO:0050709]; negative regulation of proteolysis [GO:0045861]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; neuron projection maintenance [GO:1990535]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of cytokine production [GO:0001819]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein secretion [GO:0050714]; positive regulation of respiratory burst [GO:0060267]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of protein secretion [GO:0050708]; regulation of synaptic plasticity [GO:0048167]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transmembrane transporter activity [GO:0022898]; vasodilation [GO:0042311]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=INS&keywords=INS	17572.13	4	NA	NA	406.79	4	43.58	135.83	22.34	27.08	199.84	1541.88	2026.97	119.92	38.61	2085.65	28.53	2	1	4	570.02	0.07	3.66	0.05	495	1	503	3
EDN3	endothelin 3	Yes		ENSG00000124205	P14138	Endothelin/sarafotoxin family	17	ligand	extracellular, intracellular, ligand, secreted	P23276, P24530, P25101	EDNRA, EDNRB, KEL	EDNRB [Baccin2019:11982704;Baccin2019:7524189;Baccin2019:8001160;Baccin2019:8086489;Baccin2019:8460684;Baccin2019:8904635;CellTalkDB:11982704;Cellinker:11982704;Cellinker:7524189;Cellinker:8001160;Cellinker:8086489;Cellinker:8460684;Cellinker:8904635;Guide2Pharma:7524189;Guide2Pharma:8460684;Guide2Pharma:8904635;HPMR:8001160;HPRD:11982704;HPRD:8001160;ICELLNET:8440682;LRdb:11982704;LRdb:7524189;LRdb:8001160;LRdb:8086489;LRdb:8460684;LRdb:8904635;SIGNOR:8086489;connectomeDB2020:11982704;connectomeDB2020:7524189;connectomeDB2020:8001160;connectomeDB2020:8086489;connectomeDB2020:8460684;connectomeDB2020:8904635;scConnect:7524189;scConnect:8460684;scConnect:8904635], KEL [Baccin2019:10438732;CellTalkDB:10438732;Cellinker:10438732;HPRD:10438732;LRdb:10438732;connectomeDB2020:10438732], EDNRA [Baccin2019:11982704;CellTalkDB:11982704;Cellinker:11982704;HPRD:11982704;LRdb:11982704;connectomeDB2020:11982704]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	endothelin B receptor binding [GO:0031708]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]	axon extension [GO:0048675]; axon guidance [GO:0007411]; blood circulation [GO:0008015]; cell-cell signaling [GO:0007267]; cell surface receptor signaling pathway [GO:0007166]; cellular calcium ion homeostasis [GO:0006874]; cellular magnesium ion homeostasis [GO:0010961]; inositol phosphate-mediated signaling [GO:0048016]; melanocyte differentiation [GO:0030318]; multicellular organism development [GO:0007275]; neural crest cell migration [GO:0001755]; neutrophil chemotaxis [GO:0030593]; peptide hormone secretion [GO:0030072]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of heart rate [GO:0010460]; positive regulation of hormone secretion [GO:0046887]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; regulation of developmental pigmentation [GO:0048070]; regulation of gene expression [GO:0010468]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; signal transduction [GO:0007165]; vasoconstriction [GO:0042310]; vein smooth muscle contraction [GO:0014826]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EDN3&keywords=EDN3	32.43	127	26769.6	38	5.12	74	0.00	0.02	0.01	0.01	0.03	0.69	0.43	0.42	0.78	0.56	0.09	28	41	122	0.28	2.76	2.00	0.34	17	21	378	60
CXCL8	C-X-C motif chemokine ligand 8	Yes		ENSG00000169429	P10145	Intercrine alpha (chemokine CxC) family	17	ligand	extracellular, intracellular, ligand, secreted	O75056, P08913, P11912, P14780, P18827, P25024, P25025, P34741, P35968, P48039, Q14831, Q16570	ACKR1, ADRA2A, CD79A, CXCR1, CXCR2, GRM7, KDR, MMP9, MTNR1A, SDC1, SDC2, SDC3	CXCR1 [CellPhoneDB:24218476;CellTalkDB:1379593;Cellinker:10188995;Cellinker:1379593;Cellinker:15282370;Cellinker:15946947;Cellinker:1840701;Cellinker:8137938;Cellinker:8940121;DIP:10206993;DIP:10368283;DIP:8550564;DIP:9195914;DIP:9553055;DIP:9725262;Guide2Pharma:10188995;Guide2Pharma:1379593;Guide2Pharma:15282370;Guide2Pharma:15946947;Guide2Pharma:8940121;HPRD:1840701;ICELLNET:1840701;InnateDB:10368283;InnateDB:12628493;InnateDB:1840701;InnateDB:8245475;InnateDB:8662882;InnateDB:8702798;InnateDB:9485196;LRdb:10188995;LRdb:10699158;LRdb:1379593;LRdb:15282370;LRdb:15946947;LRdb:1840701;LRdb:8137938;LRdb:8940121;Lit-BM-17:10206993;Lit-BM-17:10368283;Lit-BM-17:8550564;Lit-BM-17:9195914;Lit-BM-17:9553055;Lit-BM-17:9725262;SIGNOR:11350788;connectomeDB2020:10188995;connectomeDB2020:1379593;connectomeDB2020:15282370;connectomeDB2020:15946947;connectomeDB2020:1840701;connectomeDB2020:8137938;connectomeDB2020:8940121;scConnect:10188995;scConnect:1379593;scConnect:15282370;scConnect:15946947;scConnect:22262769;scConnect:8940121], CXCR2 [CellPhoneDB:24218476;CellTalkDB:1379593;Cellinker:10188995;Cellinker:11511101;Cellinker:1379593;Cellinker:15282370;Cellinker:15946947;Cellinker:8626516;Cellinker:8702798;Cellinker:8940121;Cellinker:9464567;DIP:10206993;DIP:10216072;DIP:22904195;DIP:7559482;DIP:8550564;DIP:9195914;DIP:9553055;DIP:9725262;Guide2Pharma:10188995;Guide2Pharma:1379593;Guide2Pharma:15282370;Guide2Pharma:15946947;Guide2Pharma:8940121;HPRD:8626516;HPRD:8702798;HPRD:9464567;ICELLNET:1891716;InnateDB:12628493;InnateDB:19190236;InnateDB:7592830;InnateDB:8245475;InnateDB:8662882;InnateDB:8702798;InnateDB:9126332;InnateDB:9464567;InnateDB:9485196;IntAct:22904195;IntAct:23597562;LRdb:10188995;LRdb:10699158;LRdb:1379593;LRdb:15282370;LRdb:15946947;LRdb:8626516;LRdb:8702798;LRdb:8940121;LRdb:9464567;Lit-BM-17:10206993;Lit-BM-17:10216072;Lit-BM-17:23597562;Lit-BM-17:7559482;Lit-BM-17:8550564;Lit-BM-17:9195914;Lit-BM-17:9464567;Lit-BM-17:9553055;Lit-BM-17:9725262;SIGNOR:11350788;connectomeDB2020:10188995;connectomeDB2020:1379593;connectomeDB2020:15282370;connectomeDB2020:15946947;connectomeDB2020:8626516;connectomeDB2020:8702798;connectomeDB2020:8940121;connectomeDB2020:9464567;scConnect:10188995;scConnect:1379593;scConnect:15282370;scConnect:15946947;scConnect:8940121], ACKR1 [CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:17416748;Cellinker:26740381;Cellinker:9921412;DIP:10206993;DIP:7592830;DIP:8558064;DIP:9195930;HPRD:17416748;HPRD:9921412;ICELLNET:22633458;InnateDB:15720550;InnateDB:7592830;InnateDB:8132497;InnateDB:9195930;LRdb:10699158;LRdb:174;LRdb:9921412;connectomeDB2020:17416748;connectomeDB2020:9921412], SDC1 [CellTalkDB:12902511;Cellinker:12902511;HPRD:12902511;InnateDB:12902511;LRdb:12902511;connectomeDB2020:12902511], SDC3 [CellTalkDB:32196115], SDC2 [CellTalkDB:14527339;Cellinker:14527339;LRdb:14527339;Ramilowski2015:14527339;connectomeDB2020:14527339;talklr:14527339], GRM7 [CellTalkDB:32196115], CD79A [CellTalkDB:32196115], KDR [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], MMP9 [HPRD:11023497;InnateDB:17375198;InnateDB:18660381]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; heparin binding [GO:0008201]; interleukin-8 receptor binding [GO:0005153]	angiogenesis [GO:0001525]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; calcium-mediated signaling [GO:0019722]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; embryonic digestive tract development [GO:0048566]; G protein-coupled receptor signaling pathway [GO:0007186]; induction of positive chemotaxis [GO:0050930]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; killing of cells of other organism [GO:0031640]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cellular biosynthetic process [GO:0031328]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil chemotaxis [GO:0090023]; receptor internalization [GO:0031623]; regulation of cell adhesion [GO:0030155]; regulation of entry of bacterium into host cell [GO:2000535]; regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045091]; response to endoplasmic reticulum stress [GO:0034976]; response to molecule of bacterial origin [GO:0002237]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCL8&keywords=CXCL8	365.56	26	2386.51	126	98.05	11	59.24	3.73	3.08	31.38	1.09	0.12	0.09	0.61	0.29	0.07	0.31	60	125	52	9.09	0.03	0.01	0.04	517	525	514	163
FGF9	fibroblast growth factor 9	Yes		ENSG00000102678	P31371	Heparin-binding growth factors family	17	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted	O15520, P11362, P21802, P22455, P22607	FGF10, FGFR1, FGFR2, FGFR3, FGFR4	FGF10 [SignaLink3:23331499;SignaLink3:8663044], FGFR3 [Baccin2019:10574949;Baccin2019:15231666;Baccin2019:8576175;CellTalkDB:16597617;Cellinker:10574949;Cellinker:15231666;Cellinker:16597617;Cellinker:25772309;Cellinker:8576175;HPRD:10574949;HPRD:8576175;LRdb:16597617;SignaLink3:10574949;SignaLink3:23331499;SignaLink3:8576175;SignaLink3:8663044;connectomeDB2020:10574949;connectomeDB2020:15231666;connectomeDB2020:8576175], FGFR2 [Baccin2019:86630448576175;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;Cellinker:8576175;Cellinker:8663044;HPRD:8576175;LRdb:16597617;connectomeDB2020:8576175;connectomeDB2020:8663044], FGFR1 [Baccin2019:10574949;CellTalkDB:16597617;Cellinker:25772309;HPRD:10574949;LRdb:16597617;connectomeDB2020:10574949], FGFR4 [Baccin2019:8663044;CellTalkDB:16597617;Cellinker:25772309;Cellinker:8663044;HPRD:8663044;LRdb:16597617;connectomeDB2020:8663044]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]	angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; cell-cell signaling [GO:0007267]; cell differentiation [GO:0030154]; chondrocyte differentiation [GO:0002062]; embryonic digestive tract development [GO:0048566]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system development [GO:0048706]; eye development [GO:0001654]; fibroblast growth factor receptor signaling pathway [GO:0008543]; inner ear morphogenesis [GO:0042472]; lung-associated mesenchyme development [GO:0060484]; lung development [GO:0030324]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching [GO:1905931]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein import into nucleus [GO:0006606]; regulation of cell migration [GO:0030334]; regulation of timing of cell differentiation [GO:0048505]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF9&keywords=FGF9	2.20	379	NA	NA	0.81	297	0.00	0.00	0.00	0.00	0.01	0.04	0.02	0.02	0.01	0.03	0.01	252	166	238	0.01	0.97	1.75	0.93	141	32	128	219
EDA	ectodysplasin A	Yes		ENSG00000158813	Q92838	Tumor necrosis factor family	17	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, secreted, transmembrane, transmembrane_predicted	Q01638, Q9HAV5, Q9UNE0	EDA2R, EDAR, IL1RL1	EDAR [CellTalkDB:11039935;Cellinker:11039935;Cellinker:11309369;Cellinker:12084975;Guide2Pharma:11039935;HPMR:12084975;HPRD:11309369;ICELLNET:10484778;LRdb:11039935;LRdb:11309369;LRdb:12084975;SIGNOR:18304980;connectomeDB2020:11039935;connectomeDB2020:11309369;connectomeDB2020:12084975;scConnect:11039935], EDA2R [Baccin2019:11039935;Baccin2019:12084975;Baccin2019:12270937;CellTalkDB:11039935;Cellinker:11039935;Cellinker:12084975;Cellinker:12270937;Guide2Pharma:11039935;HPMR:12084975;HPRD:11039935;HPRD:12270937;ICELLNET:10484778;LRdb:11039935;LRdb:12084975;LRdb:12270937;SIGNOR:12084975;connectomeDB2020:11039935;connectomeDB2020:12084975;connectomeDB2020:12270937;scConnect:11039935], IL1RL1 [Cellinker:32589946]	apical part of cell [GO:0045177]; collagen trimer [GO:0005581]; cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]	death receptor agonist activity [GO:0038177]; death receptor binding [GO:0005123]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]	animal organ development [GO:0048513]; cell differentiation [GO:0030154]; cell-matrix adhesion [GO:0007160]; cytokine-mediated signaling pathway [GO:0019221]; gene expression [GO:0010467]; hair follicle placode formation [GO:0060789]; immune response [GO:0006955]; odontogenesis of dentin-containing tooth [GO:0042475]; pigmentation [GO:0043473]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of NIK/NF-kappaB signaling [GO:1901222]; salivary gland cavitation [GO:0060662]; trachea gland development [GO:0061153]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EDA&keywords=EDA	2.64	354	NA	NA	0.93	279	0.00	0.01	0.00	0.00	0.02	0.02	0.02	0.01	0.00	0.02	0.01	291	195	261	0.01	0.65	1.41	0.81	281	61	183	222
TNFSF11	TNF superfamily member 11	Yes		ENSG00000120659	O14788	Tumor necrosis factor family	17	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, secreted, transmembrane, transmembrane_predicted	O00300, P19838, Q9BXB1, Q9Y4K3, Q9Y6Q6	LGR4, NFKB1, TNFRSF11A, TNFRSF11B, TRAF6	TNFRSF11A [Baccin2019:11581298;Baccin2019:9367155;CellTalkDB:11581298;Cellinker:11581298;Cellinker:9367155;HPMR:11581298;HPMR:15110169;HPRD:9367155;ICELLNET:11239407;IntAct:23333834;LRdb:11581298;LRdb:94;NetPath:14741739;NetPath:20483727;NetPath:9520411;SIGNOR:12897775;connectomeDB2020:11581298;connectomeDB2020:9367155], TNFRSF11B [Baccin2019:11733492;Baccin2019:12221720;Baccin2019:9520411;Baccin2019:9568710;CellTalkDB:11733492;Cellinker:11733492;Cellinker:12221720;Cellinker:9520411;Cellinker:9568710;HPMR:9568710;HPRD:12221720;HPRD:9520411;ICELLNET:11239407;IntAct:22664871;LRdb:11733492;LRdb:12221720;LRdb:9520411;LRdb:9568710;NetPath:14741739;NetPath:9568710;SIGNOR:11733492;connectomeDB2020:11733492;connectomeDB2020:12221720;connectomeDB2020:9520411;connectomeDB2020:9568710], LGR4 [CellTalkDB:27064449], TRAF6 [HPRD:10635328], NFKB1 [HPRD:10635328]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813]	bone resorption [GO:0045453]; calcium ion homeostasis [GO:0055074]; calcium-mediated signaling [GO:0019722]; cellular response to leukemia inhibitory factor [GO:1990830]; cytokine-mediated signaling pathway [GO:0019221]; ERK1 and ERK2 cascade [GO:0070371]; immune response [GO:0006955]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell proliferation [GO:0033598]; monocyte chemotaxis [GO:0002548]; ossification [GO:0001503]; osteoclast development [GO:0036035]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; paracrine signaling [GO:0038001]; positive regulation of bone resorption [GO:0045780]; positive regulation of corticotropin-releasing hormone secretion [GO:0051466]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling [GO:0071848]; positive regulation of fever generation by positive regulation of prostaglandin secretion [GO:0071812]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoclast development [GO:2001206]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of T cell activation [GO:0050870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin binding [GO:1904616]; TNFSF11-mediated signaling pathway [GO:0071847]; tooth eruption [GO:0044691]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFSF11&keywords=TNFSF11	1.56	407	NA	NA	4.32	83	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	245
CXCL5	C-X-C motif chemokine ligand 5	Yes		ENSG00000163735	P42830	Intercrine alpha (chemokine CxC) family	17	ligand	extracellular, intracellular, ligand, secreted	P08913, P25024, P25025, P48039, Q14831, Q16570	ACKR1, ADRA2A, CXCR1, CXCR2, GRM7, MTNR1A	CXCR2 [CellPhoneDB:24218476;Cellinker:8702798;Cellinker:9692902;DIP:8702798;Guide2Pharma:8702798;HPRD:8702798;HPRD:9692902;ICELLNET:22633458;InnateDB:8702798;InnateDB:9485196;LRdb:10699158;connectomeDB2020:8702798;connectomeDB2020:9692902;scConnect:8702798], MTNR1A [CellTalkDB:32196115], ACKR1 [CellChatDB:26740381;Cellinker:13679391;Cellinker:26740381;HPRD:13679391;LRdb:10699158;LRdb:13679391;connectomeDB2020:13679391], GRM7 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], CXCR1 [CellPhoneDB:24218476;Cellinker:12964882;Cellinker:8702798;Cellinker:9692902;DIP:8702798;HPRD:8702798;HPRD:9692902;InnateDB:9485196;LRdb:10699158;connectomeDB2020:12964882;connectomeDB2020:8702798;connectomeDB2020:9692902]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; identical protein binding [GO:0042802]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell population proliferation [GO:0008284]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCL5&keywords=CXCL5	13.21	206	NA	NA	2.36	133	0.49	0.01	0.00	0.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	300	307	359	0.06	0.15	0.19	0.15	456	422	447	267
CXCL11	C-X-C motif chemokine ligand 11	Yes		ENSG00000169248	O14625	Intercrine alpha (chemokine CxC) family	17	ligand	extracellular, ligand, secreted	P08913, P25106, P27487, P48039, P49682, P51677, P51681, Q14831, Q16570	ACKR1, ACKR3, ADRA2A, CCR3, CCR5, CXCR3, DPP4, GRM7, MTNR1A	CXCR3 [Baccin2019:12884299;Baccin2019:15273303;Baccin2019:15761110;Baccin2019:9625760;CellPhoneDB:24218476;Cellinker:12884299;Cellinker:15273303;Cellinker:15761110;Cellinker:9625760;DIP:11259614;DIP:9625760;Guide2Pharma:15761110;HPRD:15273303;HPRD:9625760;ICELLNET:12884299;LRdb:10699158;SIGNOR:12750173;SPIKE:16189514;connectomeDB2020:12884299;connectomeDB2020:15273303;connectomeDB2020:15761110;connectomeDB2020:9625760;scConnect:15761110], ACKR3 [CellTalkDB:27875312;ICELLNET:20161793;ICELLNET:22633458;ICELLNET:24218476;connectomeDB2020:27875312;connectomeDB2020:29180449;connectomeDB2020:29386406], CCR3 [Baccin2019:11110785;CellTalkDB:11110785;Cellinker:11110785;DIP:11110785;HPRD:11110785;ICELLNET:15178708;ICELLNET:22633458;LRdb:11110785;connectomeDB2020:11110785], CCR5 [ICELLNET:15178708;ICELLNET:22633458], DPP4 [CellPhoneDB:24218476;CellTalkDB:24218476;Cellinker:11390394;HPRD:11390394;IntAct:18275857;IntAct:21314817], ACKR1 [CellChatDB:26740381;CellTalkDB:10699158;Cellinker:26740381;Cellinker:29637711;LRdb:10699158], GRM7 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	chemokine activity [GO:0008009]; CXCR3 chemokine receptor binding [GO:0048248]; CXCR chemokine receptor binding [GO:0045236]; heparin binding [GO:0008201]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; neutrophil chemotaxis [GO:0030593]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of cell population proliferation [GO:0042127]; signal transduction [GO:0007165]; T cell chemotaxis [GO:0010818]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCL11&keywords=CXCL11	1.66	401	NA	NA	5.92	64	0.00	0.00	0.00	0.00	0.01	0.01	0.00	0.00	0.00	0.00	0.00	292	409	380	0.00	1.10	0.80	0.85	109	209	162	271
IL23A	interleukin 23 subunit alpha	Yes		ENSG00000110944	Q9NPF7	IL-6 superfamily	17	ligand	extracellular, intracellular, ligand, secreted	O43699, O75019, P42701, Q5VWK5, Q8N423, Q99665, Q9HCN6	GP6, IL12RB1, IL12RB1_IL23R, IL12RB2, IL23R, LILRA1, LILRB2, SIGLEC6	IL12RB1 [Baccin2019:11114383;Baccin2019:12023369;Baccin2019:12671732;CellTalkDB:12023369;HPMR:12023369;HPRD:11114383;HPRD:12023369;HPRD:12671732;LRdb:11114383;LRdb:12023369;LRdb:12671732;SIGNOR:12023369;SIGNOR:12671732;SignaLink3:11114383;SignaLink3:12023369;SignaLink3:12671732;SignaLink3:18988627;SignaLink3:23331499;connectomeDB2020:11114383;connectomeDB2020:12023369;connectomeDB2020:12671732], IL23R [Baccin2019:1202336912023360;CellTalkDB:12023369;HPMR:12023369;HPRD:12023369;InnateDB:12023369;LRdb:12023369;Lit-BM-17:12023369;SIGNOR:12023369;SignaLink3:12023369;SignaLink3:23331499;connectomeDB2020:12023369], IL12RB2 [CellTalkDB:32196115], LILRB2 [Cellinker:32822567], LILRA1 [Cellinker:32822567], SIGLEC6 [Cellinker:32822567], GP6 [Cellinker:32822567]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; interleukin-23 complex [GO:0070743]	cytokine activity [GO:0005125]; interleukin-23 receptor binding [GO:0045519]	defense response to Gram-negative bacterium [GO:0050829]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of interleukin-10 production [GO:0032693]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of NK T cell activation [GO:0051135]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of tissue remodeling [GO:0034105]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]; T cell proliferation [GO:0042098]; tissue remodeling [GO:0048771]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL23A&keywords=IL23A	2.32	374	NA	NA	1.48	204	0.03	0.18	0.01	0.03	0.01	0.03	0.01	0.01	0.01	0.01	0.01	277	242	269	0.03	0.44	0.52	0.42	361	310	347	283
EDN1	endothelin 1	Yes		ENSG00000078401	P05305	Endothelin/sarafotoxin family	17	ligand	extracellular, intracellular, ligand, secreted	P23276, P24530, P25101, P42892, Q9HBW9	ADGRL4, ECE1, EDNRA, EDNRB, KEL	EDNRA [Baccin2019:6479761;Baccin2019:90829707;CellTalkDB:7647976;Cellinker:10770212;Cellinker:7647976;Cellinker:9082970;Guide2Pharma:7647976;HPMR:9082970;HPRD:10770212;ICELLNET:8440682;LRdb:10770212;LRdb:7647976;LRdb:9082970;Lit-BM-17:23597562;Lit-BM-17:7509919;SIGNOR:16597412;connectomeDB2020:10770212;connectomeDB2020:7647976;connectomeDB2020:9082970;scConnect:7647976], EDNRB [Baccin2019:12972292;CellTalkDB:12972292;Cellinker:12972292;HPRD:12972292;ICELLNET:8440682;LRdb:12972292;SIGNOR:16597412;connectomeDB2020:12972292], KEL [Baccin2019:10438732;CellTalkDB:10438732;Cellinker:10438732;HPRD:10438732;LRdb:10438732;connectomeDB2020:10438732], ADGRL4 [CellTalkDB:32196115], ECE1 [HPRD:10438732;HPRD:10620363;HPRD:9595387]	basal part of cell [GO:0045178]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; rough endoplasmic reticulum lumen [GO:0048237]; transport vesicle [GO:0030133]; Weibel-Palade body [GO:0033093]	cytokine activity [GO:0005125]; endothelin A receptor binding [GO:0031707]; endothelin B receptor binding [GO:0031708]; hormone activity [GO:0005179]	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; artery smooth muscle contraction [GO:0014824]; axon extension [GO:0048675]; axonogenesis involved in innervation [GO:0060385]; body fluid secretion [GO:0007589]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cartilage development [GO:0051216]; cell-cell signaling [GO:0007267]; cell surface receptor signaling pathway [GO:0007166]; cellular calcium ion homeostasis [GO:0006874]; cellular response to calcium ion [GO:0071277]; cellular response to fatty acid [GO:0071398]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to human chorionic gonadotropin stimulus [GO:0044751]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to mineralocorticoid stimulus [GO:0071389]; cellular response to organic substance [GO:0071310]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube development [GO:0035050]; endothelin receptor signaling pathway [GO:0086100]; endothelin receptor signaling pathway involved in heart process [GO:0086101]; epithelial fluid transport [GO:0042045]; ERK1 and ERK2 cascade [GO:0070371]; G protein-coupled receptor signaling pathway [GO:0007186]; histamine secretion [GO:0001821]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inositol phosphate-mediated signaling [GO:0048016]; in utero embryonic development [GO:0001701]; leukocyte activation [GO:0045321]; maternal process involved in parturition [GO:0060137]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; membrane depolarization [GO:0051899]; middle ear morphogenesis [GO:0042474]; mitochondrion organization [GO:0007005]; multicellular organism aging [GO:0010259]; negative regulation of blood coagulation [GO:0030195]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of gene expression [GO:0010629]; negative regulation of hormone secretion [GO:0046888]; negative regulation of nitric-oxide synthase biosynthetic process [GO:0051771]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell fate commitment [GO:0014034]; nitric oxide transport [GO:0030185]; noradrenergic neuron differentiation [GO:0003357]; peptide hormone secretion [GO:0030072]; pharyngeal arch artery morphogenesis [GO:0061626]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phospholipase D-activating G protein-coupled receptor signaling pathway [GO:0031583]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of chemokine-mediated signaling pathway [GO:0070101]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of heart rate [GO:0010460]; positive regulation of hormone secretion [GO:0046887]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of odontogenesis [GO:0042482]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urine volume [GO:0035810]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostaglandin biosynthetic process [GO:0001516]; protein kinase A signaling [GO:0010737]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase C deactivation [GO:0042313]; protein phosphorylation [GO:0006468]; regulation of glucose transmembrane transport [GO:0010827]; regulation of pH [GO:0006885]; regulation of sensory perception of pain [GO:0051930]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; renal sodium ion absorption [GO:0070294]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to activity [GO:0014823]; response to amino acid [GO:0043200]; response to amphetamine [GO:0001975]; response to dexamethasone [GO:0071548]; response to leptin [GO:0044321]; response to lipopolysaccharide [GO:0032496]; response to muscle stretch [GO:0035994]; response to nicotine [GO:0035094]; response to ozone [GO:0010193]; response to prostaglandin F [GO:0034696]; response to salt [GO:1902074]; response to testosterone [GO:0033574]; rhythmic excitation [GO:0043179]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory perception of pain [GO:0019233]; superoxide anion generation [GO:0042554]; sympathetic neuron axon guidance [GO:0097492]; thyroid gland development [GO:0030878]; transcription by RNA polymerase II [GO:0006366]; vasoconstriction [GO:0042310]; vein smooth muscle contraction [GO:0014826]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EDN1&keywords=EDN1	19.71	170	NA	NA	1.57	197	0.00	1.68	0.30	0.02	0.30	0.00	0.00	0.00	0.00	0.00	0.00	298	359	330	0.21	0.05	0.05	0.06	500	494	499	305
CCL15	C-C motif chemokine ligand 15	Yes		ENSG00000275528, ENSG00000275718	Q16663	Intercrine beta (chemokine CC) family	17	ligand	intracellular, ligand, secreted	P32246, P51677	CCR1, CCR3	CCR1 [CellTalkDB:10699158;Cellinker:9346309;DIP:9346309;Guide2Pharma:9346309;HPRD:9346309;ICELLNET:9346309;LRdb:10699158;connectomeDB2020:9346309;scConnect:9346309], CCR3 [CellTalkDB:10699158;Cellinker:9346309;DIP:9346309;Guide2Pharma:9346309;HPRD:9346309;ICELLNET:9346309;LRdb:10699158;connectomeDB2020:9346309;scConnect:9346309]	extracellular space [GO:0005615]	CCR chemokine receptor binding [GO:0048020]; chemoattractant activity [GO:0042056]; chemokine activity [GO:0008009]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102]	cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL15&keywords=CCL15	1.55	408	NA	NA	1.07	250	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	329
WNT7A	Wnt family member 7A	Yes		ENSG00000154764	O00755	Wnt family	17	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted, transmembrane	O00144, O75084, O75197, O75581, O95980, P01130, Q13467, Q96PE1, Q9NPG1, Q9ULW2, Q9UP38	ADGRA2, FZD1, FZD1_LRP5, FZD1_LRP6, FZD10, FZD10_LRP5, FZD10_LRP6, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4_LRP5, FZD4_LRP6, FZD5, FZD5_LRP5, FZD5_LRP6, FZD6_LRP5, FZD6_LRP6, FZD7, FZD7_LRP5, FZD7_LRP6, FZD8_LRP5, FZD8_LRP6, FZD9, FZD9_LRP5, FZD9_LRP6, LDLR, LRP5, LRP6, RECK	FZD5 [Baccin2019:1285772412857720;CancerCellMap:12857724;CellPhoneDB:24032637;CellTalkDB:12857724;HPMR:12857724;HPRD:12857724;LRdb:12857724;NetPath:18567805;SignaLink3:12857724;SignaLink3:23331499;connectomeDB2020:12857724], FZD7 [NetPath:19497282;SIGNOR:22944199;SIGNOR:23290138], LRP5 [SIGNOR:15578921], LRP6 [CellTalkDB:12857724;SIGNOR:15578921], FZD3 [SIGNOR:15578921], LDLR [CellTalkDB:32103204], RECK [CellTalkDB:30304675], FZD9 [Baccin2019:15705594;CellTalkDB:15705594;HPRD:15705594;LRdb:15705594;NetPath:15705594;connectomeDB2020:15705594], FZD10 [LRdb:18567805;NetPath:18567805;Ramilowski2015:18567805;connectomeDB2020:12857724;connectomeDB2020:18567805;talklr:18567805], FZD1 [connectomeDB2020:28733458], ADGRA2 [Cellinker:28289266]	cell surface [GO:0009986]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]	angiogenesis [GO:0001525]; asymmetric protein localization involved in cell fate determination [GO:0045167]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cartilage condensation [GO:0001502]; cell fate commitment [GO:0045165]; cell proliferation in forebrain [GO:0021846]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system vasculogenesis [GO:0022009]; cerebellar granule cell differentiation [GO:0021707]; chondrocyte differentiation [GO:0002062]; dendritic spine morphogenesis [GO:0060997]; dorsal/ventral pattern formation [GO:0009953]; embryonic axis specification [GO:0000578]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of cell polarity [GO:0030010]; excitatory synapse assembly [GO:1904861]; lens fiber cell development [GO:0070307]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neurogenesis [GO:0050768]; neuron differentiation [GO:0030182]; neurotransmitter secretion [GO:0007269]; oviduct development [GO:0060066]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of excitatory synapse assembly [GO:1904891]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein localization to presynapse [GO:1905386]; positive regulation of synapse assembly [GO:0051965]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynapse assembly [GO:0099068]; presynapse assembly [GO:0099054]; regulation of axon diameter [GO:0031133]; regulation of postsynapse organization [GO:0099175]; regulation of presynapse assembly [GO:1905606]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; secondary palate development [GO:0062009]; sex differentiation [GO:0007548]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]; stem cell development [GO:0048864]; synaptic vesicle recycling [GO:0036465]; uterus morphogenesis [GO:0061038]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing, spreading of epidermal cells [GO:0035313]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT7A&keywords=WNT7A	0.91	461	NA	NA	1.25	232	0.00	0.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	303	408	401	0.00	0.77	0.77	0.77	234	226	204	332
TNFSF13	TNF superfamily member 13	Yes		ENSG00000161955	O75888	Tumor necrosis factor family	17	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, secreted, transmembrane, transmembrane_predicted	O00300, O14836, P19438, P25445, P34741, Q02223, Q92956	FAS, SDC2, TNFRSF11B, TNFRSF13B, TNFRSF14, TNFRSF17, TNFRSF1A	TNFRSF17 [Baccin2019:10973284;Baccin2019:14764606;CellTalkDB:14764606;Cellinker:10973284;Cellinker:14764606;HPMR:14764606;HPRD:10973284;ICELLNET:11239407;LRdb:11;LRdb:14764606;SIGNOR:10973284;connectomeDB2020:10973284;connectomeDB2020:14764606], TNFRSF13B [Baccin2019:1095664610956640;CellTalkDB:10956646;Cellinker:10956646;HPMR:10956646;HPRD:10956646;ICELLNET:11239407;LRdb:10956646;SIGNOR:10956646;connectomeDB2020:10956646], TNFRSF14 [Baccin2019:10706119;CellTalkDB:10706119;Cellinker:10706119;HPRD:10706119;LRdb:10706119;connectomeDB2020:10706119], FAS [Baccin2019:10706119;CellTalkDB:10706119;Cellinker:10706119;HPRD:10706119;LRdb:10706119;connectomeDB2020:10706119], TNFRSF1A [Baccin2019:10706119;CellTalkDB:10706119;Cellinker:10706119;HPRD:10706119;LRdb:10706119;connectomeDB2020:10706119], TNFRSF11B [Baccin2019:10706119;CellTalkDB:10706119;Cellinker:10706119;HPRD:10706119;LRdb:10706119;connectomeDB2020:10706119], SDC2 [Baccin2019:15846369;CellTalkDB:15846369;Cellinker:15846369;HPRD:15846369;LRdb:15846369;connectomeDB2020:15846369]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	cytokine activity [GO:0005125]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]	immune response [GO:0006955]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFSF13&keywords=TNFSF13	10.13	236	NA	NA	0.32	456	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	346
CLCF1	cardiotrophin like cytokine factor 1	Yes		ENSG00000175505	Q9UBD9	IL-6 superfamily	17	ligand	extracellular, intracellular, ligand, secreted	O75462, P26992, P40189, P42702, Q92673	CNTFR, CNTFR_IL6ST_LIFR, CRLF1, IL6ST, LIFR, SORL1	IL6ST [Baccin2019:10966616;CellTalkDB:10966616;HPMR:10966616;LRdb:10966616;SIGNOR:9143707;connectomeDB2020:10966616], CNTFR [CellTalkDB:10966616;HPMR:10966616;HPRD:10966616;HPRD:11285233;HPRD:11294841;LRdb:10966616;LRdb:11285233;LRdb:11294841;SIGNOR:10966616;connectomeDB2020:10966616;connectomeDB2020:11285233;connectomeDB2020:11294841], LIFR [Baccin2019:10966616;CellTalkDB:10966616;HPMR:10966616;LRdb:10966616;connectomeDB2020:10966616], CRLF1 [CellTalkDB:10966616;HPMR:10966616;HPRD:10966616;LRdb:10966616;connectomeDB2020:10966616], SORL1 [Cellinker:26858303]	CNTFR-CLCF1 complex [GO:0097059]; CRLF-CLCF1 complex [GO:0097058]; extracellular region [GO:0005576]	ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102]	B cell differentiation [GO:0030183]; cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of isotype switching to IgE isotypes [GO:0048295]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; receptor signaling pathway via JAK-STAT [GO:0007259]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CLCF1&keywords=CLCF1	4.62	297	NA	NA	0.49	384	0.02	0.22	0.01	0.17	0.12	0.00	0.00	0.00	0.00	0.00	0.00	301	376	371	0.05	0.18	0.18	0.18	446	423	430	370
FLT3LG	fms related receptor tyrosine kinase 3 ligand	Yes		ENSG00000090554	P49771	NA	17	cell_surface_ligand, ligand, receptor	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P36888	FLT3	FLT3 [Baccin2019:15147956;Baccin2019:7505204;Baccin2019:9651358;CellChatDB:25992210;CellTalkDB:9651358;Cellinker:15147956;Cellinker:15618475;Cellinker:19830725;Cellinker:25992210;Cellinker:7505204;Cellinker:9651358;HPMR:12681969;HPMR:15147956;HPRD:7505204;HPRD:9651358;ICELLNET:21389326;LRdb:15147956;LRdb:7505204;LRdb:9651358;SIGNOR:10080542;SIGNOR:12681969;SPIKE:7505204;SPIKE:9651358;connectomeDB2020:15147956;connectomeDB2020:7505204;connectomeDB2020:9651358]	cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	embryonic hemopoiesis [GO:0035162]; positive regulation of cell population proliferation [GO:0008284]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FLT3LG&keywords=FLT3LG	0.78	483	NA	NA	0.09	643	0.02	0.00	0.01	0.02	0.01	0.01	0.00	0.01	0.01	0.01	0.02	261	268	221	0.01	1.05	0.83	1.28	121	198	53	398
NRG3	neuregulin 3	Yes		ENSG00000185737	P56975	Neuregulin family	17	cell_surface_ligand, ligand	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane_transmembrane, secreted, transmembrane	P00533, P04626, P21860, Q15303	EGFR, ERBB2, ERBB2_ERBB4, ERBB3, ERBB4	ERBB4 [Baccin2019:9275162;CellTalkDB:9275162;HPMR:9275162;HPRD:9275162;LRdb:9275162;SIGNOR:14967450;SIGNOR:7477375;SIGNOR:9275162;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:9275162;connectomeDB2020:9275162], EGFR [SignaLink3:23331499;SignaLink3:9772300], ERBB3 [CellTalkDB:9772300], ERBB2 [CellTalkDB:9772300]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]	chemorepellent activity [GO:0045499]; growth factor activity [GO:0008083]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]	animal organ development [GO:0048513]; chemorepulsion involved in interneuron migration from the subpallium to the cortex [GO:0021842]; intracellular signal transduction [GO:0035556]; mammary placode formation [GO:0060596]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron migration [GO:2001223]; pattern specification process [GO:0007389]; regulation of cell growth [GO:0001558]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NRG3&keywords=NRG3	0.81	478	NA	NA	0.52	380	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	429
GDF9	growth differentiation factor 9	Yes		ENSG00000164404	O60383	TGF-beta family	17	ligand	extracellular, ligand, secreted	O00238, P27037, P36894, P36896, P36897, Q13705, Q13873, Q8NER5, Q96SN7, Q9H0Q3	ACVR1B, ACVR1B_BMPR2, ACVR1C, ACVR2A, ACVR2B, BMPR1A, BMPR1B, BMPR2, BMPR2_TGFBR1, FXYD6, ORAI2, TGFBR1	BMPR1B [Baccin2019:12135884;CellTalkDB:12135884;Cellinker:12135884;HPRD:12135884;LRdb:12135884;connectomeDB2020:12135884], ACVR2A [Baccin2019:12135884;CellTalkDB:12135884;Cellinker:12135884;HPRD:12135884;LRdb:12135884;connectomeDB2020:12135884], BMPR1A [Baccin2019:10712517;Baccin2019:12135884;CellTalkDB:12135884;Cellinker:10712517;Cellinker:12135884;HPRD:10712517;HPRD:12135884;LRdb:11;LRdb:12135884;connectomeDB2020:12135884], ACVR1B [NA], TGFBR1 [Baccin2019:14684852;CellTalkDB:14514671;Cellinker:14684852;Cellinker:27252362;LRdb:14684852;connectomeDB2020:14684852], ACVR2B [NA], BMPR2 [Baccin2019:1213588412135880;CellTalkDB:12135884;HPRD:12135884;LRdb:12135884;connectomeDB2020:12135884], ACVR1C [NA], FXYD6 [Baccin2019:16169070;Cellinker:16169070;HPRD:16169070;LRdb:16169070], ORAI2 [Baccin2019:16169070;Cellinker:16169070;HPRD:16169070;LRdb:16169070]	extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; type I activin receptor binding [GO:0070698]	BMP signaling pathway [GO:0030509]; female gamete generation [GO:0007292]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of progesterone secretion [GO:2000870]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GDF9&keywords=GDF9	0.59	510	NA	NA	0.58	354	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	432
IL12A	interleukin 12A	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000168811	P29459	IL-6 superfamily	17	ligand	extracellular, intracellular, ligand, secreted, transmembrane	P10747, P29460, P42701, Q99665	CD28, IL12B, IL12RB1, IL12RB2	IL12RB1 [Baccin2019:11086056;CellTalkDB:11086056;Cellinker:11086056;DIP:8943050;HPMR:11086056;InnateDB:7911493;InnateDB:8943050;LRdb:11086056;Lit-BM-17:11114383;Lit-BM-17:8943050;SIGNOR:12023369;SignaLink3:23331499;SignaLink3:7527811;connectomeDB2020:11086056], IL12RB2 [CellTalkDB:943050;DIP:8943050;HPMR:11086056;LRdb:943050;Ramilowski2015:943050;SIGNOR:11086056;connectomeDB2020:943050;talklr:943050], IL12B [DIP:10779781;DIP:7527811;HPRD:10899108;InnateDB:10899108;InnateDB:7527811;InnateDB:8943050;IntAct:10899108;IntAct:7527811;Lit-BM-17:10779781;Lit-BM-17:10899108;Lit-BM-17:7527811;SIGNOR:7527811], CD28 [CellTalkDB:7516408;Cellinker:7516408;HPRD:7516408;LRdb:7516408]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-12 complex [GO:0043514]; late endosome lumen [GO:0031906]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-12 beta subunit binding [GO:0042163]; interleukin-12 receptor binding [GO:0005143]; interleukin-27 binding [GO:0045513]; protein heterodimerization activity [GO:0046982]	cell migration [GO:0016477]; cellular response to virus [GO:0098586]; defense response to Gram-positive bacterium [GO:0050830]; extrinsic apoptotic signaling pathway [GO:0097191]; immune response [GO:0006955]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of protein secretion [GO:0050709]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of mononuclear cell proliferation [GO:0032946]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002860]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NK T cell activation [GO:0051135]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to lipopolysaccharide [GO:0032496]; response to UV-B [GO:0010224]; response to virus [GO:0009615]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL12A&keywords=IL12A	0.23	602	NA	NA	0.21	528	0.00	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	302	407	305	0.00	0.81	0.79	1.07	218	213	84	438
GDF6	growth differentiation factor 6	Yes		ENSG00000156466	Q6KF10	TGF-beta family	17	ligand	extracellular, intracellular, ligand, secreted	O00238, P36894, Q13873	ACVR2A_BMPR1A, ACVR2A_BMPR1B, ACVR2B_BMPR1A, ACVR2B_BMPR1B, BMPR1A, BMPR1A_BMPR1B_BMPR2, BMPR1A_BMPR2, BMPR1B, BMPR1B_BMPR2, BMPR2	BMPR2 [Baccin2019:160490149525338;CellTalkDB:16049014;HPRD:9525338;LRdb:16049014;LRdb:95;SIGNOR:16049014;SignaLink3:16446785;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:9525338;connectomeDB2020:16049014;connectomeDB2020:9525338], BMPR1A [Baccin2019:160490149525338;CellTalkDB:16049014;HPRD:9525338;LRdb:16049014;LRdb:95;SIGNOR:16049014;connectomeDB2020:16049014;connectomeDB2020:9525338], BMPR1B [Baccin2019:9525338;CellTalkDB:9525338;HPRD:9525338;LRdb:9525338;connectomeDB2020:9525338]	extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]	activin receptor signaling pathway [GO:0032924]; apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cell migration involved in metanephros development [GO:0035788]; fat cell differentiation [GO:0045444]; metanephros development [GO:0001656]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription, DNA-templated [GO:0045893]; retinal cell apoptotic process [GO:1990009]; SMAD protein signal transduction [GO:0060395]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GDF6&keywords=GDF6	0.31	572	NA	NA	0.44	404	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	488
CCL3	C-C motif chemokine ligand 3	Yes		ENSG00000278567, ENSG00000274221, ENSG00000277632	P10147	Intercrine beta (chemokine CC) family	17	ligand	extracellular, intracellular, ligand, secreted	O00590, P32246, P32302, P41597, P51677, P51679, P51681	ACKR2, CCR1, CCR2, CCR3, CCR4, CCR5, CXCR5	CCR1 [CellPhoneDB:24218476;Cellinker:10202040;Cellinker:10660125;Cellinker:11170631;Cellinker:12381680;Cellinker:7545673;Cellinker:8530354;Cellinker:9115216;Cellinker:9624164;DIP:10488147;DIP:10498628;DIP:10910894;DIP:7545673;DIP:7622448;DIP:8530354;DIP:9115216;DIP:9169459;DIP:9207005;DIP:9336350;DIP:9687537;Guide2Pharma:11170631;Guide2Pharma:12381680;Guide2Pharma:8530354;Guide2Pharma:9624164;HPRD:10202040;HPRD:10660125;HPRD:7545673;ICELLNET:22633458;InnateDB:12381680;InnateDB:23765404;InnateDB:7545673;InnateDB:8530354;InnateDB:9115216;LRdb:10699158;SIGNOR:10734056;SIGNOR:20219869;connectomeDB2020:10202040;connectomeDB2020:10660125;connectomeDB2020:11170631;connectomeDB2020:12381680;connectomeDB2020:7545673;connectomeDB2020:8530354;connectomeDB2020:9115216;connectomeDB2020:9624164;scConnect:11170631;scConnect:12381680;scConnect:8530354;scConnect:9624164], CCR5 [CellPhoneDB:15251452;Cellinker:10477718;Cellinker:11170631;Cellinker:11700073;Cellinker:12964882;Cellinker:16298345;Cellinker:9790730;DIP:10477718;DIP:9169459;DIP:9334377;DIP:9468473;Guide2Pharma:11170631;Guide2Pharma:16298345;Guide2Pharma:9790730;HPMR:12964882;HPRD:10477718;HPRD:11700073;ICELLNET:22633458;InnateDB:10477718;InnateDB:23765404;LRdb:10699158;SIGNOR:15075201;SIGNOR:20219869;connectomeDB2020:10477718;connectomeDB2020:11170631;connectomeDB2020:11700073;connectomeDB2020:12964882;connectomeDB2020:16298345;connectomeDB2020:9790730;scConnect:11170631;scConnect:16298345;scConnect:9790730], CCR2 [SIGNOR:15075201], ACKR2 [CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:26740381;Cellinker:9405404;HPRD:9405404;ICELLNET:22633458;InnateDB:9405404;LRdb:10699158;connectomeDB2020:9405404], CCR4 [CellTalkDB:8573157;HPRD:8573157;LRdb:8573157;connectomeDB2020:8573157], CCR3 [CellPhoneDB:24218476;CellTalkDB:24218476;Cellinker:7594543;DIP:7622448;HPRD:7594543;LRdb:7594543;connectomeDB2020:7594543], CXCR5 [DIP:11470772;DIP:9312096]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	calcium-dependent protein kinase C activity [GO:0004698]; CCR1 chemokine receptor binding [GO:0031726]; CCR5 chemokine receptor binding [GO:0031730]; CCR chemokine receptor binding [GO:0048020]; chemoattractant activity [GO:0042056]; chemokine activity [GO:0008009]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phospholipase activator activity [GO:0016004]; protein kinase activity [GO:0004672]	astrocyte cell migration [GO:0043615]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell activation [GO:0001775]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to organic cyclic compound [GO:0071407]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; granulocyte chemotaxis [GO:0071621]; inflammatory response [GO:0006954]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lymphocyte chemotaxis [GO:0048247]; macrophage chemotaxis [GO:0048246]; MAPK cascade [GO:0000165]; monocyte chemotaxis [GO:0002548]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of bone mineralization [GO:0030502]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast differentiation [GO:0045671]; neutrophil chemotaxis [GO:0030593]; osteoblast differentiation [GO:0001649]; positive regulation of calcium ion import [GO:0090280]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell migration [GO:0030335]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of natural killer cell chemotaxis [GO:2000503]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of tumor necrosis factor production [GO:0032760]; protein kinase B signaling [GO:0043491]; regulation of behavior [GO:0050795]; regulation of cell shape [GO:0008360]; regulation of sensory perception of pain [GO:0051930]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to cholesterol [GO:0070723]; response to toxic substance [GO:0009636]; signaling [GO:0023052]; T cell chemotaxis [GO:0010818]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL3&keywords=CCL3	1.26	426	NA	NA	0.10	636	14.12	0.00	0.00	0.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	301	383	371	1.30	0.01	0.01	0.01	528	526	527	493
IL34	interleukin 34	Yes		ENSG00000157368	Q6ZMJ4	IL-34 family	17	ligand	extracellular, ligand, secreted	P07333, P23471	CSF1R, PTPRZ1	CSF1R [Baccin2019:30205037;CellTalkDB:22729249;Cellinker:31616414;DIP:22483114;DIP:23478061;ICELLNET:26095744;IntAct:22483114;IntAct:23478061;LRdb:22729249;ProtMapper:29796177;Ramilowski2015:22729249;SIGNOR:24890514;connectomeDB2020:22729249;scConnect:18467591;talklr:22729249], PTPRZ1 [connectomeDB2020:23744080]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; macrophage colony-stimulating factor receptor binding [GO:0005157]	inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-34-mediated signaling pathway [GO:0061514]; microglial cell proliferation [GO:0061518]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL34&keywords=IL34	0.16	639	NA	NA	0.01	841	0.00	0.02	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	302	379	391	0.00	0.78	0.81	0.78	227	207	200	517
CCL17	C-C motif chemokine ligand 17	Yes		ENSG00000102970	Q92583	Intercrine beta (chemokine CC) family	17	ligand	extracellular, intracellular, ligand, secreted	O00590, P51679, P51685, Q16570	ACKR1, ACKR2, CCR4, CCR8	CCR4 [CellPhoneDB:24218476;Cellinker:29637711;DIP:10488147;DIP:10498628;DIP:9169459;DIP:9169480;DIP:9430724;Guide2Pharma:9430724;HPMR:9169480;HPRD:9169480;HPRD:9430724;ICELLNET:10540332;ICELLNET:22633458;InnateDB:9169480;LRdb:10699158;connectomeDB2020:9169480;connectomeDB2020:9430724;scConnect:9430724], ACKR1 [CellChatDB:26740381;Cellinker:13679391;Cellinker:26740381;HPRD:13679391;ICELLNET:22633458;LRdb:10699158;LRdb:13679391;connectomeDB2020:13679391], ACKR2 [CellChatDB:26740381;CellTalkDB:10699158;Cellinker:26740381;Cellinker:29637711;ICELLNET:22633458;LRdb:10699158;connectomeDB2020:25297873], CCR8 [CellTalkDB:10699158;Cellinker:12832759;Cellinker:9521068;DIP:10910894;HPRD:12832759;HPRD:9521068;LRdb:10699158;connectomeDB2020:12832759;connectomeDB2020:9521068]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR4 chemokine receptor binding [GO:0031729]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; signaling receptor binding [GO:0005102]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; multicellular organism development [GO:0007275]; negative regulation of myoblast differentiation [GO:0045662]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL17&keywords=CCL17	0.19	617	NA	NA	0.38	428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	523
PRL	prolactin	Yes		ENSG00000172179	P01236	Somatotropin/prolactin family	17	ligand	extracellular, intracellular, ligand, secreted	P04626, P05538, P16471	ERBB2, HLA-DQB2, PRLR	PRLR [CellChatDB:23192981;CellTalkDB:2558309;Cellinker:10966654;Cellinker:11356126;Cellinker:18253483;Cellinker:2558309;Cellinker:7984244;Cellinker:9175708;Cellinker:9626554;DIP:22325776;HPMR:11356126;HPMR:2558309;HPRD:10966654;HPRD:7984244;HPRD:9626554;ICELLNET:18467331;InnateDB:21889455;IntAct:23048206;LRdb:10966654;LRdb:11356126;LRdb:2558309;LRdb:7984244;LRdb:9626554;Lit-BM-17:23048206;SIGNOR:10585417;SignaLink3:10585417;SignaLink3:10966654;SignaLink3:15082796;SignaLink3:16546209;SignaLink3:18988627;SignaLink3:20053995;SignaLink3:23331499;SignaLink3:24243840;SignaLink3:29145629;SignaLink3:7984244;SignaLink3:9626554;connectomeDB2020:10966654;connectomeDB2020:11356126;connectomeDB2020:2558309;connectomeDB2020:7984244;connectomeDB2020:9626554], ERBB2 [Cellinker:22270933], HLA-DQB2 [NA]	endosome lumen [GO:0031904]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	hormone activity [GO:0005179]; prolactin receptor binding [GO:0005148]	cell surface receptor signaling pathway [GO:0007166]; female pregnancy [GO:0007565]; lactation [GO:0007595]; mammary gland development [GO:0030879]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lactation [GO:1903489]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of multicellular organism growth [GO:0040014]; response to nutrient levels [GO:0031667]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRL&keywords=PRL	0.15	644	NA	NA	0.00	905	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	300	409	401	0.00	1.02	0.92	0.92	128	162	131	530
IL17A	interleukin 17A	Yes		ENSG00000112115	Q16552	IL-17 family	17	ligand, receptor	extracellular, ligand, receptor, secreted	Q8NAC3, Q96F46	IL17RA, IL17RA_IL17RC, IL17RC	IL17RC [CellTalkDB:18684971;InnateDB:17911633;InnateDB:18684971;InnateDB:19838198;LRdb:18684971;Ramilowski2015:18684971;connectomeDB2020:18684971;talklr:18684971], IL17RA [Baccin2019:93675399367539;CellTalkDB:9367539;HPMR:9367539;HPRD:9367539;InnateDB:11058597;InnateDB:17911633;InnateDB:18684971;InnateDB:19838198;InnateDB:9367539;LRdb:9367539;SIGNOR:9367539;connectomeDB2020:9367539]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; cell death [GO:0008219]; cellular response to interleukin-1 [GO:0071347]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; fibroblast activation [GO:0072537]; granulocyte migration [GO:0097530]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-17-mediated signaling pathway [GO:0097400]; intestinal epithelial structure maintenance [GO:0060729]; Notch signaling pathway [GO:0007219]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000340]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-16 production [GO:0032739]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL17A&keywords=IL17A	0.00	855	NA	NA	1.42	211	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	533
CCL27	C-C motif chemokine ligand 27	Yes		ENSG00000213927	Q9Y4X3	Intercrine beta (chemokine CC) family	17	ligand	extracellular, ligand, secreted	O00590, P08913, P41597, P46092, P48039, P51677, Q14831	ACKR2, ADRA2A, CCR10, CCR2, CCR3, GRM7, MTNR1A	CCR10 [CellPhoneDB:24218476;CellTalkDB:11821900;Cellinker:10725697;Cellinker:11821900;Cellinker:12718728;DIP:10725697;DIP:10781587;Guide2Pharma:10725697;HPMR:11821900;HPMR:12718728;HPRD:10725697;HPRD:11821900;ICELLNET:22633458;LRdb:10725697;LRdb:11821900;LRdb:12718728;connectomeDB2020:10725697;connectomeDB2020:11821900;connectomeDB2020:12718728;scConnect:10725697], ADRA2A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], ACKR2 [CellTalkDB:10725697;Cellinker:10725696;Cellinker:10725697;Cellinker:11821900;HPRD:10725696;HPRD:10725697;HPRD:11821900;LRdb:10725696;LRdb:10725697;LRdb:11821900;connectomeDB2020:10725696;connectomeDB2020:10725697;connectomeDB2020:11821900], MTNR1A [CellTalkDB:32196115], CCR2 [NA], CCR3 [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR3 chemokine receptor binding [GO:0031728]; chemokine activity [GO:0008009]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; chemotaxis [GO:0006935]; immune response [GO:0006955]; killing of cells of other organism [GO:0031640]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of T cell chemotaxis [GO:0010820]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL27&keywords=CCL27	0.60	507	NA	NA	0.12	607	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	557
CCL26	C-C motif chemokine ligand 26	Yes		ENSG00000006606	Q9Y258	Intercrine beta (chemokine CC) family	17	ligand	extracellular, intracellular, ligand, secreted	O00590, P32246, P41597, P49238, P51677, P51681	ACKR2, CCR1, CCR2, CCR3, CCR5, CX3CR1	CCR2 [CellPhoneDB:24218476;Cellinker:15207250;Guide2Pharma:15207250;ICELLNET:22633458;InnateDB:12689946;LRdb:15207250;connectomeDB2020:15207250;scConnect:15207250], CCR3 [CellPhoneDB:24218476;Cellinker:10488147;Cellinker:15207250;Cellinker:16339911;DIP:10488147;Guide2Pharma:10488147;Guide2Pharma:15207250;Guide2Pharma:16339911;HPRD:10488147;ICELLNET:22633458;InnateDB:10488147;InnateDB:16102831;LRdb:10699158;connectomeDB2020:10488147;connectomeDB2020:15207250;connectomeDB2020:16339911;scConnect:10488147;scConnect:15207250;scConnect:16339911], CCR1 [CellPhoneDB:24218476;Cellinker:15039444;HPRD:15039444;ICELLNET:15039444;ICELLNET:22633458;InnateDB:15039444;LRdb:15039444;connectomeDB2020:15039444], CCR5 [Cellinker:29637711;ICELLNET:15039444;ICELLNET:22633458;InnateDB:15039444], CX3CR1 [Cellinker:29637711;ICELLNET:20974991;ICELLNET:22633458;InnateDB:20974991], ACKR2 [CellChatDB:26740381;Cellinker:26740381]	extracellular space [GO:0005615]	CCR3 chemokine receptor binding [GO:0031728]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; CX3C chemokine receptor binding [GO:0031737]; receptor ligand activity [GO:0048018]	cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]; T cell chemotaxis [GO:0010818]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL26&keywords=CCL26	0.01	823	NA	NA	0.01	821	0.00	0.00	0.01	0.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	303	388	375	0.06	0.15	0.16	0.16	459	442	443	619
BMP15	bone morphogenetic protein 15	Yes		ENSG00000130385	O95972	TGF-beta family	17	ligand	extracellular, intracellular, ligand, secreted	O00238, P27037, P36894, P36897, P61160, Q04771, Q13705, Q13873	ACTR2, ACVR1, ACVR2A, ACVR2B, BMPR1A, BMPR1A_BMPR1B_BMPR2, BMPR1B, BMPR1B_BMPR2, BMPR2, TGFBR1	ACTR2 [SignaLink3:16446785;SignaLink3:23331499], BMPR2 [Baccin2019:12419820;CellTalkDB:15621726;HPMR:12419820;LRdb:12419820;SIGNOR:16446785;SignaLink3:16446785;SignaLink3:23331499;connectomeDB2020:12419820], BMPR1A [LRdb:2419820;Ramilowski2015:2419820;connectomeDB2020:2419820;talklr:2419820], BMPR1B [Baccin2019:1204491412419820;CellTalkDB:15621726;HPRD:12419820;LRdb:12;LRdb:12044914;connectomeDB2020:12044914;connectomeDB2020:12419820], ACVR2A [CellTalkDB:26198319;Cellinker:27252362;Ramilowski2015:2419820;connectomeDB2020:2419820;talklr:2419820], ACVR1 [NA], ACVR2B [Cellinker:27252362], TGFBR1 [Cellinker:27252362]	endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; type I activin receptor binding [GO:0070698]	BMP signaling pathway [GO:0030509]; female gamete generation [GO:0007292]; granulosa cell development [GO:0060016]; ovarian follicle development [GO:0001541]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMP15&keywords=BMP15	0.00	899	NA	NA	0.58	349	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	624
NODAL	nodal growth differentiation factor	Yes		ENSG00000156574	Q96S42	TGF-beta family	17	ligand	extracellular, intracellular, ligand, secreted	P0CG37, P13385, P27037, P36896, P84022, Q13705, Q8NER5	ACVR1B, ACVR1B_ACVR2A, ACVR1B_ACVR2A_CFC1, ACVR1B_ACVR2B, ACVR1B_ACVR2B_CFC1, ACVR1B_ACVR2B_TDGF1, ACVR1C, ACVR1C_ACVR2A, ACVR1C_ACVR2A_CFC1, ACVR1C_ACVR2B, ACVR1C_ACVR2B_CFC1, ACVR2A, ACVR2B, CFC1, SMAD3, TDGF1	ACVR2B [Baccin2019:11952836;CellTalkDB:11952836;HPMR:11952836;LRdb:11952836;SignaLink3:16446785;SignaLink3:23331499;connectomeDB2020:11952836], ACVR1B [Baccin2019:11952836;CellTalkDB:11952836;LRdb:11952836;SIGNOR:19874624;connectomeDB2020:11952836], ACVR1C [Baccin2019:12606401;CellTalkDB:12606401;HPMR:12606401;LRdb:12606401;SIGNOR:15531507;connectomeDB2020:12606401], TDGF1 [connectomeDB2020:28126904], SMAD3 [CellTalkDB:32196115;ProtMapper:19688838;ProtMapper:21557273], ACVR2A [Baccin2019:11952836;CellTalkDB:11952836;LRdb:11952836;connectomeDB2020:11952836], CFC1 [connectomeDB2020:28126904]	extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; morphogen activity [GO:0016015]; type I activin receptor binding [GO:0070698]	axial mesodermal cell fate specification [GO:0048327]; BMP signaling pathway [GO:0030509]; brain development [GO:0007420]; cell migration involved in gastrulation [GO:0042074]; digestive tract morphogenesis [GO:0048546]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic pattern specification [GO:0009880]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; endodermal cell differentiation [GO:0035987]; epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification [GO:0060802]; floor plate morphogenesis [GO:0033505]; formation of anatomical boundary [GO:0048859]; heart looping [GO:0001947]; inhibition of neuroepithelial cell differentiation [GO:0002085]; left lung morphogenesis [GO:0060460]; liver development [GO:0001889]; maternal placenta development [GO:0001893]; maternal process involved in parturition [GO:0060137]; mesendoderm development [GO:0048382]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of cell development [GO:0010721]; negative regulation of chorionic trophoblast cell proliferation [GO:1901383]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of trophoblast cell migration [GO:1901164]; neural fold formation [GO:0001842]; nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900164]; placenta development [GO:0001890]; polarity specification of proximal/distal axis [GO:0010085]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900224]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of gastrulation [GO:0010470]; regulation of stem cell population maintenance [GO:2000036]; SMAD protein signal transduction [GO:0060395]; stem cell population maintenance [GO:0019827]; transforming growth factor beta receptor signaling pathway involved in primitive streak formation [GO:0090010]; trophectodermal cellular morphogenesis [GO:0001831]; vasculature development [GO:0001944]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NODAL&keywords=NODAL	0.11	668	NA	NA	0.14	585	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	627
PPBP	pro-platelet basic protein	Yes		ENSG00000163736	P02775	Intercrine alpha (chemokine CxC) family	17	ligand	extracellular, intracellular, ligand, secreted	P08913, P25024, P25025, P35372, P41143, P48039, Q14831, Q16570	ACKR1, ADRA2A, CXCR1, CXCR2, GRM7, MTNR1A, OPRD1, OPRM1	CXCR2 [CellPhoneDB:24218476;CellTalkDB:1427896;Cellinker:8195702;Cellinker:8702798;DIP:8550564;DIP:8702798;Guide2Pharma:8702798;HPRD:8195702;HPRD:8702798;ICELLNET:22633458;ICELLNET:24335961;InnateDB:8702798;InnateDB:9126332;LRdb:10699158;connectomeDB2020:8195702;connectomeDB2020:8702798;scConnect:8702798], OPRM1 [SIGNOR:9686407], OPRD1 [SIGNOR:9686407], CXCR1 [CellPhoneDB:24218476;CellTalkDB:1427896;Cellinker:1427896;Cellinker:8137938;Cellinker:8195702;DIP:8702798;HPRD:1427896;HPRD:8195702;ICELLNET:22633458;ICELLNET:24335961;LRdb:1427896;LRdb:8137938;LRdb:8195702;connectomeDB2020:1427896;connectomeDB2020:8137938;connectomeDB2020:8195702], ACKR1 [CellTalkDB:10699158;ICELLNET:22633458;LRdb:10699158], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; tertiary granule lumen [GO:1904724]	chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; glucose transmembrane transporter activity [GO:0005355]; growth factor activity [GO:0008083]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; defense response to bacterium [GO:0042742]; glucose transmembrane transport [GO:1904659]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell division [GO:0051781]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PPBP&keywords=PPBP	0.21	610	NA	NA	0.06	687	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	649
CCL19	C-C motif chemokine ligand 19	Yes		ENSG00000172724	Q99731	Intercrine beta (chemokine CC) family	17	ligand	extracellular, intracellular, ligand, secreted	O00421, O00590, P08913, P32248, P46092, P48039, P49682, Q14831, Q9NPB9	ACKR2, ACKR4, ADRA2A, CCR10, CCR7, CCRL2, CXCR3, GRM7, MTNR1A	ACKR4 [CellPhoneDB:24218476;CellTalkDB:23341447;Cellinker:10706668;Cellinker:23341447;Guide2Pharma:23341447;HPRD:10706668;ICELLNET:22633458;InnateDB:10706668;LRdb:11;LRdb:23341447;connectomeDB2020:10706668;connectomeDB2020:23341447;scConnect:23341447], CCR7 [Baccin2019:11342595;Baccin2019:9153236;Baccin2019:9507024;CellPhoneDB:24218476;CellTalkDB:24218476;Cellinker:11342595;Cellinker:9153236;Cellinker:9507024;DIP:9153236;DIP:9507024;Guide2Pharma:10512740;Guide2Pharma:16904643;Guide2Pharma:9153236;Guide2Pharma:9507024;HPMR:11342595;HPRD:9153236;ICELLNET:22633458;InnateDB:15546958;InnateDB:9153236;LRdb:10699158;connectomeDB2020:11342595;connectomeDB2020:9153236;connectomeDB2020:9507024;scConnect:10512740;scConnect:16904643;scConnect:9153236;scConnect:9507024], CCRL2 [Baccin2019:20002784;CellTalkDB:20002784;Cellinker:20002784;Guide2Pharma:20002784;ICELLNET:22633458;InnateDB:20002784;LRdb:20002784;connectomeDB2020:20002784;scConnect:20002784], CXCR3 [Baccin2019:9660793;CellTalkDB:9660793;Cellinker:9660793;Guide2Pharma:9660793;LRdb:9660793;connectomeDB2020:9660793;scConnect:9660793], CCR10 [Baccin2019:10706668;CellTalkDB:10706668;Cellinker:10706668;HPRD:10706668;InnateDB:10706668;LRdb:10706668;connectomeDB2020:10706668], GRM7 [CellTalkDB:32196115], ACKR2 [CellTalkDB:10706668;Cellinker:10706668;HPRD:10706668;LRdb:10706668;connectomeDB2020:10706668], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR10 chemokine receptor binding [GO:0031735]; CCR7 chemokine receptor binding [GO:0031732]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; chemokine receptor binding [GO:0042379]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell communication [GO:0007154]; cell maturation [GO:0048469]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; chemokine-mediated signaling pathway [GO:0070098]; dendritic cell chemotaxis [GO:0002407]; establishment of T cell polarity [GO:0001768]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; immunological synapse formation [GO:0001771]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; mature conventional dendritic cell differentiation [GO:0097029]; monocyte chemotaxis [GO:0002548]; myeloid dendritic cell chemotaxis [GO:0002408]; negative regulation of dendritic cell apoptotic process [GO:2000669]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell motility [GO:2000147]; positive regulation of chemotaxis [GO:0050921]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of dendritic cell dendrite assembly [GO:2000549]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell projection assembly [GO:0060491]; release of sequestered calcium ion into cytosol [GO:0051209]; response to nitric oxide [GO:0071731]; response to prostaglandin E [GO:0034695]; response to virus [GO:0009615]; T cell costimulation [GO:0031295]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL19&keywords=CCL19	0.34	560	NA	NA	0.04	739	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	650
IL21	interleukin 21	Yes		ENSG00000138684	Q9HBE4	IL-15/IL-21 family	17	ligand	extracellular, ligand, secreted	P24394, P31785, Q9HBE5	IL21R, IL21R_IL2RG, IL2RG, IL4R	IL21R [Baccin2019:1141862311418620;CellTalkDB:11418623;HPMR:11418623;HPRD:11418623;LRdb:11418623;SIGNOR:16424177;SignaLink3:11418623;SignaLink3:16424177;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:11418623], IL2RG [Baccin2019:11418623;CellTalkDB:11418623;HPMR:11418623;InnateDB:11418623;LRdb:11418623;SIGNOR:11418623;connectomeDB2020:11418623], IL4R [Cellinker:21058223]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; interleukin-2 receptor binding [GO:0005134]	cell maturation [GO:0048469]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; germinal center B cell differentiation [GO:0002314]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production [GO:0001819]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tissue remodeling [GO:0034105]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; signal transduction [GO:0007165]; T follicular helper cell differentiation [GO:0061470]; tyrosine phosphorylation of STAT protein [GO:0007260]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL21&keywords=IL21	0.00	888	NA	NA	0.32	454	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	671
IL17F	interleukin 17F	Yes		ENSG00000112116	Q96PD4	IL-17 family	17	ligand	extracellular, ligand, secreted	Q8NAC3, Q96F46	IL17RA, IL17RA_IL17RC, IL17RC	IL17RC [CellTalkDB:28827714;InnateDB:17911633;InnateDB:18684971;InnateDB:19838198], IL17RA [CellTalkDB:18684971;InnateDB:18684971;InnateDB:19838198;LRdb:18684971;Ramilowski2015:18684971;connectomeDB2020:18684971;talklr:18684971]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; cytokine binding [GO:0019955]; cytokine receptor binding [GO:0005126]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	adaptive immune response [GO:0002250]; cartilage development [GO:0051216]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-17-mediated signaling pathway [GO:0097400]; negative regulation of angiogenesis [GO:0016525]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000340]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lymphotoxin A production [GO:0032761]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of granulocyte macrophage colony-stimulating factor production [GO:0032645]; regulation of interleukin-2 production [GO:0032663]; regulation of interleukin-6 production [GO:0032675]; regulation of interleukin-8 production [GO:0032677]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL17F&keywords=IL17F	0.00	895	NA	NA	0.32	457	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	676
CCL16	C-C motif chemokine ligand 16	Yes		ENSG00000275095, ENSG00000275152	O15467	Intercrine beta (chemokine CC) family	17	ligand	extracellular, intracellular, ligand, secreted	P08913, P32246, P32302, P41597, P48039, P51681, P51685, Q14831, Q16570, Q9H3N8	ACKR1, ADRA2A, CCR1, CCR2, CCR5, CCR8, CXCR5, GRM7, HRH4, MTNR1A	CCR2 [CellPhoneDB:24218476;CellTalkDB:11470772;Cellinker:11470772;DIP:11470772;HPRD:11470772;ICELLNET:22633458;InnateDB:11470772;LRdb:11470772;connectomeDB2020:11470772], CCR5 [CellTalkDB:11470772;Cellinker:11470772;HPRD:11470772;ICELLNET:22633458;InnateDB:11470772;LRdb:11470772;connectomeDB2020:11470772], HRH4 [CellTalkDB:15265943;Cellinker:15265943;Guide2Pharma:15265943;HPRD:15265943;ICELLNET:15265943;LRdb:15265943;connectomeDB2020:15265943;scConnect:15265943], CCR1 [CellPhoneDB:24218476;CellTalkDB:11470772;Cellinker:10910894;Cellinker:11470772;DIP:10910894;DIP:11470772;HPRD:10910894;HPRD:11470772;ICELLNET:22633458;InnateDB:11470772;LRdb:11;LRdb:11470772;connectomeDB2020:10910894;connectomeDB2020:11470772], CCR8 [CellTalkDB:10910894;Cellinker:10910894;DIP:10910894;HPRD:10910894;ICELLNET:22633458;LRdb:10910894;connectomeDB2020:10910894], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], ACKR1 [CellChatDB:26740381;Cellinker:26740381], CXCR5 [DIP:11470772]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR chemokine receptor binding [GO:0048020]; chemoattractant activity [GO:0042056]; chemokine activity [GO:0008009]	cell-cell signaling [GO:0007267]; cell communication [GO:0007154]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL16&keywords=CCL16	0.09	682	NA	NA	0.06	697	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	690
IFNG	interferon gamma	Yes		ENSG00000111537	P01579	Type II (or gamma) interferon family	17	ligand	extracellular, intracellular, ligand, secreted, transmembrane	P01375, P15260, P28062, P28065, P38484, P40238, P40306, Q06323, Q9UL46	IFNG_IFNGR1, IFNGR1, IFNGR1_IFNGR2, IFNGR2, MPL, PSMB10, PSMB8, PSMB9, PSME1, PSME2, TNF	IFNGR1 [Baccin2019:10811850;Baccin2019:10986460;Baccin2019:11250200;Baccin2019:12165521;BioGRID:10986460;CellTalkDB:10811850;DIP:10860730;DIP:7617032;HPMR:10811850;HPMR:12438563;HPRD:10986460;HPRD:11250200;HPRD:12165521;InnateDB:10986460;InnateDB:7673114;IntAct:11250200;IntAct:7617032;LRdb:10811850;LRdb:10986460;LRdb:11250200;LRdb:12165521;Lit-BM-17:10860730;Lit-BM-17:10986460;Lit-BM-17:11250200;Lit-BM-17:7617032;Lit-BM-17:7673114;Macrophage:7617032;SIGNOR:10986460;SIGNOR:12438563;SIGNOR:23898330;SPIKE:16110316;SignaLink3:10986460;SignaLink3:11250200;SignaLink3:12165521;SignaLink3:12438563;SignaLink3:12915721;SignaLink3:1396683;SignaLink3:15143187;SignaLink3:15530433;SignaLink3:16237089;SignaLink3:16467876;SignaLink3:18591661;SignaLink3:18988627;SignaLink3:20304997;SignaLink3:23331499;SignaLink3:29145629;SignaLink3:7510216;SignaLink3:7514165;SignaLink3:7615558;SignaLink3:7617032;SignaLink3:7673114;SignaLink3:8550631;SignaLink3:8631301;SignaLink3:9111318;connectomeDB2020:10811850;connectomeDB2020:10986460;connectomeDB2020:11250200;connectomeDB2020:12165521], IFNGR2 [CellTalkDB:10811850;HPMR:10811850;HPMR:12438563;HPRD:7673114;InnateDB:7673114;LRdb:10811850;LRdb:77;SIGNOR:7673114;SignaLink3:10986460;SignaLink3:12438563;SignaLink3:12915721;SignaLink3:1396683;SignaLink3:15143187;SignaLink3:15530433;SignaLink3:16237089;SignaLink3:16467876;SignaLink3:18591661;SignaLink3:18988627;SignaLink3:20304997;SignaLink3:23331499;SignaLink3:29145629;SignaLink3:7510216;SignaLink3:7514165;SignaLink3:7615558;SignaLink3:7617032;SignaLink3:7673114;SignaLink3:8550631;SignaLink3:8631301;SignaLink3:9111318;connectomeDB2020:10811850;connectomeDB2020:7673114], PSME1 [Macrophage:8051173], PSME2 [Macrophage:8051173], PSMB8 [Macrophage:8811196], PSMB9 [Macrophage:8811196], PSMB10 [Macrophage:8811196], MPL [Cellinker:30803992], TNF [HPRD:3139842]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; interferon-gamma receptor binding [GO:0005133]	adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; astrocyte activation [GO:0048143]; cell surface receptor signaling pathway [GO:0007166]; defense response to virus [GO:0051607]; extrinsic apoptotic signaling pathway [GO:0097191]; humoral immune response [GO:0006959]; interferon-gamma-mediated signaling pathway [GO:0060333]; macrophage activation involved in immune response [GO:0002281]; macrophage differentiation [GO:0030225]; microglial cell activation [GO:0001774]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of gene expression [GO:0010629]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of tau-protein kinase activity [GO:1902948]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroinflammatory response [GO:0150076]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of autophagy [GO:0010508]; positive regulation of calcidiol 1-monooxygenase activity [GO:0060559]; positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response [GO:0032834]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular respiration [GO:1901857]; positive regulation of chemokine production [GO:0032722]; positive regulation of core promoter binding [GO:1904798]; positive regulation of cytokine production [GO:0001819]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity [GO:0060550]; positive regulation of fructose 1,6-bisphosphate metabolic process [GO:0060552]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of iron ion import across plasma membrane [GO:1904440]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron death [GO:1901216]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of nitrogen compound metabolic process [GO:0051173]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; positive regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000309]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vitamin D biosynthetic process [GO:0060557]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of growth [GO:0040008]; regulation of insulin secretion [GO:0050796]; regulation of protein ADP-ribosylation [GO:0010835]; response to virus [GO:0009615]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNG&keywords=IFNG	0.01	827	NA	NA	0.15	576	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	702
GDF7	growth differentiation factor 7	Yes		ENSG00000143869	Q7Z4P5	TGF-beta family	17	ligand	ligand, secreted	O00238, P27037, P36894, P36896, P36897, Q13705, Q13873, Q8NER5	ACVR1B, ACVR1C, ACVR2A, ACVR2A_BMPR1A, ACVR2A_BMPR1B, ACVR2B, ACVR2B_BMPR1A, ACVR2B_BMPR1B, BMPR1A, BMPR1A_BMPR2, BMPR1B, BMPR1B_BMPR2, BMPR2, TGFBR1	BMPR1B [NA], ACVR2A [Baccin2019:16049014;CellTalkDB:16049014;LRdb:16049014;connectomeDB2020:16049014], BMPR1A [Baccin2019:16049014;CellTalkDB:16049014;LRdb:16049014;connectomeDB2020:16049014], ACVR1B [NA], TGFBR1 [NA], ACVR2B [NA], BMPR2 [Baccin2019:16049014;CellTalkDB:16049014;LRdb:16049014;connectomeDB2020:16049014], ACVR1C [NA]	extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]	activin receptor signaling pathway [GO:0032924]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching morphogenesis of an epithelial tube [GO:0048754]; cell fate commitment [GO:0045165]; epithelial cell differentiation [GO:0030855]; forebrain morphogenesis [GO:0048853]; gland morphogenesis [GO:0022612]; midbrain development [GO:0030901]; morphogenesis of an epithelial fold [GO:0060571]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of tendon cell differentiation [GO:2001051]; positive regulation of transcription, DNA-templated [GO:0045893]; reproductive structure development [GO:0048608]; roof plate formation [GO:0021509]; SMAD protein signal transduction [GO:0060395]; spinal cord association neuron differentiation [GO:0021527]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GDF7&keywords=GDF7	0.09	684	NA	NA	0.03	755	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	720
XCL2	X-C motif chemokine ligand 2	Yes		ENSG00000143185	Q9UBD3	Intercrine gamma family	17	ligand	intracellular, ligand, secreted	P46094	XCR1	XCR1 [CellTalkDB:10699158;Cellinker:19556286;Cellinker:9632725;Guide2Pharma:25497737;HPRD:9632725;ICELLNET:22633458;LRdb:10699158;connectomeDB2020:9632725;scConnect:25497737]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]	blood circulation [GO:0008015]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of T cell chemotaxis [GO:0010820]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=XCL2&keywords=XCL2	0.02	789	NA	NA	0.05	717	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	753
CCL14	C-C motif chemokine ligand 14	Yes		ENSG00000277236, ENSG00000276409	Q16627	Intercrine beta (chemokine CC) family	17	ligand	extracellular, intracellular, ligand, secreted	O00590, P32246, P51677, P51681, Q16570	ACKR1, ACKR2, CCR1, CCR3, CCR5	CCR1 [CellPhoneDB:24218476;CellTalkDB:24218476;Cellinker:11085751;Cellinker:12381680;Cellinker:20483925;Cellinker:9687537;DIP:9687537;Guide2Pharma:12381680;HPRD:11085751;ICELLNET:22633458;InnateDB:12381680;InnateDB:15905581;InnateDB:9346309;InnateDB:9548457;LRdb:9405404;connectomeDB2020:11085751;connectomeDB2020:12381680;connectomeDB2020:9687537;scConnect:12381680], CCR5 [CellTalkDB:11085751;Cellinker:11085751;Cellinker:12964882;Cellinker:16298345;Cellinker:20483925;Guide2Pharma:16298345;HPRD:11085751;ICELLNET:22633458;LRdb:11085751;LRdb:12964882;LRdb:16298345;connectomeDB2020:11085751;connectomeDB2020:12964882;connectomeDB2020:16298345;scConnect:16298345], ACKR1 [CellChatDB:26740381;CellTalkDB:9405404;Cellinker:26740381;Cellinker:29637711;ICELLNET:22633458;LRdb:9405404], ACKR2 [CellChatDB:26740381;CellPhoneDB:24218476;CellTalkDB:9660793;Cellinker:26740381;Cellinker:9405404;HPRD:9405404;ICELLNET:22633458;InnateDB:9405404;LRdb:9660793;connectomeDB2020:9405404], CCR3 [CellPhoneDB:24218476;CellTalkDB:11085751;Cellinker:11085751;HPRD:11085751;InnateDB:9346309;InnateDB:9548457;LRdb:11085751;connectomeDB2020:11085751]	extracellular space [GO:0005615]	CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]	cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL14&keywords=CCL14	0.13	652	NA	NA	0.01	857	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	755
GDF5	growth differentiation factor 5	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000125965	P43026	TGF-beta family	17	cell_surface_ligand, ligand	cell_surface_ligand, extracellular, ligand, plasma_membrane, secreted, transmembrane	O00238, P27037, P36894, Q01974, Q04771, Q13705, Q13873, Q9UHF7	ACVR1, ACVR2A, ACVR2A_BMPR1A, ACVR2A_BMPR1B, ACVR2B, ACVR2B_BMPR1A, ACVR2B_BMPR1B, BMPR1A, BMPR1A_BMPR2, BMPR1B, BMPR1B_BMPR2, BMPR2, ROR2, TRPS1	BMPR2 [Baccin2019:87029149525338;CellTalkDB:8702914;HPRD:9525338;InnateDB:18342887;LRdb:8702914;LRdb:953;Lit-BM-17:19229295;Lit-BM-17:9525338;SignaLink3:16446785;SignaLink3:18342887;SignaLink3:23180781;SignaLink3:23331499;SignaLink3:9525338;connectomeDB2020:8702914;connectomeDB2020:9525338], ACVR2B [Baccin2019:8702914;CellTalkDB:8702914;HPRD:8702914;LRdb:8702914;SignaLink3:16446785;SignaLink3:23331499;SignaLink3:8702914;connectomeDB2020:8702914], BMPR1B [Baccin2019:11282024;Baccin2019:15569154;Baccin2019:8702914;CellTalkDB:11282024;HPMR:15569154;HPRD:11282024;IntAct:16127465;IntAct:19229295;LRdb:11282024;LRdb:15569154;LRdb:8702914;Lit-BM-17:19229295;Lit-BM-17:9525338;SIGNOR:15890363;connectomeDB2020:11282024;connectomeDB2020:15569154;connectomeDB2020:8702914], TRPS1 [SIGNOR:18363966], ROR2 [Baccin2019:15569154;Cellinker:15569154;HPMR:15569154;LRdb:15569154;connectomeDB2020:15569154], ACVR2A [Baccin2019:8702914;CellTalkDB:8702914;HPRD:8702914;LRdb:8702914;connectomeDB2020:8702914], ACVR1 [Baccin2019:8702914;CellTalkDB:8702914;HPRD:8702914;LRdb:8702914;connectomeDB2020:8702914], BMPR1A [Baccin2019:11282024;Baccin2019:9525338;CellTalkDB:11282024;HPRD:11282024;HPRD:9525338;IntAct:16127465;IntAct:19229295;IntAct:21543859;LRdb:11282024;LRdb:95;Lit-BM-17:19229295;Lit-BM-17:9525338;connectomeDB2020:9525338]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	BMP binding [GO:0036122]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]	BMP signaling pathway [GO:0030509]; cell-cell signaling [GO:0007267]; chondroblast differentiation [GO:0060591]; embryonic limb morphogenesis [GO:0030326]; forelimb morphogenesis [GO:0035136]; hindlimb morphogenesis [GO:0035137]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of neuron apoptotic process [GO:0043524]; ossification involved in bone remodeling [GO:0043932]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of multicellular organism growth [GO:0040014]; regulation of SMAD protein signal transduction [GO:0060390]; response to mechanical stimulus [GO:0009612]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GDF5&keywords=GDF5	0.01	813	NA	NA	0.05	715	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	764
FGF4	fibroblast growth factor 4	Yes		ENSG00000075388	P08620	Heparin-binding growth factors family	17	ligand	extracellular, intracellular, ligand, secreted	O14786, P11362, P21802, P22455, P22607, Q8N441	FGFR1, FGFR2, FGFR3, FGFR4, FGFRL1, NRP1	FGFR2 [Baccin2019:114860338663044;CellTalkDB:16597617;Cellinker:11486033;Cellinker:16597617;Cellinker:25772309;Cellinker:8663044;HPRD:8663044;LRdb:16597617;SIGNOR:8663044;SignaLink3:23331499;SignaLink3:8663044;connectomeDB2020:11486033;connectomeDB2020:8663044], FGFR4 [Baccin2019:114860338663044;CellTalkDB:16597617;Cellinker:11486033;Cellinker:25772309;Cellinker:8663044;HPMR:11486033;HPRD:8663044;LRdb:16597617;SIGNOR:1385111;connectomeDB2020:11486033;connectomeDB2020:8663044], FGFR1 [Baccin2019:1148603311486030;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;HPRD:11486033;LRdb:16597617;connectomeDB2020:11486033], FGFR3 [Baccin2019:114860338663044;CellTalkDB:16597617;Cellinker:11486033;Cellinker:16597617;Cellinker:25772309;Cellinker:8663044;DIP:9045692;HPRD:8663044;LRdb:16597617;connectomeDB2020:11486033;connectomeDB2020:8663044], NRP1 [Baccin2019:15695515;CellTalkDB:16597617;Cellinker:15695515;HPRD:15695515;LRdb:15695515;connectomeDB2020:15695515], FGFRL1 [connectomeDB2020:19920134]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]	animal organ morphogenesis [GO:0009887]; apoptotic process involved in morphogenesis [GO:0060561]; cartilage condensation [GO:0001502]; cell-cell signaling [GO:0007267]; cell differentiation [GO:0030154]; cellular response to leukemia inhibitory factor [GO:1990830]; chondroblast differentiation [GO:0060591]; cranial suture morphogenesis [GO:0060363]; embryonic hindlimb morphogenesis [GO:0035116]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mesenchymal cell proliferation [GO:0010463]; negative regulation of apoptotic process [GO:0043066]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell migration [GO:0030334]; regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000544]; signal transduction [GO:0007165]; stem cell population maintenance [GO:0019827]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF4&keywords=FGF4	0.00	893	NA	NA	0.07	673	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	783
WNT1	Wnt family member 1	Yes		ENSG00000125084	P04628	Wnt family	17	adhesion, ecm, ligand	adhesion, ecm, extracellular, intracellular, ligand, matrix_adhesion, secreted	O00144, O60353, O75084, O75197, O75581, P16671, P34925, P46531, P48436, P52951, P56178, P78504, Q01974, Q02962, Q06710, Q13467, Q14332, Q14469, Q6ZQN5, Q9H461, Q9NPG1, Q9ULV1, Q9ULW2, Q9UP38	CD36, DLX5, FOXI2, FZD1, FZD1_LRP5, FZD1_LRP6, FZD10, FZD10_LRP5, FZD10_LRP6, FZD2, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4, FZD4_LRP5, FZD4_LRP6, FZD5, FZD5_LRP5, FZD5_LRP6, FZD6, FZD6_LRP5, FZD6_LRP6, FZD7, FZD7_LRP5, FZD7_LRP6, FZD8, FZD8_LRP5, FZD8_LRP6, FZD9, FZD9_LRP5, FZD9_LRP6, GBX2, HES1, JAG1, LRP5, LRP6, NOTCH1, PAX2, PAX8, ROR2, RYK, SOX9	FOXI2 [SPIKE:18495817], JAG1 [SPIKE:18495817], NOTCH1 [SPIKE:18495817], DLX5 [SPIKE:18495817], GBX2 [SPIKE:18495817], PAX2 [SPIKE:18495817], PAX8 [SPIKE:18495817], HES1 [SPIKE:18495817], SOX9 [SPIKE:18495817], LRP6 [Baccin2019:11029007;Baccin2019:11448771;CancerCellMap:11029007;CancerCellMap:11448771;CellTalkDB:11029007;HPRD:11029007;HPRD:11448771;LRdb:11;LRdb:11029007;NetPath:11029007;ProtMapper:29444668;SIGNOR:21078818;SignaLink3:11029007;SignaLink3:11448771;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:11029007;connectomeDB2020:11448771], RYK [Baccin2019:1545408415454080;CellTalkDB:15454084;Cellinker:15454084;HPMR:15454084;HPRD:15454084;LRdb:15454084;NetPath:15454084;SIGNOR:15454084;SignaLink3:15454084;SignaLink3:23331499;connectomeDB2020:15454084], FZD8 [Baccin2019:1545408415454080;CellTalkDB:15454084;HPMR:15454084;HPRD:15454084;LRdb:15454084;NetPath:15454084;SIGNOR:11448771;connectomeDB2020:15454084], FZD3 [Baccin2019:14642436;CellTalkDB:14642436;HPMR:14642436;LRdb:14642436;SIGNOR:15578921;connectomeDB2020:14642436], FZD6 [SIGNOR:22944199], LRP5 [Baccin2019:11336703;CellTalkDB:11336703;HPRD:11336703;LRdb:11336703;NetPath:11336703;SIGNOR:15578921;SIGNOR:21078818], FZD1 [CancerCellMap:10557084;CellPhoneDB:24032637;CellTalkDB:24032637;NetPath:10557084;SIGNOR:15578921;SIGNOR:16936075;SIGNOR:22944199;connectomeDB2020:24032637], ROR2 [CellTalkDB:15388793;NetPath:18762249;connectomeDB2020:15388793], FZD9 [Baccin2019:91476519147651;CellTalkDB:9147651;HPMR:9147651;HPRD:9147651;LRdb:9147651;connectomeDB2020:9147651], FZD5 [CellTalkDB:32196115], FZD7 [CellTalkDB:32196115], FZD10 [connectomeDB2020:24599775], FZD2 [connectomeDB2020:28733458], FZD4 [connectomeDB2020:28733458], CD36 [InnateDB:25721714]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; morphogen activity [GO:0016015]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]	animal organ regeneration [GO:0031100]; astrocyte-dopaminergic neuron signaling [GO:0036520]; bone development [GO:0060348]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; cell-cell signaling [GO:0007267]; cell fate commitment [GO:0045165]; cell proliferation in midbrain [GO:0033278]; cellular response to peptide hormone stimulus [GO:0071375]; central nervous system morphogenesis [GO:0021551]; cerebellum formation [GO:0021588]; diencephalon development [GO:0021536]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; forebrain anterior/posterior pattern specification [GO:0021797]; hematopoietic stem cell proliferation [GO:0071425]; hepatocyte differentiation [GO:0070365]; inner ear morphogenesis [GO:0042472]; midbrain development [GO:0030901]; midbrain-hindbrain boundary maturation during brain development [GO:0022004]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell aging [GO:0090344]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neuron differentiation [GO:0030182]; neuron fate determination [GO:0048664]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dermatome development [GO:0061184]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to wounding [GO:0009611]; signal transduction in response to DNA damage [GO:0042770]; Spemann organizer formation [GO:0060061]; spinal cord association neuron differentiation [GO:0021527]; T cell differentiation in thymus [GO:0033077]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT1&keywords=WNT1	0.00	859	NA	NA	0.04	744	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	802
CCL23	C-C motif chemokine ligand 23	Yes		ENSG00000276114, ENSG00000274736	P55773	Intercrine beta (chemokine CC) family	17	ligand	extracellular, intracellular, ligand, secreted	O00590, P08913, P25090, P32246, P48039, Q14831	ACKR2, ADRA2A, CCR1, FPR2, GRM7, MTNR1A	CCR1 [CellPhoneDB:24218476;CellTalkDB:10699158;Cellinker:10660125;Cellinker:12381680;Cellinker:9558365;Cellinker:9886417;Guide2Pharma:12381680;HPRD:10660125;HPRD:9558365;HPRD:9886417;ICELLNET:22633458;LRdb:10699158;connectomeDB2020:10660125;connectomeDB2020:12381680;connectomeDB2020:9558365;connectomeDB2020:9886417;scConnect:12381680], ACKR2 [CellTalkDB:10699158;ICELLNET:22633458;LRdb:10699158], FPR2 [Cellinker:29637711;ICELLNET:22633458], ADRA2A [NA], GRM7 [NA], MTNR1A [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR1 chemokine receptor binding [GO:0031726]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; heparin binding [GO:0008201]	cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; negative regulation of C-C chemokine binding [GO:2001264]; negative regulation of cell population proliferation [GO:0008285]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL23&keywords=CCL23	0.02	800	NA	NA	0.01	851	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	826
FGF3	fibroblast growth factor 3	Yes		ENSG00000186895	P11487	Heparin-binding growth factors family	17	ligand	extracellular, intracellular, ligand, secreted, transmembrane	P11362, P21802, P22455, P22607, Q12951, Q8N441	FGFR1, FGFR2, FGFR3, FGFR4, FGFRL1, FOXI1	FOXI1 [SPIKE:12702667], FGFR2 [Baccin2019:75926248663044;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;Cellinker:7592624;Cellinker:8663044;DIP:8663044;HPRD:8663044;LRdb:16597617;SIGNOR:8663044;SignaLink3:23331499;SignaLink3:8663044;connectomeDB2020:7592624;connectomeDB2020:8663044], FGFR1 [Baccin2019:75926248663044;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;Cellinker:7592624;Cellinker:8663044;HPRD:8663044;LRdb:16597617;connectomeDB2020:7592624;connectomeDB2020:8663044], FGFR3 [Baccin2019:8663044;CellTalkDB:8663044;Cellinker:8663044;HPRD:8663044;LRdb:8663044;connectomeDB2020:8663044], FGFR4 [Baccin2019:8663044;CellTalkDB:8663044;Cellinker:8663044;HPRD:8663044;LRdb:8663044;connectomeDB2020:8663044], FGFRL1 [connectomeDB2020:19920134]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]	anatomical structure morphogenesis [GO:0009653]; animal organ morphogenesis [GO:0009887]; cell-cell signaling [GO:0007267]; cell differentiation [GO:0030154]; fibroblast growth factor receptor signaling pathway [GO:0008543]; negative regulation of cardiac muscle tissue development [GO:0055026]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF3&keywords=FGF3	0.00	894	NA	NA	0.01	825	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	860
AGT	angiotensinogen	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000135744	P01019	Serpin family	16	ligand, receptor	ecm_regulator, extracellular, intracellular, ligand, receptor, secreted	P00797, P04201, P08913, P30556, P48039, P50052, P98164, Q07075, Q14831	ADRA2A, AGTR1, AGTR2, ENPEP, GRM7, LRP2, MAS1, MTNR1A, REN	AGTR1 [CellTalkDB:10993080;Guide2Pharma:10193788;Guide2Pharma:12006574;Guide2Pharma:21464395;HPRD:15930094;LRdb:10193788;LRdb:10993080;LRdb:12006574;LRdb:15930094;LRdb:21464395;SIGNOR:16597412;SIGNOR:17346243;connectomeDB2020:10193788;connectomeDB2020:10993080;connectomeDB2020:12006574;connectomeDB2020:15930094;connectomeDB2020:21464395;scConnect:10193788;scConnect:12006574;scConnect:21464395], AGTR2 [Baccin2019:17138938;Baccin2019:21464395;Baccin2019:2775266;Baccin2019:7850406;Baccin2019:8185599;Baccin2019:8242249;Baccin2019:8315512;CellTalkDB:17138938;Guide2Pharma:21542804;Guide2Pharma:2775266;Guide2Pharma:7850406;Guide2Pharma:8242249;HPRD:8185599;LRdb:17138938;LRdb:21464395;LRdb:2775266;LRdb:7850406;LRdb:8185599;LRdb:8242249;LRdb:8315512;connectomeDB2020:17138938;connectomeDB2020:21464395;connectomeDB2020:2775266;connectomeDB2020:7850406;connectomeDB2020:8185599;connectomeDB2020:8242249;connectomeDB2020:8315512;scConnect:17138938;scConnect:21464395;scConnect:21542804;scConnect:2775266;scConnect:7850406;scConnect:8242249], REN [DIP:20927107;InnateDB:20927107;Lit-BM-17:12045255;Lit-BM-17:20927107;SIGNOR:32201502], MAS1 [Baccin2019:1282979212829790;Cellinker:12829792;HPMR:12829792;HPRD:12829792;LRdb:12829792;connectomeDB2020:12829792], LRP2 [Baccin2019:15467006;CellTalkDB:15467006;Cellinker:15467006;HPMR:15467006;LRdb:15467006;connectomeDB2020:15467006], ENPEP [CellTalkDB:29900035;HPRD:1756856;LRdb:29900035], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115]	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	growth factor activity [GO:0008083]; hormone activity [GO:0005179]; receptor ligand activity [GO:0048018]; serine-type endopeptidase inhibitor activity [GO:0004867]; sodium channel regulator activity [GO:0017080]; superoxide-generating NADPH oxidase activator activity [GO:0016176]; type 1 angiotensin receptor binding [GO:0031702]; type 2 angiotensin receptor binding [GO:0031703]	activation of phospholipase C activity [GO:0007202]; aging [GO:0007568]; angiotensin-activated signaling pathway [GO:0038166]; angiotensin-mediated drinking behavior [GO:0003051]; artery smooth muscle contraction [GO:0014824]; associative learning [GO:0008306]; blood vessel remodeling [GO:0001974]; cell-cell signaling [GO:0007267]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell surface receptor signaling pathway [GO:0007166]; cellular response to angiotensin [GO:1904385]; cellular response to mechanical stimulus [GO:0071260]; cellular sodium ion homeostasis [GO:0006883]; ERK1 and ERK2 cascade [GO:0070371]; female pregnancy [GO:0007565]; fibroblast proliferation [GO:0048144]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger [GO:0007199]; kidney development [GO:0001822]; low-density lipoprotein particle remodeling [GO:0034374]; maintenance of blood vessel diameter homeostasis by renin-angiotensin [GO:0002034]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of gene expression [GO:0010629]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neurotrophin TRK receptor signaling pathway [GO:0051387]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of tissue remodeling [GO:0034104]; nitric oxide mediated signal transduction [GO:0007263]; operant conditioning [GO:0035106]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of blood pressure [GO:0045777]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of cholesterol esterification [GO:0010873]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of extracellular matrix constituent secretion [GO:0003331]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of inflammatory response [GO:0050729]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of L-arginine import across plasma membrane [GO:1905589]; positive regulation of L-lysine import across plasma membrane [GO:1905010]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of membrane hyperpolarization [GO:1902632]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein import into nucleus [GO:0006606]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of blood volume by renin-angiotensin [GO:0002016]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac conduction [GO:1903779]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]; regulation of extracellular matrix assembly [GO:1901201]; regulation of heart rate [GO:0002027]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of norepinephrine secretion [GO:0014061]; regulation of renal output by angiotensin [GO:0002019]; regulation of renal sodium excretion [GO:0035813]; regulation of transmission of nerve impulse [GO:0051969]; regulation of vasoconstriction [GO:0019229]; renal system process [GO:0003014]; renin-angiotensin regulation of aldosterone production [GO:0002018]; response to estradiol [GO:0032355]; response to muscle activity involved in regulation of muscle adaptation [GO:0014873]; smooth muscle cell proliferation [GO:0048659]; stress-activated MAPK cascade [GO:0051403]; uterine smooth muscle contraction [GO:0070471]; vasodilation [GO:0042311]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=AGT&keywords=AGT	NA	NA	2691.67	121	NA	NA	0.00	0.09	0.01	0.02	0.04	0.20	0.18	0.13	0.13	0.20	0.15	103	75	84	0.11	1.20	1.82	1.40	86	25	40	74
GCG	glucagon	Yes		ENSG00000115263	P01275	Glucagon family	16	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, O95838, P07550, P13945, P16473, P27487, P32241, P41586, P43220, P47871, P48546, Q03431, Q12884, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, DPP4, FAP, GCGR, GIPR, GLP1R, GLP2R, GPR20, GPR84, PTH1R, RAMP2, RAMP3, TSHR, VIPR1	GLP1R [Baccin2019:11116211;Baccin2019:15528268;Baccin2019:7937318;Baccin2019:8404634;BioGRID:11116211;BioGRID:18248821;CellTalkDB:11116211;Cellinker:11116211;Cellinker:15528268;Cellinker:7937318;Cellinker:8404634;Guide2Pharma:15528268;Guide2Pharma:8404634;HPMR:8404634;HPRD:11116211;LRdb:11116211;LRdb:15528268;LRdb:7937318;LRdb:8404634;SIGNOR:7937318;connectomeDB2020:11116211;connectomeDB2020:15528268;connectomeDB2020:7937318;connectomeDB2020:8404634;scConnect:15528268;scConnect:8404634], GLP2R [CellTalkDB:9990065;Cellinker:11738243;Cellinker:24990862;Cellinker:9990065;Guide2Pharma:11738243;HPMR:9990065;HPRD:11738243;LRdb:117;LRdb:9990065;connectomeDB2020:11738243;connectomeDB2020:9990065;scConnect:11738243], GCGR [CellTalkDB:12529935;Cellinker:12529935;Cellinker:4305077;Cellinker:8382034;Guide2Pharma:4305077;HPMR:12529935;HPRD:8382034;LRdb:12529935;LRdb:4305077;LRdb:8382034;SIGNOR:12529935;SIGNOR:22863277;connectomeDB2020:12529935;connectomeDB2020:4305077;connectomeDB2020:8382034;scConnect:4305077], ADCYAP1R1 [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], RAMP3 [CellTalkDB:19886671], RAMP2 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], DPP4 [CellTalkDB:16517403;Cellinker:15655705;Cellinker:21314817], GPR20 [CellTalkDB:32196115], GIPR [DIP:17715056;Lit-BM-17:17715056], FAP [Cellinker:21314817]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule lumen [GO:0034774]	gastric inhibitory polypeptide receptor binding [GO:0031767]; glucagon receptor binding [GO:0031769]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; feeding behavior [GO:0007631]; glucose homeostasis [GO:0042593]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of apoptotic process [GO:0043066]; negative regulation of execution phase of apoptosis [GO:1900118]; positive regulation of calcium ion import [GO:0090280]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; protein kinase A signaling [GO:0010737]; regulation of insulin secretion [GO:0050796]; response to activity [GO:0014823]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GCG&keywords=GCG	60559.67	1	626838	2	9682.06	3	4.43	12.64	1.63	10.38	3.38	51.11	223.30	148.57	6.65	3.54	321.59	7	11	2	71.57	0.09	0.05	4.49	479	498	4	103
SST	somatostatin	Yes		ENSG00000157005	P61278	Somatostatin family	16	ligand	extracellular, ligand, secreted	P08913, P30872, P30874, P31391, P32745, P35346, P48039, Q14831, Q96LB1	ADRA2A, GRM7, MRGPRX2, MTNR1A, SSTR1, SSTR2, SSTR3, SSTR4, SSTR5	SSTR1 [Baccin2019:10598788;Baccin2019:11520208;Baccin2019:1346068;Baccin2019:15333679;Baccin2019:7988476;Baccin2019:8769372;Baccin2019:9600011;Baccin2019:9650799;Baccin2019:9724791;Baccin2019:9784130;CellTalkDB:9784130;Cellinker:10598788;Cellinker:11520208;Cellinker:1346068;Cellinker:15333679;Cellinker:7988476;Cellinker:8769372;Cellinker:9600011;Cellinker:9650799;Cellinker:9724791;Cellinker:9784130;Guide2Pharma:10598788;Guide2Pharma:11520208;Guide2Pharma:15333679;Guide2Pharma:7988476;Guide2Pharma:8769372;Guide2Pharma:9600011;Guide2Pharma:9650799;Guide2Pharma:9724791;Guide2Pharma:9784130;HPRD:1346068;LRdb:10598788;LRdb:11520208;LRdb:1346068;LRdb:15333679;LRdb:7988476;LRdb:8769372;LRdb:9600011;LRdb:9650799;LRdb:9724791;LRdb:9784130;connectomeDB2020:10598788;connectomeDB2020:11520208;connectomeDB2020:1346068;connectomeDB2020:15333679;connectomeDB2020:7988476;connectomeDB2020:8769372;connectomeDB2020:9600011;connectomeDB2020:9650799;connectomeDB2020:9724791;connectomeDB2020:9784130;scConnect:10598788;scConnect:11520208;scConnect:15333679;scConnect:7988476;scConnect:8769372;scConnect:9600011;scConnect:9650799;scConnect:9724791;scConnect:9784130], SSTR2 [Baccin2019:10598788;Baccin2019:11520208;Baccin2019:1346068;Baccin2019:15333679;Baccin2019:7988476;Baccin2019:8702767;Baccin2019:8769372;Baccin2019:9650799;Baccin2019:9652348;Baccin2019:9724791;Baccin2019:9784130;CellTalkDB:10598788;Cellinker:10598788;Cellinker:11520208;Cellinker:1346068;Cellinker:15333679;Cellinker:7988476;Cellinker:8702767;Cellinker:8769372;Cellinker:9650799;Cellinker:9652348;Cellinker:9724791;Cellinker:9784130;Guide2Pharma:10598788;Guide2Pharma:11520208;Guide2Pharma:15333679;Guide2Pharma:7988476;Guide2Pharma:8769372;Guide2Pharma:9650799;Guide2Pharma:9652348;Guide2Pharma:9724791;Guide2Pharma:9784130;HPMR:8702767;HPRD:1346068;LRdb:10598788;LRdb:11520208;LRdb:1346068;LRdb:15333679;LRdb:7988476;LRdb:8702767;LRdb:8769372;LRdb:9650799;LRdb:9652348;LRdb:9724791;LRdb:9784130;connectomeDB2020:10598788;connectomeDB2020:11520208;connectomeDB2020:1346068;connectomeDB2020:15333679;connectomeDB2020:7988476;connectomeDB2020:8702767;connectomeDB2020:8769372;connectomeDB2020:9650799;connectomeDB2020:9652348;connectomeDB2020:9724791;connectomeDB2020:9784130;scConnect:10598788;scConnect:11520208;scConnect:15333679;scConnect:7988476;scConnect:8769372;scConnect:9650799;scConnect:9652348;scConnect:9724791;scConnect:9784130], SSTR3 [Baccin2019:10598788;Baccin2019:11520208;Baccin2019:1337145;Baccin2019:15333679;Baccin2019:7988476;Baccin2019:8097479;Baccin2019:8769372;Baccin2019:9600011;Baccin2019:9650799;Baccin2019:9724791;Baccin2019:9784130;CellTalkDB:9784130;Cellinker:10598788;Cellinker:11520208;Cellinker:1337145;Cellinker:15333679;Cellinker:7988476;Cellinker:8097479;Cellinker:8769372;Cellinker:9600011;Cellinker:9650799;Cellinker:9724791;Cellinker:9784130;Guide2Pharma:10598788;Guide2Pharma:11520208;Guide2Pharma:15333679;Guide2Pharma:7988476;Guide2Pharma:8097479;Guide2Pharma:8769372;Guide2Pharma:9600011;Guide2Pharma:9650799;Guide2Pharma:9724791;Guide2Pharma:9784130;HPRD:1337145;LRdb:10598788;LRdb:11520208;LRdb:1337145;LRdb:15333679;LRdb:7988476;LRdb:8097479;LRdb:8769372;LRdb:9600011;LRdb:9650799;LRdb:9724791;LRdb:9784130;connectomeDB2020:10598788;connectomeDB2020:11520208;connectomeDB2020:1337145;connectomeDB2020:15333679;connectomeDB2020:7988476;connectomeDB2020:8097479;connectomeDB2020:8769372;connectomeDB2020:9600011;connectomeDB2020:9650799;connectomeDB2020:9724791;connectomeDB2020:9784130;scConnect:10598788;scConnect:11520208;scConnect:15333679;scConnect:7988476;scConnect:8097479;scConnect:8769372;scConnect:9600011;scConnect:9650799;scConnect:9724791;scConnect:9784130], SSTR4 [Baccin2019:10598788;Baccin2019:11520208;Baccin2019:15333679;Baccin2019:7988476;Baccin2019:8100352;Baccin2019:8769372;Baccin2019:9600011;Baccin2019:9650799;Baccin2019:9724791;Baccin2019:9784130;CellTalkDB:9784130;Cellinker:10598788;Cellinker:11520208;Cellinker:15333679;Cellinker:7988476;Cellinker:8100352;Cellinker:8769372;Cellinker:9600011;Cellinker:9650799;Cellinker:9724791;Cellinker:9784130;Guide2Pharma:10598788;Guide2Pharma:11520208;Guide2Pharma:15333679;Guide2Pharma:7988476;Guide2Pharma:8769372;Guide2Pharma:9600011;Guide2Pharma:9650799;Guide2Pharma:9724791;Guide2Pharma:9784130;HPMR:8769372;HPRD:8100352;LRdb:10598788;LRdb:11520208;LRdb:15333679;LRdb:7988476;LRdb:8100352;LRdb:8769372;LRdb:9600011;LRdb:9650799;LRdb:9724791;LRdb:9784130;SIGNOR:10433861;connectomeDB2020:10598788;connectomeDB2020:11520208;connectomeDB2020:15333679;connectomeDB2020:7988476;connectomeDB2020:8100352;connectomeDB2020:8769372;connectomeDB2020:9600011;connectomeDB2020:9650799;connectomeDB2020:9724791;connectomeDB2020:9784130;scConnect:10598788;scConnect:11520208;scConnect:15333679;scConnect:7988476;scConnect:8769372;scConnect:9600011;scConnect:9650799;scConnect:9724791;scConnect:9784130], SSTR5 [Baccin2019:10598788;Baccin2019:11520208;Baccin2019:15333679;Baccin2019:7908405;Baccin2019:7988476;Baccin2019:8769372;Baccin2019:9600011;Baccin2019:9650799;Baccin2019:9652348;Baccin2019:9724791;Baccin2019:9784130;CellTalkDB:7908405;Cellinker:10598788;Cellinker:11520208;Cellinker:15333679;Cellinker:7908405;Cellinker:7988476;Cellinker:8769372;Cellinker:9600011;Cellinker:9650799;Cellinker:9652348;Cellinker:9724791;Cellinker:9784130;Guide2Pharma:10598788;Guide2Pharma:11520208;Guide2Pharma:15333679;Guide2Pharma:7988476;Guide2Pharma:8769372;Guide2Pharma:9600011;Guide2Pharma:9650799;Guide2Pharma:9652348;Guide2Pharma:9724791;Guide2Pharma:9784130;HPMR:8769372;HPRD:7908405;LRdb:10598788;LRdb:11520208;LRdb:15333679;LRdb:7908405;LRdb:7988476;LRdb:8769372;LRdb:9600011;LRdb:9650799;LRdb:9652348;LRdb:9724791;LRdb:9784130;connectomeDB2020:10598788;connectomeDB2020:11520208;connectomeDB2020:15333679;connectomeDB2020:7908405;connectomeDB2020:7988476;connectomeDB2020:8769372;connectomeDB2020:9600011;connectomeDB2020:9650799;connectomeDB2020:9652348;connectomeDB2020:9724791;connectomeDB2020:9784130;scConnect:10598788;scConnect:11520208;scConnect:15333679;scConnect:7988476;scConnect:8769372;scConnect:9600011;scConnect:9650799;scConnect:9652348;scConnect:9724791;scConnect:9784130], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], MRGPRX2 [scConnect:23396314]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; synapse [GO:0045202]	hormone activity [GO:0005179]; identical protein binding [GO:0042802]	cell-cell signaling [GO:0007267]; cell surface receptor signaling pathway [GO:0007166]; chemical synaptic transmission [GO:0007268]; digestion [GO:0007586]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone-mediated apoptotic signaling pathway [GO:0008628]; hyperosmotic response [GO:0006972]; negative regulation of cell population proliferation [GO:0008285]; regulation of cell migration [GO:0030334]; response to acidic pH [GO:0010447]; response to amino acid [GO:0043200]; response to heat [GO:0009408]; response to nutrient [GO:0007584]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SST&keywords=SST	7794.81	6	205386	9	259.83	6	1.08	3.82	2.25	2.51	14.27	780.19	3.70	10.90	1621.41	2.33	1.62	1	17	18	222.19	7.30	0.01	0.01	1	523	528	112
NRTN	neurturin	Yes		ENSG00000171119	Q99748	TGF-beta family, GDNF subfamily	16	ligand	extracellular, intracellular, ligand, secreted	O00451, O60609, P07949, P56159	GFRA1, GFRA1_RET, GFRA2, GFRA2_RET, GFRA3, RET	RET [Baccin2019:91828039192898;CellTalkDB:9182803;Cellinker:9182803;Cellinker:9192898;HPMR:9182803;HPMR:9192898;HPRD:9192898;LRdb:9182803;LRdb:919;SIGNOR:9182803;connectomeDB2020:9182803;connectomeDB2020:9192898], GFRA1 [Baccin2019:91828039407096;CellTalkDB:9182803;Cellinker:9182803;Cellinker:9407096;HPRD:9407096;LRdb:9182803;LRdb:941;SIGNOR:9182803;connectomeDB2020:9182803;connectomeDB2020:9407096], GFRA2 [Baccin2019:918280310829012;CellTalkDB:9182803;Cellinker:10829012;Cellinker:11544105;Cellinker:9182803;HPMR:9182803;HPMR:9192898;HPRD:10829012;LRdb:108;LRdb:9182803;connectomeDB2020:10829012;connectomeDB2020:9182803], GFRA3 [CellTalkDB:32196115]	axon [GO:0030424]; extracellular region [GO:0005576]	glial cell-derived neurotrophic factor receptor binding [GO:0030116]; growth factor activity [GO:0008083]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	MAPK cascade [GO:0000165]; nerve development [GO:0021675]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron projection development [GO:0031175]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NRTN&keywords=NRTN	NA	NA	NA	NA	NA	NA	0.00	0.01	0.00	0.00	0.01	0.01	0.01	0.00	0.00	0.01	0.00	298	267	375	0.00	0.89	1.26	0.81	192	84	180	176
VIP	vasoactive intestinal peptide	Yes		ENSG00000146469	P01282	Glucagon family	16	ligand	extracellular, intracellular, ligand, secreted	O60894, O60895, O60896, P07550, P08588, P13945, P16473, P17342, P27487, P32241, P37288, P41586, P41587, P47872, Q03431, Q99678, Q9NQS5	ADCYAP1R1, ADRB1, ADRB2, ADRB3, AVPR1A, DPP4, GPR20, GPR84, NPR3, PTH1R, RAMP1, RAMP2, RAMP3, SCTR, TSHR, VIPR1, VIPR2	ADCYAP1R1 [Baccin2019:10583729;Baccin2019:11931347;Baccin2019:16930633;CellTalkDB:10583729;Cellinker:10583729;Cellinker:11931347;Cellinker:12488235;Cellinker:16930633;Guide2Pharma:10583729;Guide2Pharma:11931347;Guide2Pharma:16930633;LRdb:10583729;LRdb:11931347;LRdb:16930633;connectomeDB2020:10583729;connectomeDB2020:11931347;connectomeDB2020:16930633;scConnect:10583729;scConnect:11931347;scConnect:16930633], SCTR [Baccin2019:1646711;CellTalkDB:8390245;Cellinker:1646711;Guide2Pharma:1646711;LRdb:1646711;connectomeDB2020:1646711;scConnect:1646711], VIPR1 [Baccin2019:10570056;Baccin2019:10801840;Baccin2019:11027527;Baccin2019:11931347;Baccin2019:15247290;Baccin2019:16930633;Baccin2019:8074647;Baccin2019:807467;Baccin2019:8390245;Baccin2019:8791009;Baccin2019:9152366;Baccin2019:9437714;Baccin2019:9454823;Baccin2019:9726637;Baccin2019:9928018;CellChatDB:10655512;CellTalkDB:11027527;Cellinker:10570056;Cellinker:10655511;Cellinker:10801840;Cellinker:11027527;Cellinker:11931347;Cellinker:12488235;Cellinker:15247290;Cellinker:16930633;Cellinker:8074647;Cellinker:8390245;Cellinker:8791009;Cellinker:9152366;Cellinker:9437714;Cellinker:9454823;Cellinker:9726637;Cellinker:9928018;Guide2Pharma:10570056;Guide2Pharma:10801840;Guide2Pharma:11931347;Guide2Pharma:16930633;Guide2Pharma:8074647;Guide2Pharma:8390245;Guide2Pharma:8791009;Guide2Pharma:9152366;Guide2Pharma:9437714;Guide2Pharma:9454823;Guide2Pharma:9726637;Guide2Pharma:9928018;HPMR:11027527;HPRD:11027527;HPRD:15247290;HPRD:807467;LRdb:10570056;LRdb:10801840;LRdb:11027527;LRdb:11931347;LRdb:15247290;LRdb:16930633;LRdb:8074647;LRdb:807467;LRdb:8390245;LRdb:8791009;LRdb:9152366;LRdb:9437714;LRdb:9454823;LRdb:9726637;LRdb:9928018;SIGNOR:11897681;connectomeDB2020:10570056;connectomeDB2020:10801840;connectomeDB2020:11027527;connectomeDB2020:11931347;connectomeDB2020:15247290;connectomeDB2020:16930633;connectomeDB2020:8074647;connectomeDB2020:807467;connectomeDB2020:8390245;connectomeDB2020:8791009;connectomeDB2020:9152366;connectomeDB2020:9437714;connectomeDB2020:9454823;connectomeDB2020:9726637;connectomeDB2020:9928018;scConnect:10570056;scConnect:10801840;scConnect:11931347;scConnect:16930633;scConnect:8074647;scConnect:8390245;scConnect:8791009;scConnect:9152366;scConnect:9437714;scConnect:9454823;scConnect:9726637;scConnect:9928018], VIPR2 [Baccin2019:10570056;Baccin2019:10801840;Baccin2019:11931347;Baccin2019:12220741;Baccin2019:16930633;Baccin2019:8146174;Baccin2019:9152366;Baccin2019:9437714;Baccin2019:9454823;Baccin2019:9726637;Baccin2019:9928018;CellTalkDB:16930633;Cellinker:10570056;Cellinker:10801840;Cellinker:11931347;Cellinker:12220741;Cellinker:12488235;Cellinker:16930633;Cellinker:8146174;Cellinker:9152366;Cellinker:9437714;Cellinker:9454823;Cellinker:9726637;Cellinker:9928018;Guide2Pharma:10570056;Guide2Pharma:10801840;Guide2Pharma:11931347;Guide2Pharma:16930633;Guide2Pharma:9152366;Guide2Pharma:9437714;Guide2Pharma:9454823;Guide2Pharma:9726637;Guide2Pharma:9928018;HPMR:12220741;HPRD:10801840;HPRD:8146174;HPRD:9454823;LRdb:10570056;LRdb:10801840;LRdb:11931347;LRdb:12220741;LRdb:16930633;LRdb:8146174;LRdb:9152366;LRdb:9437714;LRdb:9454823;LRdb:9726637;LRdb:9928018;connectomeDB2020:10570056;connectomeDB2020:10801840;connectomeDB2020:11931347;connectomeDB2020:12220741;connectomeDB2020:16930633;connectomeDB2020:8146174;connectomeDB2020:9152366;connectomeDB2020:9437714;connectomeDB2020:9454823;connectomeDB2020:9726637;connectomeDB2020:9928018;scConnect:10570056;scConnect:10801840;scConnect:11931347;scConnect:16930633;scConnect:9152366;scConnect:9437714;scConnect:9454823;scConnect:9726637;scConnect:9928018], GPR84 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], RAMP3 [CellTalkDB:23745705], RAMP2 [CellTalkDB:23745705], RAMP1 [CellTalkDB:15361343], NPR3 [CellTalkDB:16723209], AVPR1A [CellTalkDB:32103204], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], DPP4 [CellTalkDB:26919392;Cellinker:21314817], ADRB1 [Cellinker:8190350]	extracellular region [GO:0005576]; neuron projection [GO:0043005]; perikaryon [GO:0043204]	hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184]; peptide hormone receptor binding [GO:0051428]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; body fluid secretion [GO:0007589]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; epinephrine secretion [GO:0048242]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; learning or memory [GO:0007611]; mRNA stabilization [GO:0048255]; negative regulation of apoptotic process [GO:0043066]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of smooth muscle cell proliferation [GO:0048662]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epinephrine secretion [GO:0032812]; positive regulation of penile erection [GO:0060406]; positive regulation of protein catabolic process [GO:0045732]; prolactin secretion [GO:0070459]; regulation of protein localization [GO:0032880]; regulation of sensory perception of pain [GO:0051930]; response to yeast [GO:0001878]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=VIP&keywords=VIP	14.04	198	NA	NA	2.12	145	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	303	409	314	0.00	0.97	0.97	1.26	143	143	54	224
GDF11	growth differentiation factor 11	Yes		ENSG00000135414	O95390	TGF-beta family	16	ligand	extracellular, intracellular, ligand, secreted	O00238, P27037, P36894, P36896, P61160, Q13705, Q13873, Q8NER5, Q9H6X2	ACTR2, ACVR1B, ACVR1B_ACVR2A, ACVR1B_ACVR2B, ACVR1C, ACVR2A, ACVR2A_TGFBR1, ACVR2B, ACVR2B_TGFBR1, ANTXR1, BMPR1A, BMPR1B, BMPR2	ACTR2 [SIGNOR:16446785;SignaLink3:16446785;SignaLink3:23331499], ACVR2B [Baccin2019:1241472616845370;CellTalkDB:12414726;HPRD:16845371;LRdb:12414726;LRdb:17;SIGNOR:12414726;SIGNOR:16845371;SignaLink3:16446785;SignaLink3:16845371;SignaLink3:23331499;connectomeDB2020:12414726;connectomeDB2020:16845371], ACVR1B [Baccin2019:12414726;CellTalkDB:12414726;LRdb:12414726;connectomeDB2020:12414726], BMPR2 [CellTalkDB:32196115], BMPR1A [CellTalkDB:32196115], BMPR1B [CellTalkDB:32196115], ACVR2A [Baccin2019:12414726;LRdb:12414726;connectomeDB2020:12414726], ACVR1C [Cellinker:16845371], ANTXR1 [NA]	extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]	camera-type eye morphogenesis [GO:0048593]; cell maturation [GO:0048469]; mesoderm development [GO:0007498]; metanephros development [GO:0001656]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron differentiation [GO:0045665]; nervous system development [GO:0007399]; pancreas development [GO:0031016]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; spinal cord anterior/posterior patterning [GO:0021512]; ureteric bud development [GO:0001657]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GDF11&keywords=GDF11	5.14	290	NA	NA	0.81	298	0.02	0.06	0.05	0.08	0.02	0.09	0.07	0.07	0.07	0.05	0.04	149	146	166	0.06	1.23	0.89	0.75	83	171	213	226
CRH	corticotropin releasing hormone	Yes		ENSG00000147571	P06850	Sauvagine/corticotropin-releasing factor/urotensin I family	16	ligand	extracellular, intracellular, ligand, secreted, transmembrane	O60895, O60896, P07550, P13945, P16473, P32241, P34998, P41586, Q01718, Q03431, Q13324, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, CRHR1, CRHR2, GPR20, GPR84, MC2R, PTH1R, RAMP2, RAMP3, TSHR, VIPR1	CRHR1 [Baccin2019:11123370;Baccin2019:7477349;Baccin2019:7692441;Baccin2019:8536644;Baccin2019:8612563;Baccin2019:9178757;Baccin2019:9326293;Baccin2019:9851694;BioGRID:10598591;BioGRID:19124613;CellTalkDB:11123370;Cellinker:11123370;Cellinker:7477349;Cellinker:7692441;Cellinker:8536644;Cellinker:8612563;Cellinker:9178757;Cellinker:9326293;Cellinker:9851694;Guide2Pharma:11123370;Guide2Pharma:7477349;Guide2Pharma:7692441;Guide2Pharma:8612563;Guide2Pharma:9326293;Guide2Pharma:9851694;HPMR:8536644;HPRD:9178757;IntAct:18801728;IntAct:20966082;LRdb:11123370;LRdb:7477349;LRdb:7692441;LRdb:8536644;LRdb:8612563;LRdb:9178757;LRdb:9326293;LRdb:9851694;SIGNOR:11416224;connectomeDB2020:11123370;connectomeDB2020:7477349;connectomeDB2020:7692441;connectomeDB2020:8536644;connectomeDB2020:8612563;connectomeDB2020:9178757;connectomeDB2020:9326293;connectomeDB2020:9851694;scConnect:11123370;scConnect:7477349;scConnect:7692441;scConnect:8612563;scConnect:9326293;scConnect:9851694], CRHR2 [CellTalkDB:11123370;Cellinker:11123370;Cellinker:8243338;Cellinker:8536644;Guide2Pharma:11123370;HPMR:8536644;HPRD:8243338;LRdb:11123370;LRdb:8243338;LRdb:8536644;connectomeDB2020:11123370;connectomeDB2020:8243338;connectomeDB2020:8536644;scConnect:11123370], ADCYAP1R1 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], MC2R [NA], ADRB3 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; synapse [GO:0045202]	corticotropin-releasing hormone activity [GO:0017045]; hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184]; signaling receptor binding [GO:0005102]	adrenal gland development [GO:0030325]; chemical synaptic transmission [GO:0007268]; female pregnancy [GO:0007565]; glucocorticoid biosynthetic process [GO:0006704]; inflammatory response [GO:0006954]; learning or memory [GO:0007611]; locomotory exploration behavior [GO:0035641]; lung development [GO:0030324]; negative regulation of circadian sleep/wake cycle, REM sleep [GO:0042322]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of glucagon secretion [GO:0070093]; parturition [GO:0007567]; positive regulation of circadian sleep/wake cycle, wakefulness [GO:0010841]; positive regulation of corticotropin secretion [GO:0051461]; positive regulation of cortisol secretion [GO:0051464]; regulation of NMDA receptor activity [GO:2000310]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CRH&keywords=CRH	4.39	305	16989.8	53	4.49	81	0.01	0.01	0.00	0.01	0.00	0.12	0.30	0.03	0.06	0.00	0.23	161	309	65	0.07	0.84	0.17	3.01	205	430	7	236
TNFSF12	TNF superfamily member 12	Yes		ENSG00000239697	O43508	Tumor necrosis factor family	16	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, secreted, transmembrane	P28908, Q86VB7, Q93038, Q9NP84	CD163, TNFRSF12A, TNFRSF25, TNFRSF8	TNFRSF12A [Baccin2019:11728344;Baccin2019:12529173;Baccin2019:12787562;CellTalkDB:11728344;Cellinker:11728344;Cellinker:12529173;Cellinker:12787562;HPMR:12787562;HPRD:11728344;HPRD:12529173;ICELLNET:11239407;InnateDB:23750247;LRdb:11728344;LRdb:12529173;LRdb:12787562;Lit-BM-17:23438059;NetPath:16526941;connectomeDB2020:11728344;connectomeDB2020:12529173;connectomeDB2020:12787562], TNFRSF25 [CellTalkDB:11094155;Cellinker:11094155;HPRD:11094155;LRdb:11094155;NetPath:11094155], TNFRSF8 [CellTalkDB:32196115], CD163 [NetPath:17548657;connectomeDB2020:19473660]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; endothelial cell migration [GO:0043542]; extrinsic apoptotic signaling pathway [GO:0097191]; immune response [GO:0006955]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of protein catabolic process [GO:0045732]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFSF12&keywords=TNFSF12	13.63	202	NA	NA	0.22	516	0.24	0.06	0.03	0.05	0.03	0.10	0.11	0.03	0.03	0.06	0.03	203	134	184	0.07	0.52	0.86	0.50	334	183	329	259
PDGFD	platelet derived growth factor D	Yes		ENSG00000170962	Q9GZP0	PDGF/VEGF growth factor family	16	ligand	extracellular, intracellular, ligand, secreted	P09619, P16234	PDGFRA, PDGFRA_PDGFRB, PDGFRB	PDGFRB [Baccin2019:1520781114514730;CellChatDB:15207812;CellTalkDB:15207811;Cellinker:15207812;Cellinker:28267575;HPRD:14514732;LRdb:15;LRdb:15207811;SignaLink3:14514732;SignaLink3:21098708;SignaLink3:23331499;connectomeDB2020:14514732;connectomeDB2020:15207811], PDGFRA [CellTalkDB:32196115]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]	growth factor activity [GO:0008083]; growth factor receptor binding [GO:0070851]; platelet-derived growth factor receptor binding [GO:0005161]	cellular response to amino acid stimulus [GO:0071230]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to transforming growth factor beta stimulus [GO:0071560]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of monocyte extravasation [GO:2000439]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PDGFD&keywords=PDGFD	12.58	213	1556.87	145	0.80	299	0.00	0.08	0.09	0.01	0.01	0.01	0.01	0.03	0.01	0.00	0.00	261	397	317	0.02	0.64	0.31	0.39	286	373	355	285
FGF23	fibroblast growth factor 23	Yes		ENSG00000118972	Q9GZV9	Heparin-binding growth factors family	16	ligand	extracellular, intracellular, ligand, secreted	P11362, P21802, P22455, P22607, P78562, Q9UEF7	FGFR1, FGFR2, FGFR3, FGFR4, KL, PHEX	FGFR2 [Baccin2019:1608163512032140;CellTalkDB:16597617;Cellinker:12032146;Cellinker:16081635;HPRD:12032146;LRdb:16597617;connectomeDB2020:12032146;connectomeDB2020:16081635], PHEX [Baccin2019:11409890;CellTalkDB:11409890;Cellinker:11409890;HPRD:11409890;LRdb:11409890], KL [CellTalkDB:30451736;connectomeDB2020:30605400], FGFR4 [Baccin2019:16081635;CellTalkDB:16597617;Cellinker:16081635;Cellinker:25772309;LRdb:16597617;connectomeDB2020:16081635], FGFR1 [Baccin2019:16081635;BioGRID:27879395;CellTalkDB:16597617;Cellinker:25772309;DIP:19966287;LRdb:16597617;Lit-BM-17:19966287;Lit-BM-17:22393163;connectomeDB2020:16081635], FGFR3 [Baccin2019:12032146;CellTalkDB:16597617;Cellinker:12032146;Cellinker:25772309;HPRD:12032146;LRdb:16597617;connectomeDB2020:12032146]	cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105]	animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to interleukin-6 [GO:0071354]; cellular response to leptin stimulus [GO:0044320]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to vitamin D [GO:0071305]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; negative regulation of bone mineralization [GO:0030502]; negative regulation of hormone secretion [GO:0046888]; negative regulation of osteoblast differentiation [GO:0045668]; phosphate-containing compound metabolic process [GO:0006796]; phosphate ion homeostasis [GO:0055062]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vitamin D 24-hydroxylase activity [GO:0010980]; regulation of cell migration [GO:0030334]; regulation of phosphate transport [GO:0010966]; response to magnesium ion [GO:0032026]; response to sodium phosphate [GO:1904383]; vitamin D catabolic process [GO:0042369]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF23&keywords=FGF23	0.37	552	NA	NA	12.05	41	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	297
PTHLH	parathyroid hormone like hormone	Yes		ENSG00000087494	P12272	Parathyroid hormone family	16	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, P05231, P07550, P13945, P16473, P32241, P41586, P49190, P49683, Q03431, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, GPR20, GPR84, IL6, PRLHR, PTH1R, PTH2R, RAMP2, RAMP3, TSHR, VIPR1	PRLHR [NA], PTH1R [CellChatDB:29577935;CellTalkDB:9108031;Cellinker:2558877;Cellinker:29577935;Cellinker:8702701;Cellinker:9108031;Guide2Pharma:8702701;HPMR:2558877;HPRD:9108031;IntAct:19674967;LRdb:2558877;LRdb:8702701;LRdb:9108031;connectomeDB2020:2558877;connectomeDB2020:8702701;connectomeDB2020:9108031;scConnect:8702701], PTH2R [Baccin2019:8702701;CellTalkDB:8702701;Cellinker:8702701;Guide2Pharma:8702701;LRdb:8702701;connectomeDB2020:8702701;scConnect:8702701], ADCYAP1R1 [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], IL6 [HPRD:12000745]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]	hormone activity [GO:0005179]; peptide hormone receptor binding [GO:0051428]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; cAMP metabolic process [GO:0046058]; cell-cell signaling [GO:0007267]; epidermis development [GO:0008544]; female pregnancy [GO:0007565]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte development [GO:0061182]; negative regulation of chondrocyte differentiation [GO:0032331]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; regulation of chondrocyte differentiation [GO:0032330]; regulation of gene expression [GO:0010468]; skeletal system development [GO:0001501]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PTHLH&keywords=PTHLH	2.25	377	NA	NA	1.44	207	0.00	0.02	0.00	0.06	0.03	0.00	0.01	0.02	0.00	0.00	0.10	292	341	109	0.02	0.43	0.38	3.55	366	349	6	319
GIP	gastric inhibitory polypeptide	Yes		ENSG00000159224	P09681	Glucagon family	16	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, P06213, P07550, P13945, P16473, P27487, P32241, P41586, P48546, Q03431, Q12884, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, DPP4, FAP, GIPR, GPR20, GPR84, INSR, PTH1R, RAMP2, RAMP3, TSHR, VIPR1	GIPR [Baccin2019:12627975;Baccin2019:15655707;Baccin2019:7589426;Baccin2019:8795084;CellTalkDB:15655705;Cellinker:12627975;Cellinker:15655707;Cellinker:7589426;Cellinker:8795084;DIP:17715056;Guide2Pharma:7589426;HPRD:12627975;HPRD:15655707;HPRD:7589426;HPRD:8795084;IntAct:17715056;LRdb:12627975;LRdb:15655707;LRdb:7589426;LRdb:8795084;Lit-BM-17:17715056;connectomeDB2020:12627975;connectomeDB2020:15655707;connectomeDB2020:7589426;connectomeDB2020:8795084;scConnect:26572091;scConnect:7589426], ADCYAP1R1 [CellTalkDB:32196115], DPP4 [CellTalkDB:15655705;Cellinker:15655705;LRdb:15655705;Ramilowski2015:15655705;connectomeDB2020:15655705;talklr:15655705], TSHR [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], INSR [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], FAP [Cellinker:21314817]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; secretory granule lumen [GO:0034774]	gastric inhibitory polypeptide receptor binding [GO:0031767]; glucagon receptor binding [GO:0031769]; hormone activity [GO:0005179]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adult locomotory behavior [GO:0008344]; digestive system development [GO:0055123]; endocrine pancreas development [GO:0031018]; exploration behavior [GO:0035640]; female pregnancy [GO:0007565]; gastric inhibitory peptide signaling pathway [GO:0038192]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of glucagon secretion [GO:0070094]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of insulin secretion [GO:0032024]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of insulin secretion [GO:0050796]; response to acidic pH [GO:0010447]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to glucose [GO:0009749]; response to lipid [GO:0033993]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; response to selenium ion [GO:0010269]; response to starvation [GO:0042594]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; triglyceride homeostasis [GO:0070328]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GIP&keywords=GIP	0.11	666	NA	NA	4.35	82	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.05	0.00	0.00	167	390	401	0.01	3.84	0.65	0.62	7	270	275	352
PGF	placental growth factor	Yes		ENSG00000119630	P49763	PDGF/VEGF growth factor family	16	adhesion, ligand	adhesion, cell_adhesion, extracellular, intracellular, ligand, plasma_membrane, secreted	O14786, O60462, P15692, P17948	FLT1, FLT1_KDR, NRP1, NRP2, VEGFA	NRP1 [Baccin2019:1198631111986310;CellTalkDB:11986311;Cellinker:11986311;HPRD:11986311;ICELLNET:9712843;LRdb:11986311;connectomeDB2020:11986311], NRP2 [CellTalkDB:10748121;Cellinker:10748121;HPRD:10748121;ICELLNET:12613545;LRdb:10748121;connectomeDB2020:10748121], FLT1 [Baccin2019:14684734;Baccin2019:9452434;CellChatDB:16633338;CellTalkDB:9452434;Cellinker:14684734;Cellinker:9452434;DIP:8700872;HPRD:14684734;HPRD:9452434;ICELLNET:19029957;IntAct:14684734;LRdb:147;LRdb:9452434;Lit-BM-17:14684734;Lit-BM-17:8700872;Lit-BM-17:9452434;ProtMapper:27009237;ProtMapper:29193887;connectomeDB2020:14684734;connectomeDB2020:9452434], VEGFA [DIP:8621715;HPRD:12086892;HPRD:12796773;Lit-BM-17:12086892;Lit-BM-17:25241761;Lit-BM-17:8621715]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]	chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; vascular endothelial growth factor receptor binding [GO:0005172]	animal organ regeneration [GO:0031100]; cell-cell signaling [GO:0007267]; cell differentiation [GO:0030154]; cellular response to hormone stimulus [GO:0032870]; female pregnancy [GO:0007565]; induction of positive chemotaxis [GO:0050930]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of protein phosphorylation [GO:0001934]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PGF&keywords=PGF	8.29	255	NA	NA	0.58	351	0.00	0.01	1.96	0.69	0.01	0.01	0.00	0.01	0.00	0.00	0.01	289	314	273	0.24	0.06	0.05	0.06	498	493	493	353
IL16	interleukin 16	Yes		ENSG00000172349	Q14005	NA	16	ligand, transporter	extracellular, intracellular, ion_channel, ligand, secreted, transporter	O15399, P01730, P21926, P22001, P42574, P48050, P51681, P78508, Q12879, Q13224, Q14957, Q99712, Q9NSA2, Q9NZV8	CASP3, CCR5, CD4, CD9, GRIN2A, GRIN2B, GRIN2C, GRIN2D, KCNA3, KCND1, KCND2, KCNJ10, KCNJ15, KCNJ4	CD9 [ICELLNET:16144798;ICELLNET:29884309;InnateDB:16144798], CD4 [Baccin2019:1851800;Baccin2019:7910967;CellTalkDB:1851800;Cellinker:1851800;Cellinker:7910967;DIP:7910967;HPRD:1851800;HPRD:7910967;ICELLNET:10438516;ICELLNET:7615501;InnateDB:7910967;LRdb:1851800;LRdb:791;connectomeDB2020:1851800;connectomeDB2020:7910967], GRIN2B [CellTalkDB:32103204;HPRD:10479680], KCNJ4 [Baccin2019:10479680;CellTalkDB:10479680;Cellinker:10479680;HPRD:10479680;LRdb:10479680], KCNJ15 [Baccin2019:10479680;Cellinker:10479680;HPRD:10479680;LRdb:10479680;connectomeDB2020:10479680], KCNA3 [Baccin2019:10479680;Cellinker:10479680;HPRD:10479680;LRdb:10479680], KCNJ10 [Baccin2019:10479680;CellTalkDB:32196115;Cellinker:10479680;HPRD:10479680;LRdb:10479680;connectomeDB2020:10479680], KCND2 [Baccin2019:10479680;Cellinker:10479680;HPRD:10479680;LRdb:10479680], GRIN2A [CellTalkDB:32103204;HPRD:10479680], KCND1 [Baccin2019:10479680;Cellinker:10479680;HPRD:10479680;LRdb:10479680], GRIN2D [Baccin2019:10479680;Cellinker:10479680;HPRD:10479680;LRdb:10479680;connectomeDB2020:10479680], CCR5 [CellTalkDB:32196115], GRIN2C [Baccin2019:10479680;Cellinker:10479680;HPRD:10479680;LRdb:10479680], CASP3 [HPRD:10479680;HPRD:9422780]	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]	CD4 receptor binding [GO:0042609]; cytokine activity [GO:0005125]	cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; induction of positive chemotaxis [GO:0050930]; leukocyte chemotaxis [GO:0030595]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of neutrophil activation [GO:1902565]; regulation of calcium ion transport [GO:0051924]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL16&keywords=IL16	1.97	387	58.5869	168	0.18	544	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	366
GDNF	glial cell derived neurotrophic factor	Yes		ENSG00000168621	P39905	TGF-beta family, GDNF subfamily	16	adhesion, ligand	adhesion, cell_adhesion, extracellular, intracellular, ligand, plasma_membrane, secreted	O00451, O60609, P07949, P13591, P24530, P56159, Q8NCS7	EDNRB, GFRA1, GFRA1_RET, GFRA2, GFRA2_RET, GFRA3, NCAM1, RET, SLC44A5	RET [Baccin2019:14514671;Baccin2019:8674117;Baccin2019:9182803;Baccin2019:9482105;CellTalkDB:9182803;Cellinker:14514671;Cellinker:8674117;Cellinker:9182803;Cellinker:9482105;HPMR:11106404;HPMR:14514671;HPRD:8674117;LRdb:14514671;LRdb:8674117;LRdb:9182803;LRdb:9482105;ProtMapper:22751117;ProtMapper:23429478;ProtMapper:25684228;SIGNOR:9182803;SignaLink3:23331499;SignaLink3:8674117;connectomeDB2020:14514671;connectomeDB2020:8674117;connectomeDB2020:9182803;connectomeDB2020:9482105], NCAM1 [HPRD:12837245;SIGNOR:15212950], GFRA2 [Baccin2019:91828039407096;CellTalkDB:9182803;Cellinker:9182803;Cellinker:9407096;HPRD:9407096;LRdb:9182803;LRdb:941;SIGNOR:9192898;connectomeDB2020:9182803;connectomeDB2020:9407096], GFRA1 [Baccin2019:14514671;Baccin2019:8674117;Baccin2019:9482105;CellTalkDB:14514671;Cellinker:11544105;Cellinker:14514671;Cellinker:8674117;Cellinker:9482105;DIP:20473317;HPMR:11106404;HPMR:14514671;HPRD:8674117;HPRD:9482105;LRdb:14514671;LRdb:8674117;LRdb:9482105;SIGNOR:9182803;connectomeDB2020:14514671;connectomeDB2020:8674117;connectomeDB2020:9482105], GFRA3 [CellTalkDB:32196115], EDNRB [CellTalkDB:32196115], SLC44A5 [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]	chemoattractant activity involved in axon guidance [GO:1902379]; glial cell-derived neurotrophic factor receptor binding [GO:0030116]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	adult locomotory behavior [GO:0008344]; branching involved in ureteric bud morphogenesis [GO:0001658]; commissural neuron axon guidance [GO:0071679]; dorsal spinal cord development [GO:0021516]; embryonic organ development [GO:0048568]; enteric nervous system development [GO:0048484]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; metanephros development [GO:0001656]; mRNA stabilization [GO:0048255]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron projection development [GO:0031175]; organ induction [GO:0001759]; peripheral nervous system development [GO:0007422]; peristalsis [GO:0030432]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ureteric bud formation [GO:0072107]; postganglionic parasympathetic fiber development [GO:0021784]; postsynaptic membrane organization [GO:0001941]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; regulation of gene expression [GO:0010468]; regulation of morphogenesis of a branching structure [GO:0060688]; regulation of semaphorin-plexin signaling pathway [GO:2001260]; regulation of stem cell differentiation [GO:2000736]; signal transduction [GO:0007165]; sympathetic nervous system development [GO:0048485]; ureteric bud formation [GO:0060676]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GDNF&keywords=GDNF	0.35	559	NA	NA	0.29	475	0.01	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	300	378	394	0.00	0.94	0.92	0.87	162	165	155	394
WNT3	Wnt family member 3	Yes		ENSG00000277641, ENSG00000277626, ENSG00000108379	P56703	Wnt family	16	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	O75084, O75581, P34925, Q01974, Q13467, Q9H461, Q9NPG1, Q9UP38	FZD1, FZD1_LRP5, FZD1_LRP6, FZD10_LRP5, FZD10_LRP6, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4_LRP5, FZD4_LRP6, FZD5, FZD5_LRP5, FZD5_LRP6, FZD6_LRP5, FZD6_LRP6, FZD7, FZD7_LRP5, FZD7_LRP6, FZD8, FZD8_LRP5, FZD8_LRP6, FZD9_LRP5, FZD9_LRP6, LRP6, ROR2, RYK	LRP6 [Baccin2019:18528331;CellTalkDB:18528331;LRdb:18528331;SIGNOR:15578921;connectomeDB2020:18528331], FZD3 [SIGNOR:15578921], RYK [Baccin2019:15454084;CellTalkDB:15454084;Cellinker:15454084;LRdb:15454084;connectomeDB2020:15454084], ROR2 [CellTalkDB:15388793;NetPath:15388793], FZD1 [Baccin2019:10557084;CancerCellMap:10557084;CellTalkDB:10557084;HPRD:10557084;LRdb:10557084;NetPath:10557084;connectomeDB2020:10557084], FZD7 [Baccin2019:24032637;CellPhoneDB:24032637;CellTalkDB:18313787;LRdb:18313787;NetPath:18313787;Ramilowski2015:18313787;connectomeDB2020:18313787;connectomeDB2020:25892522;talklr:18313787], FZD8 [Baccin2019:15454084;Baccin2019:18528331;CellTalkDB:18528331;LRdb:15;LRdb:18528331;connectomeDB2020:15454084;connectomeDB2020:18528331], FZD5 [CellTalkDB:32196115]	endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]	anterior/posterior axis specification [GO:0009948]; axon guidance [GO:0007411]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in osteoblast differentiation [GO:0044339]; canonical Wnt signaling pathway involved in stem cell proliferation [GO:1905474]; cell fate commitment [GO:0045165]; cell morphogenesis [GO:0000902]; cellular response to retinoic acid [GO:0071300]; dorsal/ventral axis specification [GO:0009950]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; gamete generation [GO:0007276]; head morphogenesis [GO:0060323]; limb bud formation [GO:0060174]; mammary gland epithelium development [GO:0061180]; mesoderm formation [GO:0001707]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neuron differentiation [GO:0030182]; positive regulation of collateral sprouting in absence of injury [GO:0048697]; positive regulation of gene expression [GO:0010628]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of neurogenesis [GO:0050767]; Spemann organizer formation at the anterior end of the primitive streak [GO:0060064]; stem cell proliferation [GO:0072089]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT3&keywords=WNT3	0.44	534	NA	NA	0.14	581	0.00	0.01	0.00	0.01	0.00	0.00	0.00	0.00	0.01	0.00	0.00	267	316	376	0.00	1.40	0.97	0.78	61	147	196	395
EREG	epiregulin	Yes		ENSG00000124882	O14944	NA	16	cell_surface_ligand, ligand	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	P00533, P04626, P21860, Q15303	EGFR, EGFR_ERBB2, ERBB2, ERBB2_ERBB4, ERBB3, ERBB4	EGFR [Baccin2019:8626392;Baccin2019:9419975;CellTalkDB:8626392;HPRD:9419975;IntAct:28988771;LRdb:8626392;LRdb:942;SIGNOR:20513444;SIGNOR:9419975;connectomeDB2020:8626392;connectomeDB2020:9419975], ERBB4 [Baccin2019:9419975;CellTalkDB:9419975;HPRD:9419975;LRdb:9419975;SIGNOR:16829981;SIGNOR:22891299;connectomeDB2020:9419975], ERBB3 [CellTalkDB:32196115;SIGNOR:16829981;SIGNOR:22891299], ERBB2 [CellTalkDB:32196115]	clathrin-coated endocytic vesicle membrane [GO:0030669]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]	epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]	anatomical structure morphogenesis [GO:0009653]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; cell-cell signaling [GO:0007267]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; female meiotic nuclear division [GO:0007143]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; luteinizing hormone signaling pathway [GO:0042700]; mRNA transcription [GO:0009299]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription, DNA-templated [GO:0045892]; oocyte maturation [GO:0001556]; ovarian cumulus expansion [GO:0001550]; ovulation [GO:0030728]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production [GO:0001819]; positive regulation of DNA replication [GO:0045740]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of innate immune response [GO:0045089]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of smooth muscle cell proliferation [GO:0048661]; primary follicle stage [GO:0048160]; response to peptide hormone [GO:0043434]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EREG&keywords=EREG	0.83	472	NA	NA	0.75	312	1.21	0.03	0.00	0.01	0.00	0.00	0.01	0.00	0.00	0.00	0.00	300	329	335	0.12	0.09	0.10	0.10	481	469	474	396
IL1RN	interleukin 1 receptor antagonist	Yes		ENSG00000136689	P18510	NA	16	ligand, receptor	extracellular, intracellular, ligand, ligand_regulator, receptor, secreted	P01589, P14778, P14784, P27930, P31785, Q9HB29, Q9NPH3	IL1B_IL1R1_IL1RAP, IL1B_IL1R2_IL1RAP, IL1R1, IL1R2, IL1RAP, IL1RL2, IL2RA, IL2RB, IL2RG	IL1RAP [NA], IL1R1 [Baccin2019:11641511;Baccin2019:9062194;BioGRID:9062194;CellTalkDB:11641511;Cellinker:11641511;Cellinker:9062194;HPRD:11641511;HPRD:9062194;ICELLNET:20959797;ICELLNET:24332029;InnateDB:8142597;LRdb:11641511;LRdb:91;NetPath:7589429;SIGNOR:2876877;connectomeDB2020:9062194], IL2RG [NA], IL2RA [NA], IL2RB [NA], IL1R2 [Baccin2019:1834644;CellTalkDB:1834644;Cellinker:1834644;HPRD:1834644;ICELLNET:20959797;ICELLNET:24332029;InnateDB:1833184;LRdb:1834644;NetPath:7878046;connectomeDB2020:1834644], IL1RL2 [CellTalkDB:22047735]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; interleukin-1, type II receptor binding [GO:0005151]; interleukin-1, type I receptor binding [GO:0005150]; interleukin-1 receptor antagonist activity [GO:0005152]; interleukin-1 receptor binding [GO:0005149]; interleukin-1 type II receptor antagonist activity [GO:0045353]; interleukin-1 type I receptor antagonist activity [GO:0045352]	acute-phase response [GO:0006953]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; insulin secretion [GO:0030073]; lipid metabolic process [GO:0006629]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; response to glucocorticoid [GO:0051384]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL1RN&keywords=IL1RN	12.31	215	NA	NA	0.27	480	1.28	0.17	0.00	0.02	0.02	0.00	0.00	0.00	0.00	0.00	0.00	301	404	385	0.14	0.07	0.07	0.07	491	486	490	396
GAS6	growth arrest specific 6	Yes		ENSG00000183087	Q14393	NA	16	adhesion, ecm, ligand	adhesion, cell_adhesion, ecm, extracellular, intracellular, ligand, secreted	P30530, Q06418, Q12866	AXL, MERTK, TYRO3	AXL [Baccin2019:16362042;Baccin2019:7854420;Baccin2019:8621659;Baccin2019:8939948;CellChatDB:27801848;CellTalkDB:7854420;Cellinker:16362042;Cellinker:27801848;Cellinker:7854420;Cellinker:8621659;Cellinker:8939948;DOMINO:16362042;Guide2Pharma:8939948;HPMR:7854420;HPMR:8939948;HPRD:16362042;HPRD:8621659;InnateDB:12218057;InnateDB:16362042;InnateDB:7854420;InnateDB:8939948;LRdb:16362042;LRdb:7854420;LRdb:8621659;LRdb:8939948;Lit-BM-17:16362042;Lit-BM-17:8939948;ProtMapper:27829217;SIGNOR:16362042;SIGNOR:7867073;SignaLink3:16362042;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:8621659;connectomeDB2020:16362042;connectomeDB2020:7854420;connectomeDB2020:8621659;connectomeDB2020:8939948;scConnect:8939948], MERTK [CellChatDB:27801848;CellTalkDB:9160883;Cellinker:27801848;Cellinker:8939948;Cellinker:9160883;Guide2Pharma:8939948;HPMR:9160883;HPRD:8939948;ICELLNET:9160883;InnateDB:9160883;LRdb:894;LRdb:9160883;SIGNOR:8939948;SignaLink3:23331499;SignaLink3:8939948;connectomeDB2020:8939948;connectomeDB2020:9160883;scConnect:8939948], TYRO3 [Baccin2019:7867073;Baccin2019:8621659;Baccin2019:8939948;BioGRID:8621659;BioGRID:8939948;CellChatDB:27801848;CellTalkDB:7867073;Cellinker:27801848;Cellinker:7867073;Cellinker:8621659;Cellinker:8939948;Guide2Pharma:8939948;HPMR:7867073;HPRD:8621659;HPRD:8939948;InnateDB:8939948;LRdb:7867073;LRdb:8621659;LRdb:8939948;SIGNOR:7867073;connectomeDB2020:7867073;connectomeDB2020:8621659;connectomeDB2020:8939948;scConnect:8939948]	cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; platelet alpha granule lumen [GO:0031093]	calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; phosphatidylserine binding [GO:0001786]; protein-macromolecule adaptor activity [GO:0030674]; protein tyrosine kinase activator activity [GO:0030296]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	activation of protein kinase B activity [GO:0032148]; animal organ regeneration [GO:0031100]; apoptotic cell clearance [GO:0043277]; B cell chemotaxis [GO:0035754]; blood coagulation [GO:0007596]; calcium ion transmembrane transport [GO:0070588]; cell-substrate adhesion [GO:0031589]; cellular response to glucose stimulus [GO:0071333]; cellular response to growth factor stimulus [GO:0071363]; cellular response to interferon-alpha [GO:0035457]; cellular response to starvation [GO:0009267]; cellular response to vitamin K [GO:0071307]; cellular response to xenobiotic stimulus [GO:0071466]; dendritic cell differentiation [GO:0097028]; enzyme linked receptor protein signaling pathway [GO:0007167]; extracellular matrix assembly [GO:0085029]; fusion of virus membrane with host plasma membrane [GO:0019064]; hematopoietic stem cell migration to bone marrow [GO:0097241]; negative regulation of apoptotic process [GO:0043066]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of oligodendrocyte apoptotic process [GO:1900142]; negative regulation of renal albumin absorption [GO:2000533]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of tumor necrosis factor production [GO:0032720]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; phagocytosis [GO:0006909]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular filtration [GO:0003104]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of TOR signaling [GO:0032008]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of growth [GO:0040008]; signal transduction [GO:0007165]; viral entry into host cell [GO:0046718]; viral genome replication [GO:0019079]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GAS6&keywords=GAS6	9.32	247	NA	NA	0.04	737	0.01	0.23	0.04	0.04	0.03	0.02	0.01	0.01	0.01	0.01	0.00	285	261	383	0.04	0.33	0.37	0.23	398	354	410	400
NPPC	natriuretic peptide C	Yes		ENSG00000163273	P23582	Natriuretic peptide family	16	ligand	intracellular, ligand, secreted	P16066, P17342, P20594	NPR1, NPR2, NPR3	NPR2 [CellChatDB:29934642;CellTalkDB:11952095;Cellinker:11952095;Cellinker:12709393;Cellinker:1309330;Guide2Pharma:1309330;HPRD:12709393;LRdb:11952095;LRdb:12709393;LRdb:1309330;connectomeDB2020:11952095;connectomeDB2020:12709393;connectomeDB2020:1309330;scConnect:1309330], NPR3 [Baccin2019:11533490;Baccin2019:1309330;CellTalkDB:11533490;Cellinker:11533490;Cellinker:1309330;HPRD:11533490;HPRD:1309330;LRdb:11533490;LRdb:13;connectomeDB2020:11533490;connectomeDB2020:1309330], NPR1 [CellTalkDB:32103204]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]	hormone activity [GO:0005179]; hormone receptor binding [GO:0051427]; signaling receptor binding [GO:0005102]	cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; growth plate cartilage chondrocyte differentiation [GO:0003418]; growth plate cartilage chondrocyte proliferation [GO:0003419]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of osteoblast differentiation [GO:0045669]; post-embryonic development [GO:0009791]; protein folding [GO:0006457]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of multicellular organism growth [GO:0040014]; regulation of smooth muscle cell proliferation [GO:0048660]; reproductive process [GO:0022414]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPPC&keywords=NPPC	0.10	676	NA	NA	0.09	641	0.00	0.00	0.00	0.00	0.00	0.02	0.01	0.00	0.01	0.01	0.00	278	245	366	0.00	1.22	1.36	0.77	85	68	203	408
POMC	proopiomelanocortin	Yes		ENSG00000115138	P01189	POMC family	16	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, P07550, P08913, P13945, P16473, P32241, P32245, P33032, P35372, P41143, P41145, P41146, P41586, P41968, P48039, Q01718, Q01726, Q03431, Q14831, Q8TCY5, Q99678, Q9NQS5	ADCYAP1R1, ADRA2A, ADRB2, ADRB3, GPR20, GPR84, GRM7, MC1R, MC2R, MC3R, MC4R, MC5R, MRAP, MTNR1A, OPRD1, OPRK1, OPRL1, OPRM1, PTH1R, RAMP2, RAMP3, TSHR, VIPR1	OPRD1 [Baccin2019:154641439686407;CellTalkDB:15464143;Cellinker:15464143;Cellinker:9686407;Guide2Pharma:9686407;LRdb:15464143;LRdb:97;SIGNOR:9686407;connectomeDB2020:15464143;connectomeDB2020:9686407;scConnect:9686407], OPRK1 [Baccin2019:7624359;Baccin2019:8624732;Baccin2019:9686407;CellTalkDB:8624732;Cellinker:7624359;Cellinker:8624732;Cellinker:9686407;Guide2Pharma:7624359;Guide2Pharma:9686407;HPMR:8624732;LRdb:7624359;LRdb:8624732;LRdb:9686407;SIGNOR:9686407;connectomeDB2020:7624359;connectomeDB2020:8624732;connectomeDB2020:9686407;scConnect:7624359;scConnect:9686407], MC1R [Baccin2019:10942578;Baccin2019:11041375;Baccin2019:12007532;Baccin2019:1516719;Baccin2019:7774675;CellTalkDB:10942578;Cellinker:10942578;Cellinker:11041375;Cellinker:12007532;Cellinker:1516719;Cellinker:7774675;Guide2Pharma:12007532;HPRD:10942578;HPRD:11041375;LRdb:10942578;LRdb:11041375;LRdb:12007532;LRdb:1516719;LRdb:7774675;SIGNOR:19656324;connectomeDB2020:10942578;connectomeDB2020:11041375;connectomeDB2020:12007532;connectomeDB2020:1516719;connectomeDB2020:7774675;scConnect:12007532;scConnect:7774675], MC3R [Baccin2019:10358030;Baccin2019:10493100;Baccin2019:7774675;CellChatDB:11024027;CellTalkDB:10358030;Cellinker:10358030;Cellinker:10493100;Cellinker:7774675;Guide2Pharma:10358030;Guide2Pharma:10493100;LRdb:10358030;LRdb:10493100;LRdb:7774675;SIGNOR:17702843;connectomeDB2020:10358030;connectomeDB2020:10493100;connectomeDB2020:7774675;scConnect:10358030;scConnect:10493100;scConnect:7774675], MC4R [Baccin2019:10493100;Baccin2019:11101306;Baccin2019:12165561;Baccin2019:8884876;BioGRID:11101306;BioGRID:9058374;CellChatDB:11024027;Cellinker:10493100;Cellinker:11101306;Cellinker:12165561;Cellinker:8884876;Guide2Pharma:10493100;Guide2Pharma:11101306;HPRD:11101306;HPRD:12165561;LRdb:10493100;LRdb:11101306;LRdb:12165561;LRdb:8884876;SIGNOR:20694162;connectomeDB2020:10493100;connectomeDB2020:11101306;connectomeDB2020:12165561;connectomeDB2020:8884876;scConnect:10493100;scConnect:11101306;scConnect:8884876], MC5R [Baccin2019:11606131;Baccin2019:11785979;Baccin2019:12007532;Baccin2019:7774675;Baccin2019:8185570;Cellinker:11606131;Cellinker:11785979;Cellinker:12007532;Cellinker:7774675;Cellinker:8185570;Guide2Pharma:12007532;HPMR:11785979;HPRD:11606131;HPRD:8185570;LRdb:11606131;LRdb:11785979;LRdb:12007532;LRdb:7774675;LRdb:8185570;SIGNOR:11785979;connectomeDB2020:11606131;connectomeDB2020:11785979;connectomeDB2020:12007532;connectomeDB2020:7774675;connectomeDB2020:8185570;scConnect:12007532;scConnect:7774675], ADCYAP1R1 [CellTalkDB:32196115], OPRM1 [Baccin2019:15464143;CellTalkDB:15464143;Cellinker:15464143;HPMR:15464143;LRdb:15464143;connectomeDB2020:15464143], GPR84 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], MC2R [Baccin2019:905837412213892;CellTalkDB:9058374;Cellinker:12213892;Cellinker:9058374;HPMR:9058374;HPRD:12213892;LRdb:122;LRdb:9058374;connectomeDB2020:12213892;connectomeDB2020:9058374], ADRB3 [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], OPRL1 [NA], MRAP [Cellinker:19028547]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; peroxisomal matrix [GO:0005782]; secretory granule [GO:0030141]; secretory granule lumen [GO:0034774]	G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]; type 1 melanocortin receptor binding [GO:0070996]; type 3 melanocortin receptor binding [GO:0031781]; type 4 melanocortin receptor binding [GO:0031782]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; calcium-mediated signaling [GO:0019722]; cell-cell signaling [GO:0007267]; cellular pigmentation [GO:0033059]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; killing of cells of other organism [GO:0031640]; modulation of process of other organism [GO:0035821]; negative regulation of tumor necrosis factor production [GO:0032720]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of neutrophil mediated killing of fungus [GO:0070965]; positive regulation of oxytocin production [GO:0140668]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of appetite [GO:0032098]; regulation of blood pressure [GO:0008217]; regulation of corticosterone secretion [GO:2000852]; regulation of glycogen metabolic process [GO:0070873]; response to melanocyte-stimulating hormone [GO:1990680]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=POMC&keywords=POMC	0.49	527	NA	NA	0.00	897	0.08	0.03	0.05	0.06	0.04	0.12	0.14	0.16	0.12	0.10	0.10	108	103	115	0.09	1.34	1.13	1.05	71	105	88	408
FGF5	fibroblast growth factor 5	Yes		ENSG00000138675	P12034	Heparin-binding growth factors family	16	ligand	extracellular, intracellular, ligand, secreted	P11362, P21802, P22455, P22607	FGFR1, FGFR2, FGFR3, FGFR4	FGFR1 [Baccin2019:83868288386828;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;DIP:8386828;HPRD:8386828;LRdb:16597617;SIGNOR:8386828;connectomeDB2020:8386828], FGFR2 [Baccin2019:838682811876253;CellTalkDB:16597617;Cellinker:11876253;Cellinker:16597617;Cellinker:25772309;Cellinker:8386828;HPRD:11876253;LRdb:16597617;SIGNOR:8386828;connectomeDB2020:11876253;connectomeDB2020:8386828], FGFR3 [Baccin2019:8663044;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;Cellinker:8663044;DIP:9045692;HPRD:8663044;LRdb:16597617;connectomeDB2020:8663044], FGFR4 [Baccin2019:13851118663044;CellTalkDB:16597617;Cellinker:1385111;Cellinker:25772309;Cellinker:8663044;HPRD:8663044;LRdb:16597617;connectomeDB2020:1385111;connectomeDB2020:8663044]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]	animal organ morphogenesis [GO:0009887]; cell-cell signaling [GO:0007267]; cell differentiation [GO:0030154]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glial cell differentiation [GO:0010001]; nervous system development [GO:0007399]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; signal transduction involved in regulation of gene expression [GO:0023019]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF5&keywords=FGF5	0.16	637	NA	NA	0.24	504	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	303	408	394	0.00	0.96	0.97	0.99	148	146	103	424
GUCA2A	guanylate cyclase activator 2A	Yes		ENSG00000197273	Q02747	Guanylin family	16	ligand	extracellular, ligand, secreted	P25092	GUCY2C	GUCY2C [Baccin2019:10601865;Baccin2019:10845107;Baccin2019:11889121;CellChatDB:22384056;CellTalkDB:10845107;Cellinker:10601865;Cellinker:10845107;Cellinker:11889121;Cellinker:22384056;HPMR:10845107;HPRD:10601865;HPRD:11889121;ICELLNET:23269669;LRdb:10601865;LRdb:10845107;LRdb:11889121;SIGNOR:10845107;connectomeDB2020:10601865;connectomeDB2020:10845107;connectomeDB2020:11889121]	extracellular region [GO:0005576]	guanylate cyclase activator activity [GO:0030250]; hormone activity [GO:0005179]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GUCA2A&keywords=GUCA2A	0.87	468	NA	NA	0.08	662	0.00	0.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	303	409	327	0.00	0.77	0.77	0.96	230	221	112	440
ANGPT1	angiopoietin 1	Yes		ENSG00000154188	Q15389	NA	16	ligand	extracellular, intracellular, ligand, secreted	O15123, P05556, P08648, P35590, Q02763	ANGPT2, ITGA5, ITGAV_ITGB5, ITGB1, TEK, TIE1	TEK [Baccin2019:12427764;Baccin2019:8980223;Baccin2019:8980224;Baccin2019:9723709;BioGRID:8980223;CellChatDB:20651738;CellTalkDB:8980223;Cellinker:12427764;Cellinker:20651738;Cellinker:28396397;Cellinker:8980223;Cellinker:8980224;Cellinker:9723709;HPMR:8980223;HPRD:12427764;HPRD:8980223;HPRD:8980224;HPRD:9723709;IntAct:20708158;IntAct:29106382;LRdb:12427764;LRdb:8980223;LRdb:8980224;LRdb:9723709;Lit-BM-17:12427764;Lit-BM-17:20708158;Lit-BM-17:8980223;Lit-BM-17:9204896;Lit-BM-17:9723709;ProtMapper:21858121;SIGNOR:9204896;SignaLink3:12427764;SignaLink3:18988627;SignaLink3:20937382;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:8980223;SignaLink3:8980224;SignaLink3:9204896;SignaLink3:9723709;connectomeDB2020:12427764;connectomeDB2020:8980223;connectomeDB2020:8980224;connectomeDB2020:9723709], TIE1 [Baccin2019:11172728;CellTalkDB:11172728;Cellinker:11172728;HPMR:11172728;LRdb:11172728;SIGNOR:11172728;connectomeDB2020:11172728], ITGA5 [CellTalkDB:15781448;Cellinker:15781448;HPRD:15781448;LRdb:15781448;connectomeDB2020:15781448], ITGB1 [Baccin2019:11346644;CellTalkDB:15781448;connectomeDB2020:15690488;connectomeDB2020:19379779], ANGPT2 [HPRD:9204896]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]	identical protein binding [GO:0042802]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cell-substrate adhesion [GO:0031589]; glomerulus vasculature development [GO:0072012]; hemopoiesis [GO:0030097]; heparin biosynthetic process [GO:0030210]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular permeability [GO:0043116]; positive chemotaxis [GO:0050918]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of receptor internalization [GO:0002092]; protein localization to cell surface [GO:0034394]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of macrophage migration inhibitory factor signaling pathway [GO:2000446]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; regulation of tumor necrosis factor production [GO:0032680]; sprouting angiogenesis [GO:0002040]; Tie signaling pathway [GO:0048014]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ANGPT1&keywords=ANGPT1	0.44	535	NA	NA	0.07	671	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	303	406	400	0.00	0.89	0.89	0.89	194	172	150	446
IL12B	interleukin 12B	Yes		ENSG00000113302	P29460	IL-12B family	16	ligand	extracellular, intracellular, ligand, secreted, transmembrane	P42701, Q5VWK5, Q99665, Q9BWV1	BOC, IL12RB1, IL12RB1_IL12RB2, IL12RB2, IL23R	IL12RB1 [Baccin2019:7527811;Baccin2019:7843232;CellTalkDB:7843232;HPMR:11086056;HPRD:7527811;HPRD:7843232;InnateDB:7911493;InnateDB:8943050;LRdb:753;LRdb:7843232;SIGNOR:7527811;connectomeDB2020:7527811;connectomeDB2020:7843232], IL12RB2 [Baccin2019:1108605611940480;CellTalkDB:11086056;HPMR:11086056;HPRD:11940489;InnateDB:8943050;LRdb:11086056;LRdb:12;connectomeDB2020:11086056;connectomeDB2020:11940489], IL23R [CellTalkDB:17587057;InnateDB:12023369;LRdb:17587057;Ramilowski2015:17587057;connectomeDB2020:17587057;talklr:17587057], BOC [Cellinker:32822567]	cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-12 complex [GO:0043514]; interleukin-23 complex [GO:0070743]; late endosome lumen [GO:0031906]; receptor complex [GO:0043235]	cytokine activity [GO:0005125]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; interleukin-12 alpha subunit binding [GO:0042164]; interleukin-12 receptor binding [GO:0005143]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]	cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; natural killer cell activation [GO:0030101]; natural killer cell activation involved in immune response [GO:0002323]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of protein secretion [GO:0050709]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of mononuclear cell proliferation [GO:0032946]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002860]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of NK T cell activation [GO:0051135]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of tissue remodeling [GO:0034105]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of cytokine production [GO:0001817]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]; response to UV-B [GO:0010224]; sensory perception of pain [GO:0019233]; sexual reproduction [GO:0019953]; T-helper 1 type immune response [GO:0042088]; T-helper cell differentiation [GO:0042093]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL12B&keywords=IL12B	0.08	687	NA	NA	1.46	205	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	446
SHH	sonic hedgehog signaling molecule	Yes		ENSG00000164690	Q15465	Hedgehog family	16	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, receptor, secreted	P00450, P35052, P54826, P78333, P98164, Q13635, Q4KMG0, Q96QV1, Q99835, Q9BWV1, Q9NQ36, Q9Y6C5	BOC, CDON, CP, GAS1, GPC1, GPC5, HHIP, LRP2, PTCH1, PTCH1_SMO, PTCH2, PTCH2_SMO, SCUBE2, SMO	PTCH1 [Baccin2019:16867986;Baccin2019:9811851;BioGRID:16282375;CellTalkDB:9811851;Cellinker:16867986;Cellinker:21339334;Cellinker:30613383;Cellinker:9811851;HPMR:16867986;HPRD:9811851;ICELLNET:27647915;IntAct:29954986;IntAct:30139912;LRdb:169;LRdb:9811851;NetPath:8906787;NetPath:9811851;SIGNOR:14556242;SIGNOR:15618519;SIGNOR:9811851;SPIKE:20083481;SPIKE:9811851;SignaLink3:14556242;SignaLink3:23331499;connectomeDB2020:16867986;connectomeDB2020:9811851], PTCH2 [Baccin2019:9811851;CellTalkDB:9811851;Cellinker:9811851;HPRD:9811851;LRdb:9811851;NetPath:9811851;SIGNOR:9811851;SignaLink3:23331499;SignaLink3:9811851;connectomeDB2020:9811851], HHIP [Baccin2019:1005085510050850;CellTalkDB:10050855;Cellinker:10050855;HPRD:10050855;IntAct:19561609;LRdb:10050855;Lit-BM-17:19561609;NetPath:10050855;connectomeDB2020:10050855], GAS1 [CellTalkDB:17848687;Cellinker:17848687;Cellinker:30613383;HPRD:11572986;LRdb:17848687;NetPath:11572986;connectomeDB2020:17848687;connectomeDB2020:25535338], LRP2 [CellTalkDB:16828734;Cellinker:30613383;LRdb:22340494;Ramilowski2015:22340494;connectomeDB2020:22340494;talklr:22340494], BOC [Baccin2019:17086203;CellTalkDB:17086203;Cellinker:17086203;Cellinker:30613383;HPMR:17086203;LRdb:17086203;NetPath:16647304;connectomeDB2020:17086203], CP [SIGNOR:14556242;SIGNOR:15618519;SIGNOR:17419683;SIGNOR:9811851], SCUBE2 [CellTalkDB:19480626], GPC5 [CellTalkDB:21339334;Cellinker:21339334;LRdb:21339334;Ramilowski2015:21339334;connectomeDB2020:21339334;talklr:21339334], CDON [Baccin2019:17086203;CellTalkDB:17086203;Cellinker:17086203;LRdb:17086203;NetPath:16647304;connectomeDB2020:17086203], SMO [Baccin2019:16867986;CellTalkDB:16867986;Cellinker:16867986;HPMR:16867986;LRdb:16867986;NetPath:8906787;connectomeDB2020:16867986], GPC1 [CellTalkDB:23931997]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; glycosaminoglycan binding [GO:0005539]; laminin-1 binding [GO:0043237]; morphogen activity [GO:0016015]; patched binding [GO:0005113]; zinc ion binding [GO:0008270]	androgen metabolic process [GO:0008209]; animal organ formation [GO:0048645]; apoptotic signaling pathway [GO:0097190]; artery development [GO:0060840]; axon guidance [GO:0007411]; Bergmann glial cell differentiation [GO:0060020]; blood coagulation [GO:0007596]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; branching morphogenesis of an epithelial tube [GO:0048754]; bud outgrowth involved in lung branching [GO:0060447]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway [GO:0060070]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; cell-cell signaling [GO:0007267]; cell development [GO:0048468]; cell fate specification [GO:0001708]; cellular response to lithium ion [GO:0071285]; central nervous system development [GO:0007417]; cerebellar granule cell precursor proliferation [GO:0021930]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal system development [GO:0048706]; endocytosis [GO:0006897]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial-mesenchymal signaling involved in prostate gland development [GO:0060738]; establishment of cell polarity [GO:0030010]; forebrain development [GO:0030900]; formation of anatomical boundary [GO:0048859]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; hindgut morphogenesis [GO:0007442]; inner ear development [GO:0048839]; intein-mediated protein splicing [GO:0016539]; intermediate filament organization [GO:0045109]; left lung development [GO:0060459]; limb bud formation [GO:0060174]; lung-associated mesenchyme development [GO:0060484]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung lobe morphogenesis [GO:0060463]; lymphoid progenitor cell differentiation [GO:0002320]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesenchymal smoothened signaling pathway involved in prostate gland development [GO:0060783]; metanephric collecting duct development [GO:0072205]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephros development [GO:0001656]; midbrain development [GO:0030901]; myoblast differentiation [GO:0045445]; myotube differentiation [GO:0014902]; negative regulation of alpha-beta T cell differentiation [GO:0046639]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of gene expression [GO:0010629]; negative regulation of kidney smooth muscle cell differentiation [GO:2000357]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of ureter smooth muscle cell differentiation [GO:2000062]; negative thymic T cell selection [GO:0045060]; neural crest cell migration [GO:0001755]; neuroblast proliferation [GO:0007405]; neuron fate commitment [GO:0048663]; odontogenesis of dentin-containing tooth [GO:0042475]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; osteoblast development [GO:0002076]; pancreas development [GO:0031016]; pattern specification process [GO:0007389]; polarity specification of anterior/posterior axis [GO:0009949]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of gene expression [GO:0010628]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of kidney smooth muscle cell differentiation [GO:2000358]; positive regulation of mesenchymal cell proliferation involved in ureter development [GO:2000729]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sclerotome development [GO:0061189]; positive regulation of skeletal muscle cell proliferation [GO:0014858]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of striated muscle cell differentiation [GO:0051155]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ureter smooth muscle cell differentiation [GO:2000063]; positive regulation of Wnt signaling pathway [GO:0030177]; positive thymic T cell selection [GO:0045059]; primary prostatic bud elongation [GO:0060516]; prostate epithelial cord elongation [GO:0060523]; prostate gland development [GO:0030850]; protein autoprocessing [GO:0016540]; protein localization to nucleus [GO:0034504]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of mesenchymal cell proliferation involved in prostate gland development [GO:0060782]; regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900175]; regulation of odontogenesis [GO:0042481]; regulation of prostatic bud formation [GO:0060685]; regulation of protein localization to nucleus [GO:1900180]; regulation of proteolysis [GO:0030162]; right lung development [GO:0060458]; roof of mouth development [GO:0060021]; salivary gland cavitation [GO:0060662]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation [GO:0021938]; smooth muscle tissue development [GO:0048745]; somite development [GO:0061053]; spinal cord dorsal/ventral patterning [GO:0021513]; spinal cord motor neuron differentiation [GO:0021522]; stem cell development [GO:0048864]; striated muscle tissue development [GO:0014706]; T cell differentiation in thymus [GO:0033077]; telencephalon regionalization [GO:0021978]; thalamus development [GO:0021794]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea morphogenesis [GO:0060439]; tracheoesophageal septum formation [GO:1905327]; vasculogenesis [GO:0001570]; ventral midline development [GO:0007418]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SHH&keywords=SHH	0.51	521	NA	NA	0.44	406	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	464
INHA	inhibin subunit alpha	Yes		ENSG00000123999	P05111	TGF-beta family	16	ligand	extracellular, intracellular, ligand, secreted	P27037, P36896, Q03167, Q04771, Q13705, Q8NER5	ACVR1, ACVR1B, ACVR1C, ACVR2A, ACVR2B, TGFBR3	ACVR2A [Baccin2019:12493742;CellTalkDB:12493742;LRdb:12493742;connectomeDB2020:12493742], ACVR1B [NA], ACVR2B [CellTalkDB:32196115;LRdb:29747587], ACVR1C [NA], TGFBR3 [Baccin2019:1249374210746730;CellTalkDB:12493742;Cellinker:10746731;Cellinker:12493742;HPRD:10746731;LRdb:11;LRdb:12493742;SIGNOR:10746731;connectomeDB2020:10746731;connectomeDB2020:12493742], ACVR1 [CellTalkDB:32196115;LRdb:29747587]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; inhibin A complex [GO:0043512]; inhibin B complex [GO:0043513]; inhibin-betaglycan-ActRII complex [GO:0034673]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; inhibin binding [GO:0034711]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]	cell-cell signaling [GO:0007267]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; erythrocyte differentiation [GO:0030218]; hemoglobin biosynthetic process [GO:0042541]; male gonad development [GO:0008584]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of cell cycle [GO:0045786]; negative regulation of follicle-stimulating hormone secretion [GO:0046882]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of phosphorylation [GO:0042326]; ovarian follicle development [GO:0001541]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=INHA&keywords=INHA	0.29	577	NA	NA	0.03	768	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.02	0.00	0.00	238	379	357	0.00	2.28	0.83	0.86	23	196	158	480
IFNB1	interferon beta 1	Yes		ENSG00000171855	P01574	Alpha/beta interferon family	16	ligand	extracellular, intracellular, ligand, secreted	P17181, P23458, P29597, P48551	IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2, JAK1, TYK2	IFNAR1 [Baccin2019:112785381834641;CellTalkDB:11278538;DIP:10049744;DIP:7592797;Guide2Pharma:29311663;HPRD:1834641;LRdb:11278538;LRdb:18;Macrophage:7623815;SIGNOR:11278538;SignaLink3:1834641;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:8181059;connectomeDB2020:11278538;connectomeDB2020:1834641;scConnect:29311663], IFNAR2 [Baccin2019:1127853810395660;CellTalkDB:11278538;DIP:10395669;HPRD:10395669;LRdb:1;LRdb:11278538;Macrophage:7623815;SIGNOR:11278538;SignaLink3:23331499;SignaLink3:8181059;connectomeDB2020:10395669;connectomeDB2020:11278538], TYK2 [SignaLink3:10542297;SignaLink3:23331499], JAK1 [SignaLink3:10918594;SignaLink3:23331499]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	chloramphenicol O-acetyltransferase activity [GO:0008811]; cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell activation involved in immune response [GO:0002312]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cell surface receptor signaling pathway [GO:0007166]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-beta [GO:0035458]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation [GO:0030101]; natural killer cell activation involved in immune response [GO:0002323]; negative regulation of T cell differentiation [GO:0045581]; negative regulation of T-helper 2 cell cytokine production [GO:2000552]; negative regulation of viral genome replication [GO:0045071]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of innate immune response [GO:0045089]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of MHC class I biosynthetic process [GO:0045343]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNB1&keywords=IFNB1	0.01	818	NA	NA	1.80	177	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	498
WNT2	Wnt family member 2	Yes		ENSG00000105989	P09544	Wnt family	16	ecm, ligand, receptor	ecm, intracellular, ligand, receptor, secreted	O00144, O75084, O75197, O75581, Q13467, Q14332, Q9H461, Q9NPG1, Q9ULV1, Q9UP38	FZD1, FZD1_LRP5, FZD1_LRP6, FZD10_LRP5, FZD10_LRP6, FZD2, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4, FZD4_LRP5, FZD4_LRP6, FZD5, FZD5_LRP5, FZD5_LRP6, FZD6_LRP5, FZD6_LRP6, FZD7, FZD7_LRP5, FZD7_LRP6, FZD8, FZD8_LRP5, FZD8_LRP6, FZD9, FZD9_LRP5, FZD9_LRP6, LRP5, LRP6	FZD9 [Baccin2019:12138115;CellPhoneDB:24032637;CellTalkDB:12138115;HPRD:12138115;LRdb:12138115;NetPath:19038973;SignaLink3:12138115;SignaLink3:23331499;connectomeDB2020:12138115], LRP5 [Cellinker:23209147;SIGNOR:15578921], LRP6 [CellTalkDB:32196115;Cellinker:23209147;SIGNOR:15578921], FZD1 [Baccin2019:10557084;CancerCellMap:10557084;CellTalkDB:10557084;HPRD:10557084;LRdb:10557084;NetPath:10557084;connectomeDB2020:10557084], FZD4 [CellPhoneDB:24032637;CellTalkDB:24032637;LRdb:24032637;connectomeDB2020:24032637], FZD7 [LRdb:23815780;Ramilowski2015:23815780;connectomeDB2020:23815780;talklr:23815780], FZD3 [CellPhoneDB:24032637;CellTalkDB:24032637;LRdb:24032637;NetPath:19038973;connectomeDB2020:24032637], FZD8 [CellTalkDB:23815780;LRdb:23815780;Ramilowski2015:23815780;connectomeDB2020:23815780;talklr:23815780], FZD5 [Baccin2019:24032637;LRdb:18302287;Ramilowski2015:18302287;connectomeDB2020:18302287;talklr:18302287], FZD2 [CellPhoneDB:24032637;CellTalkDB:24032637;connectomeDB2020:24032637]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; Wnt signalosome [GO:1990909]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]	atrial cardiac muscle tissue morphogenesis [GO:0055009]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell-cell signaling [GO:0007267]; cell fate commitment [GO:0045165]; cell proliferation in midbrain [GO:0033278]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; iris morphogenesis [GO:0061072]; labyrinthine layer blood vessel development [GO:0060716]; lens development in camera-type eye [GO:0002088]; lung development [GO:0030324]; lung induction [GO:0060492]; mammary gland epithelium development [GO:0061180]; midbrain dopaminergic neuron differentiation [GO:1904948]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT2&keywords=WNT2	0.06	717	NA	NA	0.06	691	0.00	0.00	0.00	0.01	0.00	0.00	0.01	0.01	0.00	0.00	0.01	298	394	243	0.00	0.82	0.72	1.50	211	245	34	512
VEGFD	vascular endothelial growth factor D	Yes		ENSG00000165197	O43915	PDGF/VEGF growth factor family	16	ligand	extracellular, intracellular, ligand, secreted	O60462, P05556, P08648, P13612, P17301, P17948, P35916, P35968, P56199, Q13797	FLT1, FLT4, FLT4_KDR, ITGA1, ITGA2, ITGA4, ITGA5, ITGA9, ITGB1, KDR, NRP2	FLT4 [BioGRID:11279005;CellChatDB:16633338;CellTalkDB:9435229;Cellinker:9435229;HPRD:9435229;ICELLNET:11532940;ICELLNET:16336962;SIGNOR:9435229;connectomeDB2020:21148085;connectomeDB2020:9435229], KDR [CellChatDB:16633338;CellTalkDB:9435229;Cellinker:9435229;HPRD:9435229;ICELLNET:16835467;SIGNOR:9435229;connectomeDB2020:9435229], ITGA4 [CellTalkDB:32196115], ITGB1 [CellTalkDB:15590642], NRP2 [CellTalkDB:16816121;Cellinker:16816121;Cellinker:9435229;connectomeDB2020:16816121;connectomeDB2020:9435229], ITGA9 [CellTalkDB:15590642;Cellinker:15590642;HPRD:15590642;connectomeDB2020:15590642], FLT1 [CellTalkDB:32196115], ITGA1 [CellTalkDB:32196115], ITGA5 [CellTalkDB:32196115], ITGA2 [CellTalkDB:32196115]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]	chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; platelet-derived growth factor receptor binding [GO:0005161]; vascular endothelial growth factor receptor 3 binding [GO:0043185]; vascular endothelial growth factor receptor binding [GO:0005172]	cell population proliferation [GO:0008283]; dopaminergic neuron differentiation [GO:0071542]; induction of positive chemotaxis [GO:0050930]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of protein phosphorylation [GO:0001934]; response to bacterium [GO:0009617]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=VEGFD&keywords=VEGFD	0.44	536	NA	NA	0.08	663	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	600
IL17B	interleukin 17B	Yes		ENSG00000127743	Q9UHF5	IL-17 family	16	ligand	ligand, secreted	Q96F46, Q9NRM6	IL17RA, IL17RB	IL17RA [NA], IL17RB [Baccin2019:1074988710749880;CellTalkDB:10749887;Cellinker:10749887;HPRD:10749887;ICELLNET:24011563;InnateDB:10749887;InnateDB:11058597;LRdb:10749887;SIGNOR:10749887;connectomeDB2020:10749887]	extracellular space [GO:0005615]	cytokine activity [GO:0005125]	cell-cell signaling [GO:0007267]; immune response [GO:0006955]; inflammatory response [GO:0006954]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL17B&keywords=IL17B	0.24	596	NA	NA	0.11	623	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	610
INSL3	insulin like 3	Yes		ENSG00000248099	P51460	Insulin family	16	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, P07550, P13945, P16473, P32241, P41586, Q03431, Q8TDU9, Q8WXD0, Q99678, Q9HBX9, Q9NQS5, Q9NSD7	ADCYAP1R1, ADRB2, ADRB3, GPR20, GPR84, PTH1R, RAMP2, RAMP3, RXFP1, RXFP2, RXFP3, RXFP4, TSHR, VIPR1	RXFP2 [Baccin2019:12114498;Baccin2019:15649866;Baccin2019:20560146;CellTalkDB:12114498;Cellinker:12114498;Cellinker:15649866;Cellinker:20560146;Cellinker:22973049;Cellinker:25761609;Guide2Pharma:15649866;Guide2Pharma:18434306;HPMR:12114498;HPRD:12114498;HPRD:15649866;LRdb:12114498;LRdb:15649866;LRdb:20560146;connectomeDB2020:12114498;connectomeDB2020:15649866;connectomeDB2020:20560146;scConnect:15649866;scConnect:18434306], ADCYAP1R1 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], RXFP1 [CellTalkDB:32103204;Cellinker:25761609;scConnect:23303914], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], RXFP4 [NA], RXFP3 [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]	G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]; insulin receptor binding [GO:0005158]; protease binding [GO:0002020]; signaling receptor binding [GO:0005102]	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cell-cell signaling [GO:0007267]; male gonad development [GO:0008584]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; oocyte maturation [GO:0001556]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of wound healing [GO:0090303]; spermatogenesis [GO:0007283]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=INSL3&keywords=INSL3	0.29	581	NA	NA	0.06	689	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	635
INHBC	inhibin subunit beta C	Yes		ENSG00000175189	P55103	TGF-beta family	16	ligand	ligand, ligand_regulator, secreted	P27037, P36896, Q04771, Q13705	ACVR1, ACVR1B, ACVR1B_ACVR2A, ACVR1B_ACVR2B, ACVR1C_ACVR2A, ACVR1C_ACVR2B, ACVR2A, ACVR2B	ACVR2B [Baccin2019:12651901;CellPhoneDB:22710174;CellTalkDB:22710174;Cellinker:22710174;HPRD:12651901;LRdb:12651901;connectomeDB2020:12651901], ACVR1B [Baccin2019:12651901;HPRD:12651901;LRdb:12651901], ACVR2A [Baccin2019:12651901;CellPhoneDB:22710174;CellTalkDB:22710174;Cellinker:22710174;HPRD:12651901;LRdb:12651901;connectomeDB2020:12651901], ACVR1 [Baccin2019:12651901;HPRD:12651901;LRdb:12651901]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; transforming growth factor beta receptor binding [GO:0005160]	positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=INHBC&keywords=INHBC	0.09	678	NA	NA	0.12	603	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	641
FASLG	Fas ligand	Yes		ENSG00000117560	P48023	Tumor necrosis factor family	16	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, receptor, secreted, transmembrane, transmembrane_predicted	O14763, O95407, P19438, P25445, P55957	BID, FAS, TNFRSF10B, TNFRSF1A, TNFRSF6B	FAS [Baccin2019:9126929;Baccin2019:9228058;BioGRID:9126929;BioGRID:9228058;CA1:1375228;CA1:1713127;CA1:7505205;CellTalkDB:9126929;Cellinker:9126929;Cellinker:9228058;HPMR:9126929;HPRD:9126929;HPRD:9228058;ICELLNET:11239407;IntAct:21803845;IntAct:25241761;LRdb:9126929;LRdb:9228058;Lit-BM-17:12753742;Lit-BM-17:12887920;Lit-BM-17:15659383;Lit-BM-17:21803845;Lit-BM-17:25241761;Lit-BM-17:9126929;Lit-BM-17:9228058;Macrophage:15725726;Macrophage:8521815;Macrophage:9039262;Macrophage:9126929;Macrophage:9228058;SIGNOR:14965271;SIGNOR:9228058;SPIKE:9126929;SPIKE:9228058;connectomeDB2020:9126929;connectomeDB2020:9228058], TNFRSF6B [BioGRID:9872321;CellTalkDB:14697332;Cellinker:10318773;Cellinker:11994433;Cellinker:14697332;Cellinker:9872321;HPMR:14697332;HPRD:10318773;HPRD:11994433;HPRD:9872321;ICELLNET:11239407;LRdb:10318773;LRdb:11994433;LRdb:14697332;LRdb:9872321;connectomeDB2020:10318773;connectomeDB2020:11994433;connectomeDB2020:14697332;connectomeDB2020:9872321], TNFRSF1A [NA], TNFRSF10B [CellTalkDB:32103204], BID [Lit-BM-17:15659383;Lit-BM-17:25241761]	caveola [GO:0005901]; cytoplasmic vesicle lumen [GO:0060205]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; lysosomal lumen [GO:0043202]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; death receptor binding [GO:0005123]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell-cell signaling [GO:0007267]; cellular chloride ion homeostasis [GO:0030644]; cellular response to interferon-gamma [GO:0071346]; endosomal lumen acidification [GO:0048388]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; inflammatory cell apoptotic process [GO:0006925]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of phosphatidylserine exposure on apoptotic cell surface [GO:1905782]; release of sequestered calcium ion into cytosol by endoplasmic reticulum [GO:1903514]; response to growth factor [GO:0070848]; response to lipopolysaccharide [GO:0032496]; retinal cell programmed cell death [GO:0046666]; signal transduction [GO:0007165]; T cell apoptotic process [GO:0070231]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FASLG&keywords=FASLG	0.03	773	NA	NA	0.12	601	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	687
WNT11	Wnt family member 11	Yes		ENSG00000085741	O96014	Wnt family	16	ecm, ligand	ecm, intracellular, ligand, secreted	A4D1S0, O00144, O15146, O60353, O75084, O75581, Q13467, Q14332, Q96CG8, Q9H461, Q9NPG1, Q9ULV1, Q9ULW2, Q9UP38	CTHRC1, FZD1, FZD10, FZD2, FZD3, FZD4, FZD5, FZD6, FZD7, FZD8, FZD9, KLRG2, LRP6, MUSK	MUSK [CellTalkDB:22309736;SIGNOR:22309736;SIGNOR:23151663], FZD6 [SIGNOR:16273260], FZD7 [Baccin2019:10862746;CellTalkDB:10862746;Cellinker:10862746;LRdb:10862746;SIGNOR:10862746;connectomeDB2020:10862746], LRP6 [SIGNOR:15578921], FZD3 [SIGNOR:15578921;SIGNOR:16273260], KLRG2 [CellTalkDB:32103204], FZD1 [NA], FZD10 [NA], FZD2 [NA], FZD4 [NA], FZD5 [NA], FZD8 [connectomeDB2020:29717114], FZD9 [NA], CTHRC1 [Cellinker:18606138]	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; GTPase activator activity [GO:0005096]; protein kinase activator activity [GO:0030295]	adrenal gland development [GO:0030325]; artery morphogenesis [GO:0048844]; atrial septum development [GO:0003283]; bicellular tight junction assembly [GO:0070830]; bone mineralization [GO:0030282]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to mechanical stimulus [GO:0071260]; cellular response to retinoic acid [GO:0071300]; cloacal septation [GO:0060197]; convergent extension involved in axis elongation [GO:0060028]; embryonic skeletal system development [GO:0048706]; epithelial to mesenchymal transition [GO:0001837]; lung-associated mesenchyme development [GO:0060484]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; mesonephric duct development [GO:0072177]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroendocrine cell differentiation [GO:0061101]; neuron differentiation [GO:0030182]; notochord morphogenesis [GO:0048570]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; paraxial mesoderm formation [GO:0048341]; planar cell polarity pathway involved in axis elongation [GO:0003402]; planar cell polarity pathway involved in gastrula mediolateral intercalation [GO:0060775]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway [GO:0090082]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta2 production [GO:0032915]; primary heart field specification [GO:0003138]; protein localization to cell surface [GO:0034394]; protein phosphorylation [GO:0006468]; response to nutrient levels [GO:0031667]; secondary heart field specification [GO:0003139]; secondary palate development [GO:0062009]; somite development [GO:0061053]; ureteric bud morphogenesis [GO:0060675]; ventricular septum morphogenesis [GO:0060412]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT11&keywords=WNT11	0.18	622	NA	NA	0.03	762	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	692
OSTN	osteocrin	Yes		ENSG00000188729	P61366	Osteocrin family	16	ligand	extracellular, ligand, secreted	P17342	NPR3	NPR3 [Baccin2019:17951249;CellChatDB:29326144;CellTalkDB:17951249;Cellinker:17951249;Cellinker:29326144;Guide2Pharma:17951249;ICELLNET:17951249;ICELLNET:19244276;LRdb:17951249;connectomeDB2020:17951249;scConnect:17951249]	extracellular space [GO:0005615]	hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]	cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; endochondral bone growth [GO:0003416]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of dendrite extension [GO:1903860]; negative regulation of glucose import [GO:0046325]; negative regulation of osteoblast differentiation [GO:0045668]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=OSTN&keywords=OSTN	0.00	884	NA	NA	0.07	678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	781
GDF2	growth differentiation factor 2	Yes		ENSG00000263761	Q9UK05	TGF-beta family	16	ligand	ligand, secreted	O00238, P17813, P27037, P36894, P37023, Q04771, Q13705, Q13873	ACVR1, ACVR2A, ACVR2A_ACVRL1, ACVR2B, ACVR2B_ACVRL1, ACVRL1, ACVRL1_BMPR2, BMPR1A, BMPR1B, BMPR2, ENG	BMPR1B [NA], ACVR2A [CellTalkDB:22622516;LRdb:19996292;Ramilowski2015:19996292;connectomeDB2020:19996292;talklr:19996292], BMPR1A [NA], ACVRL1 [Baccin2019:17068149;BioGRID:25237187;CellTalkDB:17068149;LRdb:17068149;SIGNOR:17068149;connectomeDB2020:17068149], ACVR1 [CellTalkDB:19996292;Cellinker:27252362;LRdb:19996292;Ramilowski2015:19996292;connectomeDB2020:19996292;talklr:19996292], ACVR2B [Cellinker:26047946;Cellinker:27252362;LRdb:15851468;Ramilowski2015:15851468;connectomeDB2020:15851468;talklr:15851468], BMPR2 [CellTalkDB:28646109;LRdb:15851468;Ramilowski2015:15851468;connectomeDB2020:15851468;talklr:15851468], ENG [CellTalkDB:28564608;Cellinker:31540324;IntAct:28564608;LRdb:7068149;Ramilowski2015:7068149;connectomeDB2020:7068149;talklr:7068149]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]	activin receptor signaling pathway [GO:0032924]; angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; BMP signaling pathway [GO:0030509]; branching involved in blood vessel morphogenesis [GO:0001569]; cartilage development [GO:0051216]; cellular iron ion homeostasis [GO:0006879]; cellular response to BMP stimulus [GO:0071773]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA replication [GO:0008156]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cartilage development [GO:0061036]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; SMAD protein signal transduction [GO:0060395]; vasculogenesis [GO:0001570]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GDF2&keywords=GDF2	0.00	899	NA	NA	0.06	695	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	797
GH2	growth hormone 2	Yes		ENSG00000136487	P01242	Somatotropin/prolactin family	16	ligand	extracellular, intracellular, ligand, secreted	P10912	GHR	GHR [CellTalkDB:1955498;Cellinker:1955498;HPRD:1955498;ICELLNET:2387255;LRdb:1955498;connectomeDB2020:1955498]	endosome lumen [GO:0031904]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	growth factor activity [GO:0008083]; growth hormone receptor binding [GO:0005131]; hormone activity [GO:0005179]	animal organ development [GO:0048513]; growth hormone receptor signaling pathway [GO:0060396]; positive regulation of growth [GO:0045927]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to nutrient levels [GO:0031667]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GH2&keywords=GH2	0.00	868	NA	NA	0.04	738	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	803
NPPA	natriuretic peptide A	Yes		ENSG00000175206	P01160	Natriuretic peptide family	16	ligand	extracellular, intracellular, ligand, secreted	P08473, P16066, P17342, P20594	MME, NPR1, NPR2, NPR3	NPR1 [CellChatDB:29934640;Cellinker:12488235;Cellinker:12547834;Cellinker:15911069;Cellinker:8700153;Guide2Pharma:8700153;HPMR:15911069;HPRD:12547834;LRdb:12547834;LRdb:15911069;LRdb:8700153;SIGNOR:15911069;connectomeDB2020:12547834;connectomeDB2020:15911069;connectomeDB2020:8700153;scConnect:8700153], NPR3 [Baccin2019:21697332169733;CellTalkDB:2169733;Cellinker:12488235;Cellinker:2169733;HPMR:2169733;HPRD:2169733;LRdb:2169733;Lit-BM-17:1309330;Lit-BM-17:1660465;Lit-BM-17:1672777;Lit-BM-17:16870210;connectomeDB2020:2169733], NPR2 [CellTalkDB:32103204;connectomeDB2020:1309330;connectomeDB2020:1660465;connectomeDB2020:1672777], MME [HPRD:2531377;HPRD:2972276;HPRD:9232196]	cell projection [GO:0042995]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]	hormone activity [GO:0005179]; hormone receptor binding [GO:0051427]; neuropeptide hormone activity [GO:0005184]; neuropeptide receptor binding [GO:0071855]; signaling receptor binding [GO:0005102]	aortic valve morphogenesis [GO:0003180]; cardiac conduction system development [GO:0003161]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; female pregnancy [GO:0007565]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of systemic arterial blood pressure [GO:0003085]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of heart rate [GO:0010460]; positive regulation of potassium ion export across plasma membrane [GO:1903766]; protein folding [GO:0006457]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of blood pressure [GO:0008217]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of high voltage-gated calcium channel activity [GO:1901841]; response to muscle stretch [GO:0035994]; vasodilation [GO:0042311]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPPA&keywords=NPPA	0.04	749	NA	NA	0.00	907	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	828
ADIPOQ	adiponectin, C1Q and collagen domain containing	Yes		ENSG00000181092	Q15848	NA	16	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	O15529, P07307, P34972, Q86V24, Q8NFJ6, Q8TDT2, Q96A54, Q9UHP7	ADIPOR1, ADIPOR2, ASGR2, CLEC2D, CNR2, GPR152, GPR42, PROKR2	ADIPOR2 [Baccin2019:12802330;Baccin2019:12802337;CellChatDB:21284979;CellTalkDB:12802337;Cellinker:12802337;Cellinker:21284979;HPRD:12802337;LRdb:12802337;SIGNOR:12802337;SIGNOR:16622416;connectomeDB2020:12802337], ADIPOR1 [Baccin2019:12802337;CellChatDB:21284979;CellTalkDB:12802337;Cellinker:12802337;Cellinker:21284979;HPMR:12802337;LRdb:12802337;SIGNOR:16622416;connectomeDB2020:12802337], GPR42 [CellTalkDB:32103204], CNR2 [CellTalkDB:32103204], ASGR2 [NA], PROKR2 [NA], CLEC2D [NA], GPR152 [NA]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]	brown fat cell differentiation [GO:0050873]; cellular response to cAMP [GO:0071320]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to insulin stimulus [GO:0032869]; cellular response to xenobiotic stimulus [GO:0071466]; circadian rhythm [GO:0007623]; detection of oxidative stress [GO:0070994]; fatty acid beta-oxidation [GO:0006635]; fatty acid oxidation [GO:0019395]; gene expression [GO:0010467]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; low-density lipoprotein particle clearance [GO:0034383]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell migration [GO:0030336]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of hormone secretion [GO:0046888]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of intracellular protein transport [GO:0090317]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of metanephric mesenchymal cell migration [GO:2000590]; negative regulation of phagocytosis [GO:0050765]; negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000584]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of receptor binding [GO:1900121]; negative regulation of synaptic transmission [GO:0050805]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of lipid transporter activity [GO:0110113]; positive regulation of metanephric glomerular visceral epithelial cell development [GO:2000478]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of myeloid cell apoptotic process [GO:0033034]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of renal albumin absorption [GO:2000534]; positive regulation of signal transduction [GO:0009967]; protein localization to plasma membrane [GO:0072659]; regulation of glucose metabolic process [GO:0010906]; response to activity [GO:0014823]; response to bacterium [GO:0009617]; response to ethanol [GO:0045471]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to linoleic acid [GO:0070543]; response to nutrient [GO:0007584]; response to sucrose [GO:0009744]; response to tumor necrosis factor [GO:0034612]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ADIPOQ&keywords=ADIPOQ	0.03	766	NA	NA	0.00	891	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	829
INSL5	insulin like 5	Yes		ENSG00000172410	Q9Y5Q6	Insulin family	16	ligand	extracellular, ligand, secreted	P08913, P48039, Q14831, Q8TDU9, Q8WXD0, Q9HBX9, Q9NSD7	ADRA2A, GRM7, MTNR1A, RXFP1, RXFP2, RXFP3, RXFP4	RXFP3 [Baccin2019:15525639;CellTalkDB:15525639;Cellinker:15525639;Cellinker:25761609;Guide2Pharma:18582868;LRdb:15525639;connectomeDB2020:15525639;scConnect:18582868], RXFP4 [Baccin2019:1546592515525630;CellTalkDB:15465925;Cellinker:15465925;Cellinker:15525639;Cellinker:25761609;Cellinker:27888281;Guide2Pharma:15525639;Guide2Pharma:18582868;Guide2Pharma:18682868;Guide2Pharma:22257012;Guide2Pharma:24188028;Guide2Pharma:26824523;LRdb:15465925;LRdb:16;connectomeDB2020:15465925;connectomeDB2020:15525639;scConnect:15525639;scConnect:18582868;scConnect:18682868;scConnect:22257012;scConnect:24188028;scConnect:26824523;scConnect:27243554], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], RXFP2 [NA], RXFP1 [NA]	extracellular region [GO:0005576]	G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]	positive regulation of feeding behavior [GO:2000253]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=INSL5&keywords=INSL5	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	#DIV/0!
ADCYAP1	adenylate cyclase activating polypeptide 1	Yes	also known as PACAP	ENSG00000141433	P18509	Glucagon family	15	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, P07550, P13945, P16473, P27487, P32241, P41586, P41587, P47872, Q03431, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, DPP4, GPR20, GPR84, PTH1R, RAMP2, RAMP3, SCTR, TSHR, VIPR1, VIPR2	ADCYAP1R1 [Baccin2019:10100920;Baccin2019:10583729;Baccin2019:11931347;Baccin2019:16930633;Baccin2019:8253796;Baccin2019:8703026;CellChatDB:21350482;CellTalkDB:10100920;Cellinker:10100920;Cellinker:10583729;Cellinker:11931347;Cellinker:12488235;Cellinker:16930633;Cellinker:21350482;Cellinker:8253796;Cellinker:8703026;DIP:17470806;Guide2Pharma:10583729;Guide2Pharma:11931347;Guide2Pharma:16930633;HPMR:10100920;HPRD:10583729;HPRD:8253796;LRdb:10100920;LRdb:10583729;LRdb:11931347;LRdb:16930633;LRdb:8253796;LRdb:8703026;SIGNOR:8703026;connectomeDB2020:10100920;connectomeDB2020:10583729;connectomeDB2020:11931347;connectomeDB2020:16930633;connectomeDB2020:8253796;connectomeDB2020:8703026;scConnect:10583729;scConnect:11931347;scConnect:16930633], VIPR1 [Baccin2019:11897681;Baccin2019:11931347;Baccin2019:12429744;Baccin2019:16930633;Baccin2019:8791009;Baccin2019:9928018;CellTalkDB:11897681;Cellinker:11897681;Cellinker:11931347;Cellinker:12429744;Cellinker:12488235;Cellinker:16930633;Cellinker:8791009;Cellinker:9928018;Guide2Pharma:11931347;Guide2Pharma:16930633;Guide2Pharma:8791009;Guide2Pharma:9928018;HPRD:12429744;LRdb:11897681;LRdb:11931347;LRdb:12429744;LRdb:16930633;LRdb:8791009;LRdb:9928018;SIGNOR:11897681;connectomeDB2020:11897681;connectomeDB2020:11931347;connectomeDB2020:12429744;connectomeDB2020:16930633;connectomeDB2020:8791009;connectomeDB2020:9928018;scConnect:11931347;scConnect:16930633;scConnect:8791009;scConnect:9928018], VIPR2 [Baccin2019:11931347;Baccin2019:11978642;Baccin2019:16930633;Baccin2019:8146174;Baccin2019:9928018;CellTalkDB:9928018;Cellinker:11931347;Cellinker:11978642;Cellinker:12488235;Cellinker:16930633;Cellinker:8146174;Cellinker:9928018;Guide2Pharma:11931347;Guide2Pharma:11978642;Guide2Pharma:16930633;Guide2Pharma:9928018;HPRD:8146174;LRdb:11931347;LRdb:11978642;LRdb:16930633;LRdb:8146174;LRdb:9928018;connectomeDB2020:11931347;connectomeDB2020:11978642;connectomeDB2020:16930633;connectomeDB2020:8146174;connectomeDB2020:9928018;scConnect:11931347;scConnect:11978642;scConnect:16930633;scConnect:9928018], SCTR [Baccin2019:1335692;CellTalkDB:1335692;HPRD:1335692;LRdb:1335692;connectomeDB2020:1335692], RAMP3 [CellTalkDB:23745705], RAMP2 [CellTalkDB:23745705], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], DPP4 [Cellinker:21314817], GPR20 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115]	extracellular region [GO:0005576]; neuron projection [GO:0043005]; perikaryon [GO:0043204]	neuropeptide hormone activity [GO:0005184]; peptide hormone receptor binding [GO:0051428]; pituitary adenylate cyclase activating polypeptide activity [GO:0016521]; pituitary adenylate cyclase-activating polypeptide receptor binding [GO:0031858]; signaling receptor binding [GO:0005102]	activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell-cell signaling [GO:0007267]; female pregnancy [GO:0007565]; insulin secretion [GO:0030073]; negative regulation of cell cycle [GO:0045786]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of protein localization [GO:0032880]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ADCYAP1&keywords=ADCYAP1	55.52	77	3590.02	104	30.29	21	0.01	0.10	0.01	0.01	0.07	0.90	1.23	0.11	0.02	1.20	0.03	235	25	183	0.33	0.09	3.51	0.12	482	4	466	46
NPY	neuropeptide Y	Yes		ENSG00000122585	P01303	NPY family	15	ligand	extracellular, intracellular, ligand, secreted, transmembrane	P07550, P08588, P08913, P25929, P27487, P32245, P48039, P49146, P49683, P50391, Q12884, Q14831, Q15761, Q99463, Q9NYM4, Q9Y5X5	ADRA2A, ADRB1, ADRB2, DPP4, FAP, GPR83, GRM7, MC4R, MTNR1A, NPFFR2, NPY1R, NPY2R, NPY4R, NPY5R, NPY6R, PRLHR	PRLHR [Baccin2019:15885496;CellTalkDB:15885496;Cellinker:15885496;Guide2Pharma:15885496;LRdb:15885496;connectomeDB2020:15885496;scConnect:15885496], NPY1R [Baccin2019:12007534;Baccin2019:7559383;Baccin2019:9001438;Baccin2019:9549761;CellTalkDB:9001438;Cellinker:12007534;Cellinker:7559383;Cellinker:9001438;Cellinker:9549761;HPMR:9549761;HPRD:12007534;HPRD:7559383;HPRD:9001438;LRdb:12007534;LRdb:7559383;LRdb:9001438;LRdb:9549761;Lit-BM-17:23597562;Lit-BM-17:7559383;SIGNOR:9549761;connectomeDB2020:12007534;connectomeDB2020:7559383;connectomeDB2020:9001438;connectomeDB2020:9549761], NPY2R [Baccin2019:12007534;Baccin2019:7559383;Baccin2019:7592910;Baccin2019:8632753;Baccin2019:9001438;Baccin2019:9549761;CellTalkDB:9001438;Cellinker:12007534;Cellinker:7559383;Cellinker:7592910;Cellinker:8632753;Cellinker:9001438;Cellinker:9549761;Guide2Pharma:7592910;Guide2Pharma:8632753;HPMR:9549761;HPRD:12007534;HPRD:7559383;HPRD:9001438;LRdb:12007534;LRdb:7559383;LRdb:7592910;LRdb:8632753;LRdb:9001438;LRdb:9549761;SIGNOR:9549761;connectomeDB2020:12007534;connectomeDB2020:7559383;connectomeDB2020:7592910;connectomeDB2020:8632753;connectomeDB2020:9001438;connectomeDB2020:9549761;scConnect:7592910;scConnect:8632753], NPY4R [CellTalkDB:7592911;Cellinker:7493937;Cellinker:7592911;Guide2Pharma:7493937;HPMR:7592911;HPRD:7493937;LRdb:749;LRdb:7592911;SIGNOR:7592911;connectomeDB2020:7493937;connectomeDB2020:7592911;scConnect:7493937], NPY5R [CellTalkDB:8824284;Cellinker:12007534;Cellinker:12417094;Cellinker:8824284;Guide2Pharma:8824284;HPMR:12417094;HPRD:12007534;LRdb:12007534;LRdb:12417094;LRdb:8824284;SIGNOR:11825645;connectomeDB2020:12007534;connectomeDB2020:12417094;connectomeDB2020:8824284;scConnect:8824284], FAP [Baccin2019:26621486;CellTalkDB:21314817;Cellinker:21314817;LRdb:21314817;Ramilowski2015:21314817;connectomeDB2020:21314817;talklr:21314817], ADRA2A [CellTalkDB:32196115], MC4R [Baccin2019:12015205;Cellinker:12015205;HPRD:12015205;LRdb:12015205], MTNR1A [CellTalkDB:32196115], NPFFR2 [Baccin2019:12609745;CellTalkDB:11325787;Cellinker:12609745;HPRD:12609745;LRdb:12609745;connectomeDB2020:12609745], GRM7 [CellTalkDB:32196115], DPP4 [CellTalkDB:30759373;Cellinker:21314817], NPY6R [NA], GPR83 [Cellinker:17240481], ADRB1 [Cellinker:8190350], ADRB2 [Cellinker:8190350]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; neuronal dense core vesicle [GO:0098992]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; terminal bouton [GO:0043195]	calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184]; neuropeptide Y receptor binding [GO:0031841]; signaling receptor binding [GO:0005102]	adult feeding behavior [GO:0008343]; aging [GO:0007568]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; innate immune response [GO:0045087]; intestinal epithelial cell differentiation [GO:0060575]; monocyte activation [GO:0042117]; negative regulation of acute inflammatory response to antigenic stimulus [GO:0002865]; negative regulation of blood pressure [GO:0045776]; negative regulation of neuron death [GO:1901215]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; positive regulation of appetite [GO:0032100]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of eating behavior [GO:1904000]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of nitric oxide metabolic process [GO:1904407]; regulation of nerve growth factor production [GO:0032903]; response to yeast [GO:0001878]; sensory perception of taste [GO:0050909]; short-day photoperiodism [GO:0048572]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPY&keywords=NPY	26.29	146	NA	NA	2.31	138	0.06	0.07	0.02	0.08	0.20	1.79	1.36	1.53	3.16	2.26	1.07	14	18	23	1.05	2.98	2.13	1.01	13	18	95	80
PPY	pancreatic polypeptide	Yes		ENSG00000108849	P01298	NPY family	15	ligand	extracellular, intracellular, ligand, secreted	P08913, P25929, P48039, P49146, P50391, Q14831, Q15761, Q99463, Q9NYM4	ADRA2A, GPR83, GRM7, MTNR1A, NPY1R, NPY2R, NPY4R, NPY5R, NPY6R	NPY4R [CellTalkDB:18767100;Cellinker:16807358;Cellinker:7493937;Cellinker:7592911;Cellinker:8643460;Guide2Pharma:16807358;Guide2Pharma:7493937;Guide2Pharma:7592911;Guide2Pharma:8643460;HPRD:7493937;LRdb:16807358;LRdb:7493937;LRdb:7592911;LRdb:8643460;SIGNOR:7592911;connectomeDB2020:16807358;connectomeDB2020:7493937;connectomeDB2020:7592911;connectomeDB2020:8643460;scConnect:16807358;scConnect:7493937;scConnect:7592911;scConnect:8643460], NPY5R [Baccin2019:8824284;CellTalkDB:8824284;Cellinker:8824284;Guide2Pharma:8824284;LRdb:8824284;connectomeDB2020:8824284;scConnect:8824284], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], NPY2R [CellTalkDB:15966750], GRM7 [CellTalkDB:32196115], NPY1R [CellTalkDB:15966750], NPY6R [NA], GPR83 [NA]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184]; neuropeptide Y receptor binding [GO:0031841]	feeding behavior [GO:0007631]; neuropeptide signaling pathway [GO:0007218]; protein secretion [GO:0009306]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PPY&keywords=PPY	2402.08	10	30903.5	34	10877.23	2	0.11	0.24	0.16	0.35	0.33	0.23	1.03	649.28	0.73	0.32	0.95	30	62	27	59.43	0.01	0.01	0.02	526	528	524	127
GHRL	ghrelin and obestatin prepropeptide	Yes		ENSG00000157017	Q9UBU3	Motilin family	15	ligand	extracellular, intracellular, ligand, secreted	O43193, O43194, P01303, P21731, P41159, P43115, P43119, Q02643, Q92847	GHRHR, GHSR, GPR39, LEP, MLNR, NPY, PTGER3, PTGIR, TBXA2R	GHSR [Baccin2019:10604470;Baccin2019:10628755;Baccin2019:11227737;Baccin2019:11314756;Baccin2019:12907757;Baccin2019:15905359;Baccin2019:21402696;CellChatDB:29233536;CellTalkDB:10604470;Cellinker:10604470;Cellinker:10628755;Cellinker:11227737;Cellinker:11314756;Cellinker:12907757;Cellinker:15905359;Cellinker:21402696;Guide2Pharma:10628755;Guide2Pharma:11314756;Guide2Pharma:12907757;Guide2Pharma:15905359;Guide2Pharma:21402696;HPMR:10604470;HPRD:10604470;HPRD:11227737;LRdb:10604470;LRdb:10628755;LRdb:11227737;LRdb:11314756;LRdb:12907757;LRdb:15905359;LRdb:21402696;SIGNOR:15070777;connectomeDB2020:10604470;connectomeDB2020:10628755;connectomeDB2020:11227737;connectomeDB2020:11314756;connectomeDB2020:12907757;connectomeDB2020:15905359;connectomeDB2020:21402696;scConnect:10628755;scConnect:11314756;scConnect:12907757;scConnect:15905359;scConnect:21402696;scConnect:29233536], PTGER3 [CellTalkDB:32103204;Lit-BM-17:18573679], TBXA2R [CellTalkDB:32103204;Lit-BM-17:18573679], MLNR [CellTalkDB:12606621;Cellinker:12606621;HPRD:12606621;LRdb:12606621;connectomeDB2020:12606621], PTGIR [CellTalkDB:32103204], GHRHR [Baccin2019:10461027;CellTalkDB:10461027;Cellinker:10461027;HPRD:10461027;LRdb:10461027], GPR39 [Baccin2019:16284174;CellTalkDB:16284174;Cellinker:16284174;LRdb:16284174;connectomeDB2020:16284174], NPY [HPRD:11196643;HPRD:12663466], LEP [HPRD:11196643]	axon [GO:0030424]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule lumen [GO:0034774]	ghrelin receptor binding [GO:0031768]; G protein-coupled receptor binding [GO:0001664]; growth hormone-releasing hormone activity [GO:0016608]; protein tyrosine kinase activator activity [GO:0030296]	actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cartilage development [GO:0051216]; cortisol secretion [GO:0043400]; decidualization [GO:0046697]; dendrite development [GO:0016358]; excitatory postsynaptic potential [GO:0060079]; gastric acid secretion [GO:0001696]; gastric emptying [GO:0035483]; glucose metabolic process [GO:0006006]; G protein-coupled receptor signaling pathway [GO:0007186]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of circadian sleep/wake cycle, REM sleep [GO:0042322]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of locomotion [GO:0040013]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of appetite [GO:0032100]; positive regulation of bone development [GO:1903012]; positive regulation of circadian sleep/wake cycle, non-REM sleep [GO:0046010]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of corticotropin secretion [GO:0051461]; positive regulation of cortisol secretion [GO:0051464]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of eating behavior [GO:1904000]; positive regulation of gastric mucosal blood circulation [GO:1904346]; positive regulation of growth hormone receptor signaling pathway [GO:0060399]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of growth rate [GO:0040010]; positive regulation of insulin secretion [GO:0032024]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of small intestinal transit [GO:0120058]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of synapse assembly [GO:0051965]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of cell population proliferation [GO:0042127]; regulation of gastric motility [GO:1905333]; regulation of postsynapse organization [GO:0099175]; regulation of response to food [GO:0032095]; regulation of transmission of nerve impulse [GO:0051969]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to hormone [GO:0009725]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GHRL&keywords=GHRL	30.18	137	27734.2	37	8.60	51	0.00	0.21	0.03	0.02	0.01	0.02	0.03	0.10	0.02	0.02	1.02	245	211	26	0.13	0.19	0.19	7.19	445	421	1	171
NRG1	neuregulin 1	Yes		ENSG00000157168	Q02297	Neuregulin family	15	cell_surface_ligand, ligand, receptor	cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O94910, P00533, P04440, P04626, P21860, P35052, Q15303, Q86X29, Q8NC67, Q8WWV6, Q96JQ5, Q9BXB1, Q9Y286	ADGRL1, EGFR, ERBB2, ERBB2_ERBB3, ERBB2_ERBB4, ERBB3, ERBB4, FCAMR, GPC1, HLA-DPB1, ITGAV_ITGB3, LGR4, LSR, MS4A4A, NETO2, SIGLEC7	ERBB2 [CellTalkDB:1350381;HPMR:1350381;LRdb:1350381;LRdb:751;ProtMapper:19293191;SIGNOR:7514177;SPIKE:14737100;SignaLink3:23331499;SignaLink3:9275162;connectomeDB2020:1350381;connectomeDB2020:7514177], ERBB4 [CellTalkDB:10537356;HPRD:10537356;HPRD:7721889;HPRD:8062828;HPRD:9565587;LRdb:10537356;LRdb:7721889;LRdb:8062828;LRdb:9565587;Lit-BM-17:10970856;Lit-BM-17:9168115;ProtMapper:25052836;SIGNOR:14967450;SignaLink3:23331499;SignaLink3:9275162;connectomeDB2020:10537356;connectomeDB2020:7721889;connectomeDB2020:8062828;connectomeDB2020:9565587], ERBB3 [BioGRID:7592681;CellTalkDB:7514177;DIP:17697999;HPRD:11555649;HPRD:7592681;HPRD:8702572;HPRD:9565587;IntAct:7592681;LRdb:11555649;LRdb:7514177;LRdb:7592681;LRdb:8702572;LRdb:9565587;Lit-BM-17:10970856;Lit-BM-17:11555649;Lit-BM-17:17697999;Lit-BM-17:7592681;Lit-BM-17:9168115;ProtMapper:16843264;ProtMapper:26148232;SIGNOR:7477375;SIGNOR:7514177;SignaLink3:11555649;SignaLink3:23331499;SignaLink3:9275162;connectomeDB2020:11555649;connectomeDB2020:7514177;connectomeDB2020:7592681;connectomeDB2020:8702572;connectomeDB2020:9565587], GPC1 [CellTalkDB:32196115], EGFR [BioGRID:7730382;CellTalkDB:32251632;Cellinker:30813222;Lit-BM-17:24658140;Lit-BM-17:25402006;Lit-BM-17:7730382], MS4A4A [CellTalkDB:32103204], ADGRL1 [CellTalkDB:32103204], LGR4 [CellTalkDB:32103204], FCAMR [Cellinker:32822567], SIGLEC7 [Cellinker:32822567], LSR [NA], HLA-DPB1 [NA], NETO2 [NA]	apical plasma membrane [GO:0016324]; axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic active zone membrane [GO:0099059]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]	chemorepellent activity [GO:0045499]; cytokine activity [GO:0005125]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; growth factor activity [GO:0008083]; integrin binding [GO:0005178]; protein tyrosine kinase activator activity [GO:0030296]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transcription coregulator activity [GO:0003712]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]	activation of protein kinase B activity [GO:0032148]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; animal organ development [GO:0048513]; cardiac conduction system development [GO:0003161]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell myoblast differentiation [GO:0060379]; cell communication [GO:0007154]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cellular protein complex disassembly [GO:0043624]; chemorepulsion involved in interneuron migration from the subpallium to the cortex [GO:0021842]; endocardial cell differentiation [GO:0060956]; ERBB3 signaling pathway [GO:0038129]; ERBB4 signaling pathway [GO:0038130]; ERBB signaling pathway [GO:0038127]; glial cell fate commitment [GO:0021781]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; mammary gland development [GO:0030879]; MAPK cascade [GO:0000165]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron migration [GO:2001223]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of secretion [GO:0051048]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neuron fate commitment [GO:0048663]; neurotransmitter receptor metabolic process [GO:0045213]; oligodendrocyte differentiation [GO:0048709]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of striated muscle cell differentiation [GO:0051155]; postsynapse to nucleus signaling pathway [GO:0099527]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ventricular cardiac muscle cell differentiation [GO:0055012]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NRG1&keywords=NRG1	2.77	351	NA	NA	2.61	124	0.00	0.01	0.00	0.01	0.00	0.02	0.03	0.02	0.02	0.03	0.00	230	182	297	0.01	1.37	1.57	0.63	65	45	270	176
BMP8B	bone morphogenetic protein 8b	Yes		ENSG00000116985	P34820	TGF-beta family	15	ligand	extracellular, ligand, secreted	O00238, P27037, P36894, P37023, Q03405, Q04771, Q13705, Q13873	ACVR1, ACVR1_ACVR2A, ACVR1_ACVR2B, ACVR1_BMPR2, ACVR2A, ACVR2A_BMPR1A, ACVR2A_BMPR1B, ACVR2B, ACVR2B_BMPR1A, ACVR2B_BMPR1B, ACVRL1, BMPR1A, BMPR1A_BMPR2, BMPR1B, BMPR1B_BMPR2, BMPR2, PLAUR	BMPR1A [SignaLink3:10504300;SignaLink3:23331499], ACVR1 [SignaLink3:10504300;SignaLink3:23331499], BMPR1B [NA], ACVR2A [NA], ACVRL1 [NA], ACVR2B [NA], BMPR2 [NA], PLAUR [CellTalkDB:32103204]	extracellular space [GO:0005615]	BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]	BMP signaling pathway [GO:0030509]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMP8B&keywords=BMP8B	4.51	299	NA	NA	1.17	240	0.01	0.01	0.00	0.02	0.04	0.07	0.08	0.04	0.02	0.04	0.05	238	158	152	0.03	0.66	1.14	1.37	273	103	42	200
ADM	adrenomedullin	Yes		ENSG00000148926	P35318	Adrenomedullin family	15	ligand	extracellular, intracellular, ligand, secreted	O15218, O60894, O60895, O60896, P07550, P13945, P16473, P25106, P30988, P32241, P41586, Q03431, Q16602, Q96LB1, Q99678, Q9C098, Q9NQS5	ACKR3, ADCYAP1R1, ADRB2, ADRB3, CALCR, CALCRL, CALCRL_RAMP2, DCLK3, GPR182, GPR20, GPR84, MRGPRX2, PTH1R, RAMP1, RAMP2, RAMP3, TSHR, VIPR1	CALCRL [CellTalkDB:9620797;Cellinker:9620797;Guide2Pharma:10347248;Guide2Pharma:11693189;Guide2Pharma:9620797;HPRD:9620797;LRdb:9620797;connectomeDB2020:9620797;scConnect:10347248;scConnect:11693189;scConnect:9620797], RAMP2 [CellTalkDB:9620797;Cellinker:30139742;Cellinker:9620797;Guide2Pharma:11693189;Guide2Pharma:12565884;Guide2Pharma:9620797;HPMR:9620797;LRdb:9620797;connectomeDB2020:9620797], RAMP3 [CellTalkDB:14712479;Cellinker:27391260;Guide2Pharma:10347248;Guide2Pharma:11693189;Guide2Pharma:12565884;Guide2Pharma:15692146;connectomeDB2020:30139742], CALCR [Baccin2019:12565884;Baccin2019:15692146;CellTalkDB:10781016;Cellinker:12565884;Cellinker:15692146;Guide2Pharma:12565884;Guide2Pharma:15692146;LRdb:13;LRdb:15692146;connectomeDB2020:12565884;connectomeDB2020:15692146;scConnect:12565884;scConnect:15692146], RAMP1 [CellTalkDB:15361343;Cellinker:30139742;Guide2Pharma:11693189;Guide2Pharma:12565884;Guide2Pharma:15692146;Guide2Pharma:9620797], MRGPRX2 [Baccin2019:1611167315823560;Cellinker:15823563;Cellinker:16111673;Guide2Pharma:15823563;LRdb:16;LRdb:16111673;connectomeDB2020:15823563;connectomeDB2020:16111673;scConnect:15823563], ADCYAP1R1 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], GPR182 [CellTalkDB:7592696;Cellinker:7592696;HPMR:7592696;LRdb:7592696], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], DCLK3 [Cellinker:30139742], ACKR3 [Cellinker:29637711]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	adrenomedullin receptor binding [GO:0031700]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adrenomedullin receptor signaling pathway [GO:1990410]; aging [GO:0007568]; amylin receptor signaling pathway [GO:0097647]; androgen metabolic process [GO:0008209]; animal organ regeneration [GO:0031100]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cAMP-mediated signaling [GO:0019933]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; developmental growth [GO:0048589]; female pregnancy [GO:0007565]; G protein-coupled receptor internalization [GO:0002031]; heart development [GO:0007507]; hormone secretion [GO:0046879]; inflammatory response [GO:0006954]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of vascular permeability [GO:0043116]; negative regulation of vasoconstriction [GO:0045906]; neural tube closure [GO:0001843]; neuron projection regeneration [GO:0031102]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate [GO:0010460]; positive regulation of progesterone biosynthetic process [GO:2000184]; positive regulation of vasculogenesis [GO:2001214]; receptor internalization [GO:0031623]; regulation of systemic arterial blood pressure [GO:0003073]; regulation of the force of heart contraction [GO:0002026]; regulation of urine volume [GO:0035809]; response to cold [GO:0009409]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to starvation [GO:0042594]; response to wounding [GO:0009611]; signal transduction [GO:0007165]; spongiotrophoblast layer development [GO:0060712]; vascular associated smooth muscle cell development [GO:0097084]; vasculogenesis [GO:0001570]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ADM&keywords=ADM	25.24	151	NA	NA	0.42	409	0.67	0.30	0.17	0.18	0.14	0.21	0.19	0.37	0.15	0.19	0.11	91	81	103	0.24	0.63	0.78	0.49	291	220	331	215
GAST	gastrin	Yes		ENSG00000184502	P01350	Gastrin/cholecystokinin family	15	ligand	extracellular, ligand, secreted	P32239, P43628, Q8TDT2	CCKBR, GPR152, KIR2DL3	CCKBR [Baccin2019:7681836;CellTalkDB:7681836;Cellinker:7681836;DIP:8824290;ICELLNET:8349705;LRdb:7681836;SIGNOR:10368033;connectomeDB2020:7681836], KIR2DL3 [NA], GPR152 [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	hormone activity [GO:0005179]	G protein-coupled receptor signaling pathway [GO:0007186]; response to food [GO:0032094]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GAST&keywords=GAST	1.32	419	NA	NA	16.71	32	0.00	0.00	0.00	0.00	0.00	0.04	0.00	0.00	0.24	0.01	0.00	71	283	366	0.03	6.66	0.42	0.30	2	340	395	269
MDK	midkine	Yes		ENSG00000110492	P21741	Pleiotrophin family	15	ligand	extracellular, intracellular, ligand, secreted	O60635, O75056, P05107, P05556, P13612, P18827, P19338, P23229, P23467, P23471, P31431, P34741, P98164, Q04721, Q07954, Q8N158, Q92673, Q9UM73	ALK, GPC2, ITGA4, ITGA4_ITGB1, ITGA6, ITGA6_ITGB1, ITGB1, ITGB2, LRP1, LRP2, NCL, NOTCH2, PTPRB, PTPRZ1, SDC1, SDC2, SDC3, SDC4, SORL1, TSPAN1	NOTCH2 [SIGNOR:18469519;SignaLink3:18469519;SignaLink3:23331499;connectomeDB2020:18469519], ALK [Baccin2019:1212200912122000;CellChatDB:19459784;CellTalkDB:12122009;Cellinker:19459784;HPMR:12122009;HPRD:12122009;LRdb:12122009;SignaLink3:12122009;SignaLink3:23331499;connectomeDB2020:12122009], ITGA6 [CellTalkDB:32196115;connectomeDB2020:15466886], LRP1 [Baccin2019:10772929;CellChatDB:28356350;Cellinker:10772929;Cellinker:28356350;HPRD:10772929;LRdb:10772929;connectomeDB2020:10772929], SORL1 [CellTalkDB:32103204], LRP2 [Baccin2019:10772929;CellTalkDB:10772929;Cellinker:10772929;HPRD:10772929;LRdb:10772929], GPC2 [CellTalkDB:32196115], SDC3 [Baccin2019:9089390;CellTalkDB:9089390;HPRD:9089390;LRdb:9089390;connectomeDB2020:9089390], TSPAN1 [Baccin2019:18851943;CellTalkDB:18851943;Cellinker:18851943;HPRD:18851943;LRdb:18851943;connectomeDB2020:18851943], SDC4 [Baccin2019:8621465;CellChatDB:28356350;CellTalkDB:8621465;Cellinker:28356350;Cellinker:8621465;HPRD:8621465;LRdb:8621465;connectomeDB2020:8621465], SDC1 [Baccin2019:9089390;CellChatDB:28356350;CellTalkDB:9089390;Cellinker:28356350;Cellinker:9089390;HPRD:9089390;LRdb:9089390;connectomeDB2020:9089390], PTPRZ1 [Baccin2019:10212223;CellChatDB:28356350;CellPhoneDB:10212223;CellTalkDB:10212223;Cellinker:10212223;Cellinker:28356350;HPRD:10212223;LRdb:10212223;connectomeDB2020:10212223], ITGB1 [CellTalkDB:32196115;connectomeDB2020:15466886], ITGA4 [CellTalkDB:32196115;connectomeDB2020:15466886], SDC2 [CellChatDB:28356350;Cellinker:28356350], NCL [CellChatDB:28356350;Cellinker:28356350;HPRD:12147681], PTPRB [NA], ITGB2 [Baccin2019:24458438]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]	chondroitin sulfate binding [GO:0035374]; growth factor activity [GO:0008083]; heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]	adrenal gland development [GO:0030325]; behavioral fear response [GO:0001662]; cell differentiation [GO:0030154]; cerebellar granular layer development [GO:0021681]; cerebral cortex development [GO:0021987]; cytoskeleton organization [GO:0007010]; defecation [GO:0030421]; dentate gyrus development [GO:0021542]; estrous cycle [GO:0044849]; glial cell projection elongation [GO:0106091]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell adhesion [GO:0007162]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of inflammatory response to wounding [GO:0106015]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of ossification [GO:0030279]; negative regulation of regulatory T cell differentiation [GO:0045590]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of blood vessel branching [GO:1905555]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of inflammatory response [GO:0050729]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of leukocyte cell-cell adhesion [GO:1903039]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of neutrophil extravasation [GO:2000391]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of behavior [GO:0050795]; regulation of bone remodeling [GO:0046850]; regulation of chondrocyte differentiation [GO:0032330]; response to auditory stimulus [GO:0010996]; response to glucocorticoid [GO:0051384]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; short-term memory [GO:0007614]; signal transduction [GO:0007165]; T cell activation involved in immune response [GO:0002286]; tissue regeneration [GO:0042246]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MDK&keywords=MDK	10.76	232	NA	NA	0.22	518	0.02	0.35	0.09	0.18	0.27	1.12	0.78	1.04	1.98	0.40	1.05	18	54	25	0.66	2.96	0.61	1.57	14	285	32	272
TNFSF15	TNF superfamily member 15	Yes		ENSG00000181634	O95150	Tumor necrosis factor family	15	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, receptor, secreted, transmembrane, transmembrane_predicted	O95407, Q93038	TNFRSF25, TNFRSF6B	TNFRSF25 [CellTalkDB:11911831;Cellinker:11911831;DIP:21300286;HPMR:11911831;HPRD:11911831;ICELLNET:11239407;InnateDB:20403353;LRdb:11911831;SIGNOR:14585074;connectomeDB2020:11911831], TNFRSF6B [CellTalkDB:11911831;Cellinker:11911831;HPMR:14697332;HPRD:11911831;ICELLNET:11239407;LRdb:11911831;connectomeDB2020:11911831]	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; immune response [GO:0006955]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFSF15&keywords=TNFSF15	1.86	392	NA	NA	2.83	120	0.02	0.04	0.00	0.06	0.00	0.01	0.00	0.00	0.00	0.00	0.00	295	337	348	0.01	0.57	0.54	0.50	317	303	328	288
GHRH	growth hormone releasing hormone	Yes		ENSG00000118702	P01286	Glucagon family	15	ligand	extracellular, ligand, secreted	O60895, O60896, P07550, P13945, P16473, P27487, P32241, P41586, P41587, Q02643, Q03431, Q92847, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, DPP4, GHRHR, GHSR, GPR20, GPR84, PTH1R, RAMP2, RAMP3, TSHR, VIPR1, VIPR2	GHRHR [Baccin2019:76804131333056;CellChatDB:26917260;CellTalkDB:7680413;Cellinker:1333056;Cellinker:26917260;Cellinker:7680413;HPMR:7680413;HPRD:1333056;LRdb:133;LRdb:7680413;connectomeDB2020:1333056;connectomeDB2020:7680413], VIPR1 [Baccin2019:8791009;CellChatDB:10655511;CellTalkDB:8791009;Cellinker:10655511;Cellinker:8791009;Guide2Pharma:8791009;LRdb:8791009;connectomeDB2020:8791009;scConnect:8791009], ADCYAP1R1 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], VIPR2 [CellChatDB:10655511;Cellinker:10655511], GHSR [CellChatDB:19088192;Cellinker:19088192], DPP4 [Cellinker:21314817]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; perikaryon [GO:0043204]; terminal bouton [GO:0043195]	growth hormone-releasing hormone activity [GO:0016608]; growth hormone-releasing hormone receptor binding [GO:0031770]; neuropeptide hormone activity [GO:0005184]; peptide hormone receptor binding [GO:0051428]	adenohypophysis development [GO:0021984]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell-cell signaling [GO:0007267]; growth hormone secretion [GO:0030252]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of circadian sleep/wake cycle, REM sleep [GO:0046005]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; response to food [GO:0032094]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GHRH&keywords=GHRH	NA	NA	NA	NA	NA	NA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.02	0.00	0.00	231	403	399	0.00	2.60	0.85	0.84	20	189	167	296
PSPN	persephin	Yes		ENSG00000125650	O60542	TGF-beta family, GDNF subfamily	15	ligand	extracellular, ligand, secreted	O00451, O60609, O75056, P07949, P56159, Q9GZZ7	GFRA1, GFRA2, GFRA3, GFRA4, GFRA4_RET, RET, SDC3	GFRA4 [Baccin2019:1111614411116140;CellTalkDB:11116144;Cellinker:11116144;Cellinker:11544105;HPMR:11116144;HPRD:11116144;LRdb:11116144;SIGNOR:11116144;connectomeDB2020:11116144], GFRA3 [CellTalkDB:32196115], RET [Baccin2019:11116144;CellTalkDB:11116144;Cellinker:11116144;HPMR:11116144;LRdb:11116144;connectomeDB2020:11116144], SDC3 [CellTalkDB:32196115], GFRA2 [CellTalkDB:32196115], GFRA1 [CellTalkDB:20350599;Cellinker:20350599;LRdb:20350599;Ramilowski2015:20350599;connectomeDB2020:20350599;talklr:20350599]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	glial cell-derived neurotrophic factor receptor binding [GO:0030116]; growth factor activity [GO:0008083]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	central nervous system development [GO:0007417]; nervous system development [GO:0007399]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PSPN&keywords=PSPN	0.79	480	NA	NA	0.41	410	0.00	0.01	0.00	0.00	0.00	0.02	0.01	0.00	0.00	0.01	0.00	289	272	294	0.01	0.94	1.07	0.95	163	118	119	320
MST1	macrophage stimulating 1	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000173531	P26927	Peptidase S1 family, Plasminogen subfamily	15	ligand	extracellular, ligand, secreted	P06899, P33778, Q04912, Q13043, Q15208	H2BC11, H2BC3, MST1R, STK38, STK4	H2BC11 [SPIKE:18675384], MST1R [Baccin2019:8062829;Baccin2019:9045873;CellPhoneDB:23792360;CellTalkDB:8062829;Cellinker:8062829;Cellinker:9045873;DIP:9374547;HPMR:8062829;HPRD:9045873;IntAct:22087277;IntAct:25193665;LRdb:8062829;LRdb:905;Lit-BM-17:22087277;Lit-BM-17:25193665;Lit-BM-17:9374547;SIGNOR:8062829;SignaLink3:12764615;SignaLink3:23331499;connectomeDB2020:8062829;connectomeDB2020:9045873], H2BC3 [KEA:12757711;ProtMapper:21212262;SIGNOR:21212262;iPTMnet:12757711;iPTMnet:21212262], STK4 [KEA:11805089;KEA:12223493;ProtMapper:11805089;SIGNOR:11805089;iPTMnet:11805089], STK38 [ProtMapper:19062280;ProtMapper:28137909;iPTMnet:19062280;iPTMnet:19836237;iPTMnet:21730291]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	histone H2A-S139 phosphorylation [GO:0035978]; negative regulation of gluconeogenesis [GO:0045721]; proteolysis [GO:0006508]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MST1&keywords=MST1	2.52	359	NA	NA	0.12	608	0.00	0.00	0.00	0.00	0.01	0.01	0.01	0.00	0.00	0.01	0.01	294	285	283	0.00	0.93	1.07	1.09	167	117	80	342
GAL	galanin and GMAP prepropeptide	Yes		ENSG00000069482	P22466	Galanin family	15	ligand	extracellular, intracellular, ligand, secreted, transmembrane	O43603, O60755, P08913, P20036, P47211, P48039, Q14831, Q8TDV0	ADRA2A, GALR1, GALR2, GALR3, GPR151, GRM7, HLA-DPA1, MTNR1A	GALR1 [Baccin2019:10689365;Baccin2019:11481429;Baccin2019:11600206;Baccin2019:7524088;Baccin2019:8617199;Baccin2019:9168941;Baccin2019:9685625;Baccin2019:9808667;Baccin2019:9880084;CellTalkDB:11481429;Cellinker:10689365;Cellinker:11481429;Cellinker:11600206;Cellinker:7524088;Cellinker:8617199;Cellinker:9168941;Cellinker:9685625;Cellinker:9808667;Cellinker:9880084;Guide2Pharma:11481429;Guide2Pharma:11600206;Guide2Pharma:7524088;Guide2Pharma:9168941;Guide2Pharma:9685625;Guide2Pharma:9808667;Guide2Pharma:9880084;HPMR:10689365;HPRD:7524088;HPRD:8617199;HPRD:9808667;LRdb:10689365;LRdb:11481429;LRdb:11600206;LRdb:7524088;LRdb:8617199;LRdb:9168941;LRdb:9685625;LRdb:9808667;LRdb:9880084;connectomeDB2020:10689365;connectomeDB2020:11481429;connectomeDB2020:11600206;connectomeDB2020:7524088;connectomeDB2020:8617199;connectomeDB2020:9168941;connectomeDB2020:9685625;connectomeDB2020:9808667;connectomeDB2020:9880084;scConnect:11481429;scConnect:11600206;scConnect:7524088;scConnect:9168941;scConnect:9685625;scConnect:9808667;scConnect:9880084], GALR2 [Baccin2019:11600206;Baccin2019:9480833;Baccin2019:9685625;Baccin2019:9832121;Baccin2019:9880084;CellTalkDB:9880084;Cellinker:11600206;Cellinker:9480833;Cellinker:9685625;Cellinker:9832121;Cellinker:9880084;Guide2Pharma:11600206;Guide2Pharma:9480833;Guide2Pharma:9685625;Guide2Pharma:9880084;HPMR:9832121;HPRD:9685625;ICELLNET:9685625;ICELLNET:9880084;LRdb:11600206;LRdb:9480833;LRdb:9685625;LRdb:9832121;LRdb:9880084;SIGNOR:10601261;connectomeDB2020:11600206;connectomeDB2020:9480833;connectomeDB2020:9685625;connectomeDB2020:9832121;connectomeDB2020:9880084;scConnect:11600206;scConnect:9480833;scConnect:9685625;scConnect:9880084], GALR3 [Baccin2019:9722565;Baccin2019:9832121;Baccin2019:9880084;CellTalkDB:9722565;Cellinker:9722565;Cellinker:9832121;Cellinker:9880084;Guide2Pharma:9722565;Guide2Pharma:9832121;Guide2Pharma:9880084;HPMR:9832121;LRdb:9722565;LRdb:9832121;LRdb:9880084;connectomeDB2020:9722565;connectomeDB2020:9832121;connectomeDB2020:9880084;scConnect:9722565;scConnect:9832121;scConnect:9880084], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], GPR151 [Baccin2019:15111018;CellTalkDB:15111018;Cellinker:15111018;HPRD:15111018;LRdb:15111018;connectomeDB2020:15111018], HLA-DPA1 [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; secretory granule [GO:0030141]	galanin receptor activity [GO:0004966]; galanin receptor binding [GO:0031763]; neuropeptide hormone activity [GO:0005184]; type 1 galanin receptor binding [GO:0031764]; type 2 galanin receptor binding [GO:0031765]; type 3 galanin receptor binding [GO:0031766]	cAMP-mediated signaling [GO:0019933]; feeding behavior [GO:0007631]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; negative regulation of lymphocyte proliferation [GO:0050672]; neuropeptide signaling pathway [GO:0007218]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cortisol secretion [GO:0051464]; positive regulation of large conductance calcium-activated potassium channel activity [GO:1902608]; positive regulation of timing of catagen [GO:0051795]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase A signaling [GO:0010737]; regulation of glucocorticoid metabolic process [GO:0031943]; response to estrogen [GO:0043627]; response to immobilization stress [GO:0035902]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GAL&keywords=GAL	2.81	348	NA	NA	0.23	513	0.13	0.22	0.00	0.49	0.32	0.92	0.01	0.01	0.62	0.01	0.01	35	223	270	0.25	2.42	0.09	0.06	22	472	495	389
WNT7B	Wnt family member 7B	Yes		ENSG00000188064	P56706	Wnt family	15	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted, transmembrane	O75197, Q13467, Q96PE1, Q9H461, Q9NPG1, Q9ULV1, Q9ULW2, Q9UP38, Q9Y3A6	ADGRA2, FZD1, FZD1_LRP5, FZD1_LRP6, FZD10, FZD10_LRP5, FZD10_LRP6, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4, FZD4_LRP5, FZD4_LRP6, FZD5, FZD5_LRP5, FZD5_LRP6, FZD6_LRP5, FZD6_LRP6, FZD7_LRP5, FZD7_LRP6, FZD8, FZD8_LRP5, FZD8_LRP6, FZD9_LRP5, FZD9_LRP6, LRP5, TMED5	LRP5 [Baccin2019:15923619;CellTalkDB:15923619;HPMR:15923619;LRdb:15923619;SIGNOR:15578921;SIGNOR:15923619;connectomeDB2020:15923619], FZD3 [SIGNOR:15578921], FZD10 [Baccin2019:15923619;CellPhoneDB:24032637;HPMR:15923619;LRdb:15923619;NetPath:15923619;SIGNOR:15923619;connectomeDB2020:15923619], FZD1 [Baccin2019:15923619;CellPhoneDB:24032637;CellTalkDB:15923619;LRdb:15923619;NetPath:15923619;SIGNOR:15923619;connectomeDB2020:15923619], FZD4 [CellPhoneDB:24032637;CellTalkDB:24032637;LRdb:24032637;NetPath:15923619;connectomeDB2020:24032637], TMED5 [CellTalkDB:30394198], FZD5 [connectomeDB2020:28733458], FZD8 [connectomeDB2020:28733458], ADGRA2 [Cellinker:28289266]	endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]	canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; central nervous system vasculogenesis [GO:0022009]; chorio-allantoic fusion [GO:0060710]; developmental growth involved in morphogenesis [GO:0060560]; embryonic organ development [GO:0048568]; embryonic placenta morphogenesis [GO:0060669]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; fibroblast proliferation [GO:0048144]; forebrain regionalization [GO:0021871]; homeostatic process [GO:0042592]; inner medullary collecting duct development [GO:0072061]; in utero embryonic development [GO:0001701]; lens fiber cell development [GO:0070307]; lobar bronchus development [GO:0060482]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung morphogenesis [GO:0060425]; mammary gland epithelium development [GO:0061180]; metanephric collecting duct development [GO:0072205]; metanephric epithelium development [GO:0072207]; metanephric loop of Henle development [GO:0072236]; metanephros morphogenesis [GO:0003338]; neuron differentiation [GO:0030182]; neuron projection morphogenesis [GO:0048812]; outer medullary collecting duct development [GO:0072060]; oxygen homeostasis [GO:0032364]; positive regulation of JNK cascade [GO:0046330]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of cell projection size [GO:0032536]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; response to glucocorticoid [GO:0051384]; stem cell proliferation [GO:0072089]; synapse organization [GO:0050808]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT7B&keywords=WNT7B	0.95	456	NA	NA	0.40	417	0.00	0.04	0.00	0.00	0.01	0.02	0.00	0.01	0.03	0.00	0.00	208	383	350	0.01	2.01	0.55	0.59	30	301	288	389
CCL18	C-C motif chemokine ligand 18	Yes		ENSG00000278006, ENSG00000278167, ENSG00000275385	P55774	Intercrine beta (chemokine CC) family	15	ligand	extracellular, intracellular, ligand, secreted	P32246, P51677, P51685, Q16570, Q9BZ71, Q9UKR5	ACKR1, CCR1, CCR3, CCR8, ERG28, PITPNM3	CCR8 [CellPhoneDB:24218476;CellTalkDB:24218476;Cellinker:24218476;ICELLNET:23999500;InnateDB:23999500;LRdb:24218476;connectomeDB2020:24218476], CCR3 [CellTalkDB:23951310;Cellinker:23951310;Cellinker:29637711;ICELLNET:22633458;ICELLNET:23999500;InnateDB:10640766;connectomeDB2020:24218476;scConnect:23951310], PITPNM3 [ICELLNET:22633458;InnateDB:21481794;connectomeDB2020:24218476], CCR1 [CellTalkDB:32103204;scConnect:23951310], ACKR1 [CellChatDB:26740381;Cellinker:26740381], ERG28 [HPRD:16169070;InnateDB:16169070;LRdb:16169070]	extracellular space [GO:0005615]	CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cell communication [GO:0007154]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL18&keywords=CCL18	0.36	556	NA	NA	0.12	605	0.17	0.00	0.00	0.00	0.00	0.01	0.01	0.01	0.00	0.01	0.01	299	238	254	0.02	0.38	0.69	0.62	382	254	277	413
CALCA	calcitonin related polypeptide alpha	Yes		ENSG00000110680	P01258, P06881	Calcitonin family	15	ligand	extracellular, intracellular, ligand, secreted, extracellular, ligand, secreted	O60894, O60895, O60896, P07550, P13945, P16473, P25106, P30988, P32241, P41586, Q03431, Q16602, Q99678, Q9C098, Q9NQS5	ACKR3, ADCYAP1R1, ADRB2, ADRB3, CALCR, CALCRL, DCLK3, GPR20, GPR84, PTH1R, RAMP1, RAMP2, RAMP3, TSHR, VIPR1, ACKR3, ADCYAP1R1, ADRB2, ADRB3, CALCR, CALCRL, CALCRL_RAMP1, CALCRL_RAMP2, CALCRL_RAMP3, DCLK3, GPR20, GPR84, PTH1R, RAMP1, RAMP2, RAMP3, TSHR, VIPR1	CALCRL [Baccin2019:12234182;Baccin2019:14668209;Baccin2019:3001670;Baccin2019:8626685;Baccin2019:9620797;CellTalkDB:9620797;Cellinker:12234182;Cellinker:14668209;Cellinker:3001670;Cellinker:8626685;Cellinker:9620797;Guide2Pharma:10347248;Guide2Pharma:11693189;Guide2Pharma:9620797;HPRD:12234182;HPRD:14668209;HPRD:3001670;HPRD:8626685;HPRD:9620797;LRdb:12234182;LRdb:14668209;LRdb:3001670;LRdb:8626685;LRdb:9620797;connectomeDB2020:12234182;connectomeDB2020:14668209;connectomeDB2020:3001670;connectomeDB2020:8626685;connectomeDB2020:9620797;scConnect:10347248;scConnect:11693189;scConnect:9620797], RAMP2 [Baccin2019:16531504;CellTalkDB:16531504;Cellinker:30139742;Guide2Pharma:11033437;Guide2Pharma:12565884;Guide2Pharma:14722252;Guide2Pharma:15692146;Guide2Pharma:9620797;HPRD:16531504;LRdb:16531504;connectomeDB2020:16531504], RAMP3 [CellTalkDB:30139742;Cellinker:30139742;Guide2Pharma:10347248;Guide2Pharma:11033437;Guide2Pharma:11693189;Guide2Pharma:12565884;Guide2Pharma:14722252;Guide2Pharma:15692146], CALCR [Baccin2019:10342886;Baccin2019:11023820;Baccin2019:11033437;Baccin2019:12565884;Baccin2019:14722252;Baccin2019:15692146;Baccin2019:2158663;Baccin2019:7588285;Baccin2019:9487987;CellTalkDB:2158663;Cellinker:10342886;Cellinker:11023820;Cellinker:11033437;Cellinker:12565884;Cellinker:14722252;Cellinker:15692146;Cellinker:2158663;Cellinker:7588285;Cellinker:9487987;Guide2Pharma:10342886;Guide2Pharma:11023820;Guide2Pharma:11033437;Guide2Pharma:12565884;Guide2Pharma:14722252;Guide2Pharma:15692146;Guide2Pharma:26125036;Guide2Pharma:7588285;Guide2Pharma:9487987;LRdb:10342886;LRdb:11023820;LRdb:11033437;LRdb:12565884;LRdb:14722252;LRdb:15692146;LRdb:2158663;LRdb:7588285;LRdb:9487987;connectomeDB2020:10342886;connectomeDB2020:11023820;connectomeDB2020:11033437;connectomeDB2020:12565884;connectomeDB2020:14722252;connectomeDB2020:15692146;connectomeDB2020:2158663;connectomeDB2020:7588285;connectomeDB2020:9487987;scConnect:10342886;scConnect:11023820;scConnect:11033437;scConnect:12565884;scConnect:14722252;scConnect:15692146;scConnect:26125036;scConnect:7588285;scConnect:9487987], RAMP1 [Baccin2019:962079712234182;CellTalkDB:9620797;Cellinker:30139742;Guide2Pharma:11023820;Guide2Pharma:11033437;Guide2Pharma:11693189;Guide2Pharma:12565884;Guide2Pharma:14722252;Guide2Pharma:15692146;Guide2Pharma:26125036;Guide2Pharma:9620797;HPRD:12234182;LRdb:122;LRdb:9620797;connectomeDB2020:12234182;connectomeDB2020:9620797], ADCYAP1R1 [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], DCLK3 [Cellinker:30139742], ACKR3 [Cellinker:15193773], CALCRL [CellTalkDB:9620797;Cellinker:12234182;Cellinker:14668209;Cellinker:3001670;Cellinker:8626685;Cellinker:9620797;Guide2Pharma:10347248;Guide2Pharma:11693189;Guide2Pharma:9620797;HPRD:12234182;HPRD:14668209;HPRD:3001670;HPRD:8626685;HPRD:9620797;IntAct:23597562;LRdb:12234182;LRdb:14668209;LRdb:3001670;LRdb:8626685;LRdb:9620797;Lit-BM-17:16293613;Lit-BM-17:23597562;Lit-BM-17:9620797;connectomeDB2020:12234182;connectomeDB2020:14668209;connectomeDB2020:3001670;connectomeDB2020:8626685;connectomeDB2020:9620797;scConnect:10347248;scConnect:11693189;scConnect:9620797], RAMP2 [CellTalkDB:16531504;Cellinker:30139742;Guide2Pharma:11033437;Guide2Pharma:12565884;Guide2Pharma:14722252;Guide2Pharma:15692146;Guide2Pharma:9620797;HPRD:16531504;LRdb:16531504;connectomeDB2020:16531504], RAMP3 [CellTalkDB:30139742;Cellinker:30139742;Guide2Pharma:10347248;Guide2Pharma:11033437;Guide2Pharma:11693189;Guide2Pharma:12565884;Guide2Pharma:14722252;Guide2Pharma:15692146], CALCR [CellTalkDB:2158663;Cellinker:10342886;Cellinker:11023820;Cellinker:11033437;Cellinker:12565884;Cellinker:14722252;Cellinker:15692146;Cellinker:2158663;Cellinker:7588285;Cellinker:9487987;Guide2Pharma:10342886;Guide2Pharma:11023820;Guide2Pharma:11033437;Guide2Pharma:12565884;Guide2Pharma:14722252;Guide2Pharma:15692146;Guide2Pharma:26125036;Guide2Pharma:7588285;Guide2Pharma:9487987;ICELLNET:1331173;ICELLNET:6148938;LRdb:10342886;LRdb:11023820;LRdb:11033437;LRdb:12565884;LRdb:14722252;LRdb:15692146;LRdb:2158663;LRdb:7588285;LRdb:9487987;connectomeDB2020:10342886;connectomeDB2020:11023820;connectomeDB2020:11033437;connectomeDB2020:12565884;connectomeDB2020:14722252;connectomeDB2020:15692146;connectomeDB2020:2158663;connectomeDB2020:7588285;connectomeDB2020:9487987;scConnect:10342886;scConnect:11023820;scConnect:11033437;scConnect:12565884;scConnect:14722252;scConnect:15692146;scConnect:26125036;scConnect:7588285;scConnect:9487987], RAMP1 [CellTalkDB:9620797;Cellinker:30139742;Guide2Pharma:11023820;Guide2Pharma:11033437;Guide2Pharma:11693189;Guide2Pharma:12565884;Guide2Pharma:14722252;Guide2Pharma:15692146;Guide2Pharma:26125036;Guide2Pharma:9620797;HPRD:12234182;LRdb:122;LRdb:9620797;connectomeDB2020:12234182;connectomeDB2020:9620797], ADCYAP1R1 [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], DCLK3 [Cellinker:30139742], ACKR3 [Cellinker:15193773]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; terminal bouton [GO:0043195], cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	calcitonin receptor binding [GO:0031716]; hormone activity [GO:0005179]; identical protein binding [GO:0042802], hormone activity [GO:0005179]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]	activation of adenylate cyclase activity [GO:0007190]; activation of protein kinase activity [GO:0032147]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; aging [GO:0007568]; artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001984]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; embryo implantation [GO:0007566]; feeding behavior [GO:0007631]; inflammatory response [GO:0006954]; monocyte chemotaxis [GO:0002548]; negative regulation of bone resorption [GO:0045779]; negative regulation of ossification [GO:0030279]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of transcription, DNA-templated [GO:0045892]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to pain [GO:0048265], activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; amylin receptor signaling pathway [GO:0097647]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; calcitonin gene-related peptide receptor signaling pathway [GO:1990408]; cell-cell signaling [GO:0007267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; G protein-coupled receptor internalization [GO:0002031]; innate immune response [GO:0045087]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of blood pressure [GO:0045776]; negative regulation of bone resorption [GO:0045779]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of osteoclast differentiation [GO:0045671]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of macrophage differentiation [GO:0045651]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of blood pressure [GO:0008217]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to yeast [GO:0001878]; vasculature development [GO:0001944]; vasodilation [GO:0042311]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CALCA&keywords=CALCA	0.23	601	NA	NA	0.29	474	0.00	0.00	0.00	0.01	0.00	0.01	0.00	0.00	0.13	0.00	0.01	101	325	232	0.02	5.65	0.50	0.94	4	319	121	430
PYY	peptide YY	Yes		ENSG00000131096	P10082	NPY family	15	ligand	ligand, secreted	P08913, P25929, P27487, P48039, P49146, P50391, Q12884, Q14831, Q15761, Q99463, Q9NYM4	ADRA2A, DPP4, FAP, GPR83, GRM7, MTNR1A, NPY1R, NPY2R, NPY4R, NPY5R, NPY6R	NPY1R [Baccin2019:954976112665544;CellTalkDB:9549761;Cellinker:12665544;Cellinker:9549761;HPRD:12665544;LRdb:127;LRdb:9549761;connectomeDB2020:12665544;connectomeDB2020:9549761], NPY2R [Baccin2019:11408607;Baccin2019:7592910;Baccin2019:8632753;CellTalkDB:8632753;Cellinker:11408607;Cellinker:7592910;Cellinker:8632753;Guide2Pharma:7592910;Guide2Pharma:8632753;HPRD:11408607;LRdb:11408607;LRdb:7592910;LRdb:8632753;connectomeDB2020:11408607;connectomeDB2020:7592910;connectomeDB2020:8632753;scConnect:7592910;scConnect:8632753], NPY4R [CellTalkDB:7592911;Cellinker:7493937;Cellinker:7592911;Guide2Pharma:7493937;HPRD:7493937;LRdb:749;LRdb:7592911;SIGNOR:7592911;connectomeDB2020:7493937;connectomeDB2020:7592911;scConnect:7493937], NPY5R [Baccin2019:1182564512665540;CellTalkDB:11825645;Cellinker:11825645;Cellinker:12665544;HPRD:12665544;LRdb:11825645;LRdb:13;SIGNOR:11825645;connectomeDB2020:11825645;connectomeDB2020:12665544], DPP4 [CellTalkDB:30759373;Cellinker:21314817], FAP [CellTalkDB:21314817;Cellinker:21314817;LRdb:21314817;Ramilowski2015:21314817;connectomeDB2020:21314817;talklr:21314817], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], NPY6R [NA], GPR83 [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184]; neuropeptide Y receptor binding [GO:0031841]	feeding behavior [GO:0007631]; intestinal epithelial cell differentiation [GO:0060575]; neuropeptide signaling pathway [GO:0007218]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PYY&keywords=PYY	0.34	562	NA	NA	0.26	487	0.00	0.00	0.00	0.00	0.00	0.00	0.04	0.10	0.00	0.00	0.04	301	359	170	0.02	0.39	0.42	1.76	380	342	23	438
CCL3L1	C-C motif chemokine ligand 3 like 1, C-C motif chemokine ligand 3 like 3	Yes		ENSG00000277796, ENSG00000277768, ENSG00000277336, ENSG00000276085	P16619	Intercrine beta (chemokine CC) family	15	ligand	intracellular, ligand, secreted	O00590, P32246, P51677, P51679, P51681	ACKR2, CCR1, CCR3, CCR4, CCR5	CCR5 [Baccin2019:10364178;Baccin2019:10477718;Baccin2019:11170631;Baccin2019:11700073;Baccin2019:11734558;Baccin2019:12964882;Baccin2019:16298345;Baccin2019:9790730;BioGRID:11734558;CellTalkDB:10364178;Cellinker:10364178;Cellinker:11449371;Cellinker:11734558;HPRD:10364178;HPRD:11449371;HPRD:11734558;ICELLNET:22633458;LRdb:11;LRdb:11734558;SPIKE:11734558;connectomeDB2020:10364178;connectomeDB2020:11449371;connectomeDB2020:11734558], ACKR2 [CellChatDB:26740381;CellTalkDB:10364178;Cellinker:26740381;Cellinker:29637711;HPRD:10364178;ICELLNET:22633458;LRdb:10699158;connectomeDB2020:10364178;connectomeDB2020:25297873], CCR1 [Baccin2019:10202040;Baccin2019:10660125;Baccin2019:11170631;Baccin2019:12381680;Baccin2019:7545673;Baccin2019:8530354;Baccin2019:9115216;Baccin2019:9624164;CellPhoneDB:24218476;Cellinker:11449371;HPRD:11449371;ICELLNET:22633458;LRdb:11449371;connectomeDB2020:11449371], CCR3 [Baccin2019:7594543;CellPhoneDB:24218476;Cellinker:11449371;HPRD:11449371;ICELLNET:22633458;LRdb:11449371;connectomeDB2020:11449371], CCR4 [Baccin2019:8573157]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]	cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; negative regulation of cell population proliferation [GO:0008285]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL3L1&keywords=CCL3L1	0.66	497	NA	NA	0.23	511	2.47	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	303	407	394	0.23	0.04	0.04	0.04	510	503	510	480
UCN2	urocortin 2	Yes		ENSG00000145040	Q96RP3	Sauvagine/corticotropin-releasing factor/urotensin I family	15	ligand	intracellular, ligand, secreted	P34998, Q08334, Q13324	CRHR1, CRHR2, IL10RB	CRHR1 [Baccin2019:15450949;CellTalkDB:15450949;Cellinker:15450949;Guide2Pharma:15450949;LRdb:15450949;connectomeDB2020:15450949;scConnect:15450949], CRHR2 [Baccin2019:11226328;Baccin2019:11329063;Baccin2019:11416224;Baccin2019:15450949;CellTalkDB:11329063;Cellinker:11226328;Cellinker:11329063;Cellinker:11416224;Cellinker:15450949;Guide2Pharma:15450949;HPRD:11226328;HPRD:11416224;LRdb:11226328;LRdb:11329063;LRdb:11416224;LRdb:15450949;connectomeDB2020:11226328;connectomeDB2020:11329063;connectomeDB2020:11416224;connectomeDB2020:15450949;scConnect:15450949], IL10RB [CellTalkDB:11416224;Cellinker:11416224;HPRD:11416224;LRdb:11416224;connectomeDB2020:11416224]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	corticotropin-releasing hormone receptor 2 binding [GO:0051431]; corticotropin-releasing hormone receptor binding [GO:0051429]; hormone activity [GO:0005179]; hormone binding [GO:0042562]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to nutrient levels [GO:0031669]; digestion [GO:0007586]; hormone-mediated signaling pathway [GO:0009755]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=UCN2&keywords=UCN2	0.49	526	NA	NA	0.35	447	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	487
IFNA21	interferon alpha 21	Yes		ENSG00000137080	P01568	Alpha/beta interferon family	15	ligand	extracellular, ligand, secreted	P17181, P48551	IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2	IFNAR1 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNAR2 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNA21&keywords=IFNA21	0.06	716	NA	NA	1.04	257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	487
PTN	pleiotrophin	Yes		ENSG00000105894	P21246	Pleiotrophin family	15	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	O15031, O75056, P18827, P19338, P23467, P23471, P31431, P34741, Q13332, Q9UM73, Q9Y6N8	ALK, CDH10, ITGAV_ITGB3, NCL, PLXNB2, PTPRB, PTPRS, PTPRZ1, SDC1, SDC2, SDC3, SDC4	ALK [Baccin2019:11278720;CellChatDB:25620911;CellChatDB:28356350;CellTalkDB:11278720;Cellinker:11278720;Cellinker:25620911;Cellinker:28356350;DIP:1848244;HPRD:11278720;LRdb:11278720;SIGNOR:11278720;SignaLink3:11278720;SignaLink3:23331499;connectomeDB2020:11278720], SDC1 [Baccin2019:7592855;CellChatDB:25620911;CellChatDB:28356350;CellTalkDB:15226297;Cellinker:25620911;Cellinker:28356350;Cellinker:7592855;HPRD:7592855;LRdb:7592855], SDC3 [Baccin2019:8175719;CellChatDB:25620911;CellChatDB:28356350;Cellinker:11461706;Cellinker:25620911;Cellinker:28356350;Cellinker:8175719;HPRD:8175719;LRdb:8175719;connectomeDB2020:8175719], PTPRZ1 [Baccin2019:10706604;Baccin2019:16814777;BioGRID:10706604;CellChatDB:25620911;CellChatDB:28356350;CellPhoneDB:25644401;CellTalkDB:25644401;Cellinker:10706604;Cellinker:16814777;Cellinker:25620911;Cellinker:28356350;HPMR:10706604;HPRD:10706604;HPRD:16814777;LRdb:10706604;LRdb:17;connectomeDB2020:10706604;connectomeDB2020:16814777], PTPRS [CellTalkDB:16169070;Cellinker:16169070;HPRD:16169070;LRdb:16169070;connectomeDB2020:16169070], PTPRB [CellTalkDB:26198319;Ramilowski2015:22839765;connectomeDB2020:22839765;talklr:22839765], SDC2 [CellChatDB:25620911;CellChatDB:28356350;Cellinker:25620911;Cellinker:28356350], SDC4 [CellChatDB:25620911;CellChatDB:28356350;Cellinker:25620911;Cellinker:28356350], NCL [CellChatDB:25620911;CellChatDB:28356350;Cellinker:25620911;Cellinker:28356350], PLXNB2 [Cellinker:16169070;HPRD:16169070;LRdb:16169070;connectomeDB2020:16169070], CDH10 [Baccin2019:16169070;Cellinker:16169070;HPRD:16169070;LRdb:16169070]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	chondroitin sulfate binding [GO:0035374]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; protein phosphatase inhibitor activity [GO:0004864]	bone mineralization [GO:0030282]; decidualization [GO:0046697]; dendrite arborization [GO:0140059]; dendrite regeneration [GO:0031104]; estrous cycle [GO:0044849]; integrin-mediated signaling pathway [GO:0007229]; learning [GO:0007612]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; memory [GO:0007613]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of neuroblast proliferation [GO:0007406]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; ossification involved in bone remodeling [GO:0043932]; positive regulation of axon regeneration [GO:0048680]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of ossification [GO:0045778]; positive regulation of stem cell differentiation [GO:2000738]; receptor clustering [GO:0043113]; regulation of endothelial cell migration [GO:0010594]; regulation of hemopoiesis [GO:1903706]; regulation of myelination [GO:0031641]; regulation of stem cell population maintenance [GO:2000036]; regulation of synaptic plasticity [GO:0048167]; response to auditory stimulus [GO:0010996]; tissue regeneration [GO:0042246]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PTN&keywords=PTN	0.81	475	NA	NA	0.01	823	0.01	0.00	0.00	0.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	301	403	396	0.01	0.60	0.57	0.57	303	296	300	499
IFNA4	interferon alpha 4	Yes		ENSG00000236637	P05014	Alpha/beta interferon family	15	ligand	extracellular, ligand, secreted	P17181, P48551	IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2	IFNAR1 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNAR2 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNA4&keywords=IFNA4	0.01	833	NA	NA	1.89	170	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	502
CCL3L3	C-C motif chemokine ligand 3 like 1, C-C motif chemokine ligand 3 like 3	Yes		ENSG00000277796, ENSG00000277768, ENSG00000277336, ENSG00000276085	P16619	Intercrine beta (chemokine CC) family	15	ligand	intracellular, ligand, secreted	O00590, P32246, P51677, P51679, P51681	ACKR2, CCR1, CCR3, CCR4, CCR5	CCR5 [Baccin2019:10364178;Baccin2019:10477718;Baccin2019:11170631;Baccin2019:11700073;Baccin2019:11734558;Baccin2019:12964882;Baccin2019:16298345;Baccin2019:9790730;BioGRID:11734558;CellTalkDB:10364178;Cellinker:10364178;Cellinker:11449371;Cellinker:11734558;HPRD:10364178;HPRD:11449371;HPRD:11734558;ICELLNET:22633458;LRdb:11;LRdb:11734558;SPIKE:11734558;connectomeDB2020:10364178;connectomeDB2020:11449371;connectomeDB2020:11734558], ACKR2 [CellChatDB:26740381;CellTalkDB:10364178;Cellinker:26740381;Cellinker:29637711;HPRD:10364178;ICELLNET:22633458;LRdb:10699158;connectomeDB2020:10364178;connectomeDB2020:25297873], CCR1 [Baccin2019:10202040;Baccin2019:10660125;Baccin2019:11170631;Baccin2019:12381680;Baccin2019:7545673;Baccin2019:8530354;Baccin2019:9115216;Baccin2019:9624164;CellPhoneDB:24218476;Cellinker:11449371;HPRD:11449371;ICELLNET:22633458;LRdb:11449371;connectomeDB2020:11449371], CCR3 [Baccin2019:7594543;CellPhoneDB:24218476;Cellinker:11449371;HPRD:11449371;ICELLNET:22633458;LRdb:11449371;connectomeDB2020:11449371], CCR4 [Baccin2019:8573157]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]	cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; negative regulation of cell population proliferation [GO:0008285]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL3L3&keywords=CCL3L3	0.66	497	NA	NA	0.23	511	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	504
CCK	cholecystokinin	Yes		ENSG00000187094	P06307	Gastrin/cholecystokinin family	15	ligand	extracellular, ligand, secreted	P32238, P32239	CCKAR, CCKBR	CCKAR [Baccin2019:10368033;Baccin2019:10400673;Baccin2019:10595537;Baccin2019:11300760;Baccin2019:9006937;Baccin2019:9603948;CellTalkDB:10368033;Cellinker:10368033;Cellinker:10400673;Cellinker:10595537;Cellinker:11300760;Cellinker:9006937;Cellinker:9603948;HPRD:10400673;HPRD:10595537;HPRD:11300760;HPRD:9006937;HPRD:9603948;LRdb:10368033;LRdb:10400673;LRdb:10595537;LRdb:11300760;LRdb:9006937;LRdb:9603948;SIGNOR:10368033;connectomeDB2020:10368033;connectomeDB2020:10400673;connectomeDB2020:10595537;connectomeDB2020:11300760;connectomeDB2020:9006937;connectomeDB2020:9603948], CCKBR [Baccin2019:10368033;Baccin2019:10438490;Baccin2019:12695525;Baccin2019:15001692;Baccin2019:15068617;Baccin2019:15520004;Baccin2019:7681836;Baccin2019:8349705;BioGRID:12695525;BioGRID:15001692;BioGRID:15520004;CellTalkDB:10368033;Cellinker:10368033;Cellinker:10438490;Cellinker:12695525;Cellinker:15001692;Cellinker:15068617;Cellinker:15520004;Cellinker:7681836;Cellinker:8349705;Guide2Pharma:7681836;Guide2Pharma:8349705;HPRD:10438490;HPRD:12695525;HPRD:15001692;HPRD:15068617;HPRD:15520004;LRdb:10368033;LRdb:10438490;LRdb:12695525;LRdb:15001692;LRdb:15068617;LRdb:15520004;LRdb:7681836;LRdb:8349705;Lit-BM-17:12695525;Lit-BM-17:15001692;Lit-BM-17:15520004;Lit-BM-17:23597562;SIGNOR:10368033;connectomeDB2020:10368033;connectomeDB2020:10438490;connectomeDB2020:12695525;connectomeDB2020:15001692;connectomeDB2020:15068617;connectomeDB2020:15520004;connectomeDB2020:7681836;connectomeDB2020:8349705;scConnect:7681836;scConnect:8349705]	axon [GO:0030424]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184]; peptide hormone receptor binding [GO:0051428]	axonogenesis [GO:0007409]; digestion [GO:0007586]; eating behavior [GO:0042755]; neuron migration [GO:0001764]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCK&keywords=CCK	0.31	573	NA	NA	0.01	822	0.01	0.00	0.00	0.07	0.02	0.01	0.02	0.01	0.00	0.00	0.02	297	369	210	0.01	0.51	0.46	1.19	338	329	64	523
TSHB	thyroid stimulating hormone subunit beta	Yes		ENSG00000134200	P01222	Glycoprotein hormones subunit beta family	15	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, P07550, P10321, P13945, P16473, P32241, P41586, Q03431, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, GPR20, GPR84, HLA-C, PTH1R, RAMP2, RAMP3, TSHR, VIPR1	TSHR [Baccin2019:15571461;Baccin2019:2558651;CellTalkDB:15571461;Cellinker:15571461;Cellinker:2558651;HPMR:15571461;HPRD:2558651;LRdb:15571461;LRdb:26;NetPath:20181794;SIGNOR:12045258;connectomeDB2020:15571461;connectomeDB2020:2558651], PTH1R [CellTalkDB:32196115], ADCYAP1R1 [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], HLA-C [NA]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	hormone activity [GO:0005179]	anatomical structure morphogenesis [GO:0009653]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; response to calcium ion [GO:0051592]; response to estrogen [GO:0043627]; response to vitamin A [GO:0033189]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TSHB&keywords=TSHB	1.24	429	NA	NA	0.10	626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	528
IFNA13	interferon alpha 13	Yes		ENSG00000233816	P01562	Alpha/beta interferon family	15	ligand	extracellular, ligand, secreted	P17181, P20023, P48551, P60568, Q00978	CR2, IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2, IL2, IRF9	IFNAR1 [CellTalkDB:11698684;CellTalkDB:21856167;HPMR:11698684;HPRD:7932753;LRdb:11698684;LRdb:79;Ramilowski2015:21856167;SIGNOR:8181059;SignaLink3:23331499;SignaLink3:8181059;connectomeDB2020:11698684;connectomeDB2020:21856167;connectomeDB2020:7932753;talklr:21856167], IFNAR2 [CellTalkDB:11698684;CellTalkDB:21856167;DIP:10395669;HPMR:11698684;LRdb:11698684;Ramilowski2015:21856167;SIGNOR:11278538;SignaLink3:23331499;SignaLink3:8181059;connectomeDB2020:11698684;connectomeDB2020:21856167;talklr:21856167], CR2 [CellTalkDB:16785534;Cellinker:16785534;HPRD:1849076;InnateDB:19164292], IRF9 [HPRD:8454630], IL2 [HPRD:3262520]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNA13&keywords=IFNA13	0.02	782	NA	NA	0.93	278	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	530
OXT	oxytocin/neurophysin I prepropeptide	Yes		ENSG00000101405	P01178	Vasopressin/oxytocin family	15	ligand	extracellular, intracellular, ligand, secreted	P30518, P30559, P37288, P47901	AVPR1A, AVPR1B, AVPR2, OXTR	OXTR [Baccin2019:10519430;Baccin2019:10698266;Baccin2019:12660315;Baccin2019:1313946;Baccin2019:16158071;Baccin2019:7475979;Baccin2019:7774575;Baccin2019:8955347;CellTalkDB:10519430;Cellinker:10519430;Cellinker:10698266;Cellinker:12660315;Cellinker:1313946;Cellinker:16158071;Cellinker:7475979;Cellinker:7774575;Cellinker:8955347;Guide2Pharma:10519430;Guide2Pharma:12660315;Guide2Pharma:16158071;Guide2Pharma:7475979;Guide2Pharma:7774575;Guide2Pharma:8955347;HPMR:1313946;HPRD:10698266;LRdb:10519430;LRdb:10698266;LRdb:12660315;LRdb:1313946;LRdb:16158071;LRdb:7475979;LRdb:7774575;LRdb:8955347;SIGNOR:1313946;connectomeDB2020:10519430;connectomeDB2020:10698266;connectomeDB2020:12660315;connectomeDB2020:1313946;connectomeDB2020:16158071;connectomeDB2020:7475979;connectomeDB2020:7774575;connectomeDB2020:8955347;scConnect:10519430;scConnect:12660315;scConnect:16158071;scConnect:7475979;scConnect:7774575;scConnect:8955347], AVPR1A [Baccin2019:10519430;Baccin2019:12660315;Baccin2019:8106369;Baccin2019:9264324;Baccin2019:9322919;Baccin2019:9334232;Baccin2019:9459574;Baccin2019:9884074;CellTalkDB:8106369;Cellinker:10519430;Cellinker:12660315;Cellinker:8106369;Cellinker:9264324;Cellinker:9322919;Cellinker:9334232;Cellinker:9459574;Cellinker:9884074;Guide2Pharma:10519430;Guide2Pharma:12660315;Guide2Pharma:8106369;Guide2Pharma:9264324;Guide2Pharma:9322919;Guide2Pharma:9334232;Guide2Pharma:9459574;Guide2Pharma:9884074;LRdb:10519430;LRdb:12660315;LRdb:8106369;LRdb:9264324;LRdb:9322919;LRdb:9334232;LRdb:9459574;LRdb:9884074;connectomeDB2020:10519430;connectomeDB2020:12660315;connectomeDB2020:8106369;connectomeDB2020:9264324;connectomeDB2020:9322919;connectomeDB2020:9334232;connectomeDB2020:9459574;connectomeDB2020:9884074;scConnect:10519430;scConnect:12660315;scConnect:8106369;scConnect:9264324;scConnect:9322919;scConnect:9334232;scConnect:9459574;scConnect:9884074], AVPR1B [Baccin2019:16158071;Baccin2019:9264324;Baccin2019:9322919;Baccin2019:9459574;Baccin2019:9884074;CellTalkDB:16158071;Guide2Pharma:16158071;Guide2Pharma:9264324;Guide2Pharma:9322919;Guide2Pharma:9459574;Guide2Pharma:9884074;LRdb:16158071;LRdb:9264324;LRdb:9322919;LRdb:9459574;LRdb:9884074;connectomeDB2020:16158071;connectomeDB2020:9264324;connectomeDB2020:9322919;connectomeDB2020:9459574;connectomeDB2020:9884074;scConnect:16158071;scConnect:9264324;scConnect:9322919;scConnect:9459574;scConnect:9884074], AVPR2 [Baccin2019:12660315;Baccin2019:7774575;Baccin2019:9264324;Baccin2019:9322919;Baccin2019:9459574;Baccin2019:9884074;CellTalkDB:9884074;Guide2Pharma:12660315;Guide2Pharma:7774575;Guide2Pharma:9264324;Guide2Pharma:9322919;Guide2Pharma:9459574;Guide2Pharma:9884074;LRdb:12660315;LRdb:7774575;LRdb:9264324;LRdb:9322919;LRdb:9459574;LRdb:9884074;connectomeDB2020:12660315;connectomeDB2020:7774575;connectomeDB2020:9264324;connectomeDB2020:9322919;connectomeDB2020:9459574;connectomeDB2020:9884074;scConnect:12660315;scConnect:7774575;scConnect:9264324;scConnect:9322919;scConnect:9459574;scConnect:9884074]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; terminal bouton [GO:0043195]	neurohypophyseal hormone activity [GO:0005185]; neuropeptide hormone activity [GO:0005184]; oxytocin receptor binding [GO:0031855]	drinking behavior [GO:0042756]; eating behavior [GO:0042755]; female pregnancy [GO:0007565]; grooming behavior [GO:0007625]; heart development [GO:0007507]; hyperosmotic salinity response [GO:0042538]; male mating behavior [GO:0060179]; maternal aggressive behavior [GO:0002125]; maternal behavior [GO:0042711]; memory [GO:0007613]; negative regulation of blood pressure [GO:0045776]; negative regulation of gastric acid secretion [GO:0060455]; negative regulation of urine volume [GO:0035811]; positive regulation of blood pressure [GO:0045777]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of female receptivity [GO:0045925]; positive regulation of hindgut contraction [GO:0060450]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of ossification [GO:0045778]; positive regulation of penile erection [GO:0060406]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; positive regulation of uterine smooth muscle contraction [GO:0070474]; regulation of heart rate [GO:0002027]; regulation of sensory perception of pain [GO:0051930]; response to activity [GO:0014823]; response to amphetamine [GO:0001975]; response to cAMP [GO:0051591]; response to cocaine [GO:0042220]; response to electrical stimulus [GO:0051602]; response to estradiol [GO:0032355]; response to ether [GO:0045472]; response to food [GO:0032094]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434]; response to progesterone [GO:0032570]; response to prostaglandin E [GO:0034695]; response to retinoic acid [GO:0032526]; response to sucrose [GO:0009744]; signal transduction [GO:0007165]; sleep [GO:0030431]; social behavior [GO:0035176]; sperm ejaculation [GO:0042713]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=OXT&keywords=OXT	0.00	887	NA	NA	0.00	890	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.01	0.00	289	264	346	0.00	1.08	1.27	0.86	117	83	160	531
IFNA14	interferon alpha 14	Yes		ENSG00000228083	P01570	Alpha/beta interferon family	15	ligand	extracellular, ligand, secreted	P17181, P48551	IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2	IFNAR1 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNAR2 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNA14&keywords=IFNA14	0.01	853	NA	NA	1.39	213	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	533
IFNA16	interferon alpha 16	Yes		ENSG00000147885	P05015	Alpha/beta interferon family	15	ligand	extracellular, ligand, secreted	P17181, P48551	IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2	IFNAR1 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNAR2 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNA16&keywords=IFNA16	0.00	862	NA	NA	1.38	214	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	538
FGF20	fibroblast growth factor 20	Yes		ENSG00000078579	Q9NP95	Heparin-binding growth factors family	15	ligand	extracellular, intracellular, ligand, secreted, transmembrane	P11362, P21802, P22455, P22607	FGFR1, FGFR2, FGFR3, FGFR4	FGFR2 [CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;LRdb:16597617;connectomeDB2020:16597617], FGFR4 [Cellinker:25772309;LRdb:15621532;LRdb:17;Ramilowski2015:15621532;connectomeDB2020:15621532;talklr:15621532], FGFR1 [CellTalkDB:16597617;Cellinker:25772309;Cellinker:31276493;LRdb:16597617;connectomeDB2020:16597617], FGFR3 [CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;LRdb:16597617;connectomeDB2020:16597617]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparan sulfate proteoglycan binding [GO:0043395]; receptor-receptor interaction [GO:0090722]; signaling receptor binding [GO:0005102]	animal organ morphogenesis [GO:0009887]; cell-cell signaling [GO:0007267]; cell differentiation [GO:0030154]; fibroblast growth factor receptor signaling pathway [GO:0008543]; inner ear receptor cell differentiation [GO:0060113]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dopaminergic neuron differentiation [GO:1904340]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cell migration [GO:0030334]; regulation of dopamine secretion [GO:0014059]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF20&keywords=FGF20	0.12	653	NA	NA	0.36	440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	547
IFNA1	interferon alpha 1	Yes		ENSG00000197919	P01562	Alpha/beta interferon family	15	ligand	extracellular, ligand, secreted	P17181, P20023, P48551, P60568, Q00978	CR2, IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2, IL2, IRF9	IFNAR1 [CellTalkDB:11698684;CellTalkDB:21856167;HPMR:11698684;HPRD:7932753;LRdb:11698684;LRdb:79;Ramilowski2015:21856167;SIGNOR:8181059;SignaLink3:23331499;SignaLink3:8181059;connectomeDB2020:11698684;connectomeDB2020:21856167;connectomeDB2020:7932753;talklr:21856167], IFNAR2 [CellTalkDB:11698684;CellTalkDB:21856167;DIP:10395669;HPMR:11698684;LRdb:11698684;Ramilowski2015:21856167;SIGNOR:11278538;SignaLink3:23331499;SignaLink3:8181059;connectomeDB2020:11698684;connectomeDB2020:21856167;talklr:21856167], CR2 [CellTalkDB:16785534;Cellinker:16785534;HPRD:1849076;InnateDB:19164292], IRF9 [HPRD:8454630], IL2 [HPRD:3262520]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNA1&keywords=IFNA1	0.01	824	NA	NA	0.99	269	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	547
IFNA10	interferon alpha 10	Yes		ENSG00000186803	P01566	Alpha/beta interferon family	15	ligand	extracellular, ligand, secreted	P17181, P48551	IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2	IFNAR1 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNAR2 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNA10&keywords=IFNA10	0.00	877	NA	NA	1.23	236	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	557
IFNA17	interferon alpha 17	Yes		ENSG00000234829	P01571	Alpha/beta interferon family	15	ligand	extracellular, ligand, secreted	P17181, P48551	IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2	IFNAR1 [CellTalkDB:21856167;LRdb:21856167;Macrophage:7623815;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNAR2 [CellTalkDB:21856167;LRdb:21856167;Macrophage:7623815;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNA17&keywords=IFNA17	0.00	892	NA	NA	1.06	252	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	572
ARTN	artemin	Yes		ENSG00000117407	Q5T4W7	TGF-beta family, GDNF subfamily	15	ligand	extracellular, ligand, secreted, transmembrane	O00451, O60609, P07949, P13591, P56159	GFRA1, GFRA1_RET, GFRA2, GFRA3, GFRA3_RET, NCAM1, RET	GFRA3 [Baccin2019:98837239883723;CellTalkDB:9883723;Cellinker:11544105;Cellinker:9883723;DIP:16765900;HPMR:9883723;HPRD:9883723;IntAct:16765900;LRdb:9883723;Lit-BM-17:16765900;Lit-BM-17:9883723;SIGNOR:9883723;connectomeDB2020:9883723], GFRA2 [CellTalkDB:32196115;Cellinker:9883723], GFRA1 [CellTalkDB:9883723;Cellinker:11544105;Cellinker:28937965;Cellinker:9883723;LRdb:9883723;Ramilowski2015:9883723;connectomeDB2020:9883723;talklr:9883723], RET [Baccin2019:9883723;CellTalkDB:9883723;Cellinker:9883723;HPMR:9883723;LRdb:9883723;connectomeDB2020:9883723], NCAM1 [Cellinker:30853893]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	glial cell-derived neurotrophic factor receptor binding [GO:0030116]; growth factor activity [GO:0008083]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	axon guidance [GO:0007411]; induction of positive chemotaxis [GO:0050930]; lymphocyte migration into lymphoid organs [GO:0097021]; neuroblast proliferation [GO:0007405]; peripheral nervous system development [GO:0007422]; Peyer's patch morphogenesis [GO:0061146]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ARTN&keywords=ARTN	0.25	593	NA	NA	0.16	564	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	579
IFNA7	interferon alpha 7	Yes		ENSG00000214042	P01567	Alpha/beta interferon family	15	ligand	extracellular, ligand, secreted	P17181, P48551	IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2	IFNAR1 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNAR2 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cell-cell signaling [GO:0007267]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNA7&keywords=IFNA7	0.00	899	NA	NA	0.94	276	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	588
IFNA8	interferon alpha 8	Yes		ENSG00000120242	P32881	Alpha/beta interferon family	15	ligand	extracellular, intracellular, ligand, secreted	P17181, P48551, Q8TDT2	GPR152, IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2	IFNAR1 [CellTalkDB:21856167;DIP:7592797;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNAR2 [CellTalkDB:8969169;DIP:10395669;HPRD:8969169;LRdb:8969169;connectomeDB2020:8969169], GPR152 [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNA8&keywords=IFNA8	0.00	869	NA	NA	0.59	344	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	607
RLN3	relaxin 3	Yes		ENSG00000288474, ENSG00000171136	Q8WXF3	Insulin family	15	ligand, receptor	extracellular, ligand, receptor, secreted	O60895, O60896, P07550, P08913, P13945, P16473, P32241, P41586, P48039, Q03431, Q14831, Q8TDU9, Q8WXD0, Q99678, Q9HBX9, Q9NQS5, Q9NSD7	ADCYAP1R1, ADRA2A, ADRB2, ADRB3, GPR20, GPR84, GRM7, MTNR1A, PTH1R, RAMP2, RAMP3, RXFP1, RXFP2, RXFP3, RXFP4, TSHR, VIPR1	RXFP1 [Baccin2019:12506116;Baccin2019:14522968;Baccin2019:15649866;CellTalkDB:12506116;Cellinker:12506116;Cellinker:14522968;Cellinker:15649866;Cellinker:16365033;Cellinker:25761609;Guide2Pharma:12506116;Guide2Pharma:15649866;HPRD:12506116;HPRD:14522968;HPRD:15649866;LRdb:12506116;LRdb:14522968;LRdb:15649866;connectomeDB2020:12506116;connectomeDB2020:14522968;connectomeDB2020:15649866;scConnect:12506116;scConnect:15649866], RXFP2 [Baccin2019:16411781;CellTalkDB:16411781;Cellinker:16411781;Guide2Pharma:16411781;LRdb:16411781;connectomeDB2020:16411781;scConnect:16411781], RXFP3 [Baccin2019:14522968;Baccin2019:15367576;CellTalkDB:27245781;Cellinker:14522968;Cellinker:15367576;Cellinker:25761609;Guide2Pharma:14522968;Guide2Pharma:15367576;Guide2Pharma:17351017;Guide2Pharma:18434306;Guide2Pharma:22257012;HPMR:14522968;LMPID:24615237;connectomeDB2020:14522968;connectomeDB2020:15367576;scConnect:14522968;scConnect:15367576;scConnect:17351017;scConnect:18434306;scConnect:20159943;scConnect:22257012;scConnect:24641548], RXFP4 [CellTalkDB:14522967;Cellinker:14522967;Cellinker:25761609;Cellinker:27888281;Guide2Pharma:14522967;Guide2Pharma:17606621;Guide2Pharma:18582868;HPMR:14522967;HPMR:15367576;HPRD:14522967;LMPID:24802387;LRdb:14522967;connectomeDB2020:14522967;scConnect:14522967;scConnect:15525639;scConnect:17606621;scConnect:18582868], ADCYAP1R1 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115]	extracellular region [GO:0005576]	G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RLN3&keywords=RLN3	0.02	802	NA	NA	0.37	433	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	618
FGF16	fibroblast growth factor 16	Yes		ENSG00000196468	O43320	Heparin-binding growth factors family	15	ligand	intracellular, ligand, secreted	P11362, P21802, P22455, P22607	FGFR1, FGFR2, FGFR3, FGFR4	FGFR2 [CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;LRdb:16597617;Ramilowski2015:16597617;connectomeDB2020:16597617;talklr:16597617], FGFR4 [CellTalkDB:16597617;Cellinker:25772309;LRdb:16597617;Ramilowski2015:16597617;connectomeDB2020:16597617;talklr:16597617], FGFR3 [CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;LRdb:16597617;Ramilowski2015:16597617;connectomeDB2020:16597617;talklr:16597617], FGFR1 [CellTalkDB:16597617;Cellinker:25772309;LRdb:16597617]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]	animal organ morphogenesis [GO:0009887]; cell-cell signaling [GO:0007267]; cell differentiation [GO:0030154]; fibroblast growth factor receptor signaling pathway [GO:0008543]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; response to temperature stimulus [GO:0009266]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF16&keywords=FGF16	0.01	814	NA	NA	0.24	501	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	658
GNRH1	gonadotropin releasing hormone 1	Yes		ENSG00000147437	P01148	GnRH family	15	ligand	extracellular, ligand, secreted	P10275, P18146, P30968, Q13554, Q96P88, Q9UQM7	AR, CAMK2A, CAMK2B, EGR1, GNRHR, GNRHR2	CAMK2A [SPIKE:12810529], CAMK2B [SPIKE:12810529], GNRHR [Baccin2019:11726197;Baccin2019:17095587;Baccin2019:17452338;Baccin2019:414473;Baccin2019:9414473;CellChatDB:19640273;CellTalkDB:17452338;Cellinker:11726197;Cellinker:17095587;Cellinker:17452338;Cellinker:19640273;Cellinker:414473;Cellinker:9414473;Guide2Pharma:11726197;Guide2Pharma:17095587;Guide2Pharma:17452338;Guide2Pharma:26398856;Guide2Pharma:26774084;HPRD:9414473;LRdb:11726197;LRdb:17095587;LRdb:17452338;LRdb:414473;LRdb:9414473;SPIKE:4930860;connectomeDB2020:11726197;connectomeDB2020:17095587;connectomeDB2020:17452338;connectomeDB2020:414473;connectomeDB2020:9414473;scConnect:11726197;scConnect:17095587;scConnect:17452338;scConnect:26398856;scConnect:26774084], EGR1 [SIGNOR:19106114], AR [SIGNOR:17202804], GNRHR2 [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	gonadotropin hormone-releasing hormone activity [GO:0005183]; gonadotropin-releasing hormone receptor binding [GO:0031530]; hormone activity [GO:0005179]	cell-cell signaling [GO:0007267]; negative regulation of neuron migration [GO:2001223]; regulation of gene expression [GO:0010468]; regulation of ovarian follicle development [GO:2000354]; reproduction [GO:0000003]; response to ethanol [GO:0045471]; response to steroid hormone [GO:0048545]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GNRH1&keywords=GNRH1	0.29	583	NA	NA	0.04	747	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	665
MSTN	myostatin	Yes		ENSG00000138379	O14793	TGF-beta family	15	ligand	extracellular, intracellular, ligand, secreted	Q13705	ACVR1B_ACVR2A, ACVR1B_ACVR2B, ACVR2A_TGFBR1, ACVR2B, ACVR2B_TGFBR1	ACVR2B [Baccin2019:11459935;CellTalkDB:11459935;HPRD:11459935;LRdb:11459935;Lit-BM-17:11459935;Lit-BM-17:23829672;SIGNOR:11459935;connectomeDB2020:11459935]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]	cellular response to dexamethasone stimulus [GO:0071549]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of kinase activity [GO:0033673]; negative regulation of muscle hypertrophy [GO:0014741]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myoblast proliferation [GO:2000818]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; negative regulation of skeletal muscle tissue growth [GO:0048632]; ovulation cycle process [GO:0022602]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription, DNA-templated [GO:0045893]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to gravity [GO:0009629]; response to heat [GO:0009408]; response to muscle activity [GO:0014850]; response to testosterone [GO:0033574]; skeletal muscle atrophy [GO:0014732]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MSTN&keywords=MSTN	0.06	708	NA	NA	0.09	642	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	675
IFNL3	interferon lambda 3	Yes		ENSG00000197110	Q8IZI9	Lambda interferon family	15	ligand	extracellular, ligand, secreted	Q08334, Q8IU57	IFNL3_IFNLR1_IL10RB, IFNLR1, IFNLR1_IL10RB, IL10RB	IL10RB [CellTalkDB:12974481;Cellinker:12469119;Cellinker:12974481;HPRD:12469119;LRdb:12;LRdb:12974481;SIGNOR:12469119;SignaLink3:12469119;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12469119;connectomeDB2020:12974481], IFNLR1 [CellTalkDB:12974481;LRdb:12974481;SIGNOR:12469119;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12974481]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]	defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; positive regulation of immune response [GO:0050778]; receptor signaling pathway via JAK-STAT [GO:0007259]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNL3&keywords=IFNL3	0.00	890	NA	NA	0.30	468	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	679
IHH	Indian hedgehog signaling molecule	Yes		ENSG00000163501	Q14623	Hedgehog family	15	cell_surface_ligand, ligand	cell_surface_ligand, extracellular, ligand, plasma_membrane, secreted	Q13635, Q4KMG0, Q96QV1, Q9BWV1, Q9Y6C5	BOC, CDON, HHIP, PTCH1, PTCH1_SMO, PTCH2, PTCH2_SMO	PTCH2 [Baccin2019:9811851;CancerCellMap:9811851;CellTalkDB:9811851;Cellinker:9811851;HPRD:9811851;ICELLNET:29274272;LRdb:9811851;NetPath:9811851;SIGNOR:9811851;SignaLink3:23331499;SignaLink3:9811851;connectomeDB2020:9811851], PTCH1 [Baccin2019:115627869811851;CancerCellMap:9811851;CellTalkDB:11562786;Cellinker:11562786;Cellinker:9811851;HPRD:9811851;ICELLNET:29274272;LRdb:11562786;LRdb:98;NetPath:9811851;SIGNOR:9811851;SignaLink3:19399989;SignaLink3:23331499;connectomeDB2020:11562786;connectomeDB2020:9811851], HHIP [Baccin2019:10050855;Baccin2019:11435703;CancerCellMap:10050855;CancerCellMap:11435703;CellTalkDB:10050855;Cellinker:10050855;Cellinker:11435703;HPMR:10050855;HPRD:10050855;HPRD:11435703;LRdb:10050855;LRdb:11;NetPath:10050855;connectomeDB2020:10050855;connectomeDB2020:11435703], BOC [CellTalkDB:20519495;Cellinker:20519495;LRdb:20519495;Ramilowski2015:20519495;connectomeDB2020:20519495;talklr:20519495], CDON [CellTalkDB:20519495;Cellinker:20519495;LRdb:20519495;Ramilowski2015:20519495;connectomeDB2020:20519495;talklr:20519495]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]	bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; camera-type eye photoreceptor cell fate commitment [GO:0060220]; cartilage development [GO:0051216]; cell-cell signaling [GO:0007267]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; chondrocyte proliferation [GO:0035988]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic digit morphogenesis [GO:0042733]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint development [GO:0072498]; epithelial cell-cell adhesion [GO:0090136]; epithelial cell morphogenesis [GO:0003382]; head morphogenesis [GO:0060323]; heart looping [GO:0001947]; intein-mediated protein splicing [GO:0016539]; in utero embryonic development [GO:0001701]; liver regeneration [GO:0097421]; maternal process involved in female pregnancy [GO:0060135]; multicellular organism growth [GO:0035264]; negative regulation of alpha-beta T cell differentiation [GO:0046639]; negative regulation of apoptotic process [GO:0043066]; negative regulation of eye pigmentation [GO:0048074]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; negative regulation of T cell differentiation in thymus [GO:0033085]; neuron development [GO:0048666]; osteoblast differentiation [GO:0001649]; pancreas development [GO:0031016]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoprocessing [GO:0016540]; proteoglycan metabolic process [GO:0006029]; regulation of gene expression [GO:0010468]; regulation of growth [GO:0040008]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; retinal pigment epithelium development [GO:0003406]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; smooth muscle tissue development [GO:0048745]; somite development [GO:0061053]; vitelline membrane formation [GO:0030704]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IHH&keywords=IHH	0.06	721	NA	NA	0.05	712	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	717
IFNA6	interferon alpha 6	Yes		ENSG00000120235	P05013	Alpha/beta interferon family	15	ligand	extracellular, ligand, secreted	P17181, P48551	IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2	IFNAR1 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNAR2 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNA6&keywords=IFNA6	0.00	898	NA	NA	0.18	546	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	722
PF4	platelet factor 4	Yes		ENSG00000163737	P02776	Intercrine alpha (chemokine CxC) family	15	ligand	extracellular, intracellular, ligand, secreted	P01130, P04070, P07204, P08913, P09038, P10145, P13501, P21802, P34741, P48039, P49682, Q07954, Q14831, Q16570, Q9UNN8	ACKR1, ADRA2A, CCL5, CXCL8, CXCR3, FGF2, FGFR2, GRM7, LDLR, LRP1, MTNR1A, PROC, PROCR, SDC2, THBD	CXCR3 [Baccin2019:12782716;CellPhoneDB:24218476;Cellinker:12782716;HPRD:12782716;ICELLNET:12782716;ICELLNET:21655676;LRdb:10699158;connectomeDB2020:12782716], FGFR2 [Baccin2019:9558385;CellTalkDB:9558385;Cellinker:9558385;LRdb:9558385;connectomeDB2020:9558385], SDC2 [Baccin2019:7524669;CellTalkDB:7524669;Cellinker:7524669;HPRD:7524669;LRdb:7524669;connectomeDB2020:7524669], ACKR1 [CellTalkDB:32103204;InnateDB:8132497], GRM7 [CellTalkDB:32196115], LDLR [Baccin2019:1198621511986210;CellTalkDB:11986215;Cellinker:11986215;HPRD:11986215;LRdb:11986215;connectomeDB2020:11986215], THBD [Baccin2019:93955249395524;CellTalkDB:9395524;Cellinker:9395524;HPMR:9395524;HPRD:9395524;LRdb:9395524;connectomeDB2020:9395524], MTNR1A [CellTalkDB:32196115], PROCR [Baccin2019:9395524;CellTalkDB:9395524;Cellinker:9395524;HPMR:9395524;LRdb:9395524;connectomeDB2020:9395524], LRP1 [CellTalkDB:20806113], ADRA2A [CellTalkDB:32196115], CXCL8 [HPRD:12586630;HPRD:15531763;InnateDB:12586630], PROC [HPRD:9395524], CCL5 [HPRD:15459010], FGF2 [HPRD:9558385]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]	chemokine activity [GO:0008009]; CXCR3 chemokine receptor binding [GO:0048248]; CXCR chemokine receptor binding [GO:0045236]; heparin binding [GO:0008201]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; cytokine-mediated signaling pathway [GO:0019221]; defense response to protozoan [GO:0042832]; inflammatory response [GO:0006954]; killing by host of symbiont cells [GO:0051873]; killing of cells of other organism [GO:0031640]; leukocyte chemotaxis [GO:0030595]; negative regulation of angiogenesis [GO:0016525]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of MHC class II biosynthetic process [GO:0045347]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell population proliferation [GO:0042127]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PF4&keywords=PF4	0.08	689	NA	NA	0.03	767	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	728
IL25	interleukin 25	Yes		ENSG00000166090	Q9H293	IL-17 family	15	ligand	extracellular, ligand, secreted, transmembrane	Q96F46, Q9NRM6	IL17RA, IL17RA_IL17RB, IL17RB	IL17RA [InnateDB:19838198], IL17RB [CellTalkDB:11058597;HPMR:11058597;HPRD:11058597;ICELLNET:24011563;InnateDB:11058597;InnateDB:19838198;LRdb:11058597;connectomeDB2020:11058597]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; interleukin-17E receptor binding [GO:0030380]	eosinophil differentiation [GO:0030222]; inflammatory response to antigenic stimulus [GO:0002437]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to fungus [GO:0009620]; response to nematode [GO:0009624]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL25&keywords=IL25	0.00	879	NA	NA	0.13	593	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	736
FGF22	fibroblast growth factor 22	Yes		ENSG00000070388	Q9HCT0	Heparin-binding growth factors family	15	ligand	extracellular, intracellular, ligand, secreted, transmembrane, transmembrane_predicted	P11362, P21802, Q8N441	FGFR1, FGFR2, FGFRL1	FGFR2 [Baccin2019:12591959;CellTalkDB:16597617;Cellinker:12591959;Cellinker:16597617;Cellinker:25772309;LRdb:16597617;SignaLink3:23331499;SignaLink3:8663044;connectomeDB2020:12591959], FGFR1 [CellTalkDB:16597617;LRdb:16597617;connectomeDB2020:16597617], FGFRL1 [connectomeDB2020:19920134]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]	animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; fibroblast growth factor receptor signaling pathway [GO:0008543]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF22&keywords=FGF22	0.06	724	NA	NA	0.03	780	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	752
IL27	interleukin 27	Yes		ENSG00000197272	Q8NEV9	IL-6 superfamily	15	ligand	extracellular, intracellular, ligand, secreted	P40189, Q6UWB1	IL27RA, IL6ST	IL27RA [Baccin2019:12121660;CellTalkDB:12121660;Cellinker:12121660;HPRD:12121660;LRdb:12121660;SIGNOR:14764690;SignaLink3:12121660;SignaLink3:17318299;SignaLink3:18988627;SignaLink3:23331499;connectomeDB2020:12121660], IL6ST [NA]	cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; interleukin-27 receptor binding [GO:0045523]; signaling receptor binding [GO:0005102]	inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interferon-gamma production [GO:0032729]; regulation of T cell proliferation [GO:0042129]; regulation of T-helper 1 cell differentiation [GO:0045625]; response to bacterium [GO:0009617]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL27&keywords=IL27	0.01	835	NA	NA	0.05	706	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	771
IFNA2	interferon alpha 2	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000188379	P01563	Alpha/beta interferon family	15	ligand	extracellular, ligand, secreted	P17181, P20023, P48551	CR2, IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2, IRF9_STAT1_STAT2	IFNAR1 [CellTalkDB:1834641;DIP:7592797;DIP:9334213;HPRD:1834641;LRdb:1834641;connectomeDB2020:1834641], IFNAR2 [CellTalkDB:10339405;DIP:10395669;DIP:10984492;HPRD:10339405;HPRD:11888273;InnateDB:10339405;InnateDB:17001036;InnateDB:18027911;InnateDB:21854986;LRdb:10339405;LRdb:12;Lit-BM-17:10339405;Lit-BM-17:10395669;Lit-BM-17:10984492;Lit-BM-17:21854986;connectomeDB2020:10339405;connectomeDB2020:11888273], CR2 [Cellinker:16785534]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cell-cell signaling [GO:0007267]; cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; natural killer cell activation involved in immune response [GO:0002323]; negative regulation of gene expression [GO:0010629]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of T cell differentiation [GO:0045581]; negative regulation of T-helper 2 cell cytokine production [GO:2000552]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNA2&keywords=IFNA2	0.00	899	NA	NA	0.09	650	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	775
PROK1	prokineticin 1	Yes		ENSG00000143125	P58294	AVIT (prokineticin) family	15	ligand	extracellular, intracellular, ligand, secreted	Q8NFJ6, Q8TCW9	PROKR1, PROKR2	PROKR1 [Baccin2019:11886876;Baccin2019:12054613;Baccin2019:15772293;CellChatDB:24496457;CellTalkDB:11886876;Cellinker:11886876;Cellinker:12054613;Cellinker:15772293;Cellinker:24496457;Guide2Pharma:12054613;Guide2Pharma:15772293;HPMR:11886876;HPMR:12054613;LRdb:11886876;LRdb:12054613;LRdb:15772293;SIGNOR:12054613;connectomeDB2020:11886876;connectomeDB2020:12054613;connectomeDB2020:15772293;scConnect:12054613;scConnect:15772293], PROKR2 [Baccin2019:11886876;Baccin2019:12054613;Baccin2019:15772293;CellChatDB:24496457;CellTalkDB:12054613;Cellinker:11886876;Cellinker:12054613;Cellinker:15772293;Cellinker:24496457;Guide2Pharma:12054613;Guide2Pharma:15772293;HPMR:11886876;HPMR:12054613;LRdb:11886876;LRdb:12054613;LRdb:15772293;connectomeDB2020:11886876;connectomeDB2020:12054613;connectomeDB2020:15772293;scConnect:12054613;scConnect:15772293]	extracellular region [GO:0005576]	growth factor activity [GO:0008083]	angiogenesis [GO:0001525]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; regulation of angiogenesis [GO:0045765]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PROK1&keywords=PROK1	0.03	763	NA	NA	0.00	862	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	813
ANGPT4	angiopoietin 4	Yes		ENSG00000101280	Q9Y264	NA	15	ligand	ligand, secreted, transmembrane	P35590, Q02763	TEK, TIE1	TEK [Baccin2019:10051567;CellTalkDB:10051567;Cellinker:10051567;HPRD:10051567;LRdb:10051567;SIGNOR:15284220;SignaLink3:10051567;SignaLink3:15284220;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:10051567;connectomeDB2020:15284220], TIE1 [CellTalkDB:15851516;SignaLink3:10051567;SignaLink3:23331499]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]	angiogenesis [GO:0001525]; cellular response to hypoxia [GO:0071456]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; Notch signaling pathway [GO:0007219]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ANGPT4&keywords=ANGPT4	0.01	808	NA	NA	0.01	817	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	813
AVP	arginine vasopressin	Yes		ENSG00000101200	P01185	Vasopressin/oxytocin family	15	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, P01130, P07550, P13945, P16473, P30518, P30559, P32241, P37288, P41586, P47901, P98164, Q03431, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, AVPR1A, AVPR1B, AVPR2, GPR20, GPR84, LDLR, LRP2, OXTR, PTH1R, RAMP2, RAMP3, TSHR, VIPR1	OXTR [Baccin2019:10519430;Baccin2019:11337500;Baccin2019:12446593;Baccin2019:15084136;Baccin2019:16158071;Baccin2019:7475979;Baccin2019:7774575;Baccin2019:7921229;Baccin2019:8955347;CellTalkDB:12446593;Guide2Pharma:10519430;Guide2Pharma:11337500;Guide2Pharma:12446593;Guide2Pharma:15084136;Guide2Pharma:16158071;Guide2Pharma:7475979;Guide2Pharma:7774575;Guide2Pharma:8955347;HPRD:7921229;LRdb:10519430;LRdb:11337500;LRdb:12446593;LRdb:15084136;LRdb:16158071;LRdb:7475979;LRdb:7774575;LRdb:7921229;LRdb:8955347;connectomeDB2020:10519430;connectomeDB2020:11337500;connectomeDB2020:12446593;connectomeDB2020:15084136;connectomeDB2020:16158071;connectomeDB2020:7475979;connectomeDB2020:7774575;connectomeDB2020:7921229;connectomeDB2020:8955347;scConnect:10519430;scConnect:11337500;scConnect:12446593;scConnect:15084136;scConnect:16158071;scConnect:7475979;scConnect:7774575;scConnect:8955347], AVPR1A [Baccin2019:10519430;Baccin2019:10780976;Baccin2019:10866830;Baccin2019:12446593;Baccin2019:15084136;Baccin2019:1560825;Baccin2019:8106369;Baccin2019:9264324;Baccin2019:9322919;Baccin2019:9334232;Baccin2019:9459574;Baccin2019:9864265;Baccin2019:9884074;CellTalkDB:1560825;Cellinker:10519430;Cellinker:10780976;Cellinker:10866830;Cellinker:12446593;Cellinker:15084136;Cellinker:1560825;Cellinker:8106369;Cellinker:9264324;Cellinker:9322919;Cellinker:9334232;Cellinker:9459574;Cellinker:9864265;Cellinker:9884074;Guide2Pharma:10519430;Guide2Pharma:10780976;Guide2Pharma:10866830;Guide2Pharma:12446593;Guide2Pharma:15084136;Guide2Pharma:8106369;Guide2Pharma:9264324;Guide2Pharma:9322919;Guide2Pharma:9334232;Guide2Pharma:9459574;Guide2Pharma:9864265;Guide2Pharma:9884074;HPMR:1560825;HPRD:8106369;LRdb:10519430;LRdb:10780976;LRdb:10866830;LRdb:12446593;LRdb:15084136;LRdb:1560825;LRdb:8106369;LRdb:9264324;LRdb:9322919;LRdb:9334232;LRdb:9459574;LRdb:9864265;LRdb:9884074;connectomeDB2020:10519430;connectomeDB2020:10780976;connectomeDB2020:10866830;connectomeDB2020:12446593;connectomeDB2020:15084136;connectomeDB2020:1560825;connectomeDB2020:8106369;connectomeDB2020:9264324;connectomeDB2020:9322919;connectomeDB2020:9334232;connectomeDB2020:9459574;connectomeDB2020:9864265;connectomeDB2020:9884074;scConnect:10519430;scConnect:10780976;scConnect:10866830;scConnect:12446593;scConnect:15084136;scConnect:8106369;scConnect:9264324;scConnect:9322919;scConnect:9334232;scConnect:9459574;scConnect:9864265;scConnect:9884074], AVPR1B [Baccin2019:10519430;Baccin2019:10780976;Baccin2019:12446593;Baccin2019:15084136;Baccin2019:16158071;Baccin2019:7929452;Baccin2019:9264324;Baccin2019:9322919;Baccin2019:9459574;Baccin2019:9864265;Baccin2019:9884074;CellTalkDB:7929452;Cellinker:10519430;Cellinker:10780976;Cellinker:12446593;Cellinker:15084136;Cellinker:16158071;Cellinker:7929452;Cellinker:9264324;Cellinker:9322919;Cellinker:9459574;Cellinker:9864265;Cellinker:9884074;Guide2Pharma:10519430;Guide2Pharma:10780976;Guide2Pharma:12446593;Guide2Pharma:15084136;Guide2Pharma:16158071;Guide2Pharma:9264324;Guide2Pharma:9322919;Guide2Pharma:9459574;Guide2Pharma:9864265;Guide2Pharma:9884074;HPRD:7929452;LRdb:10519430;LRdb:10780976;LRdb:12446593;LRdb:15084136;LRdb:16158071;LRdb:7929452;LRdb:9264324;LRdb:9322919;LRdb:9459574;LRdb:9864265;LRdb:9884074;connectomeDB2020:10519430;connectomeDB2020:10780976;connectomeDB2020:12446593;connectomeDB2020:15084136;connectomeDB2020:16158071;connectomeDB2020:7929452;connectomeDB2020:9264324;connectomeDB2020:9322919;connectomeDB2020:9459574;connectomeDB2020:9864265;connectomeDB2020:9884074;scConnect:10519430;scConnect:10780976;scConnect:12446593;scConnect:15084136;scConnect:16158071;scConnect:9264324;scConnect:9322919;scConnect:9459574;scConnect:9864265;scConnect:9884074], AVPR2 [Baccin2019:10519430;Baccin2019:10780976;Baccin2019:11012895;Baccin2019:11857925;Baccin2019:12446593;Baccin2019:15084136;Baccin2019:7774575;Baccin2019:9264324;Baccin2019:9322919;Baccin2019:9459574;Baccin2019:9864265;Baccin2019:9884074;CellTalkDB:9884074;Cellinker:10519430;Cellinker:10780976;Cellinker:11012895;Cellinker:11857925;Cellinker:12446593;Cellinker:15084136;Cellinker:7774575;Cellinker:9264324;Cellinker:9322919;Cellinker:9459574;Cellinker:9864265;Cellinker:9884074;Guide2Pharma:10519430;Guide2Pharma:10780976;Guide2Pharma:11012895;Guide2Pharma:12446593;Guide2Pharma:15084136;Guide2Pharma:7774575;Guide2Pharma:9264324;Guide2Pharma:9322919;Guide2Pharma:9459574;Guide2Pharma:9864265;Guide2Pharma:9884074;HPRD:11857925;LRdb:10519430;LRdb:10780976;LRdb:11012895;LRdb:11857925;LRdb:12446593;LRdb:15084136;LRdb:7774575;LRdb:9264324;LRdb:9322919;LRdb:9459574;LRdb:9864265;LRdb:9884074;SIGNOR:1560825;connectomeDB2020:10519430;connectomeDB2020:10780976;connectomeDB2020:11012895;connectomeDB2020:11857925;connectomeDB2020:12446593;connectomeDB2020:15084136;connectomeDB2020:7774575;connectomeDB2020:9264324;connectomeDB2020:9322919;connectomeDB2020:9459574;connectomeDB2020:9864265;connectomeDB2020:9884074;scConnect:10519430;scConnect:10780976;scConnect:11012895;scConnect:12446593;scConnect:15084136;scConnect:7774575;scConnect:9264324;scConnect:9322919;scConnect:9459574;scConnect:9864265;scConnect:9884074], ADCYAP1R1 [CellTalkDB:32196115], LDLR [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], LRP2 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115]	clathrin-coated endocytic vesicle membrane [GO:0030669]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]	cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; neurohypophyseal hormone activity [GO:0005185]; neuropeptide hormone activity [GO:0005184]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; V1A vasopressin receptor binding [GO:0031894]; V1B vasopressin receptor binding [GO:0031895]	cell-cell signaling [GO:0007267]; ERK1 and ERK2 cascade [GO:0070371]; generation of precursor metabolites and energy [GO:0006091]; grooming behavior [GO:0007625]; hyperosmotic salinity response [GO:0042538]; locomotory behavior [GO:0007626]; maternal aggressive behavior [GO:0002125]; maternal behavior [GO:0042711]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of female receptivity [GO:0007621]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transmission of nerve impulse [GO:0051970]; penile erection [GO:0043084]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; protein kinase C signaling [GO:0070528]; regulation of renal sodium excretion [GO:0035813]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; response to testosterone [GO:0033574]; signal transduction [GO:0007165]; social behavior [GO:0035176]; vasoconstriction [GO:0042310]; viral entry into host cell [GO:0046718]; water transport [GO:0006833]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=AVP&keywords=AVP	0.00	899	NA	NA	0.00	894	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	897
IFNW1	interferon omega 1	Yes		ENSG00000177047	P05000	Alpha/beta interferon family	15	ligand	ligand, secreted	P17181, P48551	IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2	IFNAR1 [CellTalkDB:11278538;HPRD:1834641;LRdb:11278538;LRdb:18;SIGNOR:11278538;connectomeDB2020:11278538;connectomeDB2020:1834641], IFNAR2 [CellTalkDB:11278538;InnateDB:21854986;LRdb:11278538;SIGNOR:11278538;connectomeDB2020:11278538]	extracellular space [GO:0005615]	cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; regulation of cell cycle [GO:0051726]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNW1&keywords=IFNW1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	#DIV/0!
IFNA5	interferon alpha 5	Yes		ENSG00000147873	P01569	Alpha/beta interferon family	15	ligand	extracellular, ligand, secreted	P17181, P48551	IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2	IFNAR1 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNAR2 [CellTalkDB:10395669;DIP:10395669;HPRD:10395669;LRdb:10395669;connectomeDB2020:10395669]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNA5&keywords=IFNA5	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	#DIV/0!
IAPP	islet amyloid polypeptide	Yes		ENSG00000121351	P10997	Calcitonin family	14	ligand	extracellular, intracellular, ligand, secreted	O60894, O60895, O60896, P07550, P13945, P16473, P30988, P32241, P41586, Q03431, Q16602, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, CALCR, CALCRL, GPR20, GPR84, PTH1R, RAMP1, RAMP2, RAMP3, TSHR, VIPR1	CALCR [Baccin2019:10342886;Baccin2019:12529937;Baccin2019:9487987;CellTalkDB:10342886;Cellinker:10342886;Cellinker:12529937;Cellinker:9487987;Guide2Pharma:10342886;Guide2Pharma:24169554;Guide2Pharma:9487987;LRdb:10342886;LRdb:12529937;LRdb:9487987;connectomeDB2020:10342886;connectomeDB2020:12529937;connectomeDB2020:9487987;scConnect:10342886;scConnect:24169554;scConnect:9487987], RAMP1 [Baccin2019:10385705;CellTalkDB:10385705;Cellinker:10385705;Guide2Pharma:24169554;HPRD:10385705;LRdb:10385705;connectomeDB2020:10385705], RAMP2 [Baccin2019:16531504;CellTalkDB:16531504;Cellinker:16531504;Guide2Pharma:24169554;HPRD:16531504;LRdb:16531504;connectomeDB2020:16531504], RAMP3 [CellTalkDB:25409149;Guide2Pharma:24169554], PTH1R [CellTalkDB:32196115], ADCYAP1R1 [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], CALCRL [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; inclusion body [GO:0016234]	amyloid-beta binding [GO:0001540]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; amylin receptor signaling pathway [GO:0097647]; amyloid fibril formation [GO:1990000]; apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; eating behavior [GO:0042755]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of cell death [GO:0010942]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; protein destabilization [GO:0031648]; protein homooligomerization [GO:0051260]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IAPP&keywords=IAPP	4619.41	7	4685.77	94	13660.33	1	1.65	3.70	0.40	0.43	3.79	37.34	49.50	2.22	0.51	47.55	0.43	37	2	43	13.41	0.04	3.54	0.03	513	3	517	21
UCN3	urocortin 3	Yes		ENSG00000178473	Q969E3	Sauvagine/corticotropin-releasing factor/urotensin I family	14	ligand	intracellular, ligand, secreted	P34998, Q08334, Q13324	CRHR1, CRHR2, IL10RB	CRHR2 [Baccin2019:11329063;Baccin2019:11416224;Baccin2019:15450949;CellTalkDB:11329063;Cellinker:11329063;Cellinker:11416224;Cellinker:15450949;Guide2Pharma:15450949;HPRD:11329063;HPRD:11416224;LRdb:11329063;LRdb:11416224;LRdb:15450949;connectomeDB2020:11329063;connectomeDB2020:11416224;connectomeDB2020:15450949;scConnect:15450949], CRHR1 [Baccin2019:11416224;CellTalkDB:11416224;Cellinker:11416224;HPRD:11416224;LRdb:11416224;connectomeDB2020:11416224], IL10RB [CellTalkDB:11416224;Cellinker:11416224;HPRD:11416224;LRdb:11416224;connectomeDB2020:11416224]	axon terminus [GO:0043679]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; varicosity [GO:0043196]	corticotropin-releasing hormone receptor 2 binding [GO:0051431]; corticotropin-releasing hormone receptor binding [GO:0051429]; hormone activity [GO:0005179]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to hypoxia [GO:0071456]; cellular response to nutrient levels [GO:0031669]; digestion [GO:0007586]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of insulin secretion [GO:0032024]; positive regulation of membrane potential [GO:0045838]; response to corticosterone [GO:0051412]; response to glucose [GO:0009749]; response to immobilization stress [GO:0035902]; response to starvation [GO:0042594]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=UCN3&keywords=UCN3	36.58	118	21620	45	164.08	8	0.01	0.02	0.01	0.01	0.04	0.25	0.34	0.27	0.01	0.36	0.12	261	57	100	0.13	0.15	2.62	0.93	457	9	126	47
CALCB	calcitonin related polypeptide beta	Yes		ENSG00000175868	P10092	Calcitonin family	14	ligand	extracellular, ligand, secreted	O60894, O60895, O60896, P07550, P13945, P16473, P30988, P32241, P41586, Q03431, Q16602, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, CALCR, CALCRL, GPR20, GPR84, PTH1R, RAMP1, RAMP2, RAMP3, TSHR, VIPR1	CALCRL [Baccin2019:12196113;Baccin2019:12234182;Baccin2019:14668209;Baccin2019:3001670;Baccin2019:8626685;Baccin2019:9620797;CellTalkDB:12196113;Cellinker:12196113;Guide2Pharma:10347248;Guide2Pharma:11693189;Guide2Pharma:9620797;LRdb:12196113;connectomeDB2020:12196113;scConnect:10347248;scConnect:11693189;scConnect:9620797], RAMP2 [Baccin2019:16531504;CellTalkDB:26423127;Guide2Pharma:11693189;Guide2Pharma:9620797], RAMP3 [CellTalkDB:26423127;Guide2Pharma:10347248;Guide2Pharma:11693189;Guide2Pharma:15692146], CALCR [Baccin2019:10342886;Baccin2019:11023820;Baccin2019:11033437;Baccin2019:12565884;Baccin2019:14722252;Baccin2019:15692146;Baccin2019:2158663;Baccin2019:7588285;Baccin2019:9487987;CellTalkDB:15692146;Cellinker:15692146;Guide2Pharma:15692146;LRdb:15692146;connectomeDB2020:15692146;scConnect:15692146], RAMP1 [Baccin2019:12529937;Baccin2019:962079712234182;CellTalkDB:12529937;Guide2Pharma:11693189;Guide2Pharma:15692146;Guide2Pharma:9620797;HPMR:12529937;LRdb:12529937;connectomeDB2020:12529937], ADCYAP1R1 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	calcitonin receptor binding [GO:0031716]; neuropeptide hormone activity [GO:0005184]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular calcium ion homeostasis [GO:0006874]; regulation of cytosolic calcium ion concentration [GO:0051480]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CALCB&keywords=CALCB	6.05	277	NA	NA	41.47	17	0.00	0.01	0.00	0.00	0.03	0.21	0.08	0.02	0.18	0.09	0.07	85	116	129	0.06	2.63	1.34	1.10	19	72	76	121
BMP8A	bone morphogenetic protein 8a	Yes		ENSG00000183682	Q7Z5Y6	TGF-beta family	14	ligand	extracellular, ligand, secreted	O00238, P27037, P36894, P36897, P37023, P37173, Q04771, Q13705, Q13873	ACVR1, ACVR1_ACVR2A, ACVR1_ACVR2B, ACVR1_BMPR2, ACVR2A, ACVR2A_BMPR1A, ACVR2A_BMPR1B, ACVR2B, ACVR2B_BMPR1A, ACVR2B_BMPR1B, ACVRL1, BMPR1A, BMPR1A_BMPR2, BMPR1B, BMPR1B_BMPR2, BMPR2, TGFBR1, TGFBR2	BMPR1B [CellTalkDB:15621726], ACVR2A [connectomeDB2020:28465413], BMPR1A [connectomeDB2020:28465413], ACVRL1 [NA], ACVR1 [NA], ACVR2B [connectomeDB2020:28465413], BMPR2 [connectomeDB2020:28465413], TGFBR1 [connectomeDB2020:28465413], TGFBR2 [connectomeDB2020:28465413]	extracellular space [GO:0005615]	BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]	BMP signaling pathway [GO:0030509]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; negative regulation of insulin secretion [GO:0046676]; ossification [GO:0001503]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMP8A&keywords=BMP8A	4.95	291	NA	NA	3.39	103	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	197
NMB	neuromedin B	Yes		ENSG00000197696	P08949	Bombesin/neuromedin-B/ranatensin family	14	ligand	extracellular, intracellular, ligand, secreted	P28336, P30550, P32247	BRS3, GRPR, NMBR	NMBR [Baccin2019:10454496;Baccin2019:10544247;Baccin2019:15169928;Baccin2019:7838118;Baccin2019:8253343;Baccin2019:8392057;CellTalkDB:10544247;Cellinker:10454496;Cellinker:10544247;Cellinker:15169928;Cellinker:7838118;Cellinker:8253343;Cellinker:8392057;Guide2Pharma:18055507;Guide2Pharma:21729729;Guide2Pharma:25976083;HPMR:15169928;HPRD:10544247;HPRD:8253343;HPRD:8392057;LRdb:10454496;LRdb:10544247;LRdb:15169928;LRdb:7838118;LRdb:8253343;LRdb:8392057;SIGNOR:11313903;connectomeDB2020:10454496;connectomeDB2020:10544247;connectomeDB2020:15169928;connectomeDB2020:7838118;connectomeDB2020:8253343;connectomeDB2020:8392057;scConnect:18055507;scConnect:21729729;scConnect:25976083], GRPR [Baccin2019:10454496;Baccin2019:1720612;Baccin2019:19463875;Baccin2019:21729729;Baccin2019:7838118;CellTalkDB:10454496;Cellinker:10454496;Cellinker:1720612;Cellinker:19463875;Cellinker:21729729;Cellinker:7838118;Guide2Pharma:10454496;Guide2Pharma:7838118;LRdb:10454496;LRdb:1720612;LRdb:19463875;LRdb:21729729;LRdb:7838118;connectomeDB2020:10454496;connectomeDB2020:1720612;connectomeDB2020:19463875;connectomeDB2020:21729729;connectomeDB2020:7838118;scConnect:10454496;scConnect:19463875;scConnect:21729729;scConnect:7838118], BRS3 [LRdb:9920658;Ramilowski2015:9920658;connectomeDB2020:9920658;talklr:9920658]	extracellular region [GO:0005576]; neuron projection [GO:0043005]	hormone activity [GO:0005179]; neuromedin B receptor binding [GO:0031710]; neuropeptide hormone activity [GO:0005184]	arachidonic acid secretion [GO:0050482]; cell-cell signaling [GO:0007267]; glucose homeostasis [GO:0042593]; negative regulation of hormone secretion [GO:0046888]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of hormone secretion [GO:0046887]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NMB&keywords=NMB	14.17	197	NA	NA	1.22	237	0.60	0.18	0.03	0.62	0.09	0.18	0.23	0.13	0.11	0.13	0.12	117	93	99	0.22	0.52	0.62	0.57	335	284	299	203
RLN1	relaxin 1	Yes		ENSG00000107018	P04808	Insulin family	14	ligand	ligand, secreted	Q8TDU9, Q8WXD0, Q9HBX9, Q9NSD7	RXFP1, RXFP2, RXFP3, RXFP4	RXFP1 [CellTalkDB:11809971;Cellinker:11809971;Cellinker:16411781;Cellinker:25761609;Guide2Pharma:16411781;HPRD:11809971;LRdb:11809971;LRdb:16;connectomeDB2020:11809971;connectomeDB2020:16411781;scConnect:16411781], RXFP2 [CellTalkDB:11809971;Cellinker:11809971;Cellinker:16411781;Guide2Pharma:16411781;LRdb:11809971;LRdb:16;connectomeDB2020:11809971;connectomeDB2020:16411781;scConnect:16411781], RXFP3 [NA], RXFP4 [NA]	extracellular region [GO:0005576]	hormone activity [GO:0005179]	female pregnancy [GO:0007565]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RLN1&keywords=RLN1	1.04	446	NA	NA	5.40	72	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.00	0.01	0.01	0.00	287	291	329	0.00	1.19	1.17	0.96	90	98	114	227
ANGPT2	angiopoietin 2	Yes		ENSG00000091879	O15123	NA	14	ligand	extracellular, intracellular, ligand, secreted	P35590, Q02763, Q15389	ANGPT1, ITGA5_ITGB1, TEK, TIE1	TEK [Baccin2019:9204896;Baccin2019:9723709;CellChatDB:20651738;CellTalkDB:9204896;Cellinker:20651738;Cellinker:28396397;Cellinker:9204896;Cellinker:9723709;DIP:15893672;DIP:16732286;HPRD:9723709;IntAct:15893672;IntAct:16732286;IntAct:20708158;LRdb:9204896;LRdb:972;Lit-BM-17:12427764;Lit-BM-17:15893672;Lit-BM-17:16732286;Lit-BM-17:20708158;Lit-BM-17:25237190;Lit-BM-17:9204896;Lit-BM-17:9723709;SIGNOR:9723709;SignaLink3:12427764;SignaLink3:15893672;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:9204896;SignaLink3:9723709;connectomeDB2020:9204896;connectomeDB2020:9723709], TIE1 [Baccin2019:27548530;CellTalkDB:22342979;connectomeDB2020:27548530], ANGPT1 [HPRD:9204896]	cell projection [GO:0042995]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; gene expression [GO:0010467]; germ cell development [GO:0007281]; glomerulus vasculature development [GO:0072012]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of positive chemotaxis [GO:0050928]; positive regulation of angiogenesis [GO:0045766]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to radiation [GO:0009314]; signal transduction [GO:0007165]; Tie signaling pathway [GO:0048014]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ANGPT2&keywords=ANGPT2	13.63	203	NA	NA	4.59	79	0.00	0.03	3.76	0.55	0.01	0.06	0.04	0.11	0.04	0.04	0.04	185	165	161	0.43	0.11	0.10	0.12	468	466	461	228
GRP	gastrin releasing peptide	Yes		ENSG00000134443	P07492	Bombesin/neuromedin-B/ranatensin family	14	ligand	extracellular, intracellular, ligand, secreted	P28336, P30550, P32247, Q12884	BRS3, FAP, GRPR, NMBR	GRPR [Baccin2019:10454496;Baccin2019:1720612;Baccin2019:19463875;Baccin2019:7838118;CellTalkDB:19463875;Cellinker:10454496;Cellinker:1720612;Cellinker:19463875;Cellinker:7838118;Guide2Pharma:10454496;Guide2Pharma:21729729;Guide2Pharma:7838118;HPRD:7838118;LRdb:10454496;LRdb:1720612;LRdb:19463875;LRdb:7838118;SIGNOR:17251915;connectomeDB2020:10454496;connectomeDB2020:1720612;connectomeDB2020:19463875;connectomeDB2020:7838118;scConnect:10454496;scConnect:19463875;scConnect:21729729;scConnect:7838118], BRS3 [CellTalkDB:11112777;LRdb:11112777;Ramilowski2015:11112777;connectomeDB2020:11112777;talklr:11112777], NMBR [CellTalkDB:10545285;LRdb:10545285;Ramilowski2015:10545285;connectomeDB2020:10545285;talklr:10545285], FAP [Cellinker:21314817]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule lumen [GO:0034774]	neuropeptide hormone activity [GO:0005184]; signaling receptor binding [GO:0005102]	neuropeptide signaling pathway [GO:0007218]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; psychomotor behavior [GO:0036343]; response to external biotic stimulus [GO:0043207]; signal transduction [GO:0007165]; social behavior [GO:0035176]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GRP&keywords=GRP	3.53	320	NA	NA	4.68	78	0.00	0.00	0.00	0.00	0.00	0.02	0.00	0.00	0.06	0.00	0.00	157	402	400	0.01	3.95	0.57	0.56	6	294	302	274
FGF13	fibroblast growth factor 13	Yes		ENSG00000129682	Q92913	Heparin-binding growth factors family	14	ligand	extracellular, intracellular, ligand, secreted	P00533, P11362, P21802, P22455, P22607, P35498, P35499, Q14524, Q15858, Q99250, Q9NY46, Q9UI33, Q9UQD0, Q9Y5Y9	EGFR, FGFR1, FGFR2, FGFR3, FGFR4, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN8A, SCN9A	SCN1A [SIGNOR:20679355], SCN4A [SIGNOR:20679355], SCN5A [CellTalkDB:21817159;Cellinker:21817159;LRdb:21817159;Ramilowski2015:21817159;SIGNOR:20679355;connectomeDB2020:21817159;talklr:21817159], SCN9A [SIGNOR:20679355], SCN2A [SIGNOR:20679355], SCN3A [SIGNOR:20679355], SCN11A [SIGNOR:20679355], SCN8A [Baccin2019:15282281;CellTalkDB:15282281;Cellinker:15282281;HPRD:15282281;LRdb:15282281;SIGNOR:20679355;connectomeDB2020:15282281], SCN10A [SIGNOR:20679355], FGFR1 [CellTalkDB:16597617;LRdb:16597617], FGFR2 [CellTalkDB:16597617;LRdb:16597617], FGFR3 [CellTalkDB:16597617;LRdb:16597617], EGFR [CellTalkDB:32196115], FGFR4 [CellTalkDB:16597617;LRdb:16597617]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; filopodium [GO:0030175]; growth cone [GO:0030426]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	beta-tubulin binding [GO:0048487]; growth factor activity [GO:0008083]; microtubule binding [GO:0008017]; protein kinase activator activity [GO:0030295]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]	cell-cell signaling [GO:0007267]; cerebral cortex cell migration [GO:0021795]; establishment of neuroblast polarity [GO:0045200]; hippocampus development [GO:0021766]; inhibitory synapse assembly [GO:1904862]; learning [GO:0007612]; MAPK cascade [GO:0000165]; memory [GO:0007613]; microtubule polymerization [GO:0046785]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; protein localization to plasma membrane [GO:0072659]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of voltage-gated sodium channel activity [GO:1905150]; signal transduction [GO:0007165]; sodium ion transport [GO:0006814]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF13&keywords=FGF13	4.84	293	NA	NA	2.52	127	0.00	0.05	0.00	0.00	0.10	0.00	0.00	0.00	0.00	0.00	0.00	297	362	327	0.02	0.47	0.44	0.48	353	335	333	279
UTS2B	urotensin 2B	Yes		ENSG00000188958	Q765I0	Urotensin-2 family	14	ligand	extracellular, ligand, secreted	P35346, Q9UKP6	SSTR5, UTS2R	UTS2R [Baccin2019:11015293;Baccin2019:14550283;CellChatDB:31556942;CellTalkDB:14550283;Cellinker:11015293;Cellinker:14550283;Cellinker:31556942;Guide2Pharma:14550283;Guide2Pharma:17628210;Guide2Pharma:18710417;HPRD:14550283;LRdb:11;LRdb:14550283;connectomeDB2020:11015293;connectomeDB2020:14550283;scConnect:11015293;scConnect:14550283;scConnect:18710417], SSTR5 [CellChatDB:31556942;Cellinker:31556942]	extracellular region [GO:0005576]	G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]	blood vessel diameter maintenance [GO:0097746]; regulation of blood pressure [GO:0008217]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=UTS2B&keywords=UTS2B	0.69	494	NA	NA	2.70	122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	308
NTS	neurotensin	Yes		ENSG00000133636	P30990	Neurotensin family	14	ligand	extracellular, intracellular, ligand, secreted	O95665, P08138, P30989, Q99523	NGFR, NTSR1, NTSR2, SORT1	NTSR1 [Baccin2019:10930533;Baccin2019:11559354;Baccin2019:11723247;Baccin2019:11811984;Baccin2019:1331689;Baccin2019:16087676;Baccin2019:1694443;CellTalkDB:11811984;Cellinker:10930533;Cellinker:11559354;Cellinker:11723247;Cellinker:11811984;Cellinker:1331689;Cellinker:16087676;Cellinker:1694443;DIP:17620610;Guide2Pharma:10930533;Guide2Pharma:11723247;Guide2Pharma:11811984;HPMR:1694443;HPRD:11559354;HPRD:16087676;LRdb:10930533;LRdb:11559354;LRdb:11723247;LRdb:11811984;LRdb:1331689;LRdb:16087676;LRdb:1694443;Lit-BM-17:11559354;Lit-BM-17:23597562;SIGNOR:1331689;connectomeDB2020:10930533;connectomeDB2020:11559354;connectomeDB2020:11723247;connectomeDB2020:11811984;connectomeDB2020:1331689;connectomeDB2020:16087676;connectomeDB2020:1694443;scConnect:10930533;scConnect:11723247;scConnect:11811984], NTSR2 [Baccin2019:11723247;Baccin2019:11801734;Baccin2019:16087676;Baccin2019:9851594;CellTalkDB:11723247;Cellinker:11723247;Cellinker:11801734;Cellinker:16087676;Cellinker:9851594;Guide2Pharma:11723247;HPMR:9851594;HPRD:11801734;HPRD:16087676;LRdb:11723247;LRdb:11801734;LRdb:16087676;LRdb:9851594;SIGNOR:9851594;connectomeDB2020:11723247;connectomeDB2020:11801734;connectomeDB2020:16087676;connectomeDB2020:9851594;scConnect:11723247], SORT1 [Baccin2019:16087676;Baccin2019:9756851;CellTalkDB:9756851;Cellinker:16087676;Cellinker:9756851;HPRD:16087676;HPRD:9756851;LRdb:161;LRdb:9756851;connectomeDB2020:16087676;connectomeDB2020:9756851], NGFR [CellTalkDB:32196115]	axon terminus [GO:0043679]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; transport vesicle [GO:0030133]	neuropeptide hormone activity [GO:0005184]; neuropeptide receptor binding [GO:0071855]; receptor ligand activity [GO:0048018]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; killing of cells of other organism [GO:0031640]; negative regulation of gene expression [GO:0010629]; neuropeptide signaling pathway [GO:0007218]; positive regulation of gene expression [GO:0010628]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase B signaling [GO:0051897]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NTS&keywords=NTS	1.42	415	NA	NA	0.88	288	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.02	0.00	0.01	248	395	285	0.00	2.15	0.86	1.29	27	187	50	321
APLN	apelin	Yes		ENSG00000171388	Q9ULZ1	Apelin family	14	ligand	extracellular, ligand, secreted	P08913, P35414, P48039, Q14831	ADRA2A, APLNR, GRM7, MTNR1A	APLNR [Baccin2019:10617103;Baccin2019:10777510;Baccin2019:11336787;Baccin2019:12603839;Baccin2019:12939143;Baccin2019:15341513;Baccin2019:9792798;CellTalkDB:10617103;Guide2Pharma:10777510;Guide2Pharma:11336787;Guide2Pharma:12603839;Guide2Pharma:12939143;Guide2Pharma:15341513;HPMR:10802050;HPMR:9792798;HPRD:12603839;LRdb:10617103;LRdb:10777510;LRdb:11336787;LRdb:12603839;LRdb:12939143;LRdb:15341513;LRdb:9792798;connectomeDB2020:10617103;connectomeDB2020:10777510;connectomeDB2020:11336787;connectomeDB2020:12603839;connectomeDB2020:12939143;connectomeDB2020:15341513;connectomeDB2020:9792798;scConnect:10777510;scConnect:11336787;scConnect:12603839;scConnect:12939143;scConnect:15341513], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115;LRdb:10617103;LRdb:10777510;LRdb:11336787;LRdb:12603839;LRdb:12939143;LRdb:15341513;LRdb:9792798]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	apelin receptor binding [GO:0031704]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]	angiogenesis [GO:0001525]; apelin receptor signaling pathway [GO:0060183]; coronary vasculature development [GO:0060976]; drinking behavior [GO:0042756]; gastrulation [GO:0007369]; immune response [GO:0006955]; lactation [GO:0007595]; negative regulation of blood pressure [GO:0045776]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression [GO:0010629]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of G protein-coupled receptor internalization [GO:1904022]; positive regulation of heart contraction [GO:0045823]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=APLN&keywords=APLN	1.52	410	NA	NA	0.29	471	0.00	0.00	0.07	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	303	343	368	0.01	0.57	0.69	0.63	312	255	274	370
ANGPTL3	angiopoietin like 3	Yes		ENSG00000132855	Q9Y5C1	NA	14	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted	P05106, P06756, P06858, P08648	ITGA5, ITGAV, ITGAV_ITGB3, ITGB3, LPL	ITGB3 [CellTalkDB:11877390;HPRD:11877390;LRdb:11877390;connectomeDB2020:11877390], ITGAV [CellTalkDB:11877390;HPRD:11877390;LRdb:11877390;connectomeDB2020:11877390], ITGA5 [CellTalkDB:11877390;Cellinker:11877390;HPRD:11877390;LRdb:11877390;connectomeDB2020:11877390], LPL [LMPID:19246456]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; early endosome [GO:0005769]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]	enzyme inhibitor activity [GO:0004857]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; phospholipase inhibitor activity [GO:0004859]; signaling receptor binding [GO:0005102]	acylglycerol homeostasis [GO:0055090]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; cell-matrix adhesion [GO:0007160]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; fatty acid metabolic process [GO:0006631]; glycerol metabolic process [GO:0006071]; integrin-mediated signaling pathway [GO:0007229]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; negative regulation of lipoprotein lipase activity [GO:0051005]; negative regulation of phospholipase activity [GO:0010519]; phospholipid catabolic process [GO:0009395]; phospholipid homeostasis [GO:0055091]; phospholipid metabolic process [GO:0006644]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of lipid catabolic process [GO:0050996]; response to hormone [GO:0009725]; signal transduction [GO:0007165]; triglyceride homeostasis [GO:0070328]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ANGPTL3&keywords=ANGPTL3	0.46	533	NA	NA	0.17	557	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.03	0.03	0.01	0.01	209	270	262	0.01	2.21	0.95	1.01	25	152	98	378
UTS2	urotensin 2	Yes		ENSG00000049247	O95399	Urotensin-2 family	14	ligand	extracellular, intracellular, ligand, secreted	Q9UKP6	UTS2R	UTS2R [Baccin2019:10499587;Baccin2019:10581185;Baccin2019:11976263;Baccin2019:12238917;Baccin2019:15109617;Baccin2019:15852036;Cellinker:10499587;Cellinker:10581185;Cellinker:11976263;Cellinker:12238917;Cellinker:15109617;Cellinker:15852036;Guide2Pharma:10499587;Guide2Pharma:10548501;Guide2Pharma:10559967;Guide2Pharma:10581185;HPMR:15109617;HPRD:10581185;LRdb:10499587;LRdb:10581185;LRdb:11976263;LRdb:12238917;LRdb:15109617;LRdb:15852036;connectomeDB2020:10499587;connectomeDB2020:10581185;connectomeDB2020:11976263;connectomeDB2020:12238917;connectomeDB2020:15109617;connectomeDB2020:15852036;scConnect:11976263;scConnect:12238917;scConnect:15852036]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; synapse [GO:0045202]	hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]	blood vessel diameter maintenance [GO:0097746]; chemical synaptic transmission [GO:0007268]; muscle contraction [GO:0006936]; regulation of blood pressure [GO:0008217]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=UTS2&keywords=UTS2	0.04	747	500163	3	0.48	390	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	380
NPPB	natriuretic peptide B	Yes		ENSG00000120937	P16860	Natriuretic peptide family	14	ligand	extracellular, intracellular, ligand, secreted	P16066, P17342, P20594, P27487, Q12884	DPP4, FAP, NPR1, NPR2, NPR3	NPR1 [BioGRID:15709752;CellChatDB:29934641;Cellinker:1309330;Cellinker:7901875;Cellinker:8700153;Guide2Pharma:8700153;HPRD:1309330;HPRD:7901875;LRdb:1309330;LRdb:7901875;LRdb:8700153;connectomeDB2020:1309330;connectomeDB2020:7901875;connectomeDB2020:8700153;scConnect:8700153], NPR3 [CellTalkDB:1309330;Cellinker:1309330;Cellinker:7901875;HPRD:1309330;HPRD:7901875;LRdb:1309330;LRdb:79;Lit-BM-17:1309330;Lit-BM-17:1660465;Lit-BM-17:1672777;Lit-BM-17:16870210;connectomeDB2020:1309330;connectomeDB2020:7901875], NPR2 [Cellinker:2570358;HPMR:2570358;LRdb:2570358;connectomeDB2020:2570358], DPP4 [CellTalkDB:16254193;Cellinker:21314817], FAP [Cellinker:21314817]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	diuretic hormone activity [GO:0008613]; hormone activity [GO:0005179]; hormone receptor binding [GO:0051427]; signaling receptor binding [GO:0005102]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; blood vessel diameter maintenance [GO:0097746]; body fluid secretion [GO:0007589]; cardiac conduction system development [GO:0003161]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; killing of cells of other organism [GO:0031640]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of systemic arterial blood pressure [GO:0003085]; neuropeptide signaling pathway [GO:0007218]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; protein folding [GO:0006457]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114]; vasodilation [GO:0042311]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPPB&keywords=NPPB	1.16	437	NA	NA	0.04	743	0.00	0.07	0.00	0.00	0.00	0.04	0.00	0.00	0.00	0.00	0.00	297	324	356	0.01	0.58	0.61	0.53	305	287	309	448
IL31	interleukin 31	Yes		ENSG00000204671	Q6EBC2	NA	14	ligand	extracellular, ligand, secreted	Q8NI17, Q99650	IL31RA, IL31RA_OSMR, OSMR	OSMR [CellTalkDB:15184896;HPMR:15184896;HPMR:15194700;LRdb:15184896;SIGNOR:15184896;SignaLink3:16286453;SignaLink3:23331499;connectomeDB2020:15184896], IL31RA [CellTalkDB:15184896;HPMR:15184896;HPMR:15194700;LRdb:15184896;SIGNOR:15184896;SignaLink3:15184896;SignaLink3:23331499;connectomeDB2020:15184896]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]	immune system process [GO:0002376]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL31&keywords=IL31	0.02	781	NA	NA	1.93	165	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	473
PENK	proenkephalin	Yes		ENSG00000181195	P01210	Opioid neuropeptide precursor family	14	ligand	extracellular, intracellular, ligand, secreted	P08913, P35372, P41143, P41145, P41146, P48039, Q14831, Q96LA9, Q96LB2, Q9NZT2	ADRA2A, GRM7, MRGPRX1, MRGPRX4, MTNR1A, OGFR, OPRD1, OPRK1, OPRL1, OPRM1	OPRD1 [Baccin2019:9686407;CA1:15082510;Cellinker:9686407;Guide2Pharma:9686407;LRdb:9686407;connectomeDB2020:9686407;scConnect:9686407], MRGPRX1 [CellTalkDB:15163697;Cellinker:11850634;Cellinker:15163697;Cellinker:23396314;Guide2Pharma:11850634;Guide2Pharma:15163697;Guide2Pharma:23396314;LRdb:11850634;LRdb:15163697;LRdb:23396314;connectomeDB2020:11850634;connectomeDB2020:15163697;connectomeDB2020:23396314;scConnect:11850634;scConnect:15163697;scConnect:23396314], OPRM1 [Baccin2019:9686407;CA1:15082510;Cellinker:9686407;Guide2Pharma:9686407;LRdb:9686407;connectomeDB2020:9686407;scConnect:9686407], OPRK1 [CA1:15082510;CellTalkDB:32196115], OPRL1 [CA1:15082510], GRM7 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], OGFR [Baccin2019:16820893;CellTalkDB:16820893;Cellinker:16820893;HPMR:16820893;LRdb:16820893;connectomeDB2020:16820893], MTNR1A [CellTalkDB:32196115], MRGPRX4 [Baccin2019:11850634;Baccin2019:15163697;Baccin2019:23396314]	axon terminus [GO:0043679]; cell body fiber [GO:0070852]; chromaffin granule lumen [GO:0034466]; dendrite [GO:0030425]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; neuronal dense core vesicle lumen [GO:0099013]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; symmetric synapse [GO:0032280]; synaptic vesicle lumen [GO:0034592]	neuropeptide hormone activity [GO:0005184]; opioid peptide activity [GO:0001515]; opioid receptor binding [GO:0031628]	aggressive behavior [GO:0002118]; aging [GO:0007568]; behavioral fear response [GO:0001662]; cellular response to cAMP [GO:0071320]; cellular response to oxidative stress [GO:0034599]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to virus [GO:0098586]; cellular response to vitamin D [GO:0071305]; chemical synaptic transmission [GO:0007268]; general adaptation syndrome, behavioral process [GO:0051867]; glial cell proliferation [GO:0014009]; locomotory exploration behavior [GO:0035641]; neuropeptide signaling pathway [GO:0007218]; osteoblast differentiation [GO:0001649]; positive regulation of behavioral fear response [GO:2000987]; response to calcium ion [GO:0051592]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; response to nicotine [GO:0035094]; response to radiation [GO:0009314]; response to toxic substance [GO:0009636]; sensory perception [GO:0007600]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic signaling via neuropeptide [GO:0099538]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PENK&keywords=PENK	0.68	495	NA	NA	0.05	708	0.00	0.00	0.00	0.04	0.00	0.00	0.00	0.03	0.00	0.00	0.01	299	404	274	0.01	0.64	0.57	0.90	283	297	143	476
SCT	secretin	Yes		ENSG00000274473, ENSG00000070031	P09683	Glucagon family	14	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, P07550, P13945, P16473, P32241, P41586, P41587, P47872, Q03431, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, GPR20, GPR84, PTH1R, RAMP2, RAMP3, SCTR, TSHR, VIPR1, VIPR2	SCTR [Baccin2019:7612008;Baccin2019:7782300;Baccin2019:8579602;Baccin2019:9440501;CellTalkDB:7782300;Cellinker:7612008;Cellinker:7782300;Cellinker:8579602;Cellinker:9440501;Guide2Pharma:7612008;HPMR:7782300;HPRD:7782300;HPRD:8579602;HPRD:9440501;LRdb:7612008;LRdb:7782300;LRdb:8579602;LRdb:9440501;connectomeDB2020:7612008;connectomeDB2020:7782300;connectomeDB2020:8579602;connectomeDB2020:9440501;scConnect:7612008], PTH1R [CellTalkDB:32196115], ADCYAP1R1 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], VIPR1 [Baccin2019:12133828;CellTalkDB:12133828;HPRD:12133828;LRdb:12133828;connectomeDB2020:12133828], RAMP3 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], VIPR2 [CellTalkDB:9437714;LRdb:9437714;Ramilowski2015:9437714;connectomeDB2020:9437714;talklr:9437714], ADRB3 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	digestive hormone activity [GO:0046659]; G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]; protein N-terminus binding [GO:0047485]; signaling receptor binding [GO:0005102]	brain development [GO:0007420]; cellular water homeostasis [GO:0009992]; diet induced thermogenesis [GO:0002024]; embryonic digestive tract development [GO:0048566]; hippocampus development [GO:0021766]; negative regulation of gastrin-induced gastric acid secretion [GO:1903640]; pancreatic juice secretion [GO:0030157]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of pancreatic juice secretion [GO:0090187]; positive regulation of somatostatin secretion [GO:0090274]; regulation of appetite [GO:0032098]; regulation of synaptic plasticity [GO:0048167]; response to nutrient levels [GO:0031667]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCT&keywords=SCT	0.02	799	NA	NA	0.04	741	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.00	0.00	0.00	0.00	299	321	358	0.00	0.92	1.03	0.89	173	121	149	496
PMCH	pro-melanin concentrating hormone	Yes		ENSG00000183395	P20382	Melanin-concentrating hormone family	14	ligand	extracellular, intracellular, ligand, secreted	P08913, P48039, Q12866, Q14831, Q969V1, Q99705	ADRA2A, GRM7, MCHR1, MCHR2, MERTK, MTNR1A	MCHR1 [Baccin2019:10421367;Baccin2019:10421368;Baccin2019:11375253;Baccin2019:11478907;Baccin2019:11839762;CellTalkDB:10421368;Cellinker:10421367;Cellinker:10421368;Cellinker:11375253;Cellinker:11478907;Cellinker:11839762;Guide2Pharma:10421367;Guide2Pharma:11375253;HPMR:10421367;HPMR:10421368;HPRD:11478907;HPRD:11839762;LRdb:10421367;LRdb:10421368;LRdb:11375253;LRdb:11478907;LRdb:11839762;SIGNOR:10421367;connectomeDB2020:10421367;connectomeDB2020:10421368;connectomeDB2020:11375253;connectomeDB2020:11478907;connectomeDB2020:11839762;scConnect:10421367;scConnect:11375253], MCHR2 [CellTalkDB:11416225;Cellinker:10471841;Cellinker:11274220;Cellinker:11404457;Cellinker:11416225;Cellinker:11478907;Cellinker:11839762;Guide2Pharma:11404457;HPMR:10471841;HPRD:11274220;HPRD:11404457;HPRD:11416225;HPRD:11478907;HPRD:11839762;LRdb:10471841;LRdb:11274220;LRdb:11404457;LRdb:11416225;LRdb:11478907;LRdb:11839762;SIGNOR:10471841;connectomeDB2020:10471841;connectomeDB2020:11274220;connectomeDB2020:11404457;connectomeDB2020:11416225;connectomeDB2020:11478907;connectomeDB2020:11839762;scConnect:11404457], GRM7 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], MERTK [CellChatDB:30501104;Cellinker:30501104]	extracellular region [GO:0005576]; nucleus [GO:0005634]; synapse [GO:0045202]	melanin-concentrating hormone activity [GO:0030354]; type 1 melanin-concentrating hormone receptor binding [GO:0031777]	cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; feeding behavior [GO:0007631]; neuropeptide signaling pathway [GO:0007218]; spermatogenesis [GO:0007283]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PMCH&keywords=PMCH	0.07	696	NA	NA	0.10	637	0.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	303	406	286	0.00	0.72	0.72	1.11	254	244	75	496
CGA	glycoprotein hormones, alpha polypeptide	Yes		ENSG00000135346	P01215	Glycoprotein hormones subunit alpha family	14	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, P07550, P13945, P16473, P22888, P23945, P32241, P41586, P78324, Q03431, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, FSHR, GPR20, GPR84, LHCGR, PTH1R, RAMP2, RAMP3, SIRPA, TSHR, VIPR1	FSHR [CellTalkDB:30910395;HPMR:2126341;NetPath:12374801;NetPath:15662415], LHCGR [Baccin2019:10342833;Baccin2019:12727981;Baccin2019:1922095;CellTalkDB:1922095;Cellinker:10342833;Cellinker:12727981;Cellinker:1922095;Guide2Pharma:12727981;Guide2Pharma:1922095;HPRD:10342833;LRdb:10342833;LRdb:12727981;LRdb:1922095;connectomeDB2020:10342833;connectomeDB2020:12727981;connectomeDB2020:1922095;scConnect:12727981;scConnect:1922095], TSHR [HPMR:15571461;NetPath:20181794;SIGNOR:12045258], ADCYAP1R1 [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], SIRPA [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; follicle-stimulating hormone complex [GO:0016914]; Golgi lumen [GO:0005796]; pituitary gonadotropin complex [GO:0061696]	follicle-stimulating hormone activity [GO:0016913]; hormone activity [GO:0005179]	cellular response to hormone stimulus [GO:0032870]; developmental growth [GO:0048589]; follicle-stimulating hormone secretion [GO:0046884]; gonad development [GO:0008406]; G protein-coupled receptor signaling pathway [GO:0007186]; luteinizing hormone secretion [GO:0032275]; negative regulation of organ growth [GO:0046621]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of signaling receptor activity [GO:0010469]; thyroid gland development [GO:0030878]; thyroid hormone generation [GO:0006590]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CGA&keywords=CGA	0.50	523	NA	NA	0.01	849	0.00	0.00	0.00	0.01	0.00	0.02	0.00	0.00	0.00	0.00	0.01	291	373	246	0.00	0.96	0.75	1.44	147	241	37	497
CCN3	cellular communication network factor 3	Yes		ENSG00000136999	P48745	CCN family	14	ecm, ligand	ecm, gap_junction, intracellular, ligand, secreted	P46531, Q9UIW2	NOTCH1, PLXNA1	NOTCH1 [Baccin2019:1590625312050160;CellTalkDB:15906253;Cellinker:12050162;Cellinker:15906253;HPRD:12050162;LRdb:12;LRdb:15906253;NetPath:12050162;SignaLink3:12050162;SignaLink3:23331499;connectomeDB2020:12050162;connectomeDB2020:15906253], PLXNA1 [CellTalkDB:32196115]	axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; gap junction [GO:0005921]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]	growth factor activity [GO:0008083]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]; Notch binding [GO:0005112]	angiogenesis [GO:0001525]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell chemotaxis [GO:0060326]; chondrocyte differentiation [GO:0002062]; endothelial cell-cell adhesion [GO:0071603]; endothelial cell chemotaxis [GO:0035767]; fibroblast migration [GO:0010761]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of sensory perception of pain [GO:1904057]; negative regulation of SMAD protein signal transduction [GO:0060392]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of gene expression [GO:0010468]; signal transduction [GO:0007165]; smooth muscle cell migration [GO:0014909]; smooth muscle cell proliferation [GO:0048659]; type B pancreatic cell proliferation [GO:0044342]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCN3&keywords=CCN3	3.36	327	NA	NA	0.06	701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	514
QRFP	pyroglutamylated RFamide peptide	Yes		ENSG00000188710	P83859	RFamide neuropeptide family	14	ligand	ligand, secreted, transmembrane, transmembrane_predicted	Q15391, Q96P65	P2RY14, QRFPR	QRFPR [Baccin2019:12714592;Baccin2019:16500002;Baccin2019:23396314;CellChatDB:25386115;CellTalkDB:12714592;Cellinker:12714592;Cellinker:16500002;Cellinker:23396314;Cellinker:25386115;Guide2Pharma:12714592;Guide2Pharma:14657341;Guide2Pharma:16500002;Guide2Pharma:23396314;LRdb:12714592;LRdb:16500002;LRdb:23396314;connectomeDB2020:12714592;connectomeDB2020:16500002;connectomeDB2020:23396314;scConnect:12714592;scConnect:14657341;scConnect:16500002;scConnect:23396314], P2RY14 [Baccin2019:12714592;Cellinker:12714592;LRdb:12714592;connectomeDB2020:12714592]	extracellular region [GO:0005576]	neuropeptide hormone activity [GO:0005184]; orexigenic neuropeptide QRFP receptor binding [GO:0031854]	grooming behavior [GO:0007625]; locomotory behavior [GO:0007626]; neuropeptide signaling pathway [GO:0007218]; positive regulation of blood pressure [GO:0045777]; regulation of feeding behavior [GO:0060259]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=QRFP&keywords=QRFP	0.17	626	NA	NA	0.26	491	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	559
EBI3	Epstein-Barr virus induced 3	Yes	IL-27 Subunit Beta	ENSG00000105246	Q14213	Type I cytokine receptor family, Type 3 subfamily	14	ligand	extracellular, intracellular, ligand, secreted, transmembrane	P40189, Q6UWB1	IL27RA, IL27RA_IL6ST, IL6ST	IL6ST [Baccin2019:28280243;CellTalkDB:22306691;connectomeDB2020:28280243], IL27RA [Baccin2019:12121660;CellTalkDB:12121660;HPRD:12121660;LRdb:12121660;connectomeDB2020:12121660]	endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cytokine activity [GO:0005125]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-27 receptor binding [GO:0045523]; peptide hormone binding [GO:0017046]	cytokine-mediated signaling pathway [GO:0019221]; humoral immune response [GO:0006959]; leptin-mediated signaling pathway [GO:0033210]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of interferon-gamma production [GO:0032729]; T cell proliferation [GO:0042098]; T-helper 1 type immune response [GO:0042088]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EBI3&keywords=EBI3	0.05	745	NA	NA	0.00	863	0.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	288	380	374	0.01	0.70	0.51	0.51	265	318	319	577
IFNL2	interferon lambda 2	Yes		ENSG00000183709	Q8IZJ0	Lambda interferon family	14	ligand	extracellular, ligand, secreted	Q08334, Q8IU57	IFNLR1, IFNLR1_IL10RB, IL10RB	IL10RB [CellTalkDB:12974481;Cellinker:12469119;Cellinker:12974481;HPRD:12469119;LRdb:12;LRdb:12974481;SIGNOR:12469119;SignaLink3:12469119;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12469119;connectomeDB2020:12974481], IFNLR1 [CellTalkDB:12974481;Cellinker:12469119;Cellinker:12974481;HPRD:12469119;LRdb:12;LRdb:12974481;SIGNOR:12469119;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12469119;connectomeDB2020:12974481]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]	defense response to virus [GO:0051607]; innate immune response [GO:0045087]; mucosal immune response [GO:0002385]; positive regulation of immune response [GO:0050778]; receptor signaling pathway via JAK-STAT [GO:0007259]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNL2&keywords=IFNL2	0.01	845	NA	NA	0.67	323	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	584
IFNL1	interferon lambda 1	Yes		ENSG00000182393	Q8IU54	Lambda interferon family	14	ligand	extracellular, ligand, secreted, transmembrane	Q08334, Q8IU57	IFNLR1, IFNLR1_IL10RB, IL10RB	IL10RB [CellTalkDB:12974481;Cellinker:12974481;LRdb:12974481;SIGNOR:12469119;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12974481], IFNLR1 [CellTalkDB:12974481;HPRD:12469119;LRdb:12;LRdb:12974481;SIGNOR:12469119;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12469119;connectomeDB2020:12974481]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-28 receptor complex [GO:0032002]	cytokine activity [GO:0005125]; interleukin-28 receptor binding [GO:0032003]; signaling receptor binding [GO:0005102]	defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of memory T cell differentiation [GO:0043381]; negative regulation of T cell differentiation [GO:0045581]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of immune response [GO:0050778]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; receptor signaling pathway via JAK-STAT [GO:0007259]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNL1&keywords=IFNL1	0.00	857	NA	NA	0.73	315	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	586
GALP	galanin like peptide	Yes		ENSG00000197487	Q9UBC7	Galanin family	14	ligand	ligand, secreted	O43603, O60755, P47211	GALR1, GALR2, GALR3	GALR2 [Baccin2019:15944009;Baccin2019:20880399;Baccin2019:9832121;CellChatDB:23233848;CellTalkDB:15944009;Cellinker:15944009;Cellinker:20880399;Cellinker:23233848;Cellinker:9832121;LRdb:15944009;LRdb:20880399;LRdb:9832121;SIGNOR:10601261;connectomeDB2020:15944009;connectomeDB2020:20880399;connectomeDB2020:9832121;scConnect:15944009;scConnect:20880399], GALR3 [Baccin2019:983212115944009;CellTalkDB:9832121;Cellinker:15944009;Cellinker:9832121;LRdb:159;LRdb:9832121;connectomeDB2020:15944009;connectomeDB2020:9832121;scConnect:15944009], GALR1 [Baccin2019:1068936515944000;CellChatDB:23233848;CellTalkDB:10689365;Cellinker:10689365;Cellinker:15944009;Cellinker:23233848;LRdb:10689365;LRdb:16;connectomeDB2020:10689365;connectomeDB2020:15944009;scConnect:15944009]	extracellular region [GO:0005576]	hormone activity [GO:0005179]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; behavioral response to starvation [GO:0042595]; defense response to Gram-negative bacterium [GO:0050829]; modulation of process of other organism [GO:0035821]; neuropeptide signaling pathway [GO:0007218]; regulation of appetite [GO:0032098]; response to insulin [GO:0032868]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GALP&keywords=GALP	0.00	880	NA	NA	0.48	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	636
CORT	cortistatin	Yes		ENSG00000241563	O00230	Somatostatin family	14	ligand	extracellular, intracellular, ligand, secreted	P08913, P30872, P30874, P31391, P32745, P35346, P48039, Q14831, Q92847, Q96LB1	ADRA2A, GHSR, GRM7, MRGPRX2, MTNR1A, SSTR1, SSTR2, SSTR3, SSTR4, SSTR5	SSTR1 [Baccin2019:10598788;Baccin2019:11011067;Baccin2019:15333679;Baccin2019:9125122;Baccin2019:9205124;Baccin2019:9650799;CellTalkDB:9650799;Cellinker:10598788;Cellinker:11011067;Cellinker:15333679;Cellinker:9125122;Cellinker:9205124;Cellinker:9650799;Guide2Pharma:10598788;Guide2Pharma:15333679;Guide2Pharma:9650799;HPMR:11011067;HPMR:9125122;HPRD:9125122;HPRD:9205124;LRdb:10598788;LRdb:11011067;LRdb:15333679;LRdb:9125122;LRdb:9205124;LRdb:9650799;connectomeDB2020:10598788;connectomeDB2020:11011067;connectomeDB2020:15333679;connectomeDB2020:9125122;connectomeDB2020:9205124;connectomeDB2020:9650799;scConnect:10598788;scConnect:15333679;scConnect:9650799], SSTR2 [Baccin2019:10598788;Baccin2019:15333679;Baccin2019:9125122;Baccin2019:9650799;CellTalkDB:10598788;Cellinker:10598788;Cellinker:15333679;Cellinker:9125122;Cellinker:9650799;Guide2Pharma:10598788;Guide2Pharma:15333679;Guide2Pharma:9650799;HPRD:9125122;LRdb:10598788;LRdb:15333679;LRdb:9125122;LRdb:9650799;connectomeDB2020:10598788;connectomeDB2020:15333679;connectomeDB2020:9125122;connectomeDB2020:9650799;scConnect:10598788;scConnect:15333679;scConnect:9650799], SSTR3 [Baccin2019:10598788;Baccin2019:15333679;Baccin2019:9125122;Baccin2019:9205124;Baccin2019:9650799;CellTalkDB:10598788;Cellinker:10598788;Cellinker:15333679;Cellinker:9125122;Cellinker:9205124;Cellinker:9650799;Guide2Pharma:10598788;Guide2Pharma:15333679;Guide2Pharma:9650799;HPMR:9125122;HPRD:9125122;HPRD:9205124;LRdb:10598788;LRdb:15333679;LRdb:9125122;LRdb:9205124;LRdb:9650799;connectomeDB2020:10598788;connectomeDB2020:15333679;connectomeDB2020:9125122;connectomeDB2020:9205124;connectomeDB2020:9650799;scConnect:10598788;scConnect:15333679;scConnect:9650799], SSTR4 [Baccin2019:10598788;Baccin2019:11011067;Baccin2019:9125122;Baccin2019:9205124;Baccin2019:9650799;CellTalkDB:10598788;Cellinker:10598788;Cellinker:11011067;Cellinker:9125122;Cellinker:9205124;Cellinker:9650799;Guide2Pharma:10598788;Guide2Pharma:9650799;HPRD:9125122;HPRD:9205124;LRdb:10598788;LRdb:11011067;LRdb:9125122;LRdb:9205124;LRdb:9650799;SIGNOR:11011067;connectomeDB2020:10598788;connectomeDB2020:11011067;connectomeDB2020:9125122;connectomeDB2020:9205124;connectomeDB2020:9650799;scConnect:10598788;scConnect:9650799], SSTR5 [Baccin2019:10598788;Baccin2019:11011067;Baccin2019:15333679;Baccin2019:9125122;Baccin2019:9205124;Baccin2019:9650799;CellTalkDB:9125122;Cellinker:10598788;Cellinker:11011067;Cellinker:15333679;Cellinker:9125122;Cellinker:9205124;Cellinker:9650799;Guide2Pharma:10598788;Guide2Pharma:15333679;Guide2Pharma:9650799;HPRD:9125122;HPRD:9205124;LRdb:10598788;LRdb:11011067;LRdb:15333679;LRdb:9125122;LRdb:9205124;LRdb:9650799;connectomeDB2020:10598788;connectomeDB2020:11011067;connectomeDB2020:15333679;connectomeDB2020:9125122;connectomeDB2020:9205124;connectomeDB2020:9650799;scConnect:10598788;scConnect:15333679;scConnect:9650799], GHSR [Baccin2019:1122773711227730;CellTalkDB:11227737;Cellinker:11227737;HPRD:11227737;LRdb:11227737;SIGNOR:12161511;connectomeDB2020:11227737], MRGPRX2 [Baccin2019:1291540212915400;CellTalkDB:12915402;Cellinker:12915402;HPMR:12915402;HPRD:12915402;LRdb:12915402;SIGNOR:16111673;connectomeDB2020:12915402], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; synapse [GO:0045202]	chromatin binding [GO:0003682]; G protein-coupled receptor binding [GO:0001664]; neuropeptide hormone activity [GO:0005184]	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CORT&keywords=CORT	0.24	599	NA	NA	0.05	711	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	655
AGRP	agouti related neuropeptide	Yes		ENSG00000159723	O00253	NA	14	ligand, receptor	extracellular, intracellular, ligand, ligand_regulator, receptor, secreted	O75056, P18827, P32245, P33032, P41968, Q01726	MC1R, MC3R, MC4R, MC5R, SDC1, SDC3	MC3R [Baccin2019:11747427;Baccin2019:9311920;Baccin2019:9819197;Baccin2019:9893984;CellTalkDB:9311920;Cellinker:11747427;Cellinker:9311920;Cellinker:9819197;Cellinker:9893984;Guide2Pharma:9819197;HPRD:11747427;HPRD:9893984;LRdb:11747427;LRdb:9311920;LRdb:9819197;LRdb:9893984;SIGNOR:10318826;SIGNOR:9311920;connectomeDB2020:11747427;connectomeDB2020:9311920;connectomeDB2020:9819197;connectomeDB2020:9893984;scConnect:9819197], MC4R [Baccin2019:10318826;Baccin2019:11747427;Baccin2019:12815165;Baccin2019:9299416;Baccin2019:9311920;BioGRID:10318826;BioGRID:12815165;CellTalkDB:9311920;Cellinker:10318826;Cellinker:11747427;Cellinker:12815165;Cellinker:9299416;Cellinker:9311920;Guide2Pharma:9299416;HPMR:9311920;HPRD:10318826;HPRD:11747427;HPRD:12815165;LRdb:10318826;LRdb:11747427;LRdb:12815165;LRdb:9299416;LRdb:9311920;SIGNOR:10318826;SIGNOR:9311920;connectomeDB2020:10318826;connectomeDB2020:11747427;connectomeDB2020:12815165;connectomeDB2020:9299416;connectomeDB2020:9311920;scConnect:9299416], MC5R [Baccin2019:98920209892020;CellTalkDB:9892020;Cellinker:9892020;Guide2Pharma:9892020;HPRD:9892020;LRdb:9892020;connectomeDB2020:9892020;scConnect:9892020], SDC3 [CellTalkDB:11461706;Cellinker:11461706;LRdb:11461706;Ramilowski2015:11461706;connectomeDB2020:11461706;talklr:11461706], MC1R [Cellinker:14535656], SDC1 [Cellinker:11461706]	extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; neuronal cell body [GO:0043025]	melanocortin receptor binding [GO:0031779]; neuropeptide hormone activity [GO:0005184]; signaling receptor binding [GO:0005102]; type 1 melanocortin receptor binding [GO:0070996]	adult feeding behavior [GO:0008343]; circadian rhythm [GO:0007623]; eating behavior [GO:0042755]; feeding behavior [GO:0007631]; hormone-mediated signaling pathway [GO:0009755]; long-day photoperiodism [GO:0048571]; maternal process involved in female pregnancy [GO:0060135]; neuropeptide signaling pathway [GO:0007218]; positive regulation of feeding behavior [GO:2000253]; regulation of feeding behavior [GO:0060259]; response to insulin [GO:0032868]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=AGRP&keywords=AGRP	0.03	768	NA	NA	0.07	670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	719
FGF21	fibroblast growth factor 21	Yes		ENSG00000105550	Q9NSA1	Heparin-binding growth factors family	14	ligand	intracellular, ligand, secreted	P11362, P21802, P22455, P22607, Q86Z14	FGFR1, FGFR2, FGFR3, FGFR4, KLB	KLB [CellTalkDB:22442730;HPRD:19059246], FGFR4 [CellTalkDB:22442730;Cellinker:22442730;LRdb:16597617;LRdb:22;Ramilowski2015:22442730;connectomeDB2020:22442730;talklr:22442730], FGFR3 [CellTalkDB:16597617;Cellinker:25772309;LRdb:16597617], FGFR1 [CellTalkDB:16597617;Cellinker:22442730;Cellinker:25772309;LRdb:16597617], FGFR2 [CellTalkDB:16597617;LRdb:16597617]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]	animal organ morphogenesis [GO:0009887]; cell-cell signaling [GO:0007267]; cell differentiation [GO:0030154]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to xenobiotic stimulus [GO:0071466]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell apoptotic process [GO:0072577]; fibroblast growth factor receptor signaling pathway [GO:0008543]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron death [GO:1901215]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of low-density lipoprotein receptor activity [GO:1905599]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of triglyceride catabolic process [GO:0010898]; regulation of cell migration [GO:0030334]; regulation of low-density lipoprotein particle clearance [GO:0010988]; response to activity [GO:0014823]; response to methionine [GO:1904640]; response to nutrient levels [GO:0031667]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF21&keywords=FGF21	0.02	803	NA	NA	0.08	664	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	734
HCRT	hypocretin neuropeptide precursor	Yes		ENSG00000161610	O43612	Orexin family	14	ligand	extracellular, intracellular, ligand, secreted	O43613, O43614, Q9Y5X5	HCRTR1, HCRTR2, NPFFR2	HCRTR1 [Baccin2019:10498827;Baccin2019:11162621;Baccin2019:11250867;Baccin2019:11266181;Baccin2019:11403934;Baccin2019:12208495;Baccin2019:12606634;Baccin2019:12702704;Baccin2019:14691055;Baccin2019:18599270;Baccin2019:21362456;Baccin2019:9491897;CellTalkDB:9491897;Cellinker:10498827;Cellinker:11162621;Cellinker:11250867;Cellinker:11266181;Cellinker:11403934;Cellinker:12208495;Cellinker:12606634;Cellinker:12702704;Cellinker:14691055;Cellinker:18599270;Cellinker:21362456;Cellinker:9491897;Guide2Pharma:10498827;Guide2Pharma:11162621;Guide2Pharma:11266181;Guide2Pharma:12208495;Guide2Pharma:12606634;Guide2Pharma:12702704;Guide2Pharma:14691055;Guide2Pharma:17115071;Guide2Pharma:18488139;Guide2Pharma:20002100;Guide2Pharma:21362456;Guide2Pharma:21718304;Guide2Pharma:22550093;Guide2Pharma:26582739;Guide2Pharma:9491897;HPMR:9491897;HPRD:9491897;LRdb:10498827;LRdb:11162621;LRdb:11250867;LRdb:11266181;LRdb:11403934;LRdb:12208495;LRdb:12606634;LRdb:12702704;LRdb:14691055;LRdb:18599270;LRdb:21362456;LRdb:9491897;SIGNOR:9491897;connectomeDB2020:10498827;connectomeDB2020:11162621;connectomeDB2020:11250867;connectomeDB2020:11266181;connectomeDB2020:11403934;connectomeDB2020:12208495;connectomeDB2020:12606634;connectomeDB2020:12702704;connectomeDB2020:14691055;connectomeDB2020:18599270;connectomeDB2020:21362456;connectomeDB2020:9491897;scConnect:10498827;scConnect:11162621;scConnect:11205421;scConnect:11266181;scConnect:11403934;scConnect:12208495;scConnect:12606634;scConnect:12702704;scConnect:14691055;scConnect:15271651;scConnect:17115071;scConnect:18488139;scConnect:20002100;scConnect:21362456;scConnect:21718304;scConnect:22550093;scConnect:26582739;scConnect:9491897], HCRTR2 [Baccin2019:11162621;Baccin2019:12208495;Baccin2019:12702704;Baccin2019:18599270;Baccin2019:9491897;CellTalkDB:9491897;Cellinker:11162621;Cellinker:12208495;Cellinker:12702704;Cellinker:18599270;Cellinker:9491897;Guide2Pharma:10498827;Guide2Pharma:11162621;Guide2Pharma:12208495;Guide2Pharma:12606634;Guide2Pharma:12702704;Guide2Pharma:18599270;Guide2Pharma:26582739;Guide2Pharma:27237973;Guide2Pharma:9491897;HPMR:9491897;HPRD:9491897;LRdb:11162621;LRdb:12208495;LRdb:12702704;LRdb:18599270;LRdb:9491897;SIGNOR:9491897;connectomeDB2020:11162621;connectomeDB2020:12208495;connectomeDB2020:12702704;connectomeDB2020:18599270;connectomeDB2020:9491897;scConnect:10498827;scConnect:11162621;scConnect:12208495;scConnect:12606634;scConnect:12702704;scConnect:12890892;scConnect:18599270;scConnect:26582739;scConnect:27237973;scConnect:9491897], NPFFR2 [Baccin2019:12609745;CellTalkDB:12609745;Cellinker:12609745;HPRD:12609745;LRdb:12609745;connectomeDB2020:12609745]	extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021]	neuropeptide hormone activity [GO:0005184]; type 1 hypocretin receptor binding [GO:0031771]; type 2 hypocretin receptor binding [GO:0031772]	chemical synaptic transmission [GO:0007268]; eating behavior [GO:0042755]; excitatory postsynaptic potential [GO:0060079]; negative regulation of DNA replication [GO:0008156]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of transmission of nerve impulse [GO:0051970]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of transmission of nerve impulse [GO:0051971]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of neurotransmitter secretion [GO:0046928]; response to starvation [GO:0042594]; sleep [GO:0030431]; temperature homeostasis [GO:0001659]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=HCRT&keywords=HCRT	0.02	806	NA	NA	0.03	763	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	785
DHH	desert hedgehog signaling molecule	Yes		ENSG00000139549	O43323	Hedgehog family	14	cell_surface_ligand, ligand	cell_surface_ligand, extracellular, ligand, plasma_membrane, secreted	Q13635, Q4KMG0, Q96QV1, Q9BWV1, Q9Y6C5	BOC, CDON, HHIP, PTCH1, PTCH1_SMO, PTCH2, PTCH2_SMO	PTCH2 [Baccin2019:98118519811851;CancerCellMap:9811851;CellTalkDB:9811851;Cellinker:9811851;HPMR:9811851;HPRD:9811851;LRdb:9811851;NetPath:9811851;SignaLink3:23331499;SignaLink3:9811851;connectomeDB2020:9811851], HHIP [Baccin2019:10050855;Baccin2019:11435703;CancerCellMap:10050855;CancerCellMap:11435703;CellTalkDB:10050855;Cellinker:10050855;Cellinker:11435703;DIP:19561611;HPRD:10050855;HPRD:11435703;IntAct:19561611;LRdb:10050855;LRdb:11;Lit-BM-17:19561609;Lit-BM-17:19561611;NetPath:10050855;connectomeDB2020:10050855;connectomeDB2020:11435703], PTCH1 [Baccin2019:9811851;CancerCellMap:8906787;CancerCellMap:9811851;CellTalkDB:9811851;Cellinker:9811851;HPRD:9811851;LRdb:9811851;NetPath:9811851;SignaLink3:19399989;SignaLink3:23331499;SignaLink3:9811851;connectomeDB2020:9811851], BOC [Baccin2019:18698484;CellTalkDB:20519495;Cellinker:20519495;LRdb:20519495;Ramilowski2015:20519495;connectomeDB2020:20519495;talklr:20519495], CDON [Baccin2019:18698484;CellTalkDB:20519495;Cellinker:20519495;LRdb:20519495;Ramilowski2015:20519495;connectomeDB2020:20519495;talklr:20519495]	extracellular space [GO:0005615]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]	cell-cell signaling [GO:0007267]; cell fate specification [GO:0001708]; Leydig cell differentiation [GO:0033327]; male sex determination [GO:0030238]; myelination [GO:0042552]; osteoblast differentiation [GO:0001649]; protein autoprocessing [GO:0016540]; regulation of gene expression [GO:0010468]; regulation of steroid biosynthetic process [GO:0050810]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DHH&keywords=DHH	0.03	780	NA	NA	0.02	811	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	796
IL1F10	interleukin 1 family member 10	Yes		ENSG00000136697	Q8WWZ1	IL-1 family	14	ligand	intracellular, ligand, secreted	P14778, Q6IA17, Q9HB29, Q9NP60, Q9NZN1	IL1R1, IL1RAP_IL1RL2, IL1RAPL1, IL1RAPL2, IL1RL2, SIGIRR	IL1RAPL1 [ICELLNET:22315422;ICELLNET:31387327], IL1RL2 [CellTalkDB:22315422;ICELLNET:22315422;ICELLNET:31387327], IL1RAPL2 [ICELLNET:22315422;ICELLNET:31387327], SIGIRR [ICELLNET:22315422;ICELLNET:31387327], IL1R1 [Baccin2019:11278614;CellTalkDB:11278614;Cellinker:11278614;HPRD:11278614;LRdb:11278614;connectomeDB2020:11278614]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149]	cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; positive regulation of gene expression [GO:0010628]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL1F10&keywords=IL1F10	0.00	899	NA	NA	0.02	788	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	844
FSHB	follicle stimulating hormone subunit beta	Yes		ENSG00000131808	P01225	Glycoprotein hormones subunit beta family	14	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, P07550, P13945, P16473, P23945, P32241, P41586, Q03431, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, FSHR, GPR20, GPR84, PTH1R, RAMP2, RAMP3, TSHR, VIPR1	FSHR [Baccin2019:10395410;Baccin2019:2126341;CellTalkDB:2126341;Cellinker:10395410;Cellinker:2126341;HPMR:2126341;HPRD:10395410;LRdb:104;LRdb:2126341;NetPath:15662415;connectomeDB2020:10395410;connectomeDB2020:2126341], ADCYAP1R1 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; follicle-stimulating hormone complex [GO:0016914]	follicle-stimulating hormone activity [GO:0016913]	female gamete generation [GO:0007292]; female pregnancy [GO:0007565]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone biosynthetic process [GO:0006701]; regulation of osteoclast differentiation [GO:0045670]; regulation of signaling receptor activity [GO:0010469]; Sertoli cell proliferation [GO:0060011]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FSHB&keywords=FSHB	0.00	899	NA	NA	0.00	872	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	886
TNFSF18	TNF superfamily member 18	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000120337	Q9UNG2	Tumor necrosis factor family	14	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, secreted, transmembrane	Q9Y5U5	TNFRSF18	TNFRSF18 [Baccin2019:10037686;Baccin2019:10074428;CellTalkDB:10037686;Cellinker:10037686;Cellinker:10074428;DIP:18040044;DIP:18378892;HPMR:10037686;HPRD:10037686;HPRD:10074428;ICELLNET:11239407;IntAct:18040044;IntAct:18378892;LRdb:1;LRdb:10037686;Lit-BM-17:10037686;Lit-BM-17:18040044;Lit-BM-17:18378892;connectomeDB2020:10037686;connectomeDB2020:10074428]	cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor superfamily binding [GO:0032813]	adaptive immune response [GO:0002250]; cell-cell signaling [GO:0007267]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell adhesion [GO:0045785]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of T cell proliferation [GO:0042129]; signal transduction [GO:0007165]; T cell proliferation involved in immune response [GO:0002309]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFSF18&keywords=TNFSF18	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	#DIV/0!
BMP3	bone morphogenetic protein 3	Yes		ENSG00000152785	P12645	TGF-beta family	14	ligand	extracellular, ligand, ligand_regulator, secreted	O00238, P01137, P27037, P36894, P36896, Q04771, Q13705, Q13873	ACVR1, ACVR1B, ACVR1B_ACVR2A, ACVR2A, ACVR2B, BMPR1A, BMPR1B, BMPR2, TGFB1	ACVR2B [CellTalkDB:22074949;Cellinker:27252362;Ramilowski2015:22074949;connectomeDB2020:22074949;talklr:22074949], BMPR2 [Cellinker:27252362], BMPR1A [Cellinker:26511181], BMPR1B [Cellinker:13678778], ACVR1 [NA], ACVR2A [Baccin2019:20959140;Cellinker:27252362], ACVR1B [Cellinker:27252362], TGFB1 [HPRD:9434787]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102]	cartilage development [GO:0051216]; cell-cell signaling [GO:0007267]; osteoblast differentiation [GO:0001649]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMP3&keywords=BMP3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	#DIV/0!
SPP1	secreted phosphoprotein 1	Yes	has non-integrin signalling role too	ENSG00000118785	P10451	Osteopontin family	13	ecm, ligand	ecm, intracellular, ligand, secreted	P05106, P05556, P06756, P08648, P13612, P16070, P18084, P21453, P35408, P51685, Q13797	CCR8, CD44, ITGA4, ITGA4_ITGB1, ITGA4_ITGB7, ITGA5, ITGA5_ITGB1, ITGA8_ITGB1, ITGA9, ITGA9_ITGB1, ITGAV, ITGAV_ITGB1, ITGAV_ITGB3, ITGAV_ITGB5, ITGAV_ITGB6, ITGB1, ITGB3, ITGB5, PTGER4, S1PR1	CD44 [Baccin2019:10657301;Baccin2019:12377945;CellChatDB:21907263;CellTalkDB:10657301;Cellinker:10657301;Cellinker:12377945;Cellinker:21907263;HPRD:10657301;HPRD:12377945;ICELLNET:8560266;LRdb:10657301;LRdb:12;Lit-BM-17:20146103;Lit-BM-17:20549562;connectomeDB2020:10657301;connectomeDB2020:12377945], ITGA4 [CellTalkDB:19417209;LRdb:19417209;Ramilowski2015:19417209;connectomeDB2020:19417209;talklr:19417209], ITGB1 [CellTalkDB:10593924;HPRD:10593924;LMPID:8910476;LRdb:10593924;connectomeDB2020:10593924;connectomeDB2020:7592829], ITGB3 [CellTalkDB:32196115;connectomeDB2020:7592829], ITGAV [CellTalkDB:10835423;HPRD:10835423;LRdb:10835423;connectomeDB2020:10835423;connectomeDB2020:7592829], ITGA9 [CellTalkDB:10593924;HPRD:10593924;LRdb:10593924;connectomeDB2020:10593924], ITGA5 [CellTalkDB:7592829;HPRD:7592829;LRdb:7592829], ITGB5 [CellTalkDB:32196115;connectomeDB2020:7592829], PTGER4 [CellTalkDB:32103204], S1PR1 [Cellinker:9488656;LRdb:9488656;Ramilowski2015:9488656;talklr:9488656], CCR8 [NA]	cell projection [GO:0042995]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]	cytokine activity [GO:0005125]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]	androgen catabolic process [GO:0006710]; biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; cellular response to testosterone stimulus [GO:0071394]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; negative regulation of collateral sprouting of intact axon in response to injury [GO:0048685]; osteoblast differentiation [GO:0001649]; positive regulation of bone resorption [GO:0045780]; positive regulation of estradiol secretion [GO:2000866]; positive regulation of transcription, DNA-templated [GO:0045893]; response to steroid hormone [GO:0048545]; response to vitamin D [GO:0033280]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SPP1&keywords=SPP1	2334.40	12	1671.51	140	12.97	39	0.73	2.83	0.03	0.06	0.49	0.87	3.39	0.06	0.19	2.50	0.04	84	15	168	1.02	0.19	2.44	0.05	442	14	506	44
ADM2	adrenomedullin 2	Yes		ENSG00000128165	Q7Z4H4	Adrenomedullin family	13	ligand	extracellular, ligand, secreted	O60894, O60895, O60896, P07550, P13945, P16473, P30988, P32241, P41586, Q03431, Q16602, Q99678, Q9C098, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, CALCR, CALCRL, DCLK3, GPR20, GPR84, PTH1R, RAMP1, RAMP2, RAMP3, TSHR, VIPR1	CALCRL [Baccin2019:14615490;CellTalkDB:14615490;Cellinker:14615490;Guide2Pharma:21658025;LRdb:14615490;connectomeDB2020:14615490;scConnect:21658025], RAMP2 [CellTalkDB:32196115;Cellinker:20596793;Guide2Pharma:21658025;connectomeDB2020:30139743], RAMP3 [CellTalkDB:27013657;Cellinker:20596793;Guide2Pharma:21658025;connectomeDB2020:30139742], CALCR [Baccin2019:15692146;CellTalkDB:15692146;Guide2Pharma:15692146;Guide2Pharma:21658025;LRdb:15692146;connectomeDB2020:15692146;scConnect:15692146;scConnect:21658025], RAMP1 [Baccin2019:12684503;CellTalkDB:12684503;Cellinker:12684503;Cellinker:30139742;Guide2Pharma:21658025;LRdb:12684503;connectomeDB2020:12684503], ADCYAP1R1 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], DCLK3 [Cellinker:30139742]	extracellular region [GO:0005576]	hormone activity [GO:0005179]; protein-containing complex binding [GO:0044877]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; angiogenesis [GO:0001525]; digestion [GO:0007586]; feeding behavior [GO:0007631]; negative regulation of blood pressure [GO:0045776]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ADM2&keywords=ADM2	1.21	433	NA	NA	0.79	301	0.00	0.02	0.00	0.00	0.04	0.01	0.01	0.00	0.00	0.02	0.00	292	220	310	0.01	0.69	1.29	0.68	266	78	244	258
SEMA3A	semaphorin 3A	Yes		ENSG00000075213	Q14563	Semaphorin family	13	ligand	extracellular, intracellular, ligand, secreted, transmembrane	O14786, O60462, O75051, P51805, Q9HCM2, Q9UIW2	NRP1, NRP1_PLXNA1, NRP1_PLXNA2, NRP1_PLXNA3, NRP1_PLXNA4, NRP2, PLXNA1, PLXNA2, PLXNA3, PLXNA4	NRP1 [Baccin2019:10520994;Baccin2019:15721238;Baccin2019:9331348;CellTalkDB:10520994;DIP:10498602;HPMR:10520994;HPMR:15121181;HPMR:15721238;HPMR:15814794;HPRD:10520994;HPRD:9331348;ICELLNET:29067024;LRdb:10520994;LRdb:15721238;LRdb:9331348;SIGNOR:10196546;SIGNOR:25335892;connectomeDB2020:10520994;connectomeDB2020:15721238;connectomeDB2020:9331348], PLXNA2 [CellTalkDB:10934324;LRdb:10934324;SIGNOR:10679438], PLXNA4 [Baccin2019:15721238;CellTalkDB:15721238;HPMR:15721238;HPMR:15814794;LRdb:15721238;SIGNOR:25335892;connectomeDB2020:15721238], PLXNA1 [Baccin2019:10520994;CellTalkDB:10520994;HPMR:10520994;HPMR:15121181;LRdb:10520994;SIGNOR:25335892;connectomeDB2020:10520994], PLXNA3 [CellTalkDB:32196115], NRP2 [CellTalkDB:21059704;Cellinker:26633812;LRdb:21059704;Ramilowski2015:21059704;connectomeDB2020:21059704;talklr:21059704]	axon [GO:0030424]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]	chemorepellent activity [GO:0045499]; neuropilin binding [GO:0038191]; semaphorin receptor binding [GO:0030215]	apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonogenesis involved in innervation [GO:0060385]; basal dendrite arborization [GO:0150020]; branchiomotor neuron axon guidance [GO:0021785]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of neuron projection development [GO:0010977]; nerve development [GO:0021675]; neural crest cell migration [GO:0001755]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neural crest cell migration involved in sympathetic nervous system development [GO:1903045]; neuron migration [GO:0001764]; olfactory bulb development [GO:0021772]; positive regulation of cell migration [GO:0030335]; positive regulation of JNK cascade [GO:0046330]; positive regulation of male gonad development [GO:2000020]; positive regulation of neuron migration [GO:2001224]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of heart rate [GO:0002027]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory system development [GO:0048880]; sympathetic ganglion development [GO:0061549]; sympathetic nervous system development [GO:0048485]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; trigeminal nerve structural organization [GO:0021637]; ventral trunk neural crest cell migration [GO:0036486]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SEMA3A&keywords=SEMA3A	1.23	430	NA	NA	0.60	336	0.01	0.00	0.00	0.02	0.00	0.03	0.02	0.00	0.03	0.02	0.00	211	206	301	0.01	1.78	1.31	0.66	41	74	257	262
ANGPTL1	angiopoietin like 1	Yes		ENSG00000116194	O95841	NA	13	ligand	extracellular, ligand, secreted	O75022, Q02763, Q8N423	ITGA1_ITGB1, LILRB2, LILRB3, TEK	TEK [CellTalkDB:10051567;Cellinker:10051567;HPRD:10051567;LRdb:10051567;SIGNOR:10051567;SIGNOR:15284220;SignaLink3:10051567;SignaLink3:15284220;SignaLink3:23331499;connectomeDB2020:10051567], LILRB3 [CellChatDB:24478758], LILRB2 [Cellinker:24478758]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	signaling receptor binding [GO:0005102]	transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ANGPTL1&keywords=ANGPTL1	2.08	383	NA	NA	0.11	616	0.00	0.01	0.00	0.02	0.01	0.04	0.03	0.04	0.02	0.03	0.00	236	169	332	0.02	1.07	1.50	0.44	119	53	345	305
RARRES2	retinoic acid receptor responder 2	Yes	Chemerin	ENSG00000106538	Q99969	NA	13	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	O00421, P46091, Q99788	CCRL2, CMKLR1, CMKLR2	CMKLR1 [Baccin2019:14530373;Baccin2019:14675762;Baccin2019:14701797;Baccin2019:18165312;Baccin2019:23396314;CellChatDB:24671882;CellTalkDB:14675762;Cellinker:14530373;Cellinker:14675762;Cellinker:14701797;Cellinker:18165312;Cellinker:23396314;Cellinker:24671882;Guide2Pharma:14530373;Guide2Pharma:14701797;Guide2Pharma:18165312;Guide2Pharma:23396314;HPMR:14675762;HPMR:14701797;LRdb:14530373;LRdb:14675762;LRdb:14701797;LRdb:18165312;LRdb:23396314;connectomeDB2020:14530373;connectomeDB2020:14675762;connectomeDB2020:14701797;connectomeDB2020:18165312;connectomeDB2020:23396314;scConnect:14530373;scConnect:14701797;scConnect:18165312;scConnect:23396314;scConnect:25437209], CMKLR2 [Baccin2019:18165312;Baccin2019:23396314;CellChatDB:24671882;CellTalkDB:18165312;Cellinker:18165312;Cellinker:23396314;Cellinker:24671882;Guide2Pharma:18165312;Guide2Pharma:23396314;LRdb:18165312;LRdb:23;connectomeDB2020:18165312;connectomeDB2020:23396314;scConnect:18165312;scConnect:23396314], CCRL2 [Baccin2019:24671882;CellTalkDB:18794339;Cellinker:18794339;LRdb:18794339;Ramilowski2015:18794339;connectomeDB2020:18794339;talklr:18794339]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet dense granule lumen [GO:0031089]	signaling receptor binding [GO:0005102]	antifungal humoral response [GO:0019732]; antifungal innate immune response [GO:0061760]; cell differentiation [GO:0030154]; chemotaxis [GO:0006935]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; embryonic digestive tract development [GO:0048566]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; insulin receptor signaling pathway [GO:0008286]; positive regulation of chemotaxis [GO:0050921]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of protein phosphorylation [GO:0001934]; regulation of lipid catabolic process [GO:0050994]; retinoid metabolic process [GO:0001523]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RARRES2&keywords=RARRES2	18.05	177	1264.05	151	0.11	609	0.00	0.02	0.00	0.46	1.11	0.02	0.01	0.00	0.03	0.01	0.00	212	249	331	0.15	0.23	0.12	0.08	420	461	487	329
SEMA3F	semaphorin 3F	Yes		ENSG00000001617	Q13275	Semaphorin family	13	ligand	extracellular, ligand, secreted, transmembrane	O14786, O60462, P51805, Q9UIW2	NRP1, NRP2, NRP2_PLXNA1, NRP2_PLXNA2, NRP2_PLXNA3, NRP2_PLXNA4, PLXNA1, PLXNA3	NRP2 [Baccin2019:15721238;Baccin2019:9883722;CellTalkDB:15721238;ELM:20387901;HPMR:15721238;HPRD:9883722;ICELLNET:25068647;ICELLNET:29067024;LRdb:15721238;LRdb:99;SIGNOR:16816121;connectomeDB2020:15721238;connectomeDB2020:9883722], PLXNA3 [Baccin2019:15721238;CellTalkDB:15721238;HPMR:15721238;LRdb:15721238;connectomeDB2020:15721238], PLXNA1 [CellTalkDB:26156437], NRP1 [Baccin2019:9883722;CellTalkDB:9883722;Cellinker:26633812;Cellinker:9883722;ELM:20387901;HPRD:9883722;LRdb:9883722;connectomeDB2020:9883722]	extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]	chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]	axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; facial nerve structural organization [GO:0021612]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nerve development [GO:0021675]; neural crest cell migration [GO:0001755]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; positive regulation of cell migration [GO:0030335]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal nerve structural organization [GO:0021637]; ventral trunk neural crest cell migration [GO:0036486]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SEMA3F&keywords=SEMA3F	8.28	256	NA	NA	0.36	436	0.00	0.00	0.05	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	303	406	390	0.01	0.64	0.64	0.66	289	275	255	343
TAC1	tachykinin precursor 1	Yes		ENSG00000006128	P20366	Tachykinin family	13	ligand	extracellular, ligand, secreted	P21452, P25103, P27487, P29371, Q12884, Q96LB1	DPP4, FAP, MRGPRX2, TACR1, TACR2, TACR3	TACR1 [Baccin2019:11786503;Baccin2019:12548712;Baccin2019:1311270;Baccin2019:15265501;Baccin2019:7557266;Baccin2019:8702757;Baccin2019:8985159;Baccin2019:9190866;BioGRID:8702757;CellTalkDB:7557266;Cellinker:11786503;Cellinker:12548712;Cellinker:1311270;Cellinker:15265501;Cellinker:7557266;Cellinker:8702757;Cellinker:8985159;Cellinker:9190866;Guide2Pharma:11786503;Guide2Pharma:1311270;Guide2Pharma:15265501;Guide2Pharma:8702757;Guide2Pharma:8985159;Guide2Pharma:9190866;HPRD:12548712;LRdb:11786503;LRdb:12548712;LRdb:1311270;LRdb:15265501;LRdb:7557266;LRdb:8702757;LRdb:8985159;LRdb:9190866;Lit-BM-17:11786503;Lit-BM-17:23597562;Lit-BM-17:8702757;connectomeDB2020:11786503;connectomeDB2020:12548712;connectomeDB2020:1311270;connectomeDB2020:15265501;connectomeDB2020:7557266;connectomeDB2020:8702757;connectomeDB2020:8985159;connectomeDB2020:9190866;scConnect:11786503;scConnect:1311270;scConnect:15265501;scConnect:8702757;scConnect:8985159;scConnect:9190866], TACR2 [Baccin2019:10189055;Baccin2019:11137709;Baccin2019:11786503;Baccin2019:12954451;Baccin2019:7682062;Baccin2019:7961636;Baccin2019:8925404;Baccin2019:9190866;BioGRID:7961636;CellTalkDB:12954451;Cellinker:10189055;Cellinker:11137709;Cellinker:11786503;Cellinker:12954451;Cellinker:7682062;Cellinker:7961636;Cellinker:9190866;Guide2Pharma:11137709;Guide2Pharma:11786503;Guide2Pharma:7682062;Guide2Pharma:9190866;HPMR:12954451;HPMR:7534932;HPRD:10189055;HPRD:7961636;LRdb:10189055;LRdb:11137709;LRdb:11786503;LRdb:12954451;LRdb:7682062;LRdb:7961636;LRdb:9190866;Lit-BM-17:11786503;Lit-BM-17:23597562;Lit-BM-17:7961636;SIGNOR:8925404;connectomeDB2020:10189055;connectomeDB2020:11137709;connectomeDB2020:11786503;connectomeDB2020:12954451;connectomeDB2020:7682062;connectomeDB2020:7961636;connectomeDB2020:9190866;scConnect:11137709;scConnect:11786503;scConnect:7682062;scConnect:9190866], TACR3 [Baccin2019:10189055;Baccin2019:10866201;Baccin2019:11226387;Baccin2019:1312036;Baccin2019:2176308;Baccin2019:7557266;Baccin2019:8990205;Baccin2019:9190866;Baccin2019:9272936;CellTalkDB:9272936;Cellinker:11226387;Cellinker:1312036;Cellinker:9190866;Cellinker:9272936;Guide2Pharma:11226387;Guide2Pharma:1312036;Guide2Pharma:9190866;HPRD:9272936;LRdb:11226387;LRdb:1312036;LRdb:9190866;LRdb:9272936;connectomeDB2020:11226387;connectomeDB2020:1312036;connectomeDB2020:9190866;connectomeDB2020:9272936;scConnect:11226387;scConnect:1312036;scConnect:9190866], DPP4 [Cellinker:21314817], FAP [Cellinker:21314817], MRGPRX2 [scConnect:25517090;scConnect:28288109]	axon [GO:0030424]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; synapse [GO:0045202]	neuromedin K receptor binding [GO:0031836]; receptor ligand activity [GO:0048018]; substance K receptor binding [GO:0031837]; substance P receptor binding [GO:0031835]	antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to nerve growth factor stimulus [GO:1990090]; chemical synaptic transmission [GO:0007268]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of abiotic stimulus [GO:0009582]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; insemination [GO:0007320]; killing of cells of other organism [GO:0031640]; negative regulation of neuron death [GO:1901215]; negative regulation of systemic arterial blood pressure [GO:0003085]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of neuron death [GO:1901216]; positive regulation of sensory perception of pain [GO:1904058]; regulation of sensory perception of pain [GO:0051930]; response to pain [GO:0048265]; response to yeast [GO:0001878]; sensory perception of pain [GO:0019233]; tachykinin receptor signaling pathway [GO:0007217]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TAC1&keywords=TAC1	5.91	279	NA	NA	0.40	419	0.00	0.01	0.00	0.03	0.19	0.03	0.07	0.01	0.01	0.00	0.15	251	333	83	0.05	0.44	0.22	2.91	365	404	8	359
TNFSF4	TNF superfamily member 4	Yes		ENSG00000117586	P23510	Tumor necrosis factor family	13	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, secreted, transmembrane, transmembrane_predicted	P43489, Q12933	TNFRSF4, TRAF2	TNFRSF4 [Baccin2019:12134113;CellTalkDB:12134113;Cellinker:12134113;DIP:16905106;DIP:8076595;HPMR:12134113;HPRD:12134113;ICELLNET:11239407;InnateDB:16905106;LRdb:12134113;Lit-BM-17:16905106;Lit-BM-17:8076595;SIGNOR:9488716;connectomeDB2020:12134113], TRAF2 [Baccin2019:9418902;CellTalkDB:9418902;Cellinker:9418902;HPRD:9418902;LRdb:9418902]	cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813]	acute inflammatory response [GO:0002526]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to prostaglandin E stimulus [GO:0071380]; defense response to nematode [GO:0002215]; immune response [GO:0006955]; inflammatory response [GO:0006954]; memory T cell activation [GO:0035709]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of regulatory T cell differentiation [GO:0045590]; negative regulation of T-helper 1 cell differentiation [GO:0045626]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of B cell activation [GO:0050871]; positive regulation of CD4-positive, alpha-beta T cell costimulation [GO:1900281]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production [GO:0001819]; positive regulation of immunoglobulin mediated immune response [GO:0002891]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4-dependent isotype switching to IgE isotypes [GO:2000572]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of type 2 immune response [GO:0002830]; regulation of adaptive immune response [GO:0002819]; regulation of inflammatory response [GO:0050727]; response to nitrogen dioxide [GO:0035713]; response to virus [GO:0009615]; signal transduction [GO:0007165]; T-helper 2 cell activation [GO:0035712]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFSF4&keywords=TNFSF4	1.16	436	NA	NA	0.70	319	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	378
SEMA3C	semaphorin 3C	Yes		ENSG00000075223	Q99985	Semaphorin family	13	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted, transmembrane	O14786, O60462, O75051, Q9Y4D7	NRP1, NRP1_NRP2, NRP1_NRP2_PLXND1, NRP1_PLXNA1, NRP1_PLXNA2, NRP1_PLXNA3, NRP1_PLXNA4, NRP2, NRP2_PLXNA1, NRP2_PLXNA2, NRP2_PLXNA3, NRP2_PLXNA4, PLXNA2, PLXND1	NRP2 [Baccin2019:10196546;Baccin2019:9331348;CellTalkDB:10196546;HPMR:10196546;HPRD:9331348;ICELLNET:29067024;LRdb:10196546;LRdb:93;SIGNOR:16816121;connectomeDB2020:10196546;connectomeDB2020:9331348], PLXNA2 [SIGNOR:19666519], PLXND1 [Baccin2019:27439112;CellChatDB:27533782;CellTalkDB:15239958;Cellinker:27533782;LRdb:15239958;Ramilowski2015:15239958;connectomeDB2020:15239958;talklr:15239958], NRP1 [Baccin2019:9331348;CellTalkDB:9331348;HPRD:9331348;LRdb:9331348;connectomeDB2020:9331348]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]	chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]	axon guidance [GO:0007411]; blood vessel remodeling [GO:0001974]; cardiac endothelial to mesenchymal transition [GO:0140074]; cardiac right ventricle morphogenesis [GO:0003215]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; immune response [GO:0006955]; limb bud formation [GO:0060174]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; neural tube development [GO:0021915]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of cell migration [GO:0030335]; post-embryonic development [GO:0009791]; pulmonary myocardium development [GO:0003350]; response to xenobiotic stimulus [GO:0009410]; semaphorin-plexin signaling pathway [GO:0071526]; somitogenesis [GO:0001756]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SEMA3C&keywords=SEMA3C	4.41	304	NA	NA	0.30	464	0.05	0.04	0.01	0.09	0.02	0.00	0.00	0.00	0.00	0.00	0.00	301	387	360	0.02	0.37	0.36	0.38	389	360	359	379
SAA1	serum amyloid A1	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000173432	P0DJI8	SAA family	13	ligand	extracellular, intracellular, ligand, secreted	O60603, P08913, P16671, P21462, P25090, P48039, Q14831, Q8WTV0	ADRA2A, CD36, FPR1, FPR2, GRM7, MTNR1A, SCARB1, TLR2	FPR2 [Baccin2019:9892621;CellChatDB:22610094;CellTalkDB:9892621;Cellinker:22610094;Cellinker:9892621;Guide2Pharma:9892621;ICELLNET:26130702;LRdb:9892621;connectomeDB2020:9892621;scConnect:9892621], FPR1 [Baccin2019:10753626;CellTalkDB:10753626;Cellinker:10753626;HPRD:10753626;LRdb:10753626], TLR2 [CellTalkDB:26290589], SCARB1 [CellTalkDB:15576377], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], CD36 [connectomeDB2020:20075072]	cytoplasmic microtubule [GO:0005881]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; high-density lipoprotein particle [GO:0034364]	G protein-coupled receptor binding [GO:0001664]; heparin binding [GO:0008201]	acute-phase response [GO:0006953]; lymphocyte chemotaxis [GO:0048247]; macrophage chemotaxis [GO:0048246]; negative regulation of inflammatory response [GO:0050728]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of interleukin-1 production [GO:0032732]; regulation of protein secretion [GO:0050708]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SAA1&keywords=SAA1	8.29	254	NA	NA	0.03	757	0.00	0.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	302	409	398	0.00	0.75	0.72	0.73	241	243	221	416
UCN	urocortin	Yes		ENSG00000163794	P55089	Sauvagine/corticotropin-releasing factor/urotensin I family	13	ligand	extracellular, intracellular, ligand, secreted	P34998, Q13324	CRHR1, CRHR2	CRHR1 [Baccin2019:11123370;Baccin2019:11416224;Baccin2019:15450949;Baccin2019:8612563;Baccin2019:9423932;BioGRID:8612563;CellTalkDB:11416224;Cellinker:11123370;Cellinker:11416224;Cellinker:15450949;Cellinker:8612563;Cellinker:9423932;Guide2Pharma:11123370;Guide2Pharma:15450949;Guide2Pharma:8612563;HPRD:8612563;HPRD:9423932;LRdb:11123370;LRdb:11416224;LRdb:15450949;LRdb:8612563;LRdb:9423932;connectomeDB2020:11123370;connectomeDB2020:11416224;connectomeDB2020:15450949;connectomeDB2020:8612563;connectomeDB2020:9423932;scConnect:11123370;scConnect:15450949;scConnect:8612563], CRHR2 [Baccin2019:10816663;Baccin2019:11123370;Baccin2019:11416224;Baccin2019:15450949;Baccin2019:8612563;Baccin2019:9423932;CellTalkDB:15450949;Cellinker:10816663;Cellinker:11123370;Cellinker:11416224;Cellinker:15450949;Cellinker:8612563;Cellinker:9423932;Guide2Pharma:11123370;Guide2Pharma:15450949;HPRD:11416224;HPRD:8612563;HPRD:9423932;LRdb:10816663;LRdb:11123370;LRdb:11416224;LRdb:15450949;LRdb:8612563;LRdb:9423932;connectomeDB2020:10816663;connectomeDB2020:11123370;connectomeDB2020:11416224;connectomeDB2020:15450949;connectomeDB2020:8612563;connectomeDB2020:9423932;scConnect:11123370;scConnect:15450949]	axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular region [GO:0005576]; perikaryon [GO:0043204]; varicosity [GO:0043196]	corticotropin-releasing hormone receptor 1 binding [GO:0051430]; corticotropin-releasing hormone receptor 2 binding [GO:0051431]; histone deacetylase inhibitor activity [GO:0046811]; neuropeptide hormone activity [GO:0005184]	activation of protein kinase A activity [GO:0034199]; aerobic respiration [GO:0009060]; associative learning [GO:0008306]; drinking behavior [GO:0042756]; female pregnancy [GO:0007565]; gastric emptying [GO:0035483]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; negative regulation of appetite [GO:0032099]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell size [GO:0045792]; negative regulation of feeding behavior [GO:2000252]; negative regulation of gastric acid secretion [GO:0060455]; negative regulation of gene expression [GO:0010629]; negative regulation of hormone secretion [GO:0046888]; negative regulation of necrotic cell death [GO:0060547]; negative regulation of neuron death [GO:1901215]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; pancreatic juice secretion [GO:0030157]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cell growth [GO:0030307]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of corticotropin secretion [GO:0051461]; positive regulation of DNA replication [GO:0045740]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of vascular permeability [GO:0043117]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to auditory stimulus [GO:0010996]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to oxidative stress [GO:0006979]; response to pain [GO:0048265]; sensory perception of sound [GO:0007605]; social behavior [GO:0035176]; startle response [GO:0001964]; vasodilation [GO:0042311]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=UCN&keywords=UCN	0.16	634	NA	NA	0.04	748	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.00	0.00	0.01	0.00	292	290	326	0.00	1.02	1.12	0.93	129	108	129	445
RSPO3	R-spondin 3	Yes		ENSG00000146374	Q9BXY4	R-spondin family	13	ecm, ligand	ecm, extracellular, ligand, ligand_regulator, secreted, transmembrane, transmembrane_predicted	O75473, O75581, P31431, Q68DV7, Q9BXB1, Q9H461, Q9HBX8, Q9ULT6	FZD8, LGR4, LGR5, LGR6, LRP6, RNF43, SDC4, ZNRF3	LGR4 [Baccin2019:21693646;Baccin2019:21909076;CellTalkDB:21693646;Cellinker:29405118;Cellinker:29769720;Guide2Pharma:21693646;LRdb:21693646;LRdb:21909076;Lit-BM-17:24050775;Lit-BM-17:25504990;connectomeDB2020:21693646;connectomeDB2020:21909076;scConnect:21693646;scConnect:21909076], LGR5 [Baccin2019:21693640;Baccin2019:21693646;CellTalkDB:21693646;Cellinker:21693646;Cellinker:29405118;Cellinker:29769720;Guide2Pharma:21693646;LRdb:21693646;SIGNOR:21693646;connectomeDB2020:21693646;scConnect:21693646], LGR6 [Baccin2019:21693646;Baccin2019:21727895;CellTalkDB:21727895;Cellinker:21693646;Cellinker:21727895;Cellinker:29405118;Cellinker:29769720;Guide2Pharma:21693646;Guide2Pharma:21727895;LRdb:21727895;LRdb:22;connectomeDB2020:21693646;connectomeDB2020:21727895;scConnect:21693646;scConnect:21727895], SDC4 [Baccin2019:24275095;CellTalkDB:21397842;Cellinker:21397842;LRdb:21397842;Ramilowski2015:21397842;SIGNOR:21397842;connectomeDB2020:21397842;talklr:21397842], FZD8 [Cellinker:16543246;LRdb:16543246;NetPath:17976036;Ramilowski2015:16543246;connectomeDB2020:16543246;talklr:16543246], LRP6 [Cellinker:16543246;LRdb:16543246;NetPath:17976036;Ramilowski2015:16543246;connectomeDB2020:16543246;talklr:16543246], ZNRF3 [Cellinker:29405118;Cellinker:29769720;Lit-BM-17:24050775;Lit-BM-17:25504990], RNF43 [Cellinker:29405118;Cellinker:29769720]	extracellular region [GO:0005576]	frizzled binding [GO:0005109]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102]	blood vessel remodeling [GO:0001974]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RSPO3&keywords=RSPO3	0.76	487	NA	NA	0.09	649	0.02	0.00	0.00	0.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	303	405	387	0.01	0.64	0.64	0.67	287	274	250	454
TRH	thyrotropin releasing hormone	Yes		ENSG00000170893	P20396	TRH family	13	ligand	extracellular, intracellular, ligand, secreted	P34981	TRHR	TRHR [Baccin2019:15117874;Baccin2019:2175902;Baccin2019:9794253;CellTalkDB:9794253;Cellinker:15117874;Cellinker:2175902;Cellinker:9794253;HPMR:2175902;HPRD:15117874;HPRD:9794253;LRdb:15117874;LRdb:2175902;LRdb:9794253;SIGNOR:27515033;connectomeDB2020:15117874;connectomeDB2020:2175902;connectomeDB2020:9794253]	extracellular region [GO:0005576]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]	thyrotropin-releasing hormone activity [GO:0008437]	adult walking behavior [GO:0007628]; cell-cell signaling [GO:0007267]; eating behavior [GO:0042755]; histamine metabolic process [GO:0001692]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of glutamate secretion [GO:0014050]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; positive regulation of insulin secretion [GO:0032024]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TRH&keywords=TRH	0.09	681	NA	NA	0.12	600	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.00	294	409	400	0.00	1.15	0.86	0.86	103	186	159	469
CD70	CD70 molecule	Yes	there is evidence that a soluble form of the ligand is secreted, even though traditionaly is thought to be membrane bound	ENSG00000125726	P32970	Tumor necrosis factor family	13	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, secreted, transmembrane, transmembrane_predicted	O14836, P26842, Q02223, Q9NZH0	CD27, GPRC5B, TNFRSF13B, TNFRSF17	CD27 [Baccin2019:15723067;Baccin2019:7479974;Baccin2019:8120384;Baccin2019:8186199;Baccin2019:8580829;Baccin2019:9767422;Baccin2019:9862673;BioGRID:21917027;CellPhoneDB:26697006;CellTalkDB:8120384;Cellinker:15723067;Cellinker:7479974;Cellinker:8120384;Cellinker:8186199;Cellinker:8580829;Cellinker:9767422;Cellinker:9862673;HPMR:8120384;HPRD:15723067;HPRD:7479974;HPRD:8120384;HPRD:8186199;HPRD:8580829;HPRD:9767422;HPRD:9862673;ICELLNET:26697006;ICELLNET:8120384;LRdb:15723067;LRdb:7479974;LRdb:8120384;LRdb:8186199;LRdb:8580829;LRdb:9767422;LRdb:9862673;SIGNOR:12324477;SIGNOR:8120384;SPIKE:9862673;connectomeDB2020:15723067;connectomeDB2020:7479974;connectomeDB2020:8120384;connectomeDB2020:8186199;connectomeDB2020:8580829;connectomeDB2020:9767422;connectomeDB2020:9862673], TNFRSF13B [CellTalkDB:32103204], TNFRSF17 [CellTalkDB:32103204], GPRC5B [NA]	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; protease binding [GO:0002020]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]	B cell mediated immunity [GO:0019724]; B cell proliferation [GO:0042100]; cell-cell signaling [GO:0007267]; extrinsic apoptotic signaling pathway [GO:0097191]; positive regulation of T cell proliferation [GO:0042102]; signal transduction [GO:0007165]; T cell mediated immunity [GO:0002456]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD70&keywords=CD70	0.05	732	NA	NA	0.01	836	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	303	409	397	0.00	0.88	0.88	0.90	195	177	147	539
TNFSF9	TNF superfamily member 9	Yes		ENSG00000125657	P41273	Tumor necrosis factor family	13	cell_surface_ligand, ligand	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, secreted, transmembrane, transmembrane_predicted	A4D1S0, P15151, P20036, Q07011, Q12933, Q14627, Q8IZF4, Q96LA6	ADGRG5, FCRL1, HLA-DPA1, IL13RA2, KLRG2, PVR, TNFRSF9, TRAF2	TNFRSF9 [CellTalkDB:13130507;Cellinker:13130507;Cellinker:8088337;Cellinker:9045669;DIP:8088337;HPMR:8088337;HPRD:13130507;HPRD:8088337;HPRD:9045669;ICELLNET:11239407;LRdb:13130507;LRdb:8088337;LRdb:9045669;SPIKE:16596186;connectomeDB2020:13130507;connectomeDB2020:8088337;connectomeDB2020:9045669], PVR [CellTalkDB:32103204], TRAF2 [CellTalkDB:9607925;Cellinker:9607925;HPRD:9607925;LRdb:9607925], FCRL1 [Cellinker:32589946], IL13RA2 [NA], HLA-DPA1 [NA], ADGRG5 [NA], KLRG2 [NA]	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813]	cell-cell signaling [GO:0007267]; immune response [GO:0006955]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of cytotoxic T cell differentiation [GO:0045585]; regulation of apoptotic process [GO:0042981]; regulation of T cell proliferation [GO:0042129]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFSF9&keywords=TNFSF9	0.35	558	NA	NA	0.08	660	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	609
NPVF	neuropeptide VF precursor	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000105954	Q9HCQ7	FARP (FMRFamide related peptide) family	13	ligand	extracellular, ligand, secreted	Q9GZQ6, Q9Y5X5	NPFFR1, NPFFR2	NPFFR1 [CellChatDB:29106375;CellTalkDB:11024015;Cellinker:11024015;Cellinker:12242085;Cellinker:12421602;Cellinker:17337079;Cellinker:29106375;Guide2Pharma:12242085;Guide2Pharma:12421602;Guide2Pharma:17337079;HPMR:11024015;LRdb:11024015;LRdb:12242085;LRdb:12421602;LRdb:17337079;connectomeDB2020:11024015;connectomeDB2020:12242085;connectomeDB2020:12421602;connectomeDB2020:17337079;scConnect:12242085;scConnect:12421602;scConnect:17337079], NPFFR2 [Baccin2019:12242085;Baccin2019:12421602;CellChatDB:29106375;CellTalkDB:12242085;Cellinker:12242085;Cellinker:12421602;Cellinker:29106375;LRdb:12;LRdb:12242085;connectomeDB2020:12242085;connectomeDB2020:12421602;scConnect:12242085;scConnect:12421602]	extracellular region [GO:0005576]	signaling receptor binding [GO:0005102]	negative regulation of gonadotropin secretion [GO:0032277]; neuropeptide signaling pathway [GO:0007218]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPVF&keywords=NPVF	0.00	876	NA	NA	0.56	362	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	619
PRLH	prolactin releasing hormone	Yes		ENSG00000071677	P81277	NA	13	ligand	extracellular, intracellular, ligand, secreted	P49683	PRLHR	PRLHR [CellTalkDB:11030716;Cellinker:10475064;Cellinker:11030716;Cellinker:12606605;Cellinker:9607765;Guide2Pharma:11030716;Guide2Pharma:12606605;HPMR:11030716;HPRD:10475064;HPRD:11030716;HPRD:9607765;LRdb:10475064;LRdb:11030716;LRdb:12606605;LRdb:9607765;connectomeDB2020:10475064;connectomeDB2020:11030716;connectomeDB2020:12606605;connectomeDB2020:9607765;scConnect:11030716;scConnect:12606605]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]	hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184]; prolactin-releasing peptide receptor binding [GO:0031861]	autonomic nervous system development [GO:0048483]; energy reserve metabolic process [GO:0006112]; fat cell differentiation [GO:0045444]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of multicellular organism growth [GO:0040014]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to peptide hormone [GO:0043434]; tissue homeostasis [GO:0001894]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRLH&keywords=PRLH	0.00	899	NA	NA	0.58	350	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	625
GNRH2	gonadotropin releasing hormone 2	Yes		ENSG00000125787	O43555	GnRH family	13	ligand	extracellular, ligand, secreted	P30968, Q96P88	GNRHR, GNRHR2	GNRHR [CellTalkDB:17942747;Cellinker:17452338;Cellinker:17942747;Cellinker:19638591;Guide2Pharma:17452338;Guide2Pharma:17942747;Guide2Pharma:19638591;LRdb:17452338;LRdb:17942747;LRdb:19638591;connectomeDB2020:17452338;connectomeDB2020:17942747;connectomeDB2020:19638591;scConnect:17452338;scConnect:17942747;scConnect:19638591], GNRHR2 [HPRD:11889221]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	gonadotropin hormone-releasing hormone activity [GO:0005183]; gonadotropin-releasing hormone receptor binding [GO:0031530]; hormone activity [GO:0005179]	reproduction [GO:0000003]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GNRH2&keywords=GNRH2	0.07	695	NA	NA	0.13	595	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	645
RSPO2	R-spondin 2	Yes		ENSG00000147655	Q6UXX9	R-spondin family	13	ecm, ligand, receptor	ecm, ligand, ligand_regulator, receptor, secreted	O75473, P31431, Q68DV7, Q9BXB1, Q9HBX8, Q9ULT6, Q9ULV1	FZD4, LGR4, LGR5, LGR6, RNF43, SDC4, ZNRF3	LGR4 [Baccin2019:2169364621693640;CellTalkDB:21693646;Cellinker:21693646;Cellinker:29769720;Guide2Pharma:21693646;LRdb:21693646;Lit-BM-17:24050775;Lit-BM-17:25504990;SIGNOR:21693646;connectomeDB2020:21693646;scConnect:21693646], LGR5 [Baccin2019:2169364621693640;CellTalkDB:21693646;Cellinker:21693646;Cellinker:29769720;Guide2Pharma:21693646;LRdb:21693646;SIGNOR:21693646;connectomeDB2020:21693646;scConnect:21693646], LGR6 [Baccin2019:21693646;Baccin2019:21727895;CellTalkDB:21727895;Cellinker:21693646;Cellinker:21727895;Cellinker:29769720;Guide2Pharma:21693646;Guide2Pharma:21727895;LRdb:21727895;LRdb:22;connectomeDB2020:21693646;connectomeDB2020:21727895;scConnect:21693646;scConnect:21727895], FZD4 [SIGNOR:22575959], SDC4 [SIGNOR:21397842], ZNRF3 [BioGRID:28600110;CellTalkDB:26123262;Cellinker:29405118;Cellinker:29769720;Lit-BM-17:24050775;Lit-BM-17:25504990;connectomeDB2020:29769720], RNF43 [Cellinker:29405118;Cellinker:29769720;connectomeDB2020:29769720]	cell surface [GO:0009986]; extracellular region [GO:0005576]	heparin binding [GO:0008201]; signaling receptor binding [GO:0005102]	bone mineralization [GO:0030282]; dopaminergic neuron differentiation [GO:0071542]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; limb development [GO:0060173]; lung growth [GO:0060437]; negative regulation of odontogenesis of dentin-containing tooth [GO:0042489]; osteoblast differentiation [GO:0001649]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RSPO2&keywords=RSPO2	0.08	691	NA	NA	0.05	705	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	698
RSPO1	R-spondin 1	Yes	probably regulates wnt pathway	ENSG00000169218	Q2MKA7	R-spondin family	13	ecm, ligand	ecm, extracellular, intracellular, ligand, ligand_regulator, secreted	O75473, O75581, Q68DV7, Q9BXB1, Q9H461, Q9HBX8, Q9ULT6	FZD8, LGR4, LGR5, LGR6, LRP6, RNF43, ZNRF3	LGR4 [Baccin2019:2169364621693640;BioGRID:24225776;CellTalkDB:21693646;Cellinker:21693646;Cellinker:24349440;Guide2Pharma:21693646;LRdb:21693646;Lit-BM-17:24050775;Lit-BM-17:24165923;Lit-BM-17:24225776;Lit-BM-17:25504990;connectomeDB2020:21693646;scConnect:21693646], LGR5 [Baccin2019:2169364621693640;CellTalkDB:21693646;Cellinker:21693646;Cellinker:24349440;Guide2Pharma:21693646;LRdb:21693646;connectomeDB2020:21693646;scConnect:21693646], LGR6 [Baccin2019:21693646;Baccin2019:21727895;CellTalkDB:21727895;Cellinker:21693646;Cellinker:21727895;Cellinker:24349440;Guide2Pharma:21693646;Guide2Pharma:21727895;LRdb:21727895;LRdb:22;connectomeDB2020:21693646;connectomeDB2020:21727895;scConnect:21693646;scConnect:21727895], ZNRF3 [CellTalkDB:24349440;Cellinker:24349440;Cellinker:29405118;IntAct:22575959;IntAct:24165923;LRdb:24349440;Lit-BM-17:22575959;Lit-BM-17:24050775;Lit-BM-17:24165923;Lit-BM-17:25504990;Ramilowski2015:24349440;SIGNOR:22575959;SIGNOR:23151663;connectomeDB2020:24349440;talklr:24349440], FZD8 [CellTalkDB:32196115;NetPath:17976036], LRP6 [ACSN:17804805;Baccin2019:18400942;CellTalkDB:18400942;Cellinker:18400942;LRdb:18400942;NetPath:17976036;connectomeDB2020:18400942], RNF43 [BioGRID:23756651;Cellinker:29405118]	extracellular region [GO:0005576]; nucleus [GO:0005634]	G protein-coupled receptor binding [GO:0001664]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102]	positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of receptor internalization [GO:0002090]; Wnt signaling pathway [GO:0016055]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RSPO1&keywords=RSPO1	0.05	742	NA	NA	0.01	840	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	791
TNFSF8	TNF superfamily member 8	Yes		ENSG00000106952	P32971	Tumor necrosis factor family	13	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, ligand, plasma_membrane, secreted, transmembrane, transmembrane_predicted	P28908	TNFRSF8	TNFRSF8 [Baccin2019:11754357;Baccin2019:8391931;CellTalkDB:8391931;Cellinker:11754357;Cellinker:8391931;DIP:10768840;HPMR:8391931;HPRD:11754357;ICELLNET:11239407;LRdb:118;LRdb:8391931;connectomeDB2020:11754357;connectomeDB2020:8391931]	extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]	CD8-positive, alpha-beta T cell differentiation [GO:0043374]; cell-cell signaling [GO:0007267]; defense response to Gram-positive bacterium [GO:0050830]; immune response [GO:0006955]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of T cell proliferation [GO:0042129]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFSF8&keywords=TNFSF8	0.01	816	NA	NA	0.03	777	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	797
RSPO4	R-spondin 4	Yes		ENSG00000101282	Q2I0M5	R-spondin family	13	ecm, ligand	ecm, intracellular, ligand, ligand_regulator, secreted	O75473, Q68DV7, Q9BXB1, Q9HBX8, Q9ULT6	LGR4, LGR4_LRP5, LGR4_LRP6, LGR5, LGR5_LRP5, LGR5_LRP6, LGR6, RNF43, ZNRF3	LGR4 [Baccin2019:2169364621693640;CellTalkDB:21693646;Cellinker:21693646;Guide2Pharma:21693646;LRdb:21693646;Lit-BM-17:24050775;Lit-BM-17:25504990;connectomeDB2020:21693646;scConnect:21693646], LGR5 [Baccin2019:2169364621693640;CellTalkDB:21693646;Cellinker:21693646;Guide2Pharma:21693646;LRdb:21693646;connectomeDB2020:21693646;scConnect:21693646], LGR6 [Baccin2019:21693646;Baccin2019:21727895;CellTalkDB:21727895;Cellinker:21693646;Cellinker:21727895;Guide2Pharma:21693646;Guide2Pharma:21727895;LRdb:21727895;LRdb:22;connectomeDB2020:21693646;connectomeDB2020:21727895;scConnect:21693646;scConnect:21727895], ZNRF3 [Cellinker:29405118], RNF43 [Cellinker:29405118]	extracellular region [GO:0005576]	heparin binding [GO:0008201]	nail development [GO:0035878]; positive regulation of Wnt signaling pathway [GO:0030177]; Wnt signaling pathway [GO:0016055]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RSPO4&keywords=RSPO4	0.02	786	NA	NA	0.02	812	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	799
CSH1	chorionic somatomammotropin hormone 1	Yes		ENSG00000136488	P0DML2	Somatotropin/prolactin family	13	ligand	extracellular, intracellular, ligand, secreted	P16471	PRLR	PRLR [CellTalkDB:10966654;Cellinker:10966654;HPRD:10966654;LRdb:10966654;connectomeDB2020:10966654]	endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; vesicle [GO:0031982]	growth factor activity [GO:0008083]; growth hormone receptor binding [GO:0005131]; hormone activity [GO:0005179]; metal ion binding [GO:0046872]	animal organ development [GO:0048513]; growth hormone receptor signaling pathway [GO:0060396]; positive regulation of growth [GO:0045927]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to nutrient levels [GO:0031667]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CSH1&keywords=CSH1	0.00	863	NA	NA	0.04	752	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	808
KNG1	kininogen 1	Yes	secreted & binds GPCR	ENSG00000113889	P01042	NA	13	ligand	ecm_regulator, extracellular, intracellular, ligand, secreted	P05107, P07359, P08311, P08913, P11215, P30411, P34741, P46663, P48039, Q03405, Q14831, Q8IZ08, Q8TDU9, Q9NPY3	ADRA2A, BDKRB1, BDKRB2, CD93, CTSG, GP1BA, GP1BA_GP1BB_GP5_GP9, GPR135, GRM7, ITGAM, ITGB2, MTNR1A, PLAUR, RXFP4, SDC2	BDKRB1 [CellTalkDB:8856107;Cellinker:10422787;Cellinker:8063797;Cellinker:9111052;Cellinker:9313952;Guide2Pharma:10422787;Guide2Pharma:8735629;Guide2Pharma:9111052;Guide2Pharma:9313952;HPMR:8063797;LRdb:10422787;LRdb:8063797;LRdb:9111052;LRdb:9313952;connectomeDB2020:10422787;connectomeDB2020:8063797;connectomeDB2020:9111052;connectomeDB2020:9313952;scConnect:10422787;scConnect:8735629;scConnect:9111052;scConnect:9313952], BDKRB2 [CellTalkDB:8063797;Cellinker:8063797;Cellinker:8302267;Cellinker:9203620;Guide2Pharma:8302267;Guide2Pharma:9203620;HPMR:8063797;LRdb:8063797;LRdb:8302267;LRdb:9203620;SIGNOR:28966616;connectomeDB2020:8063797;connectomeDB2020:8302267;connectomeDB2020:9203620;scConnect:8302267;scConnect:9203620], ITGAM [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], RXFP4 [CellTalkDB:14530218;Cellinker:14530218;HPRD:14530218;LRdb:14530218;connectomeDB2020:14530218], PLAUR [CellTalkDB:14764580;Cellinker:14764580;HPRD:14764580;LRdb:14764580;connectomeDB2020:14764580], MTNR1A [CellTalkDB:32196115], ITGB2 [CellTalkDB:10845911;Cellinker:10845911;HPRD:10845911;LRdb:10845911;connectomeDB2020:10845911], SDC2 [Baccin2019:10843988;CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], GP1BA [CellTalkDB:9269768;HPRD:9269768;LRdb:9269768;connectomeDB2020:9269768], CD93 [CellTalkDB:12213329;Cellinker:12213329;Cellinker:8710908;HPRD:12213329;HPRD:8710908;LRdb:12213329;LRdb:87], GPR135 [Cellinker:1374385;Cellinker:14530218;HPMR:1374385;LRdb:14;LRdb:14530218;connectomeDB2020:1374385;connectomeDB2020:14530218], CTSG [HPRD:11920276]	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]	cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; blood coagulation [GO:0007596]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; negative regulation of blood coagulation [GO:0030195]; negative regulation of cell adhesion [GO:0007162]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of proteolysis [GO:0045861]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; vasodilation [GO:0042311]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=KNG1&keywords=KNG1	0.03	770	NA	NA	0.00	876	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	823
PROK2	prokineticin 2	Yes		ENSG00000163421	Q9HC23	AVIT (prokineticin) family	13	ligand	ligand, secreted	Q8NFJ6, Q8TCW9	PROKR1, PROKR2	PROKR1 [Baccin2019:12054613;Baccin2019:15772293;CellChatDB:24496457;CellTalkDB:12054613;Cellinker:12054613;Cellinker:15772293;Cellinker:24496457;Guide2Pharma:12054613;Guide2Pharma:15772293;LRdb:12054613;LRdb:16;connectomeDB2020:12054613;connectomeDB2020:15772293;scConnect:12054613;scConnect:15772293], PROKR2 [Baccin2019:12024206;Baccin2019:12054613;Baccin2019:15772293;CellChatDB:24496457;CellTalkDB:15772293;Cellinker:12024206;Cellinker:12054613;Cellinker:15772293;Cellinker:24496457;Guide2Pharma:12054613;Guide2Pharma:15772293;LRdb:12024206;LRdb:12054613;LRdb:15772293;SIGNOR:12024206;connectomeDB2020:12024206;connectomeDB2020:12054613;connectomeDB2020:15772293;scConnect:12054613;scConnect:15772293]	extracellular region [GO:0005576]	G protein-coupled receptor binding [GO:0001664]	angiogenesis [GO:0001525]; chemotaxis [GO:0006935]; circadian rhythm [GO:0007623]; endothelial cell proliferation [GO:0001935]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of smooth muscle contraction [GO:0045987]; sensory perception of pain [GO:0019233]; spermatogenesis [GO:0007283]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PROK2&keywords=PROK2	0.01	809	NA	NA	0.00	864	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	837
PDYN	prodynorphin	Yes		ENSG00000101327	P01213	Opioid neuropeptide precursor family	13	ligand	extracellular, intracellular, ligand, secreted	P08913, P35372, P41143, P41145, P41146, P48039, Q14831	ADRA2A, GRM7, MTNR1A, OPRD1, OPRK1, OPRL1, OPRM1	OPRD1 [Baccin2019:9686407;Cellinker:9686407;Guide2Pharma:9686407;LRdb:9686407;SIGNOR:9686407;connectomeDB2020:9686407;scConnect:9686407], OPRK1 [Baccin2019:1967312;Baccin2019:7624359;Baccin2019:7869844;Baccin2019:8170987;Baccin2019:9262330;Baccin2019:9686407;CellTalkDB:7869844;Cellinker:17503481;Cellinker:1967312;Cellinker:7624359;Cellinker:7869844;Cellinker:8170987;Cellinker:9262330;Cellinker:9686407;Guide2Pharma:1967312;Guide2Pharma:7624359;Guide2Pharma:7869844;Guide2Pharma:9262330;Guide2Pharma:9686407;LRdb:1967312;LRdb:7624359;LRdb:7869844;LRdb:8170987;LRdb:9262330;LRdb:9686407;SIGNOR:9262330;SIGNOR:9686407;connectomeDB2020:1967312;connectomeDB2020:7624359;connectomeDB2020:7869844;connectomeDB2020:8170987;connectomeDB2020:9262330;connectomeDB2020:9686407;scConnect:1967312;scConnect:7624359;scConnect:7869844;scConnect:9262330;scConnect:9686407], OPRM1 [Baccin2019:9686407;Cellinker:9686407;Guide2Pharma:9686407;LRdb:9686407;SIGNOR:9686407;connectomeDB2020:9686407;scConnect:9686407], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], OPRL1 [NA]	axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	opioid peptide activity [GO:0001515]; opioid receptor binding [GO:0031628]	chemical synaptic transmission [GO:0007268]; neuropeptide signaling pathway [GO:0007218]; sensory perception [GO:0007600]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PDYN&keywords=PDYN	0.00	875	NA	NA	0.00	871	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	873
NPFF	neuropeptide FF-amide peptide precursor	Yes		ENSG00000139574	O15130	FARP (FMRFamide related peptide) family	13	ligand	extracellular, intracellular, ligand, secreted	Q9GZQ6, Q9Y5X5	NPFFR1, NPFFR2	NPFFR1 [CellTalkDB:11024015;Cellinker:11024015;Cellinker:12242085;Cellinker:12421602;Cellinker:17011599;Guide2Pharma:12242085;Guide2Pharma:12421602;Guide2Pharma:17011599;HPRD:11024015;LRdb:11024015;LRdb:12242085;LRdb:12421602;LRdb:17011599;SIGNOR:11024015;connectomeDB2020:11024015;connectomeDB2020:12242085;connectomeDB2020:12421602;connectomeDB2020:17011599;scConnect:12242085;scConnect:12421602;scConnect:17011599], NPFFR2 [Baccin2019:10851242;Baccin2019:11024015;Baccin2019:11325787;Baccin2019:12421602;Baccin2019:12609745;CellTalkDB:11024015;Cellinker:10851242;Cellinker:11024015;Cellinker:11325787;Cellinker:12421602;Cellinker:12609745;Guide2Pharma:11325787;Guide2Pharma:12421602;HPMR:11024015;HPRD:10851242;HPRD:12609745;LRdb:10851242;LRdb:11024015;LRdb:11325787;LRdb:12421602;LRdb:12609745;SIGNOR:11024015;connectomeDB2020:10851242;connectomeDB2020:11024015;connectomeDB2020:11325787;connectomeDB2020:12421602;connectomeDB2020:12609745;scConnect:11325787;scConnect:12421602]	axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perikaryon [GO:0043204]; postsynapse [GO:0098794]	G protein-coupled receptor binding [GO:0001664]; neuropeptide hormone activity [GO:0005184]; signaling receptor binding [GO:0005102]	chemical synaptic transmission [GO:0007268]; excitatory postsynaptic potential [GO:0060079]; neuropeptide signaling pathway [GO:0007218]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPFF&keywords=NPFF	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	#DIV/0!
RLN2	relaxin 2	Yes		ENSG00000107014	P04090	Insulin family	12	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, P07550, P13945, P16473, P32241, P41586, Q03431, Q8WXD0, Q99678, Q9HBX9, Q9NQS5, Q9NSD7	ADCYAP1R1, ADRB2, ADRB3, GPR20, GPR84, PTH1R, RAMP2, RAMP3, RXFP1, RXFP2, RXFP3, TSHR, VIPR1	RXFP1 [CellTalkDB:11809971;Cellinker:11809971;Cellinker:12506116;Cellinker:15649866;Cellinker:22973049;Guide2Pharma:12506116;Guide2Pharma:15649866;Guide2Pharma:18434306;HPMR:11809971;HPRD:12506116;HPRD:15649866;LRdb:11809971;LRdb:12506116;LRdb:15649866;SIGNOR:11809971;connectomeDB2020:11809971;connectomeDB2020:12506116;connectomeDB2020:15649866;scConnect:12506116;scConnect:15649866;scConnect:18434306], RXFP2 [CellTalkDB:11809971;Cellinker:11809971;Cellinker:12506116;Cellinker:15649866;Cellinker:22973049;Guide2Pharma:15649866;Guide2Pharma:18434306;HPRD:12506116;HPRD:15649866;LRdb:11809971;LRdb:12506116;LRdb:15649866;SIGNOR:11809971;connectomeDB2020:11809971;connectomeDB2020:12506116;connectomeDB2020:15649866;scConnect:15649866;scConnect:18434306], ADCYAP1R1 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], RXFP3 [CellTalkDB:32103204;connectomeDB2020:24641548;scConnect:20159943;scConnect:24641548], ADRB3 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115]	extracellular region [GO:0005576]	hormone activity [GO:0005179]	female pregnancy [GO:0007565]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; regulation of catalytic activity [GO:0050790]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RLN2&keywords=RLN2	3.04	338	NA	NA	9.52	46	0.00	0.01	0.00	0.00	0.01	0.06	0.05	0.04	0.04	0.04	0.03	188	151	192	0.03	1.37	1.54	1.01	64	50	97	146
ANXA1	annexin A1	Yes	autocrine/paracrine https://www.pnas.org/doi/full/10.1073/pnas.1209362110	ENSG00000135046	P04083	Annexin family	12	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, receptor, secreted	O75923, P00533, P08913, P12931, P21462, P25089, P25090, P48039, Q14831	ADRA2A, DYSF, EGFR, FPR1, FPR2, FPR2_FPR3, FPR3, GRM7, MTNR1A, SRC	FPR2 [Baccin2019:10882119;Baccin2019:12368905;Baccin2019:12560218;Baccin2019:16278303;CellChatDB:23230437;CellPhoneDB:22610094;CellTalkDB:22610094;Cellinker:10882119;Cellinker:12368905;Cellinker:12560218;Cellinker:16278303;Cellinker:22610094;Cellinker:23230437;Guide2Pharma:12368905;LRdb:10882119;LRdb:12368905;LRdb:12560218;LRdb:16278303;SIGNOR:15187149;connectomeDB2020:10882119;connectomeDB2020:12368905;connectomeDB2020:12560218;connectomeDB2020:16278303;scConnect:10882119;scConnect:12368905;scConnect:12560218;scConnect:16278303], FPR3 [CellTalkDB:15187149;Cellinker:15187149;Guide2Pharma:15187149;LRdb:15187149;SIGNOR:15187149;connectomeDB2020:15187149;scConnect:15187149], SRC [HPRD:2457390;SIGNOR:24103589], EGFR [CellTalkDB:15581623;Cellinker:15581623;HPRD:15581623;IntAct:15581623;IntAct:20029029;IntAct:31980649;LRdb:15581623;Lit-BM-17:15581623;Lit-BM-17:20029029;Lit-BM-17:24189400;connectomeDB2020:15581623], FPR1 [Baccin2019:10882119;Baccin2019:12560218;CellChatDB:23230437;CellTalkDB:10882119;Cellinker:10882119;Cellinker:12560218;Cellinker:23230437;HPMR:10882119;HPRD:10882119;LRdb:10882119;LRdb:13;SIGNOR:15187149;connectomeDB2020:10882119;connectomeDB2020:12560218;scConnect:10882119;scConnect:12560218], DYSF [Baccin2019:14506282;Cellinker:14506282;HPRD:14506282;LRdb:14506282;connectomeDB2020:14506282], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115]	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of external side of plasma membrane [GO:0031232]; extrinsic component of membrane [GO:0019898]; focal adhesion [GO:0005925]; lateral plasma membrane [GO:0016328]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; vesicle [GO:0031982]	cadherin binding involved in cell-cell adhesion [GO:0098641]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; phospholipase A2 inhibitor activity [GO:0019834]; phospholipid binding [GO:0005543]; signaling receptor binding [GO:0005102]	actin cytoskeleton reorganization [GO:0031532]; adaptive immune response [GO:0002250]; alpha-beta T cell differentiation [GO:0046632]; arachidonic acid secretion [GO:0050482]; cell surface receptor signaling pathway [GO:0007166]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; DNA duplex unwinding [GO:0032508]; endocrine pancreas development [GO:0031018]; gliogenesis [GO:0042063]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; granulocyte chemotaxis [GO:0071621]; hepatocyte differentiation [GO:0070365]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; insulin secretion [GO:0030073]; keratinocyte differentiation [GO:0030216]; monocyte chemotaxis [GO:0002548]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of exocytosis [GO:0045920]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of phospholipase A2 activity [GO:1900138]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; neutrophil activation [GO:0042119]; neutrophil clearance [GO:0097350]; neutrophil homeostasis [GO:0001780]; peptide cross-linking [GO:0018149]; phagocytosis [GO:0006909]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; positive regulation of vesicle fusion [GO:0031340]; positive regulation of wound healing [GO:0090303]; prolactin secretion [GO:0070459]; prostate gland development [GO:0030850]; regulation of cell shape [GO:0008360]; regulation of hormone secretion [GO:0046883]; regulation of inflammatory response [GO:0050727]; regulation of interleukin-1 production [GO:0032652]; regulation of leukocyte migration [GO:0002685]; response to estradiol [GO:0032355]; response to interleukin-1 [GO:0070555]; response to peptide hormone [GO:0043434]; response to X-ray [GO:0010165]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ANXA1&keywords=ANXA1	96.09	51	31130.4	32	0.56	363	3.46	0.27	0.21	3.73	0.10	0.00	0.01	0.01	0.01	0.01	0.01	281	279	260	0.71	0.02	0.02	0.02	523	518	521	249
SEMA3E	semaphorin 3E	Yes		ENSG00000170381	O15041	Semaphorin family	12	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted, transmembrane	O14786, O60462, Q9Y4D7	NRP1, NRP2, PLXND1	PLXND1 [Baccin2019:15550623;CellChatDB:22325954;CellPhoneDB:22325954;CellTalkDB:22325954;Cellinker:15550623;Cellinker:19887479;Cellinker:22325954;Cellinker:26633812;HPMR:15550623;LRdb:15550623;Lit-BM-17:17318185;connectomeDB2020:15550623], NRP1 [Baccin2019:27439112;CellTalkDB:20664165;Cellinker:20664165], NRP2 [Cellinker:20664165]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]	chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]	axon guidance [GO:0007411]; branching involved in blood vessel morphogenesis [GO:0001569]; negative chemotaxis [GO:0050919]; negative regulation of angiogenesis [GO:0016525]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell-matrix adhesion [GO:0001953]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; sprouting angiogenesis [GO:0002040]; synapse organization [GO:0050808]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SEMA3E&keywords=SEMA3E	5.74	283	NA	NA	5.74	67	0.00	0.02	0.00	0.01	0.01	0.17	0.21	0.42	0.21	0.01	0.28	76	269	57	0.12	1.65	0.12	2.17	48	458	12	269
CCN2	cellular communication network factor 2	Yes		ENSG00000118523	P29279	CCN family	12	ecm, ligand	ecm, extracellular, intracellular, ligand, ligand_regulator, secreted	O75581, P00533, P01137, P02751, P04629, P05107, P08648, P10600, P11215, P11717, P21802, P61812, Q07954, Q15303	EGFR, ERBB4, FGFR2, FN1, IGF2R, ITGA2B_ITGB3, ITGA5, ITGA5_ITGB1, ITGAM, ITGAV_ITGB3, ITGB2, LRP1, LRP6, NTRK1, TGFB1, TGFB2, TGFB3	LRP6 [Baccin2019:15105373;CellTalkDB:15105373;Cellinker:15105373;LRdb:15105373;SIGNOR:18528331;connectomeDB2020:15105373], ITGAM [CellTalkDB:12736251;Cellinker:12736251;LRdb:12736251;connectomeDB2020:12736251], NTRK1 [CellTalkDB:15601748;Cellinker:15601748;LRdb:15601748;Ramilowski2015:15601748;connectomeDB2020:15601748;talklr:15601748], ITGB2 [CellTalkDB:12736251;Cellinker:12736251;LRdb:12736251;connectomeDB2020:12736251], LRP1 [Baccin2019:14585398;CellTalkDB:14585398;Cellinker:14585398;HPRD:14585398;LRdb:14585398;connectomeDB2020:14585398], EGFR [CellTalkDB:23929714], ITGA5 [LRdb:18167060;Ramilowski2015:18167060;connectomeDB2020:18167060;talklr:18167060], ERBB4 [Baccin2019:12297288;Cellinker:12297288;HPRD:12297288;LRdb:12297288], FGFR2 [Baccin2019:23142580;connectomeDB2020:23142580], IGF2R [Baccin2019:22511630;connectomeDB2020:22511630], FN1 [IntAct:16457822;Lit-BM-17:16457822], TGFB1 [HPRD:10457363], TGFB2 [HPRD:10457363], TGFB3 [HPRD:10457363]	cell cortex [GO:0005938]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	fibronectin binding [GO:0001968]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]; protein C-terminus binding [GO:0008022]	aging [GO:0007568]; angiogenesis [GO:0001525]; cartilage condensation [GO:0001502]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; chondrocyte proliferation [GO:0035988]; cytosolic calcium ion transport [GO:0060401]; DNA biosynthetic process [GO:0071897]; epidermis development [GO:0008544]; extracellular matrix constituent secretion [GO:0070278]; fibroblast growth factor receptor signaling pathway [GO:0008543]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; lung development [GO:0030324]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; ossification [GO:0001503]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cell activation [GO:0050867]; positive regulation of cell death [GO:0010942]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; reactive oxygen species metabolic process [GO:0072593]; regulation of chondrocyte differentiation [GO:0032330]; response to amino acid [GO:0043200]; response to anoxia [GO:0034059]; response to estradiol [GO:0032355]; response to fatty acid [GO:0070542]; response to glucose [GO:0009749]; response to mineralocorticoid [GO:0051385]; response to peptide hormone [GO:0043434]; response to wounding [GO:0009611]; signal transduction [GO:0007165]; tissue homeostasis [GO:0001894]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCN2&keywords=CCN2	52.49	81	NA	NA	0.22	521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	301
INHBE	inhibin subunit beta E	Yes		ENSG00000139269	P58166	TGF-beta family	12	ligand	extracellular, intracellular, ligand, ligand_regulator, secreted	P17813, P27037, P36896, Q04771, Q13705	ACVR1, ACVR1B, ACVR1B_ACVR2A, ACVR1B_ACVR2B, ACVR1C_ACVR2A, ACVR1C_ACVR2B, ACVR2A, ACVR2B, ENG	ACVR2B [CellPhoneDB:22710174;CellTalkDB:22710174;Cellinker:22710174;LRdb:22710174], ACVR2A [CellPhoneDB:22710174;CellTalkDB:22710174;Cellinker:22710174], ACVR1 [NA], ACVR1B [NA], ENG [NA]	collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]	positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=INHBE&keywords=INHBE	0.55	514	NA	NA	0.33	450	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	303	386	387	0.00	0.96	1.01	1.00	151	126	100	369
KISS1	KiSS-1 metastasis suppressor	Yes		ENSG00000170498	Q15726	KISS1 family	12	ligand	extracellular, intracellular, ligand, secreted	Q969F8, Q9Y5R2	KISS1R, MMP24	KISS1R [Baccin2019:11385580;Baccin2019:11457843;Baccin2019:12944565;Baccin2019:15665093;CellTalkDB:12944565;Cellinker:11385580;Cellinker:11457843;Cellinker:12944565;Cellinker:15665093;Guide2Pharma:11385580;Guide2Pharma:11457843;HPMR:12944565;HPRD:11457843;LRdb:11385580;LRdb:11457843;LRdb:12944565;LRdb:15665093;SIGNOR:11385580;connectomeDB2020:11385580;connectomeDB2020:11457843;connectomeDB2020:12944565;connectomeDB2020:15665093;scConnect:11385580;scConnect:11457843], MMP24 [Baccin2019:12879005;CellTalkDB:12879005;HPRD:12879005;LRdb:12879005;connectomeDB2020:12879005]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]	kisspeptin receptor binding [GO:0031773]	cytoskeleton organization [GO:0007010]; generation of ovulation cycle rhythm [GO:0060112]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of synaptic transmission [GO:0050806]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=KISS1&keywords=KISS1	0.13	649	NA	NA	0.27	483	0.01	0.01	0.00	0.00	0.01	0.01	0.02	0.01	0.01	0.01	0.01	254	276	225	0.01	1.15	0.82	1.25	101	204	56	403
NPS	neuropeptide S	Yes		ENSG00000214285	P0C0P6	NA	12	ligand	extracellular, ligand, secreted	O60895, O60896, P07550, P13945, P16473, P32241, P41586, Q03431, Q6W5P4, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, GPR20, GPR84, NPSR1, PTH1R, RAMP2, RAMP3, TSHR, VIPR1	NPSR1 [Baccin2019:1531264815312640;CellChatDB:19732772;CellTalkDB:15312648;Cellinker:15312648;Cellinker:19732772;Guide2Pharma:15312648;HPMR:15312648;LRdb:15312648;connectomeDB2020:15312648;scConnect:15312648], ADCYAP1R1 [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115]	extracellular region [GO:0005576]	NA	neuropeptide signaling pathway [GO:0007218]; positive regulation of action potential [GO:0045760]; positive regulation of circadian sleep/wake cycle, wakefulness [GO:0010841]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; visual learning [GO:0008542]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPS&keywords=NPS	0.04	756	NA	NA	4.81	75	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	416
TAC3	tachykinin precursor 3	Yes		ENSG00000166863	Q9UHF0	Tachykinin family	12	ligand	extracellular, intracellular, ligand, secreted	P21452, P25103, P29371	TACR1, TACR2, TACR3	TACR1 [CellTalkDB:8925404;Cellinker:12727971;Cellinker:8925404;Cellinker:9190866;Guide2Pharma:9190866;HPRD:12727971;LRdb:12727971;LRdb:8925404;LRdb:9190866;connectomeDB2020:12727971;connectomeDB2020:8925404;connectomeDB2020:9190866], TACR2 [Baccin2019:10189055;Baccin2019:7682062;Baccin2019:7961636;Baccin2019:8925404;Baccin2019:9190866;Cellinker:10189055;Cellinker:7682062;Cellinker:7961636;Cellinker:8925404;Cellinker:9190866;Guide2Pharma:7682062;Guide2Pharma:9190866;HPRD:10189055;HPRD:7961636;LRdb:10189055;LRdb:7682062;LRdb:7961636;LRdb:8925404;LRdb:9190866;connectomeDB2020:10189055;connectomeDB2020:7682062;connectomeDB2020:7961636;connectomeDB2020:8925404;connectomeDB2020:9190866], TACR3 [Baccin2019:10189055;Baccin2019:10866201;Baccin2019:11226387;Baccin2019:1312036;Baccin2019:2176308;Baccin2019:7557266;Baccin2019:8990205;Baccin2019:9190866;CellTalkDB:11226387;Cellinker:10189055;Cellinker:10866201;Cellinker:11226387;Cellinker:1312036;Cellinker:2176308;Cellinker:7557266;Cellinker:8990205;Cellinker:9190866;Guide2Pharma:11226387;Guide2Pharma:1312036;Guide2Pharma:2176308;Guide2Pharma:9190866;HPRD:10189055;HPRD:10866201;HPRD:8990205;LRdb:10189055;LRdb:10866201;LRdb:11226387;LRdb:1312036;LRdb:2176308;LRdb:7557266;LRdb:8990205;LRdb:9190866;connectomeDB2020:10189055;connectomeDB2020:10866201;connectomeDB2020:11226387;connectomeDB2020:1312036;connectomeDB2020:2176308;connectomeDB2020:7557266;connectomeDB2020:8990205;connectomeDB2020:9190866]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	neuromedin K receptor binding [GO:0031836]; signaling receptor binding [GO:0005102]; substance K receptor binding [GO:0031837]	female pregnancy [GO:0007565]; neuropeptide signaling pathway [GO:0007218]; positive regulation of blood pressure [GO:0045777]; positive regulation of flagellated sperm motility [GO:1902093]; tachykinin receptor signaling pathway [GO:0007217]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TAC3&keywords=TAC3	0.39	546	NA	NA	0.17	561	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	303	403	400	0.00	0.92	0.93	0.92	176	155	135	416
DKK1	dickkopf WNT signaling pathway inhibitor 1	Yes	soluble WNT regulators	ENSG00000107984	O94907	Dickkopf family	12	ligand	extracellular, intracellular, ligand, ligand_regulator, secreted	O75096, O75197, O75581, P56704, Q8NCW0, Q96MU8	KREMEN1, KREMEN2, LRP4, LRP5, LRP6, WNT3A	LRP6 [Baccin2019:11357136;Baccin2019:11448771;CancerCellMap:11448771;CellTalkDB:11516963;Cellinker:11357136;Cellinker:11448771;Cellinker:12527209;Cellinker:29925589;DIP:21944579;DIP:21984209;ELM:21944579;HPRD:11357136;HPRD:11448771;IntAct:11448771;IntAct:21944579;IntAct:21984209;LMPID:21944579;LRdb:11;LRdb:11357136;NetPath:11448771;NetPath:19339249;SIGNOR:11448771;SPIKE:11516963;SignaLink3:11357136;SignaLink3:11448771;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:11357136;connectomeDB2020:11448771], LRP5 [AlzPathway:16307379;AlzPathway:18786602;AlzPathway:19101658;Baccin2019:11516963;CancerCellMap:11448771;Cellinker:11516963;HPRD:11516963;LRdb:11516963;NetPath:11448771;SPIKE:11516963;connectomeDB2020:11448771], KREMEN2 [AlzPathway:16307379;AlzPathway:18786602;AlzPathway:19101658;Baccin2019:12050670;CellTalkDB:12050670;Cellinker:12050670;Cellinker:12527209;HPMR:12050670;LRdb:12050670;SIGNOR:12050670;SignaLink3:12050670;SignaLink3:23331499;connectomeDB2020:12050670], KREMEN1 [Baccin2019:12050670;CellTalkDB:12050670;Cellinker:12050670;Cellinker:12527209;HPMR:12050670;HPRD:12050670;LRdb:12050670;SIGNOR:12050670;SignaLink3:12050670;SignaLink3:23331499;connectomeDB2020:12050670], LRP4 [connectomeDB2020:19936252], WNT3A [ACSN:11448771;ACSN:17804805;ACSN:22807036;NetPath:19339249]	early endosome membrane [GO:0031901]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	co-receptor binding [GO:0039706]; growth factor activity [GO:0008083]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]	cell morphogenesis involved in differentiation [GO:0000904]; embryonic limb morphogenesis [GO:0030326]; endoderm formation [GO:0001706]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; hair follicle development [GO:0001942]; learning or memory [GO:0007611]; limb development [GO:0060173]; mesoderm formation [GO:0001707]; modulation of age-related behavioral decline [GO:0090647]; motor learning [GO:0061743]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment [GO:1901296]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of mesodermal cell fate specification [GO:0042662]; negative regulation of neuron projection development [GO:0010977]; negative regulation of ossification [GO:0030279]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of presynapse assembly [GO:1905607]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt-Frizzled-LRP5/6 complex assembly [GO:1904723]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of cell death [GO:0010942]; positive regulation of gene expression [GO:0010628]; positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway [GO:0090082]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of midbrain dopaminergic neuron differentiation [GO:1904958]; positive regulation of neuron death [GO:1901216]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of Wnt signaling pathway, calcium modulating pathway [GO:0045813]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of dopaminergic neuron differentiation [GO:1904338]; regulation of endodermal cell fate specification [GO:0042663]; regulation of receptor internalization [GO:0002090]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to retinoic acid [GO:0032526]; synapse pruning [GO:0098883]; Wnt signaling pathway involved in somitogenesis [GO:0090244]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DKK1&keywords=DKK1	2.25	378	NA	NA	0.12	597	0.00	0.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	303	408	394	0.01	0.52	0.52	0.53	333	309	312	423
PNOC	prepronociceptin	Yes		ENSG00000168081	Q13519	Opioid neuropeptide precursor family	12	ligand	extracellular, intracellular, ligand, secreted	P08913, P41146, P48039, Q14831	ADRA2A, GRM7, MTNR1A, OPRL1	OPRL1 [Baccin2019:10369464;Baccin2019:10692489;Baccin2019:11097863;Baccin2019:12070757;Baccin2019:12967935;Baccin2019:22827708;Baccin2019:7481766;Baccin2019:8849681;BioGRID:10692489;BioGRID:11097863;CellTalkDB:12967935;Cellinker:10369464;Cellinker:10692489;Cellinker:11097863;Cellinker:12070757;Cellinker:12967935;Cellinker:22827708;Cellinker:7481766;Cellinker:8849681;Guide2Pharma:10369464;Guide2Pharma:12070757;Guide2Pharma:9413015;HPMR:7481766;HPRD:10692489;HPRD:11097863;LRdb:10369464;LRdb:10692489;LRdb:11097863;LRdb:12070757;LRdb:12967935;LRdb:22827708;LRdb:7481766;LRdb:8849681;Lit-BM-17:10692489;Lit-BM-17:11097863;Lit-BM-17:23597562;connectomeDB2020:10369464;connectomeDB2020:10692489;connectomeDB2020:11097863;connectomeDB2020:12070757;connectomeDB2020:12967935;connectomeDB2020:22827708;connectomeDB2020:7481766;connectomeDB2020:8849681;scConnect:10369464;scConnect:12070757;scConnect:9353393;scConnect:9413015], GRM7 [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115]	axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	neuropeptide hormone activity [GO:0005184]; opioid peptide activity [GO:0001515]; opioid receptor binding [GO:0031628]	chemical synaptic transmission [GO:0007268]; female pregnancy [GO:0007565]; neuropeptide signaling pathway [GO:0007218]; sensory perception [GO:0007600]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PNOC&keywords=PNOC	0.25	591	NA	NA	0.15	574	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	303	401	354	0.00	0.97	0.99	1.09	140	135	77	425
GUCA2B	guanylate cyclase activator 2B	Yes	Prepro-Uroguanylin	ENSG00000044012	Q16661	Guanylin family	12	ligand	intracellular, ligand, secreted	P25092, Q02846	GUCY2C, GUCY2D	GUCY2C [Baccin2019:10845107;CellChatDB:22384056;CellTalkDB:10845107;Cellinker:10845107;Cellinker:22384056;LRdb:10845107;SIGNOR:10845107;connectomeDB2020:10845107], GUCY2D [Baccin2019:9698373;CellTalkDB:9698373;Cellinker:9698373;HPRD:9698373;LRdb:9698373;connectomeDB2020:9698373]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]	calcium sensitive guanylate cyclase activator activity [GO:0008048]; guanylate cyclase activator activity [GO:0030250]	cGMP-mediated signaling [GO:0019934]; excretion [GO:0007588]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GUCA2B&keywords=GUCA2B	0.27	588	NA	NA	0.24	506	0.00	0.01	0.00	0.00	0.04	0.00	0.00	0.00	0.00	0.00	0.00	300	403	370	0.00	0.76	0.70	0.75	237	252	212	437
IL17C	interleukin 17C	Yes		ENSG00000124391	Q9P0M4	IL-17 family	12	ligand	ligand, secreted	Q8NFR9, Q96F46	IL17RA, IL17RA_IL17RE, IL17RE	IL17RE [CellTalkDB:21993849;connectomeDB2020:21993848], IL17RA [connectomeDB2020:21993848]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]	cell-cell signaling [GO:0007267]; cell surface receptor signaling pathway [GO:0007166]; inflammatory response [GO:0006954]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL17C&keywords=IL17C	0.06	728	NA	NA	0.46	400	0.00	0.00	0.00	0.00	0.05	0.00	0.00	0.00	0.00	0.00	0.00	302	409	401	0.00	0.70	0.67	0.67	264	263	247	450
WNT16	Wnt family member 16	Yes		ENSG00000002745	Q9UBV4	Wnt family	12	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted, transmembrane	O60353, O75197, O75581, Q14332, Q9NPG1	FZD1_LRP5, FZD1_LRP6, FZD10_LRP5, FZD10_LRP6, FZD2, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4_LRP5, FZD4_LRP6, FZD5_LRP5, FZD5_LRP6, FZD6, FZD6_LRP5, FZD6_LRP6, FZD7_LRP5, FZD7_LRP6, FZD8_LRP5, FZD8_LRP6, FZD9_LRP5, FZD9_LRP6, LRP5, LRP6	LRP6 [SIGNOR:15578921], FZD3 [SIGNOR:15578921], FZD6 [CellTalkDB:32196115], FZD2 [connectomeDB2020:26861315], LRP5 [connectomeDB2020:26861315]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]	bone remodeling [GO:0046849]; canonical Wnt signaling pathway [GO:0060070]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell fate commitment [GO:0045165]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; negative regulation of cell death [GO:0060548]; neuron differentiation [GO:0030182]; optic cup formation involved in camera-type eye development [GO:0003408]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; replicative senescence [GO:0090399]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT16&keywords=WNT16	0.37	553	NA	NA	0.56	364	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	459
MLN	motilin	Yes		ENSG00000096395	P12872	Motilin family	12	ligand	extracellular, ligand, secreted	O43193	MLNR	MLNR [CellTalkDB:10381885;Cellinker:10381885;Cellinker:11259768;Cellinker:11461914;Cellinker:11781320;Cellinker:12054506;Cellinker:15677347;Cellinker:16531413;Guide2Pharma:11461914;Guide2Pharma:11781320;Guide2Pharma:15677347;Guide2Pharma:16531413;HPMR:10381885;HPRD:10381885;HPRD:11259768;HPRD:11461914;HPRD:12054506;LRdb:10381885;LRdb:11259768;LRdb:11461914;LRdb:11781320;LRdb:12054506;LRdb:15677347;LRdb:16531413;SIGNOR:10381885;connectomeDB2020:10381885;connectomeDB2020:11259768;connectomeDB2020:11461914;connectomeDB2020:11781320;connectomeDB2020:12054506;connectomeDB2020:15677347;connectomeDB2020:16531413;scConnect:11461914;scConnect:11781320;scConnect:15677347;scConnect:16531413]	extracellular region [GO:0005576]	hormone activity [GO:0005179]; motilin receptor binding [GO:0031788]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MLN&keywords=MLN	0.04	758	NA	NA	1.33	221	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	490
PTH	parathyroid hormone	Yes		ENSG00000152266	P01270	Parathyroid hormone family	12	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, O75581, P07550, P13945, P16473, P32241, P41586, P49190, Q03431, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, GPR20, GPR84, LRP6, PTH1R, PTH2R, RAMP2, RAMP3, TSHR, VIPR1	PTH2R [CellTalkDB:7797535;Cellinker:7797535;Cellinker:9482662;HPMR:7797535;HPRD:9482662;LRdb:7797535;LRdb:948;SIGNOR:11861531;connectomeDB2020:7797535;connectomeDB2020:9482662], PTH1R [CellTalkDB:12947048;Cellinker:12947048;Cellinker:9108031;HPRD:9108031;IntAct:19674967;LRdb:12947048;LRdb:91;ProtMapper:29444827;SIGNOR:18981475;connectomeDB2020:12947048;connectomeDB2020:9108031], ADCYAP1R1 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], LRP6 [CellTalkDB:22589223;ProtMapper:19884009]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	hormone activity [GO:0005179]; parathyroid hormone receptor binding [GO:0031856]; peptide hormone receptor binding [GO:0051428]; protein N-terminus binding [GO:0047485]; receptor ligand activity [GO:0048018]; type 1 parathyroid hormone receptor binding [GO:0031857]	activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; bone resorption [GO:0045453]; cAMP metabolic process [GO:0046058]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular macromolecule biosynthetic process [GO:0034645]; G protein-coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hormone-mediated apoptotic signaling pathway [GO:0008628]; magnesium ion homeostasis [GO:0010960]; negative regulation of apoptotic process in bone marrow cell [GO:0071866]; negative regulation of bone mineralization involved in bone maturation [GO:1900158]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of gene expression [GO:0010629]; phosphate ion homeostasis [GO:0055062]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of osteoclast proliferation [GO:0090290]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to cadmium ion [GO:0046686]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to lead ion [GO:0010288]; response to parathyroid hormone [GO:0071107]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PTH&keywords=PTH	0.01	843	NA	NA	1.23	235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	539
EPGN	epithelial mitogen	Yes	member of the epidermal growth factor family	ENSG00000182585	Q6UW88	NA	12	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	P00533, Q15303	EGFR, ERBB4	EGFR [CellChatDB:27298358;CellTalkDB:28988771;Cellinker:27298358;IntAct:28988771;SIGNOR:20513444;connectomeDB2020:28988771], ERBB4 [SIGNOR:16469638;SIGNOR:16829981]	clathrin-coated endocytic vesicle membrane [GO:0030669]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]	epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]	angiogenesis [GO:0001525]; epidermal growth factor receptor signaling pathway [GO:0007173]; MAPK cascade [GO:0000165]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitotic nuclear division [GO:0045840]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EPGN&keywords=EPGN	0.17	629	NA	NA	0.31	460	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	545
NMS	neuromedin S	Yes		ENSG00000204640	Q5H8A3	NmU family	12	ligand	ligand, secreted	P08913, P48039, Q14831, Q9GZQ4, Q9HB89	ADRA2A, GRM7, MTNR1A, NMUR1, NMUR2	NMUR1 [CellChatDB:29288685;CellTalkDB:15635449;Cellinker:15635449;Cellinker:29288685;Guide2Pharma:15635449;HPRD:15635449;LRdb:15635449;SIGNOR:15635449;connectomeDB2020:15635449;scConnect:15635449], NMUR2 [Baccin2019:1563544915635440;CellChatDB:29288685;CellTalkDB:15635449;Cellinker:15635449;Cellinker:29288685;Guide2Pharma:15635449;LRdb:15635449;SIGNOR:15635449;connectomeDB2020:15635449;scConnect:15635449], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115]	extracellular region [GO:0005576]	G protein-coupled receptor binding [GO:0001664]	locomotor rhythm [GO:0045475]; neuropeptide signaling pathway [GO:0007218]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NMS&keywords=NMS	0.00	899	NA	NA	0.76	310	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	605
GDF10	growth differentiation factor 10	Yes		ENSG00000266524	P55107	TGF-beta family	12	ligand	extracellular, ligand, secreted	O00238, P27037, P36894, P36896, P36897, Q13705, Q13873, Q8NER5	ACVR1B, ACVR1B_ACVR2A, ACVR1B_ACVR2B, ACVR1C, ACVR2A, ACVR2B, BMPR1A, BMPR1B, BMPR2, TGFBR1	BMPR1B [NA], ACVR2A [NA], BMPR1A [NA], ACVR1B [CellTalkDB:22155034], TGFBR1 [NA], ACVR2B [Cellinker:27252362], BMPR2 [Cellinker:27252362], ACVR1C [NA]	collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]	cerebellum development [GO:0021549]; fat cell differentiation [GO:0045444]; negative regulation of osteoblast differentiation [GO:0045668]; osteoblast differentiation [GO:0001649]; ovulation cycle [GO:0042698]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of ossification [GO:0030278]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GDF10&keywords=GDF10	0.09	683	NA	NA	0.02	809	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	746
NMU	neuromedin U	Yes		ENSG00000109255	P48645	NmU family	12	ligand	extracellular, ligand, secreted	P08913, P48039, Q14831, Q9GZQ4, Q9HB89	ADRA2A, GRM7, MTNR1A, NMUR1, NMUR2	NMUR1 [Baccin2019:10811630;Baccin2019:10894543;Baccin2019:10899166;Baccin2019:15292653;Baccin2019:15331768;CellTalkDB:10894543;Cellinker:10811630;Cellinker:10894543;Cellinker:10899166;Cellinker:15292653;Cellinker:15331768;Guide2Pharma:10894543;Guide2Pharma:10899166;Guide2Pharma:15292653;Guide2Pharma:15331768;HPMR:10894543;HPRD:10811630;LRdb:10811630;LRdb:10894543;LRdb:10899166;LRdb:15292653;LRdb:15331768;connectomeDB2020:10811630;connectomeDB2020:10894543;connectomeDB2020:10899166;connectomeDB2020:15292653;connectomeDB2020:15331768;scConnect:10894543;scConnect:10899166;scConnect:15292653;scConnect:15331768], NMUR2 [Baccin2019:10887190;Baccin2019:10894543;Baccin2019:10899166;Baccin2019:15292653;Baccin2019:15331768;BioGRID:10887190;CellTalkDB:10894543;Cellinker:10887190;Cellinker:10894543;Cellinker:10899166;Cellinker:15292653;Cellinker:15331768;Guide2Pharma:10894543;Guide2Pharma:10899166;Guide2Pharma:15292653;Guide2Pharma:15331768;HPMR:10894543;HPRD:10887190;HPRD:10894543;HPRD:10899166;LRdb:10887190;LRdb:10894543;LRdb:10899166;LRdb:15292653;LRdb:15331768;connectomeDB2020:10887190;connectomeDB2020:10894543;connectomeDB2020:10899166;connectomeDB2020:15292653;connectomeDB2020:15331768;scConnect:10894543;scConnect:10899166;scConnect:15292653;scConnect:15331768], ADRA2A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115]	extracellular region [GO:0005576]; terminal bouton [GO:0043195]	neuromedin U receptor binding [GO:0042922]; signaling receptor binding [GO:0005102]; type 1 neuromedin U receptor binding [GO:0031839]; type 2 neuromedin U receptor binding [GO:0031840]	energy homeostasis [GO:0097009]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic transmission [GO:0050806]; regulation of feeding behavior [GO:0060259]; regulation of grooming behavior [GO:2000821]; temperature homeostasis [GO:0001659]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NMU&keywords=NMU	0.06	707	NA	NA	0.02	804	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	756
PTH2	parathyroid hormone 2	Yes		ENSG00000142538	Q96A98	Parathyroid hormone family	12	ligand	extracellular, ligand, secreted	O60895, O60896, P07550, P13945, P16473, P32241, P41586, P49190, Q03431, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, GPR20, GPR84, PTH1R, PTH2R, RAMP2, RAMP3, TSHR, VIPR1	PTH1R [Baccin2019:10854439;Baccin2019:11159842;CellTalkDB:11159842;Cellinker:10854439;Cellinker:11159842;Guide2Pharma:10854439;Guide2Pharma:11159842;LRdb:11;LRdb:11159842;connectomeDB2020:10854439;connectomeDB2020:11159842;scConnect:10854439;scConnect:11159842], PTH2R [Baccin2019:10854439;Baccin2019:11602681;Baccin2019:11861531;CellTalkDB:11861531;Cellinker:10854439;Cellinker:11602681;Cellinker:11861531;HPRD:10854439;LRdb:10854439;LRdb:11602681;LRdb:11861531;SIGNOR:11861531;connectomeDB2020:10854439;connectomeDB2020:11602681;connectomeDB2020:11861531;scConnect:10854439;scConnect:11602681], ADCYAP1R1 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], RAMP3 [CellTalkDB:12446722], RAMP2 [CellTalkDB:32196115]	extracellular region [GO:0005576]	NA	neuropeptide signaling pathway [GO:0007218]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PTH2&keywords=PTH2	0.00	899	NA	NA	0.09	648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	774
LEFTY2	left-right determination factor 2	Yes		ENSG00000143768	O00292	TGF-beta family	12	ligand	extracellular, intracellular, ligand, ligand_regulator, secreted	P27037, P36896, Q13705	ACVR1B, ACVR2A, ACVR2B	ACVR1B [CellTalkDB:32196115], ACVR2A [CellTalkDB:32196115;Cellinker:11952836], ACVR2B [Baccin2019:11952836;CellTalkDB:11952836;Cellinker:11952836;LRdb:11952836;connectomeDB2020:11952836]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; transforming growth factor beta receptor binding [GO:0005160]	BMP signaling pathway [GO:0030509]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LEFTY2&keywords=LEFTY2	0.02	788	NA	NA	0.01	850	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	819
LHB	luteinizing hormone subunit beta	Yes		ENSG00000104826	P01229	Glycoprotein hormones subunit beta family	12	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, P07550, P13945, P16473, P22888, P32241, P41586, Q03431, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, GPR20, GPR84, LHCGR, PTH1R, RAMP2, RAMP3, TSHR, VIPR1	LHCGR [CellTalkDB:1922095;Cellinker:12727981;Cellinker:1922095;Cellinker:3470775;Guide2Pharma:12727981;Guide2Pharma:1922095;HPRD:3470775;LRdb:12727981;LRdb:1922095;LRdb:3470775;SIGNOR:10446903;connectomeDB2020:12727981;connectomeDB2020:1922095;connectomeDB2020:3470775;scConnect:12727981;scConnect:1922095], PTH1R [CellTalkDB:32196115], ADCYAP1R1 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]	hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]	cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; male gonad development [GO:0008584]; progesterone biosynthetic process [GO:0006701]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LHB&keywords=LHB	0.02	792	NA	NA	0.00	901	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	847
GDF1	growth differentiation factor 1	Yes		ENSG00000130283	P27539	TGF-beta family	12	ligand	ligand, secreted	O00238, P27037, P36894, P36896, P36897, P61160, P84022, Q04771, Q13639, Q13705, Q13873, Q8NER5	ACTR2, ACVR1, ACVR1B, ACVR1B_ACVR2A, ACVR1B_ACVR2A_CFC1, ACVR1B_ACVR2B, ACVR1B_ACVR2B_CFC1, ACVR1C, ACVR1C_ACVR2A, ACVR1C_ACVR2A_CFC1, ACVR1C_ACVR2B, ACVR1C_ACVR2B_CFC1, ACVR2A, ACVR2B, BMPR1A, BMPR1B, BMPR2, HTR4, SMAD3, TGFBR1	ACTR2 [SignaLink3:16446785;SignaLink3:23331499], BMPR1B [NA], ACVR2A [CellTalkDB:24798330], BMPR1A [connectomeDB2020:28955827], ACVR1B [CellTalkDB:32196115], TGFBR1 [NA], ACVR2B [CellTalkDB:32196115], BMPR2 [connectomeDB2020:28955827], ACVR1C [NA], SMAD3 [CellTalkDB:32196115], ACVR1 [connectomeDB2020:28955827], HTR4 [NA]	extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]	BMP signaling pathway [GO:0030509]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GDF1&keywords=GDF1	0.00	899	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	899
IFNK	interferon kappa	Yes		ENSG00000147896	Q9P0W0	Alpha/beta interferon family	11	ligand	ligand, secreted, transmembrane, transmembrane_predicted	P17181, P48551	IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2	IFNAR1 [SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:22410872], IFNAR2 [SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:22410872]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation [GO:0030101]; natural killer cell activation involved in immune response [GO:0002323]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of innate immune response [GO:0045089]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; regulation of transcription, DNA-templated [GO:0006355]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNK&keywords=IFNK	NA	NA	NA	NA	NA	NA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	289	409	401	0.00	1.37	0.95	0.95	66	151	118	280
WNT5B	Wnt family member 5B	Yes		ENSG00000111186	Q9H1J7	Wnt family	11	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	A4D1S0, O00144, O60353, O75084, O75197, O75581, Q13467, Q14332, Q9H461, Q9NPG1, Q9ULV1, Q9ULW2, Q9UP38	FZD1, FZD1_LRP5, FZD1_LRP6, FZD10, FZD10_LRP5, FZD10_LRP6, FZD2, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4, FZD5, FZD5_LRP5, FZD5_LRP6, FZD6, FZD6_LRP5, FZD6_LRP6, FZD7, FZD7_LRP5, FZD7_LRP6, FZD8, FZD8_LRP5, FZD8_LRP6, FZD9, FZD9_LRP5, FZD9_LRP6, KLRG2, LRP5, LRP6	FZD6 [SIGNOR:16273260], LRP5 [SIGNOR:15578921], LRP6 [SIGNOR:15578921], FZD3 [SIGNOR:15578921;SIGNOR:16273260], KLRG2 [CellTalkDB:32103204], FZD1 [NA], FZD10 [NA], FZD2 [connectomeDB2020:27036869], FZD4 [NA], FZD5 [NA], FZD7 [NA], FZD8 [NetPath:20093360;connectomeDB2020:26849959], FZD9 [NA]	endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; signaling receptor binding [GO:0005102]	canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; chondrocyte differentiation [GO:0002062]; fat cell differentiation [GO:0045444]; lens fiber cell development [GO:0070307]; muscle cell differentiation [GO:0042692]; neuron differentiation [GO:0030182]; positive regulation of cell migration [GO:0030335]; positive regulation of convergent extension involved in gastrulation [GO:1904105]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT5B&keywords=WNT5B	2.06	384	NA	NA	0.35	446	0.00	0.01	0.00	0.03	0.01	0.00	0.02	0.00	0.00	0.01	0.00	298	251	324	0.01	0.70	1.10	0.74	261	112	218	298
IL33	interleukin 33	Yes		ENSG00000137033	O95760	IL-1 family	11	ligand	extracellular, intracellular, ligand, secreted	Q01638, Q9NPH3	IL1RAP, IL1RAP_IL1RL1, IL1RL1	IL1RAP [InnateDB:18450470;InnateDB:19836339], IL1RL1 [Baccin2019:29247993;CellTalkDB:23980170;DIP:19439663;HPRD:16286016;InnateDB:18450470;InnateDB:19439663;InnateDB:19559631;InnateDB:19836339;InnateDB:23980170;connectomeDB2020:16286016;connectomeDB2020:19996325;connectomeDB2020:20926795;connectomeDB2020:29763370]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transport vesicle [GO:0030133]	cytokine activity [GO:0005125]	interleukin-33-mediated signaling pathway [GO:0038172]; negative regulation of macrophage proliferation [GO:0120042]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of CD80 production [GO:0150145]; positive regulation of CD86 production [GO:0150142]; positive regulation of cellular defense response [GO:0010186]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production [GO:0001819]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage activation [GO:0043032]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL33&keywords=IL33	23.44	158	NA	NA	1.12	244	0.00	0.01	0.01	1.88	0.05	0.00	0.00	0.00	0.00	0.00	0.00	299	354	336	0.18	0.06	0.06	0.06	497	489	494	311
SEMA3B	semaphorin 3B	Yes		ENSG00000012171	Q13214	Semaphorin family	11	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted, transmembrane	O14786, O60462, O75051, Q9HCM2	NRP1, NRP1_PLXNA1, NRP1_PLXNA2, NRP1_PLXNA3, NRP1_PLXNA4, NRP2, NRP2_PLXNA1, NRP2_PLXNA2, NRP2_PLXNA3, NRP2_PLXNA4, PLXNA2, PLXNA4	NRP1 [Baccin2019:10196540;Baccin2019:10196546;CellTalkDB:10196546;HPRD:10196546;LRdb:10196546;SIGNOR:25335892;connectomeDB2020:10196546], NRP2 [Baccin2019:10196546;CellTalkDB:10196546;HPRD:10196546;LRdb:10196546;SIGNOR:25335892;connectomeDB2020:10196546], PLXNA2 [SIGNOR:25335892], PLXNA4 [SIGNOR:25335892]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]	chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]	axon guidance [GO:0007411]; cell-cell signaling [GO:0007267]; chemorepulsion of axon [GO:0061643]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SEMA3B&keywords=SEMA3B	7.54	264	NA	NA	0.12	598	0.00	0.18	0.00	0.00	0.14	0.00	0.00	0.00	0.00	0.00	0.00	295	346	339	0.03	0.32	0.30	0.29	400	378	399	397
SEMA3D	semaphorin 3D	Yes		ENSG00000153993	O95025	Semaphorin family	11	ligand, receptor	ligand, receptor, secreted, transmembrane, transmembrane_predicted	O14786, Q9Y4D7	NRP1, NRP1_PLXNA1, NRP1_PLXNA2, NRP1_PLXNA3, NRP1_PLXNA4, NRP2_PLXNA1, NRP2_PLXNA2, NRP2_PLXNA3, NRP2_PLXNA4, PLXND1	PLXND1 [CellTalkDB:31163177], NRP1 [Baccin2019:27439112;CellTalkDB:15456815;LRdb:15456815;Ramilowski2015:15456815;connectomeDB2020:15456815;talklr:15456815]	extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]	chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]	axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SEMA3D&keywords=SEMA3D	0.22	609	NA	NA	0.10	627	0.00	0.00	0.00	0.00	0.00	0.05	0.00	0.00	0.05	0.00	0.00	166	385	390	0.01	3.16	0.54	0.52	12	304	314	481
MIA	MIA SH3 domain containing	TBD		ENSG00000261857	Q16674	MIA/OTOR family	11	ligand	extracellular, ligand, secreted	P05556, P08648, P13612, Q9H159, Q9ULB5	CDH19, CDH7, ITGA4, ITGA5, ITGB1	CDH7 [CellTalkDB:19200257;Cellinker:19200257;LRdb:19200257;Ramilowski2015:19200257;connectomeDB2020:19200257;talklr:19200257], CDH19 [NA], ITGB1 [Cellinker:19200257], ITGA5 [Cellinker:19200257], ITGA4 [Cellinker:19200257]	extracellular space [GO:0005615]	growth factor activity [GO:0008083]	extracellular matrix organization [GO:0030198]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MIA&keywords=MIA	0.73	492	NA	NA	0.13	590	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	541
SEMA3G	semaphorin 3G	Yes		ENSG00000010319	Q9NS98	Semaphorin family	11	ligand, receptor	ligand, receptor, secreted, transmembrane	O60462, P12318, Q8N6C8, Q9HCN6	FCGR2A, GP6, LILRA3, NRP2, NRP2_PLXNA1, NRP2_PLXNA2, NRP2_PLXNA3, NRP2_PLXNA4	NRP2 [Baccin2019:27439112;CellTalkDB:19887479;LRdb:19887479;Ramilowski2015:19887479;connectomeDB2020:19887479;talklr:19887479], FCGR2A [Cellinker:32822567], LILRA3 [Cellinker:32822567], GP6 [Cellinker:32822567]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]	chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; signaling receptor binding [GO:0005102]	axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SEMA3G&keywords=SEMA3G	0.99	452	NA	NA	0.06	688	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	570
NPB	neuropeptide B	Yes		ENSG00000183979	Q8NG41	Neuropeptide B/W family	11	ligand	extracellular, ligand, secreted	P08913, P48039, P48145, P48146, Q14831	ADRA2A, GRM7, MTNR1A, NPBWR1, NPBWR2	NPBWR1 [Baccin2019:12118011;Baccin2019:12401809;CellTalkDB:12401809;Guide2Pharma:12118011;Guide2Pharma:12401809;HPMR:12401809;HPRD:12118011;HPRD:12401809;LRdb:12;LRdb:12401809;connectomeDB2020:12118011;connectomeDB2020:12401809;scConnect:12118011;scConnect:12401809], NPBWR2 [CellTalkDB:12401809;Guide2Pharma:12401809;HPRD:12401809;LRdb:12401809;connectomeDB2020:12401809;scConnect:12401809], GRM7 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115]	extracellular region [GO:0005576]	G protein-coupled receptor binding [GO:0001664]	feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPB&keywords=NPB	0.14	647	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	647
IL26	interleukin 26	Yes		ENSG00000111536	Q9NPH9	IL-10 family	11	ligand	intracellular, ligand, secreted	Q08334, Q6UXL0, Q9UHF4	IL10RB, IL10RB_IL20RA, IL20RA, IL20RB	IL20RA [CellTalkDB:14764663;InnateDB:15178681;SIGNOR:17208301;SignaLink3:17208301;SignaLink3:23106140;SignaLink3:23331499;connectomeDB2020:14764663], IL10RB [CellTalkDB:14764663;SIGNOR:17208301;SignaLink3:17208301;SignaLink3:23106140;SignaLink3:23331499], IL20RB [connectomeDB2020:14764663]	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]	cell-cell signaling [GO:0007267]; negative regulation of epithelial cell proliferation [GO:0050680]; positive regulation of cytokine production [GO:0001819]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of transcription by RNA polymerase II [GO:0045944]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL26&keywords=IL26	0.00	870	NA	NA	0.38	426	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	648
NDP	norrin cystine knot growth factor NDP	Yes		ENSG00000124479	Q00604	NA	11	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted	O75197, Q9BXB1, Q9ULV1	FZD4, LGR4, LRP5	FZD4 [Baccin2019:15035989;BioGRID:17955262;CellTalkDB:15035989;Cellinker:15035989;InnateDB:21856951;LRdb:15035989;SignaLink3:21856951;SignaLink3:23180781;SignaLink3:24186977;connectomeDB2020:15035989], LRP5 [SignaLink3:24186977], LGR4 [Baccin2019:23444378;CellTalkDB:23444378;Cellinker:23444378;LRdb:23444378;connectomeDB2020:23444378]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; protein homodimerization activity [GO:0042803]	decidualization [GO:0046697]; extracellular matrix-cell signaling [GO:0035426]; nervous system development [GO:0007399]; Norrin signaling pathway [GO:0110135]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription, DNA-templated [GO:0045893]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; vacuole organization [GO:0007033]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NDP&keywords=NDP	0.27	589	NA	NA	0.03	760	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	675
TG	thyroglobulin	Yes		ENSG00000042832	P01266	Type-B carboxylesterase/lipase family	11	ligand	extracellular, intracellular, ligand, secreted	P07202, P07306, P98164	ASGR1, LRP2, TPO	TPO [CellTalkDB:28153798], ASGR1 [Baccin2019:12477859;CellTalkDB:12477859;HPRD:12477859;LRdb:12477859;connectomeDB2020:12477859], LRP2 [Baccin2019:9492085;CellTalkDB:11029276;HPRD:9492085;LRdb:9492085;connectomeDB2020:9492085]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	hormone activity [GO:0005179]; identical protein binding [GO:0042802]	hormone biosynthetic process [GO:0042446]; iodide transport [GO:0015705]; regulation of myelination [GO:0031641]; signal transduction [GO:0007165]; thyroid gland development [GO:0030878]; thyroid hormone generation [GO:0006590]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TG&keywords=TG	0.59	509	NA	NA	0.00	866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	688
IGFL3	IGF like family member 3	Yes		ENSG00000188624	Q6UXB1	IGFL family	11	ligand	ligand, secreted	Q9H665	IGFLR1	IGFLR1 [CellChatDB:21454693;CellTalkDB:21454693;Cellinker:21454693;LRdb:21454693;Ramilowski2015:21454693;connectomeDB2020:21454693;talklr:21454693]	extracellular space [GO:0005615]	signaling receptor binding [GO:0005102]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IGFL3&keywords=IGFL3	0.07	698	NA	NA	0.06	692	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	695
CSH2	chorionic somatomammotropin hormone 2	Yes		ENSG00000213218	P0DML3	Somatotropin/prolactin family	11	ligand	extracellular, intracellular, ligand, secreted	P16471	PRLR	PRLR [Cellinker:10966654]	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; vesicle [GO:0031982]	growth factor activity [GO:0008083]; growth hormone receptor binding [GO:0005131]; hormone activity [GO:0005179]; metal ion binding [GO:0046872]	animal organ development [GO:0048513]; growth hormone receptor signaling pathway [GO:0060396]; positive regulation of growth [GO:0045927]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to nutrient levels [GO:0031667]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CSH2&keywords=CSH2	0.00	882	NA	NA	0.17	560	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	721
CSHL1	chorionic somatomammotropin hormone like 1	Yes		ENSG00000204414	Q14406	Somatotropin/prolactin family	11	ligand	extracellular, ligand, secreted	P10912, P16471	GHR, PRLR	PRLR [NA], GHR [CellTalkDB:32196115]	extracellular space [GO:0005615]	growth factor activity [GO:0008083]; growth hormone receptor binding [GO:0005131]; hormone activity [GO:0005179]; metal ion binding [GO:0046872]	animal organ development [GO:0048513]; growth hormone receptor signaling pathway [GO:0060396]; positive regulation of growth [GO:0045927]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to nutrient levels [GO:0031667]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CSHL1&keywords=CSHL1	0.01	837	NA	NA	0.10	634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	736
SLIT1	slit guidance ligand 1	Yes		ENSG00000187122	O75093	NA	10	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	P18827, P35052, Q9HCK4, Q9NZU0, Q9Y6N7	FLRT3, GPC1, ROBO1, ROBO2, SDC1	GPC1 [Baccin2019:1036423410364230;CellTalkDB:10364234;Cellinker:10364234;HPRD:10364234;LRdb:10364234;SIGNOR:10364234;connectomeDB2020:10364234], ROBO2 [Cellinker:21600986;ICELLNET:21600986;connectomeDB2020:30547091], ROBO1 [Baccin2019:1043382210433820;Cellinker:10433822;HPMR:10433822;HPMR:14761655;HPRD:10433822;ICELLNET:21600986;LRdb:10433822;connectomeDB2020:10433822], FLRT3 [CellTalkDB:24560577], SDC1 [Baccin2019:10433822;Cellinker:10433822;HPMR:10433822;HPMR:14761655;LRdb:10433822;connectomeDB2020:10433822]	extracellular space [GO:0005615]	calcium ion binding [GO:0005509]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]	axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; dorsal/ventral axon guidance [GO:0033563]; forebrain morphogenesis [GO:0048853]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of synapse assembly [GO:0051964]; nuclear migration [GO:0007097]; retinal ganglion cell axon guidance [GO:0031290]; spinal cord development [GO:0021510]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SLIT1&keywords=SLIT1	2.44	367	2814.12	119	0.61	335	0.00	0.00	0.00	0.00	0.00	0.03	0.03	0.00	0.02	0.03	0.00	221	173	291	0.01	1.52	1.75	0.66	56	30	256	205
EFNA1	ephrin A1	Yes		ENSG00000169242	P20827	Ephrin family	10	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_peripheral, secreted, transmembrane	O15197, P21709, P29317, P29320, P29322, P54756, P54762, P54764, Q15375, Q5JZY3, Q9UF33	EPHA1, EPHA10, EPHA2, EPHA3, EPHA4, EPHA5, EPHA6, EPHA7, EPHA8, EPHB1, EPHB6	EPHA1 [Baccin2019:11519828;Baccin2019:8755474;Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:11519828;Cellinker:15114347;Cellinker:8755474;Cellinker:9330863;HPMR:9330863;HPRD:11519828;HPRD:8755474;LRdb:11114742;SIGNOR:9330863;SIGNOR:9576626;SignaLink3:11519828;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:8755474;SignaLink3:9267020;connectomeDB2020:11519828;connectomeDB2020:8755474;connectomeDB2020:9330863], EPHA6 [Baccin2019:93308638755474;CellTalkDB:11114742;Cellinker:8755474;Cellinker:9330863;HPRD:8755474;LRdb:11114742;SIGNOR:9576626;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:8755474;connectomeDB2020:9330863], EPHA8 [Baccin2019:10515610;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:10515610;Cellinker:15114347;HPRD:10515610;LRdb:11114742;SIGNOR:17420126;SIGNOR:9576626;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:10515610], EPHA4 [Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;DIP:19836338;HPRD:8755474;LRdb:11114742;Lit-BM-17:10366629;Lit-BM-17:19836338;SIGNOR:9330863;SIGNOR:9576626;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:8755474;connectomeDB2020:9330863], EPHA2 [Baccin2019:11248553;Baccin2019:14692877;Baccin2019:7973638;Baccin2019:8755474;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:11248553;Cellinker:14692877;Cellinker:15114347;Cellinker:7973638;Cellinker:8755474;DIP:20505120;DIP:22244754;DIP:8139691;DOMINO:19525919;HPMR:11248553;HPRD:14692877;HPRD:7973638;HPRD:8755474;IntAct:19525919;IntAct:19573808;IntAct:20505120;LRdb:11114742;Lit-BM-17:19525919;Lit-BM-17:19573808;Lit-BM-17:8139691;SIGNOR:9330863;SIGNOR:9576626;SignaLink3:14692877;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:7973638;SignaLink3:8755474;SignaLink3:9576626;connectomeDB2020:11248553;connectomeDB2020:14692877;connectomeDB2020:7973638;connectomeDB2020:8755474], EPHA3 [Baccin2019:93308638070404;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:8070404;Cellinker:9330863;HPRD:8070404;LRdb:11114742;SIGNOR:9330863;SIGNOR:9576626;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:8070404;SignaLink3:9195962;SignaLink3:9576626;connectomeDB2020:8070404;connectomeDB2020:9330863], EPHA5 [Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:8755474;Cellinker:9330863;HPRD:8755474;LRdb:11114742;SIGNOR:9576626;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:8755474;connectomeDB2020:9330863], EPHA7 [Baccin2019:93308638755474;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:8755474;Cellinker:9330863;HPMR:9330863;HPRD:8755474;LRdb:11114742;SIGNOR:9576626;SignaLink3:23331499;SignaLink3:8755474;SignaLink3:9576626;connectomeDB2020:8755474;connectomeDB2020:9330863], EPHB6 [CellTalkDB:32196115], EPHA10 [CellTalkDB:11114742;Cellinker:28589441;LRdb:11114742], EPHB1 [CellTalkDB:8755474;HPRD:7973638;HPRD:8070404;HPRD:8755474;LRdb:7973638;LRdb:8070404;LRdb:8755474]	anchored component of plasma membrane [GO:0046658]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	ephrin receptor binding [GO:0046875]; signaling receptor binding [GO:0005102]	angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; cell-cell signaling [GO:0007267]; cell migration [GO:0016477]; endocardial cushion to mesenchymal transition involved in heart valve formation [GO:0003199]; ephrin receptor signaling pathway [GO:0048013]; mitral valve morphogenesis [GO:0003183]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of proteolysis involved in cellular protein catabolic process [GO:1903051]; negative regulation of thymocyte apoptotic process [GO:0070244]; negative regulation of transcription by RNA polymerase II [GO:0000122]; notochord formation [GO:0014028]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; protein stabilization [GO:0050821]; regulation of angiogenesis [GO:0045765]; regulation of axonogenesis [GO:0050770]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; substrate adhesion-dependent cell spreading [GO:0034446]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EFNA1&keywords=EFNA1	40.21	104	NA	NA	0.97	273	0.01	0.54	0.99	0.11	0.45	0.06	0.15	0.11	0.05	0.03	0.24	173	177	62	0.25	0.21	0.15	0.97	428	446	110	250
NTN1	netrin 1	Yes	act as growth factors	ENSG00000065320	O95631	NA	10	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	O60469, O95185, P29275, P43121, P43146, Q6UXZ4, Q6ZN44, Q8IZJ1, Q92859	ADORA2B, DCC, DSCAM, MCAM, NEO1, UNC5A, UNC5B, UNC5C, UNC5D	UNC5C [Baccin2019:10399920;Baccin2019:12810718;CellTalkDB:12810718;Cellinker:10399920;Cellinker:12810718;HPMR:12810718;HPRD:12810718;LRdb:1;LRdb:12810718;SIGNOR:10399920;connectomeDB2020:10399920;connectomeDB2020:12810718], UNC5D [CellTalkDB:9126742;LRdb:9126742;Ramilowski2015:9126742;connectomeDB2020:9126742;talklr:9126742], UNC5B [Baccin2019:23599441;CellTalkDB:9126742;Cellinker:26840727;LRdb:9126742;Ramilowski2015:9126742;connectomeDB2020:9126742;talklr:9126742], DCC [Baccin2019:10399920;Baccin2019:12810718;Baccin2019:8861902;Baccin2019:9950216;BioGRID:12810718;BioGRID:9950216;CellTalkDB:8861902;Cellinker:10399920;Cellinker:12810718;Cellinker:8861902;Cellinker:9950216;DIP:19721007;HPMR:11239160;HPMR:12810718;HPMR:8861902;HPRD:12810718;HPRD:9950216;IntAct:19721007;IntAct:26190107;LRdb:10399920;LRdb:12810718;LRdb:8861902;LRdb:9950216;connectomeDB2020:10399920;connectomeDB2020:12810718;connectomeDB2020:8861902;connectomeDB2020:9950216], UNC5A [CellTalkDB:9126742;Cellinker:28710382;LRdb:9126742;Ramilowski2015:9126742;connectomeDB2020:9126742;talklr:9126742], ADORA2B [Baccin2019:11048721;CellTalkDB:11048721;HPRD:11048721;LRdb:11048721;connectomeDB2020:11048721], NEO1 [Baccin2019:12636918;Baccin2019:8861902;CellTalkDB:8861902;Cellinker:12636918;Cellinker:8861902;HPRD:12636918;HPRD:8861902;LRdb:126;LRdb:8861902;connectomeDB2020:12636918;connectomeDB2020:8861902], MCAM [connectomeDB2020:25656845], DSCAM [Cellinker:25754961]	basement membrane [GO:0005604]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]	NA	animal organ morphogenesis [GO:0009887]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; Cdc42 protein signal transduction [GO:0032488]; cell-cell adhesion [GO:0098609]; chemorepulsion of axon [GO:0061643]; dendrite development [GO:0016358]; inner ear morphogenesis [GO:0042472]; mammary gland duct morphogenesis [GO:0060603]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; positive regulation of axon extension [GO:0045773]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; Ras protein signal transduction [GO:0007265]; regulation of cell migration [GO:0030334]; regulation of synapse assembly [GO:0051963]; substrate-dependent cell migration, cell extension [GO:0006930]; tissue development [GO:0009888]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NTN1&keywords=NTN1	2.33	373	NA	NA	0.18	548	0.00	0.01	0.00	0.00	0.00	0.03	0.01	0.00	0.00	0.02	0.00	302	205	353	0.01	0.64	1.73	0.70	284	34	239	290
NTN4	netrin 4	Yes	act as growth factors	ENSG00000074527	Q9HB63	NA	10	ecm, ligand	ecm, extracellular, ligand, secreted	P43146, Q6ZN44	DCC, UNC5A	UNC5A [Baccin2019:17174565;CellTalkDB:17174565;Cellinker:17174565;LRdb:17174565;SIGNOR:12598531;connectomeDB2020:17174565], DCC [Baccin2019:17174565;CellTalkDB:17174565;Cellinker:17174565;DIP:19721007;LRdb:17174565;connectomeDB2020:17174565]	extracellular region [GO:0005576]; laminin complex [GO:0043256]; plasma membrane [GO:0005886]	laminin-1 binding [GO:0043237]	animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; neuron remodeling [GO:0016322]; regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling [GO:0060668]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NTN4&keywords=NTN4	30.30	135	NA	NA	1.29	227	0.00	0.37	0.02	0.03	0.11	0.00	0.00	0.00	0.00	0.00	0.00	294	385	302	0.05	0.23	0.18	0.24	422	424	407	293
CCN1	cellular communication network factor 1	Yes		ENSG00000142871	O00622	CCN family	10	ecm, ligand	ecm, extracellular, intracellular, ligand, ligand_regulator, secreted	O00206, O60603, P05106, P05107, P06756, P08648, P11215, P18084, P31431, Q03135	CAV1, ITGA2B_ITGB3, ITGA5, ITGA6_ITGB1, ITGAD_ITGB2, ITGAM, ITGAV, ITGAV_ITGB3, ITGB2, ITGB3, ITGB5, SDC4, TLR2, TLR4	ITGAM [CellTalkDB:12036876;Cellinker:12036876;LRdb:12036876;connectomeDB2020:12036876], ITGB3 [CellTalkDB:9446626;Cellinker:9446626;LRdb:9446626;connectomeDB2020:9446626], TLR2 [CellTalkDB:32144270], ITGAV [CellTalkDB:10821835;Cellinker:10821835;Cellinker:11287419;HPRD:10821835;HPRD:11287419;LRdb:10821835;LRdb:11;connectomeDB2020:11287419], ITGA5 [CellTalkDB:9446626;Cellinker:9446626;LRdb:9446626;connectomeDB2020:9446626], ITGB5 [CellTalkDB:11287419;Cellinker:11287419;HPRD:11287419;LRdb:11287419;connectomeDB2020:11287419], CAV1 [CellTalkDB:32196115], TLR4 [CellTalkDB:32144270], ITGB2 [CellTalkDB:12036876;Cellinker:12036876;LRdb:12036876;connectomeDB2020:12036876], SDC4 [Baccin2019:16275757;connectomeDB2020:16275757]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]	apoptotic process involved in heart morphogenesis [GO:0003278]; atrial septum morphogenesis [GO:0060413]; atrioventricular valve morphogenesis [GO:0003181]; cell adhesion [GO:0007155]; chemotaxis [GO:0006935]; chondroblast differentiation [GO:0060591]; chorio-allantoic fusion [GO:0060710]; extracellular matrix organization [GO:0030198]; intussusceptive angiogenesis [GO:0002041]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reactive oxygen species metabolic process [GO:0072593]; regulation of ERK1 and ERK2 cascade [GO:0070372]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]; wound healing, spreading of cells [GO:0044319]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCN1&keywords=CCN1	55.08	78	NA	NA	0.23	510	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	294
WNT2B	Wnt family member 2B	Yes		ENSG00000134245	Q93097	Wnt family	10	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted, transmembrane, transmembrane_predicted	O75084, O75197, O75581, Q9NPG1, Q9ULV1	FZD1_LRP5, FZD1_LRP6, FZD10_LRP5, FZD10_LRP6, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4, FZD4_LRP5, FZD4_LRP6, FZD5_LRP5, FZD5_LRP6, FZD6_LRP5, FZD6_LRP6, FZD7, FZD7_LRP5, FZD7_LRP6, FZD8_LRP5, FZD8_LRP6, FZD9_LRP5, FZD9_LRP6, LRP5, LRP6	LRP5 [Cellinker:23209147;SIGNOR:15578921], FZD3 [SIGNOR:15578921], FZD4 [CellPhoneDB:24032637;CellTalkDB:24032637;InnateDB:21856951;LRdb:24032637;connectomeDB2020:24032637], FZD7 [connectomeDB2020:18567805], LRP6 [Cellinker:23209147]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]	canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to starvation [GO:0009267]; chondrocyte differentiation [GO:0002062]; cornea development in camera-type eye [GO:0061303]; forebrain regionalization [GO:0021871]; hematopoietic stem cell proliferation [GO:0071425]; iris morphogenesis [GO:0061072]; lens development in camera-type eye [GO:0002088]; lung induction [GO:0060492]; male gonad development [GO:0008584]; mesenchymal-epithelial cell signaling [GO:0060638]; neuron differentiation [GO:0030182]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT2B&keywords=WNT2B	0.90	464	NA	NA	0.25	492	0.02	0.06	0.04	0.03	0.01	0.06	0.04	0.02	0.02	0.02	0.04	224	210	173	0.03	0.80	0.65	1.13	223	272	71	360
EFNA4	ephrin A4	Yes		ENSG00000243364	P52798	Ephrin family	10	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, ligand, plasma_membrane, plasma_membrane_peripheral, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	P09619, P21709, P29317, P29320, P29322, P54756, P54764, Q15375, Q5JZY3, Q9UF33	EPHA1, EPHA10, EPHA2, EPHA3, EPHA4, EPHA5, EPHA6, EPHA7, EPHA8, PDGFRB	EPHA6 [Baccin2019:933086310607706;CellTalkDB:11114742;Cellinker:10607706;Cellinker:9330863;HPRD:10607706;LRdb:11114742;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:10607706;connectomeDB2020:9330863], EPHA4 [Baccin2019:10366629;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;DIP:19836338;HPRD:10366629;ICELLNET:9530499;LRdb:11114742;SignaLink3:23331499;SignaLink3:9267020;connectomeDB2020:10366629], EPHA7 [Baccin2019:8755474;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:8755474;HPRD:8755474;ICELLNET:9530499;LRdb:11114742;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:8755474], EPHA8 [Baccin2019:10515610;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:10515610;Cellinker:15114347;HPRD:10515610;LRdb:11114742;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:10515610], EPHA2 [Baccin2019:10607706;Baccin2019:8755474;Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:10607706;Cellinker:15114347;Cellinker:8755474;Cellinker:9330863;HPRD:10607706;HPRD:8755474;ICELLNET:9530499;LRdb:11114742;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:10607706;connectomeDB2020:8755474;connectomeDB2020:9330863], EPHA3 [CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:28589441;ICELLNET:9530499;LRdb:11114742;Ramilowski2015:8755474;SignaLink3:23331499;SignaLink3:9195962;SignaLink3:9576626;connectomeDB2020:8755474;talklr:8755474], EPHA5 [Baccin2019:10607706;Baccin2019:8755474;Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:10607706;Cellinker:15114347;Cellinker:8755474;Cellinker:9330863;HPRD:10607706;HPRD:8755474;LRdb:11114742;SIGNOR:9330863;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:10607706;connectomeDB2020:8755474;connectomeDB2020:9330863], EPHA1 [CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:28589441;LRdb:11114742;connectomeDB2020:15114347], EPHA10 [CellTalkDB:11114742;Cellinker:28589441;LRdb:11114742], PDGFRB [Cellinker:32116646]	anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]	ephrin receptor binding [GO:0046875]; transmembrane-ephrin receptor activity [GO:0005005]	axon guidance [GO:0007411]; cell-cell signaling [GO:0007267]; ephrin receptor signaling pathway [GO:0048013]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EFNA4&keywords=EFNA4	4.28	309	NA	NA	0.48	394	0.02	0.13	0.04	0.05	0.05	0.00	0.00	0.00	0.00	0.00	0.00	300	376	364	0.03	0.30	0.29	0.29	409	384	397	366
GPHA2	glycoprotein hormone subunit alpha 2	Yes		ENSG00000149735	Q96T91	Glycoprotein hormones subunit alpha family	10	adhesion, ligand	adhesion, cell_adhesion, ligand, plasma_membrane, secreted	P16473, Q8WXG9, Q9UF33	ADGRV1, EPHA6, TSHR	TSHR [Baccin2019:12045258;CellTalkDB:12045258;Cellinker:12045258;LRdb:12045258;SIGNOR:12045258;connectomeDB2020:12045258], EPHA6 [CellTalkDB:32103204], ADGRV1 [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	hormone activity [GO:0005179]; hormone receptor binding [GO:0051427]; protein heterodimerization activity [GO:0046982]; thyrotropin-releasing hormone receptor binding [GO:0031531]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GPHA2&keywords=GPHA2	0.85	469	NA	NA	0.59	345	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	407
NPW	neuropeptide W	Yes		ENSG00000183971	Q8N729	Neuropeptide B/W family	10	ligand	extracellular, ligand, secreted	P08913, P48039, P48145, P48146, Q14831	ADRA2A, GRM7, MTNR1A, NPBWR1, NPBWR2	NPBWR1 [CellTalkDB:12130646;Guide2Pharma:12130646;HPRD:12130646;HPRD:12401809;LRdb:12130646;LRdb:12401809;connectomeDB2020:12130646;connectomeDB2020:12401809;scConnect:12130646], NPBWR2 [CellTalkDB:12130646;Guide2Pharma:12401809;HPMR:12130646;HPRD:12130646;HPRD:12719537;LRdb:12130646;LRdb:12401809;LRdb:12719537;connectomeDB2020:12130646;connectomeDB2020:12401809;connectomeDB2020:12719537;scConnect:12401809], GRM7 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115]	extracellular region [GO:0005576]	G protein-coupled receptor binding [GO:0001664]	feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPW&keywords=NPW	0.12	654	NA	NA	0.17	558	0.00	0.01	0.00	0.00	0.00	0.09	0.02	0.17	0.02	0.02	0.00	220	207	320	0.03	0.85	0.66	0.31	203	267	389	422
SCGB3A1	secretoglobin family 3A member 1	Yes		ENSG00000161055	Q96QR1	Secretoglobin family, UGRP subfamily	10	ligand	ligand, ligand_regulator, secreted	Q9UEW3, Q9UM47	MARCO, NOTCH3	MARCO [Baccin2019:12847263;CellTalkDB:12847263;Cellinker:12847263;HPRD:12847263;LRdb:12847263;connectomeDB2020:12847263], NOTCH3 [CellTalkDB:32103204]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]	negative regulation of cell growth [GO:0030308]; positive regulation of myoblast fusion [GO:1901741]; regulation of cell population proliferation [GO:0042127]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCGB3A1&keywords=SCGB3A1	2.11	382	NA	NA	0.13	587	0.00	0.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	303	406	401	0.02	0.32	0.32	0.32	402	371	387	437
IL36G	interleukin 36 gamma	Yes		ENSG00000136688	Q9NZH8	IL-1 family	10	ligand	intracellular, ligand, secreted	P17181, P48551, Q9HB29, Q9NPH3, Q9UBH0	IFNAR1, IFNAR2, IL1RAP, IL1RAP_IL1RL2, IL1RL2, IL36RN	IFNAR1 [SignaLink3:17208301;SignaLink3:23331499], IFNAR2 [SignaLink3:17208301;SignaLink3:23331499], IL1RAP [NA], IL1RL2 [CellTalkDB:25673295], IL36RN [CellTalkDB:25673295]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149]	cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; positive regulation of gene expression [GO:0010628]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL36G&keywords=IL36G	0.12	655	NA	NA	0.13	588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	622
DKK2	dickkopf WNT signaling pathway inhibitor 2	Yes		ENSG00000155011	Q9UBU2	Dickkopf family	10	ligand	ligand, ligand_regulator, secreted	O75197, O75581, Q8NCW0, Q96MU8	KREMEN1, KREMEN2, LRP5, LRP6	KREMEN2 [CellTalkDB:12527209;Cellinker:12527209;LRdb:12527209;Ramilowski2015:12527209;connectomeDB2020:12527209;talklr:12527209], LRP6 [Baccin2019:11357136;Baccin2019:11742004;CellTalkDB:11357136;Cellinker:11357136;Cellinker:11742004;Cellinker:12527209;Cellinker:29925589;DIP:21944579;HPRD:11357136;HPRD:11742004;LMPID:21944579;LRdb:11357136;LRdb:11742004;connectomeDB2020:11357136;connectomeDB2020:11742004], KREMEN1 [Cellinker:12527209;connectomeDB2020:23484855], LRP5 [connectomeDB2020:22589387]	extracellular space [GO:0005615]	co-receptor binding [GO:0039706]; receptor antagonist activity [GO:0048019]	negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; Wnt signaling pathway [GO:0016055]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DKK2&keywords=DKK2	0.07	694	NA	NA	0.08	657	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	676
WNT8A	Wnt family member 8A	Yes		ENSG00000061492	Q9H1J5	Wnt family	10	ecm, ligand	ecm, ligand, secreted	O75084, O75197, O75581, Q13467, Q9H461, Q9NPG1, Q9ULV1	FZD1_LRP5, FZD1_LRP6, FZD10_LRP5, FZD10_LRP6, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4, FZD4_LRP5, FZD4_LRP6, FZD5, FZD5_LRP5, FZD5_LRP6, FZD6_LRP5, FZD6_LRP6, FZD7, FZD7_LRP5, FZD7_LRP6, FZD8, FZD8_LRP5, FZD8_LRP6, FZD9_LRP5, FZD9_LRP6, LRP5, LRP6	FZD7 [SignaLink3:10097073;SignaLink3:23331499], FZD8 [SignaLink3:10097073;SignaLink3:23331499;connectomeDB2020:28733458], LRP5 [CellTalkDB:32196115;Cellinker:23209147;SIGNOR:15578921], FZD3 [SIGNOR:15578921], FZD4 [connectomeDB2020:28733458], FZD5 [connectomeDB2020:28733458], LRP6 [Cellinker:23209147;ProtMapper:24316074]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]	anterior/posterior axis specification [GO:0009948]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment [GO:0061317]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; cell fate commitment [GO:0045165]; neural crest cell fate commitment [GO:0014034]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to retinoic acid [GO:0032526]; secondary palate development [GO:0062009]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT8A&keywords=WNT8A	0.01	821	NA	NA	0.20	532	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	677
GDF3	growth differentiation factor 3	Yes		ENSG00000184344	Q9NR23	TGF-beta family	10	ligand	extracellular, intracellular, ligand, secreted	O00238, P13385, P27037, P36894, P36896, P36897, Q13705, Q13873, Q8NER5	ACVR1B, ACVR1B_ACVR2A, ACVR1B_ACVR2A_CFC1, ACVR1B_ACVR2B, ACVR1B_ACVR2B_CFC1, ACVR1C, ACVR1C_ACVR2A, ACVR1C_ACVR2A_CFC1, ACVR1C_ACVR2B, ACVR1C_ACVR2B_CFC1, ACVR2A, ACVR2B, BMPR1A, BMPR1B, BMPR2, TDGF1, TGFBR1	BMPR1B [NA], ACVR2A [NA], BMPR1A [NA], ACVR1B [NA], TGFBR1 [NA], ACVR2B [NA], BMPR2 [NA], ACVR1C [NA], TDGF1 [connectomeDB2020:28126904]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein kinase binding [GO:0019901]	BMP signaling pathway [GO:0030509]; endoderm development [GO:0007492]; eye development [GO:0001654]; formation of anatomical boundary [GO:0048859]; in utero embryonic development [GO:0001701]; mesoderm development [GO:0007498]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of myoblast differentiation [GO:0045662]; notochord development [GO:0030903]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; primitive streak formation [GO:0090009]; regulation of cell fate commitment [GO:0010453]; response to dietary excess [GO:0002021]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GDF3&keywords=GDF3	0.02	798	NA	NA	0.16	566	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	682
IL37	interleukin 37	Yes		ENSG00000125571	Q9NZH6	IL-1 family	10	ligand	extracellular, intracellular, ligand, secreted	O95256, Q13478, Q6IA17, Q9NZN1	IL18R1, IL18R1_IL18RAP, IL18R1_SIGIRR, IL18RAP, IL1RAPL1, SIGIRR	IL18R1 [HPRD:12096920;InnateDB:12096920;InnateDB:25654981], IL18RAP [NA], IL1RAPL1 [CellTalkDB:25654981;InnateDB:25654981], SIGIRR [Cellinker:25729923;scConnect:25729923]	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149]	cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of gene expression [GO:0010628]; regulation of inflammatory response [GO:0050727]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL37&keywords=IL37	0.01	820	NA	NA	0.01	853	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	837
IL36A	interleukin 36 alpha	Yes		ENSG00000136694	Q9UHA7	IL-1 family	10	ligand	intracellular, ligand, secreted	Q9HB29, Q9NPH3, Q9UBH0	IL1RAP, IL1RAP_IL1RL2, IL1RL2, IL36RN	IL1RAP [NA], IL1RL2 [CellTalkDB:11466363;connectomeDB2020:30452921], IL36RN [CellTalkDB:29180446]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149]	cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-6 production [GO:0032755]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL36A&keywords=IL36A	0.00	883	NA	NA	0.00	873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	878
EDIL3	EGF like repeats and discoidin domains 3	TBD		ENSG00000164176	O43854	NA	9	adhesion, ecm, ligand	adhesion, cell_adhesion, ecm, extracellular, ligand, secreted	P05106, P06756, P18084	ITGA5_ITGB1, ITGAV, ITGAV_ITGB3, ITGB3, ITGB5	ITGAV [CellTalkDB:11959660;Cellinker:11959660;HPRD:11959660;LRdb:11959660], ITGB5 [CellTalkDB:32196115], ITGB3 [connectomeDB2020:28846069]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]	calcium ion binding [GO:0005509]; integrin binding [GO:0005178]	cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EDIL3&keywords=EDIL3	39.28	108	14225.2	57	1.55	199	0.04	0.08	0.02	0.13	0.08	0.74	1.36	0.49	0.26	0.62	0.82	63	40	28	0.42	0.63	1.46	1.93	290	56	21	92
FGF14	fibroblast growth factor 14	Yes		ENSG00000102466	Q92915	Heparin-binding growth factors family	9	ligand	intracellular, ligand, secreted	P11362, P21802, P22455, P22607, P35498, P35499, Q14524, Q15858, Q99250, Q9NY46, Q9UI33, Q9UQD0, Q9Y5Y9	FGFR1, FGFR2, FGFR3, FGFR4, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN8A, SCN9A	SCN1A [SIGNOR:20679355], SCN4A [SIGNOR:20679355], SCN5A [SIGNOR:20679355], SCN9A [SIGNOR:20679355], SCN2A [SIGNOR:20679355], SCN3A [SIGNOR:20679355], SCN11A [SIGNOR:20679355], SCN8A [BioGRID:29359916;IntAct:22364545;IntAct:25659151;SIGNOR:20679355], SCN10A [SIGNOR:20679355], FGFR2 [CellTalkDB:16597617;LRdb:16597617], FGFR1 [CellTalkDB:16597617;LRdb:16597617], FGFR4 [CellTalkDB:16597617;LRdb:16597617], FGFR3 [CellTalkDB:16597617;LRdb:16597617]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634]	growth factor activity [GO:0008083]; heparin binding [GO:0008201]; sodium channel regulator activity [GO:0017080]	cell-cell signaling [GO:0007267]; JNK cascade [GO:0007254]; nervous system development [GO:0007399]; regulation of voltage-gated sodium channel activity [GO:1905150]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF14&keywords=FGF14	5.92	278	NA	NA	3.00	113	0.02	0.02	0.01	0.02	0.02	0.32	0.26	0.22	0.33	0.16	0.15	55	88	85	0.14	2.26	1.16	1.06	24	101	86	145
FGF12	fibroblast growth factor 12	Yes		ENSG00000114279	P61328	Heparin-binding growth factors family	9	ligand	intracellular, ligand, secreted	P11362, P21802, P22455, P22607, P35498, P35499, Q14524, Q15858, Q99250, Q9NY46, Q9UI33, Q9UQD0, Q9Y5Y9	FGFR1, FGFR2, FGFR3, FGFR4, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN8A, SCN9A	SCN1A [DIP:22705208;SIGNOR:20679355], SCN4A [SIGNOR:20679355], SCN5A [DIP:22705208;SIGNOR:20679355], SCN9A [SIGNOR:20679355], SCN2A [SIGNOR:20679355], SCN3A [SIGNOR:20679355], SCN11A [SIGNOR:20679355], SCN8A [SIGNOR:20679355], SCN10A [SIGNOR:20679355], FGFR4 [CellTalkDB:16597617;LRdb:16597617], FGFR3 [CellTalkDB:16597617;LRdb:16597617], FGFR1 [CellTalkDB:16597617;LRdb:16597617], FGFR2 [CellTalkDB:16597617;LRdb:16597617]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; synapse [GO:0045202]	growth factor activity [GO:0008083]; heparin binding [GO:0008201]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]	adult locomotory behavior [GO:0008344]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell-cell signaling [GO:0007267]; chemical synaptic transmission [GO:0007268]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart development [GO:0007507]; JNK cascade [GO:0007254]; nervous system development [GO:0007399]; neuromuscular process [GO:0050905]; positive regulation of sodium ion transport [GO:0010765]; regulation of neuronal action potential [GO:0098908]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of voltage-gated sodium channel activity [GO:1905150]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF12&keywords=FGF12	15.08	193	NA	NA	3.11	106	0.02	0.02	0.05	0.01	0.03	0.23	0.21	0.20	0.20	0.10	0.16	78	106	78	0.11	1.72	0.88	1.40	44	178	41	146
GDF15	growth differentiation factor 15	Yes	adding exogenous GDF15 reduced diabetes incidence in NOD mice https://www.sciencedirect.com/science/article/pii/S1550413119306709	ENSG00000130513	Q99988	TGF-beta family	9	ligand	extracellular, intracellular, ligand, secreted	P04626, P07949, P37173, Q6UXV0	ERBB2, GFRAL, RET, TGFBR2	GFRAL [CellTalkDB:28846098;Guide2Pharma:28846098;connectomeDB2020:28846097;connectomeDB2020:28846098;connectomeDB2020:28846099;connectomeDB2020:28953886;scConnect:28846098], ERBB2 [CA1:6328316], RET [CellTalkDB:28846099], TGFBR2 [NA]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]	BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]	BMP signaling pathway [GO:0030509]; cell-cell signaling [GO:0007267]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; negative regulation of growth hormone receptor signaling pathway [GO:0060400]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein kinase B signaling [GO:0051897]; reduction of food intake in response to dietary excess [GO:0002023]; signal transduction [GO:0007165]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GDF15&keywords=GDF15	47.31	92	NA	NA	3.93	93	0.02	0.64	0.01	0.16	4.04	0.32	0.11	0.15	0.24	0.08	0.16	72	120	81	0.54	0.45	0.16	0.30	358	440	394	186
ANGPTL2	angiopoietin like 2	Yes		ENSG00000136859	Q9UKU9	NA	9	ligand	extracellular, ligand, secreted	O00206, O75022, P05556, P08648, P35590, Q8N423	ITGA5, ITGA5_ITGB1, ITGB1, LILRB2, LILRB3, TIE1, TLR4	LILRB2 [CellTalkDB:24899623;Cellinker:24478758;DIP:22660330;IntAct:22660330;IntAct:24899623;connectomeDB2020:26056041], TIE1 [CellTalkDB:32196115], TLR4 [CellChatDB:24478758;Cellinker:24478758], LILRB3 [CellChatDB:24478758], ITGA5 [connectomeDB2020:29074299], ITGB1 [connectomeDB2020:29074299]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	signaling receptor binding [GO:0005102]	multicellular organism development [GO:0007275]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ANGPTL2&keywords=ANGPTL2	12.63	211	NA	NA	0.33	449	0.00	0.01	0.71	0.33	0.02	0.15	0.16	0.01	0.03	0.18	0.00	218	83	295	0.15	0.23	1.22	0.09	423	90	476	208
ZP3	zona pellucida glycoprotein 3	TBD		ENSG00000188372	P21754	ZP domain family, ZPC subfamily	9	ecm, ligand, receptor	cell_surface, ecm, extracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P00533, P36544, Q12866	CHRNA7, EGFR, MERTK	EGFR [CellTalkDB:22577141;connectomeDB2020:22577141], CHRNA7 [connectomeDB2020:22577141], MERTK [Baccin2019:7541556;Cellinker:7541556;LRdb:7541556;connectomeDB2020:7541556]	collagen-containing extracellular matrix [GO:0062023]; egg coat [GO:0035805]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	acrosin binding [GO:0032190]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; receptor ligand activity [GO:0048018]; structural constituent of egg coat [GO:0035804]	binding of sperm to zona pellucida [GO:0007339]; blastocyst formation [GO:0001825]; egg coat formation [GO:0035803]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; negative regulation of transcription, DNA-templated [GO:0045892]; oocyte development [GO:0048599]; positive regulation of acrosomal vesicle exocytosis [GO:2000368]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of antral ovarian follicle growth [GO:2000388]; positive regulation of humoral immune response [GO:0002922]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type IV hypersensitivity [GO:0001809]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ZP3&keywords=ZP3	4.48	300	NA	NA	2.51	128	0.05	0.00	0.01	0.01	0.01	0.01	0.00	0.01	0.01	0.00	0.01	284	293	249	0.01	0.72	0.67	0.88	255	264	151	246
SCGB3A2	secretoglobin family 3A member 2	Yes		ENSG00000164265	Q96PL1	Secretoglobin family, UGRP subfamily	9	ligand	intracellular, ligand, ligand_regulator, secreted	Q9UEW3	MARCO	MARCO [Baccin2019:12847263;CellChatDB:12847263;CellTalkDB:12847263;Cellinker:12847263;HPRD:12847263;InnateDB:12847263;LRdb:12847263;connectomeDB2020:12847263]	endocytic vesicle lumen [GO:0071682]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	NA	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCGB3A2&keywords=SCGB3A2	3.08	336	NA	NA	1.34	217	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	277
TAC4	tachykinin precursor 4	Yes		ENSG00000176358	Q86UU9	Tachykinin family	9	ligand	ligand, secreted	P21452, P25103, P29371	TACR1, TACR2, TACR3	TACR2 [CellTalkDB:11786503;Cellinker:11786503;HPRD:11786503;LRdb:11786503;connectomeDB2020:11786503], TACR3 [CellTalkDB:11786503;Cellinker:11786503;HPRD:11786503;LRdb:11786503;connectomeDB2020:11786503], TACR1 [CellTalkDB:11786503;Cellinker:11062498;Cellinker:11786503;Cellinker:15224188;HPRD:11786503;LRdb:11062498;LRdb:11786503;LRdb:15224188;connectomeDB2020:11062498;connectomeDB2020:11786503;connectomeDB2020:15224188]	extracellular space [GO:0005615]	receptor ligand activity [GO:0048018]; substance K receptor binding [GO:0031837]; substance P receptor binding [GO:0031835]	detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; inflammatory response [GO:0006954]; negative regulation of sensory perception of pain [GO:1904057]; negative regulation of systemic arterial blood pressure [GO:0003085]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of sensory perception of pain [GO:1904058]; regulation of blood pressure [GO:0008217]; regulation of sensory perception of pain [GO:0051930]; tachykinin receptor signaling pathway [GO:0007217]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TAC4&keywords=TAC4	0.87	467	NA	NA	2.05	149	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	308
IL36B	interleukin 36 beta	Yes		ENSG00000136696	Q9NZH7	IL-1 family	9	ligand	extracellular, intracellular, ligand, secreted	Q9HB29, Q9NPH3, Q9UBH0	IL1RAP, IL1RAP_IL1RL2, IL1RL2, IL36RN	IL1RAP [NA], IL1RL2 [CellTalkDB:21965679], IL36RN [CellTalkDB:25673295]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149]	cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; positive regulation of gene expression [GO:0010628]; positive regulation of T cell differentiation [GO:0045582]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL36B&keywords=IL36B	0.35	557	NA	NA	1.43	209	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	303	400	401	0.00	0.97	1.00	0.97	145	133	109	325
APELA	apelin receptor early endogenous ligand	Yes		ENSG00000248329	P0DMC3	Elabela/Toddler family	9	ligand	intracellular, ligand, secreted	P35414	APLNR	APLNR [CellChatDB:25995451;CellTalkDB:28663440;Cellinker:25995451;Cellinker:29079036;Cellinker:29357134;Guide2Pharma:25995451;connectomeDB2020:25639753;connectomeDB2020:26611206;connectomeDB2020:28137936;scConnect:25995451]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	apelin receptor binding [GO:0031704]; hormone activity [GO:0005179]	adult heart development [GO:0007512]; angiogenesis [GO:0001525]; apelin receptor signaling pathway [GO:0060183]; cell migration involved in mesendoderm migration [GO:0090134]; coronary vasculature development [GO:0060976]; embryonic heart tube development [GO:0035050]; endoderm development [GO:0007492]; heart development [GO:0007507]; mesendoderm migration [GO:0090133]; mesoderm migration involved in gastrulation [GO:0007509]; placenta blood vessel development [GO:0060674]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor internalization [GO:1904022]; positive regulation of heart contraction [GO:0045823]; positive regulation of trophoblast cell migration [GO:1901165]; vasculogenesis [GO:0001570]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=APELA&keywords=APELA	0.31	571	NA	NA	2.83	121	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	346
S100A8	S100 calcium binding protein A8	TBD		ENSG00000143546	P05109	S-100 family	9	ligand	extracellular, intracellular, ligand, plasma_membrane, secreted	O00206, P05107, P16671, P34810, Q07108, Q15109	AGER, CD36, CD68, CD69, ITGB2, TLR4	AGER [CellTalkDB:28504650;Cellinker:28504650;SIGNOR:28137827], TLR4 [CellTalkDB:17767165;LRdb:17767165;Ramilowski2015:17767165;SIGNOR:28137827;connectomeDB2020:17767165;talklr:17767165], ITGB2 [CellTalkDB:9570563], CD36 [CellTalkDB:31794767], CD69 [CellTalkDB:26296369], CD68 [CellTalkDB:27312849]	collagen-containing extracellular matrix [GO:0062023]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]	arachidonic acid binding [GO:0050544]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; RAGE receptor binding [GO:0050786]; Toll-like receptor 4 binding [GO:0035662]; zinc ion binding [GO:0008270]	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; acute inflammatory response [GO:0002526]; apoptotic process [GO:0006915]; astrocyte development [GO:0014002]; autocrine signaling [GO:0035425]; autophagy [GO:0006914]; chronic inflammatory response [GO:0002544]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; leukocyte migration involved in inflammatory response [GO:0002523]; neutrophil aggregation [GO:0070488]; neutrophil chemotaxis [GO:0030593]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of cell growth [GO:0030307]; positive regulation of inflammatory response [GO:0050729]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptide secretion [GO:0002793]; regulation of cytoskeleton organization [GO:0051493]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to zinc ion [GO:0010043]; sequestering of zinc ion [GO:0032119]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=S100A8&keywords=S100A8	37.32	114	4039.57	99	0.07	666	3.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	302	401	392	0.30	0.03	0.03	0.03	516	512	515	358
NXPH3	neurexophilin 3	Yes		ENSG00000182575	O95157	Neurexophilin family	9	ligand	ligand, secreted	P58400, P58401, Q9HDB5, Q9P2S2, Q9ULB1, Q9Y4C0	NRXN1, NRXN2, NRXN3	NRXN1 [Baccin2019:98569949856994;Cellinker:9856994;HPRD:9856994;LRdb:9856994;connectomeDB2020:9856994], NRXN1 [Baccin2019:98569949856994;Cellinker:9856994;HPRD:9856994;LRdb:9856994;connectomeDB2020:9856994], NRXN3 [Baccin2019:9856994;Cellinker:9856994;LRdb:9856994;connectomeDB2020:9856994], NRXN3 [Baccin2019:9856994;Cellinker:9856994;LRdb:9856994;connectomeDB2020:9856994], NRXN2 [Cellinker:9856994;LRdb:9856994;connectomeDB2020:9856994], NRXN2 [Baccin2019:9856994;Cellinker:9856994;LRdb:9856994;connectomeDB2020:9856994]	extracellular region [GO:0005576]	signaling receptor binding [GO:0005102]	neuropeptide signaling pathway [GO:0007218]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NXPH3&keywords=NXPH3	0.46	532	NA	NA	0.04	749	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.00	0.00	0.01	0.00	301	248	394	0.00	0.83	1.48	0.80	207	55	190	396
SLIT2	slit guidance ligand 2	Yes		ENSG00000145147	O94813	NA	9	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	O60565, P05067, P18827, P35052, P43146, Q8WZ75, Q9HCK4, Q9UIW2, Q9Y6N7	APP, DCC, GPC1, GREM1, PLXNA1, ROBO1, ROBO2, ROBO4, SDC1	GPC1 [Baccin2019:10364234;Baccin2019:11375980;CellTalkDB:11375980;Cellinker:10364234;Cellinker:11375980;Cellinker:29317497;HPRD:10364234;HPRD:11375980;LRdb:10364234;LRdb:11375980;SIGNOR:10364234;connectomeDB2020:10364234;connectomeDB2020:11375980], ROBO4 [Baccin2019:15894287;CellTalkDB:15894287;Cellinker:15894287;Cellinker:31217826;HPMR:15894287;LRdb:15894287;SIGNOR:12941633;connectomeDB2020:15894287], SDC1 [Baccin2019:10102268;Baccin2019:15130495;CellTalkDB:10102268;Cellinker:10102268;Cellinker:15130495;HPMR:14761655;HPMR:15130495;LRdb:10102268;LRdb:15;connectomeDB2020:10102268;connectomeDB2020:15130495], DCC [CellTalkDB:32196115], ROBO2 [Baccin2019:1513049510102260;CellTalkDB:15130495;Cellinker:10102268;Cellinker:15130495;Cellinker:29317497;Cellinker:31217826;HPMR:14761655;HPMR:15130495;HPRD:10102268;LRdb:1;LRdb:15130495;connectomeDB2020:10102268;connectomeDB2020:15130495], ROBO1 [Baccin2019:1010226810102260;CellTalkDB:10102268;Cellinker:10102268;Cellinker:31217826;DIP:17848514;HPRD:10102268;LRdb:10102268;Lit-BM-17:17848514;connectomeDB2020:10102268], APP [connectomeDB2020:28785723], GREM1 [Cellinker:29317497], PLXNA1 [Cellinker:29317497]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]	calcium ion binding [GO:0005509]; GTPase inhibitor activity [GO:0005095]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; laminin-1 binding [GO:0043237]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Roundabout binding [GO:0048495]	aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to heparin [GO:0071504]; cellular response to hormone stimulus [GO:0032870]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; corticospinal neuron axon guidance through spinal cord [GO:0021972]; induction of negative chemotaxis [GO:0050929]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of leukocyte chemotaxis [GO:0002689]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular permeability [GO:0043116]; positive regulation of apoptotic process [GO:0043065]; positive regulation of axonogenesis [GO:0050772]; pulmonary valve morphogenesis [GO:0003184]; response to cortisol [GO:0051414]; retinal ganglion cell axon guidance [GO:0031290]; Roundabout signaling pathway [GO:0035385]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SLIT2&keywords=SLIT2	2.52	358	NA	NA	0.21	527	0.00	0.05	0.00	0.05	0.00	0.00	0.00	0.01	0.00	0.00	0.00	300	389	396	0.01	0.55	0.52	0.51	326	311	322	396
SLIT3	slit guidance ligand 3	Yes		ENSG00000184347	O75094	NA	9	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	Q8WZ75, Q9HCK4, Q9Y6N7	ROBO1, ROBO2, ROBO4	ROBO2 [Baccin2019:11754167;CellTalkDB:11754167;Cellinker:11754167;HPRD:11754167;LRdb:11754167;connectomeDB2020:31180321], ROBO1 [CellTalkDB:30288875;connectomeDB2020:19741192], ROBO4 [Cellinker:30288875;connectomeDB2020:19741192]	extracellular space [GO:0005615]; mitochondrion [GO:0005739]	calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]	aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; atrioventricular valve morphogenesis [GO:0003181]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cellular response to hormone stimulus [GO:0032870]; negative chemotaxis [GO:0050919]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; response to cortisol [GO:0051414]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SLIT3&keywords=SLIT3	1.03	448	NA	NA	0.05	719	0.00	0.00	0.00	0.04	0.00	0.00	0.00	0.02	0.00	0.00	0.00	299	390	389	0.01	0.74	0.67	0.67	248	262	248	455
C1QTNF1	C1q and TNF related 1	TBD		ENSG00000173918	Q9BXJ1	NA	9	adhesion, ligand	adhesion, cell_adhesion, intracellular, ligand, plasma_membrane, secreted, transmembrane	P30518	AVPR2	AVPR2 [Baccin2019:12409230;CellTalkDB:12409230;Cellinker:12409230;HPRD:12409230;LRdb:12409230;Lit-BM-17:12409230;connectomeDB2020:12409230]	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]	collagen binding [GO:0005518]; identical protein binding [GO:0042802]	negative regulation of platelet activation [GO:0010544]; negative regulation of platelet aggregation [GO:0090331]; positive regulation of aldosterone secretion [GO:2000860]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of glucose metabolic process [GO:0010906]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=C1QTNF1&keywords=C1QTNF1	2.42	370	NA	NA	0.05	707	0.09	0.02	0.00	0.38	0.00	0.01	0.00	0.00	0.00	0.00	0.00	299	363	392	0.05	0.20	0.20	0.18	433	415	427	464
LTB	lymphotoxin beta			ENSG00000223448, ENSG00000231314, ENSG00000204487, ENSG00000236925, ENSG00000238114, ENSG00000236237, ENSG00000206437, ENSG00000227507	Q06643	Tumor necrosis factor family	9	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, secreted, transmembrane, transmembrane_predicted	P19438, P25942, P36941	CD40, LTBR, TNFRSF1A	LTBR [Baccin2019:7916655;Baccin2019:7995952;CellTalkDB:7995952;Cellinker:7916655;Cellinker:7995952;HPRD:7916655;InnateDB:8171323;LRdb:792;LRdb:7995952;SIGNOR:7995952;SPIKE:12387745;connectomeDB2020:7916655;connectomeDB2020:7995952], TNFRSF1A [Baccin2019:7995952;CellTalkDB:7995952;Cellinker:7995952;HPRD:7995952;LRdb:7995952;connectomeDB2020:7995952], CD40 [CellTalkDB:7916655;LRdb:7916655;connectomeDB2020:7916655]	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]	cell-cell signaling [GO:0007267]; gene expression [GO:0010467]; immune response [GO:0006955]; lymph node development [GO:0048535]; positive regulation of interleukin-12 production [GO:0032735]; signal transduction [GO:0007165]; skin development [GO:0043588]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LTB&keywords=LTB	0.91	463	NA	NA	0.07	677	0.00	0.12	0.01	0.00	0.31	0.00	0.00	0.00	0.00	0.00	0.00	303	393	387	0.04	0.20	0.21	0.21	436	414	418	487
IL36RN	interleukin 36 receptor antagonist	Yes		ENSG00000136695	Q9UBH0	IL-1 family	9	ligand	extracellular, intracellular, ligand, ligand_regulator, secreted	Q9HB29, Q9NPH3	IL1RAP, IL1RAP_IL1RL2, IL1RL2	IL1RAP [NA], IL1RL2 [ICELLNET:20959797;ICELLNET:24332029;connectomeDB2020:20081871]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; interleukin-1 receptor antagonist activity [GO:0005152]; interleukin-1 receptor binding [GO:0005149]	antifungal humoral response [GO:0019732]; cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL36RN&keywords=IL36RN	0.04	750	NA	NA	0.02	803	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	303	409	401	0.00	0.89	0.89	0.89	188	174	148	534
FGF11	fibroblast growth factor 11	Yes		ENSG00000283903, ENSG00000161958	Q92914	Heparin-binding growth factors family	9	ligand	intracellular, ligand, secreted	P11362, P21802, P22455, P22607, P35498, P35499, Q14524, Q15858, Q99250, Q9NY46, Q9UI33, Q9UQD0, Q9Y5Y9	FGFR1, FGFR2, FGFR3, FGFR4, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN8A, SCN9A	SCN1A [SIGNOR:20679355], SCN4A [SIGNOR:20679355], SCN5A [SIGNOR:20679355], SCN9A [SIGNOR:20679355], SCN2A [SIGNOR:20679355], SCN3A [SIGNOR:20679355], SCN11A [SIGNOR:20679355], SCN8A [SIGNOR:20679355], SCN10A [SIGNOR:20679355], FGFR2 [CellTalkDB:16597617;LRdb:16597617], FGFR1 [CellTalkDB:16597617;LRdb:16597617], FGFR3 [CellTalkDB:16597617;LRdb:16597617], FGFR4 [CellTalkDB:16597617;LRdb:16597617]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634]	growth factor activity [GO:0008083]; sodium channel regulator activity [GO:0017080]	cell-cell signaling [GO:0007267]; nervous system development [GO:0007399]; regulation of voltage-gated sodium channel activity [GO:1905150]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF11&keywords=FGF11	0.66	498	NA	NA	0.15	579	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	539
WNT9B	Wnt family member 9B	Yes		ENSG00000276799, ENSG00000158955	O14905	Wnt family	9	ecm, ligand	ecm, ligand, secreted	O75197, O75581, P02708, Q13467, Q9H461, Q9NPG1, Q9ULV1, Q9ULW2	CHRNA1, FZD1_LRP5, FZD1_LRP6, FZD10, FZD10_LRP5, FZD10_LRP6, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4, FZD4_LRP5, FZD4_LRP6, FZD5, FZD5_LRP5, FZD5_LRP6, FZD6_LRP5, FZD6_LRP6, FZD7_LRP5, FZD7_LRP6, FZD8, FZD8_LRP5, FZD8_LRP6, FZD9_LRP5, FZD9_LRP6, LRP5, LRP6	LRP6 [CellTalkDB:20093360;NetPath:20093360;SIGNOR:20093360], LRP5 [Cellinker:23209147;SIGNOR:15578921], CHRNA1 [SIGNOR:22309736], FZD3 [SIGNOR:15578921], FZD10 [connectomeDB2020:28733458], FZD4 [connectomeDB2020:28733458], FZD5 [connectomeDB2020:25892522;connectomeDB2020:28733458;connectomeDB2020:30978219], FZD8 [connectomeDB2020:28733458]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	co-receptor binding [GO:0039706]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]	branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; cellular response to starvation [GO:0009267]; collecting duct development [GO:0072044]; cornea development in camera-type eye [GO:0061303]; embryonic cranial skeleton morphogenesis [GO:0048701]; establishment of planar polarity involved in nephron morphogenesis [GO:0072046]; in utero embryonic development [GO:0001701]; kidney rudiment formation [GO:0072003]; male genitalia development [GO:0030539]; mesenchymal stem cell maintenance involved in nephron morphogenesis [GO:0072038]; mesonephric duct formation [GO:0072181]; metanephric tubule formation [GO:0072174]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of stem cell population maintenance [GO:1902455]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1905438]; positive regulation of catalytic activity [GO:0043085]; regulation of asymmetric cell division [GO:0009786]; regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003339]; regulation of protein phosphorylation [GO:0001932]; regulation of tube size [GO:0035150]; response to retinoic acid [GO:0032526]; roof of mouth development [GO:0060021]; uterus morphogenesis [GO:0061038]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT9B&keywords=WNT9B	0.05	735	NA	NA	0.28	477	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	606
IFNE	interferon epsilon	Yes		ENSG00000184995	Q86WN2	Alpha/beta interferon family	9	ligand	extracellular, ligand, secreted	P17181, P48551, Q8WXG9	ADGRV1, IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2	IFNAR1 [CellTalkDB:32196115;connectomeDB2020:22410872], IFNAR2 [CellTalkDB:32196115;connectomeDB2020:22410872], ADGRV1 [CellTalkDB:32103204]	extracellular space [GO:0005615]	cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNE&keywords=IFNE	0.07	704	NA	NA	0.22	517	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	611
NXPH2	neurexophilin 2	Yes		ENSG00000144227	O95156	Neurexophilin family	9	ligand	intracellular, ligand, secreted	P58400, Q9ULB1	NRXN1	NRXN1 [Baccin2019:8699246;CellTalkDB:8699246;Cellinker:8699246;HPRD:8699246;LRdb:8699246;connectomeDB2020:8699246], NRXN1 [Baccin2019:8699246;CellTalkDB:8699246;Cellinker:8699246;HPRD:8699246;LRdb:8699246;connectomeDB2020:8699246]	extracellular region [GO:0005576]	signaling receptor binding [GO:0005102]	neuropeptide signaling pathway [GO:0007218]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NXPH2&keywords=NXPH2	0.04	761	NA	NA	0.17	556	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	659
NXPH1	neurexophilin 1	Yes		ENSG00000122584	P58417	Neurexophilin family	9	ligand	extracellular, ligand, secreted	P58400, P58401, Q9HDB5, Q9P2S2, Q9ULB1, Q9Y4C0	NRXN1, NRXN2, NRXN3	NRXN1 [Baccin2019:8699246;Baccin2019:9856994;Cellinker:8699246;Cellinker:9856994;HPMR:9856994;HPRD:8699246;HPRD:9856994;LRdb:8699246;LRdb:9856994;SIGNOR:9856994;connectomeDB2020:8699246;connectomeDB2020:9856994], NRXN1 [Baccin2019:8699246;Baccin2019:9856994;Cellinker:8699246;Cellinker:9856994;HPRD:8699246;HPRD:9856994;LRdb:8699246;LRdb:9856994;SIGNOR:9856994;connectomeDB2020:8699246;connectomeDB2020:9856994], NRXN3 [Baccin2019:9856994;Cellinker:9856994;HPMR:9856994;LRdb:9856994;SIGNOR:9856994;connectomeDB2020:9856994], NRXN3 [Baccin2019:9856994;Cellinker:9856994;LRdb:9856994;connectomeDB2020:9856994], NRXN2 [Cellinker:9856994;HPMR:9856994;LRdb:9856994;connectomeDB2020:9856994], NRXN2 [Baccin2019:9856994;Cellinker:9856994;LRdb:9856994;connectomeDB2020:9856994]	extracellular region [GO:0005576]	signaling receptor binding [GO:0005102]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NXPH1&keywords=NXPH1	0.04	751	NA	NA	0.03	785	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	768
CD5L	CD5 molecule like	Yes		ENSG00000073754	O43866	NA	9	ligand	extracellular, intracellular, ligand, secreted	P06127	CD5	CD5 [CellTalkDB:9723705;Cellinker:9723705;LRdb:9723705;Ramilowski2015:9723705;connectomeDB2020:9723705;talklr:9723705]	blood microparticle [GO:0072562]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]	apoptotic process [GO:0006915]; cellular defense response [GO:0006968]; immune system process [GO:0002376]; inflammatory response [GO:0006954]; positive regulation of complement-dependent cytotoxicity [GO:1903661]; regulation of complement activation [GO:0030449]; zymogen activation [GO:0031638]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD5L&keywords=CD5L	0.05	746	NA	NA	0.01	855	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	801
WNT6	Wnt family member 6	Yes		ENSG00000115596	Q9Y6F9	Wnt family	9	ecm, ligand, receptor	ecm, intracellular, ligand, receptor, secreted	O75084, O75197, O75581, Q9BQ69, Q9NPG1, Q9ULV1, Q9UP38	FZD1, FZD1_LRP5, FZD1_LRP6, FZD10_LRP5, FZD10_LRP6, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4, FZD4_LRP5, FZD4_LRP6, FZD5_LRP5, FZD5_LRP6, FZD6_LRP5, FZD6_LRP6, FZD7, FZD7_LRP5, FZD7_LRP6, FZD8_LRP5, FZD8_LRP6, FZD9_LRP5, FZD9_LRP6, LRP5, LRP6, MACROD1	FZD1 [CA1:12857724;CA1:8717036], MACROD1 [CA1:12857724], LRP5 [Cellinker:23209147;SIGNOR:15578921], FZD3 [SIGNOR:15578921], FZD4 [CellTalkDB:31618077], FZD7 [connectomeDB2020:27122540], LRP6 [Cellinker:23209147]	cell surface [GO:0009986]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]	axis specification [GO:0009798]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; cornea development in camera-type eye [GO:0061303]; epithelial-mesenchymal cell signaling [GO:0060684]; nephron tubule formation [GO:0072079]; neuron differentiation [GO:0030182]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of gene expression [GO:0010628]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription, DNA-templated [GO:0045893]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT6&keywords=WNT6	0.01	834	NA	NA	0.00	867	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	851
MIF	macrophage migration inhibitory factor	Yes		ENSG00000276701, ENSG00000240972	P14174	MIF family	8	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted	P00441, P00533, P04233, P16070, P25025, P25106, P61073, Q92956, Q9UBN6	ACKR3, CD44, CD44_CD74, CD74, CD74_CXCR2, CD74_CXCR4, CXCR2, CXCR4, EGFR, SOD1, TNFRSF10D, TNFRSF14	CD74 [HPRD:12782713;ICELLNET:12782713;SIGNOR:12782713;connectomeDB2020:12782713;connectomeDB2020:26039541], CXCR2 [CellTalkDB:18852457;ICELLNET:17435771;SIGNOR:17435771;connectomeDB2020:17435771], SOD1 [SIGNOR:29371591], CXCR4 [CellTalkDB:19665027;ICELLNET:17435771;SIGNOR:17435771;connectomeDB2020:17435771], CD44 [CellTalkDB:30682543], EGFR [CellTalkDB:26280537;Cellinker:26280537], ACKR3 [CellChatDB:26175090;Cellinker:26175090;Cellinker:29637711], TNFRSF14 [NA], TNFRSF10D [NA]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]	chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; dopachrome isomerase activity [GO:0004167]; identical protein binding [GO:0042802]; phenylpyruvate tautomerase activity [GO:0050178]; protease binding [GO:0002020]	carboxylic acid metabolic process [GO:0019752]; cell aging [GO:0007569]; cell surface receptor signaling pathway [GO:0007166]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of macrophage chemotaxis [GO:0010760]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of myeloid cell apoptotic process [GO:0033033]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cytokine production [GO:0001819]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of myeloid leukocyte cytokine production involved in immune response [GO:0061081]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphorylation [GO:0042327]; positive regulation of prostaglandin secretion involved in immune response [GO:0061078]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of tumor necrosis factor production [GO:0032760]; prostaglandin biosynthetic process [GO:0001516]; protein homotrimerization [GO:0070207]; regulation of macrophage activation [GO:0043030]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MIF&keywords=MIF	41.97	102	704583	1	8.88	50	0.26	0.87	0.30	1.04	1.60	1.04	0.98	0.88	0.76	0.86	0.78	29	33	29	0.85	0.90	1.00	0.92	185	129	132	63
SCGB1A1	secretoglobin family 1A member 1	Yes		ENSG00000149021	P11684	Secretoglobin family	8	ligand	extracellular, intracellular, ligand, ligand_regulator, secreted	P98164, Q6UX01	LMBR1L, LRP2	LRP2 [Baccin2019:11278724;CellTalkDB:11278724;Cellinker:11278724;HPRD:11278724;LRdb:11278724;connectomeDB2020:11278724], LMBR1L [Baccin2019:16423471;CellTalkDB:16423471;Cellinker:16423471;HPRD:16423471;LRdb:16423471]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nuclear envelope [GO:0005635]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141]	phospholipase A2 inhibitor activity [GO:0019834]; polychlorinated biphenyl binding [GO:0097160]	embryo implantation [GO:0007566]; female pregnancy [GO:0007565]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-4 production [GO:0032713]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of inflammatory response [GO:0050727]; regulation of mRNA stability [GO:0043488]; response to cytokine [GO:0034097]; response to fibroblast growth factor [GO:0071774]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to ozone [GO:0010193]; response to silicon dioxide [GO:0034021]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCGB1A1&keywords=SCGB1A1	17.49	183	NA	NA	4.56	80	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	132
OLFM2	olfactomedin 2	Yes		ENSG00000105088	O95897	NA	8	ligand	intracellular, ligand, secreted	Q9HCK4	ROBO2	ROBO2 [Baccin2019:16169070;Cellinker:16169070;HPRD:16169070;LRdb:16169070]	AMPA glutamate receptor complex [GO:0032281]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]	NA	positive regulation of smooth muscle cell differentiation [GO:0051152]; protein secretion [GO:0009306]; regulation of vascular associated smooth muscle cell dedifferentiation [GO:1905174]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=OLFM2&keywords=OLFM2	18.91	173	3501.32	106	0.58	348	0.00	0.02	0.00	0.34	0.03	0.42	0.33	0.14	0.19	0.28	0.01	82	65	227	0.16	1.19	1.70	0.14	89	36	452	146
THBS1	thrombospondin 1	TBD	look at all spondins	ENSG00000137801	P07996	Thrombospondin family	8	adhesion, cell_surface_ligand, ecm, ligand, receptor	adhesion, cell_surface_ligand, ecm, extracellular, intracellular, ligand, ligand_regulator, matrix_adhesion, receptor, secreted	O00300, O75096, O75197, P00747, P01137, P01138, P02751, P05106, P05556, P07359, P08246, P08253, P08514, P13224, P13612, P14770, P14780, P16671, P18827, P23229, P26006, P31431, P40197, P98164, Q07954, Q08722, Q12913, Q8WTV0	CALR_LRP1, CD36, CD47, ELANE, FN1, GP1BA, GP1BB, GP5, GP9, ITGA2B, ITGA2B_ITGB3, ITGA3, ITGA3_ITGB1, ITGA4, ITGA6, ITGA6_ITGB1, ITGAV_ITGB3, ITGB1, ITGB3, LRP1, LRP2, LRP4, LRP5, MMP2, MMP9, NGF, PLG, PTPRJ, SCARB1, SDC1, SDC4, TGFB1, TNFRSF11B	NGF [SIGNOR:10708953], ITGA4 [CellTalkDB:14699013;Cellinker:14699013;LRdb:14699013;Ramilowski2015:14699013;connectomeDB2020:14699013;talklr:14699013], CD47 [Baccin2019:10397731;Baccin2019:11980922;Baccin2019:8550562;Baccin2019:9169439;CellTalkDB:11980922;Cellinker:10397731;Cellinker:11980922;Cellinker:15842360;Cellinker:8550562;Cellinker:9169439;HPMR:11980922;HPRD:10397731;HPRD:8550562;HPRD:9169439;LRdb:10397731;LRdb:11980922;LRdb:8550562;LRdb:9169439;connectomeDB2020:10397731;connectomeDB2020:11980922;connectomeDB2020:8550562;connectomeDB2020:9169439], SDC1 [Baccin2019:11257118;CellTalkDB:11257118;Cellinker:11257118;Cellinker:1969657;LRdb:11257118;connectomeDB2020:11257118], ITGB1 [CellTalkDB:15292271;LRdb:15292271;Ramilowski2015:15292271;connectomeDB2020:15292271;talklr:15292271], LRP5 [CellTalkDB:7775583;Cellinker:7775583;HPRD:7775583;LRdb:7775583], ITGA2B [CellTalkDB:2478219;LRdb:2478219;Ramilowski2015:2478219;connectomeDB2020:2478219;talklr:2478219], ITGB3 [BioGRID:14963009;BioGRID:2478219;CellTalkDB:2478219;HPRD:2478219;LRdb:2478219;connectomeDB2020:2478219], SDC4 [Baccin2019:17879962;CellTalkDB:32196115;connectomeDB2020:17879962], SCARB1 [CellTalkDB:32196115], ITGA6 [CellTalkDB:12909644;Cellinker:12909644;LRdb:12909644;Ramilowski2015:12909644;connectomeDB2020:12909644;talklr:12909644], TNFRSF11B [Baccin2019:15799029;CellTalkDB:15799029;Cellinker:15799029;HPRD:15799029;LRdb:15799029;connectomeDB2020:15799029], CD36 [Baccin2019:10487979;Baccin2019:10772961;Baccin2019:1379600;CellTalkDB:10487979;Cellinker:10487979;Cellinker:10772961;Cellinker:1379600;HPRD:10487979;HPRD:10772961;LRdb:10487979;LRdb:10772961;LRdb:1379600;Lit-BM-17:23640500;connectomeDB2020:10487979;connectomeDB2020:10772961;connectomeDB2020:1379600], ITGA3 [CellTalkDB:10196234;LRdb:10196234;Ramilowski2015:10196234;connectomeDB2020:10196234;talklr:10196234], LRP1 [Baccin2019:14991768;Baccin2019:9045712;BioGRID:14991768;BioGRID:7775583;BioGRID:9045712;CellTalkDB:9045712;Cellinker:14991768;Cellinker:9045712;HPRD:14991768;HPRD:9045712;LRdb:15;LRdb:9045712;connectomeDB2020:14991768;connectomeDB2020:7775583;connectomeDB2020:9045712], PTPRJ [Baccin2019:22308318;connectomeDB2020:22308318], GP1BA [Cellinker:19286885], GP9 [Cellinker:19286885], LRP4 [Cellinker:12871303], GP1BB [Cellinker:19286885], LRP2 [Cellinker:12871303], GP5 [Cellinker:19286885], PLG [BioGRID:2522013;BioGRID:6438154;HPRD:2522013], FN1 [HPRD:11773026;IntAct:19542224;Lit-BM-17:18042364;Lit-BM-17:18226512;Lit-BM-17:19542224;MatrixDB:18226512;MatrixDB:19542224], MMP2 [HPRD:10900205;Lit-BM-17:10900205], TGFB1 [ACSN:21900405;ACSN:22943793;ACSN:8349738;HPRD:1550960], MMP9 [HPRD:10900205;HPRD:11606713], ELANE [HPRD:8463250]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141]	calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibroblast growth factor binding [GO:0017134]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; proteoglycan binding [GO:0043394]; transforming growth factor beta binding [GO:0050431]	behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heat [GO:0034605]; cellular response to tumor necrosis factor [GO:0071356]; chronic inflammatory response [GO:0002544]; engulfment of apoptotic cell [GO:0043652]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002581]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of sprouting angiogenesis [GO:1903671]; peptide cross-linking [GO:0018149]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transforming growth factor beta1 production [GO:0032914]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor production [GO:0032760]; response to calcium ion [GO:0051592]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to magnesium ion [GO:0032026]; response to mechanical stimulus [GO:0009612]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to unfolded protein [GO:0006986]; response to xenobiotic stimulus [GO:0009410]; sprouting angiogenesis [GO:0002040]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=THBS1&keywords=THBS1	66.01	66	1735.85	138	0.63	331	0.72	0.39	1.27	0.98	0.36	0.01	0.01	0.00	0.00	0.00	0.01	291	315	287	0.34	0.04	0.04	0.04	512	507	509	271
WNT9A	Wnt family member 9A	Yes		ENSG00000143816	O14904	Wnt family	8	ecm, ligand	ecm, extracellular, ligand, secreted	O15146, O75197, O75581, P02708, Q9NPG1, Q9ULV1, Q9ULW2	CHRNA1, FZD1_LRP5, FZD1_LRP6, FZD10, FZD10_LRP5, FZD10_LRP6, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4, FZD4_LRP5, FZD4_LRP6, FZD5_LRP5, FZD5_LRP6, FZD6_LRP5, FZD6_LRP6, FZD7_LRP5, FZD7_LRP6, FZD8_LRP5, FZD8_LRP6, FZD9_LRP5, FZD9_LRP6, LRP5, LRP6, MUSK	MUSK [SIGNOR:22309736], LRP5 [Cellinker:23209147;SIGNOR:15578921], LRP6 [Cellinker:23209147;SIGNOR:15578921], CHRNA1 [SIGNOR:22309736], FZD3 [SIGNOR:15578921], FZD10 [connectomeDB2020:28733458], FZD4 [connectomeDB2020:28733458]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]	canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; cornea development in camera-type eye [GO:0061303]; embryonic skeletal joint development [GO:0072498]; iris morphogenesis [GO:0061072]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; neuron differentiation [GO:0030182]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT9A&keywords=WNT9A	2.50	363	NA	NA	0.48	392	0.00	0.00	0.00	0.01	0.01	0.01	0.00	0.00	0.00	0.01	0.00	295	262	358	0.00	0.90	1.18	0.78	184	97	201	279
ANGPTL4	angiopoietin like 4	Yes		ENSG00000167772	Q9BY76	NA	8	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted, transmembrane	O75056, P06858, P18827, P31431, P33151, P34741, P35590, P55287, Q8IV16	CDH11, CDH5, GPIHBP1, ITGA5_ITGB1, ITGAV_ITGB3, LPL, SDC1, SDC2, SDC3, SDC4, TIE1	GPIHBP1 [CellTalkDB:25809481], TIE1 [CellTalkDB:32196115], CDH5 [CellChatDB:30049845;Cellinker:30049845], CDH11 [CellChatDB:30049845;Cellinker:30049845], SDC1 [CellChatDB:29017031;Cellinker:29017031], SDC2 [CellChatDB:29017031;Cellinker:29017031], SDC3 [CellChatDB:29017031;Cellinker:29017031], SDC4 [CellChatDB:29017031;Cellinker:29017031], LPL [LMPID:19246456]	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]	angiogenesis [GO:0001525]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of lipoprotein lipase activity [GO:0051005]; positive regulation of angiogenesis [GO:0045766]; protein unfolding [GO:0043335]; response to hypoxia [GO:0001666]; triglyceride homeostasis [GO:0070328]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ANGPTL4&keywords=ANGPTL4	28.22	140	NA	NA	0.93	280	0.00	0.04	0.05	1.01	0.06	0.01	0.01	0.02	0.01	0.01	0.01	287	254	235	0.11	0.13	0.15	0.20	467	443	423	279
THBS2	thrombospondin 2	TBD		ENSG00000186340	P35442	Thrombospondin family	8	adhesion, ecm, ligand	adhesion, ecm, extracellular, intracellular, ligand, matrix_adhesion, secreted	O75096, P05106, P05556, P13612, P16671, P18827, P23229, P31431, P98164, Q08722, Q99466, Q9UM47	CD36, CD47, ITGA3_ITGB1, ITGA4, ITGA6, ITGAV_ITGB3, ITGB1, ITGB3, LRP2, LRP4, NOTCH3, NOTCH4, SDC1, SDC4	CD47 [Baccin2019:8550562;CellTalkDB:8550562;Cellinker:8550562;LRdb:8550562;SIGNOR:8550562;connectomeDB2020:8550562], ITGA4 [CellTalkDB:14699013;Cellinker:14699013;LRdb:14699013;Ramilowski2015:14699013;connectomeDB2020:14699013;talklr:14699013], ITGB1 [CellTalkDB:15292271;LRdb:15292271;Ramilowski2015:15292271;connectomeDB2020:15292271;talklr:15292271], ITGB3 [CellTalkDB:32196115], NOTCH4 [CellTalkDB:32196115], ITGA6 [CellTalkDB:12909644;Cellinker:12909644;LRdb:12909644;Ramilowski2015:12909644;connectomeDB2020:12909644;talklr:12909644], CD36 [CellTalkDB:20714802], NOTCH3 [Baccin2019:19147503;CellTalkDB:19147503;Cellinker:19147503;LRdb:19147503;Ramilowski2015:19147503;connectomeDB2020:19147503;talklr:19147503], SDC1 [Cellinker:1969657], SDC4 [NA], LRP2 [Cellinker:12871303], LRP4 [Cellinker:12871303]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; platelet alpha granule [GO:0031091]	calcium ion binding [GO:0005509]; heparin binding [GO:0008201]	cell adhesion [GO:0007155]; negative regulation of angiogenesis [GO:0016525]; positive regulation of synapse assembly [GO:0051965]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=THBS2&keywords=THBS2	26.14	148	NA	NA	0.57	359	0.00	0.00	0.00	0.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	301	382	375	0.05	0.17	0.17	0.17	451	431	436	330
DEFB4B	defensin beta 4B	TBD		ENSG00000275444, ENSG00000285433, ENSG00000177257	O15263	Beta-defensin family, LAP/TAP subfamily	8	ligand	extracellular, intracellular, ligand, secreted	O00206, P51684	CCR6, TLR4	CCR6 [CellTalkDB:20068036;CellTalkDB:26198319;Guide2Pharma:10521347;HPRD:11714836;InnateDB:10521347;LRdb:20068036;LRdb:25122636;LRdb:25585877;connectomeDB2020:10521347;connectomeDB2020:11714836;scConnect:10521347], TLR4 [HPRD:12411706;LRdb:12411706;connectomeDB2020:12411706]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]	CCR6 chemokine receptor binding [GO:0031731]; chemoattractant activity [GO:0042056]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; killing of cells of other organism [GO:0031640]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DEFB4B&keywords=DEFB4B	0.16	635	NA	NA	17.41	31	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	333
DEFB4A	defensin beta 4A	TBD		ENSG00000285181, ENSG00000171711	O15263	Beta-defensin family, LAP/TAP subfamily	8	ligand	extracellular, intracellular, ligand, secreted	O00206, P51684	CCR6, TLR4	CCR6 [CellTalkDB:20068036;CellTalkDB:26198319;Guide2Pharma:10521347;HPRD:11714836;InnateDB:10521347;LRdb:20068036;LRdb:25122636;LRdb:25585877;connectomeDB2020:10521347;connectomeDB2020:11714836;scConnect:10521347], TLR4 [HPRD:12411706;LRdb:12411706;connectomeDB2020:12411706]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]	CCR6 chemokine receptor binding [GO:0031731]; chemoattractant activity [GO:0042056]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; killing of cells of other organism [GO:0031640]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DEFB4A&keywords=DEFB4A	0.16	635	NA	NA	2.43	132	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.00	272	395	304	0.00	1.56	0.88	1.16	54	179	68	335
CGB5	chorionic gonadotropin subunit beta 5	Yes		ENSG00000189052	P0DN86	Glycoprotein hormones subunit beta family	8	ligand	extracellular, intracellular, ligand, secreted	P22888, P78324	LHCGR, SIRPA	LHCGR [CellTalkDB:24554412;CellTalkDB:26441830;Guide2Pharma:12727981;Guide2Pharma:1922095;HPRD:2254302;SIGNOR:10446903;connectomeDB2020:10446903;connectomeDB2020:12727981;connectomeDB2020:1922095;connectomeDB2020:2254302], SIRPA [NA]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; pituitary gonadotropin complex [GO:0061696]	hormone activity [GO:0005179]	apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; female gamete generation [GO:0007292]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CGB5&keywords=CGB5	0.03	777	NA	NA	2.06	147	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	462
CCL4L2	C-C motif chemokine ligand 4 like 2	Yes		ENSG00000282604, ENSG00000275313, ENSG00000276125, ENSG00000276070	Q8NHW4	Intercrine beta (chemokine CC) family	8	ligand	intracellular, ligand, secreted	O00590, O15173, O15529, O15552, P32246, P51677, P51681, Q8TDT2, Q8TDV0, Q96P66, Q9H7M9	ACKR2, CCR1, CCR3, CCR5, FFAR2, GPR101, GPR151, GPR152, GPR42, PGRMC2, VSIR	ACKR2 [Cellinker:29637711;ICELLNET:22633458], CCR1 [connectomeDB2020:15240137], CCR3 [connectomeDB2020:15240137], CCR5 [connectomeDB2020:15240137], FFAR2 [NA], GPR42 [NA], GPR151 [NA], VSIR [NA], GPR152 [NA], GPR101 [NA], PGRMC2 [NA]	extracellular space [GO:0005615]	CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]	cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL4L2&keywords=CCL4L2	0.31	574	NA	NA	0.15	573	3.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	303	406	400	0.36	0.03	0.03	0.03	520	515	520	517
IGFL2	IGF like family member 2	Yes		ENSG00000204866	Q6UWQ7	IGFL family	8	ligand	intracellular, ligand, secreted	Q9H665	IGFLR1	IGFLR1 [CellTalkDB:21454693;LRdb:21454693;Ramilowski2015:21454693;connectomeDB2020:21454693;talklr:21454693]	extracellular space [GO:0005615]	signaling receptor binding [GO:0005102]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IGFL2&keywords=IGFL2	0.30	576	NA	NA	0.15	577	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	577
WNT10A	Wnt family member 10A	Yes		ENSG00000135925	Q9GZT5	Wnt family	8	ecm, ligand	ecm, ligand, secreted	O75197, O75581, Q13467, Q9H461, Q9NPG1, Q9UP38	FZD1, FZD1_LRP5, FZD1_LRP6, FZD10_LRP5, FZD10_LRP6, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4_LRP5, FZD4_LRP6, FZD5, FZD5_LRP5, FZD5_LRP6, FZD6_LRP5, FZD6_LRP6, FZD7_LRP5, FZD7_LRP6, FZD8, FZD8_LRP5, FZD8_LRP6, FZD9_LRP5, FZD9_LRP6, LRP5, LRP6	LRP5 [SIGNOR:15578921], LRP6 [SIGNOR:15578921], FZD3 [SIGNOR:15578921], FZD1 [connectomeDB2020:28733458], FZD5 [connectomeDB2020:28733458], FZD8 [connectomeDB2020:28733458]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]	canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to transforming growth factor beta stimulus [GO:0071560]; epidermis morphogenesis [GO:0048730]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; neural crest cell differentiation [GO:0014033]; neuron differentiation [GO:0030182]; odontogenesis [GO:0042476]; positive regulation of gene expression [GO:0010628]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; sebaceous gland development [GO:0048733]; skin development [GO:0043588]; tongue development [GO:0043586]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT10A&keywords=WNT10A	0.24	597	NA	NA	0.11	613	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	605
CGB3	chorionic gonadotropin subunit beta 3	Yes		ENSG00000104827	P0DN86	Glycoprotein hormones subunit beta family	8	ligand	extracellular, intracellular, ligand, secreted	P22888, P78324	LHCGR, SIRPA	LHCGR [CellTalkDB:24554412;CellTalkDB:26441830;Guide2Pharma:12727981;Guide2Pharma:1922095;HPRD:2254302;SIGNOR:10446903;connectomeDB2020:10446903;connectomeDB2020:12727981;connectomeDB2020:1922095;connectomeDB2020:2254302], SIRPA [NA]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; pituitary gonadotropin complex [GO:0061696]	hormone activity [GO:0005179]	apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; female gamete generation [GO:0007292]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CGB3&keywords=CGB3	0.01	850	NA	NA	0.38	430	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	640
WNT8B	Wnt family member 8B	Yes		ENSG00000075290	Q93098	Wnt family	8	ecm, ligand	ecm, ligand, secreted	O75197, O75581, Q9NPG1	FZD1_LRP5, FZD1_LRP6, FZD10_LRP5, FZD10_LRP6, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4_LRP5, FZD4_LRP6, FZD5_LRP5, FZD5_LRP6, FZD6_LRP5, FZD6_LRP6, FZD7_LRP5, FZD7_LRP6, FZD8_LRP5, FZD8_LRP6, FZD9_LRP5, FZD9_LRP6, LRP5, LRP6	LRP6 [SIGNOR:15578921], FZD3 [SIGNOR:15578921], LRP5 [CellTalkDB:32196115]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]	canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; determination of dorsal identity [GO:0048263]; gastrulation [GO:0007369]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; response to estradiol [GO:0032355]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT8B&keywords=WNT8B	0.02	785	NA	NA	0.19	537	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	661
PIP	prolactin induced protein	TBD		ENSG00000159763	P12273	PIP family	8	ligand	extracellular, intracellular, ligand, secreted	P01730, P55064, Q9Y639	AQP5, CD4, NPTN	AQP5 [CellTalkDB:18696337], CD4 [Baccin2019:10820003;CellTalkDB:10820003;Cellinker:10820003;HPRD:10820003;InnateDB:10820003;LRdb:10820003;connectomeDB2020:10820003], NPTN [CellTalkDB:32196115]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]	actin binding [GO:0003779]; aspartic-type endopeptidase activity [GO:0004190]; identical protein binding [GO:0042802]; IgG binding [GO:0019864]	detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of gene expression [GO:0010628]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; retina homeostasis [GO:0001895]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PIP&keywords=PIP	0.49	525	NA	NA	0.00	884	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	705
IGFL1	IGF like family member 1	Yes		ENSG00000188293	Q6UW32	IGFL family	8	ligand	ligand, secreted	Q9H665	IGFLR1	IGFLR1 [CellTalkDB:21454693;IntAct:21454693;LRdb:21454693;Ramilowski2015:21454693;connectomeDB2020:21454693;talklr:21454693]	extracellular space [GO:0005615]	signaling receptor binding [GO:0005102]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IGFL1&keywords=IGFL1	0.06	718	NA	NA	0.04	722	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	720
NTN3	netrin 3	Yes		ENSG00000162068	O00634	NA	8	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	Q4KMG0, Q92859	CDON, NEO1	NEO1 [CellTalkDB:15520228;Cellinker:10366627;Cellinker:15520228;HPMR:15520228;HPRD:10366627;LRdb:1;LRdb:15520228;connectomeDB2020:10366627;connectomeDB2020:15520228], CDON [CellTalkDB:15520228;Cellinker:15520228;HPMR:15520228;LRdb:15520228;connectomeDB2020:15520228]	basement membrane [GO:0005604]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]	signaling receptor binding [GO:0005102]	animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; dendrite development [GO:0016358]; motor neuron axon guidance [GO:0008045]; tissue development [GO:0009888]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NTN3&keywords=NTN3	0.00	889	NA	NA	0.07	684	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	787
WNT10B	Wnt family member 10B	Yes		ENSG00000169884	O00744	Wnt family	8	ecm, ligand	ecm, ligand, secreted	O75084, O75197, O75581, Q13467, Q14332, Q9NPG1, Q9UP38	FZD1, FZD1_LRP5, FZD1_LRP6, FZD10_LRP5, FZD10_LRP6, FZD2, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4_LRP5, FZD4_LRP6, FZD5, FZD5_LRP5, FZD5_LRP6, FZD6_LRP5, FZD6_LRP6, FZD7, FZD7_LRP5, FZD7_LRP6, FZD8_LRP5, FZD8_LRP6, FZD9_LRP5, FZD9_LRP6, LRP5, LRP6	FZD5 [SIGNOR:12055200;SignaLink3:11092808;SignaLink3:23331499], LRP6 [Cellinker:23209147;SIGNOR:15578921], FZD1 [SIGNOR:12055200;SIGNOR:19008118], LRP5 [Cellinker:23209147;SIGNOR:15578921], FZD2 [SIGNOR:12055200], FZD3 [SIGNOR:15578921], FZD7 [connectomeDB2020:29979633]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]	bone trabecula formation [GO:0060346]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to cAMP [GO:0071320]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to retinoic acid [GO:0071300]; chondrocyte differentiation [GO:0002062]; fungiform papilla development [GO:0061196]; G2/M transition of mitotic cell cycle [GO:0000086]; hematopoietic stem cell proliferation [GO:0071425]; lipid metabolic process [GO:0006629]; myoblast differentiation involved in skeletal muscle regeneration [GO:0014835]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of timing of anagen [GO:0051885]; protein stabilization [GO:0050821]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of skeletal muscle tissue development [GO:0048641]; sensory perception of taste [GO:0050909]; skeletal muscle fiber development [GO:0048741]; smoothened signaling pathway [GO:0007224]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT10B&keywords=WNT10B	0.03	771	NA	NA	0.01	839	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	805
CGB8	chorionic gonadotropin subunit beta 8	Yes		ENSG00000213030	P0DN86	Glycoprotein hormones subunit beta family	8	ligand	extracellular, intracellular, ligand, secreted	P22888, P78324	LHCGR, SIRPA	LHCGR [CellTalkDB:24554412;CellTalkDB:26441830;Guide2Pharma:12727981;Guide2Pharma:1922095;HPRD:2254302;SIGNOR:10446903;connectomeDB2020:10446903;connectomeDB2020:12727981;connectomeDB2020:1922095;connectomeDB2020:2254302], SIRPA [NA]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; pituitary gonadotropin complex [GO:0061696]	hormone activity [GO:0005179]	apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; female gamete generation [GO:0007292]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CGB8&keywords=CGB8	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	#DIV/0!
DLK1	delta like non-canonical Notch ligand 1	Yes		ENSG00000185559	P80370	NA	7	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P02751, P46531, Q04721, Q99466, Q9UM47	FN1, NOTCH1, NOTCH2, NOTCH3, NOTCH4	FN1 [SIGNOR:20457810], NOTCH1 [Baccin2019:26791579;CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:22353464;Cellinker:21419176;Cellinker:22353464;LRdb:22353464;Ramilowski2015:21419176;SIGNOR:21419176;connectomeDB2020:21419176;talklr:21419176], NOTCH2 [CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:22353464;Cellinker:22353464;LRdb:22353464;connectomeDB2020:22353464], NOTCH3 [CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:22353464;Cellinker:22353464;LRdb:22353464;connectomeDB2020:22353464], NOTCH4 [CellChatDB:22353464;CellPhoneDB:22353464;Cellinker:22353464;LRdb:22353464;connectomeDB2020:22353464]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	calcium ion binding [GO:0005509]	cell differentiation [GO:0030154]; negative regulation of Notch signaling pathway [GO:0045746]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DLK1&keywords=DLK1	71.64	62	NA	NA	2.89	116	0.06	0.10	0.00	0.02	0.23	0.82	1.02	0.07	0.03	1.17	0.02	215	26	220	0.32	0.11	3.54	0.08	470	2	485	52
GRN	granulin precursor	Yes		ENSG00000030582	P28799	Granulin family	7	ligand	extracellular, intracellular, ligand, secreted	P00533, P04629, P19438, P20333, Q99523, Q9H2X3	CLEC4M, EGFR, NTRK1, SORT1, TNFRSF1A, TNFRSF1B	TNFRSF1A [CellTalkDB:24070898;IntAct:24070898;Lit-BM-17:24070898;SIGNOR:21393509;connectomeDB2020:21393509], EGFR [CellTalkDB:32103204], SORT1 [CellChatDB:29555433;CellTalkDB:23706646;Cellinker:29555433;IntAct:23236149;IntAct:24070898;connectomeDB2020:22361451;connectomeDB2020:24163244], TNFRSF1B [CellTalkDB:29740434;IntAct:24070898;Lit-BM-17:24070898;connectomeDB2020:21393509], CLEC4M [CellTalkDB:32103204], NTRK1 [NA]	azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	chaperone binding [GO:0051087]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; RNA binding [GO:0003723]	astrocyte activation involved in immune response [GO:0002265]; lysosomal lumen acidification [GO:0007042]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein folding [GO:1903334]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GRN&keywords=GRN	97.88	49	3214.94	110	0.74	313	3.46	0.65	0.58	0.50	0.47	1.07	1.20	0.99	0.85	0.85	1.07	26	34	24	1.06	0.80	0.80	1.00	222	211	99	143
GREM1	gremlin 1, DAN family BMP antagonist	Yes		ENSG00000276886, ENSG00000282046, ENSG00000166923	O60565	DAN family	7	ligand, receptor	extracellular, intracellular, ligand, ligand_regulator, plasma_membrane, receptor, secreted, transmembrane	P35968	KDR	KDR [Baccin2019:27174917;CellTalkDB:20660291;IntAct:20660291;connectomeDB2020:20660291;connectomeDB2020:25810250;connectomeDB2020:27174917;connectomeDB2020:27894090]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]	BMP binding [GO:0036122]; cytokine activity [GO:0005125]; morphogen activity [GO:0016015]; protein homodimerization activity [GO:0042803]; receptor ligand activity [GO:0048018]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; vascular endothelial growth factor receptor 2 binding [GO:0043184]	animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell morphogenesis [GO:0000902]; collagen fibril organization [GO:0030199]; determination of dorsal identity [GO:0048263]; embryonic limb morphogenesis [GO:0030326]; limb development [GO:0060173]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of bone mineralization [GO:0030502]; negative regulation of bone mineralization involved in bone maturation [GO:1900158]; negative regulation of bone remodeling [GO:0046851]; negative regulation of bone trabecula formation [GO:1900155]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of osteoclast proliferation [GO:0090291]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of angiogenesis [GO:0045766]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of receptor internalization [GO:0002092]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003257]; proximal/distal pattern formation [GO:0009954]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; sequestering of BMP from receptor via BMP binding [GO:0038098]; signal transduction [GO:0007165]; ureteric bud formation [GO:0060676]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GREM1&keywords=GREM1	11.06	231	NA	NA	1.24	233	0.05	0.09	0.03	1.50	0.16	0.48	0.42	0.36	0.26	0.40	0.21	64	53	68	0.36	0.74	1.12	0.58	247	109	289	157
CGN	cingulin	TBD	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000143375	Q9P2M7	Cingulin family	7	cell_surface_ligand, ligand, receptor	cell_surface, cell_surface_ligand, intracellular, ligand, receptor, secreted, tight_junction	P36897, P37173, Q16625, Q92974, Q9Y624	ARHGEF2, F11R, OCLN, TGFBR1, TGFBR2	F11R [Baccin2019:10877843;CellTalkDB:10877843;HPRD:10877843;LRdb:10877843;connectomeDB2020:10877843], TGFBR2 [CellTalkDB:32196115], OCLN [CellTalkDB:32196115], TGFBR1 [CellTalkDB:32196115], ARHGEF2 [HPRD:15866167]	bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]	actin binding [GO:0003779]; cadherin binding [GO:0045296]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CGN&keywords=CGN	23.18	162	10859.9	67	2.06	148	0.00	0.25	0.00	0.00	0.15	0.08	0.04	0.02	0.05	0.01	0.01	168	230	234	0.06	0.92	0.35	0.36	172	363	368	194
C1QTNF5	C1q and TNF related 5	TBD		ENSG00000223953	Q9BXJ0	NA	7	adhesion, ligand	adhesion, cell_adhesion, extracellular, intracellular, ligand, plasma_membrane, secreted, tight_junction	Q9BY79	MFRP	MFRP [Baccin2019:12944416;CellTalkDB:21810984;Cellinker:12944416;HPRD:12944416;LRdb:12944416]	apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell projection [GO:0042995]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]	identical protein binding [GO:0042802]	inner ear development [GO:0048839]; protein secretion [GO:0009306]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=C1QTNF5&keywords=C1QTNF5	7.20	266	NA	NA	11.81	42	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	154
TF	transferrin	TBD		ENSG00000091513	P02787	Transferrin family	7	adhesion, ligand, receptor	adhesion, cell_adhesion, extracellular, intracellular, ligand, plasma_membrane, receptor, secreted	P01130, P02786, P07550, P17936, P98164, Q16538, Q30201, Q9UP52	ADRB2, GPR162, HFE, IGFBP3, LDLR, LRP2, TFR2, TFRC	LDLR [CellTalkDB:32196115], TFR2 [Baccin2019:11027676;CellTalkDB:11027676;Cellinker:11027676;HPRD:11027676;LRdb:11027676;connectomeDB2020:11027676], HFE [CellTalkDB:15056661;InnateDB:19254567], LRP2 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], TFRC [Baccin2019:12210842;Baccin2019:16354665;Baccin2019:6268632;Baccin2019:6270680;CellTalkDB:16354665;Cellinker:12210842;Cellinker:16354665;Cellinker:6268632;Cellinker:6270680;DIP:14691533;DIP:16271884;DIP:20404192;DIP:21788477;DIP:9546397;HPMR:6270680;HPRD:12210842;HPRD:16354665;HPRD:6268632;IntAct:14691533;IntAct:16271884;IntAct:16354665;IntAct:20404192;IntAct:21788477;IntAct:29302006;LRdb:12210842;LRdb:16354665;LRdb:6268632;LRdb:6270680;Lit-BM-17:11027676;Lit-BM-17:14691533;Lit-BM-17:16271884;Lit-BM-17:16354665;Lit-BM-17:9546397;connectomeDB2020:12210842;connectomeDB2020:16354665;connectomeDB2020:6268632;connectomeDB2020:6270680], GPR162 [NA], IGFBP3 [HPRD:11297622;HPRD:11749962]	apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; basal plasma membrane [GO:0009925]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; HFE-transferrin receptor complex [GO:1990712]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]	ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; iron chaperone activity [GO:0034986]; transferrin receptor binding [GO:1990459]	actin filament organization [GO:0007015]; antibacterial humoral response [GO:0019731]; cellular iron ion homeostasis [GO:0006879]; cellular response to iron ion [GO:0071281]; ERK1 and ERK2 cascade [GO:0070371]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; osteoclast differentiation [GO:0030316]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell motility [GO:2000147]; positive regulation of phosphorylation [GO:0042327]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of iron ion transport [GO:0034756]; regulation of protein stability [GO:0031647]; retina homeostasis [GO:0001895]; SMAD protein signal transduction [GO:0060395]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TF&keywords=TF	1.96	388	12972	61	0.02	797	0.01	0.00	0.00	0.00	0.00	0.00	0.01	0.00	0.01	0.01	0.01	281	255	289	0.00	1.10	1.21	1.02	110	91	92	318
DEFB103A	defensin beta 103A	TBD		ENSG00000285376, ENSG00000284978, ENSG00000176797	P81534	Beta-defensin family	7	ligand	extracellular, intracellular, ligand, secreted	P41597, P51684	CCR2, CCR6	CCR6 [CellTalkDB:23390582;HPRD:11714836;LRdb:23390582;Ramilowski2015:23390582;connectomeDB2020:11714836;connectomeDB2020:23390582;talklr:23390582], CCR2 [CellTalkDB:23390582;InnateDB:20483750;LRdb:23390582;Ramilowski2015:23390582;connectomeDB2020:23390582;talklr:23390582]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]	CCR6 chemokine receptor binding [GO:0031731]; chemoattractant activity [GO:0042056]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell chemotaxis [GO:0060326]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; killing by host of symbiont cells [GO:0051873]; killing of cells of other organism [GO:0031640]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DEFB103A&keywords=DEFB103A	0.08	688	NA	NA	9.16	49	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	369
ORM1	orosomucoid 1	TBD	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000229314	P02763	Calycin superfamily, Lipocalin family	7	ligand	extracellular, intracellular, ligand, secreted	P51681	CCR5	CCR5 [CellTalkDB:11336643;Cellinker:11336643;HPRD:11336643;LRdb:11336643;connectomeDB2020:11336643]	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	NA	acute-phase response [GO:0006953]; inflammatory response [GO:0006954]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of immune system process [GO:0002682]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ORM1&keywords=ORM1	0.02	797	NA	NA	0.00	904	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	851
DEFB103B	defensin beta 103B	TBD		ENSG00000273641, ENSG00000177243	P81534	Beta-defensin family	7	ligand	extracellular, intracellular, ligand, secreted	P41597, P51684	CCR2, CCR6	CCR6 [CellTalkDB:23390582;HPRD:11714836;LRdb:23390582;Ramilowski2015:23390582;connectomeDB2020:11714836;connectomeDB2020:23390582;talklr:23390582], CCR2 [CellTalkDB:23390582;InnateDB:20483750;LRdb:23390582;Ramilowski2015:23390582;connectomeDB2020:23390582;talklr:23390582]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]	CCR6 chemokine receptor binding [GO:0031731]; chemoattractant activity [GO:0042056]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell chemotaxis [GO:0060326]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; killing by host of symbiont cells [GO:0051873]; killing of cells of other organism [GO:0031640]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DEFB103B&keywords=DEFB103B	0.00	872	NA	NA	1.27	229	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	551
DEFB1	defensin beta 1	TBD		ENSG00000284881, ENSG00000164825	P60022	Beta-defensin family	6	ligand	extracellular, intracellular, ligand, secreted	P51684	CCR6	CCR6 [CellTalkDB:20068036;HPRD:12149255;LRdb:20068036;LRdb:25122636;LRdb:25585877;connectomeDB2020:12149255]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; Golgi lumen [GO:0005796]; microvesicle [GO:1990742]; sperm midpiece [GO:0097225]	CCR6 chemokine receptor binding [GO:0031731]; identical protein binding [GO:0042802]	antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cAMP-mediated signaling [GO:0019933]; chemotaxis [GO:0006935]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; positive regulation of flagellated sperm motility involved in capacitation [GO:0060474]; response to bacterium [GO:0009617]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DEFB1&keywords=DEFB1	142.70	41	NA	NA	1.48	202	0.01	0.98	0.00	0.00	0.64	0.00	0.00	0.00	0.00	0.00	0.00	297	386	344	0.15	0.08	0.07	0.07	489	488	489	279
NLGN1	neuroligin 1	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000169760	Q8N2Q7	Type-B carboxylesterase/lipase family	6	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	P58400, P58401, P78352, Q9HDB5, Q9P2S2, Q9ULB1, Q9Y4C0	DLG4, NRXN1, NRXN2, NRXN3	DLG4 [BioGRID:30864948;CA1:9278515;DOMINO:11937501;HPRD:9278515;Lit-BM-17:11937501;Lit-BM-17:9278515;SIGNOR:18923512], NRXN2 [CellTalkDB:7736595;LRdb:7736595;Ramilowski2015:7736595;SIGNOR:18923512;connectomeDB2020:7736595;talklr:7736595], NRXN1 [Baccin2019:14522992;Baccin2019:8576240;BioGRID:12796785;BioGRID:14522992;BioGRID:8576240;CellTalkDB:8576240;Cellinker:14522992;Cellinker:8576240;HPRD:14522992;HPRD:8576240;LRdb:145;LRdb:8576240;SIGNOR:18923512;connectomeDB2020:14522992;connectomeDB2020:8576240], NRXN3 [Baccin2019:8576240;CellTalkDB:8576240;Cellinker:8576240;LRdb:8576240;SIGNOR:18923512;connectomeDB2020:8576240], NRXN1 [Baccin2019:14522992;Baccin2019:8576240;BioGRID:12796785;BioGRID:14522992;BioGRID:8576240;CellTalkDB:8576240;Cellinker:14522992;Cellinker:8576240;HPRD:14522992;HPRD:8576240;LRdb:145;LRdb:8576240;SIGNOR:18923512;connectomeDB2020:14522992;connectomeDB2020:8576240], NRXN2 [CellTalkDB:7736595;LRdb:7736595;Ramilowski2015:7736595;SIGNOR:18923512;connectomeDB2020:7736595;talklr:7736595], NRXN3 [Baccin2019:8576240;CellTalkDB:8576240;Cellinker:8576240;LRdb:8576240;SIGNOR:18923512;connectomeDB2020:8576240]	asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; filopodium tip [GO:0032433]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; receptor complex [GO:0043235]; spanning component of membrane [GO:0089717]; synapse [GO:0045202]; synaptic cleft [GO:0043083]	amyloid-beta binding [GO:0001540]; cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; neurexin family protein binding [GO:0042043]; PDZ domain binding [GO:0030165]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]	AMPA glutamate receptor clustering [GO:0097113]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; cytoskeletal matrix organization at active zone [GO:0048789]; establishment of protein localization [GO:0045184]; excitatory synapse assembly [GO:1904861]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine morphogenesis [GO:0061002]; nervous system development [GO:0007399]; neurexin clustering involved in presynaptic membrane assembly [GO:0097115]; neuronal signal transduction [GO:0023041]; neuron cell-cell adhesion [GO:0007158]; neuron projection arborization [GO:0140058]; neuron projection development [GO:0031175]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of circadian sleep/wake cycle, wakefulness [GO:0010841]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; postsynaptic specialization assembly [GO:0098698]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; protein localization to synapse [GO:0035418]; protein targeting [GO:0006605]; receptor localization to synapse [GO:0097120]; regulation of AMPA receptor activity [GO:2000311]; regulation of neuron differentiation [GO:0045664]; regulation of NMDA receptor activity [GO:2000310]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; rhythmic process [GO:0048511]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NLGN1&keywords=NLGN1	5.79	282	NA	NA	4.18	87	0.00	0.02	0.00	0.01	0.01	0.16	0.16	0.11	0.07	0.10	0.09	147	109	121	0.07	1.09	1.39	1.30	112	65	49	136
ENHO	energy homeostasis associated	Yes		ENSG00000168913	Q6UWT2	NA	6	ligand	ligand, secreted, transmembrane, transmembrane_predicted	Q15760	GPR19	GPR19 [CellChatDB:28476646;Cellinker:28476646;connectomeDB2020:28476646;scConnect:28476646]	extracellular region [GO:0005576]; plasma membrane [GO:0005886]	hormone activity [GO:0005179]	positive regulation of Notch signaling pathway [GO:0045747]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ENHO&keywords=ENHO	0.61	504	NA	NA	0.01	829	0.00	0.00	0.00	0.00	0.01	0.02	0.03	0.00	0.00	0.02	0.00	300	197	391	0.01	0.65	1.79	0.61	278	26	282	389
CXCL14	C-X-C motif chemokine ligand 14	Yes		ENSG00000145824	O95715	Intercrine alpha (chemokine CxC) family	6	ligand	intracellular, ligand, secreted	P61073	CXCR4	CXCR4 [CellTalkDB:32239134;connectomeDB2020:28360196]	extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]	chemokine activity [GO:0008009]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; chemotaxis [GO:0006935]; killing of cells of other organism [GO:0031640]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCL14&keywords=CXCL14	0.17	627	NA	NA	0.00	892	0.02	0.02	0.01	0.03	0.06	0.09	0.02	0.03	0.03	0.03	0.02	219	179	197	0.03	0.82	0.86	0.80	216	188	189	472
PDCD1LG2	programmed cell death 1 ligand 2	TBD		ENSG00000197646	Q9BQ51	Immunoglobulin superfamily, BTN/MOG family	6	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	Q15116, Q16342, Q6NW40	PDCD1, PDCD2, RGMB	PDCD1 [CellChatDB:23954143;CellPhoneDB:23954143;CellTalkDB:23954143;Cellinker:23223433;Cellinker:23954143;Cellinker:31727844;ICELLNET:23954143;InnateDB:12893276;IntAct:20587542;IntAct:23417675;connectomeDB2020:12810690], PDCD2 [CellTalkDB:15207811;LRdb:15207811;LRdb:25], RGMB [connectomeDB2020:24752301]	endomembrane system [GO:0012505]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	NA	adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; cellular response to lipopolysaccharide [GO:0071222]; immune response [GO:0006955]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of T cell proliferation [GO:0042102]; T cell costimulation [GO:0031295]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PDCD1LG2&keywords=PDCD1LG2	0.25	592	NA	NA	0.11	610	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	601
PF4V1	platelet factor 4 variant 1	Yes		ENSG00000109272	P10720	Intercrine alpha (chemokine CxC) family	6	ligand	extracellular, intracellular, ligand, secreted	P49682	CXCR3	CXCR3 [ICELLNET:22633458;connectomeDB2020:28859966]	extracellular space [GO:0005615]	chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; heparin binding [GO:0008201]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; inflammatory response [GO:0006954]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PF4V1&keywords=PF4V1	0.13	651	NA	NA	0.52	379	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	515
PRND	prion like protein doppel			ENSG00000171864	Q9UKY0	Prion family	6	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, intracellular, ligand, plasma_membrane, secreted, transmembrane, transmembrane_predicted	P08865	RPSA	RPSA [Baccin2019:1524687315246870;Cellinker:15246873;HPRD:15246873;LRdb:15246873;connectomeDB2020:15246873]	anchored component of external side of plasma membrane [GO:0031362]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	copper ion binding [GO:0005507]	acrosome reaction [GO:0007340]; cellular copper ion homeostasis [GO:0006878]; protein homooligomerization [GO:0051260]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRND&keywords=PRND	0.04	755	NA	NA	0.02	806	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	781
OBP2A	odorant binding protein 2A	TBD		ENSG00000122136	Q9NY56	Calycin superfamily, Lipocalin family	6	ligand	extracellular, ligand, secreted	P47890	OR1G1	OR1G1 [CellTalkDB:12379593;Cellinker:12379593;HPRD:12379593;LRdb:12379593]	extracellular space [GO:0005615]	odorant binding [GO:0005549]; small molecule binding [GO:0036094]	response to stimulus [GO:0050896]; sensory perception of chemical stimulus [GO:0007606]; sensory perception of smell [GO:0007608]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=OBP2A&keywords=OBP2A	0.01	838	NA	NA	0.08	661	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	750
RETN	resistin	Yes		ENSG00000104918	Q9HD89	Resistin/FIZZ family	6	ligand	extracellular, intracellular, ligand, secreted	O00155, O00206, Q01518	CAP1, GPR25, TLR4	GPR25 [CellTalkDB:32103204], TLR4 [CellChatDB:30809105;Cellinker:30809105], CAP1 [CellChatDB:30809105;Cellinker:30809105]	azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]	hormone activity [GO:0005179]	aging [GO:0007568]; fat cell differentiation [GO:0045444]; negative regulation of feeding behavior [GO:2000252]; positive regulation of progesterone secretion [GO:2000872]; positive regulation of synaptic transmission [GO:0050806]; response to insulin [GO:0032868]; response to mechanical stimulus [GO:0009612]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RETN&keywords=RETN	0.03	779	NA	NA	0.01	835	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	807
SLURP1	secreted LY6/PLAUR domain containing 1	TBD		ENSG00000126233	P55000	NA	6	ligand	ligand, secreted, secreted_receptor, transmembrane	P02708, P07510, P11230, P17787, P30532, P30926, P32297, P36544, P43681, Q04844, Q05901, Q07001, Q15822, Q15825, Q9GZZ6, Q9UGM1	CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG	CHRNA7 [CellChatDB:29545933;CellTalkDB:29545933;Cellinker:25558396;connectomeDB2020:29545933], CHRNB1 [NA], CHRNB2 [Cellinker:29192197], CHRNB3 [NA], CHRNB4 [Cellinker:29192197], CHRNA1 [NA], CHRNA2 [NA], CHRNA3 [Cellinker:29192197], CHRNA4 [Cellinker:29192197], CHRNA5 [NA], CHRNA6 [NA], CHRNA9 [Cellinker:29192197], CHRNA10 [Cellinker:29192197], CHRND [NA], CHRNE [NA], CHRNG [NA]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	acetylcholine receptor activator activity [GO:0030549]; cytokine activity [GO:0005125]	cell activation [GO:0001775]; cell adhesion [GO:0007155]; locomotory behavior [GO:0007626]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; neuromuscular process controlling posture [GO:0050884]; urokinase plasminogen activator signaling pathway [GO:0038195]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SLURP1&keywords=SLURP1	0.00	899	NA	NA	0.00	903	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	901